pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites,P_joint,Q_joint
Metabolism,Reactome,435,GLDC;PI4K2B;EPHX2;GLYAT;AADAC;PPARA;ADAL;MAOB;ACADM;ACADSB;ACADVL;ACAT1;GGT6;ACOX1;CHDH;BCKDK;ETFDH;TPTE;PIPOX;CYGB;L2HGDH;DDAH2;PTGR2;ACOT4;B3GNT3;ADA;CYP39A1;ME1;ME2;PANK1;ADCY2;ADCY9;ACOX2;ACOX3;FABP4;FABP2;FABP3;FABP7;ADH4;ADK;AFMID;FAH;BPNT1;ACSM3;ACAD11;CHST15;SC5D;RAPGEF3;OSBPL1A;AGXT;OSBPL5;LYPLA1;AHR;SCP2;ACADL;PYGL;AK1;CHST12;PLA2G6;ALAS1;ALB;ECI2;SMPD3;PRKAG2;ALDH9A1;ALDH3A2;ALDOA;ALDOB;DHTKD1;BBOX1;ALDH6A1;SDC1;ALOX12;ALOX5;OPLAH;MPST;PLCD3;AMPD1;AMPD3;ADCY4;CPS1;FMO2;FMO3;MAT1A;HACD3;FOLR2;CPT1A;FLVCR1;IYD;SHMT1;CHSY1;GPAM;DDO;APOA4;SRR;ST3GAL2;CHST1;ACOT1;ACSF2;NUBPL;PAICS;SLC2A2;KMO;ARSG;FMOD;NUP35;BCO1;ARG1;TPK1;SLC6A12;ITPKC;SEPHS2;KYNU;RPIA;AS3MT;NDC1;SLC10A2;SLC10A1;PLCD1;PLPP1;GSTK1;SLC16A1;MTHFD1;CERS4;SLC22A1;SLC22A5;GNB5;ASPA;AOC3;GOT2;ABCB11;PNPLA3;PLPP2;FUT2;SLC37A4;ALDH7A1;SORD;B4GALT2;ACER2;PECR;UPB1;MBOAT1;CHST14;ACSS1;UGT3A1;BAAT;SRD5A1;AKR1D1;CHAC2;LPCAT4;GBE1;BCAT1;LHPP;BCHE;GCDH;BCKDHB;UROC1;MCCC2;ALDH1L1;SUCLG2;SUCLG1;HPSE;SLC26A1;BDH1;PGAM2;INPP4B;GGT1;ME3;IQGAP1;BHMT;GGT7;SLC35D1;LYVE1;ADHFE1;SULT1B1;GK;GPC3;SUOX;SYNJ2;DGAT2;GCLM;BST1;VNN1;SDC3;GLUD1;GLUL;ACSF3;GNAI1;ACOT2;ELOVL7;DDHD2;PPIP5K2;GPT2;NNMT;GNG11;GNGT2;GPAT4;NOS3;SDS;TAT;GOT1;SLC27A5;SLC27A2;GPD1;CACNA1C;CACNA1D;FUT10;PLEKHA8;SLC25A20;ACSL1;HYKK;GPT;RAPGEF4;GPAT3;OAT;B3GNT7;ACAD10;TDO2;CAV1;OMD;PLA2G4E;SERPINA6;PAPSS2;HIBADH;OGN;CBR3;CBS;CERS5;CYB5B;GSTZ1;MFSD2A;OTC;OXCT1;QPRT;MID1IP1;GYS2;PAH;TM7SF2;MGST1;KYAT3;CDA;HSD17B10;HADHA;HADHB;HADH;HAL;ACMSD;PLA1A;PCCA;PCCB;NNT;PCK1;CHP1;CMBL;TPMT;HGD;SDSL;CDO1;PHYKPL;DDAH1;PDK4;ENPP1;GNG2;GLYCTK;ELOVL5;HLCS;MGLL;HMGCS2;PFKFB1;PFKFB2;CYP2S1;PFKFB4;HAO1;HNMT;TTPA;FMO1;B4GALT6;AHCY;PRKD3;CKM;CKMT2;PHKG1;PHYH;SGMS1;PIK3C2G;HPD;SHPK;UCP3;PIP4K2A;UGDH;BHMT2;UGP2;PKLR;PKM;FADS2;PLCB4;PLA2G4F;UGT3A2;PLCG2;UQCRC2;CHST2;ABCC2;HSD17B4;HILPDA;CHAC1;VDR;ABCG2;CERS2;DMGDH;PRKD2;HSPG2;CERK;TNFAIP8;NUDT7;CYP26B1;HYAL1;UGT1A5;ACBD5;PTGES;PON1;PON3;THTPA;PM20D1;PODXL2;CHST11;PPA1;IDH1;CPOX;ASB15;IDI1;CPT2;CRAT;ACOT12;UGT1A1;AGXT2;IDO2;CROT;TKFC;SDC2;CYP2R1;PDP1;VCAN;PRKAA2;AGMO;PRKAR1B;PRKAR2A;PPIP5K1;DECR2;PNPLA8;CTH;GC;SELENOI;FITM2;CHST3;GDPD1;CYP1A1;CYP1B1;CYP2E1;CYP4B1;CYP7A1;CYP8B1;CYP17A1;INPP5D;CYP26A1;ACSM1;ABHD3;RPL3L;SERINC2;DBT;RETSAT;DDC;PTGS2;ELOVL2;AMT;LCLAT1;ITPKA;NSDHL;IVD;DECR1;HSD17B7;GDPD5;PTGIS;NUDT12;POM121;CHPT1;HIBCH;DHCR24;DHFR;AKR1B10;ARNT2;NQO1;PXMP2;DIO1;LPGAT1;ALDH18A1;PYGB;ACSM5;DLST;ACP6;SARDH;HS3ST3A1;HS3ST1;SLC23A1;ADIPOR2;NR1H4;ITPR3;ACSS3;DPEP1;DPYD;DPYS;SLC25A21;ENTPD5;AADAT;SLC44A2;LBR;SLC25A16;LDHA;LDHB;PNPO;UPP2;SEPSECS;NADSYN1;FADS1;EHHADH;AASS;SLC25A13;SLC25A15;UGT2A3;ETNK2;HSD17B12;ADI1;DSEL;HSD17B11;ENO3;APOB,1952 (1954),7.47e-32,3.5e-28,9,HMDB0000036;HMDB0010404;HMDB0006752;HMDB0001860;HMDB0010711;HMDB0000128;HMDB0000273;HMDB0013461;HMDB0002183,863 (1411),0.231,1,1.28e-30,3.98e-27
Extracellular matrix organization,Reactome,109,PHYKPL;HTRA1;ADAM19;PDGFB;SPP1;ASPN;ADAM15;PECAM1;HSPG2;ITGA6;DDR1;COL6A5;LAMC3;ITGA3;ITGA5;ITGAL;ITGAM;ADAM8;ADAM10;ITGB2;ITGB4;ITGB6;ITGB7;ITGB8;JAM2;CAPN8;BMP2;MFAP4;FBLN1;FBLN2;FBN1;PXDN;COL16A1;BMP10;ADAMTS9;COMP;CMA1;FGA;FGB;FGF2;NID1;KDR;CAPN5;MMP2;FGG;MMP7;MMP9;MMP12;MMP13;MMP17;LTBP4;KLKB1;SDC1;SDC2;JAM3;COL1A1;COL1A2;COL3A1;COL4A1;COL28A1;COL4A2;COL4A4;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;COL8A1;FBLN5;VTN;COL13A1;COL15A1;FMOD;COL17A1;FN1;ADAMTS2;ADAMTS1;P3H3;PLG;TNC;TMPRSS6;ICAM2;DDR2;LAMA2;LAMA4;LAMA5;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;ADAMTS8;ADAMTS5;SERPINH1;TGFB2;TGFB3;NTN4;THBS1;ITGA8;TIMP2;LOX;LOXL1;VCAN;SDC3;LTBP1;LTBP2;LTBP3;TNXB;PCOLCE,287 (287),4.05e-26,9.47e-23,0,,21 (30),1,1,2.41e-24,3.75e-21
Fatty acid metabolism,Reactome,64,SCP2;DECR1;ACSL1;EPHX2;CYP1A1;DPEP1;CYP1B1;PHYH;PECR;SLC25A20;CROT;NUDT7;FADS1;ACSM3;ALOX12;MID1IP1;ACAD11;ACADM;ACADVL;HACD3;EHHADH;CYP4B1;CYP8B1;ACOX1;PRKAG2;CPT2;SLC22A5;PRKAA2;ACBD5;PTGR2;PTGES;ELOVL5;PON1;ACOX3;PON3;FADS2;HSD17B12;ACSF3;DECR2;ACAD10;ACOT2;HADHA;ECI2;HADHB;HADH;ACOT4;ACOT1;ACSF2;CPT1A;HSD17B4;ALDH3A2;ACADL;PCCA;PCCB;PTGIS;PTGS2;ALOX5;CRAT;ELOVL2;ACOX2;GGT1;ELOVL7;SLC27A2;ACOT12,176 (177),8.88e-15,1.39e-11,2,HMDB0010404;HMDB0002183,182 (257),0.436,1,1.32e-13,1.38e-10
Beta1 integrin cell surface interactions,PID,34,COL3A1;COL4A1;COL4A4;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;THBS1;FBN1;FGB;FN1;SPP1;TNC;VTN;FGA;ITGA8;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;LAMA5;FGG;ITGA3;ITGA5;NID1;F13A1;JAM2;LAMA2;COL1A1;COL1A2,66 (66),1.42e-13,1.66e-10,0,,0 (0),1,1,1.42e-13,1.66e-10
Metabolism of lipids,Reactome,153,GDPD1;PI4K2B;ACP6;CYP1A1;CYP1B1;TPTE;PECR;MBOAT1;ACER2;ACADL;ACADM;CYP2E1;ACADVL;ACAT1;CYP4B1;CYP7A1;CYP8B1;CYP17A1;INPP5D;CPT1A;BAAT;SRD5A1;AKR1D1;ELOVL5;ABHD3;LPCAT4;PTGR2;GC;MGLL;SLC22A5;ACOT2;HMGCS2;ACOT4;CYP39A1;PTGIS;BDH1;PTGS2;LPGAT1;ELOVL2;ACOX2;GGT1;FABP4;FABP2;FABP3;FABP7;NSDHL;DECR1;PRKD3;ACSL1;GDPD5;PHYH;GK;ACSM3;MID1IP1;ACAD11;CHPT1;PLA1A;SYNJ2;PIK3C2G;DGAT2;DHCR24;PIP4K2A;OSBPL1A;OSBPL5;ACOX3;SCP2;FADS2;ACSF3;OXCT1;LCLAT1;PLA2G6;INPP4B;ALB;ECI2;SMPD3;DDHD2;EPHX2;PRKAG2;HSD17B4;ALDH3A2;HILPDA;PLPP1;GPAT4;ALOX12;ALOX5;NR1H4;PLEKHA8;SLC27A5;SLC27A2;ACSS3;VDR;PLA2G4F;GPD1;CERS2;DPEP1;PRKD2;CERK;TNFAIP8;SLC25A20;HSD17B7;NUDT7;HACD3;ACOX1;ACBD5;PTGES;SLC44A2;GPAT3;PON1;PON3;GPAM;ACAD10;PPARA;LBR;ACOT1;ACSF2;IDI1;CPT2;PLA2G4E;SERPINA6;CRAT;ARSG;ACOT12;CERS5;MFSD2A;CROT;FADS1;SLC10A1;SLC10A2;CYP2R1;PLPP2;EHHADH;CERS4;SGMS1;ETNK2;PRKAA2;AGMO;TM7SF2;ABCB11;HSD17B12;DECR2;PNPLA8;HADH;PNPLA3;BCHE;HADHA;HADHB;SELENOI;SC5D;HSD17B11;FITM2;PCCA;PCCB;ELOVL7,645 (646),2.44e-13,2.29e-10,6,HMDB0000036;HMDB0010404;HMDB0006752;HMDB0010711;HMDB0013461;HMDB0002183,352 (626),0.0532,1,4.29e-13,3.34e-10
Peroxisome - Homo sapiens (human),KEGG,36,ACSL1;EPHX2;NUDT12;PHYH;PECR;CROT;NUDT7;MPV17L;GSTK1;PEX5;EHHADH;ACOX1;PEX3;BAAT;AGXT;PEX19;ABCD3;PXMP2;PIPOX;PEX1;SCP2;PEX7;PEX13;DECR2;DDO;ECI2;IDH1;HAO1;HSD17B4;PEX11A;ABCD2;CAT;CRAT;ACOX2;ACOX3;SLC27A2,82 (82),1.2e-11,5.11e-09,0,,0 (0),1,1,1.2e-11,5.11e-09
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,49,FSTL1;QSOX1;MFGE8;FBN1;IGFALS;SERPINA10;PRSS23;FN1;IGFBP6;IGFBP7;APOA5;SPP1;IGFBP1;TNC;VCAN;MXRA8;GAS6;RCN1;FGA;AHSG;HRC;LAMB1;LAMB2;LAMC1;CHRDL1;CP;PAPPA;C3;APOB;SPARCL1;SERPINC1;VWA1;MMP2;CKAP4;PLG;APP;MIA3;PENK;ADAM10;F5;SERPIND1;FGG;SDC2;ITIH2;KNG1;LGALS1;LTBP1;GPC3;ALB,124 (124),3.29e-13,2.56e-10,0,,3 (3),1,1,9.78e-12,6.09e-09
Amino Acid metabolism,Wikipathways,40,BHMT;MPST;FAH;OTC;IDH1;ACADM;HIBCH;SDS;GCLM;PDK4;ACSS1;GLUD1;AOC3;GLUL;PKM;ALDH18A1;BCAT1;ALDH7A1;SUCLG1;OAT;DLST;CTH;HMGCS2;TDO2;HADH;HAL;CPS1;GPT2;LDHA;HIBADH;CBS;DDC;HNMT;TAT;PCK1;GOT1;GOT2;ADH4;EHHADH;ARG1,91 (91),8.29e-13,5.54e-10,1,HMDB0000128,92 (108),0.531,1,1.3e-11,6.73e-09
Complement and coagulation cascades - Homo sapiens (human),KEGG,36,CFH;CFHR1;F8;THBD;VTN;FGB;VWF;C7;F11;PLG;FGA;CD55;ITGB2;SERPINC1;C3AR1;CPB2;CD46;C3;C5AR1;C6;FGG;C8A;C8B;C9;CFI;ITGAM;CR2;KLKB1;SERPIND1;F9;BDKRB2;F13A1;KNG1;F13B;F5;MASP2,85 (85),4.27e-11,9.91e-09,0,,0 (1),1,1,4.27e-11,9.91e-09
Post-translational protein phosphorylation,Reactome,44,FSTL1;QSOX1;MFGE8;FBN1;SERPINA10;PRSS23;FN1;IGFBP7;APOA5;SPP1;IGFBP1;TNC;VCAN;MXRA8;GAS6;RCN1;FGA;AHSG;HRC;LAMB1;LAMB2;LAMC1;CHRDL1;CP;C3;APOB;SPARCL1;SERPINC1;VWA1;CKAP4;APP;MIA3;PENK;ADAM10;F5;SERPIND1;FGG;SDC2;ITIH2;KNG1;LGALS1;LTBP1;GPC3;ALB,107 (107),1.03e-12,6.04e-10,0,,2 (2),1,1,2.95e-11,1.31e-08
Focal Adhesion,Wikipathways,65,BLK;VEGFC;LAMA2;TNC;COL4A2;COL4A4;HGF;FLNA;COL4A1;FLNC;ERBB2;THBS1;COL6A2;IGF1R;MYL2;VWF;ITGB7;SHC2;VASP;PDGFB;PDGFRA;MYLK3;PDGFRB;SPP1;PAK6;MYLPF;FN1;TESK2;PDGFD;COMP;LAMC3;VTN;PAK1;ACTG1;ITGA8;MYLK2;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;CHAD;LAMC2;KDR;LAMA5;BCL2;COL5A2;CAV1;CAV2;ITGA3;FGR;ARHGAP35;ITGA5;ITGB4;TNXB;ITGB6;ZYX;ITGB8;VAV1;PAK3;BCAR1;PARVB;COL1A1;COL1A2,198 (198),1.32e-12,6.88e-10,0,,1 (2),1,1,3.75e-11,1.46e-08
Beta3 integrin cell surface interactions,PID,24,COL4A1;COL4A4;TGFBR2;THBS1;VTN;FBN1;THY1;FN1;PDGFB;PDGFRB;SPP1;TNC;PECAM1;PVR;FGA;FGB;LAMA4;LAMB1;LAMC1;KDR;FGG;SDC1;COL1A1;COL1A2,44 (44),1.16e-10,2.26e-08,0,,0 (0),1,1,1.16e-10,2.26e-08
Striated Muscle Contraction Pathway,Wikipathways,22,TPM1;TPM2;VIM;DES;MYH8;MYL1;MYL2;MYL3;MYL4;TMOD1;ACTA1;ACTA2;ACTG1;ACTN2;ACTN3;NEB;TNNI2;TNNT3;TTN;TCAP;MYBPC1;MYBPC2,38 (38),1.44e-10,2.59e-08,0,,0 (0),1,1,1.44e-10,2.59e-08
Focal adhesion - Homo sapiens (human),KEGG,65,VEGFC;COL4A1;TNC;COL4A2;COL4A4;HGF;COL6A1;FLNA;COL6A3;FLNC;ERBB2;THBS1;FLT4;SHC2;VTN;MYL2;VWF;ZYX;MYLK3;VASP;PDGFB;PDGFRA;PDGFRB;SPP1;BCAR1;MYLPF;PDGFD;LAMB2;FN1;KDR;IGF1R;ACTG1;ITGA8;LAMA4;ITGA6;LAMB1;COL6A2;LAMB3;LAMC1;COL6A5;CHAD;LAMC2;LAMC3;COMP;LAMA5;PAK3;PARVB;CAV1;CAV2;ITGA3;PAK6;ARHGAP35;ITGA5;PAK1;ITGB4;TNXB;ITGB6;ITGB7;ITGB8;VAV1;MYLK2;LAMA2;BCL2;COL1A1;COL1A2,201 (201),2.85e-12,1.33e-09,0,,1 (2),1,1,7.86e-11,2.72e-08
Non-integrin membrane-ECM interactions,Reactome,23,HSPG2;DDR1;NTN4;THBS1;VTN;PDGFB;TNC;SDC3;DDR2;LAMA2;LAMA4;FGF2;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;LAMC3;LAMA5;ITGB4;SDC1;SDC2;ITGA6,42 (42),2.55e-10,4.42e-08,0,,0 (3),1,1,2.55e-10,4.42e-08
Nuclear Receptors Meta-Pathway,Wikipathways,84,TGFB2;AHR;IL11;CYP1A1;TGFBR2;SRXN1;HGF;NRIP1;UGT1A1;THBD;ABCC4;VDR;PDK4;PDE4B;MFGE8;NR1I3;SLC10A1;SLC39A5;IGFBP1;SLC2A9;MGST1;ACADM;PDGFB;SLC6A13;LRRC8A;EGR1;ABCG8;ACKR3;PPP1R14C;SLC2A10;CYP7A1;CYP8B1;HBEGF;ABHD2;ACOX1;GPR153;TGFBR3;ETNK2;CAVIN2;BAAT;ENC1;GPX3;NQO1;SLC6A9;CCL2;CYP1B1;SLC27A5;SCP2;ABCB11;CES4A;SPRY1;ANKRD1;B3GNT5;GPAM;MYOF;APOA5;ALAS1;MAFF;PPARA;PPARD;ABCC2;CPT1A;CPT2;IL1B;EPB41L4B;GCLM;ME1;CDC42EP3;HSPA1A;PLK2;EHHADH;PTGS2;ABCG5;PCK1;SLC2A2;NR1H4;PRDX6;SLC2A4;GGT1;CBR3;EPHA3;SLC5A1;ABCB4;SEC14L1,317 (317),2.67e-10,4.46e-08,0,,0 (0),1,1,2.67e-10,4.46e-08
Striated Muscle Contraction,Reactome,22,TPM1;TPM2;VIM;DES;MYH7;MYH8;MYL1;MYL2;MYL3;MYL4;TMOD1;TMOD4;TMOD2;ACTN2;ACTN3;NEB;TNNI2;TNNT3;TTN;TCAP;MYBPC1;MYBPC2,35 (35),1.43e-11,5.23e-09,0,,4 (5),1,1,3.72e-10,1.07e-07
Platelet degranulation ,Reactome,48,VEGFC;A1BG;TGFB2;MMRN1;QSOX1;HGF;ISLR;FLNA;ORM2;SELENOP;THBS1;TGFB3;VWF;FN1;PDGFB;TIMP3;RAB27B;ITIH3;PECAM1;GAS6;FGA;FGB;AHSG;CD63;LHFPL2;ENDOD1;TMSB4X;TOR4A;CLEC3B;ALB;TAGLN2;ACTN2;FGG;PLG;APOH;APP;ALDOA;HRG;ABCC4;F5;PCDH7;F8;CTSW;F13A1;KNG1;ITIH4;TTN;FERMT3,131 (131),1.45e-11,5.23e-09,0,,9 (9),1,1,3.77e-10,1.07e-07
Metabolism of amino acids and derivatives,Reactome,91,HGD;SERINC2;CDO1;PHYKPL;ACADSB;ACAT1;MAT1A;CHDH;BCKDK;SDSL;PIPOX;BCAT1;GCDH;BCKDHB;UROC1;MCCC2;HAO1;DBT;HNMT;DDC;AHCY;IVD;GLUL;AFMID;CKM;CKMT2;HIBCH;SUOX;HPD;GLDC;GLUD1;AGXT;BHMT2;NQO1;PXMP2;DIO1;ALDH18A1;DLST;SARDH;ALDH9A1;GPT2;BHMT;NNMT;DHTKD1;BBOX1;ALDH6A1;KYNU;SDS;TAT;GOT1;GOT2;MPST;DMGDH;SLC25A21;AMT;HYKK;FAH;IYD;GPT;IDO2;SHMT1;OAT;DDO;SRR;TDO2;CPS1;PAPSS2;HIBADH;CBS;KMO;ARG1;AGXT2;GSTZ1;SLC6A12;SEPHS2;OTC;SEPSECS;AASS;SLC25A13;SLC25A15;ASPA;PAH;KYAT3;CTH;HSD17B10;ADI1;HAL;ACMSD;AADAT;RPL3L;ALDH7A1,339 (339),2.22e-11,7.41e-09,1,HMDB0000128,222 (286),0.847,1,4.82e-10,1.25e-07
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,26,IVD;HADHA;AGXT2;ABAT;OXCT1;ACADM;HIBCH;ACADSB;ACAT1;EHHADH;BCAT1;ACSF3;BCKDHB;HSD17B10;HMGCS2;MCCC2;HADHB;HADH;DBT;ALDH9A1;ALDH3A2;PCCA;PCCB;ALDH6A1;HIBADH;ALDH7A1,48 (48),2.39e-11,7.46e-09,0,,34 (42),1,1,6.09e-10,1.46e-07
ECM-receptor interaction - Homo sapiens (human),KEGG,37,COL4A1;COL4A2;COL4A4;HSPG2;COL6A2;COL6A3;THBS1;SDC1;VTN;LAMA2;VWF;FN1;SPP1;TNC;COMP;COL6A1;ITGA8;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;COL6A5;CHAD;LAMC2;LAMC3;LAMA5;ITGA3;ITGA5;ITGB4;TNXB;ITGB6;ITGB7;ITGB8;COL1A1;COL1A2,88 (88),2.98e-11,8.4e-09,0,,1 (1),1,1,7.51e-10,1.6e-07
Tryptophan metabolism - Homo sapiens (human),KEGG,24,AFMID;CYP1A1;CYP1B1;IDO2;GCDH;MAOB;ACAT1;EHHADH;ALDH8A1;KYAT3;CAT;HADHA;TDO2;HADH;DLST;ACMSD;AADAT;ALDH9A1;ALDH3A2;DHTKD1;DDC;KYNU;KMO;ALDH7A1,42 (42),3.05e-11,8.4e-09,0,,59 (83),1,1,7.69e-10,1.6e-07
Saturated fatty acids beta-oxidation,EHMN,18,ACADL;ACADM;ACADSB;HADHA;ACAT1;EHHADH;GCDH;PECR;ACOX1;HSD17B10;ACOX2;ACOX3;HADH;HADHB;SLC25A20;BAAT;ACOT4;HSD17B4,25 (25),3.41e-11,8.87e-09,0,,43 (43),1,1,8.56e-10,1.67e-07
Integrin cell surface interactions,Reactome,31,COL4A1;COL4A2;COL4A4;HSPG2;THBS1;FBN1;COL13A1;COL16A1;COMP;SPP1;TNC;PECAM1;ICAM2;FN1;VTN;FGA;ITGA8;ITGA6;KDR;FGB;FGG;ITGA3;ITGA5;ITGAL;ITGAM;ITGB2;ITGB6;ITGB7;ITGB8;JAM3;JAM2,66 (66),3.78e-11,9.32e-09,0,,1 (2),1,1,9.46e-10,1.73e-07
Valine_ leucine and isoleucine degradation,EHMN,26,IVD;SLC43A2;SLC7A1;ABAT;IARS2;ACADL;ACADM;HIBCH;ACADSB;SLC16A1;EHHADH;SLC38A4;ALDH9A1;BCAT1;BCKDHB;HSD17B10;HADHA;MCCC2;HADHB;HADH;HSD17B4;PCCA;PCCB;ALDH6A1;HIBADH;ALDH7A1,49 (49),4.45e-11,9.91e-09,0,,52 (62),1,1,1.1e-09,1.91e-07
Response to elevated platelet cytosolic Ca2+,Reactome,48,VEGFC;A1BG;TGFB2;MMRN1;QSOX1;HGF;ISLR;FLNA;ORM2;SELENOP;THBS1;TGFB3;VWF;FN1;PDGFB;TIMP3;RAB27B;ITIH3;PECAM1;GAS6;FGA;FGB;AHSG;CD63;LHFPL2;ENDOD1;TMSB4X;TOR4A;CLEC3B;ALB;TAGLN2;ACTN2;FGG;PLG;APOH;APP;ALDOA;HRG;ABCC4;F5;PCDH7;F8;CTSW;F13A1;KNG1;ITIH4;TTN;FERMT3,136 (136),6.72e-11,1.43e-08,0,,10 (11),1,1,1.64e-09,2.69e-07
Peroxisomal protein import,Reactome,30,EPHX2;PHYH;PECR;CROT;NUDT7;GSTK1;PEX5;LONP2;EHHADH;ACOX1;BAAT;AGXT;PIPOX;PEX1;SCP2;PEX7;PEX13;CAT;DDO;ACOT2;ECI2;IDH1;ACOT4;HAO1;HSD17B4;DECR2;CRAT;ACOX2;ACOX3;SLC27A2,64 (64),8.33e-11,1.7e-08,0,,1 (1),1,1,2.02e-09,3.14e-07
Valine Leucine Isoleucine degradation,INOH,20,IVD;ACAD11;ACADM;HADHA;PCCA;PCCB;ALDH6A1;BCAT1;ALDH3A2;ALDH1A2;HIBADH;HSD17B10;ALDH7A1;HMGCS2;MCCC2;HADHB;HADH;OXCT1;EHHADH;ALDH9A1,32 (32),1.43e-10,2.59e-08,0,,36 (40),1,1,3.39e-09,5.04e-07
Muscle contraction,Reactome,55,TPM1;TPM2;TRIM72;VIM;DES;CACNB1;TCAP;MYH7;MYH8;ACTN3;KCNE3;MYL2;MYL3;MYL4;CALD1;GUCY1A1;GUCY1B1;TMOD2;ANXA2;KCNQ1;SCN1B;SCN5A;TMOD1;KCNJ12;SCN4B;ACTA2;SCN7A;KCNK1;TNNI2;FXYD6;TMOD4;MYLPF;ACTG2;LMOD1;KCNK6;KCNK13;ACTN2;MYBPC2;ATP1A2;NEB;DMPK;DYSF;TNNT3;MYL1;NPR1;TTN;ATP2A1;ATP2B4;CACNA1C;RYR1;ATP2A3;TRDN;SCN3B;MYBPC1;ITPR3,174 (174),3.56e-10,5.74e-08,0,,15 (16),1,1,8.1e-09,1.15e-06
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,21,MAOB;GLDC;PIPOX;AGXT2;DMGDH;PGAM2;SDSL;CTH;AGXT;BHMT;SDS;SRR;AMT;CHDH;CBS;ALDH7A1;SHMT1;ALAS1;SARDH;GLYCTK;AOC3,40 (40),4.29e-09,6.28e-07,1,HMDB0000128,42 (50),0.29,1,2.67e-08,3.62e-06
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,75,VEGFC;COL3A1;GHR;TNC;COL4A2;COL4A4;COL5A1;COL5A2;COL6A2;DDIT4;THBS1;ITGB4;FLT4;NOS3;IGF1R;ITGA8;VWF;ANGPT1;COMP;ITGA3;PDGFB;PDGFRA;LAMA4;IKBKG;PDGFRB;SPP1;FGF2;SLC2A2;GNG11;LAMC3;FN1;FGF21;GYS2;PRKAA2;HGF;VTN;NGF;NGFR;PDGFD;FGF1;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;CHAD;LAMC2;KDR;CAB39L;LAMA5;ITGAL;FGFR1;PFKFB1;PFKFB2;PFKFB4;CREB3L3;ITGA5;TEK;GNG2;KIT;IL2RB;GNGT2;COL4A1;IL3RA;TNXB;ITGB6;ITGB7;ITGB8;PRLR;SLC2A4;ITGB2;LAMA2;COL1A1;COL1A2;PIK3IP1,302 (302),4.91e-08,3.9e-06,0,,0 (2),1,1,4.91e-08,3.9e-06
Propanoate metabolism - Homo sapiens (human),KEGG,19,SUCLG2;SUCLG1;LDHA;HADHA;ACAT1;PCCA;PCCB;ALDH6A1;EHHADH;BCKDHB;ABAT;ACOX1;ACSS1;HIBCH;ECHDC1;LDHB;ACOX3;ACSS3;DBT,34 (34),5.95e-09,8.41e-07,1,HMDB0006805,38 (48),0.266,1,3.37e-08,4.37e-06
Elastic fibre formation,Reactome,18,FBLN1;TGFB2;TGFB3;ITGA8;BMP10;LTBP4;BMP2;ITGB6;MFAP4;ITGB8;FBN1;LTBP1;LTBP2;LTBP3;FBLN2;VTN;FBLN5;ITGA5,35 (35),8.43e-08,5.41e-06,0,,0 (1),1,1,8.43e-08,5.41e-06
Hemostasis,Reactome,145,A1BG;KIF21B;HGF;ENDOD1;ABCC4;ABL1;PDE9A;PDGFB;PRKAR1B;SPN;CENPE;KIF26A;DOCK11;INPP5D;ITGA5;PECAM1;GNG2;GAS6;ABHD6;GATA2;CLEC1B;GATA6;ITGA6;MGLL;SIRPA;ISLR;ACTN2;TNFRSF10B;PDE10A;ITGAL;ITGAM;F5;PTGIR;LCK;F8;F9;F11;F13A1;ITIH3;ITIH4;F13B;ITGB2;AK3;CEACAM1;ITPR3;CD84;QSOX1;EHD2;RBSN;FGA;SDC3;RAPGEF3;LHFPL2;P2RX6;KCNMB1;FGB;AHSG;HRG;GNAI1;MAFF;ALB;TAGLN2;PLCG2;FGG;FGR;ALDOA;GNG11;GNGT2;KLKB1;DAGLA;NOS3;SDC2;VAV1;RAB27B;KNG1;JAM3;JAM2;APBB1IP;FERMT3;VEGFC;DAGLB;SELPLG;FLNA;SELENOP;TGFB3;KIF23;VWF;ANGPT1;FN1;ITGA3;PLG;KIF21A;TTN;RAPGEF4;ESAM;KIF1B;ORM2;APOB;DOK2;CAV1;BCAR1;APOH;APP;SLC7A6;TEK;SH2B2;KIF20B;ZFPM2;TGFB2;MMRN1;SLC7A8;GATA4;ATP2B4;THBD;THBS1;CD2;SDC1;ARRB1;ARRB2;LAT;P2RX7;SLC16A1;GUCY1B1;GRB14;JCHAIN;GNB5;PAFAH2;TSPAN7;CD63;PRKAR2A;TMSB4X;SERPINC1;PRKCH;IGLC2;CLEC3B;PRKCQ;GUCY1A1;TOR4A;TIMP3;ATP2A1;EPCAM;ATP2A3;PCDH7;SERPIND1;CTSW,677 (677),2.61e-09,4.08e-07,0,,42 (67),1,1,5.42e-08,6.76e-06
Platelet activation_ signaling and aggregation,Reactome,71,VEGFC;A1BG;TGFB2;TGFB3;QSOX1;HGF;ISLR;FLNA;ORM2;SELENOP;ABCC4;MMRN1;F5;TOR4A;ARRB2;VWF;FN1;LAT;PDGFB;TIMP3;VAV1;BCAR1;RAPGEF3;RAB27B;PCDH7;ITIH3;PECAM1;GNB5;GNG2;GAS6;ABHD6;PLG;CLEC1B;FGA;FGB;AHSG;CD63;LHFPL2;ENDOD1;TMSB4X;MGLL;GNAI1;CLEC3B;PRKCQ;ALB;TAGLN2;ACTN2;FGG;PRKCH;LCK;APOH;APP;THBS1;ALDOA;HRG;GNG11;TTN;DAGLA;F8;RAPGEF4;CTSW;F13A1;KNG1;ITIH4;APBB1IP;GNGT2;DAGLB;ARRB1;FERMT3;PLCG2;ITPR3,263 (263),2.76e-09,4.16e-07,0,,22 (28),1,1,5.71e-08,6.85e-06
Neovascularisation processes,Wikipathways,16,EPHB2;EPHB4;PDGFB;KIT;DLL4;CXCR4;TGFB2;KDR;TGFB3;FLT4;ACVRL1;SMAD1;SMAD3;ANGPT1;SMAD9;MMP9,29 (29),1.23e-07,7.69e-06,0,,0 (0),1,1,1.23e-07,7.69e-06
Molecules associated with elastic fibres,Reactome,16,FBLN1;TGFB2;TGFB3;ITGA8;BMP10;LTBP4;BMP2;ITGB6;MFAP4;ITGB8;LTBP1;LTBP2;LTBP3;FBLN2;VTN;FBLN5,30 (30),2.31e-07,1.35e-05,0,,0 (1),1,1,2.31e-07,1.35e-05
Mitochondrial LC-Fatty Acid Beta-Oxidation,Wikipathways,13,CPT2;ACADL;ACADM;ACSL1;ACADVL;SCP2;EHHADH;PECR;SLC25A20;HADHA;HADH;ACSF2;CPT1A,17 (17),6.11e-09,8.41e-07,0,,2 (6),1,1,1.22e-07,1.4e-05
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,96,EPHB2;HTRA1;ABL1;ERG;RHOJ;MYO6;GATA2;SRF;HLX;ACTG1;NCF2;FJX1;BCL2;NR4A1;ADAM10;TRIP4;PTGS2;MEF2C;INPP4B;IQGAP1;NRP2;DECR1;NRARP;GJA1;BMP2;ADAMTS9;ARMCX1;KANK1;MYL2;PTPN14;ADRB2;MAPK12;SHC2;NFATC2;BMP10;APOLD1;CLIC1;ACKR3;NFKBIA;GLUD1;FGA;FGB;CCL2;KDR;FGD5;ALB;MMP2;FGG;FHL2;TAL1;HSPA1A;NOS3;HSPB1;CHAC1;NOTCH4;DOK1;PRKD2;CACNA2D1;FN1;ADAMTS1;DLL4;HBEGF;DUSP5;RCN1;GRB10;NOX4;ALDOA;SH2D2A;CAV1;BCAR1;LDHA;SHROOM2;HDAC7;GRSF1;PRDX6;FMNL3;SLC7A1;LIMK1;ARRB2;LMAN1;IGFBP7;EGR1;EGR3;FHOD1;CSRP1;PRKAA2;PAK1;SMARCA2;MMRN2;TMOD1;TMSB4X;CGNL1;NEXN;CDH5;TNXB;SH3BGRL3,433 (433),2.67e-07,1.52e-05,0,,0 (0),1,1,2.67e-07,1.52e-05
TYROBP causal network in microglia,Wikipathways,24,CD84;DPYD;ABCC4;KCNE3;ZFP36L2;SPP1;PYCARD;CAPG;CD37;HLX;LHFPL2;PPP1R18;C3;ELF4;BIN2;NRROS;RUNX3;NCF2;LYL1;ITGAM;ITGB2;SLC1A5;APBB1IP;MAF,60 (60),2.72e-07,1.52e-05,0,,0 (0),1,1,2.72e-07,1.52e-05
Complement and Coagulation Cascades,Wikipathways,26,CFH;F8;THBD;CD55;VWF;LMAN1;FGB;C3;C3AR1;CPB2;CD46;SERPINC1;C5AR1;C6;C7;PLG;C9;CFI;CR2;F5;KLKB1;SERPIND1;F9;KNG1;F13B;MASP2,59 (59),7.77e-09,1.04e-06,0,,1 (2),1,1,1.53e-07,1.7e-05
Complement system,Wikipathways,34,CFH;SELPLG;CD93;THBS1;VTN;ARRB2;C7;WAS;CD19;SPP1;CD55;ICAM2;FGA;FGB;APCS;LAMA5;LAMB1;LAMC1;C3;C3AR1;CD46;ALB;C5AR1;C6;FGG;C8A;PLG;C9;CFI;CR2;KLKB1;F13A1;CRP;MASP2,93 (93),1.43e-08,1.84e-06,0,,2 (5),1,1,2.73e-07,2.87e-05
Integrin,INOH,41,COL3A1;COL4A1;COL4A2;COL4A4;COL5A1;COL5A2;HSPG2;COL6A2;COL8A1;ITGB6;COL15A1;COL16A1;FN1;BCAR1;TNC;VCAN;SHC2;COL6A1;ITGA8;ITGA6;SDC3;LAMB3;LAMC2;SDC2;ELN;CAV1;ITGA3;LCK;ITGA5;ITGAL;ITGAM;ITGB2;ITGB4;TNXB;SDC1;ITGB7;ITGB8;VAV1;ARHGEF6;COL1A1;COL1A2,124 (124),1.45e-08,1.84e-06,0,,2 (2),1,1,2.77e-07,2.87e-05
Alpha6 beta4 integrin-ligand interactions,PID,9,LAMC1;LAMA2;ITGA6;LAMB1;LAMB2;LAMB3;ITGB4;LAMC2;LAMA5,11 (11),5.85e-07,2.88e-05,0,,0 (0),1,1,5.85e-07,2.88e-05
Fatty acid degradation - Homo sapiens (human),KEGG,21,ALDH3A2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;EHHADH;GCDH;CPT1C;HADH;ACOX1;CPT2;ALDH7A1;HADHA;ECI2;HADHB;ACADSB;ADH4;ACOX3;CPT1A;ALDH9A1,43 (43),2.3e-08,2.35e-06,0,,40 (50),1,1,4.27e-07,3.2e-05
Bile acid biosynthesis,EHMN,23,ADHFE1;SLC10A1;SLC10A2;EHHADH;CYP7A1;CYP8B1;SLC38A4;ACOX1;BAAT;SRD5A1;AKR1D1;ACOX2;ACOX3;SCP2;ABCB11;ACOT2;ACOT4;ACOT1;ALDH9A1;ALDH3A2;ALDH7A1;SLC27A5;SLC27A2,53 (53),8.04e-08,5.28e-06,1,HMDB0000036,47 (55),0.318,1,4.73e-07,3.2e-05
PPAR signaling pathway - Homo sapiens (human),KEGG,29,ACSL1;GK;ACADL;ACADM;APOA5;EHHADH;CYP7A1;CYP8B1;FABP2;CPT1C;ACOX1;SLC27A5;SCP2;FADS2;HMGCS2;ME3;PPARA;PPARD;CPT1A;CPT2;ME1;PCK1;ACOX2;ACOX3;FABP4;SLC27A2;FABP3;PLIN2;FABP7,74 (76),2.74e-08,2.35e-06,0,,5 (5),1,1,5.04e-07,3.2e-05
Peroxisomal lipid metabolism,Reactome,17,ALDH3A2;CRAT;SCP2;CROT;EHHADH;NUDT7;DECR2;PHYH;PECR;ACOX1;ACOX2;ACOX3;ECI2;SLC27A2;ACOT4;ACBD5;HSD17B4,30 (30),2.87e-08,2.35e-06,0,,38 (61),1,1,5.28e-07,3.2e-05
3-Methylglutaconic Aciduria Type I,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Valine_ Leucine and Isoleucine Degradation,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Isovaleric Aciduria,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Propionic Acidemia,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Maple Syrup Urine Disease,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Isobutyryl-coa dehydrogenase deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-hydroxyisobutyric aciduria,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Isovaleric acidemia,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Methylmalonic Aciduria,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-Methylglutaconic Aciduria Type IV,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
3-Methylglutaconic Aciduria Type III,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Beta-Ketothiolase Deficiency,SMPDB,17,IVD;ACADM;HIBCH;ACADSB;ACAT1;PCCA;HIBADH;ALDH6A1;BCAT1;ABAT;PCCB;BCKDHB;HSD17B10;HMGCS2;MCCC2;OXCT1;DBT,30 (30),2.87e-08,2.35e-06,0,,54 (58),1,1,5.28e-07,3.2e-05
Myometrial relaxation and contraction pathways,Wikipathways,47,GJA1;ARRB1;ADCY4;NOS3;PDE4B;MYL2;PDE4D;ARRB2;RAMP2;CAMK2A;IGFBP1;CALD1;IGFBP6;MYL4;GUCY1A1;RGS10;ACTG1;RGS19;GPR182;GNB5;ACTA1;ACTA2;ATF5;PKIA;ETS2;PRKAR1B;PRKAR2A;PRKCH;ATF3;MAFF;PLCD1;PLCG2;IL1B;GNG2;GNG11;ATP2A3;ADCY2;RGS3;CNN1;CNN2;ADCY9;RYR1;MYLK2;PRKCQ;SFN;ACKR3;ITPR3,155 (155),2.91e-08,2.35e-06,0,,4 (4),1,1,5.34e-07,3.2e-05
Syndecan-1-mediated signaling events,PID,19,COL3A1;COL4A1;COL4A4;FGF1;FGF2;COL5A1;HGF;COL6A1;COL6A2;COL6A3;SDC1;LAMA5;FGFR1;COL1A2;HPSE;COL5A2;MMP7;COL1A1;MMP9,43 (43),7.69e-07,3.64e-05,0,,0 (1),1,1,7.69e-07,3.64e-05
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Trifunctional protein deficiency,SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Carnitine palmitoyl transferase deficiency (II),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Fatty acid Metabolism,SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Glutaric Aciduria Type I,SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Ethylmalonic Encephalopathy,SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
Carnitine palmitoyl transferase deficiency (I),SMPDB,11,CPT2;ACADL;ACADM;ACSL1;ACADVL;ACAT1;GCDH;HADHA;HADHB;ACADSB;CPT1A,14 (14),6.03e-08,4.09e-06,0,,43 (43),1,1,1.06e-06,5.34e-05
TCR,NetPath,60,CD84;DOK1;PRKD2;ARHGEF2;ARHGDIB;DPYSL2;CD2;CD3D;STK39;CD5;ABL1;CD8A;WAS;LAT;NFATC2;TUBA1A;CASKIN2;ARHGEF7;ANXA2;ARHGAP35;MAP4K1;INPP5D;PECAM1;NFKBIA;GRAP2;BMF;ENAH;AHCY;MAPK11;PAK1;PKM;CARD11;LDHA;PRKCQ;CTLA4;DOK2;SH2D2A;PLCG2;NFAM1;LCK;ACTA1;MAPK7;LY9;PARD3;DEF6;ADA;EGR1;MUC1;SIT1;OGN;HDAC7;BDH1;VASP;VAV1;ARHGEF6;GAB2;LDHB;EPHA3;CHUK;GRAP,243 (244),1.3e-06,5.45e-05,0,,0 (0),1,1,1.3e-06,5.45e-05
Omega-6 fatty acid metabolism,EHMN,16,DECR1;ACSL1;ACOX3;FADS2;EHHADH;DECR2;FADS1;HADH;ACOX1;HSD17B10;ACOX2;HADHA;ECI2;HADHB;SLC27A2;HSD17B4,28 (28),6.31e-08,4.22e-06,0,,20 (23),1,1,1.11e-06,5.48e-05
Glycine Serine metabolism,INOH,19,MAOB;CBS;PIPOX;DMGDH;SHMT1;HSD17B12;GLDC;CDO1;NSDHL;SDS;CTH;GOT1;GOT2;AKR1B10;BHMT;ALAS1;AGXT;AGXT2;AOC3,40 (40),1.88e-07,1.13e-05,1,HMDB0000128,53 (68),0.351,1,1.16e-06,5.65e-05
Biosynthesis of unsaturated fatty acids - Homo sapiens (human),KEGG,15,ELOVL5;SCP2;HACD3;HSD17B12;FADS2;ELOVL2;ACOX1;ACOT2;ACOX3;FADS1;ELOVL7;ACOT4;ACOT1;BAAT;HSD17B4,27 (27),2.72e-07,1.52e-05,1,HMDB0002183,39 (74),0.272,1,1.29e-06,6.19e-05
Hypertrophic cardiomyopathy - Homo sapiens (human),KEGG,32,TPM1;TPM2;TGFB2;TGFB3;CACNA1C;CACNA1D;DES;CACNA1S;CACNA2D1;CACNB1;MYH7;CACNG1;MYL2;MYL3;SGCB;SGCG;ITGA8;ITGA5;PRKAA2;LAMA2;ITGA6;ACTG1;ITGA3;PRKAG2;ACE;ATP2A1;TTN;ITGB4;ITGB6;ITGB7;ITGB8;ATP2A3,90 (90),8.12e-08,5.28e-06,0,,3 (3),1,1,1.41e-06,6.64e-05
Collagen formation,Reactome,32,COL3A1;COL4A1;COL4A2;COL4A4;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;COL8A1;COL13A1;COL15A1;COL16A1;COL17A1;PXDN;ADAMTS2;P3H3;COL28A1;LOX;LOXL1;ITGA6;LAMB3;COL6A5;LAMC2;MMP7;MMP9;MMP13;SERPINH1;ITGB4;PCOLCE;COL1A1;COL1A2,91 (91),1.09e-07,6.91e-06,0,,13 (16),1,1,1.86e-06,8.66e-05
Vitamin D Receptor Pathway,Wikipathways,48,TPM1;TGFB2;CYP1A1;CDKN2D;CLMN;NRIP1;EPHB4;BMP6;HNF1A;THBD;SFRP1;COL13A1;ADRB2;IGFBP1;SATB1;TIMP2;TIMP3;SPP1;LRRC25;CYP7A1;CST6;KNG1;G0S2;IRF8;LPGAT1;ID4;ORM2;BTLA;PRKCQ;CTLA4;ADAMTS5;CYP2S1;PPARD;CRACR2B;NFATC2;ADGRE5;KLF4;HILPDA;ITGAM;CBS;ALOX5;CLDN2;SLC2A4;CD200;CEACAM1;PRDM1;VDR;DUSP10,184 (184),2.89e-06,0.000102,0,,0 (1),1,1,2.89e-06,0.000102
Cell adhesion molecules - Homo sapiens (human),KEGG,41,SELPLG;MPZ;CLDN4;CD2;ITGB7;CD8A;PTPRF;CD6;SPN;CLDN1;SDC3;CLDN2;VCAN;PECAM1;ICAM2;PVR;CNTNAP1;ITGA8;ITGA6;ESAM;NCAM2;CLDN5;IGSF11;CTLA4;CLDN7;LRRC4C;CD34;PTPRM;ITGAL;ITGAM;LRRC4;ITGB2;CDH5;SDC1;SDC2;ITGB8;VSIR;JAM3;CDH3;CD22;JAM2,148 (149),2.99e-06,0.000103,0,,0 (0),1,1,2.99e-06,0.000103
Di-unsaturated fatty acid beta-oxidation,EHMN,14,ACADL;DECR1;ACSL1;ACOX3;EHHADH;DECR2;HADH;ACOX1;HSD17B10;HADHA;ECI2;HADHB;SLC27A2;HSD17B4,23 (23),1.44e-07,8.75e-06,0,,19 (19),1,1,2.41e-06,0.000109
Laminin interactions,Reactome,14,HSPG2;LAMA2;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;ITGB4;LAMC2;LAMC3;NID1;LAMA5;LAMC1;ITGA3,23 (23),1.44e-07,8.75e-06,0,,1 (2),1,1,2.41e-06,0.000109
Hippo-Merlin Signaling Dysregulation,Wikipathways,35,ITGB4;ITGB2;PPP1R14A;FLT4;IGF1R;NGFR;PDGFRA;PDGFRB;PAK3;NTRK2;PAK1;ITGA8;PRKAR1B;PRKAR2A;ITGA6;TEK;KDR;FGFR1;ITGA3;PAK6;ITGA5;CDH19;AJUBA;ITGAL;ITGAM;KIT;CDH3;CDH5;ITGB6;ITGB7;ITGB8;CDH11;CDH13;CDH17;PLCB4,120 (120),4.43e-06,0.000146,0,,0 (0),1,1,4.43e-06,0.000146
Nervous system development,Reactome,87,EPHB2;EPHB4;SOX10;RGMB;ERBB2;ABL1;MPZ;ARHGAP35;RPS6KA2;SPTB;SPTBN2;SEMA4D;ACTG1;VLDLR;COL6A5;PLXND1;PAK6;ITGA5;GFRA1;GFRA2;GAB2;NRP2;FARP2;RGMA;UNC5A;GJB1;COL4A2;ARHGEF7;CXCR4;SCN1B;SCN4B;SCN5A;SCN7A;DLG4;CACNA1I;FGFR1;SDC2;VASP;HOXA2;PMP22;COL4A1;DOK1;COL4A4;CACNA1C;CACNA1D;COL6A1;COL6A2;COL6A3;CACNB1;DPYSL2;DPYSL3;ARHGEF28;DRP2;ANK1;ANK2;CNTNAP1;LAMA2;GRB10;LAMB1;LAMC1;SEMA5A;WWTR1;DOK2;ASB15;SHTN1;ABLIM3;CACNA1S;SHANK3;ADGRG6;MSN;NTN4;LIMK1;EFNB2;PLXNC1;SLIT3;ENAH;PLXNA4;PAK1;PAK3;PRKAR2A;PRKCQ;MAPK7;ABLIM2;SCN3B;EPHA3;EPHA4;EPHA7,379 (379),2e-07,1.18e-05,0,,11 (17),1,1,3.28e-06,0.000146
Bile secretion - Homo sapiens (human),KEGG,30,UGT1A1;ABCC4;ADCY4;SLC10A1;SLC10A2;CYP7A1;UGT1A5;SLC22A1;SCARB1;NR1H4;BAAT;KCNN2;ABCB11;SCTR;UGT2A3;NCEH1;ABCG2;ABCC2;ATP1A2;SLC4A4;AQP1;AQP4;ADCY2;AQP9;ABCG5;ABCG8;ADCY9;SLC27A5;SLC5A1;ABCB4,90 (90),1.01e-06,4.67e-05,2,HMDB0000036;HMDB0014487,112 (161),0.227,1,3.73e-06,0.000164
PPAR signaling pathway,Wikipathways,26,ACSL1;ACADL;ACADM;APOA5;EHHADH;CYP7A1;CYP8B1;CPT1C;ACOX1;ACOX3;SCP2;FADS2;HMGCS2;FABP2;PPARA;PPARD;CPT1A;CPT2;ME1;PCK1;ACOX2;SLC27A5;FABP4;SLC27A2;FABP3;FABP7,68 (68),2.54e-07,1.47e-05,0,,1 (7),1,1,4.11e-06,0.000178
Collagen chain trimerization,Reactome,18,COL3A1;COL4A1;COL28A1;COL4A2;COL4A4;COL6A5;COL5A2;COL6A1;COL6A2;COL6A3;COL8A1;COL5A1;COL13A1;COL15A1;COL16A1;COL17A1;COL1A1;COL1A2,44 (44),5.76e-06,0.000178,0,,0 (0),1,1,5.76e-06,0.000178
prion pathway,BioCarta,11,LAMA2;LAMA4;LAMA5;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;LAMC3;BCL2;GFAP,19 (19),6.54e-06,0.000194,0,,0 (0),1,1,6.54e-06,0.000194
Mono-unsaturated fatty acid beta-oxidation,EHMN,13,ACADL;ACADM;ACADSB;ACOX3;EHHADH;SLC27A2;ACOX1;HSD17B10;HADHA;HADH;HADHB;ACSL1;HSD17B4,21 (21),3.09e-07,1.62e-05,0,,12 (12),1,1,4.94e-06,0.0002
Ardeparin Action Pathway,SMPDB,13,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;SERPINC1;FGG;PLG;COL1A1;F13B,21 (21),3.09e-07,1.62e-05,0,,4 (4),1,1,4.94e-06,0.0002
Heparin Action Pathway,SMPDB,13,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;SERPINC1;FGG;PLG;COL1A1;F13B,21 (21),3.09e-07,1.62e-05,0,,5 (5),1,1,4.94e-06,0.0002
Fondaparinux Action Pathway,SMPDB,13,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;SERPINC1;FGG;PLG;COL1A1;F13B,21 (21),3.09e-07,1.62e-05,0,,4 (5),1,1,4.94e-06,0.0002
Enoxaparin Action Pathway,SMPDB,13,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;SERPINC1;FGG;PLG;COL1A1;F13B,21 (21),3.09e-07,1.62e-05,0,,5 (5),1,1,4.94e-06,0.0002
Biological oxidations,Reactome,57,SLC35D1;UGT1A1;CMBL;TPMT;CYP1A1;DPEP1;CYP1B1;GSTZ1;BPNT1;AADAC;SULT1B1;FMO1;FMO2;FMO3;AS3MT;GGT6;MGST1;CYP2E1;GSTK1;GCLM;CYP4B1;CYP7A1;CYP8B1;MAT1A;CYP26B1;UGT1A5;ACSS1;UGT2A3;UGT3A1;CHAC2;ARNT2;ACSM1;UGDH;AOC3;UGP2;AHR;GGT1;MAOB;ACSM5;PODXL2;CYP26A1;CYP2R1;GLYAT;UGT3A2;CYP2S1;PAPSS2;NNMT;CYP39A1;CBR3;PTGIS;SLC26A1;CYB5B;CHAC1;OPLAH;AHCY;GGT7;ADH4,219 (219),3.81e-07,1.94e-05,1,HMDB0001860,231 (320),0.858,1,5.21e-06,0.000208
Dilated cardiomyopathy - Homo sapiens (human),KEGG,32,TPM1;TPM2;TGFB2;TGFB3;CACNA1C;CACNA1D;DES;CACNA1S;CACNA2D1;CACNB1;MYH7;CACNG1;ADCY4;MYL2;MYL3;SGCB;SGCG;ITGA8;LAMA2;ITGA6;ACTG1;ITGA3;ITGA5;ATP2A1;TTN;ITGB4;ADCY2;ITGB6;ITGB7;ITGB8;ADCY9;ATP2A3,95 (96),3.39e-07,1.76e-05,0,,3 (3),1,1,5.39e-06,0.000213
L-kynurenine degradation,HumanCyc,10,IDO2;AFMID;DHTKD1;KYAT3;KYNU;KMO;GOT2;TDO2;ACMSD;AADAT,13 (13),3.56e-07,1.83e-05,0,,29 (30),1,1,5.65e-06,0.00022
Glucocorticoid Receptor Pathway,Wikipathways,24,IL11;TGFBR3;SPRY1;THBD;PLK2;PDE4B;B3GNT5;EPB41L4B;PPP1R14C;ACKR3;ABHD2;GPR153;ANKRD1;ETNK2;ENC1;LRRC8A;MGAM;CCL2;MFGE8;CDC42EP3;PTGS2;NR1I3;CAVIN2;SEC14L1,71 (71),9.09e-06,0.000266,0,,0 (1),1,1,9.09e-06,0.000266
Tryptophan metabolism,Wikipathways,19,ALDH3A2;MAOB;CYP2E1;AFMID;ACAT1;CYP1A1;CYP1B1;DDC;KYNU;GCDH;ALDH1A2;HSD17B10;DHCR24;TDO2;HADH;CAT;ACMSD;AADAT;ALDH9A1,42 (42),4.91e-07,2.47e-05,0,,30 (38),1,1,7.62e-06,0.000293
Nuclear Receptors in Lipid Metabolism and Toxicity,Wikipathways,17,ABCD3;CYP2E1;RARG;ABCB11;ABCC2;ABCD2;CYP4B1;CYP7A1;CYP8B1;ABCG5;NR1I3;NR1H4;CYP26A1;PPARA;PPARD;ABCB4;VDR,35 (35),5.59e-07,2.78e-05,0,,6 (12),1,1,8.61e-06,0.000327
Propanoate metabolism,INOH,14,ALDH3A2;ACAD11;ACADM;LDHA;ALDH1A2;PCCA;PCCB;LDHB;EHHADH;ALDH7A1;HADHA;ALDH6A1;HADHB;ALDH9A1,25 (25),6.03e-07,2.94e-05,0,,24 (26),1,1,9.24e-06,0.000347
Omega-3-Omega-6 FA synthesis,Wikipathways,9,ELOVL5;ACSL1;FADS2;PLA2G6;ELOVL2;ACOX1;ACOT2;ACOX3;FADS1,14 (14),1.45e-05,0.00036,0,,0 (1),1,1,1.45e-05,0.00036
Leukotriene metabolism,EHMN,33,ACSL1;CYP1A1;DPEP1;CYP1B1;GSTZ1;ECI2;ADHFE1;CYP2S1;MGST1;CYP2E1;GSTK1;EHHADH;CYP4B1;ACOX1;BAAT;ALDH9A1;ACOX2;DECR2;HSD17B10;ACOT2;HADHA;SLC27A2;HADHB;HADH;ACOT4;ACOT1;HSD17B4;ALDH3A2;CBR3;ALOX5;ALDH7A1;ACOX3;NUP35,102 (102),6.42e-07,3.1e-05,0,,25 (27),1,1,9.8e-06,0.000363
Tryptophan metabolism,EHMN,13,MAOB;GSTK1;MGST1;GSTZ1;ACMSD;ADHFE1;KMO;ALDH7A1;SLC22A1;SLC16A10;SLC18A1;AADAT;AOC3,22 (22),6.62e-07,3.16e-05,0,,72 (78),1,1,1.01e-05,0.000369
bile acid biosynthesis_ neutral pathway,HumanCyc,10,CYP2R1;SCP2;CYP7A1;CYP8B1;ACOX2;SLC27A5;SLC27A2;BAAT;AKR1D1;HSD17B4,15 (15),2.89e-06,0.000102,1,HMDB0000036,38 (44),0.266,1,1.16e-05,0.00042
miRNA targets in ECM and membrane receptors,Wikipathways,17,COL3A1;COL4A1;LAMC1;COL4A2;LAMA4;TNXB;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;ITGB6;SDC2;THBS1;LAMB2;COL1A2;FN1,43 (43),1.79e-05,0.000439,0,,0 (0),1,1,1.79e-05,0.000439
Assembly of collagen fibrils and other multimeric structures,Reactome,20,MMP13;COL6A1;COL4A2;LOX;COL4A4;ITGA6;COL6A5;LAMB3;ITGB4;COL6A2;COL4A1;LAMC2;COL6A3;LOXL1;PCOLCE;COL15A1;COL8A1;MMP7;PXDN;MMP9,47 (47),8.26e-07,3.87e-05,0,,6 (7),1,1,1.24e-05,0.000444
BMP2 signaling TGF-beta MV,INOH,20,GDF2;TGFB3;BMP10;GDF10;TGFBR2;BMP2;WT1;BMP5;BMP6;SMAD6;INHBE;BAMBI;INHBC;MAML1;ACVRL1;SMAD1;SMAD3;ACVR1B;SMAD9;TGFB2,56 (56),2e-05,0.000482,0,,0 (0),1,1,2e-05,0.000482
Arrhythmogenic right ventricular cardiomyopathy - Homo sapiens (human),KEGG,27,CACNA1C;CACNA1D;GJA1;DES;CACNA1S;CACNA2D1;CACNB1;CACNG1;ITGA8;DSC2;DSP;SGCB;SGCG;LAMA2;PKP2;ITGA6;ACTN2;ACTN3;ACTG1;ITGA3;ITGA5;ATP2A1;ATP2A3;ITGB4;ITGB6;ITGB7;ITGB8,77 (77),1.13e-06,5.19e-05,0,,2 (2),1,1,1.66e-05,0.000588
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,19,MMP12;MMP13;FGA;FGB;GPLD1;PDGFRB;BCAR1;HGF;VLDLR;MMP9;PDGFD;ITGB2;VTN;ITGAM;FGG;ITGA3;PLG;ITGA5;FN1,44 (44),1.18e-06,5.38e-05,0,,2 (2),1,1,1.73e-05,0.000596
Tranexamic Acid Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Urokinase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Aminocaproic Acid Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Reteplase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Streptokinase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Tenecteplase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Alteplase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Anistreplase Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Aprotinin Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Phenindione Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Dicoumarol Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Warfarin Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Acenocoumarol Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (5),1,1,2.09e-05,0.000596
Coagulation ,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Bivalirudin Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Argatroban Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Phenprocoumon Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (5),1,1,2.09e-05,0.000596
Dicumarol Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,5 (5),1,1,2.09e-05,0.000596
Ximelagatran Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (5),1,1,2.09e-05,0.000596
Lepirudin Action Pathway,SMPDB,12,FGA;FGB;F5;KLKB1;F8;F9;F11;F13A1;F13B;FGG;PLG;COL1A1,20 (20),1.44e-06,5.45e-05,0,,4 (4),1,1,2.09e-05,0.000596
Protein localization,Reactome,45,HSPD1;EPHX2;PHYH;OTC;CROT;NUDT7;MTX2;SLC25A4;GSTK1;PEX5;LONP2;EHHADH;ACOX1;SLC25A13;PEX3;BAAT;APP;ACBD5;AGXT;PEX19;ABCD3;PXMP2;PIPOX;PEX1;SCP2;PEX7;PEX13;DECR2;DDO;ACOT2;ECI2;IDH1;ACOT4;HAO1;HSD17B4;ALDH3A2;ABCD2;CAT;PECR;CRAT;HSPA9;ACOX2;ACOX3;SLC27A2;GRPEL2,165 (165),1.6e-06,6e-05,0,,4 (4),1,1,2.3e-05,0.000651
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,9,ACADL;ACADM;ACADSB;EHHADH;HSD17B10;HADHA;HADHB;HADH;HSD17B4,12 (12),2.06e-06,7.54e-05,0,,10 (10),1,1,2.9e-05,0.000801
Lysine catabolism,Reactome,9,PIPOX;HYKK;AASS;DLST;SLC25A21;ALDH7A1;GCDH;PHYKPL;AADAT,12 (12),2.06e-06,7.54e-05,0,,30 (32),1,1,2.9e-05,0.000801
Trihydroxycoprostanoyl-CoA beta-oxidation,EHMN,9,HADHA;EHHADH;ACOX1;HSD17B10;ACOX2;ACOX3;HADHB;HADH;HSD17B4,12 (12),2.06e-06,7.54e-05,0,,10 (10),1,1,2.9e-05,0.000801
Tryptophan degradation,INOH,24,AFMID;CYP1A1;CYP1B1;ALDH1A2;MAOB;CYP2E1;ACAT1;EHHADH;CYP4B1;QPRT;AOC3;CAT;HSD17B10;HADHA;TDO2;HADH;GCDH;ACMSD;ALDH9A1;ALDH3A2;DDC;KYNU;KMO;ALDH7A1,66 (66),2.1e-06,7.62e-05,0,,56 (62),1,1,2.95e-05,0.000808
beta-Alanine metabolism - Homo sapiens (human),KEGG,14,ALDH3A2;HIBCH;ACOX3;ALDH6A1;EHHADH;ALDH7A1;DPYD;DPYS;ABAT;ACOX1;UPB1;HADHA;ALDH9A1;AOC3,30 (30),1.02e-05,0.000294,1,HMDB0006805,29 (32),0.21,1,3.01e-05,0.000815
FOXA2 and FOXA3 transcription factor networks,PID,17,PKLR;ACADM;HNF4A;ACADVL;PCK1;TAT;BDH1;HNF1A;CPT1C;SLC2A2;ALAS1;ALB;FOXF1;HADH;IGFBP1;CPT1A;ALDOB,45 (45),3.6e-05,0.000827,0,,0 (0),1,1,3.6e-05,0.000827
Degradation of the extracellular matrix,Reactome,32,CAPN8;HSPG2;PHYKPL;HTRA1;COL16A1;COL17A1;TIMP2;ADAMTS1;ADAMTS9;SPP1;PLG;ADAM15;TMPRSS6;CMA1;LAMC1;LAMA5;LAMB1;LAMB3;NID1;LAMC2;CAPN5;ADAMTS8;ADAMTS5;MMP2;MMP7;MMP9;ADAM8;MMP12;MMP13;ADAM10;MMP17;KLKB1,103 (103),2.56e-06,9.2e-05,0,,6 (8),1,1,3.55e-05,0.000953
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,20,KYAT3;MPST;AGXT2;LDHB;GCLM;SDSL;CDO1;CTH;MAT1A;BHMT;SDS;TAT;LDHA;GOT1;GOT2;ADI1;CBS;AHCY;BCAT1;BHMT2,50 (50),2.67e-06,9.54e-05,0,,50 (63),1,1,3.69e-05,0.000984
Axon guidance,Reactome,79,EPHB2;COL4A1;RGMA;DOK1;COL4A4;CACNA1C;CACNA1D;UNC5A;COL6A1;COL6A2;NTN4;CACNB1;DPYSL2;DPYSL3;PLXND1;ABL1;ARHGEF28;EFNB2;ANK1;ANK2;SLIT3;ERBB2;ARHGEF7;ACTG1;CXCR4;ASB15;LAMB1;SCN1B;ITGA5;SPTB;SPTBN2;RPS6KA2;SCN4B;SCN5A;ENAH;PLXNA4;ABLIM2;EPHB4;SEMA4D;GAB2;COL4A2;GRB10;PRKAR2A;VLDLR;LAMC1;COL6A5;SEMA5A;DLG4;CACNA1I;FGFR1;DOK2;COL6A3;CNTNAP1;PAK6;ARHGAP35;MAPK7;PAK1;LIMK1;SHTN1;EPHA4;ABLIM3;RGMB;CACNA1S;SCN7A;SHANK3;SDC2;VASP;GFRA1;GFRA2;PLXNC1;PAK3;SCN3B;PRKCQ;EPHA3;FARP2;NRP2;EPHA7;MSN;HOXA2,356 (356),2.94e-06,0.000103,0,,11 (17),1,1,4.03e-05,0.00106
Branched-chain amino acid catabolism,Reactome,12,IVD;HIBCH;ACADSB;ACAT1;HIBADH;ALDH6A1;BCAT1;BCKDK;BCKDHB;HSD17B10;MCCC2;DBT,21 (21),2.96e-06,0.000103,0,,34 (39),1,1,4.06e-05,0.00106
Propanoate metabolism,EHMN,11,ACADL;ACADM;HIBCH;ACADSB;PCCA;ALDH6A1;EHHADH;ACSS1;ALDH7A1;HADHA;HADHB,18 (18),3.14e-06,0.000107,0,,29 (33),1,1,4.29e-05,0.00111
Leukocyte transendothelial migration - Homo sapiens (human),KEGG,34,MYL2;MAPK12;THY1;RAPGEF3;CXCR4;SIPA1;PECAM1;JAM3;RAPGEF4;ACTG1;ESAM;NCF2;GNAI1;MAPK13;CLDN4;MSN;CLDN7;PLCG2;MMP2;BCAR1;ARHGAP35;MMP9;MAPK11;ITGAL;ITGAM;ITGB2;CDH5;CLDN5;VASP;VAV1;CLDN2;CLDN1;JAM2;MYLPF,114 (114),3.5e-06,0.000119,0,,3 (4),1,1,4.75e-05,0.00122
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMPDB,8,CPT2;ACADL;ACSL1;SLC25A20;HADHA;HADHB;HADH;CPT1A,10 (10),3.6e-06,0.000121,0,,26 (26),1,1,4.87e-05,0.00124
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,11,SCP2;ABCB11;PTGIS;CYP7A1;CYP8B1;ACOX2;SLC27A5;SLC27A2;BAAT;AKR1D1;HSD17B4,20 (20),1.28e-05,0.000354,1,HMDB0000036,43 (49),0.295,1,5.09e-05,0.00129
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,78,VEGFC;GHR;ITGB4;COL4A2;COL4A4;HGF;COL6A1;COL6A2;COL4A1;KIT;ERBB2;THBS1;FLT4;EREG;IGF1R;NGFR;VWF;ANGPT1;PRKAA2;FN1;CD19;PDGFB;PDGFRA;LAMA4;PDGFRB;SPP1;TNC;SGK1;KDR;NTRK2;COL6A3;FGF21;PDGFD;GYS2;GNB5;DDIT4;TLR4;LAMB3;VTN;NGF;ITGA8;IKBKG;FGF1;FGF2;LAMB1;LAMB2;ITGA6;LAMC1;COL6A5;CHAD;LAMC2;LAMC3;COMP;LAMA5;BCL2;CREB3L3;NR4A1;ITGB6;ITGA5;TEK;GNG2;GNG11;IL2RB;GNGT2;ITGA3;IL3RA;TNXB;NOS3;ITGB7;ITGB8;PCK1;PRLR;SGK2;LAMA2;FGFR1;CHUK;COL1A1;COL1A2,353 (354),4.01e-06,0.000134,0,,3 (4),1,1,5.39e-05,0.00135
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,32,GSTZ1;SLC6A12;SLC6A13;OTC;ABAT;SLC25A20;SLC1A5;MGST1;ANPEP;GSTK1;GCLM;ALDH18A1;SLC38A4;SLC25A15;GLUD1;AOC3;GLUL;MAOB;L2HGDH;OAT;DDO;CPS1;ALDH9A1;ALDH3A2;CRAT;ALDH5A1;NOS3;NARS2;ALDH7A1;GOT2;NUP35;SFXN3,105 (105),4.05e-06,0.000134,0,,93 (125),1,1,5.43e-05,0.00135
Butanoate metabolism - Homo sapiens (human),KEGG,13,HMGCS2;ACAT1;L2HGDH;EHHADH;ALDH5A1;ACSM5;BDH1;ABAT;HADHA;ACSM3;HADH;OXCT1;ACSM1,28 (28),2.27e-05,0.000534,1,HMDB0001290,28 (42),0.203,1,6.14e-05,0.00151
Amoebiasis - Homo sapiens (human),KEGG,31,COL3A1;COL4A1;TGFB3;COL4A2;COL4A4;TGFB2;FN1;TLR4;LAMA2;LAMA4;LAMA5;LAMB1;LAMB2;LAMB3;LAMC1;RAB7B;LAMC3;PLCB4;LAMC2;C8A;C8B;C9;IL1B;ITGAM;CXCL2;ITGB2;HSPB1;CXCL3;COL1A1;COL1A2;ARG1,101 (102),4.84e-06,0.000158,0,,11 (13),1,1,6.4e-05,0.00151
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Glycine and Serine Metabolism,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Non Ketotic Hyperglycinemia,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Dimethylglycine Dehydrogenase Deficiency,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Hyperglycinemia_ non-ketotic,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Dimethylglycine Dehydrogenase Deficiency,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Sarcosinemia,SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,13,CBS;SHMT1;DMGDH;ALAS1;GLDC;CTH;AGXT;SDS;SRR;AMT;BHMT;SARDH;GLYCTK,27 (27),1.39e-05,0.00036,1,HMDB0000128,54 (55),0.356,1,6.53e-05,0.00151
Methionine Cysteine metabolism,INOH,12,LDHA;MPST;LDHB;CBS;CDO1;MAT1A;CTH;GOT1;GOT2;BAAT;BHMT;AHCY,24 (24),1.84e-05,0.000449,1,HMDB0000036,41 (45),0.284,1,6.88e-05,0.00154
Mitochondrial Fatty Acid Beta-Oxidation,Reactome,16,ACAD11;DECR1;ACADVL;ACADL;PCCB;PCCA;ACADM;ACSM3;ACAD10;ACOT2;HADHA;HADHB;HADH;ACOT1;ACSF2;ACOT12,36 (37),5.24e-06,0.00017,0,,53 (66),1,1,6.9e-05,0.00154
Glucose-Alanine Cycle,SMPDB,7,GPT2;SLC25A22;SLC38A4;SLC2A2;SLC2A4;GLUD1;GPT,8 (8),5.44e-06,0.000176,0,,10 (11),1,1,7.14e-05,0.00154
Bile Acid Biosynthesis,SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
27-Hydroxylase Deficiency,SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Congenital Bile Acid Synthesis Defect Type II,SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Cerebrotendinous Xanthomatosis (CTX),SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Zellweger Syndrome,SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Familial Hypercholanemia (FHCA),SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Congenital Bile Acid Synthesis Defect Type III,SMPDB,10,CYP39A1;SCP2;CYP7A1;CYP8B1;LIPA;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),1.45e-05,0.00036,1,HMDB0000036,58 (64),0.377,1,7.17e-05,0.00154
Lysine degradation,INOH,12,ALDH3A2;ACAT1;SHMT1;BBOX1;EHHADH;AASS;ALDH1A2;GCDH;ALDH7A1;HADHA;AADAT;ALDH9A1,22 (22),5.71e-06,0.000178,0,,33 (36),1,1,7.46e-05,0.00156
PI3K-Akt signaling pathway,Wikipathways,75,VEGFC;GHR;TNC;COL4A2;COL4A4;TLR4;CHAD;HGF;NTRK2;COL6A2;DDIT4;THBS1;ITGB4;FLT4;ITGB6;VTN;ITGA8;VWF;ANGPT1;COMP;ITGA3;PDGFB;PDGFRA;LAMA4;IKBKG;PDGFRB;SPP1;FGF2;GNG11;FN1;COL6A3;FGF21;GYS2;GNB5;PRKAA2;LAMC3;IGF1R;NGF;NGFR;PDGFD;FGF1;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;COL6A5;CD19;LAMC2;KDR;LAMA5;BCL2;SGK1;COL6A1;CREB3L3;ITGA5;TEK;GNG2;KIT;IL2RB;GNGT2;COL4A1;IL3RA;TNXB;NOS3;ITGB7;ITGB8;PCK1;PRLR;COL1A2;LAMA2;FGFR1;CHUK;COL1A1;SGK2,339 (340),5.84e-06,0.000178,0,,3 (4),1,1,7.63e-05,0.00156
Lysine Degradation,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
2-aminoadipic 2-oxoadipic aciduria,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Glutaric Aciduria Type I,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Hyperlysinemia I_ Familial,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Pyridoxine dependency with seizures,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Saccharopinuria/Hyperlysinemia II,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Hyperlysinemia II or Saccharopinuria,SMPDB,9,PIPOX;DHTKD1;ACAT1;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.9e-06,0.000178,0,,26 (27),1,1,7.69e-05,0.00156
Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,25,CACNA1C;CACNA1D;GJA1;DES;CACNA1S;CACNA2D1;CACNB1;CACNG1;ITGA8;DSC2;DSP;SGCB;SGCG;LAMA2;PKP2;ITGA6;ACTN2;ACTN3;ACTG1;ITGA3;ITGA5;ITGB4;ITGB6;ITGB7;ITGB8,74 (74),6.02e-06,0.000181,0,,2 (2),1,1,7.84e-05,0.00158
superpathway of methionine degradation,HumanCyc,11,SUOX;PCCA;PCCB;CBS;CDO1;MAT1A;BCKDHB;CTH;GOT1;DBT;AHCY,19 (19),6.54e-06,0.000194,0,,34 (36),1,1,8.47e-05,0.00169
Bile acid and bile salt metabolism,Reactome,17,ALB;CYP39A1;SCP2;ABCB11;PTGIS;CYP7A1;CYP8B1;NR1H4;ACOX2;SLC27A5;SLC27A2;SLC10A1;SLC10A2;OSBPL1A;BAAT;AKR1D1;HSD17B4,43 (43),1.79e-05,0.000439,1,HMDB0000036,59 (79),0.382,1,8.84e-05,0.00175
Transport of small molecules,Reactome,118,SLC43A2;ABCC4;SLC29A3;ABCB7;ATP7A;ATP7B;APOD;ACO1;MB;GNG2;SCARB1;FXYD6;CYGB;SLCO3A1;ASIC5;TRDN;ADCY2;SLC26A1;HEPH;RYR1;SLC1A1;ABCB4;TPCN1;SLC35D1;SLC2A10;ATP8B2;NIPAL2;ADCY9;PEX19;ANGPTL3;ATP11C;NCEH1;ALB;CREB3L3;ABCC2;ABCD2;GNG11;GNGT2;SLC30A10;SLC39A5;ABCG5;ABCG8;ABCG2;NPC1;VLDLR;ADCY4;SLC2A9;CYB5RL;SLC25A4;EMB;SLC17A5;SGK1;SLC38A4;WWP1;FLVCR1;PEX3;SLC44A2;ANO1;ABCB6;AQP11;CP;SLC13A3;APOB;TTYH3;ABCD3;LCAT;ATP9A;SLC7A6;AQP1;AQP4;SLC1A2;SLC1A3;AQP9;SLC2A2;SLC2A4;SLC5A1;TFR2;SGK2;SLC7A8;SLC25A22;SLC6A9;SLC22A18;SLC6A12;SLC6A13;SLC7A1;APOA4;SLC35A3;LIPA;SLC11A1;ABCA6;SLC15A2;SLC16A1;SLC16A2;SLC17A1;SLC18A1;SLC35B4;SLC22A1;SLC1A5;PCSK6;SLC22A5;GNB5;ATP6V0E2;SLC28A2;MTTP;SLC17A8;LRRC8A;PRKAR1B;PRKAR2A;SLC47A1;SLC41A1;ATP1A2;SLC4A4;ATP2A1;ATP2A3;SLC16A7;ATP2B4;HDLBP;SLC16A10,641 (641),0.000157,0.00278,4,HMDB0000036;HMDB0010404;HMDB0000273;HMDB0013461,172 (219),0.0451,1,9.12e-05,0.0018
Metapathway biotransformation Phase I and II,Wikipathways,44,UGT1A1;TPMT;EPHX2;CYP1A1;CYP1B1;GSTZ1;SULT1B1;FMO1;FMO2;FMO3;FMO4;FMO5;CYP26B1;MGST1;CYP2R1;GSTK1;CHST14;GAL3ST1;CYP4B1;CYP7A1;CYP8B1;CYP17A1;UGT1A5;GLYAT;CYP26A1;BAAT;AKR1D1;KCNAB2;KCNAB1;UGT2A3;CHST12;AKR1B10;CHST11;CHST1;CYP2S1;CHST2;NNMT;HS3ST3A1;HS3ST1;CYP39A1;HNMT;CYP2E1;GPX3;CHST3,186 (186),9.64e-05,0.00193,0,,0 (0),1,1,9.64e-05,0.00193
Glycolysis Gluconeogenesis,INOH,18,UGP2;PKLR;ALDOA;LDHA;ALDOB;AGXT2;ME1;PGAM2;LDHB;ENO3;GPT2;ME2;PKM;PFKFB1;PFKFB2;ME3;GPT;AGXT,45 (46),8.4e-06,0.000247,0,,32 (34),1,1,0.000107,0.00209
NOTCH4 Intracellular Domain Regulates Transcription,Reactome,6,MAML1;FLT4;NOTCH4;SMAD3;RBPJ;MAMLD1,8 (8),0.000127,0.00237,0,,0 (0),1,1,0.000127,0.00237
inhibition of matrix metalloproteinases,BioCarta,6,TIMP2;TIMP3;TIMP4;RECK;MMP2;MMP9,8 (8),0.000127,0.00237,0,,0 (0),1,1,0.000127,0.00237
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,14,GLUL;SHMT1;AFMID;ACAT1;PCCA;PCCB;GLDC;CAT;ACO1;AMT;ACSS1;HAO1;AGXT;GLYCTK,30 (30),1.02e-05,0.000294,0,,46 (62),1,1,0.000127,0.00248
Butanoate metabolism,EHMN,12,HMGCS2;SLC16A1;SLC16A7;BDH1;EHHADH;SLC13A3;ALDH7A1;HADHA;HADHB;OXCT1;ACSM1;AADAT,23 (23),1.05e-05,0.000299,0,,34 (36),1,1,0.000131,0.00251
intrinsic prothrombin activation pathway,BioCarta,12,COL4A1;FGA;COL4A2;COL4A4;F5;KLKB1;F8;F9;F11;KNG1;FGB;FGG,23 (23),1.05e-05,0.000299,0,,1 (1),1,1,0.000131,0.00251
chaperones modulate interferon signaling pathway,BioCarta,8,WT1;IFNGR1;DNAJA3;HSPA1A;HSPA1B;NFKBIA;CHUK;IKBKG,14 (14),0.000145,0.00266,0,,0 (0),1,1,0.000145,0.00266
Fatty acid beta-oxidation,Wikipathways,15,CPT2;ACADL;ACADM;ACSL1;GK;ACAT1;CRAT;DECR1;GCDH;SLC25A20;HADHA;HADHB;HADH;CPT1A;ACADVL,34 (34),1.15e-05,0.000327,0,,32 (34),1,1,0.000143,0.00273
3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,8,DECR1;EHHADH;ACOX1;HSD17B10;HADHA;HADHB;HADH;HSD17B4,11 (11),1.16e-05,0.000328,0,,10 (10),1,1,0.000144,0.00273
Integrins in angiogenesis,PID,22,COL3A1;COL4A1;COL4A4;TGFBR2;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;MFGE8;IGF1R;VTN;FN1;SPP1;ANGPTL3;FGF2;KDR;BCAR1;ADGRA2;SDC1;COL1A1;COL1A2,63 (63),1.18e-05,0.00033,0,,2 (2),1,1,0.000146,0.00275
alpha-linolenic acid (ALA) metabolism,Reactome,8,ELOVL5;ACSL1;SCP2;FADS2;ELOVL2;ACOX1;FADS1;HSD17B4,13 (13),7.06e-05,0.00144,1,HMDB0002183,23 (32),0.17,1,0.000148,0.00278
Signal Transduction,Reactome,382,NRIP1;CNKSR1;EREG;ABL1;RAMP2;SPRED2;RHOJ;RGS19;RPS6KA2;ABHD6;OBSCN;MCAM;ACTG1;SPRY1;SKA2;COL6A5;ACTN2;ACVR1B;RRAD;ACVRL1;ERBB2;WLS;F2RL1;ADCY2;MEF2C;ADCY9;ADH4;FZD4;ESRP2;FZD8;ADORA1;PLEKHG1;CDC14A;STRADB;CCR2;MFNG;ADRA1A;NTRK2;ADRB2;DLC1;MAPK12;ARHGAP31;RAPGEF3;LYPLA1;FGA;FGB;FGD1;FGF1;FGF2;SCTR;CCL2;CCL11;SMPD3;MMP2;FGG;MMP7;PRKAG2;ALDH3A2;CXCL5;CX3CL1;PREX1;MAF1;RANBP10;FLNA;ADCY4;FLT4;SFRP1;ANGPT1;SH3RF1;FN1;FGD2;SGK1;FOSB;CXCL13;IKBKG;ZDHHC7;GPAM;CHD8;APOD;APP;PENK;CDC42EP3;SH2B2;HDAC7;SLC1A5;PREX2;MST1R;ARHGAP1;ARHGAP4;BEX3;ARHGDIB;ARRB1;ARRB2;RDH16;FMNL1;CXCR6;PDGFD;GNB5;LAT;SNAI1;KDM1B;S1PR4;GRAP;GABRB3;STARD13;GALNT3;IQGAP2;NRG4;MYO6;SPP1;KDM4C;DOCK11;TEX2;SPTB;SPTBN2;WASF3;GAS1;SRF;NCF2;BCL2;PLXND1;TNFRSF10B;PDE10A;GDF2;DEF6;ADAM10;GFAP;BDKRB2;GFRA1;GFRA2;IQGAP1;NRP2;FFAR4;GJA1;BMP2;RGL1;KSR1;ALDH1A2;BAIAP2L1;BMP10;ARHGEF7;NFKBIA;ANGPTL3;NGF;NGFR;ARC;P2RY10;C3;C3AR1;FGD5;GNAI1;C5AR1;CKAP4;GNAT1;MCF2L;GNG11;GNGT2;DAGLA;NOS3;ABCG5;ABCG8;NOTCH4;SFN;DAGLB;USP13;CXCR3;ADAP1;ARHGEF28;FZD9;GPR35;CAMK2A;ADORA2B;WWP1;ROR2;NTS;RAPGEF4;PPP1R14A;GRB10;DUSP5;ARHGAP9;SH2D2A;CAV1;CAV2;ARHGAP35;TEK;ARHGEF25;CXCL2;CXCL3;TFF1;TFF3;FMNL3;RSPO3;TGFBR2;HHIP;THBS1;ARAP3;FSTL1;CD19;P2RY4;P2RY6;CBX6;PCSK6;GZMB;PAK1;PAK3;ADGRE5;DUSP10;ARHGEF2;PARD3;AVPR1A;ARHGAP45;PCDH7;PAQR3;PCK1;HGF;DLG5;PDE3A;PDE3B;PDE4B;PDE4D;TLR9;PDGFB;PDGFRA;CENPE;PDGFRB;PDK4;RUNX1;GNG2;ALDH8A1;GPR55;S1PR2;MGLL;NR4A1;GRAP2;CHN2;CHUK;SHC2;RRAGD;GFOD1;RASGRP3;PIP4K2A;AMOTL1;CMA1;BAMBI;CCR5;PLCB4;ACKR2;PLCG2;PLG;RHOF;VAV1;ARHGEF6;CNR2;APBB1IP;MYO9A;FGFR1;KLB;VEGFC;COL4A1;PROK2;COL4A2;COL4A4;VIM;COL6A1;COL6A2;COL6A3;CMKLR1;VWF;CYP26B1;WAS;DLL4;NEURL1B;SOX4;MMP9;POLR2A;POLR2D;BAG4;ACBD5;ID4;WWTR1;PPARD;BCAR1;ASB15;CPT1A;GABBR2;SYDE1;IGF1R;RASAL3;CSNK1E;HSPB1;ATP6V0E2;PRKAA2;RBPJ;PRKAR1B;PRKAR2A;PRKCH;CTBP2;PRKCQ;CAVIN1;MAPK7;MAPK11;IL17RD;IL2RB;IL3RA;DAB2IP;BOC;CCP110;STARD8;INCENP;CYP26A1;ESRP1;MAML1;CD55;PAK6;DBT;ARHGEF17;PTGIR;PTH1R;GAB2;ITPR3;FARP2;SOX7;PTPN7;CDC42SE2;CXCR4;ACKR3;CAMKK1;ABCD3;PXMP2;KIF14;CHRDL1;DLG4;KDR;CAB39L;ARHGAP25;KIT;KNG1;FGD3;CDON;DOK1;EVC2;RARG;ATN1;DSP;ARHGAP10;HBEGF;DTX1;DUSP1;DUSP4;STK10;DUSP7;DUSP8;MAMLD1;WNT7B;WNT11;LBR;LCK;PTPN18;WNT9B;RGS3;RGS10;LFNG;FOSL1;CCDC88C;CDH5;ARL4C;LIMK1;LMAN1;FAM13A;LMNB1;EGR1;EGR3;ZDHHC9;WASF2;ELF3;LYL1;ARHGAP27;PRICKLE1;SMAD1;SMAD3;SMAD6;SMAD9,2431 (2432),0.00016,0.00282,4,HMDB0010404;HMDB0034927;HMDB0013461;HMDB0002183,206 (290),0.078,1,0.000154,0.00286
MAPK signaling pathway - Homo sapiens (human),KEGG,66,VEGFC;NTRK2;TGFB3;CACNA1C;CACNA1D;HGF;CACNA1S;FLNA;CACNA2D1;FLNC;IL1B;ERBB2;IGF1R;CACNG1;FLT4;EREG;ARRB1;ARRB2;MAPK12;TGFB2;IKBKG;PDGFB;PDGFRA;PDGFRB;ANGPT1;MAP4K1;TGFBR2;FGF21;RASGRP3;DUSP4;DUSP5;DUSP1;DUSP8;SRF;NGF;NGFR;PDGFD;FGF1;FGF2;CACNB1;KDR;RELB;FGFR1;DUSP10;DUSP7;CACNA1I;NR4A1;MAPK7;RPS6KA2;MAPK11;PLA2G4E;TEK;MAPK13;PAK1;KIT;HSPA1B;HSPA1L;HSPA1A;PTPN7;MEF2C;MAP3K6;HSPB1;MAP3K1;MAP3K3;CHUK;PLA2G4F,294 (294),1.27e-05,0.000354,0,,5 (5),1,1,0.000156,0.0029
Validated transcriptional targets of AP1 family members Fra1 and Fra2,PID,14,MGP;TXLNG;NFATC2;LIF;GJA1;ITGB4;NOS3;THBD;FOSL2;COL1A2;CCL2;MMP2;FOSL1;MMP9,37 (37),0.000171,0.00298,0,,0 (0),1,1,0.000171,0.00298
Inflammatory Response Pathway,Wikipathways,13,COL3A1;IL2RB;LAMA5;LAMB1;LAMB2;LAMC1;LAMC2;THBS1;VTN;LCK;COL1A1;COL1A2;FN1,33 (33),0.000181,0.00314,0,,0 (0),1,1,0.000181,0.00314
Malonic Aciduria,SMPDB,9,ACADM;HIBCH;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;ACSS1;ACSS3,14 (14),1.45e-05,0.00036,0,,35 (38),1,1,0.000177,0.0032
Malonyl-coa decarboxylase deficiency,SMPDB,9,ACADM;HIBCH;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;ACSS1;ACSS3,14 (14),1.45e-05,0.00036,0,,35 (38),1,1,0.000177,0.0032
Propanoate Metabolism,SMPDB,9,ACADM;HIBCH;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;ACSS1;ACSS3,14 (14),1.45e-05,0.00036,0,,35 (38),1,1,0.000177,0.0032
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,9,ACADM;HIBCH;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;ACSS1;ACSS3,14 (14),1.45e-05,0.00036,0,,35 (38),1,1,0.000177,0.0032
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Reactome,8,ELOVL5;ACSL1;SCP2;FADS2;ELOVL2;ACOX1;FADS1;HSD17B4,13 (13),7.06e-05,0.00144,1,HMDB0002183,31 (42),0.223,1,0.00019,0.00341
Drug Induction of Bile Acid Pathway,Wikipathways,9,ABCB11;CYP7A1;VDR;ABCC4;NR1I3;NR1H4;SLC10A1;ABCC2;BAAT,17 (17),0.000121,0.00232,1,HMDB0000036,18 (28),0.136,1,0.000197,0.00353
Selenium Micronutrient Network,Wikipathways,25,SELENOP;SEPHS2;SAA4;SCARB1;GPX3;FGA;FGB;DIO1;CCL2;CAT;APOB;CTH;ALB;SELENOI;FGG;PLG;IL1B;CBS;KYNU;PTGS2;ALOX5;KMO;GGT1;CRP;PNPO,86 (86),0.000105,0.00209,2,HMDB0001904;HMDB0002183,91 (107),0.165,1,0.000208,0.0037
RAF/MAP kinase cascade,Reactome,55,DAB2IP;HGF;RGL1;KSR1;CNKSR1;PTPN7;EREG;ARRB1;ARRB2;VWF;HBEGF;MAPK12;SPRED2;FN1;LAT;PDGFB;PDGFRA;NRG4;PDGFRB;ANGPT1;ZDHHC9;CAMK2A;DUSP1;RASGRP3;RASAL3;DUSP4;DUSP5;SPTBN2;DUSP7;DUSP8;SHC2;LYPLA1;FGA;FGB;SPTB;FGF1;FGF2;DLG4;FGFR1;DUSP10;ACTN2;FGG;ERBB2;TEK;IL17RD;KIT;IL2RB;IL3RA;PAQR3;GFRA1;GFRA2;APBB1IP;PRKCQ;IQGAP1;KLB,235 (235),1.91e-05,0.000463,0,,22 (36),1,1,0.000227,0.00401
Synthesis of bile acids and bile salts,Reactome,13,CYP39A1;SCP2;ABCB11;PTGIS;CYP7A1;CYP8B1;ACOX2;SLC27A5;SLC27A2;BAAT;OSBPL1A;AKR1D1;HSD17B4,30 (30),5.6e-05,0.00124,1,HMDB0000036,55 (75),0.362,1,0.000239,0.00421
Protein digestion and absorption - Homo sapiens (human),KEGG,30,COL3A1;COL4A1;COL4A2;COL4A4;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;COL8A1;KCNE3;COL13A1;COL15A1;COL16A1;COL17A1;COL28A1;KCNN4;KCNQ1;COL6A5;CPA3;CPB2;ELN;MME;SLC7A8;ATP1A2;SLC1A1;SLC1A5;COL1A1;COL1A2;SLC16A10,103 (103),2.15e-05,0.000516,0,,44 (47),1,1,0.000253,0.00439
tryptophan degradation,HumanCyc,7,AFMID;DHTKD1;IDO2;KYNU;KMO;TDO2;ACMSD,9 (9),2.16e-05,0.000516,0,,21 (22),1,1,0.000254,0.00439
Folate Metabolism,Wikipathways,22,SAA4;MTHFD1;FOLR2;MAT1A;SCARB1;DHFR;GPX3;AHCY;FGA;FGB;SHMT1;CCL2;CAT;APOB;CTH;ALB;FGG;PLG;IL1B;IZUMO1R;CBS;CRP,69 (69),5.9e-05,0.0013,1,HMDB0001904,56 (66),0.367,1,0.000254,0.00439
MAPK1/MAPK3 signaling,Reactome,55,DAB2IP;HGF;RGL1;KSR1;CNKSR1;PTPN7;EREG;ARRB1;ARRB2;VWF;HBEGF;MAPK12;SPRED2;FN1;LAT;PDGFB;PDGFRA;NRG4;PDGFRB;ANGPT1;ZDHHC9;CAMK2A;DUSP1;RASGRP3;RASAL3;DUSP4;DUSP5;SPTBN2;DUSP7;DUSP8;SHC2;LYPLA1;FGA;FGB;SPTB;FGF1;FGF2;DLG4;FGFR1;DUSP10;ACTN2;FGG;ERBB2;TEK;IL17RD;KIT;IL2RB;IL3RA;PAQR3;GFRA1;GFRA2;APBB1IP;PRKCQ;IQGAP1;KLB,236 (236),2.17e-05,0.000516,0,,22 (36),1,1,0.000255,0.00439
MAPK family signaling cascades,Reactome,61,DAB2IP;HGF;RGL1;KSR1;LYPLA1;ERBB2;PTPN7;EREG;ARRB1;ARRB2;VWF;HBEGF;ANGPT1;SPRED2;FN1;LAT;PDGFB;PDGFRA;NRG4;PDGFRB;MAPK12;ZDHHC9;PAK3;CAMK2A;HSPB1;RASGRP3;RASAL3;DUSP4;DUSP5;SPTBN2;DUSP1;DUSP8;SHC2;PAK1;FGA;FGB;SPTB;FGF1;FGF2;DLG4;FGFR1;DUSP10;DUSP7;ACTN2;MMP2;FGG;CNKSR1;TEK;IL17RD;KIT;IL2RB;CDC42EP3;IL3RA;CDC14A;PAQR3;GFRA1;GFRA2;APBB1IP;PRKCQ;IQGAP1;KLB,270 (270),2.18e-05,0.000516,0,,22 (36),1,1,0.000256,0.00439
Sphingolipid metabolism - Homo sapiens (human),KEGG,11,PLPP1;CERS5;ACER2;CERS2;GAL3ST1;CERK;B4GALT6;CERS4;SMPD3;PLPP2;SGMS1,49 (49),0.0564,0.281,3,HMDB0010711;HMDB0006752;HMDB0013461,19 (25),0.000401,1,0.000264,0.0045
Phase II - Conjugation of compounds,Reactome,31,SLC35D1;UGT1A1;TPMT;GLYAT;GSTZ1;BPNT1;SULT1B1;GGT6;MGST1;GSTK1;GCLM;MAT1A;UGT1A5;UGT2A3;UGT3A1;ACSM1;UGDH;AHCY;UGP2;AS3MT;GGT1;ACSM5;PODXL2;UGT3A2;PAPSS2;NNMT;SLC26A1;CHAC1;OPLAH;CHAC2;GGT7,111 (111),3.91e-05,0.000891,1,HMDB0001860,115 (149),0.613,1,0.000279,0.00473
Linoleic acid metabolism known to be affected by coronavirus infection,Wikipathways,4,FADS1;ELOVL5;ELOVL2;ACOT2,4 (4),0.000322,0.00533,0,,0 (1),1,1,0.000322,0.00533
Oxidation of Branched Chain Fatty Acids,SMPDB,8,CPT2;ABCD2;ACSL1;CRAT;PEX13;PHYH;SLC25A20;CROT,12 (12),3.08e-05,0.00072,0,,23 (25),1,1,0.000351,0.0059
Alanine Aspartate Asparagine metabolism,INOH,12,PKLR;GPT2;GPT;AGXT2;DDO;ABAT;PKM;GOT1;GOT2;ASPA;AGXT;UPB1,25 (25),3.11e-05,0.000724,0,,39 (45),1,1,0.000354,0.00593
alk in cardiac myocytes,BioCarta,11,TGFB2;TGFB3;BMP10;TGFBR2;BMP2;BMP5;MEF2C;GATA4;SMAD1;MYL2;SMAD6,27 (27),0.000403,0.00625,0,,0 (0),1,1,0.000403,0.00625
Primary bile acid biosynthesis - Homo sapiens (human),KEGG,9,SCP2;CYP39A1;CYP7A1;CYP8B1;ACOX2;SLC27A5;BAAT;AKR1D1;HSD17B4,17 (17),0.000121,0.00232,1,HMDB0000036,40 (47),0.278,1,0.000379,0.00632
Collagen biosynthesis and modifying enzymes,Reactome,22,COL3A1;COL4A1;COL4A2;COL4A4;COL5A1;COL5A2;COL6A1;COL6A2;COL6A3;COL8A1;COL13A1;COL15A1;COL16A1;COL17A1;ADAMTS2;P3H3;COL28A1;COL6A5;SERPINH1;PCOLCE;COL1A1;COL1A2,67 (67),3.55e-05,0.000823,0,,8 (10),1,1,0.000399,0.00662
superpathway of choline degradation to L-serine,HumanCyc,6,DMGDH;SHMT1;ALDH7A1;BHMT;SARDH;CHDH,7 (7),3.57e-05,0.000824,0,,16 (16),1,1,0.000402,0.00662
Metabolism of steroids,Reactome,33,HSD17B7;SLC10A1;SLC10A2;CYP2R1;SC5D;CYP7A1;CYP8B1;CYP17A1;DHCR24;BAAT;SRD5A1;OSBPL1A;AKR1D1;TM7SF2;SCP2;ABCB11;HSD17B12;SERPINA6;GPAM;GC;LBR;IDI1;HSD17B4;HSD17B11;CYP39A1;PTGIS;NR1H4;ACOX2;SLC27A5;SLC27A2;VDR;NSDHL;ALB,124 (124),6.43e-05,0.00138,1,HMDB0000036,113 (142),0.607,1,0.000435,0.00713
Formation of Fibrin Clot (Clotting Cascade),Reactome,15,THBD;FGA;FGB;F8;F5;KLKB1;F9;SERPINC1;SERPIND1;F11;F13A1;KNG1;F13B;VWF;FGG,37 (37),3.92e-05,0.000891,0,,1 (14),1,1,0.000437,0.00713
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs),Wikipathways,5,FMO3;FMO4;FMO5;FMO1;FMO2,5 (5),4.31e-05,0.000965,0,,8 (8),1,1,0.000476,0.00765
tyrosine degradation,HumanCyc,5,FAH;HGD;HPD;TAT;GSTZ1,5 (5),4.31e-05,0.000965,0,,13 (13),1,1,0.000476,0.00765
Tyrosine catabolism,Reactome,5,FAH;HGD;HPD;TAT;GSTZ1,5 (5),4.31e-05,0.000965,0,,14 (16),1,1,0.000476,0.00765
Syndecan interactions,Reactome,9,TNC;FGF2;SDC3;ITGA6;SDC1;SDC2;THBS1;ITGB4;VTN,20 (20),0.000571,0.00865,0,,0 (3),1,1,0.000571,0.00865
Angiogenesis,Wikipathways,9,TEK;PDGFB;TIMP2;TIMP3;FGF2;NOS3;KDR;SMAD1;MMP9,20 (20),0.000571,0.00865,0,,0 (0),1,1,0.000571,0.00865
fatty acid &beta;-oxidation (peroxisome),HumanCyc,10,ACSL1;SCP2;EHHADH;ACOX1;HSD17B10;ACOX2;HADH;HADHB;SLC27A2;HSD17B4,19 (19),5.32e-05,0.00119,0,,61 (85),1,1,0.000577,0.00922
7-oxo-C and 7beta-HC pathways,Wikipathways,7,NPC1;SCP2;CYP7A1;ACOX2;SLC27A5;SLC27A2;BAAT,13 (13),0.00063,0.00933,0,,0 (0),1,1,0.00063,0.00933
Integrin-mediated Cell Adhesion,Wikipathways,26,SELENOP;ITGB7;MAPK12;VASP;PAK6;ARHGEF7;ITGA6;MAPK7;MYPN;PAK1;ITGA8;PAK3;CAPN5;CAV1;CAV2;ITGA3;BCAR1;ITGA5;ITGAL;ITGAM;ITGB2;ITGB4;ITGB6;ZYX;ITGB8;MYLK2,101 (101),0.000643,0.00949,0,,0 (0),1,1,0.000643,0.00949
Terminal pathway of complement,Reactome,5,C6;C7;C8A;C8B;C9,7 (7),0.000715,0.0104,0,,0 (0),1,1,0.000715,0.0104
Pathways in clear cell renal cell carcinoma,Wikipathways,23,TGFB2;TGFB3;BHLHE41;SDSL;KSR1;SSPN;DEPTOR;PDGFB;PDGFRA;PDGFRB;PKLR;PKM;SHMT1;GRB10;KDR;ALDOA;LDHA;ALDOB;ME1;LDHB;ENO3;SDS;CDH13,86 (86),0.00073,0.0106,0,,0 (1),1,1,0.00073,0.0106
Proteoglycans in cancer - Homo sapiens (human),KEGG,48,FZD4;FZD8;FZD9;HGF;HSPG2;FLNA;TGFB2;FLNC;ERBB2;THBS1;CAV1;VTN;HBEGF;MAPK12;ANK1;FN1;TIMP3;FGF2;DROSHA;CAMK2A;ANK2;ITGA5;COL1A2;WNT11;GPC3;WNT9B;WNT7B;MAPK11;IGF1R;ACTG1;KDR;MAPK13;FGFR1;PLCG2;MMP2;CAV2;MMP9;PAK1;TLR4;HPSE;SDC1;SDC2;VAV1;MSN;CD63;IQGAP1;COL1A1;ITPR3,205 (205),6.24e-05,0.00137,0,,5 (7),1,1,0.000667,0.0106
Beta Oxidation of Very Long Chain Fatty Acids,SMPDB,7,CPT2;ABCD2;ACSL1;CRAT;PEX13;SLC25A20;CROT,10 (10),6.37e-05,0.00138,0,,13 (14),1,1,0.000679,0.0106
Adrenoleukodystrophy_ X-linked,SMPDB,7,CPT2;ABCD2;ACSL1;CRAT;PEX13;SLC25A20;CROT,10 (10),6.37e-05,0.00138,0,,13 (14),1,1,0.000679,0.0106
Carnitine-acylcarnitine translocase deficiency,SMPDB,7,CPT2;ABCD2;ACSL1;CRAT;PEX13;SLC25A20;CROT,10 (10),6.37e-05,0.00138,0,,13 (14),1,1,0.000679,0.0106
Omega-3 fatty acid metabolism,EHMN,9,ACSL1;FADS2;EHHADH;ACOX1;ACOX2;ACOX3;FADS1;SLC27A2;HSD17B4,16 (16),6.45e-05,0.00138,0,,15 (16),1,1,0.000686,0.0106
Phytanic acid peroxisomal oxidation,EHMN,9,ACSL1;SCP2;EHHADH;PHYH;ACOX1;ACOX2;ACOX3;SLC27A2;HSD17B4,16 (16),6.45e-05,0.00138,0,,21 (22),1,1,0.000686,0.0106
Blood Clotting Cascade,Wikipathways,11,FGA;FGB;F5;KLKB1;F8;F9;F11;F13B;FGG;PLG;VWF,23 (23),6.99e-05,0.00144,0,,1 (2),1,1,0.000738,0.0111
Valproic acid pathway,Wikipathways,8,IVD;ACADSB;EHHADH;ABAT;HSD17B10;HADHA;HADHB;ACSM1,13 (13),7.06e-05,0.00144,0,,14 (14),1,1,0.000745,0.0111
valine degradation,HumanCyc,8,HIBCH;HIBADH;ALDH6A1;BCAT1;ABAT;BCKDHB;HADHA;DBT,13 (13),7.06e-05,0.00144,0,,19 (20),1,1,0.000745,0.0111
Argininemia,SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Citrullinemia Type I,SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Carbamoyl Phosphate Synthetase Deficiency,SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Argininosuccinic Aciduria,SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Urea Cycle,SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMPDB,8,SLC25A15;SLC1A5;OTC;GOT2;GLUD1;GPT;CPS1;ARG1,13 (13),7.06e-05,0.00144,0,,27 (27),1,1,0.000745,0.0111
Sulfur amino acid metabolism,Reactome,12,MPST;SUOX;CBS;CDO1;BHMT2;MAT1A;CTH;GOT1;GOT2;ADI1;BHMT;AHCY,27 (27),8.02e-05,0.00162,0,,49 (67),1,1,0.000836,0.0124
O-glycosylation of TSR domain-containing proteins,Reactome,15,ADAMTS15;ADAMTS10;THSD4;ADAMTS2;ADAMTS1;ADAMTSL2;ADAMTSL4;SEMA5A;THBS1;SPON1;ADAMTSL1;ADAMTS8;ADAMTS5;ADAMTS9;THSD7A,39 (39),8.1e-05,0.00163,0,,2 (2),1,1,0.000844,0.0124
Pathways Regulating Hippo Signaling,Wikipathways,25,PRKD3;PLCB4;FLT4;IGF1R;PDGFRA;PDGFRB;NTRK2;PRKAA2;NGFR;PRKAR1B;PRKAR2A;KDR;FGFR1;PRKCH;PRKAG2;CDH19;TEK;KIT;CDH3;CDH5;CDH11;CDH13;CDH17;SMAD3;PRKCQ,98 (98),0.000933,0.013,0,,0 (0),1,1,0.000933,0.013
Common Pathway of Fibrin Clot Formation,Reactome,10,FGA;FGB;F5;SERPIND1;SERPINC1;F8;THBD;F13A1;F13B;FGG,20 (20),9.37e-05,0.00188,0,,1 (7),1,1,0.000963,0.0141
Metabolism of carbohydrates,Reactome,61,B4GALT2;HSPG2;PHKG1;FUT10;SLC37A4;RPIA;TKFC;NDC1;FMOD;GPC3;CHST15;SDC3;CHST14;SHPK;HYAL1;GBE1;B4GALT6;SLC25A13;VCAN;GLYCTK;UGP2;PKLR;DSEL;PKM;GYS2;CHSY1;PYGB;PYGL;CHST12;SDC2;B3GNT7;ST3GAL2;LYVE1;CHST1;PFKFB1;PFKFB2;PFKFB4;CHST2;FUT2;OMD;HS3ST1;ALDOA;HS3ST3A1;PAPSS2;ALDOB;HPSE;PGAM2;OGN;ENO3;SLC26A1;SDC1;CHP1;PCK1;B3GNT3;CHST11;GOT1;GOT2;NUP35;SORD;CHST3;POM121,284 (285),0.000104,0.00207,0,,90 (157),1,1,0.00106,0.0154
EGFR1,NetPath,84,EPHB2;EPN3;EPHB4;DOK1;DOK2;VIM;GJA1;EFNB2;EPS8;SPRY1;KRT7;ERBB2;HIP1;NOS3;ABL1;COL17A1;PRKAA2;PTPRE;CALD1;BAIAP2L1;SDC3;MYO6;PDGFRB;DSP;LCK;ARHGEF7;ANXA2;ASB15;ANTXR1;AHNAK;PKP3;RPS6KA2;TOM1L1;ACTA2;BCL2;KRT17;PTPRF;PAK1;PKM;MAP3K1;PKP2;GRB10;GRB14;PYGB;MAP3K3;ELF3;SPRY4;SNX33;ALB;CRIM1;TAGLN2;PLCG2;CAV1;CAV2;ITGA3;BCAR1;ARHGAP35;MAPK7;APP;PARD3;REPS2;ALDOA;LDHA;IL17RD;PTPN18;CAVIN1;KIT;GPRC5A;CDH3;ITGB4;RIN1;SDC1;VASP;VAV1;CAVIN2;GSN;CASKIN2;SMAD3;EPN2;IQGAP1;EPHA4;PDLIM4;EEF1A2;SIRPA,454 (455),0.00115,0.0158,0,,0 (0),1,1,0.00115,0.0158
Eicosanoid metabolism via cyclooxygenases (COX),Wikipathways,11,PTGES;PTGR2;PTGIR;PTGIS;PLA2G6;PTGS2;ACOX1;ACOX2;ACOX3;PPARD;EHHADH,30 (30),0.00115,0.0158,0,,0 (1),1,1,0.00115,0.0158
TGF-beta signaling pathway - Homo sapiens (human),KEGG,24,TGFB2;THSD4;RGMB;BMP2;BMP5;BMP6;THBS1;RGMA;FBN1;FMOD;INHBC;TGFBR2;TGFB3;ID4;NBL1;BAMBI;LTBP1;GREM1;ACVR1B;INHBE;SMAD1;SMAD3;SMAD6;SMAD9,94 (94),0.00115,0.0158,0,,0 (0),1,1,0.00115,0.0158
Rap1 signaling pathway - Homo sapiens (human),KEGG,48,VEGFC;PRKD3;PARD6B;ADORA2B;PRKD2;HGF;THBS1;ADCY4;FLT4;IGF1R;ARAP3;MAPK12;FGF2;LAT;PDGFB;PDGFRA;PDGFRB;ANGPT1;RAPGEF3;FGF21;RASGRP3;PDGFD;ENAH;RAPGEF4;PARD3;NGF;NGFR;FGF1;ACTG1;KDR;GNAI1;MAPK13;PLCB4;BCAR1;SIPA1;MAPK11;TEK;ITGAL;ITGAM;KIT;ITGB2;ADCY2;VASP;VAV1;ADCY9;APBB1IP;FGFR1;FARP2,210 (210),0.000117,0.00231,0,,5 (5),1,1,0.00118,0.017
RHOA GTPase cycle,Reactome,37,FMNL3;STARD13;ABCD3;ARHGAP1;STK10;ARHGDIB;STARD8;ARAP3;LMAN1;FAM13A;ARHGEF28;MYO9A;ARHGAP31;TEX2;ARHGEF2;ARHGAP4;DEF6;ACBD5;OBSCN;MCAM;ARHGAP9;ARHGEF7;CAVIN1;CAV1;LBR;ARHGAP35;MCF2L;ARHGEF17;ARHGEF25;ARHGAP45;PCDH7;PREX1;VAV1;PREX2;DLC1;IQGAP1;ARHGAP10,149 (149),0.000118,0.00231,0,,4 (4),1,1,0.00118,0.017
EGR2 and SOX10-mediated initiation of Schwann cell myelination,Reactome,10,PMP22;LAMC1;LAMA2;SOX10;LAMB1;MPZ;WWTR1;GJB1;ADGRG6;DRP2,26 (26),0.00126,0.0171,0,,0 (0),1,1,0.00126,0.0171
CDC42 GTPase cycle,Reactome,39,FMNL3;STARD13;ARHGEF7;ARHGAP1;ARHGAP4;ARHGDIB;STARD8;ARAP3;CDC42SE2;FGD2;FMNL1;DLC1;IQGAP2;DOCK11;ARHGAP10;ARHGAP35;PLEKHG1;ARHGEF6;WAS;DEF6;PAK1;FGD1;PAK3;ARHGAP9;ARHGAP27;CAV1;LBR;PAK6;ASB15;MCF2L;ARHGEF25;ARHGAP45;CDC42EP3;PREX1;SYDE1;PREX2;FGD3;IQGAP1;ARHGAP31,160 (160),0.00012,0.00232,0,,4 (4),1,1,0.0012,0.0172
Phenylalanine metabolism - Homo sapiens (human),KEGG,9,MAOB;GLYAT;HPD;DDC;TAT;GOT1;GOT2;PAH;AOC3,17 (17),0.000121,0.00232,0,,40 (60),1,1,0.00121,0.0172
Butanoate metabolism,INOH,9,HADHA;ACAT1;EHHADH;BDH1;HSD17B10;HMGCS2;HADH;OXCT1;ACSM1,17 (17),0.000121,0.00232,0,,21 (23),1,1,0.00121,0.0172
Calcium Regulation in the Cardiac Cell,Wikipathways,34,CACNA1C;CACNA1D;GJA1;CACNA1S;CACNB1;GJB1;GJB2;ADCY4;ADRA1A;ARRB1;ARRB2;ADRB2;CAMK2A;KCNB1;RGS19;GNB5;GNG2;PKIA;PRKAR1B;PRKAR2A;CASQ1;PRKCH;GNAI1;PRKCQ;GJA5;GNG11;ATP2A3;ADCY2;RGS3;RGS10;ADCY9;RYR1;SFN;ITPR3,151 (151),0.00143,0.019,1,HMDB0009888,11 (11),0.0852,1,0.00122,0.0172
Sphingolipid pathway,Wikipathways,8,PLPP1;CERS5;GAL3ST1;CERK;B4GALT6;CERS4;CERS2;SGMS1,28 (28),0.0268,0.176,2,HMDB0010711;HMDB0006752,13 (14),0.00456,1,0.00122,0.0172
Calcium signaling pathway - Homo sapiens (human),KEGG,53,VEGFC;PLCD3;PLCB4;MST1R;CACNA1C;ADORA2B;HGF;CACNA1S;PHKG1;ITPKC;ERBB2;ADCY4;ADRA1A;NTRK2;ADRB2;CAMK1D;MYLK3;PDGFB;PDGFRA;HRC;PDGFRB;AVPR1A;CXCR4;CAMK2A;CACNA1D;FGF21;PDGFD;P2RX7;NGF;FGF1;FGF2;CASQ1;KDR;SLC25A4;FGFR1;PLCD1;PLCG2;CACNA1I;ATP2A1;TRDN;P2RX6;ADCY2;ATP2B4;NOS3;BDKRB2;ADCY9;RYR1;MYLK2;ATP2A3;FLT4;ITPKA;TPCN1;ITPR3,239 (240),0.000123,0.00236,0,,8 (11),1,1,0.00123,0.0173
Developmental Biology,Reactome,124,EPHB2;EPHB4;BOC;SOX10;RGMB;ERBB2;ABL1;SPI1;ADAM23;MPZ;RUNX1;RPS6KA2;SPTB;SPTBN2;CDK19;GATA2;PERP;GATA4;SEMA4D;ACTG1;VLDLR;COL6A5;EVPL;PLXND1;ACVR1B;PAK6;ITGA5;KLF4;MEF2C;GFRA1;GFRA2;KRT80;GAB2;FABP4;NRP2;HOXA2;RGMA;UNC5A;GJB1;MAPK12;ST14;COL4A2;ARHGEF7;CXCR4;KLF5;SCN1B;SCN4B;SCN5A;SCN7A;KRT17;PKP2;FGF2;DLG4;CACNA1I;FGFR1;TAL1;SDC2;VASP;KRT19;CDON;FARP2;SPINK5;PMP22;COL4A1;DOK1;COL4A4;CACNA1C;CACNA1D;FLI1;COL6A1;COL6A2;COL6A3;CACNB1;KRT7;DPYSL2;DPYSL3;ARHGEF28;DRP2;ANK1;ANK2;DSC2;DSP;CNTNAP1;MAPK11;WT1;LAMA2;ARHGAP35;GRB10;LAMB1;LAMC1;SEMA5A;WWTR1;DOK2;ASB15;SHTN1;ABLIM3;CACNA1S;SHANK3;ZFPM2;ADGRG6;MSN;NTN4;LIMK1;GATA6;EFNB2;LGI2;PLXNC1;PKP3;PCSK6;SLIT3;ENAH;PLXNA4;PAK1;MED13L;PAK3;PRKAR2A;SMAD3;PRKCQ;MAPK7;ABLIM2;SCN3B;EPHA3;EPHA4;EPHA7,676 (676),0.000126,0.00237,0,,20 (30),1,1,0.00126,0.0174
NAD Biosynthesis II (from tryptophan),Wikipathways,6,AFMID;NADSYN1;KYNU;QPRT;KMO;TDO2,8 (8),0.000127,0.00237,0,,24 (24),1,1,0.00126,0.0174
oleate biosynthesis,HumanCyc,6,FADS2;FADS6;ACOT2;FADS1;ACOT4;ACOT1,8 (8),0.000127,0.00237,0,,7 (7),1,1,0.00126,0.0174
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMPDB,6,ACADM;SLC25A20;HADHA;HADHB;HADH;ACSM1,8 (8),0.000127,0.00237,0,,25 (25),1,1,0.00126,0.0174
Endochondral Ossification,Wikipathways,20,MGP;RUNX3;MMP13;IGF1R;ADAMTS1;TIMP3;SERPINH1;SPP1;FGF2;TGFB2;BMP6;ENPP1;MEF2C;PTH1R;CHST11;FGFR1;GHR;ADAMTS5;DDR2;MMP9,63 (63),0.000135,0.00251,0,,2 (4),1,1,0.00134,0.0183
Endochondral Ossification with Skeletal Dysplasias,Wikipathways,20,MGP;RUNX3;MMP13;IGF1R;ADAMTS1;TIMP3;SERPINH1;SPP1;FGF2;TGFB2;BMP6;ENPP1;MEF2C;PTH1R;CHST11;FGFR1;GHR;ADAMTS5;DDR2;MMP9,63 (63),0.000135,0.00251,0,,2 (4),1,1,0.00134,0.0183
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,37,TPM1;TPM2;CACNA1C;CACNA1D;CACNA1S;CACNA2D1;CACNB1;MYH7;CACNG1;ADCY4;ADRA1A;MYL2;MYL3;MYL4;MAPK12;ADRB2;RAPGEF3;CAMK2A;SCN1B;SCN4B;SCN5A;SCN7A;RAPGEF4;KCNQ1;GNAI1;PLCB4;CREB3L3;ATP1A2;MAPK11;MAPK13;ATP2A1;ATP2A3;ADCY2;ATP2B4;ADCY9;BCL2;PPP1R1A,150 (150),0.000136,0.00252,0,,10 (10),1,1,0.00135,0.0184
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,39,TGFB2;TGFB3;COL4A2;FZD8;COL4A4;TGFBR2;FZD4;VTN;MAPK12;FN1;FZD9;DLL4;DSP;ITGA5;WNT11;RBPJ;WNT7B;MAPK11;PAK1;PKP2;CLDN5;CLDN4;CLDN7;SNAI1;MMP2;MMP9;NUBPL;MAPK13;WNT9B;COL4A1;CDKL2;CLDN12;CLDN2;CLDN1;NOTCH4;SMAD3;NRP2;PROX1;FOXC2,161 (161),0.000138,0.00254,0,,1 (1),1,1,0.00136,0.0185
TGF-beta receptor signaling in skeletal dysplasias,Wikipathways,17,RUNX3;ADAMTS10;LTBP3;SPP1;LIF;TGFBR3;BAMBI;ITGB6;THBS1;TGFBR2;LTBP1;SMAD3;SMAD1;ADAMTSL2;FBN1;SMAD6;SMAD9,59 (59),0.00143,0.019,0,,0 (0),1,1,0.00143,0.019
Tryptophan catabolism,Reactome,8,IDO2;AFMID;KYAT3;KYNU;KMO;TDO2;ACMSD;AADAT,14 (14),0.000145,0.00266,0,,31 (34),1,1,0.00143,0.0193
Tyrosine metabolism,EHMN,29,UGT1A1;CYP1A1;CYP1B1;MAOB;CYP2E1;GSTK1;SLC16A2;UGT1A5;SLC18A1;CYP4B1;ACOX1;BAAT;ALDH9A1;AOC3;DIO1;HSD17B10;HPD;CYP2S1;ACOT4;ACOT1;ACOX3;HSD17B4;ALDH3A2;SLC1A5;PRDX6;ACOX2;GOT2;EHHADH;SLC16A10,108 (108),0.000147,0.00268,0,,94 (105),1,1,0.00145,0.0194
Carnitine metabolism,Reactome,7,CPT2;PRKAG2;SLC25A20;CPT1A;SLC22A5;PRKAA2;MID1IP1,11 (11),0.000155,0.00275,0,,9 (13),1,1,0.00151,0.0197
mitochondrial fatty acid beta-oxidation of saturated fatty acids,Reactome,7,ACADL;ACADM;ACADVL;ACSM3;HADHA;HADHB;HADH,11 (11),0.000155,0.00275,0,,42 (42),1,1,0.00151,0.0197
Phenylalanine and Tyrosine Metabolism,SMPDB,7,FAH;HGD;HPD;PAH;TAT;GOT1;GSTZ1,11 (11),0.000155,0.00275,0,,27 (28),1,1,0.00151,0.0197
Valproic Acid Metabolism Pathway,SMPDB,7,IVD;ACADSB;EHHADH;HSD17B10;HADHA;HADHB;ACSM1,11 (11),0.000155,0.00275,0,,29 (30),1,1,0.00151,0.0197
Phenylketonuria,SMPDB,7,FAH;HGD;HPD;PAH;TAT;GOT1;GSTZ1,11 (11),0.000155,0.00275,0,,27 (28),1,1,0.00151,0.0197
Tyrosinemia Type 3 (TYRO3),SMPDB,7,FAH;HGD;HPD;PAH;TAT;GOT1;GSTZ1,11 (11),0.000155,0.00275,0,,27 (28),1,1,0.00151,0.0197
Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMPDB,7,FAH;HGD;HPD;PAH;TAT;GOT1;GSTZ1,11 (11),0.000155,0.00275,0,,27 (28),1,1,0.00151,0.0197
Glycosaminoglycan metabolism,Reactome,31,B4GALT2;HSPG2;LYVE1;FMOD;GPC3;CHST15;CHST14;HYAL1;CHSY1;B4GALT6;DSEL;VCAN;CHST2;SDC3;CHST12;SDC2;B3GNT7;CHST11;CHST1;B3GNT3;OMD;HS3ST3A1;PAPSS2;HS3ST1;HPSE;OGN;SLC26A1;SDC1;CHP1;ST3GAL2;CHST3,119 (119),0.000162,0.00284,0,,30 (60),1,1,0.00157,0.0204
NCAM1 interactions,Reactome,14,COL4A1;CACNA1S;COL4A2;COL4A4;CACNA1C;CACNA1D;COL6A5;COL6A1;COL6A2;COL6A3;CACNB1;CACNA1I;GFRA1;GFRA2,37 (37),0.000171,0.00298,0,,1 (3),1,1,0.00166,0.0214
Acyl chain remodeling of CL,Reactome,4,HADHB;HADHA;LCLAT1;PLA2G6,6 (6),0.00385,0.042,1,HMDB0010404,6 (12),0.0474,1,0.00175,0.0226
Cell junction organization,Reactome,25,ITGB4;PARD6B;FLNA;FLNC;COL17A1;CLDN2;PVR;CDH13;ITGA6;LAMB3;LAMC2;CLDN5;PARVB;CLDN7;FBLIM1;PARD3;CDH3;CDH5;CLDN12;VASP;CDH11;ARHGEF6;CLDN1;CDH17;CLDN4,89 (89),0.000192,0.00331,0,,1 (2),1,1,0.00183,0.0235
Glycine_ serine_ alanine and threonine metabolism,EHMN,22,DMGDH;SLC43A2;CKMT2;GLYAT;SLC6A12;SLC7A1;AMT;SLC15A2;SLC16A1;GLDC;SLC38A4;CHDH;SLC22A5;AGXT;PIPOX;ALAS1;HAO1;SARDH;SLC7A6;SLC16A7;SLC1A5;NUP35,78 (78),0.000427,0.0066,1,HMDB0000128,73 (88),0.45,1,0.00184,0.0235
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,9,MAPK11;NQO1;MAPK13;SRXN1;GCLM;ABCC4;ABCC2;ABCG2;MAPK12,23 (23),0.00191,0.024,0,,0 (0),1,1,0.00191,0.024
SLC-mediated transmembrane transport,Reactome,51,SLC35D1;SLC7A8;SLC2A10;SLC6A9;SLC22A18;SLC6A12;SLC6A13;SLC7A1;SLC16A7;SLC35A3;SLC17A5;SLC11A1;SLC2A9;SLC25A4;SLC15A2;SLC16A1;SLC16A2;SLC17A1;SLC18A1;SLC43A2;SLC35B4;SLC38A4;SLC25A22;HEPH;SLC22A1;SLC22A5;SLC28A2;SLC17A8;SLCO3A1;CP;SLC47A1;SLC44A2;SLC13A3;ALB;APOD;SLC41A1;SLC4A4;SLC7A6;SLC1A1;SLC1A2;SLC1A3;SLC30A10;SLC26A1;SLC1A5;SLC39A5;SLC2A2;SLC29A3;SLC2A4;SLC5A1;EMB;SLC16A10,243 (243),0.000651,0.00959,2,HMDB0000036;HMDB0000273,139 (164),0.309,1,0.00191,0.0243
Farnesoid X receptor pathway,Wikipathways,8,ABCB11;CYP7A1;CYP8B1;NR1H4;SLC27A5;SLC10A1;ABCB4;BAAT,19 (19),0.00196,0.0246,0,,0 (1),1,1,0.00196,0.0246
Alpha6Beta4Integrin,NetPath,19,EPHB2;PAK1;LAMC1;LAMA2;MST1R;VIM;DSP;LAMB2;LAMB3;ITGB4;LAMC2;ERBB2;LAMB1;LAMA5;ITGA6;SMAD3;ABL1;SFN;COL17A1,71 (71),0.00203,0.0254,0,,0 (0),1,1,0.00203,0.0254
Mechanoregulation and pathology of YAP-TAZ via Hippo and non-Hippo mechanisms,Wikipathways,14,ITGB8;PAK1;ITGB4;PAK3;ACTG2;ITGB2;ACTG1;ITGB6;ITGB7;MAP4K1;ACTA1;ACTA2;PAK6;SGMS1,46 (46),0.00209,0.0259,0,,0 (0),1,1,0.00209,0.0259
Ovarian steroidogenesis - Homo sapiens (human),KEGG,17,PLA2G4E;ADCY9;ACOT2;CYP1A1;CYP1B1;ADCY2;BMP6;PTGS2;ALOX5;CYP17A1;ADCY4;SCARB1;HSD17B7;IGF1R;ACOT4;ACOT1;PLA2G4F,51 (51),0.000218,0.00376,0,,23 (24),1,1,0.00206,0.0261
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human),KEGG,27,VEGFC;COL3A1;COL4A1;TGFB3;COL4A2;COL4A4;TGFBR2;PLCD3;THBD;MAPK12;TGFB2;FN1;EGR1;CCL2;NOX4;PLCB4;PLCD1;PLCG2;MMP2;MAPK11;IL1B;MAPK13;NOS3;SMAD3;BCL2;COL1A1;COL1A2,100 (100),0.000222,0.00382,0,,4 (9),1,1,0.00209,0.0264
Arginine Proline metabolism,INOH,17,GLUL;MAOB;CKM;CKMT2;AOC3;NOS3;ALDH3A2;OAT;OTC;ABAT;ARG1;ALDH7A1;GOT2;GLUD1;ALDH9A1;GCLM;GOT1,55 (55),0.000596,0.00897,1,HMDB0000128,58 (68),0.377,1,0.00211,0.0266
pyrimidine ribonucleosides degradation,HumanCyc,5,CDA;UPP2;UPB1;DPYD;DPYS,6 (6),0.00023,0.00391,0,,14 (14),1,1,0.00215,0.0269
Choline catabolism,Reactome,5,SARDH;BHMT;ALDH7A1;DMGDH;CHDH,6 (6),0.00023,0.00391,0,,13 (15),1,1,0.00215,0.0269
One-carbon metabolism and related pathways,Wikipathways,16,CHPT1;DMGDH;SHMT1;CDO1;BCAT1;SARDH;MAT1A;CTH;CHDH;ETNK2;AGXT2;BAAT;BHMT;GCLM;GPX3;BHMT2,52 (52),0.000904,0.0127,1,HMDB0000036,37 (42),0.26,1,0.0022,0.0273
ECM proteoglycans,Reactome,18,TGFB2;TGFB3;LAMA2;LAMA4;LAMA5;LAMB1;LAMB2;LAMC1;HSPG2;TNXB;ASPN;ITGB6;ITGA8;VCAN;VTN;TNC;FMOD;COMP,56 (56),0.000242,0.0041,0,,2 (4),1,1,0.00226,0.0279
Axon guidance - Homo sapiens (human),KEGG,42,EPHB2;EPHB4;RGMA;SEMA6C;BOC;UNC5A;SEMA4D;SEMA4B;SEMA3C;ABL1;PARD6B;EFNB2;SEMA3F;NFATC2;NFATC4;PLXNC1;CXCR4;CAMK2A;SLIT3;ENAH;PLXNA4;ABLIM2;PAK1;PAK3;NTN4;SEMA5A;SEMA3D;GNAI1;PLCG2;LRRC4C;PAK6;LRRC4;PARD3;DPYSL2;LIMK1;SEMA6B;ABLIM3;RGS3;SEMA4G;EPHA3;EPHA4;EPHA7,182 (182),0.000244,0.00413,0,,1 (1),1,1,0.00228,0.0281
Signaling by Receptor Tyrosine Kinases,Reactome,89,GABRB3;HGF;SPRY1;ERBB2;PDE3B;EREG;SPRED2;GALNT3;PDGFB;PDGFRA;NRG4;PDGFRB;SPP1;BCAR1;RPS6KA2;WASF3;ESRP1;SRF;PDGFD;COL6A5;NCF2;RRAD;ADAM10;GFAP;MEF2C;GAB2;NRP2;ITPR3;ESRP2;SHC2;ARHGEF7;GRAP2;CMA1;NGF;ARC;FGF1;FGF2;WWP1;DLG4;KDR;FGFR1;PLG;MMP9;KIT;DUSP7;NOS3;VAV1;KLB;VEGFC;COL4A1;COL4A2;COL4A4;RANBP10;COL6A1;COL6A2;COL6A3;FLT4;ADAP1;SGK1;HBEGF;FOSB;NTRK2;DUSP4;POLR2D;POLR2A;GRB10;ID4;SH2D2A;CAV1;TLR9;LCK;PTPN18;SH2B2;FOSL1;MST1R;THBS1;IGF1R;EGR1;EGR3;WASF2;PCSK6;ATP6V0E2;PAK1;PAK3;MAPK7;MAPK11;LYL1;CDH5;GRAP,464 (464),0.000247,0.00417,0,,35 (53),1,1,0.0023,0.0282
Arginine biosynthesis - Homo sapiens (human),KEGG,10,GLUL;GPT2;NOS3;OTC;GOT1;GOT2;GLUD1;GPT;CPS1;ARG1,22 (22),0.000254,0.00426,0,,18 (23),1,1,0.00236,0.0288
Transport of connexins along the secretory pathway,Reactome,3,GJA1;GJB2;GJB1,3 (3),0.00241,0.029,0,,0 (0),1,1,0.00241,0.029
Oligomerization of connexins into connexons,Reactome,3,GJA1;GJB2;GJB1,3 (3),0.00241,0.029,0,,0 (0),1,1,0.00241,0.029
Gap junction assembly,Reactome,3,GJA1;GJB2;GJB1,3 (3),0.00241,0.029,0,,0 (1),1,1,0.00241,0.029
Cholesterol metabolism - Homo sapiens (human),KEGG,14,NPC1;ANGPTL3;ABCG8;ABCB11;NCEH1;CYP7A1;ABCG5;APOA4;APOB;LIPA;SCARB1;LCAT;APOH;OSBPL5,50 (50),0.00487,0.0506,1,HMDB0000036,7 (10),0.055,1,0.00247,0.0301
Oxysterols derived from cholesterol,Wikipathways,8,CYP39A1;SCP2;CYP8B1;ACOX2;SLC27A5;SLC27A2;BAAT;AKR1D1,15 (15),0.000275,0.00459,0,,5 (10),1,1,0.00253,0.0307
Spinal Cord Injury,Wikipathways,30,COL4A1;RGMA;VIM;GJA1;CCR2;BTG2;EFNB2;EGR1;VCAN;SLIT3;TLR4;CCL2;NGFR;MMP12;NOX4;PLA2G6;LTB;CHST11;NR4A1;MMP9;IL1B;MBP;AQP1;CXCL2;AQP4;GFAP;PTGS2;LGALS3;EPHA4;ARG1,117 (117),0.000276,0.00461,0,,5 (9),1,1,0.00254,0.0307
Class I peroxisomal membrane protein import,Reactome,8,PEX19;ABCD2;PXMP2;ABCD3;PEX13;ALDH3A2;PEX3;ACBD5,20 (20),0.00289,0.034,0,,0 (0),1,1,0.00289,0.034
Deregulation of Rab and Rab Effector Genes in Bladder Cancer,Wikipathways,7,TBC1D10A;MYRIP;MLPH;UNC13D;RAB27B;SYTL2;SYTL1,16 (16),0.00291,0.034,0,,0 (0),1,1,0.00291,0.034
lysine degradation I (saccharopine pathway),HumanCyc,4,AADAT;AASS;DHTKD1;ALDH7A1,4 (4),0.000322,0.00533,0,,16 (16),1,1,0.00291,0.035
NAD <i>de novo</i> biosynthesis,HumanCyc,7,AFMID;IDO2;KYNU;QPRT;KMO;TDO2;NADSYN1,12 (12),0.000329,0.00536,0,,23 (24),1,1,0.00296,0.0351
isoleucine degradation,HumanCyc,7,ACADSB;ACAT1;BCAT1;BCKDHB;HSD17B10;HADHA;DBT,12 (12),0.000329,0.00536,0,,14 (16),1,1,0.00296,0.0351
lectin induced complement pathway,BioCarta,7,C8A;C3;C6;C7;MASP2;C8B;C9,12 (12),0.000329,0.00536,0,,2 (2),1,1,0.00296,0.0351
Ammonia Recycling,SMPDB,7,GLUL;GLUD1;GLDC;SDS;AMT;HAL;CPS1,12 (12),0.000329,0.00536,0,,29 (29),1,1,0.00296,0.0351
Beta-oxidation of pristanoyl-CoA,Reactome,6,SCP2;CRAT;ACOX2;ACOX3;CROT;HSD17B4,9 (9),0.000336,0.00537,0,,17 (21),1,1,0.00303,0.0351
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,6,NNMT;HNMT;CBS;MAT1A;CTH;AHCY,9 (9),0.000336,0.00537,0,,30 (33),1,1,0.00303,0.0351
Carnosinuria_ carnosinemia,SMPDB,6,ALDH6A1;DPYD;DPYS;ABAT;UPB1;AOC3,9 (9),0.000336,0.00537,0,,34 (34),1,1,0.00303,0.0351
Ureidopropionase deficiency,SMPDB,6,ALDH6A1;DPYD;DPYS;ABAT;UPB1;AOC3,9 (9),0.000336,0.00537,0,,34 (34),1,1,0.00303,0.0351
GABA-Transaminase Deficiency,SMPDB,6,ALDH6A1;DPYD;DPYS;ABAT;UPB1;AOC3,9 (9),0.000336,0.00537,0,,34 (34),1,1,0.00303,0.0351
Beta-Alanine Metabolism,SMPDB,6,ALDH6A1;DPYD;DPYS;ABAT;UPB1;AOC3,9 (9),0.000336,0.00537,0,,34 (34),1,1,0.00303,0.0351
ABC transporters in lipid homeostasis,Reactome,7,PEX19;ABCD2;ABCA6;ABCD3;ABCG5;ABCG8;PEX3,18 (18),0.00635,0.062,1,HMDB0013461,7 (11),0.055,1,0.00313,0.0361
RAC1 GTPase cycle,Reactome,42,ARHGEF7;ARHGAP1;ARHGAP4;PAK1;ARAP3;WAS;FAM13A;BAIAP2L1;IQGAP2;DOCK11;ARHGAP10;ARHGAP35;PLEKHG1;ARHGEF6;WASF3;DEF6;WASF2;MCAM;PAK3;ARHGAP9;ARHGDIB;NCF2;FGD5;ARHGAP25;ARHGAP27;CAV1;LBR;PAK6;ASB15;MCF2L;CHN2;ARHGEF25;ARHGAP45;PREX1;SLC1A5;FMNL1;VAV1;PREX2;DLC1;IQGAP1;ARHGAP31;FARP2,185 (185),0.000354,0.00563,0,,6 (6),1,1,0.00317,0.0363
fatty acid &beta;-oxidation,HumanCyc,9,ACADL;ACSL1;SCP2;EHHADH;ECI2;HSD17B10;HADH;HADHB;SLC27A2,19 (19),0.000356,0.00563,0,,60 (84),1,1,0.00318,0.0363
Tryptophan Metabolism,SMPDB,9,AFMID;CYP1A1;DDC;KYNU;CAT;KMO;TDO2;ACMSD;AADAT,19 (19),0.000356,0.00563,0,,58 (60),1,1,0.00318,0.0363
Histidine metabolism,EHMN,13,MAOB;SLC17A8;SLC1A1;SLC1A2;SLC1A3;SLC1A5;SLC38A4;ABAT;ALDH7A1;HAL;AOC3;SLC18A1;ALDH9A1,35 (35),0.00036,0.00568,0,,43 (45),1,1,0.00322,0.0366
Eicosanoid metabolism via lipooxygenases (LOX),Wikipathways,10,DPEP1;PTGR2;ALOX12;ALOX5;ACOX1;ACOX2;ACOX3;PPARA;PPARD;EHHADH,29 (29),0.00324,0.0373,0,,0 (0),1,1,0.00324,0.0373
Type I hemidesmosome assembly,Reactome,5,LAMB3;ITGB4;COL17A1;LAMC2;ITGA6,9 (9),0.00339,0.0385,0,,0 (1),1,1,0.00339,0.0385
amb2 Integrin signaling,PID,12,SELPLG;MST1R;ITGB2;MYH2;JAM2;ITGAM;APOB;JAM3;MMP9;MMP2;PLG;THY1,31 (31),0.000388,0.0061,0,,2 (2),1,1,0.00344,0.0389
Eicosanoid Synthesis,Wikipathways,10,PTGES;ALOX5;DPEP1;PTGIS;PLA2G6;ALOX12;PNPLA8;PNPLA3;GGT1;PTGS2,23 (23),0.000396,0.0062,0,,18 (23),1,1,0.0035,0.0395
Fatty acid elongation - Homo sapiens (human),KEGG,11,ELOVL5;HACD3;HSD17B12;ELOVL2;ACOT2;HADHA;ELOVL7;HADHB;HADH;ACOT4;ACOT1,27 (27),0.000403,0.00625,0,,27 (40),1,1,0.00355,0.0398
Glutamate Glutamine metabolism,INOH,11,GLUL;ALDH3A2;GPT2;GCLM;ALDH5A1;ABAT;ALDH7A1;GLUD1;GPT;CPS1;ALDH9A1,27 (27),0.000403,0.00625,0,,28 (34),1,1,0.00355,0.0398
BMP signaling Dro,INOH,11,GDF2;BMP10;GDF10;BMP2;WT1;BMP5;BMP6;MAML1;SMAD1;SMAD3;SMAD9,34 (34),0.00362,0.0409,0,,0 (0),1,1,0.00362,0.0409
Lung fibrosis,Wikipathways,17,FAM13A;IL1B;PDGFB;FGF1;FGF2;CXCL2;HGF;CCL2;CCR2;DSP;SPP1;CCL11;ELN;GREM1;MMP2;MMP9;CMA1,64 (64),0.00371,0.0417,0,,0 (1),1,1,0.00371,0.0417
aspirin triggered resolvin D biosynthesis,HumanCyc,2,ALOX5;PTGS2,2 (2),0.018,0.135,1,HMDB0002183,3 (7),0.024,1,0.00377,0.0421
Recycling of bile acids and salts,Reactome,7,ABCB11;NR1H4;ALB;SLC27A5;SLC10A1;SLC10A2;BAAT,16 (16),0.00291,0.034,1,HMDB0000036,20 (20),0.15,1,0.00381,0.0423
O-linked glycosylation,Reactome,29,GALNT15;ADAMTS10;THSD4;THBS1;ADAMTSL1;THSD7A;GALNT3;B3GNT5;ADAMTS2;ADAMTS1;ADAMTS9;SPON1;ADAMTS15;SEMA5A;GALNT12;ST6GALNAC4;ST3GAL2;ADAMTS8;ADAMTS5;GALNT6;B3GNT3;GCNT4;MUC1;GALNT18;ADAMTSL4;GALNT16;B3GNT7;B4GALT6;ADAMTSL2,115 (115),0.000468,0.0072,0,,15 (18),1,1,0.00405,0.045
Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,10,ERBB2;TGFB2;TGFB3;TGFBR2;TGFBR3;PROM1;MFGE8;SMAD3;HGF;TSPAN8,30 (30),0.00429,0.0452,0,,0 (0),1,1,0.00429,0.0452
Cells and molecules involved in local acute inflammatory response,Wikipathways,7,ITGAL;SELPLG;ITGB2;C3;KNG1;C6;C7,17 (17),0.00438,0.046,0,,0 (0),1,1,0.00438,0.046
Beta5 beta6 beta7 and beta8 integrin cell surface interactions,PID,7,ITGB6;ITGB7;ITGB8;FBN1;SDC1;VTN;FN1,17 (17),0.00438,0.046,0,,0 (0),1,1,0.00438,0.046
a6b1 and a6b4 Integrin signaling,PID,15,PMP22;LAMC1;LAMA2;MST1R;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;ITGB4;LAMC2;ERBB2;LAMA5;SFN;COL17A1,45 (45),0.000506,0.00777,0,,3 (3),1,1,0.00435,0.0478
Fabry disease,SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
Sphingolipid Metabolism,SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
Gaucher Disease,SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
Globoid Cell Leukodystrophy,SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
Metachromatic Leukodystrophy (MLD),SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
Krabbe disease,SMPDB,5,B4GALT6;GAL3ST1;PLPP1;CERK;SGMS1,22 (22),0.163,0.553,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.00441,0.0478
B Cell Receptor Signaling Pathway,Wikipathways,23,BLK;GTF2I;CD19;CD22;CAMK2A;MAP4K1;INPP5D;RASGRP3;NFKBIA;BLNK;IKBKG;CD79A;CD79B;CARD11;PLCG2;LCK;NFATC2;CR2;PTPN18;MEF2C;VAV1;GAB2;CHUK,98 (98),0.00462,0.0483,0,,0 (0),1,1,0.00462,0.0483
Glyoxylate metabolism and glycine degradation,Reactome,12,PXMP2;DHTKD1;AGXT2;GLDC;DLST;DDO;BCKDHB;AMT;GOT2;HAO1;AGXT;DBT,32 (32),0.000546,0.00835,0,,32 (42),1,1,0.00465,0.0501
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,47,LIMK1;MYLPF;MYL2;MYLK3;BDKRB2;PDGFB;PDGFRA;PDGFRB;BCAR1;ARHGEF7;FGF2;CXCR4;FGF21;PDGFD;PIP4K2A;FN1;ENAH;WASF2;PAK1;ITGA8;GSN;FGF1;ITGA6;TMSB4X;ARHGEF6;FGD3;PAK3;FGFR1;IQGAP2;ACTG1;ITGA3;PAK6;ARHGAP35;ITGA5;FGD1;ITGAL;ITGAM;ITGB2;ITGB4;ITGB6;ITGB7;ITGB8;VAV1;KNG1;MYLK2;IQGAP1;MSN,218 (218),0.000564,0.00861,0,,2 (5),1,1,0.00479,0.0514
PPAR-alpha pathway,Wikipathways,9,CPT2;ACADM;SCP2;APOA5;EHHADH;CYP7A1;CYP8B1;PPARA;CPT1A,26 (26),0.00501,0.0514,0,,0 (1),1,1,0.00501,0.0514
Signaling by high-kinase activity BRAF mutants,Reactome,11,FGA;FGB;IQGAP1;KSR1;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,28 (28),0.000584,0.00882,0,,6 (15),1,1,0.00493,0.0528
Diltiazem Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,2,HMDB0009888;HMDB0014487,11 (11),0.00325,1,0.00512,0.0546
Estrogen Receptor Pathway,Wikipathways,7,CYP1A1;CYP1B1;GPAM;PCK1;ACOX1;PDK4;PPARA,13 (13),0.00063,0.00933,0,,1 (2),1,1,0.00527,0.0555
eicosapentaenoate biosynthesis,HumanCyc,7,ACSL1;FADS2;ACSM5;ACSM3;FADS1;ACOT1;ACSM1,13 (13),0.00063,0.00933,0,,13 (17),1,1,0.00527,0.0555
Glutathione synthesis and recycling,Reactome,7,GGT1;GCLM;GGT6;CHAC1;OPLAH;GGT7;CHAC2,13 (13),0.00063,0.00933,0,,13 (14),1,1,0.00527,0.0555
sarcosine oncometabolite pathway ,SMPDB,7,SLC44A2;SHMT1;DMGDH;CHDH;BHMT;SARDH;ALDH7A1,13 (13),0.00063,0.00933,0,,25 (26),1,1,0.00527,0.0555
EGF-Ncore,Signalink,15,KSR1;MBIP;FLNA;CNKSR1;INPP5D;DUSP1;DUSP10;DUSP4;DUSP5;ARRB1;DUSP8;SMAD6;MTSS1;SH3RF1;SIRPA,56 (56),0.00571,0.0576,0,,0 (0),1,1,0.00571,0.0576
Extracellular vesicles in the crosstalk of cardiac cells,Wikipathways,8,ETS2;CD63;SPP1;GATA4;KDR;HSPB1;TLR4;MMP9,22 (22),0.00574,0.0576,0,,0 (0),1,1,0.00574,0.0576
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,13,GLUL;GPT2;GPT;AGXT2;ALDH5A1;AGXT;DDO;ABAT;GOT1;GOT2;GLUD1;ASPA;CPS1,37 (37),0.000671,0.00985,0,,25 (28),1,1,0.00557,0.0585
Toxoplasmosis - Homo sapiens (human),KEGG,28,TGFB2;TGFB3;IFNGR1;MAPK12;CIITA;LAMA5;NFKBIA;TLR4;LAMA2;IKBKG;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;LAMC3;CCR5;BCL2;MAPK11;MAPK13;HSPA1A;HSPA1B;HSPA1L;GNAI1;ALOX5;CHUK,112 (112),0.000674,0.00986,0,,3 (3),1,1,0.00559,0.0585
BMP receptor signaling,PID,12,RGMA;AHSG;RGMB;CTDSPL;BMP2;CHRDL1;BAMBI;BMP6;SMAD1;GREM1;SMAD6;SMAD9,41 (41),0.00603,0.0603,0,,0 (0),1,1,0.00603,0.0603
BCR,NetPath,28,BLK;DOK1;GTF2I;CD5;CD19;CHST15;NFATC2;BCAR1;FOSB;RASGRP3;NFKBIA;PIP4K2A;BLNK;CD79A;CD79B;BTLA;CARD11;PRKCQ;PLCG2;LCK;FCGR2B;CR2;PTPN18;SH2B2;BANK1;VAV1;CD22;CHUK,129 (129),0.00615,0.0613,0,,0 (0),1,1,0.00615,0.0613
tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde,HumanCyc,5,IDO2;KMO;AFMID;KYNU;TDO2,7 (7),0.000715,0.0104,0,,12 (13),1,1,0.00589,0.0614
Chemokine receptors bind chemokines,Reactome,16,CXCL13;CXCL5;CXCR6;CXCL2;CXCL3;CCL2;CXCR4;CCR2;ACKR3;CXCR3;CCR5;PXMP2;CCL11;ACKR2;CYP26B1;CX3CL1,62 (62),0.00649,0.0633,0,,0 (0),1,1,0.00649,0.0633
alternative complement pathway,BioCarta,6,C3;C6;C7;C8A;C8B;C9,10 (10),0.000745,0.0107,0,,2 (2),1,1,0.00611,0.0633
Trans-sulfuration pathway,Wikipathways,6,MPST;GCLM;CBS;CTH;GOT1;AHCY,10 (10),0.000745,0.0107,0,,14 (14),1,1,0.00611,0.0633
Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human),KEGG,6,B4GALT2;FUT8;B3GNT7;ST3GAL2;CHST1;CHST2,14 (14),0.0066,0.0637,0,,0 (0),1,1,0.0066,0.0637
Glycerolipid metabolism - Homo sapiens (human),KEGG,18,ALDH3A2;PLPP5;PLPP1;PLPP2;LCLAT1;DGAT2;GPAT4;GPAM;MGLL;PNPLA3;ALDH7A1;GK;TKFC;AKR1B10;GPAT3;MBOAT1;GLYCTK;ALDH9A1,61 (61),0.000773,0.0111,0,,13 (38),1,1,0.00631,0.0651
Cell-Cell communication,Reactome,30,ITGB4;PARD6B;FLNA;FLNC;COL17A1;CLDN1;CLDN2;PVR;ITGA6;LAMB3;LAMC2;CLDN5;PARVB;SIRPA;CLDN7;ACTN2;ACTN3;ASB15;FBLIM1;PARD3;CDH3;CDH5;CLDN12;VASP;CDH11;ARHGEF6;CDH13;CDH17;CLDN4;IQGAP1,124 (124),0.000793,0.0113,0,,3 (4),1,1,0.00645,0.0661
Platelet activation - Homo sapiens (human),KEGG,30,COL3A1;ADCY4;VWF;MAPK12;MYLK3;GUCY1A1;GUCY1B1;FGA;FGB;MYLK2;ACTG1;GNAI1;PLCB4;PLA2G4F;PLCG2;FGG;ARHGAP35;MAPK11;PLA2G4E;MAPK13;PTGIR;ADCY2;NOS3;VASP;ADCY9;ITPR3;APBB1IP;FERMT3;COL1A1;COL1A2,124 (124),0.000793,0.0113,0,,14 (14),1,1,0.00645,0.0661
Beta2 integrin cell surface interactions,PID,11,ITGAL;FGB;FGA;ITGB2;C3;KNG1;JAM3;ICAM2;ITGAM;FGG;THY1,29 (29),0.000828,0.0118,0,,1 (1),1,1,0.0067,0.0685
Pyruvate metabolism - Homo sapiens (human),KEGG,15,ALDH3A2;PKLR;PKM;ACAT1;ME1;ME2;LDHB;PCK1;LDHA;ACSS1;ALDH7A1;ME3;ADH4;ACOT12;ALDH9A1,47 (47),0.00085,0.012,0,,26 (32),1,1,0.00686,0.0696
agrin in postsynaptic differentiation,BioCarta,15,PAK1;LAMC1;LAMA2;LAMA4;PAK3;LAMB1;LAMB2;LAMB3;LAMA5;LAMC2;LAMC3;ARHGEF6;ACTA1;PAK6;ARHGEF7,47 (47),0.00085,0.012,0,,2 (2),1,1,0.00686,0.0696
Validated transcriptional targets of deltaNp63 isoforms,PID,13,PERP;ADA;COL5A1;POU2F2;RUNX1;BDKRB2;FOSL2;WWP1;SEC14L2;SFN;ITGA3;RRAD;VDR,47 (47),0.00732,0.0697,0,,0 (0),1,1,0.00732,0.0697
Heart Development,Wikipathways,13,VEGFC;TBX20;GATA4;GATA6;NFATC2;BMP10;NFATC4;BMP2;SRF;MEF2C;TBX1;SMAD1;FOXC2,47 (47),0.00732,0.0697,0,,0 (0),1,1,0.00732,0.0697
Disulfiram Action Pathway,SMPDB,10,CYP2E1;FAH;HGD;GSTZ1;DDC;CAT;TAT;ACSS1;GOT1;HPD,25 (25),0.000877,0.0124,0,,72 (77),1,1,0.00705,0.0714
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,9,ALDH3A2;BCAT1;VNN1;DPYD;DPYS;UPB1;VNN3;ENPP1;PANK1,21 (21),0.000881,0.0124,0,,24 (30),1,1,0.00708,0.0714
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,Wikipathways,14,LAT;PAK1;IKBKG;CD8A;CARD11;CD3D;PRKCQ;CTLA4;NFKBIA;GRAP2;CHUK;LCK;CHP1;NFATC2,63 (63),0.0369,0.225,1,HMDB0009888,3 (3),0.024,1,0.0071,0.0714
NRF2 pathway,Wikipathways,30,TGFB2;SLC2A10;TGFBR2;SRXN1;HGF;SLC6A13;UGT1A1;ABCC4;SLC2A9;PDGFB;EGR1;GCLM;HBEGF;SLC6A9;GPX3;NQO1;CES4A;MAFF;PPARD;ABCC2;HSPA1A;CBR3;ME1;SLC39A5;SLC2A2;PRDX6;SLC2A4;GGT1;EPHA3;SLC5A1,143 (143),0.00777,0.0728,0,,0 (1),1,1,0.00777,0.0728
PDGF receptor signaling network,PID,4,PDGFB;PDGFRA;PDGFD;PDGFRB,7 (7),0.00804,0.0742,0,,0 (0),1,1,0.00804,0.0742
NOTCH-Ncore,Signalink,9,BHLHE41;ADAM10;DLL4;DTX1;MFNG;LFNG;NOTCH4;ARRB1;NUMBL,28 (28),0.00864,0.0775,0,,0 (0),1,1,0.00864,0.0775
Proteoglycan syndecan-mediated signaling events,PID,3,SDC3;SDC1;SDC2,4 (4),0.00866,0.0775,0,,0 (0),1,1,0.00866,0.0775
generation of amyloid b-peptide by ps1,BioCarta,3,BACE1;ADAM10;APP,4 (4),0.00866,0.0775,0,,0 (0),1,1,0.00866,0.0775
IL-18 signaling pathway,Wikipathways,51,COL3A1;SEMA6C;SPP1;BMP2;EPS8;PYGB;MYH7;PTPN7;KIFC3;BTG2;FN1;HOXD8;TIMP3;HSPB8;LONP2;NR4A1;SPON1;MMP9;NFKBIA;ACTA1;ACTA2;DES;CCL2;ZDHHC7;TMSB4X;NFATC4;NCF2;LTB;ATF3;BCL2;ADAMTS5;HADH;LCK;CPT1A;IL1B;MMP13;MMP2;CXCL2;CXCL3;GPAT4;CLDN12;PTGS2;SNTB1;HSPB1;CLDN1;CLDN4;S1PR4;CHUK;COL1A1;COL1A2;ARG1,274 (274),0.00875,0.0782,0,,0 (0),1,1,0.00875,0.0782
superpathway of tryptophan utilization,HumanCyc,14,ALDH3A2;MAOB;AFMID;DHTKD1;CYP1B1;IDO2;DDC;KYNU;QPRT;KMO;TDO2;CYP2S1;NADSYN1;ACMSD,43 (43),0.00101,0.014,0,,59 (70),1,1,0.00795,0.0797
Sphingolipid de novo biosynthesis,Reactome,10,ALDH3A2;PLPP1;PLPP2;ACER2;PRKD2;PRKD3;CERS4;CERS2;CERS5;SGMS1,41 (41),0.0407,0.231,2,HMDB0013461;HMDB0006752,31 (35),0.0249,1,0.00801,0.08
Pyruvate metabolism,INOH,12,ALDH3A2;PKLR;LDHA;ACAT1;ME1;ME2;LDHB;PKM;ALDH7A1;ALDH1A2;ME3;ALDH9A1,34 (34),0.00103,0.0142,0,,30 (31),1,1,0.00808,0.0805
TGF-beta super family signaling pathway canonical,INOH,25,TGFB2;TGFB3;TGFBR2;BMP2;BMP5;BMP6;INHBE;MAPK12;BMP10;INHBC;MAPK7;WT1;PSMD1;ACVR1B;ACVRL1;MAPK11;GDF2;MAPK13;GDF10;HDAC7;MAML1;SMAD1;SMAD3;SMAD6;SMAD9,115 (115),0.0091,0.0805,0,,0 (0),1,1,0.0091,0.0805
Phase I - Functionalization of compounds,Reactome,25,CMBL;CYP1A1;CYP1B1;AADAC;FMO1;FMO2;FMO3;CYP26B1;MAOB;CYP2E1;CYP4B1;CYP7A1;CYP8B1;ACSS1;CYB5B;CYP26A1;ARNT2;AOC3;AHR;CYP2R1;CYP2S1;CYP39A1;CBR3;PTGIS;ADH4,101 (101),0.00148,0.0196,1,HMDB0001860,143 (191),0.695,1,0.00812,0.0806
ceramide signaling pathway,BioCarta,8,IKBKG;AIFM1;KSR1;BCL2;MAP3K1;NFKBIA;BAG4;CHUK,33 (33),0.0656,0.31,1,HMDB0013461,2 (2),0.016,1,0.00826,0.0817
Hematopoietic cell lineage - Homo sapiens (human),KEGG,22,IL11;CD2;CD3D;CD5;CD8A;ANPEP;MS4A1;CD22;CD34;CD37;CD55;ITGA6;CD19;MME;CR2;ITGA3;ITGA5;IL1B;ITGAM;KIT;IL3RA;IL9R,98 (99),0.00951,0.0833,0,,0 (0),1,1,0.00951,0.0833
Nicotinate and Nicotinamide Metabolism,SMPDB,7,NNMT;NNT;BST1;ENPP1;QPRT;NADSYN1;NUDT12,14 (14),0.00111,0.0154,0,,34 (35),1,1,0.00869,0.0857
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,37,ADORA1;CACNA1C;CACNA1D;CACNA1S;SRF;MYH7;PDE3A;PDE3B;GTF2I;ADRB2;MYLK3;MEF2C;SLC25A4;NFATC2;GUCY1A1;GUCY1B1;NFATC4;KNG1;BDKRB2;GATA4;KCNMB1;ADCY4;GNAI1;PLCB4;CREB3L3;ATP1A2;NPR1;ATP2A3;ATP2A1;ADCY2;ATP2B4;NOS3;VASP;ADCY9;MYLK2;ADRA1A;ITPR3,167 (167),0.00124,0.017,0,,10 (10),1,1,0.00954,0.0938
Activation of Matrix Metalloproteinases,Reactome,9,MMP13;TIMP2;MMP17;MMP7;KLKB1;MMP2;PLG;MMP9;CMA1,29 (29),0.0111,0.0945,0,,0 (0),1,1,0.0111,0.0945
Taurine and hypotaurine metabolism - Homo sapiens (human),KEGG,5,BAAT;CDO1;GGT7;GGT1;GGT6,11 (11),0.00987,0.0854,1,HMDB0000036,18 (22),0.136,1,0.0102,0.0999
HIF-1-alpha transcription factor network,PID,16,GATA2;ALDOA;LDHA;HNF4A;BHLHE41;ITGB2;HDAC7;BNIP3;PKM;ABCG2;CXCR4;SMAD3;TFF3;CP;PLIN2;IGFBP1,66 (66),0.0121,0.1,0,,0 (0),1,1,0.0121,0.1
HH-Ncore,Signalink,7,BOC;CDO1;HHIP;ARRB1;GAS1;MTSS1;GPC3,20 (20),0.0121,0.1,0,,0 (0),1,1,0.0121,0.1
Insulin Signaling,Wikipathways,32,PPP1R3A;SGK2;IGF1R;TBC1D4;MAPK12;SHC2;PTPRF;RHOJ;EGR1;PIK3C2G;STXBP1;SGK1;ENPP1;MAP4K1;RPS6KA2;GYS2;PRKAA2;SRF;GRB10;GRB14;PRKCH;PRKCQ;RRAD;MAPK7;MAPK11;MAPK13;MAP3K6;SH2B2;SLC2A4;MAP3K1;MAP3K3;EHD2,160 (160),0.0124,0.103,0,,0 (0),1,1,0.0124,0.103
NCAM signaling for neurite out-growth,Reactome,17,COL4A1;CACNA1S;COL4A2;COL4A4;CACNA1C;CACNA1D;COL6A5;COL6A1;COL6A2;COL6A3;CACNB1;CACNA1I;GFRA1;GFRA2;FGFR1;SPTB;SPTBN2,59 (59),0.00143,0.019,0,,5 (7),1,1,0.0108,0.103
Synthesis and Degradation of Ketone Bodies,Wikipathways,4,BDH1;OXCT1;HMGCS2;ACAT1,5 (5),0.00144,0.019,0,,4 (5),1,1,0.0108,0.103
glycine betaine degradation,HumanCyc,4,BHMT;SHMT1;SARDH;DMGDH,5 (5),0.00144,0.019,0,,11 (11),1,1,0.0108,0.103
fatty acid &alpha;-oxidation,HumanCyc,4,PHYH;ALDH3A2;ACSL1;SLC27A2,5 (5),0.00144,0.019,0,,19 (20),1,1,0.0108,0.103
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Reactome,4,HADHB;ACADL;HADHA;HADH,5 (5),0.00144,0.019,0,,13 (13),1,1,0.0108,0.103
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Reactome,4,HADHB;HADH;ACADM;HADHA,5 (5),0.00144,0.019,0,,13 (13),1,1,0.0108,0.103
Arachidonate production from DAG,Reactome,4,DAGLB;DAGLA;ABHD6;MGLL,5 (5),0.00144,0.019,0,,5 (8),1,1,0.0108,0.103
Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMPDB,4,BDH1;OXCT1;HMGCS2;ACAT1,5 (5),0.00144,0.019,0,,13 (13),1,1,0.0108,0.103
Ketone Body Metabolism,SMPDB,4,BDH1;OXCT1;HMGCS2;ACAT1,5 (5),0.00144,0.019,0,,13 (13),1,1,0.0108,0.103
MAPK Signaling Pathway,Wikipathways,50,TGFB2;TGFB3;CACNA1C;TGFBR2;CACNA1S;FLNA;CACNA2D1;FLNC;IL1B;PTPN7;ARRB1;ARRB2;MAPK12;PDGFB;PDGFRB;MAP4K1;CACNA1D;DUSP1;RASGRP3;FGF21;DUSP4;NTRK2;DUSP7;DUSP8;SRF;NGF;IKBKG;FGF1;FGF2;CACNB1;CACNA1I;RELB;FGFR1;PLA2G4F;NR4A1;MAPK7;MAPK11;PLA2G4E;MAPK13;PAK1;HSPA1A;MAP3K6;HSPA1L;CACNG1;MEF2C;HSPA1B;HSPB1;MAP3K1;CHUK;DUSP10,246 (246),0.00153,0.0201,0,,5 (5),1,1,0.0114,0.109
Relaxin signaling pathway - Homo sapiens (human),KEGG,30,VEGFC;COL3A1;COL4A1;COL4A2;COL4A4;TGFBR2;ADCY4;ARRB1;ARRB2;MAPK12;SHC2;NFKBIA;GNB5;ACTA2;GNAI1;MAPK13;PLCB4;MMP2;CREB3L3;MMP9;MAPK11;MMP13;GNG2;GNG11;GNGT2;ADCY2;NOS3;ADCY9;COL1A1;COL1A2,129 (129),0.00156,0.0204,0,,6 (6),1,1,0.0116,0.11
Cell-extracellular matrix interactions,Reactome,6,FLNA;FLNC;VASP;ARHGEF6;PARVB;FBLIM1,16 (16),0.0139,0.112,0,,0 (1),1,1,0.0139,0.112
bone remodeling,BioCarta,6,IKBKG;TNFRSF11A;FOSL2;NFKBIA;CHUK;FOSL1,16 (16),0.0139,0.112,0,,0 (0),1,1,0.0139,0.112
Ligand-receptor interactions,Reactome,4,CDON;GAS1;BOC;HHIP,8 (8),0.0144,0.114,0,,0 (0),1,1,0.0144,0.114
Warburg Effect,SMPDB,14,PKLR;SUCLG1;PKM;ALDOB;SLC16A1;SUCLG2;PGAM2;SLC1A5;DLST;ACO1;SLC2A2;RPIA;IDH1;GLUD1,45 (45),0.00165,0.0216,0,,52 (58),1,1,0.0122,0.116
Linoleic acid (LA) metabolism,Reactome,5,FADS1;ELOVL5;ELOVL2;ACSL1;FADS2,8 (8),0.0017,0.0219,0,,19 (24),1,1,0.0125,0.117
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMPDB,5,HADH;ACSS3;HSD17B10;ACAT1;ACADL,8 (8),0.0017,0.0219,0,,19 (19),1,1,0.0125,0.117
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMPDB,5,HADH;ACSS3;HSD17B10;ACAT1;ACADL,8 (8),0.0017,0.0219,0,,19 (19),1,1,0.0125,0.117
Butyrate Metabolism,SMPDB,5,HADH;OXCT1;HMGCS2;ACAT1;ACSM1,8 (8),0.0017,0.0219,0,,19 (19),1,1,0.0125,0.117
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Reactome,2,ALOX5;PTGS2,2 (2),0.018,0.135,1,HMDB0002183,13 (28),0.0999,1,0.0131,0.122
RHO GTPase cycle,Reactome,81,FMNL3;DOCK11;LMAN1;VIM;ARHGAP1;STK10;CCP110;MYO6;ARAP3;PAK1;DLG5;SH3RF1;STARD13;PLXND1;ARHGDIB;STARD8;ARHGEF28;CKAP4;WAS;FAM13A;LMNB1;BAIAP2L1;IQGAP2;RHOJ;GFOD1;ARHGEF6;DSP;MYO9A;ARHGAP31;PAK3;ARHGEF7;ARHGAP35;PLEKHG1;TEX2;WASF2;CDC42SE2;ARHGAP4;WASF3;ARHGEF2;ACBD5;FMNL1;PAK6;ABCD3;MCAM;FGD1;ACTG1;KIF14;ARHGAP9;FGD2;NCF2;OBSCN;ARHGAP25;ASB15;CAVIN1;ARHGAP27;CAV1;LBR;LCK;DBT;MCF2L;ALDH3A2;CHN2;DEF6;ARHGEF17;ARHGEF25;ARHGAP45;FGD5;GJA1;CDC42EP3;PCDH7;PREX1;RHOF;SLC1A5;SYDE1;VAV1;PREX2;DLC1;FGD3;IQGAP1;ARHGAP10;FARP2,442 (442),0.00185,0.0238,0,,6 (6),1,1,0.0135,0.125
p130Cas linkage to MAPK signaling for integrins,Reactome,7,FGA;FGB;APBB1IP;FGG;BCAR1;VWF;FN1,15 (15),0.00185,0.0238,0,,6 (8),1,1,0.0135,0.125
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
Homocarnosinosis,SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
Succinic semialdehyde dehydrogenase deficiency,SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
Glutamate Metabolism,SMPDB,9,GLUL;GCLM;ALDH5A1;ABAT;GOT2;NADSYN1;GLUD1;GPT;CPS1,23 (23),0.00191,0.024,0,,47 (49),1,1,0.0138,0.126
Ceramide signalling,Reactome,2,NGF;NGFR,3 (3),0.0491,0.254,1,HMDB0013461,5 (5),0.0396,1,0.0141,0.128
Scavenging by Class A Receptors,Reactome,8,MSR1;COL4A1;COL4A2;COL3A1;MARCO;APOB;COL1A1;COL1A2,19 (19),0.00196,0.0246,0,,11 (32),1,1,0.0142,0.128
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,18,MAPK11;MAPK13;CERS2;ACER2;ADORA1;S1PR2;BDKRB2;GNAI1;KNG1;BCL2;NOS3;GAB2;CERS4;PLCB4;CERS5;MAPK12;S1PR4;SGMS1,119 (119),0.328,0.832,2,HMDB0006752;HMDB0013461,15 (15),0.00608,1,0.0144,0.13
Photodynamic therapy-induced HIF-1 survival signaling,Wikipathways,10,TGFB3;BAK1;LDHA;SLC16A1;IGFBP1;PTGS2;PKM;PMAIP1;BNIP3;ANGPT1,36 (36),0.0171,0.134,0,,0 (0),1,1,0.0171,0.134
ALK1 signaling events,PID,8,GDF2;TGFB3;TGFBR2;SMAD1;CAV1;ARRB2;SMAD9;ACVRL1,26 (26),0.0172,0.134,0,,0 (0),1,1,0.0172,0.134
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways),Wikipathways,14,ELOVL5;ACSL1;HSD17B7;FADS2;ELOVL2;ACOT2;DHCR24;FADS1;TM7SF2;LBR;HMGCS2;NSDHL;IDI1;SC5D,46 (46),0.00209,0.0259,0,,4 (4),1,1,0.015,0.134
Regulation of RhoA activity,PID,14,OBSCN;DLC1;ARHGEF17;ARHGEF25;ARHGAP35;ARHGEF28;ARHGAP4;ARAP3;ARHGAP9;ARHGDIB;VAV1;DEF6;ARHGEF2;MCF2L,46 (46),0.00209,0.0259,0,,3 (3),1,1,0.015,0.134
Matrix Metalloproteinases,Wikipathways,9,MMP12;MMP13;TIMP2;TIMP3;TIMP4;MMP17;MMP2;MMP7;MMP9,31 (31),0.0174,0.135,0,,0 (0),1,1,0.0174,0.135
Transport of connexons to the plasma membrane,Reactome,2,GJA1;GJB2,2 (2),0.018,0.135,0,,0 (1),1,1,0.018,0.135
NFG and proNGF binds to p75NTR,Reactome,2,NGF;NGFR,2 (2),0.018,0.135,0,,0 (0),1,1,0.018,0.135
Glycerophospholipid biosynthesis,Reactome,28,GPD1;ACP6;MFSD2A;GPAT3;MBOAT1;CHPT1;PLA1A;DGAT2;ETNK2;BCHE;OSBPL5;SLC44A2;ABHD3;LPCAT4;LPGAT1;GPAM;MGLL;PNPLA8;PNPLA3;PLA2G6;HADHA;HADHB;SELENOI;DDHD2;PLA2G4E;GPAT4;LCLAT1;PLA2G4F,130 (130),0.00687,0.0659,1,HMDB0010404,47 (94),0.318,1,0.0156,0.139
Primary immunodeficiency - Homo sapiens (human),KEGG,10,BLNK;TNFRSF13C;ADA;IKBKG;CD19;CD79A;CD3D;LCK;CD8A;CIITA,37 (38),0.0207,0.146,0,,0 (0),1,1,0.0207,0.146
Vitamin D in inflammatory diseases,Wikipathways,7,IKBKG;NFKBIA;DUSP1;MAP3K1;SMAD3;CHUK;VDR,22 (22),0.021,0.146,0,,0 (1),1,1,0.021,0.146
Methionine metabolism leading to sulfur amino acids and related disorders,Wikipathways,3,CBS;ADK;CTH,3 (3),0.00241,0.029,0,,16 (21),1,1,0.0169,0.147
COVID-19_ thrombosis and anticoagulation,Wikipathways,3,FGG;FGA;FGB,3 (3),0.00241,0.029,0,,1 (5),1,1,0.0169,0.147
uracil degradation,HumanCyc,3,UPB1;DPYD;DPYS,3 (3),0.00241,0.029,0,,10 (10),1,1,0.0169,0.147
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Reactome,3,HADHB;ACADVL;HADHA,3 (3),0.00241,0.029,0,,13 (13),1,1,0.0169,0.147
Beta oxidation of myristoyl-CoA to lauroyl-CoA,Reactome,3,HADHB;ACADL;HADHA,3 (3),0.00241,0.029,0,,13 (13),1,1,0.0169,0.147
thymine degradation,HumanCyc,3,UPB1;DPYD;DPYS,3 (3),0.00241,0.029,0,,10 (10),1,1,0.0169,0.147
FMO oxidises nucleophiles,Reactome,3,FMO3;FMO1;FMO2,3 (3),0.00241,0.029,0,,12 (13),1,1,0.0169,0.147
Formation of the active cofactor_ UDP-glucuronate,Reactome,3,UGP2;SLC35D1;UGDH,3 (3),0.00241,0.029,0,,10 (10),1,1,0.0169,0.147
Keratan sulfate biosynthesis,Reactome,10,B4GALT2;FMOD;OGN;ST3GAL2;B3GNT7;B4GALT6;CHST1;CHST2;B3GNT3;OMD,28 (28),0.00241,0.029,0,,9 (9),1,1,0.0169,0.147
Mammary gland development pathway - Puberty (Stage 2 of 4),Wikipathways,5,ERBB2;VIM;NRIP1;FOSL1;FN1,13 (13),0.0218,0.151,0,,0 (1),1,1,0.0218,0.151
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,14,NPC1;ANGPTL3;MTTP;LCAT;VLDLR;NCEH1;APOA4;APOB;LIPA;SCARB1;PCSK6;CREB3L3;HDLBP;ALB,60 (60),0.0251,0.17,1,HMDB0010404,13 (21),0.0999,1,0.0175,0.152
actions of nitric oxide in the heart,BioCarta,13,PDE3A;GUCY1A1;FLT4;GUCY1B1;PRKAR2A;PRKAR1B;SLC7A1;NOS3;KDR;BDKRB2;KNG1;PDE3B;CAV1,42 (42),0.00252,0.0303,0,,9 (10),1,1,0.0176,0.152
ABC transporters - Homo sapiens (human),KEGG,13,ABCD3;ABCA6;ABCB11;DEFB1;ABCB4;ABCB6;ABCD2;ABCG5;ABCC4;ABCG2;ABCB7;ABCG8;ABCC2,45 (45),0.00491,0.0507,1,HMDB0039721,88 (138),0.515,1,0.0176,0.152
Omega-9 FA synthesis,Wikipathways,6,ELOVL5;ACSL1;FADS2;ELOVL2;ACOT2;FADS1,12 (12),0.00258,0.0307,0,,1 (1),1,1,0.018,0.154
Beta-oxidation of very long chain fatty acids,Reactome,6,EHHADH;DECR2;ACOX1;ECI2;ACOT4;HSD17B4,12 (12),0.00258,0.0307,0,,16 (26),1,1,0.018,0.154
Alanine and aspartate metabolism,Wikipathways,6,ASPA;ABAT;GOT1;GOT2;GPT;AGXT,12 (12),0.00258,0.0307,0,,19 (20),1,1,0.018,0.154
Biosynthesis of DHA-derived SPMs,Reactome,6,CYP2E1;EPHX2;CYP1A1;ALOX12;ALOX5;PTGS2,17 (17),0.0191,0.141,1,HMDB0002183,18 (75),0.136,1,0.018,0.154
Legionellosis - Homo sapiens (human),KEGG,16,HSPD1;ITGAM;IL1B;CXCL2;HSPA1L;HSPA1A;C3;EEF1A2;NFKBIA;PYCARD;ITGB2;CXCL3;BNIP3;TLR4;TLR5;HSPA1B,57 (57),0.00263,0.0313,0,,1 (2),1,1,0.0183,0.155
Glycosphingolipid metabolism,EHMN,8,PLPP1;ACER2;GAL3ST1;B4GALT6;SLC16A12;SMPD3;NUP35;SGMS1,69 (69),0.723,1,3,HMDB0010711;HMDB0006752;HMDB0013461,40 (52),0.00366,1,0.0184,0.156
Metabolism of Spingolipids in ER and Golgi apparatus,Wikipathways,0,,12 (12),1,1,2,HMDB0010711;HMDB0006752,10 (21),0.00267,1,0.0185,0.157
Metabolism of vitamins and cofactors,Reactome,38,NOS3;TPK1;NUDT12;HSPG2;FOLR2;NADSYN1;SDC2;GPC3;MTHFD1;BST1;VNN1;CYP8B1;ENPP1;QPRT;DHFR;AKR1B10;HLCS;SHMT1;SDC3;THTPA;APOA4;APOB;MCCC2;ALDH1L1;IDH1;SLC25A16;RETSAT;NNMT;PCCA;PCCB;TTPA;SLC23A1;PTGIS;SDC1;PTGS2;PNPO;PANK1;BCO1,180 (180),0.00268,0.0318,0,,136 (188),1,1,0.0186,0.157
Supression of HMGB1 mediated inflammation by THBD,Wikipathways,4,THBD;NFKBIA;CHUK;IKBKG,9 (9),0.0232,0.159,0,,0 (0),1,1,0.0232,0.159
Role of Altered Glycolysation of MUC1 in Tumour Microenvironment,Wikipathways,4,NFKBIA;CHUK;IKBKG;MUC1,9 (9),0.0232,0.159,0,,0 (0),1,1,0.0232,0.159
Prostaglandin formation from arachidonate,EHMN,11,MGST1;PLPP1;GSTK1;SLCO3A1;CBR3;PTGIS;PTGS2;ABCC4;SLC22A1;ALOX12;GSTZ1,33 (33),0.00278,0.0329,0,,43 (48),1,1,0.0192,0.161
Adherens junction - Homo sapiens (human),KEGG,16,PTPRF;PARD3;PTPRM;ACTG1;TGFBR2;ERBB2;IGF1R;WASF2;FGFR1;SNAI1;SMAD3;WASF3;PTPRB;IQGAP1;WAS;FARP2,71 (71),0.0238,0.162,0,,0 (0),1,1,0.0238,0.162
Steroid biosynthesis - Homo sapiens (human),KEGG,8,CYP2R1;TM7SF2;DHCR24;LIPA;HSD17B7;LBR;NSDHL;SC5D,20 (20),0.00289,0.034,0,,40 (58),1,1,0.0198,0.166
Adipogenesis,Wikipathways,26,LIF;LIFR;BMP2;NRIP1;HNF1A;SFRP4;CYP26B1;KLF5;CYP26A1;GATA2;GATA4;AHR;WWTR1;PNPLA3;PPARA;PPARD;GDF10;PTGIS;MEF2C;PCK1;PRLR;SLC2A4;CNTFR;SMAD3;PLIN2;FOXC2,131 (131),0.0247,0.168,0,,0 (0),1,1,0.0247,0.168
NHR,Signalink,12,HNF4A;RARG;THRB;NR2F2;NR1I3;NR1H4;ESRRB;SMAD3;PPARA;PPARD;NR4A1;VDR,49 (49),0.0256,0.171,0,,0 (0),1,1,0.0256,0.171
MAP2K and MAPK activation,Reactome,12,FGA;FGB;IQGAP1;KSR1;IL17RD;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,38 (38),0.00303,0.0353,0,,6 (15),1,1,0.0206,0.172
Regulation of RAC1 activity,PID,12,CHN2;ARHGEF25;ARHGEF6;ARHGAP1;ARHGEF7;EPS8;PREX1;ARHGAP9;VAV1;PREX2;DEF6;ARHGEF2,38 (38),0.00303,0.0353,0,,3 (3),1,1,0.0206,0.172
Alpha 6 Beta 4 signaling pathway,Wikipathways,9,ITGB4;LAMA2;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;LAMC2;LAMA5,33 (33),0.026,0.173,0,,0 (0),1,1,0.026,0.173
Lysine degradation - Homo sapiens (human),KEGG,17,ALDH3A2;PIPOX;DHTKD1;ACAT1;HYKK;EHHADH;ALDH7A1;AASS;GCDH;PRDM16;AADAT;HADHA;HADH;PHYKPL;BBOX1;DLST;ALDH9A1,63 (63),0.0031,0.036,0,,40 (50),1,1,0.021,0.175
ctcf: first multivalent nuclear factor,BioCarta,7,TGFB2;TGFB3;TGFBR2;CD79A;CD79B;SMAD1;SMAD6,23 (23),0.0268,0.176,0,,0 (0),1,1,0.0268,0.176
TGF-beta Receptor Signaling,Wikipathways,13,RUNX3;SPP1;LIF;TGFBR3;BAMBI;ITGB6;THBS1;TGFBR2;LTBP1;SMAD1;SMAD3;SMAD6;SMAD9,55 (55),0.0273,0.18,0,,0 (0),1,1,0.0273,0.18
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,15,SUCLG2;SUCLG1;LDHA;SLC16A1;ME1;L2HGDH;LDHB;NNT;PDK4;DLST;ADHFE1;ME2;PDP1;ME3;GSTZ1,53 (53),0.00324,0.0373,0,,38 (44),1,1,0.0218,0.18
Cardiac Progenitor Differentiation,Wikipathways,15,TBX20;GATA4;PDGFRA;FGF2;KIT;CXCR4;ANPEP;KDR;MEF2C;SIRPA;ROR2;MYL2;SCN5A;THY1;MYLK3,53 (53),0.00324,0.0373,0,,1 (1),1,1,0.0218,0.18
nfkb activation by nontypeable hemophilus influenzae,BioCarta,10,MAPK11;IL1B;TGFB2;TGFB3;IKBKG;TGFBR2;NFKBIA;DUSP1;SMAD3;CHUK,29 (29),0.00324,0.0373,0,,1 (1),1,1,0.0218,0.18
Regulatory circuits of the STAT3 signaling pathway,Wikipathways,17,MAPK11;GHR;IFNGR1;PDGFRA;PDGFRB;IL2RB;LIFR;CNTFR;PTPRD;MAPK13;MAPK7;IL21R;IL27RA;MAPK12;IL9R;DEPTOR;IL3RA,78 (78),0.0275,0.18,0,,0 (0),1,1,0.0275,0.18
Sphingolipid metabolism,Reactome,13,ALDH3A2;PRKD3;PLPP2;ACER2;PRKD2;PLPP1;CERK;CERS4;ARSG;SMPD3;CERS2;CERS5;SGMS1,87 (87),0.382,0.88,3,HMDB0010711;HMDB0013461;HMDB0006752,54 (65),0.00856,1,0.022,0.181
RHOC GTPase cycle,Reactome,19,ABCD3;FMNL3;STARD13;ARHGEF17;ARHGEF25;ARHGEF28;ARHGAP1;STK10;PREX1;MCAM;ARHGAP35;CAVIN1;CAV1;LBR;DLC1;ACBD5;IQGAP1;LMAN1;MCF2L,74 (74),0.00338,0.0385,0,,4 (4),1,1,0.0226,0.185
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,5,GCLM;CTH;CDO1;GOT1;MPST,9 (9),0.00339,0.0385,0,,26 (26),1,1,0.0227,0.185
Cysteine Metabolism,SMPDB,5,GCLM;CTH;CDO1;GOT1;MPST,9 (9),0.00339,0.0385,0,,26 (26),1,1,0.0227,0.185
Cystinosis_ ocular nonnephropathic,SMPDB,5,GCLM;CTH;CDO1;GOT1;MPST,9 (9),0.00339,0.0385,0,,26 (26),1,1,0.0227,0.185
Threonine and 2-Oxobutanoate Degradation,SMPDB,5,PCCB;SDS;BCKDHB;DBT;PCCA,9 (9),0.00339,0.0385,0,,17 (19),1,1,0.0227,0.185
Neutrophil degranulation,Reactome,80,A1BG;CRISPLD2;CD93;QSOX1;STK10;MGAM;ORM2;AMPD3;CPPED1;CKAP4;ADGRG3;PTPRB;SLC11A1;HSPA1B;MGST1;ANPEP;IQGAP2;TIMP2;PGRMC1;DSP;BST1;VNN1;PLEKHO2;ANXA2;ITGAL;CD300A;PYCARD;SIRPA;PECAM1;SYNGR1;DOK3;SLPI;C3;SLC44A2;KCNAB2;PKM;CD55;AHSG;CD63;PYGB;PSMD1;PYGL;ARHGAP9;UNC13D;C3AR1;ADGRE5;CREG1;CDA;BIN2;LGALS3;MME;C5AR1;NFAM1;IDH1;CAT;FGR;IQGAP1;MMP9;ADAM8;XRCC5;ALDOA;PIGR;ITGAM;ARHGAP45;ADAM10;HPSE;PADI2;HVCN1;HSPA1A;RHOF;COTL1;ALOX5;CNN2;PRDX6;GSN;ITGB2;SLC27A2;CEACAM1;FGL2;ARG1,486 (487),0.0283,0.185,0,,0 (0),1,1,0.0283,0.185
Platelet homeostasis,Reactome,21,PDE9A;PAFAH2;ATP2A1;GUCY1A1;GNG11;ATP2A3;PTGIR;GUCY1B1;ATP2B4;NOS3;PECAM1;APOB;P2RX7;P2RX6;KCNMB1;GNGT2;GNB5;GNG2;FGR;ITPR3;PDE10A,85 (85),0.0035,0.0396,0,,24 (28),1,1,0.0233,0.189
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition,Wikipathways,5,SMAD3;FN1;TNC;SNAI1;VIM,14 (14),0.0303,0.196,0,,0 (0),1,1,0.0303,0.196
superpathway of cholesterol biosynthesis,HumanCyc,9,HSD17B7;TM7SF2;SC5D;ACAT1;DHCR24;NSDHL;HMGCS2;LBR;IDI1,25 (25),0.00371,0.0417,0,,40 (62),1,1,0.0245,0.198
SHP2 signaling,PID,16,NGF;TEK;IFNGR1;PDGFRB;IL2RB;ANGPT1;NOS3;SDC2;GNAI1;PDGFB;GAB2;IGF1R;NTRK2;KDR;LCK;ARHGAP35,59 (59),0.00384,0.042,0,,6 (6),1,1,0.0252,0.198
Smooth Muscle Contraction,Reactome,12,TPM1;CALD1;DYSF;TPM2;TRIM72;GUCY1A1;MYLPF;ACTG2;LMOD1;GUCY1B1;ANXA2;ACTA2,39 (39),0.00385,0.042,0,,9 (9),1,1,0.0253,0.198
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Reactome,4,HADHB;HADH;ACADM;HADHA,6 (6),0.00385,0.042,0,,15 (15),1,1,0.0253,0.198
Phenylalanine_ tyrosine and tryptophan biosynthesis - Homo sapiens (human),KEGG,4,TAT;GOT1;GOT2;PAH,6 (6),0.00385,0.042,0,,18 (34),1,1,0.0253,0.198
threonine degradation,HumanCyc,4,SDS;BCKDHB;SDSL;DBT,6 (6),0.00385,0.042,0,,8 (8),1,1,0.0253,0.198
lysine degradation II (pipecolate pathway),HumanCyc,4,AADAT;PIPOX;ALDH7A1;DHTKD1,6 (6),0.00385,0.042,0,,21 (21),1,1,0.0253,0.198
Alpha-oxidation of phytanate,Reactome,4,ALDH3A2;SLC27A2;PHYH;PECR,6 (6),0.00385,0.042,0,,23 (27),1,1,0.0253,0.198
mitochondrial L-carnitine shuttle,HumanCyc,4,CPT2;CPT1C;CPT1A;CRAT,6 (6),0.00385,0.042,0,,10 (12),1,1,0.0253,0.198
zymosterol biosynthesis,HumanCyc,4,LBR;TM7SF2;HSD17B7;NSDHL,6 (6),0.00385,0.042,0,,16 (22),1,1,0.0253,0.198
ethanol degradation IV,HumanCyc,4,ALDH3A2;ACSS3;ACSS1;CAT,6 (6),0.00385,0.042,0,,13 (13),1,1,0.0253,0.198
Refsum Disease,SMPDB,4,PHYH;SLC27A2;ALDH3A2;ABCD2,6 (6),0.00385,0.042,0,,22 (24),1,1,0.0253,0.198
Phytanic Acid Peroxisomal Oxidation,SMPDB,4,PHYH;SLC27A2;ALDH3A2;ABCD2,6 (6),0.00385,0.042,0,,22 (24),1,1,0.0253,0.198
Plasma lipoprotein remodeling,Reactome,7,ANGPTL3;LCAT;APOA4;APOB;ALB;PCSK6;CREB3L3,26 (26),0.0503,0.26,1,HMDB0010404,10 (16),0.0777,1,0.0256,0.2
Pyrimidine catabolism,Reactome,5,AGXT2;UPP2;UPB1;DPYD;DPYS,12 (12),0.0151,0.119,1,HMDB0000273,37 (39),0.26,1,0.0256,0.2
Signaling by PDGF,Reactome,15,COL4A1;PDGFB;PDGFRA;COL4A4;PDGFRB;SPP1;BCAR1;COL6A1;COL6A2;COL6A3;COL6A5;THBS1;PDGFD;COL4A2;PLG,54 (54),0.00394,0.0428,0,,7 (17),1,1,0.0258,0.201
Splicing factor NOVA regulated synaptic proteins,Wikipathways,6,GABBR2;EPB41L3;CLSTN1;EPB41L1;PLCB4;CAV2,42 (42),0.501,0.995,1,HMDB0009888,1 (1),0.00805,1,0.0263,0.201
Imatinib and Chronic Myeloid Leukemia,Wikipathways,8,LYL1;PDGFRA;KIT;PDGFRB;ABCG2;GAB2;ABL1;SPRED2,21 (21),0.00413,0.0447,0,,2 (2),1,1,0.0268,0.201
Ornithine Aminotransferase Deficiency (OAT Deficiency),SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Hyperornithinemia with gyrate atrophy (HOGA),SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Creatine deficiency_ guanidinoacetate methyltransferase deficiency,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
L-arginine:glycine amidinotransferase deficiency,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Prolinemia Type II,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Prolidase Deficiency (PD),SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Arginine and Proline Metabolism,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Hyperprolinemia Type I,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Hyperprolinemia Type II,SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMPDB,7,OAT;OTC;GOT1;SLC25A15;GLUD1;CPS1;ARG1,20 (20),0.0121,0.1,1,HMDB0000128,52 (52),0.346,1,0.0272,0.201
chondroitin sulfate biosynthesis (late stages),HumanCyc,6,CHST15;CHSY1;CHST12;CHST11;CHST2;CHST3,13 (13),0.00425,0.0449,0,,4 (5),1,1,0.0275,0.201
Phenylalanine degradation,INOH,6,MAOB;DDC;TAT;GOT1;GOT2;AOC3,13 (13),0.00425,0.0449,0,,14 (14),1,1,0.0275,0.201
cholesterol biosynthesis II (via 24_25-dihydrolanosterol),HumanCyc,6,TM7SF2;SC5D;DHCR24;HSD17B7;LBR;NSDHL,13 (13),0.00425,0.0449,0,,19 (32),1,1,0.0275,0.201
cholesterol biosynthesis III (via desmosterol),HumanCyc,6,TM7SF2;SC5D;DHCR24;HSD17B7;LBR;NSDHL,13 (13),0.00425,0.0449,0,,24 (32),1,1,0.0275,0.201
cholesterol biosynthesis I,HumanCyc,6,TM7SF2;SC5D;DHCR24;HSD17B7;LBR;NSDHL,13 (13),0.00425,0.0449,0,,24 (32),1,1,0.0275,0.201
Phenylalanine and tyrosine metabolism,Reactome,6,FAH;HGD;HPD;PAH;TAT;GSTZ1,13 (13),0.00425,0.0449,0,,30 (33),1,1,0.0275,0.201
Glycerol Kinase Deficiency,SMPDB,6,PLPP1;PLPP2;GPAM;GPD1;GK;GLYCTK,13 (13),0.00425,0.0449,0,,24 (24),1,1,0.0275,0.201
Glycerolipid Metabolism,SMPDB,6,PLPP1;PLPP2;GPAM;GPD1;GK;GLYCTK,13 (13),0.00425,0.0449,0,,24 (24),1,1,0.0275,0.201
eNOS activation,Reactome,6,LYPLA1;CYGB;DDAH2;NOS3;DDAH1;CAV1,13 (13),0.00425,0.0449,0,,26 (26),1,1,0.0275,0.201
Familial lipoprotein lipase deficiency,SMPDB,6,PLPP1;PLPP2;GPAM;GPD1;GK;GLYCTK,13 (13),0.00425,0.0449,0,,24 (24),1,1,0.0275,0.201
D-glyceric acidura,SMPDB,6,PLPP1;PLPP2;GPAM;GPD1;GK;GLYCTK,13 (13),0.00425,0.0449,0,,24 (24),1,1,0.0275,0.201
Biosynthesis of maresins,Reactome,3,ALOX5;CYP2E1;EPHX2,8 (8),0.0801,0.356,1,HMDB0002183,7 (23),0.055,1,0.0283,0.207
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,8,AJUBA;DCHS1;RASSF6;RASSF2;PAK1;CSNK1E;WWTR1;FRMD6,29 (29),0.0328,0.211,0,,0 (0),1,1,0.0328,0.211
role of mal in rho-mediated activation of srf,BioCarta,6,SRF;MAP3K1;HNF1A;LIMK1;MAL;ACTA1,19 (19),0.0331,0.211,0,,0 (0),1,1,0.0331,0.211
Senescence and Autophagy in Cancer,Wikipathways,14,IL1B;IGFBP7;CREG1;COL3A1;BMP2;CXCL14;IGF1R;THBS1;BCL2;SMAD3;GSN;VTN;COL1A1;FN1,106 (106),0.567,1,1,HMDB0009888,1 (1),0.00805,1,0.0292,0.213
Validated targets of C-MYC transcriptional repression,PID,16,NDRG2;SPI1;IRF8;SFRP1;PDGFRB;ITGA6;ITGB4;ERBB2;LGALS1;HMGCS2;SMAD3;BCL2;ALDH9A1;SLC11A1;COL1A2;SFXN3,74 (74),0.034,0.215,0,,0 (0),1,1,0.034,0.215
T-cell receptor (TCR) signaling pathway,Wikipathways,19,LAT;IL1B;PAK1;IKBKG;VIM;CARD11;MAP4K1;VAV1;CCR5;CD3D;PRKCQ;GAB2;NFKBIA;GRAP2;CHUK;LCK;CD8A;WAS;NFATC2,92 (92),0.0346,0.215,0,,0 (0),1,1,0.0346,0.215
Corticotropin-releasing hormone signaling pathway,Wikipathways,19,NFKBIA;TLR4;GJA1;RAPGEF3;FOSB;NOS3;CAMK2A;BCL2;PLCG2;GNAI1;FOSL2;PRKCQ;CASP12;GNB5;ARRB1;ARRB2;PRKAA2;NR4A1;FOSL1,92 (92),0.0346,0.215,0,,0 (0),1,1,0.0346,0.215
VEGF and VEGFR signaling network,PID,4,VEGFC;NRP2;FLT4;KDR,10 (10),0.0346,0.215,0,,0 (0),1,1,0.0346,0.215
NADE modulates death signalling,Reactome,3,BEX3;NGF;NGFR,6 (6),0.0351,0.215,0,,0 (0),1,1,0.0351,0.215
RUNX1 regulates transcription of genes involved in BCR signaling,Reactome,3,BLK;RUNX1;PAX5,6 (6),0.0351,0.215,0,,0 (0),1,1,0.0351,0.215
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,9,MAPK11;PAK1;ADORA2B;ARHGEF7;RAPGEF3;ADCY2;MAP3K1;NFKBIA;CHUK,38 (38),0.0599,0.296,1,HMDB0009888,10 (10),0.0777,1,0.0296,0.216
Alpha Linolenic Acid and Linoleic Acid Metabolism,SMPDB,3,FADS1;ELOVL5;FADS2,6 (6),0.0351,0.215,1,HMDB0002183,18 (18),0.136,1,0.0303,0.22
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,14,CHST15;CHST14;SDC3;HSPG2;HYAL1;SDC1;CHST12;CHSY1;CHST11;VCAN;SDC2;CHST3;DSEL;GPC3,50 (50),0.00487,0.0506,0,,12 (24),1,1,0.0308,0.222
Sensory processing of sound by outer hair cells of the cochlea,Reactome,14,EPB41L3;KCNMB1;KCNN2;XIRP2;RIPOR2;EPS8;KCNQ4;TWF2;EPS8L2;EPB41L1;GSN;TPRN;CLIC5;MSN,50 (50),0.00487,0.0506,0,,6 (7),1,1,0.0308,0.222
Malaria - Homo sapiens (human),KEGG,14,IL1B;TGFB2;TGFB3;ITGB2;HGF;CCL2;SDC1;SDC2;THBS1;ITGAL;PECAM1;TLR9;TLR4;COMP,50 (50),0.00487,0.0506,0,,3 (5),1,1,0.0308,0.222
Arginine and proline metabolism - Homo sapiens (human),KEGG,13,ALDH3A2;MAOB;CKM;L3HYPDH;CKMT2;NOS3;ALDH7A1;OAT;ALDH18A1;GOT1;GOT2;ARG1;ALDH9A1,50 (51),0.0126,0.104,1,HMDB0000128,60 (78),0.388,1,0.0309,0.222
Glycolysis and Gluconeogenesis,Wikipathways,13,PKLR;ALDOA;PKM;ALDOB;PGAM2;LDHB;ENO3;PCK1;SLC2A2;LDHA;GOT1;GOT2;SLC2A4,45 (45),0.00491,0.0507,0,,14 (18),1,1,0.031,0.223
Ectoderm Differentiation,Wikipathways,27,CCDC88C;FZD4;SOCS2;GRAMD1B;BOC;PODXL;ABCC4;RGMA;PTPRB;FZD8;ARHGAP10;BCAS3;ELOVL2;ROR2;GATA6;POU2F2;CCL2;HMGB2;KIFC3;PPARD;PRKAG2;BCOR;FHL2;EDA2R;NR2F2;NARS2;CDON,142 (142),0.0368,0.224,0,,0 (0),1,1,0.0368,0.224
Transport of vitamins_ nucleosides_ and related molecules,Reactome,10,SLC29A3;SLC35D1;SLC25A4;SLC28A2;SLCO3A1;SLC16A2;SLC35B4;SLC35A3;ALB;APOD,44 (44),0.0624,0.305,2,HMDB0000036;HMDB0000273,59 (63),0.0802,1,0.0315,0.225
Signaling by BMP,Reactome,9,GDF2;BMP10;BMP2;CHRDL1;SMAD1;SMAD6;SMAD9;ACVRL1;FSTL1,26 (26),0.00501,0.0514,0,,2 (2),1,1,0.0315,0.225
Glypican 1 network,PID,9,BLK;TGFB3;FGF2;TGFBR2;FGR;SERPINC1;FGFR1;LCK;APP,26 (26),0.00501,0.0514,0,,2 (2),1,1,0.0315,0.225
Cell migration and invasion through p75NTR,Wikipathways,8,PARD3;PAK1;NGFR;CDH11;NTRK2;MMP2;EFNB2;MMP9,30 (30),0.0396,0.228,0,,0 (0),1,1,0.0396,0.228
BMP2 signaling TAK1,INOH,5,MAPK11;BMP2;MAPK13;MAPK12;SMAD6,15 (15),0.0406,0.231,0,,0 (0),1,1,0.0406,0.231
Regulation of Actin Cytoskeleton,Wikipathways,32,VIL1;LIMK1;MYL1;MYL3;WAS;FN1;PDGFB;PDGFRA;PDGFRB;PIK3C2G;PAK6;ARHGEF7;PAK3;WASF2;FGF21;PIP4K2A;ENAH;PAK1;FGD1;FGF1;FGF2;TMSB4X;FGFR1;ACTG1;BCAR1;ARHGAP35;BDKRB2;VAV1;ARHGEF6;GSN;IQGAP1;MSN,151 (151),0.00523,0.0536,0,,4 (5),1,1,0.0327,0.233
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,Wikipathways,7,TGFBR2;TGFBR3;FLNA;FBN1;LTBP1;LTBP2;SMAD3,25 (25),0.0414,0.233,0,,0 (0),1,1,0.0414,0.233
VEGFR3 signaling in lymphatic endothelium,PID,7,VEGFC;MAPK11;FLT4;COL1A2;COL1A1;ITGA5;FN1,25 (25),0.0414,0.233,0,,0 (0),1,1,0.0414,0.233
IL-17 signaling pathway - Homo sapiens (human),KEGG,19,MAPK11;IL1B;MMP13;MAPK13;IKBKG;CXCL5;CXCL2;CXCL3;CCL2;PTGS2;FOSB;CCL11;MAPK7;NFKBIA;IL17RB;CHUK;MAPK12;FOSL1;MMP9,94 (94),0.0421,0.233,0,,0 (0),1,1,0.0421,0.233
TGF-beta signaling TAK1,INOH,6,MAPK11;TGFB2;MAPK13;TGFBR2;TGFB3;MAPK12,20 (20),0.0421,0.233,0,,0 (0),1,1,0.0421,0.233
Nuclear Events (kinase and transcription factor activation),Reactome,16,MAPK11;LYL1;ARC;EGR1;EGR3;SRF;SGK1;MEF2C;ID4;FOSB;RPS6KA2;DUSP4;DUSP7;RRAD;FOSL1;MAPK7,61 (61),0.00548,0.056,0,,4 (4),1,1,0.034,0.241
rac1 cell motility signaling pathway,BioCarta,9,NCF2;PAK1;PDGFRA;ARHGAP1;ARHGAP4;LIMK1;VAV1;MAP3K1;MYL2,36 (36),0.0441,0.242,0,,0 (0),1,1,0.0441,0.242
Trans-sulfuration and one-carbon metabolism,Wikipathways,10,SHMT1;GCLM;CBS;CTH;MAT1A;AMT;DHFR;BHMT;MTHFD1;AHCY,31 (31),0.00558,0.0567,0,,31 (33),1,1,0.0346,0.244
Statin inhibition of cholesterol production,Wikipathways,10,LCAT;APOA5;CYP7A1;ABCG5;APOA4;APOB;MTTP;ACSS1;SCARB1;ABCG8,31 (31),0.00558,0.0567,0,,8 (17),1,1,0.0346,0.244
Regulation of p38-alpha and p38-beta,PID,10,BLK;MAPK11;PAK1;PAK3;FGR;DUSP1;DUSP10;MAP3K3;DUSP8;LCK,31 (31),0.00558,0.0567,0,,2 (2),1,1,0.0346,0.244
Heroin metabolism,Wikipathways,1,BCHE,3 (3),0.351,0.834,1,HMDB0041812,2 (3),0.016,1,0.0347,0.244
Metabolism of water-soluble vitamins and cofactors,Reactome,25,TPK1;NUDT12;FOLR2;NADSYN1;MTHFD1;BST1;VNN1;CYP8B1;ENPP1;QPRT;DHFR;HLCS;SHMT1;THTPA;MCCC2;ALDH1L1;SLC25A16;NNMT;PCCA;PCCB;PANK1;SLC23A1;PTGIS;PTGS2;PNPO,111 (111),0.00571,0.0576,0,,91 (125),1,1,0.0352,0.247
Complement Activation,Wikipathways,8,MASP2;CD55;C3;C6;C7;C8A;C8B;C9,22 (22),0.00574,0.0576,0,,1 (1),1,1,0.0353,0.247
Histidine metabolism - Homo sapiens (human),KEGG,8,ALDH3A2;MAOB;HNMT;ALDH7A1;UROC1;HAL;ASPA;ALDH9A1,22 (22),0.00574,0.0576,0,,36 (47),1,1,0.0353,0.247
Arachidonic acid metabolism,Reactome,15,PTGES;PON1;EPHX2;PON3;CYP1A1;DPEP1;CYP4B1;PTGR2;PTGIS;CYP8B1;PTGS2;ALOX5;GGT1;CYP1B1;ALOX12,60 (60),0.0112,0.095,1,HMDB0010404,89 (114),0.519,1,0.0356,0.248
Tyrosine metabolism - Homo sapiens (human),KEGG,11,MAOB;FAH;HGD;GSTZ1;DDC;TAT;GOT1;GOT2;ADH4;HPD;AOC3,36 (36),0.0059,0.0592,0,,58 (78),1,1,0.0362,0.252
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,50,GHR;IFNGR1;IL11;TGFBR2;LIFR;BMP2;BMP5;BMP6;CXCR3;CXCL13;TGFB2;ACVR1B;IL2RB;BMP10;CXCR6;TNFSF9;INHBC;CXCR4;ACKR3;LIF;IL21R;CXCL2;TGFB3;TNFRSF13C;NGF;NGFR;IL1B;CCL2;CCR5;CCL11;CCR2;TNFRSF11A;TNFRSF10B;ACVRL1;CCL24;GDF2;CXCL5;GDF10;INHBE;CX3CL1;CXCL3;IL3RA;CXCL14;LTB;EDA2R;PRLR;IL17RB;CNTFR;IL27RA;IL9R,295 (295),0.046,0.252,0,,0 (0),1,1,0.046,0.252
Neural Crest Cell Migration in Cancer,Wikipathways,10,EPHB2;PAK1;NGFR;PAK3;EPHB4;CDH11;NTRK2;MMP2;PAK6;MMP9,42 (42),0.0472,0.254,0,,0 (0),1,1,0.0472,0.254
Tight junction interactions,Reactome,8,PARD3;PARD6B;CLDN12;CLDN5;CLDN2;CLDN4;CLDN7;CLDN1,31 (31),0.0474,0.254,0,,0 (0),1,1,0.0474,0.254
RUNX3 regulates RUNX1-mediated transcription,Reactome,2,RUNX3;RUNX1,3 (3),0.0491,0.254,0,,0 (0),1,1,0.0491,0.254
Felodipine Metabolism Pathway,SMPDB,2,CACNB1;CACNA1C,3 (3),0.0491,0.254,0,,0 (1),1,1,0.0491,0.254
resolvin D biosynthesis,HumanCyc,1,ALOX5,2 (2),0.25,0.699,1,HMDB0002183,3 (5),0.024,1,0.0367,0.254
Ketone body metabolism,Reactome,5,HMGCS2;ACSS3;OXCT1;ACAT1;BDH1,10 (10),0.00604,0.0603,0,,15 (16),1,1,0.0369,0.256
Phospholipid Biosynthesis,SMPDB,5,GPD1;LYPLA1;PLPP1;CHPT1;GPAM,28 (28),0.319,0.818,2,HMDB0009888;HMDB0010404,27 (27),0.0192,1,0.0373,0.258
pyrimidine deoxyribonucleosides degradation,HumanCyc,2,CDA;UPP2,4 (4),0.0895,0.377,1,HMDB0000273,9 (10),0.0702,1,0.0382,0.259
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,20,PLPP5;CHPT1;LPCAT4;PLPP2;PLA1A;LPGAT1;PLA2G4E;PLPP1;GPAT4;LYPLA1;PLA2G6;GPD1;GPAM;PLA2G4F;LCLAT1;ETNK2;SELENOI;GPAT3;LCAT;MBOAT1,98 (98),0.0344,0.215,1,HMDB0010404,25 (55),0.184,1,0.0383,0.259
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,Wikipathways,3,TFEB;NOS3;GRB10,30 (30),0.786,1,1,HMDB0009888,1 (1),0.00805,1,0.0384,0.259
Tyrosinemia_ transient_ of the newborn,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Metabolism of nitric oxide: NOS3 activation and regulation,Reactome,7,LYPLA1;CYGB;DDAH2;NOS3;DDAH1;CAV1;ASB15,18 (18),0.00635,0.062,0,,26 (26),1,1,0.0385,0.259
Dopamine beta-hydroxylase deficiency,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Tyrosine Metabolism,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Alkaptonuria,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Monoamine oxidase-a deficiency (MAO-A),SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Hawkinsinuria,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Tyrosinemia Type I,SMPDB,7,FAH;HGD;GSTZ1;DDC;TAT;GOT1;HPD,18 (18),0.00635,0.062,0,,62 (67),1,1,0.0385,0.259
Basigin interactions,Reactome,7,SLC7A6;SLC7A8;SPN;SLC16A1;ITGA6;CAV1;ITGA3,26 (26),0.0503,0.26,0,,0 (0),1,1,0.0503,0.26
IL-7 signaling,INOH,33,TGFBR2;FLT4;IGF1R;RIPK3;MAPK12;ACVR1B;PDGFRA;PDGFRB;PAK6;CSNK1E;CAMK2A;RPS6KA2;ACVRL1;MAPK7;PRKAA2;PAK1;NGFR;IKBKG;PRKAR1B;PRKAR2A;PRKCH;FGFR1;KDR;LCK;PRKAG2;MAPK11;MAPK13;KIT;GFRA1;MAP3K1;MAP3K3;PRKCQ;CHUK,185 (185),0.0512,0.264,0,,0 (0),1,1,0.0512,0.264
Osteoblast Signaling,Wikipathways,6,PDGFB;PDGFRA;SLC17A2;PDGFRB;PTH1R;COL1A1,14 (14),0.0066,0.0637,0,,2 (3),1,1,0.0398,0.266
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,6,CYP39A1;PTGIS;CYP8B1;SLC27A5;SLC27A2;AKR1D1,14 (14),0.0066,0.0637,0,,20 (29),1,1,0.0398,0.266
&gamma;-linolenate biosynthesis,HumanCyc,6,ACSL1;FADS2;ACSM5;ACSM3;SLC27A2;ACSM1,14 (14),0.0066,0.0637,0,,9 (9),1,1,0.0398,0.266
classical complement pathway,BioCarta,6,C3;C6;C7;C8A;C8B;C9,14 (14),0.0066,0.0637,0,,2 (2),1,1,0.0398,0.266
Integrin signaling,Reactome,9,FGA;FGB;RAPGEF3;RAPGEF4;APBB1IP;VWF;BCAR1;FGG;FN1,27 (27),0.00664,0.0638,0,,9 (12),1,1,0.0399,0.266
triacylglycerol biosynthesis,HumanCyc,9,PLPP1;PLPP2;DGAT2;GPAT4;GPAM;LPCAT4;LCLAT1;GPAT3;MBOAT1,27 (27),0.00664,0.0638,0,,24 (43),1,1,0.0399,0.266
IGF-Ncore,Signalink,5,ARRB1;IGFBP1;GRAP;SGK1;GRB10,16 (16),0.0527,0.267,0,,0 (0),1,1,0.0527,0.267
ABC-family proteins mediated transport,Reactome,12,PEX19;ABCD3;ABCA6;ABCD2;ABCB4;ABCB6;ABCG5;ABCC4;ABCB7;PEX3;ABCG8;ABCC2,58 (58),0.0806,0.358,1,HMDB0013461,11 (20),0.0852,1,0.0411,0.273
EPO signaling,INOH,33,TGFBR2;FLT4;IGF1R;RIPK3;MAPK12;ACVR1B;PDGFRA;PDGFRB;PAK6;CSNK1E;CAMK2A;RPS6KA2;ACVRL1;MAPK7;PRKAA2;PAK1;NGFR;IKBKG;PRKAR1B;PRKAR2A;PRKCH;FGFR1;KDR;LCK;PRKAG2;MAPK11;MAPK13;KIT;GFRA1;MAP3K1;MAP3K3;PRKCQ;CHUK,186 (186),0.0545,0.276,0,,0 (0),1,1,0.0545,0.276
NrCAM interactions,Reactome,3,NRP2;ANK1;DLG4,7 (7),0.0554,0.278,0,,0 (0),1,1,0.0554,0.278
Oxytocin signaling pathway - Homo sapiens (human),KEGG,32,CACNA1C;CACNA1D;CACNA1S;CACNA2D1;CACNB1;NPR1;CACNG1;ADCY4;CAMK1D;MYLK3;NFATC2;GUCY1A1;GUCY1B1;NFATC4;CAMK2A;MAPK7;KCNJ12;PRKAA2;ACTG1;GNAI1;PLCB4;PLA2G4F;PRKAG2;PLA2G4E;ADCY2;NOS3;PTGS2;MEF2C;ADCY9;RYR1;MYLK2;ITPR3,154 (154),0.00708,0.0678,0,,11 (12),1,1,0.0421,0.279
Citrate cycle,INOH,10,PKLR;SUCLG1;PKM;ACAT1;SUCLG2;FAH;ENO3;DLST;ACO1;PCK1,32 (32),0.00716,0.0684,0,,35 (35),1,1,0.0425,0.281
Validated transcriptional targets of TAp63 isoforms,PID,12,NQO1;PERP;CHUK;ADA;ITGB4;EVPL;MFGE8;WWP1;PMAIP1;ABL1;ITGA3;VDR,55 (55),0.0575,0.286,0,,0 (0),1,1,0.0575,0.286
Signaling downstream of RAS mutants,Reactome,12,FGA;FGB;IQGAP1;KSR1;CAMK2A;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,42 (42),0.00744,0.0699,0,,6 (9),1,1,0.0439,0.287
Signaling by RAS mutants,Reactome,12,FGA;FGB;IQGAP1;KSR1;CAMK2A;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,42 (42),0.00744,0.0699,0,,6 (9),1,1,0.0439,0.287
Signaling by moderate kinase activity BRAF mutants,Reactome,12,FGA;FGB;IQGAP1;KSR1;CAMK2A;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,42 (42),0.00744,0.0699,0,,6 (9),1,1,0.0439,0.287
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,12,FGA;FGB;IQGAP1;KSR1;CAMK2A;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,42 (42),0.00744,0.0699,0,,6 (10),1,1,0.0439,0.287
Signaling by RAF1 mutants,Reactome,12,FGA;FGB;IQGAP1;KSR1;CAMK2A;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;FGG;FN1,42 (42),0.00744,0.0699,0,,6 (9),1,1,0.0439,0.287
Binding and Uptake of Ligands by Scavenger Receptors,Reactome,12,MSR1;COL4A1;COL4A2;COL3A1;STAB1;SSC5D;MARCO;APOB;SCARB1;COL1A1;COL1A2;ALB,42 (42),0.00744,0.0699,0,,15 (41),1,1,0.0439,0.287
G13 Signaling Pathway,Wikipathways,9,IQGAP2;PAK3;ARHGDIB;LIMK1;WAS;MYL1;PIP4K2A;IQGAP1;SH3RF1,38 (38),0.0599,0.296,0,,0 (0),1,1,0.0599,0.296
Histidine degradation,INOH,8,ALDH3A2;MAOB;HNMT;ALDH7A1;ALDH1A2;HAL;AOC3;ALDH9A1,23 (23),0.00778,0.0728,0,,26 (28),1,1,0.0455,0.297
Cholesterol Biosynthesis with Skeletal Dysplasias,Wikipathways,4,LBR;NSDHL;SC5D;DHCR24,7 (7),0.00804,0.0742,0,,12 (14),1,1,0.0468,0.301
oxidative ethanol degradation III,HumanCyc,4,ALDH3A2;CYP2E1;ACSS1;ACSS3,7 (7),0.00804,0.0742,0,,15 (15),1,1,0.0468,0.301
Fructose metabolism,Reactome,4,SORD;ALDOB;GLYCTK;TKFC,7 (7),0.00804,0.0742,0,,16 (20),1,1,0.0468,0.301
Sulfate/Sulfite Metabolism,SMPDB,4,BPNT1;CHST11;PAPSS2;SUOX,7 (7),0.00804,0.0742,0,,20 (22),1,1,0.0468,0.301
TYSND1 cleaves peroxisomal proteins,Reactome,4,PHYH;ACOX1;SCP2;HSD17B4,7 (7),0.00804,0.0742,0,,1 (1),1,1,0.0468,0.301
Sulfite oxidase deficiency,SMPDB,4,BPNT1;CHST11;PAPSS2;SUOX,7 (7),0.00804,0.0742,0,,20 (22),1,1,0.0468,0.301
Nucleotide salvage,Reactome,7,ADA;UPP2;AMPD1;AMPD3;CDA;ADK;ADAL,23 (23),0.0268,0.176,1,HMDB0000273,44 (45),0.301,1,0.047,0.301
Integration of energy metabolism,Reactome,21,PRKAA2;PRKAR1B;GNG11;CACNA1D;GNGT2;RAPGEF3;ADCY2;SLC2A2;ADIPOR2;CACNA1C;PRKAR2A;GNAI1;ADCY4;ITPR3;ADCY9;PFKFB1;GNB5;IQGAP1;GNG2;RAPGEF4;PRKAG2,91 (91),0.00808,0.0743,0,,29 (34),1,1,0.047,0.301
Sensory processing of sound,Reactome,15,EPB41L3;KCNMB1;KCNN2;XIRP2;CACNA1D;RIPOR2;EPS8;KCNQ4;TWF2;EPS8L2;EPB41L1;GSN;TPRN;CLIC5;MSN,58 (58),0.00808,0.0743,0,,6 (7),1,1,0.047,0.301
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,6,CYP2E1;EPHX2;CYP1A1;PTGS2;ALOX5;ALOX12,19 (19),0.0331,0.211,1,HMDB0002183,35 (143),0.248,1,0.0476,0.304
glutaryl-CoA degradation,HumanCyc,2,ACAT1;GCDH,4 (4),0.0895,0.377,1,HMDB0001290,12 (12),0.0926,1,0.048,0.306
Cerebral organic acidurias_ including diseases,Wikipathways,2,L2HGDH;ALDH7A1,3 (3),0.0491,0.254,1,HMDB0001290,23 (27),0.17,1,0.0483,0.307
Kynurenine Pathway and links to Cellular Senescence,Wikipathways,2,KLF5;QPRT,3 (3),0.0491,0.254,1,HMDB0001290,23 (25),0.17,1,0.0483,0.307
EGF-Core,Signalink,20,MAPK11;MEF2C;PAK1;MAP4K1;NRG4;TAL1;MAP3K6;HBEGF;ERBB2;TGFBR2;MAPK13;ELK3;SMAD3;MAP3K1;MAP3K3;IGF1R;GRAP;MAPK12;MAPK7;SHC2,105 (105),0.0643,0.307,0,,0 (0),1,1,0.0643,0.307
Phospholipid metabolism,Reactome,39,GDPD1;GPD1;PI4K2B;ACP6;GDPD5;TPTE;MFSD2A;TNFAIP8;PLEKHA8;MBOAT1;CHPT1;PLA1A;SYNJ2;PIK3C2G;DGAT2;INPP5D;ETNK2;PIP4K2A;BCHE;OSBPL5;SLC44A2;ABHD3;GPAT3;LPGAT1;GPAM;MGLL;PNPLA8;PNPLA3;PLA2G6;HADHA;HADHB;SELENOI;DDHD2;PLA2G4E;GPAT4;LPCAT4;INPP4B;LCLAT1;PLA2G4F,213 (213),0.0254,0.17,1,HMDB0010404,50 (104),0.335,1,0.049,0.308
Nanomaterial-induced inflammasome activation,Wikipathways,3,IL1B;TLR4;PYCARD,4 (4),0.00866,0.0775,0,,1 (2),1,1,0.0498,0.308
Vitamin B6-dependent and responsive disorders,Wikipathways,3,PNPO;ALDH7A1;AASS,4 (4),0.00866,0.0775,0,,12 (19),1,1,0.0498,0.308
Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension),Wikipathways,3,HAL;GPT2;GLUD1,4 (4),0.00866,0.0775,0,,16 (16),1,1,0.0498,0.308
Biosynthesis of DPAn-3 SPMs,Reactome,3,ALOX5;PTGS2;ALOX12,4 (4),0.00866,0.0775,0,,7 (30),1,1,0.0498,0.308
Biosynthesis of DPA-derived SPMs,Reactome,3,ALOX5;PTGS2;ALOX12,4 (4),0.00866,0.0775,0,,8 (34),1,1,0.0498,0.308
Astrocytic Glutamate-Glutamine Uptake And Metabolism,Reactome,3,GLUL;SLC1A2;SLC1A3,4 (4),0.00866,0.0775,0,,6 (6),1,1,0.0498,0.308
Neurotransmitter uptake and metabolism In glial cells,Reactome,3,GLUL;SLC1A2;SLC1A3,4 (4),0.00866,0.0775,0,,6 (6),1,1,0.0498,0.308
Carnitine synthesis,Reactome,3,BBOX1;SHMT1;ALDH9A1,4 (4),0.00866,0.0775,0,,14 (17),1,1,0.0498,0.308
Utilization of Ketone Bodies,Reactome,3,OXCT1;BDH1;ACAT1,4 (4),0.00866,0.0775,0,,9 (10),1,1,0.0498,0.308
tryptophan degradation X (mammalian_ via tryptamine),HumanCyc,3,ALDH3A2;MAOB;DDC,4 (4),0.00866,0.0775,0,,15 (15),1,1,0.0498,0.308
Valine_ leucine and isoleucine biosynthesis - Homo sapiens (human),KEGG,3,SDS;BCAT1;SDSL,4 (4),0.00866,0.0775,0,,18 (23),1,1,0.0498,0.308
Leptin,NetPath,13,ERBB2;PRKAA2;IKBKG;NFKBIA;NOS3;LIMK1;IGF1R;PDE3A;RPS6KA2;SLC2A4;PLCG2;CRP;CHUK,62 (62),0.0649,0.309,0,,0 (0),1,1,0.0649,0.309
NOTCH2 intracellular domain regulates transcription,Reactome,4,GZMB;RBPJ;MAML1;MAMLD1,12 (12),0.0656,0.31,0,,0 (0),1,1,0.0656,0.31
Gap junction trafficking,Reactome,4,GJB1;GJB2;MYO6;GJA1,12 (12),0.0656,0.31,0,,0 (1),1,1,0.0656,0.31
Osteoblast differentiation,Wikipathways,22,FZD4;FZD8;FZD9;BMP2;MAPK12;DLL4;PIK3C2G;WNT7B;WNT11;RBPJ;FGF1;FGF2;PRKCH;PRKCQ;MAPK7;MAPK11;MAPK13;WNT9B;SMAD1;NOTCH4;FGFR1;SMAD9,118 (118),0.0662,0.312,0,,0 (0),1,1,0.0662,0.312
Canonical and non-canonical TGF-B signaling,Wikipathways,5,SMAD3;GREM1;TGFBR2;LOXL1;LOX,17 (17),0.0667,0.312,0,,0 (0),1,1,0.0667,0.312
Keratan sulfate/keratin metabolism,Reactome,10,B4GALT2;FMOD;OGN;ST3GAL2;B3GNT7;B4GALT6;CHST1;CHST2;B3GNT3;OMD,33 (33),0.00907,0.0805,0,,12 (19),1,1,0.0517,0.318
Tyrosine metabolism,INOH,10,MAOB;FAH;HGD;GSTZ1;DDC;ADHFE1;TAT;ADH4;HPD;AOC3,33 (33),0.00907,0.0805,0,,43 (44),1,1,0.0517,0.318
Vitamin E metabolism,EHMN,12,SLC16A1;EHHADH;ACOX1;HSD17B10;ACOT2;HADHA;HADH;HADHB;NUP35;BAAT;ACOT1;HSD17B4,43 (43),0.00909,0.0805,0,,21 (21),1,1,0.0518,0.318
Fat digestion and absorption - Homo sapiens (human),KEGG,12,MTTP;PLPP2;ACAT1;ABCG8;DGAT2;ABCG5;APOA4;APOB;PLPP1;SCARB1;GOT2;FABP2,43 (43),0.00909,0.0805,0,,6 (13),1,1,0.0518,0.318
Small cell lung cancer - Homo sapiens (human),KEGG,21,BAK1;ITGA3;COL4A2;LAMA4;COL4A4;ITGA6;LAMB1;LAMB2;LAMB3;LAMA5;COL4A1;LAMC2;LAMC3;BCL2;IKBKG;LAMC1;NFKBIA;LAMA2;CHUK;PTGS2;FN1,92 (92),0.00918,0.0811,0,,3 (3),1,1,0.0522,0.32
Neural Crest Cell Migration during Development,Wikipathways,9,EPHB2;PAK1;NGFR;PAK3;EPHB4;CDH11;MMP2;PAK6;MMP9,39 (39),0.0689,0.321,0,,0 (0),1,1,0.0689,0.321
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,28,CACNA1C;ADORA2B;CACNA1S;NPR1;ADCY4;ADRA1A;RAMP2;MYLK3;CALD1;GUCY1A1;GUCY1B1;AVPR1A;CACNA1D;ACTA2;PPP1R14A;KCNMB1;ACTG2;PLA2G6;PRKCH;PLCB4;PLA2G4F;PLA2G4E;PTGIR;ADCY2;ADCY9;MYLK2;PRKCQ;ITPR3,133 (133),0.00942,0.0831,0,,15 (16),1,1,0.0534,0.327
Fluid shear stress and atherosclerosis - Homo sapiens (human),KEGG,29,THBD;NOS3;MMP2;MAPK12;MGST1;PDGFB;DUSP1;MAPK7;PECAM1;PRKAA2;NQO1;IKBKG;ACTG1;CCL2;KDR;NCF2;BCL2;CAV1;CAV2;ARHGEF2;MMP9;MAPK11;IL1B;MAPK13;CDH5;SDC1;SDC2;MEF2C;CHUK,139 (139),0.00947,0.0833,0,,8 (8),1,1,0.0536,0.327
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,22,ADCY4;MAPK12;CAMK2A;KNG1;NGF;PLA2G4E;PLA2G6;PRKCH;PLCB4;PLA2G4F;PLCG2;ASIC5;MAPK11;IL1B;MAPK13;F2RL1;ADCY2;ALOX12;BDKRB2;ADCY9;PRKCQ;ITPR3,98 (98),0.00951,0.0833,0,,26 (35),1,1,0.0538,0.328
Notch Signaling,Wikipathways,10,DTX1;MAML1;NUMBL;DLL4;CTBP2;MFNG;DTX3;NOTCH4;LFNG;RBPJ,45 (45),0.071,0.33,0,,0 (0),1,1,0.071,0.33
AP-1 transcription factor network,PID,17,GATA2;NFATC2;EGR1;GJA1;CCL2;ATF3;COL1A2;FOSB;FOSL2;MMP9;FABP4;DUSP1;ACTA1;PENK;NTS;FOSL1;MAF,70 (70),0.0097,0.0847,0,,1 (1),1,1,0.0547,0.332
RHOB GTPase cycle,Reactome,17,MCAM;STARD13;ARHGEF17;ARHGEF25;ARHGEF28;ARHGAP1;MYO9A;PCDH7;PREX1;ARHGEF2;STK10;CAVIN1;CAV1;STARD8;DLC1;ARHGAP35;MCF2L,70 (70),0.0097,0.0847,0,,4 (4),1,1,0.0547,0.332
GRB2:SOS provides linkage to MAPK signaling for Integrins ,Reactome,6,FGA;FGB;APBB1IP;FGG;VWF;FN1,15 (15),0.00977,0.0852,0,,4 (6),1,1,0.055,0.333
&gamma;-glutamyl cycle,HumanCyc,5,OPLAH;GCLM;GGT1;GGT7;GGT6,11 (11),0.00987,0.0854,0,,29 (29),1,1,0.0554,0.334
regulators of bone mineralization,BioCarta,5,SPP1;COL4A1;COL4A2;COL4A4;ENPP1,11 (11),0.00987,0.0854,0,,3 (4),1,1,0.0554,0.334
VEGF,INOH,37,VEGFC;TGFBR2;FLT4;IGF1R;RIPK3;MAPK12;ACVR1B;PDGFRA;PDGFRB;LCK;CSNK1E;CAMK2A;RPS6KA2;ACVRL1;MAPK7;PRKAA2;PAK1;NGFR;IKBKG;PRKAR1B;PRKAR2A;PRKCH;FGFR1;SH2D2A;PLCG2;KDR;PAK6;PRKAG2;MAPK11;MAPK13;KIT;GFRA1;MAP3K1;MAP3K3;PRKCQ;CHUK;ITPR3,188 (188),0.00987,0.0854,0,,3 (4),1,1,0.0555,0.334
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,8,MAPK11;PAK1;ARHGEF7;RAPGEF3;ADCY2;MAP3K1;NFKBIA;CHUK,38 (38),0.128,0.486,1,HMDB0009888,10 (10),0.0777,1,0.0557,0.335
Cardiac muscle contraction - Homo sapiens (human),KEGG,20,TPM1;TPM2;COX7A1;COX6A2;ATP2A1;HRC;CACNA1C;CACNA1D;TRDN;CACNA1S;CACNA2D1;CACNB1;ATP2A3;MYH7;CACNG1;UQCRC2;MYL2;MYL3;MYL4;ATP1A2,87 (87),0.01,0.0865,0,,4 (4),1,1,0.0561,0.337
Carvedilol Action Pathway,SMPDB,12,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;ADRA1A;SCN5A;TPM2;ATP1A2;KCNK1,62 (62),0.119,0.465,1,HMDB0009888,11 (11),0.0852,1,0.0568,0.34
Labetalol Action Pathway,SMPDB,12,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;ADRA1A;SCN5A;TPM2;ATP1A2;KCNK1,62 (62),0.119,0.465,1,HMDB0009888,11 (11),0.0852,1,0.0568,0.34
Nicotinate metabolism,Reactome,8,NNMT;NUDT12;BST1;PTGIS;CYP8B1;PTGS2;QPRT;NADSYN1,24 (24),0.0103,0.089,0,,40 (50),1,1,0.0575,0.343
Aquaporin-mediated transport,Reactome,13,AQP1;GNG11;ADCY4;GNGT2;PRKAR1B;ADCY2;AQP9;PRKAR2A;AQP11;ADCY9;AQP4;GNB5;GNG2,49 (49),0.0106,0.0911,0,,15 (15),1,1,0.0587,0.35
Canonical NF-KB pathway,Wikipathways,3,NFKBIA;CHUK;IKBKG,8 (8),0.0801,0.356,0,,0 (0),1,1,0.0801,0.356
AUF1 (hnRNP D0) binds and destabilizes mRNA,Reactome,3,HSPA1B;HSPB1;HSPA1A,8 (8),0.0801,0.356,0,,0 (1),1,1,0.0801,0.356
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,Reactome,3,BMF;BCL2;PMAIP1,8 (8),0.0801,0.356,0,,0 (0),1,1,0.0801,0.356
cell to cell adhesion signaling,BioCarta,3,ACTA1;BCAR1;PECAM1,8 (8),0.0801,0.356,0,,0 (0),1,1,0.0801,0.356
VEGF binds to VEGFR leading to receptor dimerization,Reactome,3,VEGFC;FLT4;KDR,8 (8),0.0801,0.356,0,,0 (0),1,1,0.0801,0.356
VEGF ligand-receptor interactions,Reactome,3,VEGFC;FLT4;KDR,8 (8),0.0801,0.356,0,,0 (0),1,1,0.0801,0.356
Phase I biotransformations_ non P450,Wikipathways,3,PON1;LIPA;PON3,8 (8),0.0801,0.356,0,,0 (4),1,1,0.0801,0.356
Cardiac conduction,Reactome,23,CACNA1C;CACNB1;NPR1;KCNE3;SCN1B;KCNJ12;SCN4B;SCN5A;SCN7A;KCNK1;FXYD6;KCNQ1;KCNK6;KCNK13;ATP1A2;DMPK;ATP2A1;TRDN;ATP2B4;RYR1;ATP2A3;SCN3B;ITPR3,105 (105),0.011,0.0943,0,,10 (11),1,1,0.0605,0.36
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,9,GALNT15;GCNT4;GALNT18;GALNT16;GALNT12;ST3GAL2;GALNT6;B3GNT3;GALNT3,29 (29),0.0111,0.0945,0,,6 (8),1,1,0.0609,0.361
Interaction between L1 and Ankyrins,Reactome,9,SPTBN2;SCN1B;SPTB;SCN3B;SCN4B;SCN5A;SCN7A;ANK1;ANK2,29 (29),0.0111,0.0945,0,,2 (3),1,1,0.0609,0.361
RHOQ GTPase cycle,Reactome,15,OBSCN;PAK1;GFOD1;ARHGEF7;ARHGAP1;GJA1;CDC42EP3;PREX1;SLC1A5;ARHGAP35;SYDE1;CAV1;IQGAP1;DLC1;ASB15,60 (60),0.0112,0.095,0,,4 (4),1,1,0.0614,0.363
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway,Wikipathways,5,NQO1;IGFBP7;DDR1;BMP2;FN1,18 (18),0.0825,0.363,0,,0 (0),1,1,0.0825,0.363
miR-509-3p alteration of YAP1-ECM axis,Wikipathways,5,BCAR1;COL3A1;COL5A1;COL1A1;FN1,18 (18),0.0825,0.363,0,,0 (0),1,1,0.0825,0.363
Genes targeted by miRNAs in adipocytes,Wikipathways,5,KCNQ1;GJA1;SRF;TMSB4X;ERG,18 (18),0.0825,0.363,0,,0 (0),1,1,0.0825,0.363
Chemokine signaling pathway,Wikipathways,33,PREX1;CCR2;CXCR3;ADCY4;ARRB1;ARRB2;WAS;SHC2;CXCR6;BCAR1;CXCR4;NFKBIA;GNB5;GNG2;PAK1;CXCL13;IKBKG;CXCL14;GNAI1;PLCB4;FGR;PARD3;CCL24;CXCL5;GNG11;CX3CL1;GNGT2;ADCY2;VAV1;ADCY9;CXCL3;CCL11;CHUK,165 (165),0.0113,0.0957,0,,5 (5),1,1,0.0618,0.365
Selective expression of chemokine receptors during T-cell polarization,Wikipathways,7,TGFB2;TGFB3;CXCR4;CCR2;CXCR3;CCR5;IFNGR1,29 (29),0.0839,0.366,0,,0 (0),1,1,0.0839,0.366
Neurophilin interactions with VEGF and VEGFR,Reactome,2,NRP2;KDR,4 (4),0.0895,0.377,0,,0 (0),1,1,0.0895,0.377
CLEC7A/inflammasome pathway,Reactome,2,IL1B;PYCARD,4 (4),0.0895,0.377,0,,0 (0),1,1,0.0895,0.377
Lipophagy,Reactome,2,PLIN2;PRKAA2,4 (4),0.0895,0.377,0,,0 (0),1,1,0.0895,0.377
Invadopodia formation,Reactome,2,ADAM19;ADAM15,4 (4),0.0895,0.377,0,,0 (1),1,1,0.0895,0.377
hop pathway in cardiac development,BioCarta,2,SRF;GATA4,4 (4),0.0895,0.377,0,,0 (0),1,1,0.0895,0.377
Syndecan-2-mediated signaling events,PID,9,EPHB2;FGF1;FGF2;SDC2;KNG1;FGFR1;MMP2;CAV2;FN1,41 (41),0.0896,0.377,0,,0 (1),1,1,0.0896,0.377
Other types of O-glycan biosynthesis - Homo sapiens (human),KEGG,10,B4GALT2;GALNT15;XXYLT1;GALNT18;GALNT16;GALNT12;MFNG;LFNG;GALNT6;GALNT3,47 (47),0.0903,0.379,0,,0 (0),1,1,0.0903,0.379
IL1 and megakaryocytes in obesity,Wikipathways,6,IL1B;TIMP2;CCL2;HBEGF;TLR1;MMP9,24 (24),0.0921,0.385,0,,0 (0),1,1,0.0921,0.385
Glycolysis and Gluconeogenesis,EHMN,16,PKM;ALDOB;SLC16A1;ME1;ME2;SLC16A7;ENO3;ME3;ADHFE1;PCK1;ACSS1;ALDH7A1;PFKFB1;NUP35;ACOT12;ALDH9A1,66 (67),0.0121,0.1,0,,48 (52),1,1,0.0655,0.386
EGF-EGFR signaling pathway,Wikipathways,28,GJA1;RIN1;EPS8;ERBB2;ABL1;STXBP1;PXDN;CAMK2A;MAP4K1;FOSB;INPP5D;RPS6KA2;PAK1;MAP3K1;GRB10;DOK2;SH2D2A;CAV1;CAV2;BCAR1;MAPK7;REPS2;NOS3;MEF2C;VAV1;GAB2;MAP3K3;IQGAP1,162 (162),0.0929,0.388,0,,0 (0),1,1,0.0929,0.388
p53 transcriptional gene network,Wikipathways,14,XRCC5;ACAD11;PERP;ADORA2B;CPT1C;CCL2;SESN1;NCF2;THBS1;LIF;SESN2;PMAIP1;BTG2;CX3CL1,72 (72),0.0952,0.396,0,,0 (0),1,1,0.0952,0.396
Direct p53 effectors,PID,29,LIF;HGF;DDIT4;HIC1;CAV1;BTG2;SPP1;DROSHA;DUSP1;PYCARD;VCAN;DUSP5;RGCC;PERP;BAK1;ATF3;BCL2;MMP2;TNFRSF10B;HSPA1A;CX3CL1;SESN1;BDKRB2;HSPA1B;PMAIP1;SCN3B;SFN;VDR;PRDM1,142 (142),0.0127,0.104,0,,1 (1),1,1,0.0681,0.4
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human),KEGG,25,FZD4;FZD8;FZD9;LIF;LIFR;INHBE;IGF1R;MAPK12;INHBC;WNT7B;ESRRB;WNT11;WNT9B;FGF2;ID4;FGFR1;ACVR1B;MAPK11;KLF4;MAPK13;ONECUT1;SMAD1;SMAD3;SMAD9;HOXA1,143 (143),0.0973,0.403,0,,0 (0),1,1,0.0973,0.403
Ebola Virus Pathway on Host,Wikipathways,23,NPC1;DAB2IP;FLNA;FLNC;MFGE8;IGF1R;TIMD4;ACTG1;CD300A;ICAM2;TLR4;GAS6;CLEC4G;VPS41;PAK1;ITGA6;RELB;CAV1;CAV2;ITGA3;ITGA5;GSN;IQGAP1,130 (130),0.0979,0.405,0,,0 (0),1,1,0.0979,0.405
ATF-2 transcription factor network,PID,12,MAPK11;TGFB2;PDGFRA;JDP2;ATF3;DUSP1;BCL2;DUSP10;DUSP5;MMP2;DUSP8;ARG1,60 (60),0.0989,0.408,0,,0 (0),1,1,0.0989,0.408
Other semaphorin interactions,Reactome,5,PLXNA4;PLXND1;PLXNC1;SEMA4D;SEMA5A,19 (19),0.1,0.411,0,,0 (0),1,1,0.1,0.411
TGF-Core,Signalink,9,TGFB2;TGFB3;TGFBR2;BMP2;BMP6;SMAD1;SMAD3;ACVR1B;ACVRL1,42 (42),0.101,0.415,0,,0 (0),1,1,0.101,0.415
Glucuronidation,Reactome,8,UGP2;SLC35D1;UGT1A1;UGT2A3;UGT1A5;UGT3A2;UGT3A1;UGDH,25 (25),0.0134,0.11,0,,28 (31),1,1,0.0713,0.415
Alpha9 beta1 integrin signaling events,PID,8,VEGFC;ADAM8;SPP1;TNC;ADAM15;F13A1;BCAR1;FN1,25 (25),0.0134,0.11,0,,11 (11),1,1,0.0713,0.415
Chemokine signaling pathway - Homo sapiens (human),KEGG,37,PREX1;CCR2;CXCR3;ADCY4;ARRB1;ARRB2;WAS;SHC2;CXCR6;BCAR1;CXCR4;NFKBIA;GNB5;GNG2;PAK1;CXCL13;IKBKG;CCL2;CCR5;CCL11;CXCL2;FGR;PARD3;CCL24;CXCL5;GNG11;CX3CL1;GNGT2;ADCY2;GNAI1;VAV1;ADCY9;CXCL3;PLCB4;CXCL14;CHUK;PLCG2,192 (192),0.0137,0.112,0,,5 (5),1,1,0.0725,0.415
Fibrin Complement Receptor 3 Signaling Pathway,Wikipathways,11,CHUK;FGB;IKBKG;CXCL3;CCL2;FGA;ITGB2;ITGAM;FGG;TLR4;PLG,40 (40),0.0137,0.112,0,,1 (2),1,1,0.0726,0.415
Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,11,AQP1;GNG11;ADCY4;GNGT2;PRKAR1B;ADCY2;PRKAR2A;ADCY9;AQP4;GNB5;GNG2,40 (40),0.0137,0.112,0,,8 (8),1,1,0.0726,0.415
Glucagon signaling pathway - Homo sapiens (human),KEGG,23,PHKG1;PDE3B;CAMK2A;CPT1C;PRKAG2;GYS2;PRKAA2;PKM;PYGB;PYGL;SIK1;PLCB4;PFKFB1;PPARA;CREB3L3;CPT1A;LDHA;PGAM2;LDHB;ADCY2;PCK1;SLC2A2;ITPR3,107 (107),0.0137,0.112,0,,21 (26),1,1,0.0726,0.415
Acyl chain remodelling of PC,Reactome,5,PNPLA8;PLA2G4E;LPCAT4;PLA2G4F;PLA2G6,27 (27),0.291,0.763,1,HMDB0010404,6 (13),0.0474,1,0.0729,0.415
RAF-independent MAPK1/3 activation,Reactome,6,DUSP1;DUSP10;DUSP4;DUSP5;DUSP7;DUSP8,16 (16),0.0139,0.112,0,,4 (4),1,1,0.0733,0.415
Regulation of TLR by endogenous ligand,Reactome,6,FGA;FGB;APOB;TLR1;FGG;TLR4,16 (16),0.0139,0.112,0,,5 (13),1,1,0.0733,0.415
Heroin Metabolism Pathway,SMPDB,1,BCHE,4 (4),0.438,0.927,1,HMDB0041812,4 (5),0.0318,1,0.0735,0.415
RHOJ GTPase cycle,Reactome,14,FMNL3;RHOJ;PAK3;ARHGAP1;GJA1;ARHGEF7;PREX1;PAK1;SLC1A5;ARHGAP35;SYDE1;CAV1;ASB15;WAS,56 (56),0.014,0.113,0,,4 (4),1,1,0.0736,0.415
Collagen degradation,Reactome,10,MMP12;MMP13;ADAM10;COL17A1;PHYKPL;TMPRSS6;MMP2;COL16A1;MMP7;MMP9,35 (35),0.014,0.113,0,,5 (6),1,1,0.0738,0.415
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,19,SLC44A2;SLC41A1;SLC16A1;SLC6A9;SLC30A10;SLC16A7;SLC6A12;CP;SLC22A18;SLC39A5;SLC13A3;SLC47A1;HEPH;SLC22A1;SLC22A5;SLC6A13;EMB;SLC11A1;SLC18A1,84 (84),0.0141,0.113,0,,67 (79),1,1,0.0741,0.415
cysteine biosynthesis,HumanCyc,4,CBS;CTH;AHCY;MAT1A,8 (8),0.0144,0.114,0,,16 (16),1,1,0.0754,0.415
2-oxobutanoate degradation,HumanCyc,4,PCCB;BCKDHB;DBT;PCCA,8 (8),0.0144,0.114,0,,13 (14),1,1,0.0754,0.415
palmitate biosynthesis,HumanCyc,4,ACOT4;ACOT1;ACOT2;OXSM,8 (9),0.0144,0.114,0,,9 (10),1,1,0.0754,0.415
GABA shunt,HumanCyc,4,GLUL;GLUD1;ALDH5A1;ABAT,8 (8),0.0144,0.114,0,,13 (13),1,1,0.0754,0.415
Synthesis of Ketone Bodies,Reactome,4,ACSS3;HMGCS2;ACAT1;BDH1,8 (8),0.0144,0.114,0,,14 (14),1,1,0.0754,0.415
Betaine Metabolism,SMPDB,4,CHDH;BHMT;ALDH7A1;AHCY,8 (8),0.0144,0.114,0,,20 (22),1,1,0.0754,0.415
Endothelin Pathways,Wikipathways,7,PTGIR;NOS3;CNN1;GNAI1;ADRA1A;MYL1;GNB5,33 (33),0.144,0.502,1,HMDB0009888,13 (13),0.0999,1,0.0756,0.415
Arbutamine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,10 (11),0.0777,1,0.0762,0.415
Alprenolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,10 (11),0.0777,1,0.0762,0.415
Muscle/Heart Contraction,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,10 (10),0.0777,1,0.0762,0.415
Felodipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,10 (11),0.0777,1,0.0762,0.415
Small cell lung cancer,Wikipathways,21,BAK1;ITGA3;LAMA2;IKBKG;LAMA4;ITGA6;LAMB1;LAMB2;LAMC3;LAMA5;COL4A4;COL4A1;LAMC2;PTGS2;BCL2;LAMC1;NFKBIA;COL4A2;CHUK;LAMB3;FN1,96 (96),0.0149,0.118,0,,2 (3),1,1,0.0774,0.415
leucine degradation,HumanCyc,5,IVD;BCKDHB;BCAT1;DBT;MCCC2,12 (12),0.0151,0.119,0,,19 (20),1,1,0.0783,0.415
Nicotinamide salvaging,Reactome,5,NUDT12;PTGIS;NNMT;CYP8B1;PTGS2,12 (12),0.0151,0.119,0,,30 (37),1,1,0.0783,0.415
Selenoamino Acid Metabolism,SMPDB,5,SEPHS2;CBS;CTH;GGT1;AHCY,12 (12),0.0151,0.119,0,,27 (28),1,1,0.0783,0.415
L1CAM interactions,Reactome,22,EPHB2;DPYSL2;ANK1;ANK2;RPS6KA2;SPTB;SPTBN2;SCN1B;SCN4B;SCN5A;SCN7A;PAK1;LAMB1;LAMC1;DLG4;FGFR1;CNTNAP1;ITGA5;SHTN1;SCN3B;NRP2;MSN,102 (102),0.0151,0.119,0,,7 (10),1,1,0.0785,0.415
Thermogenesis,Wikipathways,23,ACSL1;NPR1;ADCY4;SLC25A20;MAPK12;CPT1C;FGF21;RPS6KA2;CPT1A;PRKAA2;MAPK11;SMARCA2;ACTG1;MGLL;FGFR1;CREB3L3;PRKAG2;CPT2;MAPK13;PRDM16;ADCY2;ADCY9;KLB,108 (108),0.0153,0.12,0,,17 (25),1,1,0.0792,0.415
Disopyramide Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Dobutamine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Amiodarone Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Bopindolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Timolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Carteolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Bevantolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Practolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Isoprenaline Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Levobunolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Metipranolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Mexiletine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Quinidine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Sotalol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Epinephrine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Betaxolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Atenolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Acebutolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Propranolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Pindolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Penbutolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Oxprenolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Metoprolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Esmolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Bisoprolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Bupranolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nebivolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Amlodipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Verapamil Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nitrendipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nisoldipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nimodipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Ibutilide Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Tocainide Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Flecainide Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Isradipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nifedipine Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
Nadolol Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,11 (11),0.0852,1,0.0821,0.415
BCR signaling pathway,PID,16,BLNK;FCGR2B;CD19;DOK1;IKBKG;NFKBIA;POU2F2;CD79A;CD79B;MAP4K1;CARD11;INPP5D;MAP3K1;PLCG2;CHUK;CD22,68 (68),0.0161,0.126,0,,4 (4),1,1,0.0824,0.415
Ras signaling pathway - Homo sapiens (human),KEGG,43,VEGFC;NTRK2;HGF;RGL1;KSR1;PAK1;FLT4;IGF1R;ABL1;ANGPT1;RASAL3;SHC2;LAT;PDGFB;PDGFRA;PLA1A;PDGFRB;PAK3;FGF21;RASGRP3;PDGFD;GNB5;GNG2;RIN1;ETS2;NGF;NGFR;IKBKG;FGF1;FGF2;PLA2G6;KDR;FGFR1;PLA2G4F;PLCG2;PAK6;PLA2G4E;TEK;KIT;GNGT2;GNG11;GAB2;CHUK,232 (232),0.0162,0.127,0,,7 (7),1,1,0.083,0.415
Morphine addiction - Homo sapiens (human),KEGG,20,GABBR2;GABRB3;ADCY9;ADCY4;ADORA1;GNG11;GABRP;GNGT2;ADCY2;ARRB1;GNAI1;PDE3A;PDE3B;PDE4B;GNB5;PDE4D;ARRB2;GNG2;GABRA3;PDE10A,91 (91),0.0163,0.128,0,,9 (12),1,1,0.0835,0.415
Rofecoxib Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Leukotriene C4 Synthesis Deficiency,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;ALOX12;ALOX5;GGT1;PTGS2,30 (30),0.0396,0.228,1,HMDB0010404,66 (71),0.417,1,0.0844,0.415
Flurbiprofen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Lumiracoxib Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Trisalicylate-choline Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (71),0.417,1,0.0844,0.415
Nepafenac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Salsalate Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Tiaprofenic Acid Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Salicylate-sodium Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Valdecoxib Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Nabumetone Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Bromfenac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,66 (72),0.417,1,0.0844,0.415
Arachidonic Acid Metabolism,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;ALOX12;ALOX5;GGT1;PTGS2,30 (30),0.0396,0.228,1,HMDB0010404,66 (71),0.417,1,0.0844,0.415
Etodolac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Ketoprofen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Acetylsalicylic Acid Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Diflunisal Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Acetaminophen  Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Sulindac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Diclofenac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Ketorolac Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Naproxen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Etoricoxib Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Carprofen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Fenoprofen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Antrafenine Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Antipyrine Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Magnesium salicylate Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Phenylbutazone Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Lornoxicam Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Tenoxicam Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Tolmetin Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Salicylic Acid Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Oxaprozin Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Meloxicam Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Suprofen Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Mefenamic Acid Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
Piroxicam Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,30 (30),0.0396,0.228,1,HMDB0010404,67 (72),0.422,1,0.0851,0.415
RXR and RAR heterodimerization with other nuclear receptor,PID,8,RARG;THRB;NR1H4;BCL2;PPARA;PPARD;NR4A1;VDR,26 (26),0.0172,0.134,0,,6 (6),1,1,0.087,0.423
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,61 (61),0.188,0.585,1,HMDB0009888,12 (12),0.0926,1,0.0877,0.425
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,8,UGP2;UGT1A1;UGT1A5;DHDH;UGT2A3;AKR1B10;SORD;UGDH,34 (34),0.0761,0.349,1,HMDB0039721,32 (58),0.229,1,0.088,0.425
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,13,PRKAR1B;HSPA1A;PRKAR2A;EHHADH;ME1;NRIP1;HSPA1B;ACOX1;NFKBIA;PPARA;DUSP1;CPT1A;HSD17B4,52 (52),0.0175,0.135,0,,1 (9),1,1,0.0882,0.425
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA,HumanCyc,2,ACMSD;DHTKD1,2 (2),0.018,0.135,0,,12 (12),1,1,0.0902,0.425
L-cysteine degradation II,HumanCyc,2,GOT1;MPST,2 (2),0.018,0.135,0,,8 (8),1,1,0.0902,0.425
cysteine biosynthesis/homocysteine degradation (trans-sulfuration),HumanCyc,2,CBS;CTH,2 (2),0.018,0.135,0,,7 (7),1,1,0.0902,0.425
L-cysteine degradation I,HumanCyc,2,CDO1;GOT1,2 (2),0.018,0.135,0,,9 (10),1,1,0.0902,0.425
Biosynthesis of DPAn-3-derived maresins,Reactome,2,ALOX5;ALOX12,2 (2),0.018,0.135,0,,6 (14),1,1,0.0902,0.425
phytol degradation,HumanCyc,2,ALDH3A2;PECR,2 (2),0.018,0.135,0,,12 (14),1,1,0.0902,0.425
aspirin triggered resolvin E biosynthesis,HumanCyc,2,ALOX5;PTGS2,2 (2),0.018,0.135,0,,3 (5),1,1,0.0902,0.425
hydrogen sulfide biosynthesis (trans-sulfuration),HumanCyc,2,CBS;CTH,2 (2),0.018,0.135,0,,6 (6),1,1,0.0902,0.425
aspirin-triggered lipoxin biosynthesis,HumanCyc,2,ALOX5;PTGS2,2 (2),0.018,0.135,0,,7 (9),1,1,0.0902,0.425
4-aminobutyrate degradation,HumanCyc,2,ABAT;ALDH5A1,2 (2),0.018,0.135,0,,9 (9),1,1,0.0902,0.425
Degradation of GABA,Reactome,2,ABAT;ALDH5A1,2 (2),0.018,0.135,0,,8 (10),1,1,0.0902,0.425
&beta;-alanine degradation,HumanCyc,2,ALDH6A1;ABAT,2 (2),0.018,0.135,0,,11 (11),1,1,0.0902,0.425
Sterols are 12-hydroxylated by CYP8B1,Reactome,2,PTGIS;CYP8B1,2 (2),0.018,0.135,0,,9 (12),1,1,0.0902,0.425
choline degradation,HumanCyc,2,CHDH;ALDH7A1,2 (2),0.018,0.135,0,,7 (7),1,1,0.0902,0.425
Alanine metabolism,Reactome,2,GPT2;GPT,2 (2),0.018,0.135,0,,4 (4),1,1,0.0902,0.425
alanine biosynthesis/degradation,HumanCyc,2,GPT2;GPT,2 (2),0.018,0.135,0,,4 (4),1,1,0.0902,0.425
glycine biosynthesis,HumanCyc,2,AGXT;AGXT2,2 (2),0.018,0.135,0,,4 (4),1,1,0.0902,0.425
Choline metabolism in cancer - Homo sapiens (human),KEGG,16,SLC44A2;LYPLA1;PDGFB;PDGFRA;PDGFRB;CHPT1;PLPP1;SLC22A1;PLA2G4F;PDGFD;SLC22A5;PLPP2;WASF3;WASF2;WAS;PLA2G4E,98 (98),0.235,0.695,1,HMDB0010404,10 (11),0.0777,1,0.0915,0.431
Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,21,PRKD3;ADCY4;CACNA1C;CACNA1D;PRKD2;DAGLA;ADCY2;ATP2B4;CACNA1S;CAMK2A;NPR1;ADCY9;PLCB4;CAMK1D;DAGLB;SCARB1;CREB3L3;NR4A1;ATP1A2;ITPR3;CACNA1I,98 (98),0.0186,0.139,0,,21 (22),1,1,0.0926,0.434
T-Cell Receptor and Co-stimulatory Signaling,Wikipathways,4,CD8A;LCK;NFATC2;CTLA4,30 (30),0.585,1,1,HMDB0009888,4 (4),0.0318,1,0.0928,0.434
Mercaptopurine Action Pathway,SMPDB,12,SLC28A2;ADK;ADA;GUCY1B1;AK1;PAICS;ABCC4;AMPD1;PDE4D;TPMT;ENTPD5;PDE10A,47 (47),0.0187,0.139,0,,78 (84),1,1,0.093,0.434
Azathioprine Action Pathway,SMPDB,12,SLC28A2;ADK;ADA;GUCY1B1;AK1;PAICS;ABCC4;AMPD1;PDE4D;TPMT;ENTPD5;PDE10A,47 (47),0.0187,0.139,0,,80 (86),1,1,0.093,0.434
Thioguanine Action Pathway,SMPDB,12,SLC28A2;ADK;ADA;GUCY1B1;AK1;PAICS;ABCC4;AMPD1;PDE4D;TPMT;ENTPD5;PDE10A,47 (47),0.0187,0.139,0,,79 (85),1,1,0.093,0.434
RUNX3 regulates NOTCH signaling,Reactome,4,RUNX3;MAML1;RBPJ;MAMLD1,14 (14),0.107,0.434,0,,0 (0),1,1,0.107,0.434
JNK signaling in the CD4+ TCR pathway,PID,4,LAT;MAP4K1;GRAP2;MAP3K1,14 (14),0.107,0.434,0,,0 (0),1,1,0.107,0.434
regulation of map kinase pathways through dual specificity phosphatases,BioCarta,3,DUSP8;DUSP1;DUSP4,9 (9),0.108,0.436,0,,0 (0),1,1,0.108,0.436
TNF signaling pathway - Homo sapiens (human),KEGG,20,VEGFC;MAPK11;DAB2IP;CREB3L3;IKBKG;CXCL5;IL1B;CX3CL1;CXCL3;CCL2;PTGS2;CXCL2;LIF;RIPK3;MAPK13;NFKBIA;BAG4;CHUK;MAPK12;MMP9,112 (112),0.109,0.436,0,,0 (0),1,1,0.109,0.436
Intrinsic Pathway of Fibrin Clot Formation,Reactome,6,KLKB1;F8;F9;F11;KNG1;VWF,17 (17),0.0191,0.141,0,,1 (8),1,1,0.0946,0.441
nicotine degradation IV,HumanCyc,6,FMO1;FMO2;FMO3;CYP2S1;FMO5;FMO4,17 (17),0.0191,0.141,0,,16 (28),1,1,0.0946,0.441
alpha-Linolenic acid metabolism - Homo sapiens (human),KEGG,6,PLA2G4E;FADS2;PLA2G6;ACOX1;PLA2G4F;ACOX3,25 (25),0.108,0.436,1,HMDB0060376,24 (44),0.177,1,0.0948,0.441
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),Reactome,3,KLKB1;F8;F9,5 (5),0.0195,0.142,0,,1 (1),1,1,0.0962,0.442
Diseases of hemostasis,Reactome,3,KLKB1;F8;F9,5 (5),0.0195,0.142,0,,1 (1),1,1,0.0962,0.442
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,Reactome,3,BIN2;KANK1;KDR,5 (5),0.0195,0.142,0,,2 (2),1,1,0.0962,0.442
fructose 2_6-bisphosphate synthesis,HumanCyc,3,PFKFB2;PFKFB4;PFKFB1,5 (5),0.0195,0.142,0,,6 (7),1,1,0.0962,0.442
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Reactome,3,HADHB;HADH;HADHA,5 (5),0.0195,0.142,0,,13 (13),1,1,0.0962,0.442
ornithine <i>de novo </i> biosynthesis,HumanCyc,3,ALDH18A1;GLUD1;OAT,5 (5),0.0195,0.142,0,,15 (15),1,1,0.0962,0.442
Fructose catabolism,Reactome,3,ALDOB;GLYCTK;TKFC,5 (5),0.0195,0.142,0,,11 (15),1,1,0.0962,0.442
ketolysis,HumanCyc,3,OXCT1;ACAT1;BDH1,5 (5),0.0195,0.142,0,,10 (10),1,1,0.0962,0.442
Carnitine Synthesis,SMPDB,3,BBOX1;SHMT1;ALDH9A1,5 (5),0.0195,0.142,0,,19 (20),1,1,0.0962,0.442
Toll-like Receptor Signaling related to MyD88,Wikipathways,7,TLR4;IKBKG;RELB;TLR1;TLR9;CHUK;TLR5,31 (31),0.112,0.446,0,,0 (0),1,1,0.112,0.446
Hedgehog Signaling Pathway,Wikipathways,9,BOC;CDON;CSNK1E;HHIP;BCL2;ARRB2;ARRB1;EVC2;GAS1,43 (43),0.113,0.446,0,,0 (0),1,1,0.113,0.446
Genes controlling nephrogenesis,Wikipathways,9,WT1;PDGFB;ITGA8;PDGFRB;LAMB2;CXCR4;KDR;ITGA3;FOXC2,43 (43),0.113,0.446,0,,0 (0),1,1,0.113,0.446
Creatine metabolism,Reactome,3,CKMT2;SLC6A12;CKM,11 (11),0.174,0.583,1,HMDB0000128,15 (15),0.114,1,0.0981,0.448
Indomethacin Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,31 (31),0.0474,0.254,1,HMDB0010404,67 (72),0.422,1,0.0982,0.448
Sensory processing of sound by inner hair cells of the cochlea,Reactome,13,EPB41L3;KCNMB1;RIPOR2;XIRP2;CACNA1D;EPS8;KCNQ4;TWF2;EPS8L2;EPB41L1;TPRN;CLIC5;MSN,53 (53),0.0204,0.146,0,,5 (6),1,1,0.0998,0.448
GnRH signaling pathway - Homo sapiens (human),KEGG,20,MAPK11;PLA2G4E;MAPK13;EGR1;CACNA1C;CACNA1D;ADCY4;CACNA1S;ADCY2;CAMK2A;ADCY9;PLCB4;PLA2G4F;MAP3K1;MAP3K3;MAPK7;MMP2;HBEGF;MAPK12;ITPR3,93 (93),0.0205,0.146,0,,6 (6),1,1,0.1,0.448
Glutathione conjugation,Reactome,10,MGST1;GSTK1;GGT1;GCLM;GGT6;CHAC1;OPLAH;GSTZ1;GGT7;CHAC2,37 (37),0.0207,0.146,0,,25 (31),1,1,0.101,0.448
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,16,MAPK11;PAK1;MAPK13;IGSF5;IKBKG;ADAM10;CXCL2;CXCL3;HBEGF;PLCG2;JAM3;NFKBIA;ATP6V0E2;CHUK;MAPK12;JAM2,70 (70),0.021,0.146,0,,5 (7),1,1,0.102,0.448
Atorvastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
CDP-diacylglycerol biosynthesis,HumanCyc,7,LPCAT4;GK;GPAT4;GPAM;GPAT3;LCLAT1;MBOAT1,22 (22),0.021,0.146,0,,14 (19),1,1,0.102,0.448
Wolman disease,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Phase 0 - rapid depolarisation,Reactome,7,CACNA1C;CACNB1;SCN1B;SCN3B;SCN4B;SCN5A;SCN7A,22 (22),0.021,0.146,0,,2 (2),1,1,0.102,0.448
Cerivastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (47),1,1,0.102,0.448
Simvastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (47),1,1,0.102,0.448
Pravastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Hyper-IgD syndrome,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Cholesteryl ester storage disease,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Alendronate Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Rosuvastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (47),1,1,0.102,0.448
Lovastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Mevalonic aciduria,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Risedronate Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Pamidronate Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Fluvastatin Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,44 (47),1,1,0.102,0.448
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
CHILD Syndrome,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Desmosterolosis,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Hypercholesterolemia,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Steroid Biosynthesis,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Zoledronate Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (47),1,1,0.102,0.448
Ibandronate Action Pathway,SMPDB,7,TM7SF2;DHCR24;LIPA;IDI1;HSD17B7;NSDHL;SC5D,22 (22),0.021,0.146,0,,43 (46),1,1,0.102,0.448
Transport of organic anions,Reactome,3,SLCO3A1;ALB;SLC16A2,12 (12),0.211,0.643,1,HMDB0000036,13 (15),0.0999,1,0.102,0.448
Hydrolysis of LPC,Reactome,2,PLA2G4E;PLA2G4F,11 (11),0.445,0.927,1,HMDB0010404,6 (9),0.0474,1,0.102,0.448
Syndecan-4-mediated signaling events,PID,9,FGF2;TNC;CXCR4;THBS1;FGFR1;MMP9;PLG;ITGA5;FN1,32 (32),0.0214,0.149,0,,2 (2),1,1,0.104,0.453
stearate biosynthesis,HumanCyc,5,SLC27A2;ACOT4;ACOT1;ACSL1;ACOT2,13 (13),0.0218,0.151,0,,15 (17),1,1,0.105,0.458
Degradation of cysteine and homocysteine,Reactome,5,CTH;CDO1;SUOX;GOT2;MPST,13 (13),0.0218,0.151,0,,31 (40),1,1,0.105,0.458
Purine salvage,Reactome,5,AMPD3;ADK;ADA;AMPD1;ADAL,13 (13),0.0218,0.151,0,,30 (31),1,1,0.105,0.458
Irinotecan pathway,Wikipathways,5,NPC1;UGT1A1;ABCC2;ABCG2;BCHE,13 (13),0.0218,0.151,0,,3 (4),1,1,0.105,0.458
Hypertrophy Model,Wikipathways,5,HBEGF;IFRD1;ATF3;ADAM10;ANKRD1,20 (20),0.12,0.465,0,,0 (0),1,1,0.12,0.465
Ca-dependent events,Reactome,7,ADCY9;PRKAR1B;PRKAR2A;ADCY2;CAMK2A;ADCY4;CAMKK1,39 (39),0.263,0.728,1,HMDB0010404,11 (11),0.0852,1,0.107,0.466
Opioid Signalling,Reactome,16,ADCY9;GNG11;PRKAR2A;GNGT2;PRKAR1B;ADCY2;CAMK2A;GNAI1;ADCY4;PLCB4;CAMKK1;PDE4B;PDE4D;GNB5;GNG2;ITPR3,91 (91),0.154,0.533,1,HMDB0010404,20 (23),0.15,1,0.11,0.476
Bile acids synthesis and enterohepatic circulation,Wikipathways,4,ABCG5;ABCG8;CYP7A1;ABCB11,9 (9),0.0232,0.159,0,,1 (3),1,1,0.11,0.477
Methylation Pathways,Wikipathways,4,HNMT;TPMT;NNMT;MAT1A,9 (9),0.0232,0.159,0,,5 (5),1,1,0.11,0.477
Ca2+ activated K+ channels,Reactome,4,KCNMB1;KCNN1;KCNN2;KCNN4,9 (9),0.0232,0.159,0,,1 (1),1,1,0.11,0.477
Vitamin A and carotenoid metabolism,Wikipathways,11,CYP2E1;RETSAT;ABCG5;ABCG8;SCARB1;ALDH1A2;CYP26A1;CYP26B1;RARG;BCO1;ADH4,43 (43),0.0234,0.16,0,,21 (21),1,1,0.111,0.479
Activation of GABAB receptors,Reactome,11,GABBR2;GNG11;ADCY4;GNGT2;ADCY2;GNAI1;ADCY9;KCNJ10;KCNJ12;GNB5;GNG2,43 (43),0.0234,0.16,0,,6 (6),1,1,0.111,0.479
GABA B receptor activation,Reactome,11,GABBR2;GNG11;ADCY4;GNGT2;ADCY2;GNAI1;ADCY9;KCNJ10;KCNJ12;GNB5;GNG2,43 (43),0.0234,0.16,0,,6 (6),1,1,0.111,0.479
p75 NTR receptor-mediated signalling,Reactome,15,FGD2;OBSCN;NGF;ARHGEF17;FGD1;BEX3;PREX1;ARHGEF2;VAV1;ARHGEF6;FGD3;NFKBIA;NGFR;ARHGEF7;MCF2L,96 (96),0.302,0.786,1,HMDB0013461,10 (11),0.0777,1,0.112,0.479
Gastrin signaling pathway,Wikipathways,20,PAK1;KLF4;ARHGEF28;MMP7;EGR1;KIT;PRKD2;BMP2;HDAC7;PTGS2;ANXA2;PRKCH;MEF2C;NFKBIA;PRKCQ;ARRB2;ARRB1;CLDN1;CHUK;BCAR1,114 (114),0.124,0.48,0,,0 (0),1,1,0.124,0.48
Maturity onset diabetes of the young - Homo sapiens (human),KEGG,6,PKLR;HNF4A;ONECUT1;HNF1A;SLC2A2;MAFA,26 (26),0.125,0.482,0,,0 (0),1,1,0.125,0.482
ID,NetPath,6,FHL2;ID4;ATF3;ELK3;PAX5;SMAD3,26 (26),0.125,0.482,0,,0 (0),1,1,0.125,0.482
G-protein mediated events,Reactome,10,PRKAR1B;ADCY4;ADCY2;CAMK2A;PRKAR2A;GNAI1;ADCY9;PLCB4;ITPR3;CAMKK1,55 (55),0.195,0.607,1,HMDB0010404,16 (17),0.122,1,0.113,0.482
Glycosphingolipid metabolism,Reactome,3,SMPD3;ARSG;CERK,46 (46),0.956,1,2,HMDB0010711;HMDB0013461,31 (38),0.0249,1,0.113,0.483
rho cell motility signaling pathway,BioCarta,7,NCF2;ARHGAP1;ARHGAP4;LIMK1;VAV1;GSN;MYL2,32 (32),0.128,0.486,0,,0 (0),1,1,0.128,0.486
WNT-Ncore,Signalink,7,MARK1;ROR2;NPR1;SMAD3;SFRP1;ARRB1;GPC3,32 (32),0.128,0.486,0,,0 (0),1,1,0.128,0.486
IL-6-type cytokine receptor ligand interactions,Reactome,4,LIF;LIFR;IL11;CNTFR,15 (15),0.131,0.486,0,,0 (0),1,1,0.131,0.486
ErbB receptor signaling network,PID,4,NRG4;ERBB2;EREG;HBEGF,15 (15),0.131,0.486,0,,0 (0),1,1,0.131,0.486
PDGFR mutants bind TKIs,Reactome,1,PDGFRA,1 (1),0.134,0.486,0,,0 (6),1,1,0.134,0.486
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Reactome,1,GJA1,1 (1),0.134,0.486,0,,0 (1),1,1,0.134,0.486
Defective F8 accelerates dissociation of the A2 domain,Reactome,1,F8,1 (1),0.134,0.486,0,,0 (0),1,1,0.134,0.486
Defective factor VIII causes hemophilia A,Reactome,1,F8,1 (1),0.134,0.486,0,,0 (0),1,1,0.134,0.486
KIT mutants bind TKIs,Reactome,1,KIT,1 (1),0.134,0.486,0,,0 (6),1,1,0.134,0.486
Vatalanib Action Pathway,SMPDB,1,KDR,1 (1),0.134,0.486,0,,0 (0),1,1,0.134,0.486
RUNX1 regulates expression of components of tight junctions,Reactome,2,CLDN5;RUNX1,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
RUNX3 regulates CDKN1A transcription,Reactome,2,SMAD3;RUNX3,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
RUNX3 Regulates Immune Response and Cell Migration,Reactome,2,RUNX3;ITGAL,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
RUNX3 regulates BCL2L11 (BIM) transcription,Reactome,2,SMAD3;RUNX3,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
MECP2 regulates transcription factors,Reactome,2,MEF2C;RBFOX1,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
Binding and entry of HIV virion,Reactome,2,CCR5;CXCR4,5 (5),0.136,0.486,0,,0 (2),1,1,0.136,0.486
basic mechanism of action of ppara pparb(d) and pparg and effects on gene expression,BioCarta,2,PPARA;PPARD,5 (5),0.136,0.486,0,,0 (1),1,1,0.136,0.486
RUNX1 regulates transcription of genes involved in interleukin signaling,Reactome,2,LIFR;RUNX1,5 (5),0.136,0.486,0,,0 (0),1,1,0.136,0.486
Liver X receptor pathway,Wikipathways,3,ABCG5;ABCG8;CYP7A1,10 (10),0.14,0.493,0,,0 (1),1,1,0.14,0.493
NLR Proteins,Wikipathways,3,EPHB2;CHUK;IKBKG,10 (10),0.14,0.493,0,,0 (0),1,1,0.14,0.493
LIF signaling,INOH,3,LIF;LIFR;SMAD1,10 (10),0.14,0.493,0,,0 (0),1,1,0.14,0.493
Removal of aminoterminal propeptides from gamma-carboxylated proteins,Reactome,3,PROZ;GAS6;F9,10 (10),0.14,0.493,0,,0 (0),1,1,0.14,0.493
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),Reactome,3,CTLA4;RUNX1;NFATC2,10 (10),0.14,0.493,0,,0 (0),1,1,0.14,0.493
Nef mediated downregulation of MHC class I complex cell surface expression,Reactome,3,AP1S2;PACS1;AP1M2,10 (10),0.14,0.493,0,,0 (0),1,1,0.14,0.493
Vitamin B12 metabolism,Wikipathways,11,IL1B;CCL2;SAA4;CBS;MAT1A;APOB;CTH;SCARB1;CRP;PLG;ALB,51 (51),0.072,0.333,1,HMDB0001904,51 (61),0.34,1,0.115,0.493
GPCR downstream signalling,Reactome,88,PROK2;PDE3B;PDE4B;PDE4D;RAMP2;AVPR1A;RGS19;RPS6KA2;PENK;ABHD6;OBSCN;GPR55;S1PR2;MGLL;PDE10A;ARHGEF17;F2RL1;PTGIR;ADCY2;BDKRB2;PTH1R;ADCY9;FFAR4;ITPR3;ADORA1;ADORA2B;CCR2;ADRA1A;ADRB2;ARHGEF7;CXCR4;ACKR3;PXMP2;FGD1;P2RY10;SCTR;C3;C3AR1;GNAI1;PLCB4;C5AR1;GNAT1;MCF2L;PDE3A;CXCL5;GNG11;CX3CL1;GNGT2;DAGLA;PREX1;CCR5;VAV1;KNG1;CNR2;FGD3;DAGLB;CXCR3;ADCY4;CYP26B1;CAMKK1;FGD2;HBEGF;NTS;CXCL13;APP;GABBR2;GNG2;ARHGEF25;CXCL2;CXCL3;RGS3;RGS10;ARRB1;ARRB2;CAMK2A;P2RY4;P2RY6;ARHGEF6;GNB5;PAK1;PRKAR1B;PRKAR2A;PRKCH;PRKCQ;ARHGEF2;MAPK7;CXCR6;S1PR4,633 (633),0.372,0.865,3,HMDB0010404;HMDB0034927;HMDB0002183,118 (152),0.0662,1,0.116,0.494
Nuclear receptors,Wikipathways,10,HNF4A;RARG;THRB;NR2F2;NR1I3;ESRRB;PPARA;PPARD;NR4A1;VDR,38 (38),0.0249,0.169,0,,1 (5),1,1,0.117,0.497
Linoleate metabolism,EHMN,13,FADS2;UGT1A1;CYP2E1;EPHX2;CYP1A1;CYP1B1;SLC23A1;CYP4B1;PTGS2;UGT1A5;FADS1;CYP2S1;GPX3,72 (72),0.161,0.551,1,HMDB0010404,21 (24),0.157,1,0.118,0.499
GABAergic synapse - Homo sapiens (human),KEGG,19,GLUL;GABBR2;GABRB3;CACNA1S;GNG11;GABRP;GNGT2;CACNA1C;ADCY2;GNAI1;CACNA1D;ABAT;ADCY9;ADCY4;GNB5;SLC6A13;GNG2;SLC6A12;GABRA3,89 (89),0.0252,0.17,0,,9 (9),1,1,0.118,0.499
Serotonergic synapse - Homo sapiens (human),KEGG,23,GABRB3;CACNA1C;CACNA1D;CACNA1S;ALOX12;MAOB;SLC18A1;RAPGEF3;DUSP1;GNB5;GNG2;KCNN2;GNAI1;PLCB4;PLA2G4F;APP;PLA2G4E;GNG11;GNGT2;DDC;PTGS2;ALOX5;ITPR3,113 (115),0.0254,0.17,0,,39 (42),1,1,0.119,0.499
Metabolism of Angiotensinogen to Angiotensins,Reactome,6,ANPEP;ACE;CPA3;CPB2;MME;CMA1,18 (18),0.0255,0.17,0,,12 (28),1,1,0.119,0.499
Glycogen synthetase deficiency,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Sucrase-isomaltase deficiency,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Glycogenosis_ Type VI. Hers disease,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Starch and Sucrose Metabolism,SMPDB,6,UGP2;GBE1;MGAM;PYGL;GYS2;UGDH,18 (18),0.0255,0.17,0,,29 (29),1,1,0.119,0.499
Purine nucleotides nucleosides metabolism,INOH,22,ADK;AMPD1;AMPD3;NPR1;PDE3A;PDE3B;PDE4B;PDE4D;PDE9A;GUCY1A1;GUCY1B1;ENTPD5;PKLR;PKM;ADCY4;AK1;PAPSS2;PDE10A;ADA;ADCY2;PAICS;ADCY9,107 (107),0.0255,0.17,0,,77 (80),1,1,0.119,0.499
Canonical and non-canonical Notch signaling,Wikipathways,6,MAML1;ADAM10;DLL4;NOTCH4;CHUK;RBPJ,27 (27),0.144,0.502,0,,0 (0),1,1,0.144,0.502
FGFR3 signaling in chondrocyte proliferation and terminal differentiation,Wikipathways,6,MAPK11;MAPK13;BMP2;PTH1R;SNAI1;MAPK12,27 (27),0.144,0.502,0,,0 (1),1,1,0.144,0.502
Resistin as a regulator of inflammation,Wikipathways,7,PLCD3;IKBKG;NFKBIA;PLCB4;PLCD1;PLCG2;CHUK,33 (33),0.144,0.502,0,,0 (0),1,1,0.144,0.502
Signaling by GPCR,Reactome,101,PROK2;PDE3B;PDE4B;PDE4D;RAMP2;AVPR1A;RGS19;RPS6KA2;PENK;ABHD6;OBSCN;CD55;GPR55;S1PR2;MGLL;PDE10A;ARHGEF17;F2RL1;PTGIR;ADCY2;BDKRB2;PTH1R;PDE3A;FFAR4;ITPR3;FZD4;FZD8;ADORA1;ADORA2B;CCR2;ADRA1A;ADRB2;ARHGEF7;CXCR4;ACKR3;ADCY9;PXMP2;FGD1;P2RY10;SCTR;CCL2;C3;C3AR1;GNAI1;CCL11;ACKR2;C5AR1;GNAT1;MCF2L;CXCL5;GNG11;CX3CL1;GNGT2;DAGLA;PREX1;CCR5;VAV1;ARHGEF6;CNR2;FGD3;PLCB4;DAGLB;CXCR3;ADCY4;CYP26B1;CAMKK1;FGD2;FZD9;GPR35;HBEGF;WNT7B;WNT11;NTS;WNT9B;CXCL13;APP;GABBR2;GNG2;ARHGEF25;CXCL2;CXCL3;RGS3;RGS10;CMKLR1;ARRB1;ARRB2;CAMK2A;P2RY4;CXCR6;KNG1;GNB5;PAK1;PRKAR1B;PRKAR2A;PRKCH;ADGRE5;PRKCQ;ARHGEF2;MAPK7;P2RY6;S1PR4,706 (706),0.251,0.701,3,HMDB0010404;HMDB0034927;HMDB0002183,142 (190),0.102,1,0.12,0.502
Purinergic signaling,Wikipathways,9,P2RX7;P2RY4;ADORA1;P2RY6;ADORA2B;P2RX6;P2RY10;GNAI1;GNAT1,33 (33),0.026,0.173,0,,15 (55),1,1,0.121,0.506
Fructose and mannose metabolism - Homo sapiens (human),KEGG,9,ALDOA;ALDOB;HKDC1;TKFC;PFKFB2;PFKFB1;AKR1B10;PFKFB4;SORD,33 (33),0.026,0.173,0,,31 (54),1,1,0.121,0.506
Death Receptor Signalling,Reactome,20,FGD2;OBSCN;FGD1;TNFRSF10B;ARHGEF17;IKBKG;NGF;VAV1;BEX3;PREX1;ARHGEF2;NFKBIA;ARHGEF6;FGD3;SMPD3;NGFR;BAG4;CHUK;ARHGEF7;MCF2L,134 (134),0.338,0.834,1,HMDB0013461,10 (12),0.0777,1,0.122,0.509
Hippo signaling pathway - Homo sapiens (human),KEGG,26,FZD4;TGFB3;PARD6B;FZD8;FZD9;TGFBR2;BMP2;BMP5;BMP6;DLG5;TGFB2;FRMD6;RASSF6;CSNK1E;WNT7B;WNT11;WNT9B;FGF1;ACTG1;DLG4;WWTR1;PARD3;AJUBA;ITGB2;SMAD1;SMAD3,157 (157),0.147,0.512,0,,0 (0),1,1,0.147,0.512
Prostaglandin Leukotriene metabolism,INOH,7,PTGES;CBR3;PTGIS;ALOX12;ALOX5;GGT1;PTGS2,23 (23),0.0268,0.176,0,,23 (25),1,1,0.124,0.514
One-carbon metabolism,Wikipathways,8,SHMT1;MTHFD1;MAT1A;AMT;DHFR;ALDH1L1;BHMT;AHCY,28 (28),0.0268,0.176,0,,22 (25),1,1,0.124,0.514
HDL remodeling,Reactome,2,LCAT;ALB,9 (9),0.345,0.834,1,HMDB0010404,10 (13),0.0777,1,0.124,0.514
PLC beta mediated events,Reactome,9,ADCY9;PRKAR1B;PRKAR2A;ADCY2;CAMK2A;ADCY4;PLCB4;ITPR3;CAMKK1,50 (50),0.221,0.659,1,HMDB0010404,16 (17),0.122,1,0.124,0.514
Biosynthesis of maresin-like SPMs,Reactome,1,CYP2E1,6 (6),0.578,1,1,HMDB0002183,6 (17),0.0474,1,0.126,0.522
Chagas disease - Homo sapiens (human),KEGG,21,MAPK11;IL1B;TGFB2;TGFB3;ACE;IKBKG;TGFBR2;TLR4;CCL2;IFNGR1;CD3D;C3;MAPK13;BDKRB2;GNAI1;KNG1;PLCB4;NFKBIA;TLR9;CHUK;MAPK12,102 (102),0.0282,0.185,0,,6 (6),1,1,0.129,0.533
Pyrimidine Metabolism,SMPDB,6,UPP2;DPYD;DPYS;CDA;UPB1;AK3,23 (23),0.0775,0.352,1,HMDB0000273,56 (57),0.367,1,0.13,0.533
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,6,UPP2;DPYD;DPYS;CDA;UPB1;AK3,23 (23),0.0775,0.352,1,HMDB0000273,56 (57),0.367,1,0.13,0.533
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,6,UPP2;DPYD;DPYS;CDA;UPB1;AK3,23 (23),0.0775,0.352,1,HMDB0000273,56 (57),0.367,1,0.13,0.533
Beta Ureidopropionase Deficiency,SMPDB,6,UPP2;DPYD;DPYS;CDA;UPB1;AK3,23 (23),0.0775,0.352,1,HMDB0000273,56 (57),0.367,1,0.13,0.533
Dihydropyrimidinase Deficiency,SMPDB,6,UPP2;DPYD;DPYS;CDA;UPB1;AK3,23 (23),0.0775,0.352,1,HMDB0000273,56 (57),0.367,1,0.13,0.533
Aryl Hydrocarbon Receptor Pathway,Wikipathways,9,NQO1;MGST1;UGT1A1;AHR;CYP1A1;CYP1B1;MYOF;IL1B;IGFBP1,46 (46),0.155,0.537,0,,0 (1),1,1,0.155,0.537
Envelope proteins and their potential roles in EDMD physiopathology,Wikipathways,9,SRF;TGFB3;ADCY2;TGFB2;ADCY9;ADCY4;TMEM43;SMAD3;LBR,46 (46),0.155,0.537,0,,0 (0),1,1,0.155,0.537
Oxidative Damage,Wikipathways,8,BAK1;MAPK13;CR2;C3AR1;BCL2;MAP3K1;C5AR1;BAG4,40 (40),0.159,0.546,0,,0 (0),1,1,0.159,0.546
Viral myocarditis - Homo sapiens (human),KEGG,11,ITGAL;CD55;ACTG1;ITGB2;SGCB;SGCG;PRF1;MYH7;CAV1;LAMA2;ABL1,59 (60),0.16,0.548,0,,0 (0),1,1,0.16,0.548
TCR signaling in na&#xef;ve CD4+ T cells,PID,15,LAT;IKBKG;VAV1;FLNA;CD3D;MAP4K1;CARD11;STK39;PRKCQ;GAB2;INPP5D;GRAP2;CHUK;LCK;WAS,67 (67),0.0296,0.193,0,,4 (4),1,1,0.134,0.549
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,15,ALDH3A2;PKLR;ALDOA;PKM;ALDOB;PGAM2;HKDC1;ENO3;PCK1;LDHA;ACSS1;ALDH7A1;LDHB;ADH4;ALDH9A1,67 (67),0.0296,0.193,0,,25 (31),1,1,0.134,0.549
Osteoclast differentiation - Homo sapiens (human),KEGG,25,TGFB2;IFNGR1;TGFBR2;TNFRSF11A;MAPK12;SPI1;NFATC2;FOSB;FOSL2;NFKBIA;BLNK;IKBKG;NCF2;RELB;SIRPA;PLCG2;LCK;FCGR2B;MAPK11;IL1B;FHL2;MAPK13;GAB2;CHUK;FOSL1,127 (128),0.0298,0.194,0,,3 (3),1,1,0.135,0.551
Methylation,Reactome,5,AS3MT;AHCY;TPMT;NNMT;MAT1A,14 (14),0.0303,0.196,0,,30 (38),1,1,0.136,0.555
Heme biosynthesis,Reactome,5,CPOX;FLVCR1;ABCG2;ALAS1;ALB,14 (14),0.0303,0.196,0,,24 (33),1,1,0.136,0.555
fibrinolysis pathway,BioCarta,5,PLG;CPB2;FGG;FGA;FGB,14 (14),0.0303,0.196,0,,1 (1),1,1,0.136,0.555
TCR signaling,Reactome,16,LAT;PAK1;IKBKG;PAK3;ENAH;NFKBIA;VASP;CARD11;CD3D;PRKCQ;PLCG2;INPP5D;GRAP2;CHUK;LCK;WAS,73 (73),0.0303,0.196,0,,7 (10),1,1,0.136,0.555
G alpha (i) signalling events,Reactome,47,PDE4B;ADORA1;CCR2;CXCR3;ADCY4;PXMP2;PDE4D;CYP26B1;CAMKK1;P2RY4;CXCR6;CXCR4;CAMK2A;ADCY9;GNB5;GNG2;CXCL13;PRKAR1B;PRKAR2A;RGS19;GPR55;C3;C3AR1;CCR5;PLCB4;S1PR2;C5AR1;GNAT1;APP;GABBR2;PENK;CXCL5;GNG11;CXCL2;CXCL3;ADCY2;GNAI1;RGS3;BDKRB2;RGS10;KNG1;CNR2;GNGT2;CX3CL1;S1PR4;ACKR3;ITPR3,316 (316),0.242,0.699,2,HMDB0010404;HMDB0034927,77 (106),0.126,1,0.137,0.556
Nuclear Receptor transcription pathway,Reactome,10,HNF4A;RARG;THRB;NR1I3;NR1H4;ESRRB;PPARA;PPARD;NR4A1;VDR,53 (53),0.165,0.559,0,,0 (0),1,1,0.165,0.559
Constitutive Signaling by Aberrant PI3K in Cancer,Reactome,17,CD19;PDGFB;PDGFRA;NRG4;FGF1;KIT;HGF;PDGFRB;HBEGF;ERBB2;VAV1;FGFR1;EREG;GAB2;LCK;FGF2;KLB,79 (79),0.0308,0.199,0,,5 (18),1,1,0.138,0.561
Ras signaling,Wikipathways,34,RIN1;RGL1;KSR1;PAK1;FLT4;IGF1R;ABL1;RASAL3;SHC2;LAT;PDGFRA;PLA1A;PDGFRB;NTRK2;RASGRP3;GNB5;GNG2;ETS2;NGFR;IKBKG;PAK3;PLA2G6;KDR;FGFR1;PLA2G4F;PLCG2;PAK6;PLA2G4E;TEK;GNG11;GNGT2;KIT;GAB2;CHUK,184 (184),0.0311,0.2,0,,7 (7),1,1,0.139,0.563
Potassium Channels,Reactome,21,GABBR2;KCNB1;KCNAB2;KCNMB1;KCNN1;KCNN2;GNG11;KCNQ1;GNGT2;KCNN4;KCNQ4;KCNK6;KCNK13;KCNJ10;KCNAB1;KCNJ12;GNB5;GNG2;KCNG4;KCNK1;KCNA7,103 (103),0.0311,0.2,0,,3 (3),1,1,0.139,0.563
RHOV GTPase cycle,Reactome,9,PAK1;MYO9A;CCP110;DLG5;ASB15;IQGAP1;PAK6;ARHGEF7;SH3RF1,34 (34),0.0313,0.201,0,,1 (1),1,1,0.14,0.565
Gluconeogenesis,Reactome,9,ALDOA;ALDOB;PGAM2;ENO3;SLC37A4;PCK1;GOT1;GOT2;SLC25A13,34 (35),0.0313,0.201,0,,25 (31),1,1,0.14,0.565
Mesodermal commitment pathway,Wikipathways,25,FZD4;FZD8;DDAH1;ADAM19;RARG;MTF2;KLF5;SRF;GATA6;EPB41L5;CTBP2;FGFR1;SNAI1;KLF4;HNF4A;GRHL2;SESN1;ATP8B2;RGS10;EMSY;TBX1;SMAD1;SMAD3;SMAD6;FOXC2,153 (153),0.17,0.574,0,,0 (0),1,1,0.17,0.574
granzyme a mediated apoptosis pathway,BioCarta,3,GZMB;HMGB2;PRF1,11 (11),0.174,0.583,0,,0 (0),1,1,0.174,0.583
cxcr4 signaling pathway,BioCarta,3,PIK3C2G;GNAI1;CXCR4,11 (11),0.174,0.583,0,,0 (0),1,1,0.174,0.583
Nucleotide-binding Oligomerization Domain (NOD) pathway,Wikipathways,8,IL1B;IKBKG;CARD9;ACAP1;PYCARD;NFKBIA;CHUK;PRDM1,41 (41),0.176,0.585,0,,0 (0),1,1,0.176,0.585
Photodynamic therapy-induced NF-kB survival signaling,Wikipathways,7,IL1B;CXCL2;PTGS2;RELB;MMP2;CHUK;MMP9,35 (35),0.181,0.585,0,,0 (0),1,1,0.181,0.585
RUNX1 regulates estrogen receptor mediated transcription,Reactome,2,RUNX1;GPAM,6 (6),0.187,0.585,0,,0 (1),1,1,0.187,0.585
RUNX1 regulates transcription of genes involved in WNT signaling,Reactome,2,RUNX1;RSPO3,6 (6),0.187,0.585,0,,0 (1),1,1,0.187,0.585
Alternative NF-kappaB pathway,PID,2,RELB;CHUK,6 (6),0.187,0.585,0,,0 (0),1,1,0.187,0.585
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,Reactome,2,RUNX1;LGALS3,6 (6),0.187,0.585,0,,0 (0),1,1,0.187,0.585
p75NTR negatively regulates cell cycle via SC1,Reactome,2,NGF;NGFR,6 (6),0.187,0.585,0,,0 (0),1,1,0.187,0.585
Staphylococcus aureus infection - Homo sapiens (human),KEGG,16,KRT17;CFI;ITGAL;ITGAM;FCGR2B;KRT19;ITGB2;C3;C3AR1;DEFB1;CFH;C5AR1;SELPLG;FGG;MASP2;PLG,94 (96),0.187,0.585,0,,0 (2),1,1,0.187,0.585
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human),KEGG,3,PGAP1;GPLD1;PIGL,26 (26),0.697,1,1,HMDB0011668,6 (16),0.0474,1,0.146,0.585
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Reactome,3,SLC29A3;SLC28A2;SLC25A4,12 (12),0.211,0.643,1,HMDB0000273,21 (21),0.157,1,0.146,0.585
Xenobiotics metabolism,EHMN,11,MGST1;UGT1A1;CYP2E1;GSTK1;EPHX2;CYP1A1;CYP1B1;GSTZ1;CYP4B1;UGT1A5;CYP2S1,51 (51),0.072,0.333,1,HMDB0060326,75 (93),0.459,1,0.146,0.585
Overview of nanoparticle effects,Wikipathways,6,COL4A1;CDH3;PTGS2;BCL2;CRP;FN1,19 (19),0.0331,0.211,0,,1 (3),1,1,0.146,0.585
GABA synthesis_ release_ reuptake and degradation,Reactome,6,ALDH5A1;SYT1;SLC6A12;SLC6A13;ABAT;STXBP1,19 (19),0.0331,0.211,0,,15 (17),1,1,0.146,0.585
Ephrin signaling,Reactome,6,EPHB2;PAK1;PAK3;ARHGEF7;EPHB4;EFNB2,19 (19),0.0331,0.211,0,,4 (4),1,1,0.146,0.585
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,14,NQO1;TNNI2;UGT1A1;CYP2E1;TNNT3;TPM1;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,82 (82),0.204,0.63,1,HMDB0009888,22 (22),0.163,1,0.146,0.587
RAC1-PAK1-p38-MMP2 Pathway,Wikipathways,15,MAPK11;PAK1;TIE1;IKBKG;GRB14;MAPK12;TEK;ERBB2;MAPK13;DOK2;NFKBIA;MMP2;CHUK;ANGPT1;FN1,68 (68),0.0335,0.213,0,,1 (1),1,1,0.147,0.588
Synthesis of very long-chain fatty acyl-CoAs,Reactome,7,ELOVL5;ACSL1;HACD3;HSD17B12;ACSF3;ELOVL2;ELOVL7,24 (24),0.0336,0.213,0,,20 (27),1,1,0.148,0.589
Ephrin B reverse signaling,PID,7,BLK;EPHB2;EPHB4;FGR;EFNB2;RGS3;LCK,24 (24),0.0336,0.213,0,,2 (2),1,1,0.148,0.589
Phosphatidylinositol Phosphate Metabolism,SMPDB,4,ERBB2;PIP4K2A;INPP5D;INPP4B,23 (23),0.372,0.865,1,HMDB0009888,12 (12),0.0926,1,0.151,0.593
Joubert syndrome,SMPDB,4,ERBB2;PIP4K2A;INPP5D;INPP4B,23 (23),0.372,0.865,1,HMDB0009888,12 (12),0.0926,1,0.151,0.593
Urea cycle,Reactome,4,OTC;CPS1;SLC25A15;ARG1,10 (10),0.0346,0.215,0,,21 (23),1,1,0.151,0.593
Steroid Biosynthesis,Wikipathways,4,CYP17A1;F13B;HSD17B7;HSD17B4,10 (10),0.0346,0.215,0,,12 (12),1,1,0.151,0.593
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Reactome,4,MAPK11;PRKAA2;MAPK12;PRKAG2,10 (10),0.0346,0.215,0,,3 (3),1,1,0.151,0.593
Abacavir transport and metabolism,Reactome,4,PCK1;SLC22A1;ABCG2;ADAL,10 (10),0.0346,0.215,0,,15 (19),1,1,0.151,0.593
Organic anion transporters,Reactome,4,SLC17A1;SLC25A22;SLC17A8;SLC17A5,10 (10),0.0346,0.215,0,,13 (15),1,1,0.151,0.593
Synthesis and degradation of ketone bodies - Homo sapiens (human),KEGG,4,OXCT1;HMGCS2;BDH1;ACAT1,10 (10),0.0346,0.215,0,,6 (6),1,1,0.151,0.593
Crosslinking of collagen fibrils,Reactome,4,LOXL1;PXDN;PCOLCE;LOX,10 (10),0.0346,0.215,0,,6 (7),1,1,0.151,0.593
Sulfur metabolism - Homo sapiens (human),KEGG,4,BPNT1;PAPSS2;MPST;SUOX,10 (10),0.0346,0.215,0,,22 (33),1,1,0.151,0.593
NGF-stimulated transcription,Reactome,10,LYL1;ARC;EGR1;EGR3;SRF;SGK1;ID4;FOSB;RRAD;FOSL1,40 (40),0.0348,0.215,0,,2 (2),1,1,0.152,0.593
urea cycle,HumanCyc,3,OTC;CPS1;ARG1,6 (6),0.0351,0.215,0,,17 (17),1,1,0.153,0.593
Benzene metabolism,Wikipathways,3,NQO1;CYP2E1;DHDH,6 (6),0.0351,0.215,0,,7 (12),1,1,0.153,0.593
histidine degradation,HumanCyc,3,HAL;UROC1;MTHFD1,6 (6),0.0351,0.215,0,,12 (12),1,1,0.153,0.593
Vitamins,Reactome,3,CYP26B1;CYP26A1;CYP2R1,6 (6),0.0351,0.215,0,,11 (13),1,1,0.153,0.593
Proton-coupled monocarboxylate transport,Reactome,3,EMB;SLC16A7;SLC16A1,6 (6),0.0351,0.215,0,,4 (5),1,1,0.153,0.593
NOSTRIN mediated eNOS trafficking,Reactome,3,CAV1;ASB15;NOS3,6 (6),0.0351,0.215,0,,4 (4),1,1,0.153,0.593
platelet amyloid precursor protein pathway,BioCarta,3,PLG;F9;APP,6 (6),0.0351,0.215,0,,1 (1),1,1,0.153,0.593
FGFR1b ligand binding and activation,Reactome,3,FGFR1;FGF1;FGF2,6 (6),0.0351,0.215,0,,3 (3),1,1,0.153,0.593
estradiol biosynthesis I,HumanCyc,3,HSD17B11;HSD17B7;HSD17B4,6 (6),0.0351,0.215,0,,13 (13),1,1,0.153,0.593
Pantothenate and CoA Biosynthesis,SMPDB,3,PANK1;VNN1;ENPP1,6 (6),0.0351,0.215,0,,21 (21),1,1,0.153,0.593
Purine metabolism - Homo sapiens (human),KEGG,25,ADK;AMPD1;AMPD3;NPR1;ADCY4;PDE3B;PDE4B;PDE4D;PDE9A;GUCY1A1;GUCY1B1;ENPP1;ENTPD5;PKLR;PKM;AK1;PAPSS2;PDE10A;PDE3A;URAD;ADA;ADCY2;PAICS;ADCY9;AK3,129 (130),0.0354,0.216,0,,78 (95),1,1,0.154,0.596
Caspase Cascade in Apoptosis,PID,13,SATB1;LMNB1;MAP3K1;VIM;ARHGDIB;PRF1;LIMK1;BCL2;GSN;ACTA1;TNFRSF10B;GZMB;APP,57 (57),0.0358,0.219,0,,1 (2),1,1,0.155,0.6
Glutathione metabolism - Homo sapiens (human),KEGG,13,MGST1;ANPEP;GSTK1;GGT1;GCLM;GGT6;PRDX6;GGT7;CHAC1;IDH1;OPLAH;GPX3;CHAC2,57 (57),0.0358,0.219,0,,21 (38),1,1,0.155,0.6
Cytochrome P450 - arranged by substrate type,Reactome,12,CYP2R1;CYP39A1;CYP1A1;PTGIS;CYP4B1;CYP7A1;CYP8B1;CYP2E1;CYP1B1;CYP26A1;CYP2S1;CYP26B1,57 (57),0.0724,0.333,1,HMDB0001860,87 (120),0.511,1,0.159,0.614
Vitamin D-sensitive calcium signaling in depression,Wikipathways,9,CACNA1C;ATP2B4;PVALB;BCL2;GGT1;KDM1B;VDR;ITPR3;KDM6B,35 (35),0.0373,0.227,0,,13 (15),1,1,0.16,0.617
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,9,PRKAR1B;GNG11;PRKAR2A;GNGT2;RAPGEF3;GNB5;IQGAP1;GNG2;RAPGEF4,35 (35),0.0373,0.227,0,,5 (5),1,1,0.16,0.617
Human papillomavirus infection - Homo sapiens (human),KEGG,56,FZD4;COL4A2;FZD8;FZD9;ITGA8;COL6A1;COL6A2;COL4A1;THBS1;MFNG;VTN;PARD6B;VWF;PTGS2;COMP;ITGA3;COL4A4;PDGFRB;SPP1;TNC;COL6A3;WNT7B;WNT11;ATP6V0E2;FN1;WNT9B;BAK1;PKM;LAMA2;IKBKG;LAMA4;ITGA6;LAMB1;LAMB2;LAMB3;LAMC1;COL6A5;CHAD;LAMC2;LAMC3;LAMA5;CREB3L3;ITGA5;PARD3;RBPJ;ITGB4;TNXB;ITGB6;ITGB7;ITGB8;LFNG;MAML1;NOTCH4;CHUK;COL1A1;COL1A2,331 (331),0.0376,0.228,0,,3 (3),1,1,0.161,0.62
Renin secretion - Homo sapiens (human),KEGG,15,AQP1;ACE;GUCY1A1;ADORA1;CACNA1C;CACNA1D;CACNA1S;NPR1;GNAI1;PDE3A;PDE3B;GUCY1B1;PLCB4;ADRB2;ITPR3,69 (69),0.0376,0.228,0,,17 (17),1,1,0.161,0.62
Transcriptional misregulation in cancer - Homo sapiens (human),KEGG,30,LYL1;TGFBR2;FLI1;PROM1;BAK1;BCL11B;IGF1R;ERG;SPI1;SPINT1;MMP9;GZMB;ARNT2;TSPAN7;WT1;MLF1;NGFR;ETV5;MLLT3;FUT8;PAX5;RUNX1;RUNX1T1;CDK14;ITGAM;IL2RB;ITGB7;MEF2C;SMAD1;MAF,191 (192),0.2,0.621,0,,0 (0),1,1,0.2,0.621
phospholipases,HumanCyc,8,PLA2G4E;PLCD3;PLA2G6;PNPLA8;PLCB4;PLA2G4F;PLCG2;PLCD1,41 (41),0.176,0.585,1,HMDB0002183,31 (55),0.223,1,0.166,0.638
Regulation of CDC42 activity,PID,8,ARHGEF25;ARHGAP1;ARHGEF7;FARP2;ARHGEF6;MCF2L;DOCK11;FGD1,30 (30),0.0396,0.228,0,,3 (3),1,1,0.168,0.641
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,8,ALDH3A2;UGT1A1;RGN;UGT1A5;ALDH7A1;UGT2A3;UGDH;ALDH9A1,30 (30),0.0396,0.228,0,,28 (57),1,1,0.168,0.641
vegf hypoxia and angiogenesis,BioCarta,8,NOS3;KDR;BDKRB2;KNG1;FLT4;CAV1;ACTA1;BCAR1,30 (30),0.0396,0.228,0,,6 (6),1,1,0.168,0.641
phospholipids as signalling intermediaries,BioCarta,3,PIK3C2G;GNAI1;PDGFRA,33 (33),0.838,1,1,HMDB0013461,6 (7),0.0474,1,0.168,0.641
Bone morphogenic protein (BMP) signaling and regulation,Wikipathways,3,BMP2;SMAD6;SMAD1,12 (12),0.211,0.643,0,,0 (0),1,1,0.211,0.643
Airway smooth muscle cell contraction,Wikipathways,5,MYL1;PPP1R14A;RYR1;ITPR3;ADRB2,15 (15),0.0406,0.231,0,,4 (7),1,1,0.171,0.647
Glutamate and glutamine metabolism,Reactome,5,GLUL;ALDH18A1;GLUD1;GOT2;OAT,15 (15),0.0406,0.231,0,,22 (24),1,1,0.171,0.647
Fanconi-bickel syndrome,SMPDB,5,PGAM2;PKLR;SLC2A2;ALDOA;PANK1,15 (15),0.0406,0.231,0,,21 (24),1,1,0.171,0.647
Glycolysis,SMPDB,5,PGAM2;PKLR;SLC2A2;ALDOA;PANK1,15 (15),0.0406,0.231,0,,21 (24),1,1,0.171,0.647
Glycogenosis_ Type VII. Tarui disease,SMPDB,5,PGAM2;PKLR;SLC2A2;ALDOA;PANK1,15 (15),0.0406,0.231,0,,21 (24),1,1,0.171,0.647
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Wikipathways,4,DEPTOR;CP;SCP2;PLA2G6,44 (44),0.859,1,1,HMDB0013461,6 (23),0.0474,1,0.171,0.647
CLEC7A (Dectin-1) signaling,Reactome,10,IL1B;IKBKG;CARD9;NFKBIA;RELB;PYCARD;PLCG2;CHUK;ITPR3;NFATC2,41 (41),0.0407,0.231,0,,8 (12),1,1,0.171,0.647
Netrin-1 signaling,Reactome,10,ABLIM2;PAK1;RGMA;ABLIM3;RGMB;UNC5A;NTN4;PRKCQ;SLIT3;ASB15,41 (41),0.0407,0.231,0,,7 (8),1,1,0.171,0.647
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,11,TNNI2;TPM1;TNNT3;CACNA1C;KCNQ1;CACNB1;SNTB1;SCN5A;TPM2;ATP1A2;KCNK1,63 (63),0.217,0.655,1,HMDB0009888,26 (26),0.19,1,0.173,0.649
Cholesterol biosynthesis,Reactome,7,HSD17B7;TM7SF2;SC5D;NSDHL;DHCR24;LBR;IDI1,25 (25),0.0414,0.233,0,,40 (46),1,1,0.173,0.649
stathmin and breast cancer resistance to antimicrotubule agents,BioCarta,7,MAPK13;TUBA1A;PRKAR1B;PRKAR2A;CAMK2A;CD2;TUBB1,25 (25),0.0414,0.233,0,,2 (2),1,1,0.173,0.649
Cell-cell junction organization,Reactome,14,PARD3;PARD6B;CDH17;CDH3;CDH5;CLDN12;CDH11;CLDN5;CLDN2;CLDN4;CLDN7;PVR;CLDN1;CDH13,64 (64),0.0416,0.233,0,,1 (2),1,1,0.174,0.649
Cannabinoid receptor signaling,Wikipathways,6,DAGLB;AHR;PRKAR1B;CYP1A1;DAGLA;CNR2,20 (20),0.0421,0.233,0,,12 (23),1,1,0.175,0.649
Chondroitin sulfate biosynthesis,Reactome,6,CHST15;CHSY1;CHST12;CHST11;VCAN;CHST3,20 (20),0.0421,0.233,0,,5 (5),1,1,0.175,0.649
Methionine Adenosyltransferase Deficiency,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human),KEGG,6,CHST15;CHST14;CHSY1;CHST12;CHST11;CHST3,20 (20),0.0421,0.233,0,,3 (12),1,1,0.175,0.649
Purinergic signaling in leishmaniasis infection,Reactome,6,IL1B;P2RX7;C3;C3AR1;PYCARD;ENTPD5,20 (20),0.0421,0.233,0,,16 (20),1,1,0.175,0.649
Cell recruitment (pro-inflammatory response),Reactome,6,IL1B;P2RX7;C3;C3AR1;PYCARD;ENTPD5,20 (20),0.0421,0.233,0,,16 (20),1,1,0.175,0.649
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Methionine Metabolism,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Glycine N-methyltransferase Deficiency,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Glutathione metabolism,Wikipathways,6,ANPEP;GCLM;GGT1;IDH1;OPLAH;GPX3,20 (20),0.0421,0.233,0,,12 (19),1,1,0.175,0.649
Hypermethioninemia,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism_ cblG complementation type,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
Cystathionine Beta-Synthase Deficiency,SMPDB,6,SHMT1;CBS;CTH;CHDH;BHMT;AHCY,20 (20),0.0421,0.233,0,,41 (42),1,1,0.175,0.649
G beta:gamma signalling through CDC42,Reactome,6,PAK1;GNG11;GNGT2;ARHGEF6;GNB5;GNG2,20 (20),0.0421,0.233,0,,1 (1),1,1,0.175,0.649
Heroin Action Pathway,SMPDB,5,ADRA1A;SCN1B;CACNB1;BCHE;ATP1A2,32 (32),0.432,0.927,1,HMDB0041812,13 (14),0.0999,1,0.179,0.659
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,11,IL1B;GUCY1A1;GUCY1B1;NFKBIA;NOS3;CAMK2A;NPR1;PDE3A;BCL2;DLG4;ACTN2,47 (47),0.0432,0.238,0,,12 (15),1,1,0.179,0.659
ion channels and their functional role in vascular endothelium,BioCarta,11,GUCY1A1;GUCY1B1;CXCR4;KCNQ4;NOS3;BDKRB2;CCR5;KNG1;CCL11;CAV1;ADRB2,47 (47),0.0432,0.238,0,,10 (11),1,1,0.179,0.659
signal transduction through il1r,BioCarta,7,IL1B;TGFB2;TGFB3;IKBKG;MAP3K1;NFKBIA;CHUK,37 (37),0.22,0.659,0,,0 (0),1,1,0.22,0.659
TGF-beta receptor signaling,PID,9,TGFB3;TGFBR2;TGFBR3;BAMBI;CAMK2A;WWP1;CAV1;SMAD3;ARRB2,50 (50),0.221,0.659,0,,0 (0),1,1,0.221,0.659
Insulin Signalling,SMPDB,1,SLC2A4,17 (17),0.914,1,1,HMDB0009888,6 (7),0.0474,1,0.179,0.66
Celecoxib Action Pathway,SMPDB,8,PTGES;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,36 (36),0.1,0.411,1,HMDB0010404,70 (76),0.436,1,0.18,0.664
Cell surface interactions at the vascular wall,Reactome,38,CD84;SELPLG;THBD;CD2;SLC7A8;ANGPT1;FN1;ITGA3;SPN;SLC16A1;SDC3;INPP5D;PECAM1;JCHAIN;GAS6;TSPAN7;ITGA6;ESAM;GRB14;IGLC2;SIRPA;DOK2;CAV1;TNFRSF10B;LCK;ITGA5;SLC7A6;TEK;ITGAL;ITGAM;EPCAM;ITGB2;APOB;SDC1;SDC2;JAM3;CEACAM1;JAM2,215 (215),0.0438,0.241,0,,9 (13),1,1,0.181,0.664
Triglyceride metabolism,Reactome,9,DGAT2;GPAM;MGLL;GK;FABP4;FABP2;FABP3;AGMO;FABP7,36 (36),0.0441,0.242,0,,19 (28),1,1,0.182,0.667
Pathogenic Escherichia coli infection - Homo sapiens (human),KEGG,35,TUBB1;MYO1G;PAK1;ABL1;MAPK12;BAIAP2L1;MYO6;PAK3;SEC24A;WASF2;PYCARD;NFKBIA;WASF3;TLR4;TLR5;MYO1F;BAK1;IKBKG;ACTG1;MYO1B;CLDN5;CLDN4;TUBB2B;CLDN7;TNFRSF10B;ARHGEF2;MAPK11;IL1B;MAPK13;TUBA1A;CLDN2;CLDN1;CYTH4;MYO5C;CHUK,196 (197),0.0452,0.248,0,,2 (3),1,1,0.185,0.678
mapkinase signaling pathway,BioCarta,10,MAPK11;MAP4K1;PAK1;MAPK13;MEF2C;MAP3K1;MAP3K3;CHUK;MAPK12;MAPK7,57 (57),0.228,0.679,0,,0 (0),1,1,0.228,0.679
ErbB4 signaling events,PID,6,DLG4;HBEGF;ERBB2;PRLR;WWP1;CBFA2T3,31 (31),0.229,0.681,0,,0 (0),1,1,0.229,0.681
fatty acid activation,HumanCyc,2,SLC27A2;ACSL1,8 (8),0.292,0.763,1,HMDB0002183,21 (38),0.157,1,0.187,0.684
VEGF signaling pathway - Homo sapiens (human),KEGG,13,MAPK11;PLA2G4E;MAPK13;NFATC2;NOS3;KDR;HSPB1;PLA2G4F;SH2D2A;PLCG2;PTGS2;MAPK12;SHC2,59 (59),0.046,0.252,0,,6 (6),1,1,0.188,0.684
NRAGE signals death through JNK,Reactome,13,FGD2;OBSCN;NGF;NGFR;FGD1;ARHGEF7;PREX1;VAV1;ARHGEF6;FGD3;ARHGEF17;ARHGEF2;MCF2L,59 (59),0.046,0.252,0,,4 (4),1,1,0.188,0.684
Cortisol synthesis and secretion - Homo sapiens (human),KEGG,14,ADCY9;CACNA1C;CACNA1D;CACNA1S;ADCY2;CACNA1I;NCEH1;CYP17A1;ADCY4;PLCB4;SCARB1;CREB3L3;NR4A1;ITPR3,65 (65),0.0468,0.254,0,,12 (12),1,1,0.19,0.684
COPI-independent Golgi-to-ER retrograde traffic,Reactome,3,RAB6B;BICD1;PLA2G6,34 (34),0.853,1,1,HMDB0010404,7 (9),0.055,1,0.191,0.684
Metabolic reprogramming in colon cancer,Wikipathways,10,SUCLG2;PKM;RPIA;SLC1A5;DLST;LDHA;PAICS;GOT2;GLUD1;ALDOB,42 (42),0.0472,0.254,0,,29 (35),1,1,0.191,0.684
Plasma membrane estrogen receptor signaling,PID,10,MAPK11;NOS3;HBEGF;GNAI1;MSN;IGF1R;MMP2;GNG2;BCAR1;MMP9,42 (42),0.0472,0.254,0,,9 (9),1,1,0.191,0.684
chrebp regulation by carbohydrates and camp,BioCarta,10,PKLR;PRKAR1B;PRKAR2A;CXCR4;CCR5;CCL11;ADRB2;PRKAA2;ACSM1;PRKAG2,42 (42),0.0472,0.254,0,,8 (12),1,1,0.191,0.684
Generation of second messenger molecules,Reactome,10,LAT;PAK1;PAK3;ENAH;VASP;CD3D;PLCG2;GRAP2;LCK;WAS,42 (42),0.0472,0.254,0,,5 (7),1,1,0.191,0.684
3q29 copy number variation syndrome,Wikipathways,2,NRROS;ADAM10,86 (86),1,1,1,HMDB0000036,6 (17),0.0474,1,0.192,0.684
mRNA decay by 5_ to 3_ exoribonuclease,Reactome,0,,15 (15),1,1,1,HMDB0001107,6 (7),0.0474,1,0.192,0.684
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation,Wikipathways,4,SFRP1;SMAD9;SMAD1;BMP2,11 (11),0.0487,0.254,0,,1 (1),1,1,0.196,0.684
Aspirin and miRNAs,Wikipathways,4,PPARA;ABCC4;NOS3;PTGS2,11 (11),0.0487,0.254,0,,1 (1),1,1,0.196,0.684
Nucleotide GPCRs,Wikipathways,4,ADORA2B;ADORA1;P2RY4;P2RY6,11 (11),0.0487,0.254,0,,2 (2),1,1,0.196,0.684
RIP-mediated NFkB activation via ZBP1,Reactome,4,NFKBIA;CHUK;RIPK3;IKBKG,11 (11),0.0487,0.254,0,,2 (3),1,1,0.196,0.684
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Reactome,4,AKR1D1;PTGIS;CYP7A1;CYP8B1,11 (11),0.0487,0.254,0,,14 (16),1,1,0.196,0.684
Biotin transport and metabolism,Reactome,4,PCCB;MCCC2;HLCS;PCCA,11 (11),0.0487,0.254,0,,8 (9),1,1,0.196,0.684
Gamma-glutamyl-transpeptidase deficiency,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
5-oxoprolinase deficiency,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
Gamma-Glutamyltransferase Deficiency,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
Glutathione Metabolism,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
Glutathione Synthetase Deficiency,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
5-Oxoprolinuria,SMPDB,4,OPLAH;ANPEP;GCLM;GGT6,11 (11),0.0487,0.254,0,,20 (22),1,1,0.196,0.684
SARS-CoV-2 and COVID-19 Pathway,Wikipathways,2,SCARB1;ACAT1,3 (3),0.0491,0.254,0,,4 (5),1,1,0.197,0.684
pyrimidine ribonucleosides degradation,HumanCyc,2,CDA;UPP2,3 (3),0.0491,0.254,0,,8 (8),1,1,0.197,0.684
Defective factor IX causes thrombophilia,Reactome,2,F8;F9,3 (3),0.0491,0.254,0,,1 (1),1,1,0.197,0.684
methionine salvage,HumanCyc,2,BHMT;BHMT2,3 (3),0.0491,0.254,0,,7 (8),1,1,0.197,0.684
Fibronectin matrix formation,Reactome,2,ITGA5;FN1,3 (3),0.0491,0.254,0,,1 (2),1,1,0.197,0.684
acetate conversion to acetyl-CoA,HumanCyc,2,ACSS3;ACSS1,3 (3),0.0491,0.254,0,,6 (6),1,1,0.197,0.684
fatty acid &beta;-oxidation (unsaturated_ odd number),HumanCyc,2,EHHADH;ECI2,3 (3),0.0491,0.254,0,,8 (10),1,1,0.197,0.684
lipoxin biosynthesis,HumanCyc,2,ALOX5;ALOX12,3 (3),0.0491,0.254,0,,7 (7),1,1,0.197,0.684
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Reactome,2,DECR1;ACADM,3 (3),0.0491,0.254,0,,11 (11),1,1,0.197,0.684
L-carnitine biosynthesis,HumanCyc,2,BBOX1;ALDH9A1,3 (3),0.0491,0.254,0,,14 (14),1,1,0.197,0.684
Cysteine formation from homocysteine,Reactome,2,CBS;CTH,3 (3),0.0491,0.254,0,,6 (8),1,1,0.197,0.684
methylglyoxal degradation III,HumanCyc,2,AKR1B10;CYP2E1,3 (3),0.0491,0.254,0,,8 (8),1,1,0.197,0.684
Intestinal hexose absorption,Reactome,2,SLC2A2;SLC5A1,3 (3),0.0491,0.254,0,,3 (5),1,1,0.197,0.684
Biotin metabolism - Homo sapiens (human),KEGG,2,OXSM;HLCS,3 (3),0.0491,0.254,0,,9 (28),1,1,0.197,0.684
glycine cleavage,HumanCyc,2,AMT;GLDC,3 (3),0.0491,0.254,0,,8 (8),1,1,0.197,0.684
Signaling by plasma membrane FGFR1 fusions,Reactome,2,BAG4;FGFR1,3 (3),0.0491,0.254,0,,2 (2),1,1,0.197,0.684
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),Reactome,2,KCNK6;KCNK1,3 (3),0.0491,0.254,0,,1 (1),1,1,0.197,0.684
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,Reactome,2,ADHFE1;L2HGDH,3 (3),0.0491,0.254,0,,5 (7),1,1,0.197,0.684
Phenylacetate Metabolism,SMPDB,2,GLYAT;ACSM1,3 (3),0.0491,0.254,0,,9 (9),1,1,0.197,0.684
Signaling by FGFR2 IIIa TM,Reactome,2,FGF1;FGF2,3 (3),0.0491,0.254,0,,1 (2),1,1,0.197,0.684
Homocysteine Degradation,SMPDB,2,CBS;CTH,3 (3),0.0491,0.254,0,,7 (8),1,1,0.197,0.684
Gamma-cystathionase deficiency (CTH),SMPDB,2,CBS;CTH,3 (3),0.0491,0.254,0,,7 (8),1,1,0.197,0.684
Homocystinuria_ cystathionine beta-synthase deficiency,SMPDB,2,CBS;CTH,3 (3),0.0491,0.254,0,,7 (8),1,1,0.197,0.684
Intracellular oxygen transport,Reactome,2,CYGB;MB,3 (3),0.0491,0.254,0,,2 (2),1,1,0.197,0.684
TGF-beta Signaling Pathway,Wikipathways,21,TGFB1I1;TNC;PRKAR2A;MMP12;TGFBR2;TGFBR3;APP;ITGB4;FOSB;SIK1;MAP4K1;THBS1;MEF2C;WWP1;ATF3;SMAD3;CAV1;PJA1;BCAR1;COL1A2;FN1,132 (132),0.231,0.686,0,,0 (0),1,1,0.231,0.686
Differentiation of white and brown adipocyte,Wikipathways,5,PRDM16;BMP2;SMAD9;SMAD1;MPZL2,25 (25),0.237,0.696,0,,0 (0),1,1,0.237,0.696
HSF1 activation,Reactome,5,SERPINH1;HSPA1L;HSPB1;HSPA1B;HSPA1A,25 (25),0.237,0.696,0,,0 (1),1,1,0.237,0.696
Cancer immunotherapy by PD-1 blockade,Wikipathways,5,NFATC4;CD3D;LCK;NFATC2;CD8A,25 (25),0.237,0.696,0,,0 (0),1,1,0.237,0.696
Endoderm differentiation,Wikipathways,12,GATA4;GATA6;DUSP4;EPB41L5;ONECUT1;LAMC1;SOX7;SFRP1;DUSP5;SMAD3;HOXA1;APP,71 (71),0.238,0.696,0,,0 (0),1,1,0.238,0.696
Hfe effect on hepcidin production,Wikipathways,2,TMPRSS6;BMP6,7 (7),0.239,0.696,0,,0 (0),1,1,0.239,0.696
Activation of NLRP3 Inflammasome by SARS-CoV-2,Wikipathways,2,IL1B;PYCARD,7 (7),0.239,0.696,0,,0 (0),1,1,0.239,0.696
DDX1 as a regulatory component of the Drosha microprocessor,Wikipathways,2,DROSHA;RAD50,7 (7),0.239,0.696,0,,0 (0),1,1,0.239,0.696
Aryl hydrocarbon receptor signalling,Reactome,2,ARNT2;AHR,7 (7),0.239,0.696,0,,0 (1),1,1,0.239,0.696
GLI proteins bind promoters of Hh responsive genes to promote transcription,Reactome,2,BOC;HHIP,7 (7),0.239,0.696,0,,0 (0),1,1,0.239,0.696
Anchoring fibril formation,Reactome,2,LAMB3;LAMC2,7 (7),0.239,0.696,0,,0 (1),1,1,0.239,0.696
Glucuronidation,Wikipathways,7,UGP2;UGT1A1;UGT2A3;UGT1A5;PGM3;PGM5;UGDH,26 (26),0.0503,0.26,0,,14 (14),1,1,0.201,0.697
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,29,HSPD1;GJA1;FMO3;THRB;CDCA7L;ACADM;SLC25A4;EGR1;KCNQ1;NTRK2;SCN4B;SCN5A;PAH;GATA2;NGF;PRKAR1B;PRKAR2A;POU2F2;HADHA;HADHB;CPT1A;RUNX3;IL1B;ALDOA;AQP4;SLC1A3;DDC;MEF2C;SCN3B,159 (159),0.0506,0.261,0,,13 (15),1,1,0.202,0.698
Transcriptional regulation of testis differentiation,Reactome,3,GATA4;WT1;ZFPM2,13 (13),0.248,0.699,0,,0 (0),1,1,0.248,0.699
Osteopontin Signaling,Wikipathways,3,SPP1;CHUK;MMP9,13 (13),0.248,0.699,0,,0 (0),1,1,0.248,0.699
role of mitochondria in apoptotic signaling,BioCarta,3,BAK1;AIFM1;BCL2,13 (13),0.248,0.699,0,,0 (0),1,1,0.248,0.699
attenuation of gpcr signaling,BioCarta,3,PRKAR2A;ARRB1;PRKAR1B,13 (13),0.248,0.699,0,,0 (0),1,1,0.248,0.699
IL4-mediated signaling events,PID,11,SPI1;PIGR;INPP5D;CCL11;COL1A2;DOK2;SOCS5;TFF3;COL1A1;THY1;ARG1,65 (65),0.249,0.699,0,,0 (0),1,1,0.249,0.699
FABP4 in ovarian cancer,Wikipathways,1,FABP4,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
NTF3 activates NTRK2 (TRKB) signaling,Reactome,1,NTRK2,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
Defective factor XII causes hereditary angioedema,Reactome,1,KLKB1,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
Formation of editosomes by ADAR proteins,Reactome,1,ADARB1,2 (2),0.25,0.699,0,,0 (1),1,1,0.25,0.699
Activation and oligomerization of BAK protein,Reactome,1,BAK1,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
Regulation of PAK-2p34 activity by PS-GAP/RHG10,Reactome,1,ARHGAP10,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
Regulation of TP53 Expression,Reactome,1,PRDM1,2 (2),0.25,0.699,0,,0 (0),1,1,0.25,0.699
Platelet Aggregation (Plug Formation),Reactome,9,FGA;FGB;RAPGEF3;APBB1IP;FGG;VWF;BCAR1;RAPGEF4;FN1,37 (37),0.0516,0.265,0,,11 (15),1,1,0.204,0.707
Glutaminolysis and Cancer,SMPDB,9,SUCLG2;SUCLG1;LDHA;SLC16A1;ME1;SLC1A5;DLST;GOT2;GLUD1,37 (37),0.0516,0.265,0,,42 (44),1,1,0.204,0.707
GABA receptor activation,Reactome,13,GABBR2;GABRB3;GNG11;ADCY4;GNGT2;ADCY2;GNAI1;ADCY9;KCNJ10;KCNJ12;GNB5;GNG2;GABRA3,60 (60),0.0519,0.266,0,,7 (7),1,1,0.205,0.709
O-linked glycosylation of mucins,Reactome,14,GALNT15;B3GNT5;B4GALT6;GCNT4;MUC1;GALNT18;GALNT16;B3GNT7;GALNT12;ST6GALNAC4;ST3GAL2;GALNT6;B3GNT3;GALNT3,66 (66),0.0523,0.267,0,,8 (8),1,1,0.207,0.71
Methionine De Novo and Salvage Pathway,Wikipathways,6,MAT1A;TAT;CHDH;ADI1;BHMT;AHCY,21 (21),0.0524,0.267,0,,47 (48),1,1,0.207,0.71
chondroitin sulfate biosynthesis,HumanCyc,6,CHST15;CHSY1;CHST12;CHST11;CHST2;CHST3,21 (21),0.0524,0.267,0,,7 (8),1,1,0.207,0.71
HS-GAG degradation,Reactome,6,HPSE;SDC3;HSPG2;SDC1;SDC2;GPC3,21 (21),0.0524,0.267,0,,10 (22),1,1,0.207,0.71
Fructose and mannose metabolism,EHMN,6,ALDOB;SLC2A10;SLC2A2;SLC2A4;SLC5A1;SLC2A9,21 (21),0.0524,0.267,0,,28 (34),1,1,0.207,0.71
BMP Signalling Pathway,HumanCyc,6,BMP2;CHRDL1;SMAD1;SMAD6;SMAD9;FSTL1,21 (21),0.0524,0.267,0,,2 (2),1,1,0.207,0.71
ERK/MAPK targets,Reactome,6,MAPK11;MEF2C;RPS6KA2;DUSP4;DUSP7;MAPK7,21 (21),0.0524,0.267,0,,4 (4),1,1,0.207,0.71
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc),Wikipathways,5,ACO1;IDH1;PCK1;DLST;SUCLG2,16 (16),0.0527,0.267,0,,16 (19),1,1,0.208,0.71
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,5,PTGES;PTGR2;PTGIS;CYP8B1;PTGS2,16 (16),0.0527,0.267,0,,39 (50),1,1,0.208,0.71
Netrin-UNC5B signaling pathway,Wikipathways,9,RLF;CCL2;ITGB4;CDH5;NTN4;KDR;INPP5D;RGMA;COL1A1,52 (52),0.257,0.713,0,,0 (0),1,1,0.257,0.713
Viral protein interaction with cytokine and cytokine receptor - Homo sapiens (human),KEGG,16,CCL24;CXCL13;IL2RB;CXCL5;CX3CL1;CXCL3;CCL2;CXCR4;CCR2;ACKR3;CXCR3;CCR5;CCL11;CXCL2;CXCL14;TNFRSF10B,100 (100),0.262,0.727,0,,0 (0),1,1,0.262,0.727
Notch signaling pathway - Homo sapiens (human),KEGG,10,CTBP2;MAML1;NUMBL;DLL4;DTX1;MFNG;LFNG;NOTCH4;DTX3;RBPJ,59 (59),0.262,0.727,0,,0 (0),1,1,0.262,0.727
NF-kappa B signaling pathway - Homo sapiens (human),KEGG,20,BLNK;LAT;TNFRSF13C;TLR4;IKBKG;CARD11;CXCL2;LCK;EDA2R;PTGS2;IL1B;NFKBIA;LTB;RELB;BCL2;CXCL3;TNFRSF11A;PRKCQ;CHUK;PLCG2,103 (104),0.0544,0.276,0,,3 (3),1,1,0.213,0.727
Signaling by SCF-KIT,Reactome,10,KIT;SH2B2;VAV1;GRB10;MMP9;GAB2;GRAP2;LCK;GRAP;CMA1,43 (43),0.0545,0.276,0,,5 (12),1,1,0.213,0.727
Ghrelin,NetPath,7,DOK1;NOS3;NFKBIA;PRKCQ;ARRB1;ARRB2;PRKAA2,39 (39),0.263,0.728,0,,0 (0),1,1,0.263,0.728
phospho-PLA2 pathway,Reactome,0,,2 (2),1,1,1,HMDB0010404,7 (7),0.055,1,0.215,0.729
Circadian entrainment - Homo sapiens (human),KEGG,19,CAMK2A;ADCY4;GUCY1A1;GNG11;CACNA1D;GNGT2;CACNA1C;ADCY2;CACNA1I;RASD1;GNAI1;ADCY9;PLCB4;RYR1;GNB5;GNG2;GUCY1B1;ITPR3;PER3,97 (97),0.0554,0.278,0,,9 (9),1,1,0.216,0.729
Lipoate metabolism,EHMN,3,SLC22A5;SLC38A4;SLC7A1,7 (7),0.0554,0.278,0,,11 (12),1,1,0.216,0.729
Scavenging by Class B Receptors,Reactome,3,SSC5D;APOB;SCARB1,7 (7),0.0554,0.278,0,,5 (16),1,1,0.216,0.729
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,3,HADHB;HSD17B10;HADHA,7 (7),0.0554,0.278,0,,34 (34),1,1,0.216,0.729
Docetaxel Action Pathway,SMPDB,3,TUBB1;ABCC2;ABCG2,7 (7),0.0554,0.278,0,,5 (5),1,1,0.216,0.729
Paclitaxel Action Pathway,SMPDB,3,TUBB1;ABCC2;ABCG2,7 (7),0.0554,0.278,0,,6 (6),1,1,0.216,0.729
Fatty Acid Elongation In Mitochondria,SMPDB,3,HADHB;HSD17B10;HADHA,7 (7),0.0554,0.278,0,,34 (34),1,1,0.216,0.729
Ethanol Degradation,SMPDB,3,CYP2E1;ACSS1;CAT,7 (7),0.0554,0.278,0,,18 (18),1,1,0.216,0.729
Syndecan-3-mediated signaling events,PID,5,SDC3;PTN;FGFR1;FGF1;FGF2,26 (26),0.264,0.732,0,,0 (1),1,1,0.264,0.732
Mucin type O-glycan biosynthesis - Homo sapiens (human),KEGG,8,GALNT15;GCNT4;GALNT18;GALNT16;GALNT12;ST3GAL2;GALNT6;GALNT3,32 (32),0.056,0.28,0,,1 (16),1,1,0.217,0.733
Amino acid transport across the plasma membrane,Reactome,8,SLC7A6;SLC7A8;SLC43A2;SLC6A12;SLC7A1;SLC1A5;SLC38A4;SLC16A10,32 (32),0.056,0.28,0,,29 (32),1,1,0.217,0.733
Osteopontin-mediated events,PID,8,MAP3K1;SPP1;GSN;NFKBIA;MMP2;CHUK;BCAR1;MMP9,32 (32),0.056,0.28,0,,4 (4),1,1,0.217,0.733
Metabolism of fat-soluble vitamins,Reactome,11,RETSAT;SDC3;TTPA;HSPG2;SDC1;SDC2;APOA4;APOB;AKR1B10;BCO1;GPC3,49 (49),0.0564,0.281,0,,31 (49),1,1,0.218,0.734
Ether lipid metabolism - Homo sapiens (human),KEGG,11,GDPD1;CHPT1;PLPP1;PLPP2;PLA2G4E;GAL3ST1;PLA2G6;LPCAT4;PLA2G4F;SELENOI;PAFAH2,49 (49),0.0564,0.281,0,,9 (25),1,1,0.218,0.734
AGE-RAGE pathway,Wikipathways,11,MSR1;MMP13;NOS3;NFKBIA;MMP9;LGALS3;SMAD3;MMP2;CHUK;MMP7;MSN,66 (66),0.266,0.736,0,,0 (0),1,1,0.266,0.736
ESC Pluripotency Pathways,Wikipathways,22,FZD4;FZD8;FZD9;LIF;LIFR;SELENOP;HNF1A;MAPK12;PDGFB;PDGFRA;PDGFRB;FGF21;WNT7B;WNT11;WNT9B;FGF1;FGF2;FGFR1;MAPK7;SMAD1;SMAD6;SMAD9,116 (116),0.0566,0.282,0,,4 (5),1,1,0.219,0.736
Regulation of Microtubule Cytoskeleton,Wikipathways,8,EPHB2;LIMK1;PAK1;MAP1B;MARK1;DPYSL2;TESK2;ABL1,46 (46),0.27,0.744,0,,0 (0),1,1,0.27,0.744
Neural Crest Differentiation,Wikipathways,16,PMP22;DLL4;MPZ;SOX10;FGF2;HDAC7;GFAP;NOTCH4;CTBP2;GJB1;FGFR1;SMAD1;SNAI1;MBP;RBPJ;HOXA1,101 (101),0.275,0.744,0,,0 (0),1,1,0.275,0.744
Apoptosis-related network due to altered Notch3 in ovarian cancer,Wikipathways,9,NQO1;HSPD1;VIM;BEX3;THBS1;HSPB1;ABL1;TNFRSF10B;APP,53 (53),0.275,0.744,0,,0 (0),1,1,0.275,0.744
BMP Signaling Pathway in Eyelid Development,Wikipathways,4,FOXC2;SFRP1;SMAD1;MAP3K1,20 (20),0.276,0.744,0,,0 (0),1,1,0.276,0.744
NOTCH3 Intracellular Domain Regulates Transcription,Reactome,4,PLXND1;MAML1;RBPJ;MAMLD1,20 (20),0.276,0.744,0,,0 (0),1,1,0.276,0.744
tgf beta signaling pathway,BioCarta,4,SMAD3;TGFBR2;TGFB2;TGFB3,20 (20),0.276,0.744,0,,0 (0),1,1,0.276,0.744
Oxidative Stress,Wikipathways,6,NQO1;MGST1;CYP1A1;NOX4;CAT;GPX3,33 (33),0.276,0.744,0,,0 (1),1,1,0.276,0.744
Signal transduction through IL1R,Wikipathways,6,IL1B;TGFB2;TGFB3;MAP3K1;NFKBIA;CHUK,33 (33),0.276,0.744,0,,0 (0),1,1,0.276,0.744
integrin signaling pathway,BioCarta,6,ZYX;CAV1;ACTN2;ACTN3;ACTA1;BCAR1,33 (33),0.276,0.744,0,,0 (0),1,1,0.276,0.744
Necroptosis - Homo sapiens (human),KEGG,16,GLUL;IL1B;RIPK3;IFNGR1;PLA2G4E;PYGB;AIFM1;PYGL;TLR4;CAMK2A;SLC25A4;BCL2;PLA2G4F;PYCARD;GLUD1;TNFRSF10B,159 (159),0.918,1,1,HMDB0013461,8 (10),0.0627,1,0.222,0.744
Signaling by BRAF and RAF fusions,Reactome,13,FGA;FGB;IQGAP1;KSR1;ESRP1;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;CAMK2A;FGG;FN1,61 (61),0.0581,0.288,0,,6 (9),1,1,0.224,0.747
Arachidonic acid metabolism - Homo sapiens (human),KEGG,13,PTGES;PLA2G4E;CYP2E1;EPHX2;CBR3;PTGIS;PLA2G6;ALOX12;ALOX5;PLA2G4F;GGT1;PTGS2;GPX3,61 (61),0.0581,0.288,0,,66 (75),1,1,0.224,0.747
Extra-nuclear estrogen signaling,Reactome,15,SRF;CAV1;GNG11;ZDHHC7;GNGT2;NOS3;HBEGF;GNAI1;EREG;GNB5;MMP2;CAV2;GNG2;MMP7;MMP9,73 (73),0.0581,0.288,0,,22 (24),1,1,0.224,0.747
Regulation of insulin secretion,Reactome,14,RAPGEF3;PRKAR1B;CACNA1C;CACNA1D;GNGT2;GNG11;SLC2A2;PRKAR2A;GNAI1;GNB5;IQGAP1;GNG2;RAPGEF4;ITPR3,67 (67),0.0583,0.289,0,,22 (26),1,1,0.224,0.748
LGI-ADAM interactions,Reactome,3,ADAM23;LGI2;DLG4,14 (14),0.287,0.763,0,,0 (0),1,1,0.287,0.763
Atypical NF-kappaB pathway,PID,3,NFKBIA;ARRB2;LCK,14 (14),0.287,0.763,0,,0 (0),1,1,0.287,0.763
transcription regulation by methyltransferase of carm1,BioCarta,3,PRKAR2A;BCL2;PRKAR1B,14 (14),0.287,0.763,0,,0 (0),1,1,0.287,0.763
phosphorylation of mek1 by cdk5/p35 down regulates the map kinase pathway,BioCarta,3,NGF;NGFR;EGR1,14 (14),0.287,0.763,0,,0 (0),1,1,0.287,0.763
Development of ureteric collection system,Wikipathways,8,WT1;ITGA8;SPRY1;TGFB2;GFRA1;SMAD1;WNT11;RARG,47 (47),0.29,0.763,0,,0 (1),1,1,0.29,0.763
Intracellular trafficking proteins involved in CMT neuropathy,Wikipathways,5,PMP22;HSPB8;MPZ;HSPB1;KIF1B,27 (27),0.291,0.763,0,,0 (0),1,1,0.291,0.763
FTO Obesity Variant Mechanism,Wikipathways,2,PRDM16;TBX1,8 (8),0.292,0.763,0,,0 (0),1,1,0.292,0.763
MAPK and NFkB signaling pathways inhibited by Yersinia YopJ,Wikipathways,2,CHUK;IKBKG,8 (8),0.292,0.763,0,,0 (0),1,1,0.292,0.763
Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway,Wikipathways,2,PPARA;EPHX2,8 (8),0.292,0.763,0,,0 (0),1,1,0.292,0.763
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Reactome,2,ARHGEF6;PARVB,8 (8),0.292,0.763,0,,0 (0),1,1,0.292,0.763
Inhibition of Signaling by Overexpressed EGFR,Reactome,2,EREG;HBEGF,8 (8),0.292,0.763,0,,0 (4),1,1,0.292,0.763
Signaling by Overexpressed Wild-Type EGFR in Cancer,Reactome,2,EREG;HBEGF,8 (8),0.292,0.763,0,,0 (4),1,1,0.292,0.763
Glial Cell Differentiation,Wikipathways,2,MBP;MSN,8 (8),0.292,0.763,0,,0 (0),1,1,0.292,0.763
Effects of PIP2 hydrolysis,Reactome,7,DAGLB;DAGLA;MGLL;PRKCQ;ITPR3;PRKCH;ABHD6,27 (27),0.0604,0.298,0,,10 (13),1,1,0.23,0.766
Signaling by NOTCH4,Reactome,7,MAML1;DLL4;FLT4;NOTCH4;SMAD3;RBPJ;MAMLD1,27 (27),0.0604,0.298,0,,2 (2),1,1,0.23,0.766
Arachidonic acid metabolism,EHMN,19,MGST1;CYP2E1;GSTK1;EPHX2;CYP1A1;CYP1B1;CBR3;CYP4B1;PTGS2;ALOX5;PRDX6;SLC27A5;CYP2S1;PCTP;NUP35;ALOX12;ABCB4;GSTZ1;GPX3,98 (98),0.0604,0.298,0,,47 (53),1,1,0.23,0.766
Yersinia infection - Homo sapiens (human),KEGG,25,LIMK1;ARHGEF28;MAPK12;CD8A;WAS;FN1;LAT;NFATC2;BCAR1;ARHGEF7;WASF2;RPS6KA2;NFKBIA;PYCARD;TLR4;IKBKG;ACTG1;CCL2;LCK;ITGA5;MAPK11;IL1B;MAPK13;VAV1;CHUK,136 (137),0.0609,0.299,0,,4 (5),1,1,0.231,0.769
Th1 and Th2 cell differentiation - Homo sapiens (human),KEGG,18,RUNX3;LAT;MAML1;IFNGR1;NFATC2;DLL4;IL2RB;LCK;RBPJ;MAPK13;CD3D;PRKCQ;MAPK11;NFKBIA;CHUK;MAPK12;MAF;IKBKG,92 (92),0.0616,0.303,0,,3 (3),1,1,0.233,0.775
Negative regulation of MAPK pathway,Reactome,10,KSR1;PAQR3;PTPN7;DUSP1;DUSP10;DUSP4;DUSP5;DUSP7;DUSP8;MAPK12,44 (44),0.0624,0.305,0,,5 (5),1,1,0.235,0.776
Signaling by Retinoic Acid,Reactome,10,RDH16;ALDH8A1;CYP26B1;PDK4;ALDH1A2;CYP26A1;PPARD;RARG;CPT1A;ADH4,44 (44),0.0624,0.305,0,,23 (26),1,1,0.235,0.776
Insulin secretion - Homo sapiens (human),KEGG,17,KCNMB1;KCNN1;KCNN2;KCNN4;CACNA1D;CACNA1S;CACNA1C;ADCY2;CAMK2A;ATP1A2;SLC2A2;ADCY9;PLCB4;ADCY4;CREB3L3;RAPGEF4;ITPR3,86 (86),0.0626,0.306,0,,10 (12),1,1,0.236,0.776
mRNA decay by 3_ to 5_ exoribonuclease,Reactome,0,,16 (16),1,1,1,HMDB0001107,8 (10),0.0627,1,0.236,0.776
creatine biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0000128,8 (8),0.0627,1,0.236,0.776
Deadenylation-dependent mRNA decay,Reactome,0,,56 (56),1,1,1,HMDB0001107,8 (11),0.0627,1,0.236,0.776
G alpha (12/13) signalling events,Reactome,16,FGD2;OBSCN;ARHGEF17;FGD1;GNG11;GNGT2;ARHGEF7;PREX1;VAV1;ARHGEF6;ADRA1A;FGD3;GNB5;GNG2;ARHGEF2;MCF2L,80 (80),0.0635,0.307,0,,5 (5),1,1,0.239,0.776
B cell receptor signaling pathway - Homo sapiens (human),KEGG,16,BLNK;CD19;CR2;FCGR2B;CARD11;VAV1;CD79A;CD79B;NFATC2;INPP5D;RASGRP3;NFKBIA;CD22;CHUK;PLCG2;IKBKG,80 (82),0.0635,0.307,0,,4 (4),1,1,0.239,0.776
Neurotransmitter release cycle,Reactome,11,ALDH5A1;SYT1;SLC1A2;SLC6A12;SLC6A13;ABAT;PPFIA2;SLC22A1;SLC1A1;SLC1A3;STXBP1,50 (50),0.0639,0.307,0,,41 (45),1,1,0.24,0.776
Angiopoietin receptor Tie2-mediated signaling,PID,11,TEK;FGF2;GRB14;PLG;PAK1;NOS3;DOK2;MMP2;ANGPT1;ITGA5;FN1,50 (50),0.0639,0.307,0,,10 (11),1,1,0.24,0.776
NAD+ biosynthetic pathways,Wikipathways,6,BST1;SIRT5;TDO2;QPRT;NADSYN1;ACMSD,22 (22),0.0642,0.307,0,,13 (13),1,1,0.241,0.776
RA biosynthesis pathway,Reactome,6,RDH16;ALDH8A1;ALDH1A2;CYP26A1;CYP26B1;ADH4,22 (22),0.0642,0.307,0,,15 (17),1,1,0.241,0.776
Acyl chain remodelling of PS,Reactome,6,PLA2G4E;LPCAT4;PLA1A;PLA2G4F;MBOAT1;OSBPL5,22 (22),0.0642,0.307,0,,4 (9),1,1,0.241,0.776
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Citric acid cycle (TCA cycle),Reactome,6,SUCLG2;SUCLG1;ME2;NNT;DLST;ME3,22 (22),0.0642,0.307,0,,28 (31),1,1,0.241,0.776
Primary hyperoxaluria II_ PH2,SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Pyruvate kinase deficiency,SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Gluconeogenesis,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Leigh Syndrome,SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Glycogenosis_ Type IA. Von gierke disease,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Glycogenosis_ Type IC,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Pyruvate Metabolism,SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,6,PKLR;ACAT1;ME1;ME2;PCK1;ACOT12,22 (22),0.0642,0.307,0,,43 (46),1,1,0.241,0.776
Triosephosphate isomerase,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Fructose-1_6-diphosphatase deficiency,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Glycogenosis_ Type IB,SMPDB,6,ALDOA;PGAM2;PANK1;SLC37A4;PCK1;SLC2A2,22 (22),0.0642,0.307,0,,29 (34),1,1,0.241,0.776
Non-genomic actions of 1_25 dihydroxyvitamin D3,Wikipathways,14,MAPK11;CAMK2A;MAPK13;CCL2;PRKCH;RELB;PLCB4;PLCD1;PLCG2;PRKCQ;TLR4;MAPK12;VDR;MAPK7,68 (68),0.0648,0.309,0,,3 (4),1,1,0.242,0.78
Oxidation by Cytochrome P450,Wikipathways,13,CYP2R1;CYP39A1;CYP1A1;CYP1B1;CYP4B1;CYP7A1;CYP8B1;CYP17A1;CYP2E1;CYB5B;CYP26A1;CYP2S1;CYP26B1,62 (62),0.0649,0.309,0,,8 (8),1,1,0.242,0.78
sphingomyelin metabolism/ceramide salvage,HumanCyc,2,SMPD3;SGMS1,8 (8),0.292,0.763,1,HMDB0002183,31 (55),0.223,1,0.243,0.781
Apelin signaling pathway - Homo sapiens (human),KEGG,25,ADCY4;PDE3B;MYL2;MYL3;MYL4;PRKAA2;MYLK3;EGR1;SPP1;GNB5;ACTA2;GNAI1;PLCB4;PRKAG2;GNG2;GNG11;GNGT2;ADCY2;NOS3;MEF2C;ADCY9;RYR1;MYLK2;SMAD3;ITPR3,137 (137),0.0654,0.31,0,,8 (9),1,1,0.244,0.781
Computational Model of Aerobic Glycolysis,Wikipathways,4,PGAM2;ALDOA;LDHA;PKM,12 (12),0.0656,0.31,0,,16 (20),1,1,0.244,0.781
Aspartate and asparagine metabolism,Reactome,4,ASPA;GOT1;GOT2;SLC25A13,12 (12),0.0656,0.31,0,,23 (24),1,1,0.244,0.781
phospholipase c-epsilon pathway,BioCarta,4,PRKAR2A;ADRB2;RAPGEF3;PRKAR1B,12 (12),0.0656,0.31,0,,4 (6),1,1,0.244,0.781
CD28 dependent Vav1 pathway,Reactome,4,VAV1;PAK1;LCK;PAK3,12 (12),0.0656,0.31,0,,5 (5),1,1,0.244,0.781
Type I collagen synthesis in the context of Osteogenesis imperfecta,Wikipathways,8,ADAMTS2;SERPINH1;FKBP10;LOX;MIA3;TNFRSF11A;COL1A1;COL1A2,33 (33),0.0656,0.31,0,,2 (2),1,1,0.244,0.781
ACE Inhibitor Pathway,Wikipathways,5,BDKRB2;KNG1;ACE;NOS3;CMA1,17 (17),0.0667,0.312,0,,6 (10),1,1,0.247,0.784
Selenocompound metabolism - Homo sapiens (human),KEGG,5,SEPHS2;SEPSECS;KYAT3;PAPSS2;CTH,17 (17),0.0667,0.312,0,,16 (27),1,1,0.247,0.784
Metabolism of folate and pterines,Reactome,5,ALDH1L1;MTHFD1;SHMT1;FOLR2;DHFR,17 (17),0.0667,0.312,0,,20 (25),1,1,0.247,0.784
PKA activation,Reactome,5,ADCY4;PRKAR2A;ADCY9;ADCY2;PRKAR1B,17 (17),0.0667,0.312,0,,4 (4),1,1,0.247,0.784
superpathway of steroid hormone biosynthesis,HumanCyc,5,CYP17A1;SRD5A1;HSD17B11;HSD17B7;HSD17B4,17 (17),0.0667,0.312,0,,34 (35),1,1,0.247,0.784
PKA activation in glucagon signalling,Reactome,5,ADCY4;PRKAR2A;ADCY9;ADCY2;PRKAR1B,17 (17),0.0667,0.312,0,,5 (5),1,1,0.247,0.784
Doxorubicin Metabolism Pathway,SMPDB,5,NQO1;CBR3;ABCC2;ABCG2;NOS3,17 (17),0.0667,0.312,0,,14 (15),1,1,0.247,0.784
Transmission across Chemical Synapses,Reactome,42,GABRB3;SLC1A3;SLC6A12;SLC6A13;CACNA2D1;CACNB1;ABAT;ADCY4;NCALD;STXBP1;CAMKK1;MYO6;ARHGEF7;CAMK2A;PPFIA2;SLC22A1;KCNJ10;KCNJ12;GNB5;PRKAA2;GLUL;PRKAR1B;PRKAR2A;SYT1;DLG4;GNAI1;BCHE;ACTN2;PRKAG2;RPS6KA2;GABBR2;GNG2;GNG11;SLC1A1;SLC1A2;ALDH5A1;ADCY2;CHRNA2;ADCY9;EPB41L1;GNGT2;GABRA3,249 (249),0.067,0.313,0,,69 (78),1,1,0.248,0.786
Golgi-to-ER retrograde transport,Reactome,10,KIF21B;CENPE;RAB6B;KIF26A;PLA2G6;KIF20B;KIF23;KIF1B;BICD1;KIF21A,116 (116),0.958,1,1,HMDB0010404,9 (11),0.0702,1,0.249,0.788
Regulation of apoptosis by parathyroid hormone-related protein,Wikipathways,4,BAK1;ITGB4;BCL2;ITGA6,21 (21),0.308,0.795,0,,0 (0),1,1,0.308,0.795
Host-pathogen interaction of human coronaviruses - apoptosis,Wikipathways,4,MAPK11;MAPK12;MAPK13;BCL2,21 (21),0.308,0.795,0,,0 (1),1,1,0.308,0.795
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Reactome,4,AP1S2;PACS1;LCK;AP1M2,21 (21),0.308,0.795,0,,0 (0),1,1,0.308,0.795
p38 signaling mediated by MAPKAP kinases,PID,4,MAPK11;SFN;HSPB1;SRF,21 (21),0.308,0.795,0,,0 (0),1,1,0.308,0.795
Androgen and estrogen biosynthesis and metabolism,EHMN,17,MGST1;UGT1A1;CYP2E1;GSTK1;CYP1A1;SLCO3A1;CYP1B1;GSTZ1;CYP4B1;ABCC4;UGT1A5;HSD17B12;CYP2S1;PRDX6;SLC10A1;SRD5A1;AKR1D1,87 (87),0.0686,0.32,0,,53 (62),1,1,0.252,0.798
Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,20,MMP13;FGFR1;EGR1;MMP17;PTH1R;ADCY4;ADCY2;HBEGF;MEF2C;ARRB1;GNAI1;ADCY9;BCL2;PDE4B;ARRB2;PDE4D;PLCB4;CREB3L3;VDR;ITPR3,106 (106),0.0697,0.325,0,,9 (10),1,1,0.255,0.807
Acetylation,Reactome,0,,2 (2),1,1,1,HMDB0001860,9 (14),0.0702,1,0.257,0.81
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Reactome,0,,1 (1),1,1,1,HMDB0001860,9 (10),0.0702,1,0.257,0.81
Class I PI3K signaling events,PID,10,BLK;LAT;BLNK;FGR;SGK1;INPP5D;PLCG2;ADAP1;ARAP3;LCK,45 (45),0.071,0.33,0,,4 (4),1,1,0.259,0.814
Retinoid metabolism and transport,Reactome,10,RETSAT;SDC3;HSPG2;SDC1;SDC2;APOA4;APOB;AKR1B10;BCO1;GPC3,45 (45),0.071,0.33,0,,24 (37),1,1,0.259,0.814
ncRNAs involved in Wnt signaling in hepatocellular carcinoma,Wikipathways,14,CTBP2;KLF4;FZD8;FZD9;SOX7;CSNK1E;CHD8;ROR2;WNT7B;SFRP1;WNT11;SFRP4;SFRP5;FOSL1,90 (90),0.317,0.815,0,,0 (0),1,1,0.317,0.815
Vesicle-mediated transport,Reactome,87,KIF21B;HIP1;EREG;MYO6;KIF26A;SEC24A;SPTB;KIF1B;SPTBN2;CD55;TBC1D8B;F5;FCHO1;BICD1;STAB1;FZD4;SSC5D;F8;GJB1;GJB2;ADRB2;MIA2;SYNJ2;RAB30;SYT1;GOLIM4;AP1S2;PLA2G6;ALB;PRKAG2;COG5;CENPE;RAB3IL1;RAB27B;SEC23A;SFN;MVB12B;COL1A2;COL3A1;COL4A1;COL4A2;DENND5B;SEC16B;MIA3;VPS37A;KIF23;UBQLN1;STON1;ANK1;ANK2;PACSIN1;MAN1C1;HBEGF;KIF21A;GJA1;RALGAPB;AP1M2;TBC1D4;APOB;ASB15;APP;RAB6B;KIF20B;DENND3;EPN2;MSR1;RAB36;RIN1;CD3D;OPTN;ARRB1;ARRB2;SEC22C;LMAN1;TBC1D10A;USO1;SCARB1;SH3D19;PRKAA2;RAB7B;SYTL1;RINL;REPS2;PUM1;MARCO;COL1A1;CYTH4,617 (617),0.32,0.819,1,HMDB0010404,31 (66),0.223,1,0.259,0.816
RAS and bradykinin pathways in COVID-19,Wikipathways,7,IL1B;ACE;KLKB1;NOS3;BDKRB2;KNG1;VDR,28 (28),0.0716,0.332,0,,14 (16),1,1,0.26,0.817
FOXO-mediated transcription of oxidative stress_ metabolic and neuronal genes,Reactome,7,PLXNA4;ABCA6;CAT;PCK1;SMAD3;TRIM63;IGFBP1,28 (28),0.0716,0.332,0,,4 (4),1,1,0.26,0.817
Notch-HLH transcription pathway,Reactome,5,RBPJ;MAML1;HDAC7;MAMLD1;NOTCH4,28 (28),0.319,0.818,0,,0 (0),1,1,0.319,0.818
Wnt signaling network,PID,5,ROR2;FZD4;WNT7B;FZD9;FZD8,28 (28),0.319,0.818,0,,0 (0),1,1,0.319,0.818
Modulators of TCR signaling and T cell activation,Wikipathways,13,LAT;IKBKG;VAV1;MAP4K1;CARD11;CD3D;PRKCQ;NFKBIA;CD5;GRAP2;CHUK;LCK;CD8A,63 (63),0.0722,0.333,0,,1 (1),1,1,0.262,0.821
C21-steroid hormone biosynthesis and metabolism,EHMN,12,NPC1;CYP2E1;CYP1A1;HSD17B12;CYP1B1;CYP4B1;ABCG5;ABCG8;CYP17A1;CYP2S1;HDLBP;AKR1D1,57 (57),0.0724,0.333,0,,46 (61),1,1,0.262,0.821
Proximal tubule transport,Wikipathways,12,SLC7A8;AQP1;ABCC4;SLC1A1;SLC47A1;SLC13A3;SLC2A2;ABCG2;SLC16A10;SLC5A1;ABCC2;SLC4A4,57 (57),0.0724,0.333,0,,16 (28),1,1,0.262,0.821
triacylglycerol degradation,HumanCyc,3,PNPLA3;ABHD6;MGLL,15 (15),0.326,0.826,1,HMDB0002183,31 (54),0.223,1,0.263,0.822
CRH,NetPath,6,NFKBIA;ARRB1;GNAI1;GNB5;PLCG2;ARRB2,35 (35),0.326,0.826,0,,0 (0),1,1,0.326,0.826
GPCRs_ Class C Metabotropic glutamate_ pheromone,Wikipathways,3,GPRC5B;GABBR2;GPRC5A,15 (15),0.326,0.826,0,,0 (0),1,1,0.326,0.826
double stranded rna induced gene expression,BioCarta,3,NFKBIA;CHUK;IKBKG,15 (15),0.326,0.826,0,,0 (0),1,1,0.326,0.826
FOXM1 transcription factor network,PID,7,LAMA4;ETV5;HSPA1B;HSPA1A;ONECUT1;MMP2;GAS1,42 (42),0.33,0.834,0,,0 (0),1,1,0.33,0.834
Unfolded protein response,Wikipathways,4,IL1B;TNFRSF10B;BCL2;PMAIP1,22 (22),0.34,0.834,0,,0 (0),1,1,0.34,0.834
hypoxia and p53 in the cardiovascular system,BioCarta,4,HSPA1B;FHL2;HIC1;HSPA1A,22 (22),0.34,0.834,0,,0 (0),1,1,0.34,0.834
ras-independent pathway in nk cell-mediated cytotoxicity,BioCarta,4,LAT;VAV1;CD2;PAK1,22 (22),0.34,0.834,0,,0 (0),1,1,0.34,0.834
Somitogenesis in the context of spondylocostal dysostosis,Wikipathways,2,LFNG;EPHA4,9 (9),0.345,0.834,0,,0 (0),1,1,0.345,0.834
NOTCH4 Activation and Transmission of Signal to the Nucleus,Reactome,2,NOTCH4;DLL4,9 (9),0.345,0.834,0,,0 (0),1,1,0.345,0.834
cd40l signaling pathway,BioCarta,2,NFKBIA;MAP3K1,9 (9),0.345,0.834,0,,0 (0),1,1,0.345,0.834
Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex,Wikipathways,5,CRP;IGLC2;LCK;CD2;CD8A,29 (29),0.347,0.834,0,,0 (0),1,1,0.347,0.834
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors,Wikipathways,1,CCR2,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Endoplasmic reticulum stress response in coronavirus infection,Wikipathways,1,BCL2,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
RUNX2 regulates genes involved in differentiation of myeloid cells,Reactome,1,LGALS3,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Progressive trimming of alpha-1_2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2,Reactome,1,MAN1C1,3 (3),0.351,0.834,0,,0 (7),1,1,0.351,0.834
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Reactome,1,SLC25A4,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
The AIM2 inflammasome,Reactome,1,PYCARD,3 (3),0.351,0.834,0,,0 (2),1,1,0.351,0.834
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Reactome,1,IGF2BP2,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Breakdown of the nuclear lamina,Reactome,1,LMNB1,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
AlphaE beta7 integrin cell surface interactions,PID,1,ITGB7,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
opposing roles of aif in apoptosis and cell survival,BioCarta,1,AIFM1,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Bevacizumab Action Pathway,SMPDB,1,KDR,3 (3),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,Wikipathways,6,TRIM63;TNFSF9;IGF1R;SMAD3;DEPTOR;NEB,36 (36),0.351,0.834,0,,0 (1),1,1,0.351,0.834
Host-pathogen interaction of human coronaviruses - MAPK signaling,Wikipathways,6,MAPK11;MAPK13;BCL2;MAP3K1;RPS6KA2;MAPK12,36 (36),0.351,0.834,0,,0 (0),1,1,0.351,0.834
Kinesins,Reactome,7,KIF21B;CENPE;KIF26A;KIF20B;KIF23;KIF1B;KIF21A,43 (43),0.353,0.836,0,,0 (1),1,1,0.353,0.836
Genotoxicity pathway,Wikipathways,10,EI24;CENPE;TM7SF3;CCP110;ITPKC;IKBIP;E2F8;BTG2;ACTA2;PHLDA3,64 (64),0.353,0.836,0,,0 (0),1,1,0.353,0.836
JAK STAT MolecularVariation 2,INOH,8,GHR;IFNGR1;IL2RB;LIFR;IL3RA;PRLR;CNTFR;IL9R,50 (50),0.353,0.837,0,,0 (0),1,1,0.353,0.837
Gap junction - Homo sapiens (human),KEGG,17,PDGFB;PDGFRA;GUCY1A1;TUBA1A;PDGFRB;ADCY4;GJA1;GUCY1B1;ADCY2;GNAI1;ADCY9;PLCB4;TUBB2B;PDGFD;TUBB1;MAPK7;ITPR3,88 (88),0.0748,0.344,0,,10 (11),1,1,0.269,0.839
Th17 cell differentiation - Homo sapiens (human),KEGG,20,LAT;IL1B;IFNGR1;AHR;NFATC2;TGFBR2;LCK;SMAD3;MAPK13;IL2RB;CD3D;PRKCQ;MAPK11;IL21R;NFKBIA;IL27RA;CHUK;MAPK12;RUNX1;IKBKG,107 (107),0.0754,0.347,0,,4 (4),1,1,0.27,0.843
Pyrimidine salvage,Reactome,2,CDA;UPP2,11 (11),0.445,0.927,1,HMDB0000273,23 (23),0.17,1,0.271,0.845
Fluoropyrimidine Activity,Wikipathways,8,UPP2;DPYD;DPYS;ABCC4;CDA;UPB1;DHFR;ABCG2,34 (34),0.0761,0.349,0,,11 (16),1,1,0.272,0.847
Glutamate Neurotransmitter Release Cycle,Reactome,6,SYT1;SLC1A2;SLC1A3;PPFIA2;SLC1A1;STXBP1,23 (23),0.0775,0.352,0,,8 (8),1,1,0.276,0.854
Signaling events mediated by the Hedgehog family,PID,6,TGFB2;BOC;HHIP;ARRB2;CDON;GAS1,23 (23),0.0775,0.352,0,,2 (2),1,1,0.276,0.854
regulation of bad phosphorylation,BioCarta,6,PRKAR1B;PRKAR2A;IL3RA;KIT;BCL2;IGF1R,23 (23),0.0775,0.352,0,,2 (4),1,1,0.276,0.854
Nitric oxide stimulates guanylate cyclase,Reactome,6,PDE9A;KCNMB1;GUCY1A1;GUCY1B1;NOS3;PDE10A,23 (23),0.0775,0.352,0,,11 (11),1,1,0.276,0.854
Leishmaniasis - Homo sapiens (human),KEGG,15,MAPK11;IL1B;TGFB2;TGFB3;ITGAM;ITGB2;PTGS2;C3;MAPK13;NCF2;IFNGR1;NFKBIA;TLR4;MAPK12;EEF1A2,76 (77),0.0778,0.354,0,,6 (6),1,1,0.276,0.856
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits,Wikipathways,3,CYTIP;TNC;CXCR4,16 (16),0.365,0.856,0,,0 (0),1,1,0.365,0.856
FOXO-mediated transcription of cell cycle genes,Reactome,3,SMAD3;CAV1;KLF4,16 (16),0.365,0.856,0,,0 (0),1,1,0.365,0.856
Glutamatergic synapse - Homo sapiens (human),KEGG,21,GLUL;PLA2G4E;SLC1A3;ADCY4;GNG11;CACNA1D;GNGT2;SLC1A2;CACNA1C;ADCY2;DLG4;GNAI1;ADCY9;PLCB4;PLA2G4F;SLC1A1;GNB5;GNG2;SHANK3;ITPR3;SLC17A8,114 (114),0.0791,0.356,0,,8 (8),1,1,0.28,0.86
Semaphorin interactions,Reactome,13,PLXNA4;DPYSL2;PAK1;ERBB2;PAK3;PLXNC1;SEMA4D;SEMA5A;LIMK1;DPYSL3;PLXND1;ARHGAP35;FARP2,64 (64),0.08,0.356,0,,6 (6),1,1,0.282,0.86
GnRH secretion - Homo sapiens (human),KEGG,13,GABBR2;KCNN1;KCNN2;CACNA1C;CACNA1D;CACNA1S;KCNN4;CACNA1I;SPP1;PLCB4;ARRB1;ARRB2;ITPR3,64 (64),0.08,0.356,0,,8 (9),1,1,0.282,0.86
HIF1A and PPARG regulation of glycolysis,Wikipathways,3,GPD1;GPAT3;LDHA,8 (8),0.0801,0.356,0,,8 (10),1,1,0.282,0.86
RUNX2 regulates genes involved in cell migration,Reactome,3,MMP13;ITGA5;ITGBL1,8 (8),0.0801,0.356,0,,2 (2),1,1,0.282,0.86
AMPK inhibits chREBP transcriptional activation activity,Reactome,3,ADIPOR2;PRKAA2;PRKAG2,8 (8),0.0801,0.356,0,,3 (3),1,1,0.282,0.86
Histidine catabolism,Reactome,3,HNMT;HAL;UROC1,8 (8),0.0801,0.356,0,,22 (22),1,1,0.282,0.86
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Reactome,3,CYP1B1;EPHX2;CYP1A1,8 (8),0.0801,0.356,0,,14 (15),1,1,0.282,0.86
ketogenesis,HumanCyc,3,HMGCS2;ACAT1;BDH1,8 (8),0.0801,0.356,0,,12 (12),1,1,0.282,0.86
Organic cation transport,Reactome,3,SLC22A5;SLC22A18;SLC22A1,8 (8),0.0801,0.356,0,,23 (28),1,1,0.282,0.86
glycogen biosynthesis,HumanCyc,3,UGP2;GBE1;GYS2,8 (8),0.0801,0.356,0,,5 (7),1,1,0.282,0.86
Acyl chain remodeling of DAG and TAG,Reactome,3,DGAT2;PNPLA3;MGLL,8 (8),0.0801,0.356,0,,5 (10),1,1,0.282,0.86
sucrose degradation,HumanCyc,3,ALDOA;ALDOB;TKFC,8 (8),0.0801,0.356,0,,10 (12),1,1,0.282,0.86
Androgen biosynthesis,Reactome,3,HSD17B12;CYP17A1;SRD5A1,8 (8),0.0801,0.356,0,,16 (16),1,1,0.282,0.86
ethanol degradation II,HumanCyc,3,ALDH3A2;ACSS3;ACSS1,8 (8),0.0801,0.356,0,,12 (12),1,1,0.282,0.86
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,3,MYL3;PTGIR;ADCY2,8 (8),0.0801,0.356,0,,9 (9),1,1,0.282,0.86
Glycerophospholipid metabolism,EHMN,22,GPD1;ADHFE1;MTTP;LIPA;ATP8B2;GK;CHPT1;PLPP1;DGAT2;SLC38A4;SLC22A5;LPCAT4;GPAM;LCAT;ALDH9A1;ALDH3A2;ALDOB;GPAT4;SLC1A5;SLC16A12;ALDH7A1;NUP35,136 (136),0.201,0.624,1,HMDB0010404,62 (95),0.398,1,0.282,0.86
Phosphodiesterases in neuronal function,Wikipathways,11,PDE9A;ADCY9;GUCY1A1;GUCY1B1;ADCY2;ADCY4;PDE3B;PDE4B;PDE4D;PDE10A;PDE3A,52 (52),0.0808,0.358,0,,11 (12),1,1,0.284,0.863
Signaling events mediated by PTP1B,PID,11,BLK;LAT;PDGFB;DOK1;PDGFRB;FGR;NOX4;PRLR;BCAR1;CAV1;LCK,52 (52),0.0808,0.358,0,,1 (1),1,1,0.284,0.863
Ebstein-Barr virus LMP1 signaling,Wikipathways,4,NFKBIA;CHUK;IKBKG;MAP3K3,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
GPCRs_ Class B Secretin-like,Wikipathways,4,ADGRE5;PTH1R;ADGRL4;SCTR,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
NRF2-ARE regulation,Wikipathways,4,NQO1;EPHB2;GCLM;MAF,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
GDNF-RET signaling axis,Wikipathways,4,GREM1;GFRA1;SPRY1;FOXC2,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
caspase cascade in apoptosis,BioCarta,4,LMNB1;GZMB;ARHGDIB;PRF1,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
tnf/stress related signaling,BioCarta,4,BAG4;CHUK;IKBKG;MAP3K1,23 (23),0.372,0.865,0,,0 (0),1,1,0.372,0.865
Insulin resistance - Homo sapiens (human),KEGG,20,PTPRF;PPP1R3A;PRKAA2;GYS2;PYGB;PRKCQ;PYGL;NOS3;PCK1;SLC2A2;RPS6KA2;CPT1A;SLC27A5;SLC27A2;NFKBIA;PPARA;TBC1D4;CREB3L3;PRKAG2;SLC2A4,108 (108),0.0814,0.36,0,,12 (20),1,1,0.286,0.867
IL2 signaling events mediated by STAT5,PID,5,IL2RB;LCK;BCL2;GAB2;PRF1,30 (30),0.375,0.868,0,,0 (0),1,1,0.375,0.868
Fatty acid transporters,Wikipathways,5,FABP2;FABP3;ACSL1;FABP7;FABP4,18 (18),0.0825,0.363,0,,1 (2),1,1,0.288,0.873
Endogenous sterols,Reactome,5,CYP1B1;PTGIS;CYP39A1;CYP8B1;CYP7A1,18 (18),0.0825,0.363,0,,31 (40),1,1,0.288,0.873
Lamivudine Metabolism Pathway,SMPDB,5,ABCC2;CHPT1;SLC22A1;ABCG2;ABCC4,18 (18),0.0825,0.363,0,,13 (13),1,1,0.288,0.873
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,16,RAB36;COG5;MAN1C1;KIF23;KIF21B;CENPE;RAB6B;KIF26A;PLA2G6;KIF20B;RAB30;KIF21A;KIF1B;CYTH4;BICD1;GOLIM4,186 (186),0.984,1,1,HMDB0010404,11 (13),0.0852,1,0.292,0.876
Synthesis of IP3 and IP4 in the cytosol,Reactome,7,PLCD3;ITPKC;INPP5D;PLCB4;PLCD1;PLCG2;ITPKA,29 (29),0.0839,0.366,0,,11 (14),1,1,0.292,0.876
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,7,GABBR2;GNG11;GNGT2;KCNJ10;KCNJ12;GNB5;GNG2,29 (29),0.0839,0.366,0,,2 (2),1,1,0.292,0.876
Metabolism of porphyrins,Reactome,7,UGT1A1;ALAS1;ABCG2;FLVCR1;CPOX;ABCC2;ALB,29 (29),0.0839,0.366,0,,34 (43),1,1,0.292,0.876
Plasma lipoprotein clearance,Reactome,7,NPC1;VLDLR;NCEH1;APOB;LIPA;SCARB1;HDLBP,29 (29),0.0839,0.366,0,,5 (9),1,1,0.292,0.876
Activation of G protein gated Potassium channels,Reactome,7,GABBR2;GNG11;GNGT2;KCNJ10;KCNJ12;GNB5;GNG2,29 (29),0.0839,0.366,0,,2 (2),1,1,0.292,0.876
Pyruvate metabolism,Reactome,7,LDHA;SLC16A1;ME1;LDHB;GSTZ1;PDK4;PDP1,29 (29),0.0839,0.366,0,,24 (25),1,1,0.292,0.876
G protein gated Potassium channels,Reactome,7,GABBR2;GNG11;GNGT2;KCNJ10;KCNJ12;GNB5;GNG2,29 (29),0.0839,0.366,0,,2 (2),1,1,0.292,0.876
The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMPDB,7,SUCLG2;SUCLG1;L2HGDH;DLST;ACO1;IDH1;GLUD1,29 (29),0.0839,0.366,0,,39 (41),1,1,0.292,0.876
Passive transport by Aquaporins,Reactome,4,AQP4;AQP1;AQP9;AQP11,13 (13),0.085,0.369,0,,8 (8),1,1,0.295,0.88
ERBB2 Activates PTK6 Signaling,Reactome,4,NRG4;ERBB2;EREG;HBEGF,13 (13),0.085,0.369,0,,2 (2),1,1,0.295,0.88
ZBP1(DAI) mediated induction of type I IFNs,Reactome,4,NFKBIA;CHUK;RIPK3;IKBKG,13 (13),0.085,0.369,0,,2 (3),1,1,0.295,0.88
visual signal transduction,BioCarta,4,ARRB1;GNGT2;GNAT1;SLC25A22,13 (13),0.085,0.369,0,,6 (6),1,1,0.295,0.88
extrinsic prothrombin activation pathway,BioCarta,4,F5;FGG;FGA;FGB,13 (13),0.085,0.369,0,,1 (1),1,1,0.295,0.88
Caffeine and Theobromine metabolism,Wikipathways,0,,4 (4),1,1,1,HMDB0001860,11 (11),0.0852,1,0.295,0.88
Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,18,LAT;PLA2G4E;LIMK1;PLPP1;PLPP2;FCGR2B;GAB2;PLA2G6;PAK1;VASP;VAV1;INPP5D;PLA2G4F;GSN;PLCG2;WASF3;WASF2;WAS,96 (97),0.0861,0.374,0,,7 (8),1,1,0.297,0.887
Free fatty acid receptors,Reactome,1,FFAR4,5 (5),0.513,0.995,1,HMDB0002183,23 (24),0.17,1,0.3,0.889
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,8,NNMT;NUDT12;BST1;ENPP1;SIRT5;QPRT;NADSYN1;NNT,35 (35),0.0876,0.377,0,,32 (55),1,1,0.301,0.889
RET signaling,Reactome,8,DOK1;DOK2;GRB10;SHANK3;GFRA1;GFRA2;GAB2;MAPK7,35 (35),0.0876,0.377,0,,2 (2),1,1,0.301,0.889
Neuronal System,Reactome,62,GABRB3;ALDH5A1;SLC6A12;SLC6A13;CACNA2D1;CACNB1;ABAT;ADCY4;NCALD;BEGAIN;STXBP1;PTPRD;CAMKK1;KCNA7;PTPRF;KCNB1;MYO6;ARHGEF7;PRKAR1B;KCNQ4;CAMK2A;PRKAR2A;PPFIA2;SLC22A1;KCNJ10;KCNAB1;KCNJ12;GNB5;PRKAA2;EPB41L5;KCNK1;GLUL;EPB41L3;KCNAB2;KCNMB1;KCNN1;KCNN2;KCNN4;KCNQ1;SYT1;DLG4;KCNK6;GNAI1;KCNK13;BCHE;ACTN2;KCNG4;PRKAG2;RPS6KA2;GABBR2;GNG2;GNG11;SLC1A1;SLC1A2;SLC1A3;ADCY2;SHANK3;CHRNA2;ADCY9;EPB41L1;GNGT2;GABRA3,391 (391),0.0878,0.377,0,,69 (78),1,1,0.301,0.889
Membrane Trafficking,Reactome,76,TBC1D8B;FZD4;KIF1B;KIF21B;SEC22C;GJA1;RIN1;F8;MIA3;GJB1;GJB2;CD3D;HIP1;KIF23;ARRB2;ARRB1;SYT1;ADRB2;HBEGF;STON1;ANK1;ANK2;TBC1D10A;UBQLN1;DENND5B;MYO6;SYNJ2;KIF26A;GOLIM4;LMAN1;RAB27B;MAN1C1;MIA2;SEC24A;KIF21A;SPTB;RAB36;SPTBN2;PRKAA2;RALGAPB;SEC16B;CD55;AP1M2;TBC1D4;AP1S2;SH3D19;COG5;RAB7B;PRKAG2;APOB;PLA2G6;EPN2;ASB15;SYTL1;APP;RINL;REPS2;PUM1;CENPE;RAB30;RAB6B;F5;RAB3IL1;USO1;EREG;FCHO1;KIF20B;DENND3;SEC23A;PACSIN1;CYTH4;VPS37A;SFN;BICD1;MVB12B;OPTN,578 (578),0.593,1,1,HMDB0010404,20 (31),0.15,1,0.304,0.889
dermatan sulfate biosynthesis (late stages),HumanCyc,2,CHST15;CHST14,4 (4),0.0895,0.377,0,,3 (3),1,1,0.306,0.889
phenylethylamine degradation I,HumanCyc,2,ALDH3A2;AOC3,4 (4),0.0895,0.377,0,,10 (10),1,1,0.306,0.889
NGF processing,Reactome,2,NGF;PCSK6,4 (4),0.0895,0.377,0,,1 (1),1,1,0.306,0.889
Expression and Processing of Neurotrophins,Reactome,2,NGF;PCSK6,4 (4),0.0895,0.377,0,,1 (1),1,1,0.306,0.889
Polyol Pathway,Wikipathways,2,SORD;ALDOB,4 (4),0.0895,0.377,0,,7 (8),1,1,0.306,0.889
propionyl-CoA degradation,HumanCyc,2,PCCB;PCCA,4 (4),0.0895,0.377,0,,8 (9),1,1,0.306,0.889
Reuptake of GABA,Reactome,2,SLC6A12;SLC6A13,4 (4),0.0895,0.377,0,,6 (6),1,1,0.306,0.889
Ion influx/efflux at host-pathogen interface,Reactome,2,ATP7A;SLC11A1,4 (4),0.0895,0.377,0,,9 (12),1,1,0.306,0.889
Cholesterol biosynthesis via desmosterol,Reactome,2,SC5D;DHCR24,4 (4),0.0895,0.377,0,,10 (10),1,1,0.306,0.889
Cholesterol biosynthesis via lathosterol,Reactome,2,SC5D;DHCR24,4 (4),0.0895,0.377,0,,10 (10),1,1,0.306,0.889
Mitochondrial ABC transporters,Reactome,2,ABCB6;ABCB7,4 (4),0.0895,0.377,0,,5 (6),1,1,0.306,0.889
2-oxoisovalerate decarboxylation to isobutanoyl-CoA,HumanCyc,2,BCKDHB;DBT,4 (4),0.0895,0.377,0,,7 (7),1,1,0.306,0.889
Glycine degradation,Reactome,2,AMT;GLDC,4 (4),0.0895,0.377,0,,8 (11),1,1,0.306,0.889
Intestinal absorption,Reactome,2,SLC2A2;SLC5A1,4 (4),0.0895,0.377,0,,4 (8),1,1,0.306,0.889
Regulation of Apoptosis,Reactome,2,OPA1;ARHGAP10,4 (4),0.0895,0.377,0,,1 (1),1,1,0.306,0.889
Scavenging by Class H Receptors,Reactome,2,APOB;STAB1,4 (4),0.0895,0.377,0,,7 (11),1,1,0.306,0.889
phospholipase c delta in phospholipid associated cell signaling,BioCarta,2,DLC1;PLCD1,4 (4),0.0895,0.377,0,,1 (1),1,1,0.306,0.889
Axonal growth stimulation,Reactome,2,NGF;NGFR,4 (4),0.0895,0.377,0,,1 (1),1,1,0.306,0.889
Fosphenytoin (Antiarrhythmic) Metabolism Pathway,SMPDB,2,SNTB1;SCN5A,4 (4),0.0895,0.377,0,,2 (2),1,1,0.306,0.889
Thiamine Metabolism,SMPDB,2,TPK1;THTPA,4 (4),0.0895,0.377,0,,9 (9),1,1,0.306,0.889
G alpha (z) signalling events,Reactome,9,GNG11;ADCY4;GNGT2;ADCY2;PRKCH;ADCY9;PRKCQ;GNB5;GNG2,41 (41),0.0896,0.377,0,,12 (13),1,1,0.306,0.889
Posttranslational regulation of adherens junction stability and dissassembly,PID,11,ADAM10;FGF1;FGF2;DSP;GFRA1;NTRK2;FGFR1;IGF1R;ABL1;IQGAP1;MMP7,53 (53),0.0902,0.379,0,,3 (3),1,1,0.307,0.892
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,10,PKLR;ALDOA;PKM;ALDOB;SUCLG2;PGAM2;ENO3;SUCLG1;DLST;ACO1,47 (48),0.0903,0.379,0,,33 (36),1,1,0.307,0.892
Ion transport by P-type ATPases,Reactome,10,FXYD6;ATP2A1;ATP2A3;ATP11C;ATP2B4;ATP8B2;ATP7A;ATP7B;ATP1A2;ATP9A,47 (47),0.0903,0.379,0,,13 (17),1,1,0.307,0.892
Triacylglyceride synthesis,Wikipathways,6,GPD1;PLPP2;DGAT2;GPAM;PLPP1;GK,24 (24),0.0921,0.385,0,,6 (10),1,1,0.312,0.901
glycolysis,HumanCyc,6,PKLR;ALDOA;PKM;ALDOB;PGAM2;ENO3,24 (25),0.0921,0.385,0,,17 (20),1,1,0.312,0.901
Plexin-D1 Signaling,PID,6,ITGA8;ITGA6;SEMA3C;PLXND1;ITGA3;ITGA5,24 (24),0.0921,0.385,0,,2 (2),1,1,0.312,0.901
Glycogen metabolism,Reactome,6,UGP2;GBE1;PHKG1;PYGB;PYGL;GYS2,24 (24),0.0921,0.385,0,,14 (16),1,1,0.312,0.901
Kit receptor signaling pathway,Wikipathways,9,DOK1;KIT;SH2B2;VAV1;GRB10;INPP5D;BCL2;GAB2;SNAI1,59 (59),0.394,0.902,0,,0 (0),1,1,0.394,0.902
GP1b-IX-V activation signalling,Reactome,2,VWF;FLNA,10 (10),0.396,0.902,0,,0 (1),1,1,0.396,0.902
Growth hormone signaling,INOH,2,GHR;SOCS2,10 (10),0.396,0.902,0,,0 (0),1,1,0.396,0.902
Gap junction degradation,Reactome,2,GJA1;MYO6,10 (10),0.396,0.902,0,,0 (1),1,1,0.396,0.902
Apoptotic cleavage of cellular proteins,Reactome,6,SATB1;LMNB1;VIM;DSP;PRKCQ;GSN,38 (38),0.402,0.903,0,,0 (0),1,1,0.402,0.903
Ovarian infertility,Wikipathways,5,SMAD3;PRLR;NRIP1;VDR;EGR1,31 (31),0.404,0.903,0,,0 (0),1,1,0.404,0.903
NOTCH1 regulation of endothelial cell calcification,Wikipathways,3,MGP;GJA5;DLL4,17 (17),0.404,0.903,0,,0 (0),1,1,0.404,0.903
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,Reactome,3,TNFRSF11A;LTB;TNFRSF13C,17 (17),0.404,0.903,0,,0 (0),1,1,0.404,0.903
role of pi3k subunit p85 in regulation of actin organization and cell migration,BioCarta,3,PAK1;PDGFRA;ASB15,17 (17),0.404,0.903,0,,0 (0),1,1,0.404,0.903
y branching of actin filaments,BioCarta,3,PIR;WASF2;ASB15,17 (17),0.404,0.903,0,,0 (0),1,1,0.404,0.903
SRF and miRs in Smooth Muscle Differentiation and Proliferation,Wikipathways,3,MEF2C;SRF;KLF4,17 (17),0.404,0.903,0,,0 (0),1,1,0.404,0.903
GABA receptor Signaling,Wikipathways,4,GABRP;GABRB3;GABRA3;ALDH9A1,24 (24),0.405,0.903,0,,0 (0),1,1,0.405,0.903
Fibroblast growth factor-1,NetPath,11,FGF1;SLC7A6;PTPN18;MUC1;SDC1;FGFR1;DOK2;APP;TPCN1;MAPK7;PDLIM3,74 (74),0.406,0.905,0,,0 (1),1,1,0.406,0.905
Acute viral myocarditis,Wikipathways,15,ITGAL;LAMA2;ITGB2;PYCARD;CXCR4;SGCG;CD55;CCR5;BCL2;SGCB;ABL1;CAV1;TLR4;TLR5;MMP9,78 (78),0.093,0.388,0,,3 (7),1,1,0.314,0.906
Methionine and cysteine metabolism,EHMN,15,AHCY;SLC7A8;SUOX;SLC43A2;CP;CBS;CDO1;SLC26A1;SLC1A5;TAT;SLC25A13;GOT2;NUP35;TRDMT1;MPST,78 (78),0.093,0.388,0,,65 (80),1,1,0.314,0.906
Novel intracellular components of RIG-I-like receptor (RLR) pathway,Wikipathways,9,MAPK11;CHUK;IKBKG;MAPK13;MAP3K1;TKFC;NFKBIA;TBKBP1;MAPK12,60 (60),0.414,0.921,0,,0 (0),1,1,0.414,0.921
GPCR signaling-cholera toxin,INOH,44,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;ADCY4;EREG;RGS19;FZD8;PDGFB;ADORA1;BMP10;DLL4;INHBC;PRKAR1B;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;TGFB3;HGF;NGF;FZD4;FGF2;PRKAR2A;GNAI1;GNB5;WNT9B;NRG4;IL1B;GDF2;GDF10;GNGT2;ADCY2;RGS3;RGS10;ADCY9;KNG1,270 (270),0.0961,0.4,0,,4 (4),1,1,0.321,0.926
hiv-1 nef: negative effector of fas and tnf,BioCarta,8,LMNB1;GSN;ARHGDIB;BCL2;MAP3K1;NFKBIA;BAG4;CHUK,53 (53),0.418,0.927,0,,0 (0),1,1,0.418,0.927
Aryl Hydrocarbon Receptor Netpath,Wikipathways,7,NQO1;AHR;CYP1A1;CYP1B1;NRIP1;PTGS2;FGF21,46 (46),0.422,0.927,0,,0 (2),1,1,0.422,0.927
Constitutive Androstane Receptor Pathway,Wikipathways,5,EHHADH;ALAS1;ABCC2;NR1I3;UGT1A1,32 (32),0.432,0.927,0,,0 (1),1,1,0.432,0.927
Signal Transduction of S1P Receptor,Wikipathways,4,GNAI1;MAPK12;MAPK7;S1PR2,25 (25),0.436,0.927,0,,0 (0),1,1,0.436,0.927
RORA activates gene expression,Reactome,1,CPT1A,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
Activation_ myristolyation of BID and translocation to mitochondria,Reactome,1,GZMB,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
IkBA variant leads to EDA-ID,Reactome,1,NFKBIA,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
Diseases associated with the TLR signaling cascade,Reactome,1,NFKBIA,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
Diseases of Immune System,Reactome,1,NFKBIA,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
Microbial modulation of RIPK1-mediated regulated necrosis,Reactome,1,RIPK3,4 (4),0.438,0.927,0,,0 (1),1,1,0.438,0.927
ahr signal transduction pathway,BioCarta,1,AHR,4 (4),0.438,0.927,0,,0 (1),1,1,0.438,0.927
transcriptional activation of dbpb from mrna,BioCarta,1,PDGFB,4 (4),0.438,0.927,0,,0 (0),1,1,0.438,0.927
IL-4 signaling pathway,Wikipathways,8,MAPK11;GAB2;FLNA;INPP5D;DOK2;SOCS5;NFKBIA;CHUK,54 (54),0.439,0.927,0,,0 (0),1,1,0.439,0.927
Mammary gland development pathway - Embryonic development (Stage 1 of 4),Wikipathways,3,CLDN4;SFRP1;ITGA6,18 (18),0.441,0.927,0,,0 (1),1,1,0.441,0.927
AndrogenReceptor,NetPath,20,XRCC5;TGFB1I1;FHL2;SLC25A4;AHR;HSPA1A;FLNA;KAT7;HDAC7;SVIL;HSPB1;DDC;GSN;KDM4C;SMAD3;CAV1;ZMIZ1;PAK6;DBT;NCOA4,142 (142),0.443,0.927,0,,0 (0),1,1,0.443,0.927
Gene regulatory network modelling somitogenesis,Wikipathways,2,LFNG;EPHA4,11 (11),0.445,0.927,0,,0 (0),1,1,0.445,0.927
PTF1A related regulatory pathway,Wikipathways,2,RBPJ;PROX1,11 (11),0.445,0.927,0,,0 (0),1,1,0.445,0.927
SUMOylation of immune response proteins,Reactome,2,NFKBIA;IKBKG,11 (11),0.445,0.927,0,,0 (1),1,1,0.445,0.927
Dissolution of Fibrin Clot,Reactome,2,HRG;PLG,11 (11),0.445,0.927,0,,0 (1),1,1,0.445,0.927
ALK2 signaling events,PID,2,SMAD9;SMAD1,11 (11),0.445,0.927,0,,0 (0),1,1,0.445,0.927
Signaling mediated by p38-gamma and p38-delta,PID,2,MAPK13;MAPK12,11 (11),0.445,0.927,0,,0 (0),1,1,0.445,0.927
apoptotic dna-fragmentation and tissue homeostasis,BioCarta,2,GZMB;HMGB2,11 (11),0.445,0.927,0,,0 (0),1,1,0.445,0.927
T cell receptor signaling pathway - Homo sapiens (human),KEGG,19,LAT;MAPK11;PAK1;MAPK13;NFATC2;PAK3;LCK;PAK6;VAV1;CARD11;CD3D;PRKCQ;CTLA4;NFKBIA;GRAP2;CHUK;MAPK12;CD8A;IKBKG,104 (104),0.0974,0.403,0,,4 (4),1,1,0.324,0.931
C-type lectin receptor signaling pathway - Homo sapiens (human),KEGG,19,MAPK11;IL1B;CLEC1B;MAPK13;NFATC2;EGR3;NFATC4;CARD9;KSR1;PAK1;PTGS2;PLCG2;RELB;PYCARD;NFKBIA;CHUK;MAPK12;ITPR3;IKBKG,104 (104),0.0974,0.403,0,,6 (12),1,1,0.324,0.931
TCA cycle,EHMN,7,SUCLG2;SUCLG1;SLC13A3;DLST;ACO1;PCK1;IDH1,30 (30),0.0974,0.403,0,,36 (36),1,1,0.324,0.931
The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMPDB,7,SUCLG2;SUCLG1;L2HGDH;DLST;ACO1;IDH1;GLUD1,30 (30),0.0974,0.403,0,,39 (41),1,1,0.324,0.931
Innate Immune System,Reactome,157,A1BG;CFH;CFHR1;CPPED1;ABL1;ATP7A;CPN2;PLPP5;IQGAP2;BST1;CD300A;RPS6KA2;GSN;PECAM1;WASF3;CD55;ACTG1;BPIFB1;UNC13D;NCF2;PGLYRP2;CD46;BCL2;SIRPA;CR2;ITGAL;ITGAM;ADAM8;ADAM10;HPSE;ITGB2;MEF2C;MAP3K1;PGRMC1;CEACAM1;FGL2;ITPR3;DEFB1;STK10;CCR2;DOK3;PTPRB;MAPK12;MGST1;PIGR;NFATC2;CARD9;PAK3;VNN1;CD300LB;NFKBIA;GRAP2;PKM;FGB;AHSG;PYGB;PYGL;C3;C3AR1;CREG1;BIN2;MME;PLCG2;C6;CKAP4;C8A;C8B;IQGAP1;MMP9;C9;ALDOA;CHUK;HSPA1A;HSPA1B;CDA;NOS3;ALOX5;CNN2;SLC27A2;CRISPLD2;MGAM;GAB2;AMPD3;C5AR1;ADGRG3;VTN;RIPK3;FGG;WAS;ANPEP;FGA;DSP;FGR;ANXA2;QSOX1;DUSP4;ICAM2;DUSP7;SLC44A2;KCNAB2;IKBKG;ARHGAP9;CAT;CPB2;APOB;RELB;IDH1;TLR9;LCK;ASB15;APP;XRCC5;CFI;NFAM1;MUC1;HVCN1;COTL1;PRDX6;LGALS3;ARG1;CD93;ORM2;RHOF;LIMK1;TKFC;SLC11A1;LAT;ART1;CD19;P2RX7;TIMP2;VAV1;C7;PLEKHO2;WASF2;PYCARD;TLR1;SYNGR1;ATP6V0E2;TLR4;TLR5;SLPI;PAK1;PSMD1;CD63;ADGRE5;CARD11;IGLC2;PRKCQ;MAPK7;MAPK11;IL1B;MAPK13;ARHGAP45;PADI2;CD300E;MASP2,1064 (1065),0.098,0.405,0,,57 (119),1,1,0.326,0.934
Phosphatidylinositol phosphate metabolism,EHMN,14,PLCD3;GPLD1;SLC17A5;PIK3C2G;SLC37A4;ITPKC;OXSM;PLCB4;ATP8B2;PIP4K2A;NUP35;ITPKA;PIGL;PLCD1,93 (93),0.364,0.856,1,HMDB0011668,39 (48),0.272,1,0.328,0.94
O-Glycan biosynthesis,EHMN,8,GALNT15;SLC35D1;GALNT18;GALNT16;GALNT12;ST3GAL2;GALNT6;GALNT3,36 (36),0.1,0.411,0,,7 (17),1,1,0.33,0.943
Starch and sucrose metabolism - Homo sapiens (human),KEGG,8,UGP2;GBE1;MGAM;PYGB;PYGL;ENPP1;GYS2;HKDC1,36 (36),0.1,0.411,0,,16 (37),1,1,0.33,0.943
PKA-mediated phosphorylation of CREB,Reactome,5,ADCY4;PRKAR2A;ADCY9;ADCY2;PRKAR1B,19 (19),0.1,0.411,0,,5 (5),1,1,0.331,0.943
Nucleotide-like (purinergic) receptors,Reactome,5,ADORA2B;P2RY10;ADORA1;P2RY4;P2RY6,19 (19),0.1,0.411,0,,9 (12),1,1,0.331,0.943
Prostacyclin signalling through prostacyclin receptor,Reactome,5,GNB5;GNGT2;GNG2;PTGIR;GNG11,19 (19),0.1,0.411,0,,3 (3),1,1,0.331,0.943
Na+/Cl- dependent neurotransmitter transporters,Reactome,5,SLC6A9;SLC6A13;SLC18A1;SLC6A12;SLC22A1,19 (19),0.1,0.411,0,,28 (32),1,1,0.331,0.943
Ibuprofen Action Pathway,SMPDB,9,PTGES;UGT1A1;CYP2E1;EPHX2;PTGIS;PTGS2;ALOX5;GGT1;ALOX12,50 (50),0.221,0.659,1,HMDB0010404,74 (79),0.455,1,0.331,0.943
GPCR signaling-G alpha s PKA and ERK,INOH,46,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;ADCY4;EREG;RGS19;FZD8;PDGFB;PRKAR1B;ADORA1;BMP10;DLL4;INHBC;RAPGEF3;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;TGFB3;HGF;NGF;FZD4;FGF2;PRKAR2A;GNAI1;GNB5;WNT9B;NRG4;IL1B;GDF2;GDF10;GNGT2;ADCY2;RGS3;RAPGEF4;RGS10;ADCY9;KNG1,285 (285),0.102,0.418,0,,4 (4),1,1,0.335,0.953
TGF_beta_Receptor,NetPath,24,TGFB2;TGFB3;TGFBR2;TGFBR3;ANAPC10;ARRB2;MAP4K1;FOSB;PRKAR1B;PRKAR2A;SIK1;WWTR1;ATF3;CAV1;PJA1;BCAR1;RUNX1;RUNX3;HNF4A;SDC2;MEF2C;SMAD3;SMAD6;VDR,173 (173),0.462,0.955,0,,0 (0),1,1,0.462,0.955
Prolactin,NetPath,10,PAK1;SOCS2;FLNA;ERBB2;VAV1;PRLR;RPS6KA2;SIRPA;NFKBIA;THRB,70 (70),0.467,0.961,0,,0 (0),1,1,0.467,0.961
KitReceptor,NetPath,10,DOK1;KIT;MAPK12;SPRED2;MSN;INPP5D;WAS;ABL1;FGR;GRAP,70 (70),0.467,0.961,0,,0 (0),1,1,0.467,0.961
Activation of gene expression by SREBF (SREBP),Reactome,4,IDI1;TM7SF2;SC5D;GPAM,26 (26),0.468,0.961,0,,0 (0),1,1,0.468,0.961
Exercise-induced Circadian Regulation,Wikipathways,7,UGP2;GFRA1;CLDN5;G0S2;UCP3;IDI1;NCOA4,48 (48),0.468,0.961,0,,0 (0),1,1,0.468,0.961
Rett syndrome causing genes,Wikipathways,7,GABBR2;SMARCA2;GABRA3;SHANK3;MEF2C;KCNJ10;STXBP1,48 (48),0.468,0.961,0,,0 (0),1,1,0.468,0.961
Nephrotic syndrome,Wikipathways,7,WT1;COL4A4;LAMB2;ITGB4;PODXL;CTLA4;ITGA3,48 (48),0.468,0.961,0,,0 (0),1,1,0.468,0.961
Rheumatoid arthritis - Homo sapiens (human),KEGG,17,IL1B;TEK;ITGAL;IL11;CXCL5;CXCL2;ITGB2;CCL2;TGFB2;LTB;TGFB3;CTLA4;CXCL3;TNFRSF11A;ATP6V0E2;TLR4;ANGPT1,92 (93),0.104,0.424,0,,3 (3),1,1,0.339,0.962
Glucose metabolism,Reactome,17,PKLR;ALDOA;PKM;ALDOB;PGAM2;ENO3;SLC37A4;PCK1;GOT1;GOT2;PFKFB1;PFKFB2;NUP35;PFKFB4;POM121;NDC1;SLC25A13,92 (93),0.104,0.424,0,,32 (39),1,1,0.339,0.962
GPCR signaling-G alpha s Epac and ERK,INOH,44,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;ADCY4;EREG;RGS19;FZD8;PDGFB;ADORA1;BMP10;DLL4;INHBC;RAPGEF3;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;TGFB3;HGF;NGF;FZD4;FGF2;GNAI1;GNB5;WNT9B;NRG4;IL1B;GDF2;GDF10;GNGT2;ADCY2;RGS3;RAPGEF4;RGS10;ADCY9;KNG1,272 (272),0.105,0.429,0,,4 (4),1,1,0.341,0.969
IL12-mediated signaling events,PID,9,IL1B;HLX;IL2RB;LCK;CCR5;RELB;GZMB;CD3D;CD8A,63 (63),0.474,0.972,0,,0 (0),1,1,0.474,0.972
Common Pathways Underlying Drug Addiction,Wikipathways,6,ACTG1;ACTG2;CAMK2A;GJB1;GNAI1;PPP1R1A,41 (41),0.477,0.976,0,,0 (0),1,1,0.477,0.976
Gastrin,NetPath,6,KIT;PRKD2;ANXA2;PRKCQ;NFKBIA;BCAR1,41 (41),0.477,0.976,0,,0 (0),1,1,0.477,0.976
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway,Wikipathways,6,TRIM63;CCL2;RELB;NFKBIA;CHUK;MMP9,41 (41),0.477,0.976,0,,0 (0),1,1,0.477,0.976
Apoptosis Modulation by HSP70,Wikipathways,3,AIFM1;MAP3K1;HSPA1A,19 (19),0.478,0.976,0,,0 (0),1,1,0.478,0.976
akt signaling pathway,BioCarta,3,NFKBIA;GHR;CHUK,19 (19),0.478,0.976,0,,0 (0),1,1,0.478,0.976
FGF,INOH,13,SPI1;ETS2;FGF1;FGF2;FLI1;ETV5;SPRY1;FGF21;FGFR1;PLCG2;ELK3;SFN;ERG,67 (67),0.106,0.434,0,,4 (5),1,1,0.345,0.977
Triglyceride biosynthesis,Reactome,4,DGAT2;AGMO;GK;GPAM,14 (14),0.107,0.434,0,,13 (18),1,1,0.346,0.977
Gap junction trafficking and regulation,Reactome,4,GJB1;GJB2;MYO6;GJA1,14 (14),0.107,0.434,0,,2 (3),1,1,0.346,0.977
Adenylate cyclase inhibitory pathway,Reactome,4,ADCY4;GNAI1;ADCY9;ADCY2,14 (14),0.107,0.434,0,,4 (4),1,1,0.346,0.977
Digestion of dietary lipid,Reactome,0,,7 (7),1,1,1,HMDB0000036,14 (17),0.107,1,0.347,0.977
MTHFR deficiency,Wikipathways,0,,10 (10),1,1,1,HMDB0013461,14 (21),0.107,1,0.347,0.977
Caffeine Metabolism,SMPDB,1,CYP2E1,7 (7),0.635,1,1,HMDB0001860,23 (24),0.17,1,0.349,0.977
Synthesis of 5-eicosatetraenoic acids,Reactome,3,ALOX5;PON1;PON3,9 (9),0.108,0.436,0,,13 (17),1,1,0.349,0.977
Vitamin D (calciferol) metabolism,Reactome,3,CYP2R1;VDR;GC,9 (9),0.108,0.436,0,,8 (9),1,1,0.349,0.977
Transport of nucleotide sugars,Reactome,3,SLC35B4;SLC35D1;SLC35A3,9 (9),0.108,0.436,0,,13 (13),1,1,0.349,0.977
Conjugation of carboxylic acids,Reactome,3,GLYAT;ACSM5;ACSM1,9 (9),0.108,0.436,0,,12 (16),1,1,0.349,0.977
Amino Acid conjugation,Reactome,3,GLYAT;ACSM5;ACSM1,9 (9),0.108,0.436,0,,12 (16),1,1,0.349,0.977
Chylomicron assembly,Reactome,3,APOA4;APOB;MTTP,9 (9),0.108,0.436,0,,3 (4),1,1,0.349,0.977
Sperm Motility And Taxes,Reactome,3,HVCN1;CATSPER2;CATSPERD,9 (9),0.108,0.436,0,,4 (4),1,1,0.349,0.977
C20 prostanoid biosynthesis,HumanCyc,3,PTGES;PTGIS;PTGS2,9 (9),0.108,0.436,0,,8 (8),1,1,0.349,0.977
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,3,ALDH1L1;CYP2E1;CBS,9 (9),0.108,0.436,0,,11 (12),1,1,0.349,0.977
Steroid hormone biosynthesis - Homo sapiens (human),KEGG,12,UGT1A1;CYP2E1;CYP1A1;HSD17B12;CYP1B1;CYP7A1;CYP17A1;UGT1A5;HSD17B7;UGT2A3;SRD5A1;AKR1D1,61 (61),0.109,0.437,0,,87 (99),1,1,0.35,0.979
Digestion and absorption,Reactome,4,PIR;SLC2A2;SLC5A1;MGAM,26 (26),0.468,0.961,1,HMDB0000036,33 (45),0.235,1,0.353,0.985
TCR signaling in na&#xef;ve CD8+ T cells,PID,11,LAT;IKBKG;VAV1;PRF1;CARD11;CD3D;PRKCQ;GRAP2;CHUK;LCK;CD8A,55 (55),0.111,0.445,0,,4 (4),1,1,0.355,0.986
Regulation of lipolysis in adipocytes - Homo sapiens (human),KEGG,11,ADCY9;ADORA1;ADCY2;PTGS2;NPR1;GNAI1;ADCY4;PDE3B;FABP4;ADRB2;MGLL,55 (57),0.111,0.445,0,,12 (14),1,1,0.355,0.986
Allograft Rejection,Wikipathways,17,IL1B;CXCL13;PDGFRA;VIM;COL5A1;BHMT2;C3;PRF1;CD55;PECR;CTLA4;C6;GZMB;C8A;C8B;C7;C9,93 (93),0.112,0.446,0,,4 (10),1,1,0.357,0.986
HS-GAG biosynthesis,Reactome,7,HS3ST3A1;HS3ST1;SDC3;HSPG2;SDC1;SDC2;GPC3,31 (31),0.112,0.446,0,,9 (9),1,1,0.357,0.986
Nectin adhesion pathway,PID,7,PDGFB;PTPRM;PDGFRB;CLDN1;PVR;IQGAP1;FARP2,31 (31),0.112,0.446,0,,2 (2),1,1,0.357,0.986
Folate metabolism,INOH,7,PKLR;PKM;SHMT1;MTHFD1;AMT;DHFR;ALDH1L1,31 (31),0.112,0.446,0,,43 (46),1,1,0.357,0.986
PI3K/AKT Signaling in Cancer,Reactome,19,CD19;PDGFB;PDGFRA;NRG4;FGF1;KIT;LCK;HGF;PDGFRB;HBEGF;ERBB2;VAV1;FGFR1;EREG;GAB2;CHUK;NR4A1;FGF2;KLB,106 (106),0.112,0.446,0,,5 (21),1,1,0.358,0.986
EPH-Ephrin signaling,Reactome,14,EPHB2;EPHB4;EPHA4;PAK3;ARHGEF7;ACTG1;PAK1;SDC2;LIMK1;ASB15;EPHA3;ARHGEF28;EFNB2;EPHA7,74 (74),0.113,0.446,0,,8 (10),1,1,0.36,0.986
Synthesis of PA,Reactome,8,GPD1;ACP6;GPAT4;GPAM;LPCAT4;GPAT3;LCLAT1;DDHD2,37 (37),0.113,0.446,0,,17 (27),1,1,0.36,0.986
Purine Nucleoside Phosphorylase Deficiency,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Adenylosuccinate Lyase Deficiency,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
AICA-Ribosiduria,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Adenine phosphoribosyltransferase deficiency (APRT),SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Mitochondrial DNA depletion syndrome,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Myoadenylate deaminase deficiency,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Purine Metabolism,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Molybdenum Cofactor Deficiency,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Adenosine Deaminase Deficiency,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Gout or Kelley-Seegmiller Syndrome,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Lesch-Nyhan Syndrome (LNS),SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Xanthinuria type I,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Xanthinuria type II,SMPDB,8,ADA;GUCY1B1;AK1;AMPD1;PAICS;PDE4D;ENTPD5;PDE10A,37 (37),0.113,0.446,0,,70 (73),1,1,0.36,0.986
Wnt signaling pathway and pluripotency,Wikipathways,14,FZD4;FZD8;FZD9;MMP7;CSNK1E;PRKCH;CTBP2;PRKCQ;WNT7B;ESRRB;WNT11;PPARD;WNT9B;FOSL1,101 (101),0.491,0.989,0,,0 (1),1,1,0.491,0.989
Unwinding of DNA,Reactome,2,MCM3;MCM4,12 (12),0.492,0.989,0,,0 (1),1,1,0.492,0.989
Caspase-mediated cleavage of cytoskeletal proteins,Reactome,2,GSN;VIM,12 (12),0.492,0.989,0,,0 (0),1,1,0.492,0.989
tnfr2 signaling pathway,BioCarta,2,NFKBIA;MAP3K1,12 (12),0.492,0.989,0,,0 (0),1,1,0.492,0.989
pyrimidine deoxyribonucleosides salvage,HumanCyc,1,CDA,5 (5),0.513,0.995,1,HMDB0000273,31 (31),0.223,1,0.362,0.989
Diseases of signal transduction by growth factor receptors and second messengers,Reactome,44,HGF;KSR1;KLB;ERBB2;KANK1;ARRB1;ARRB2;VWF;CAMK2A;FN1;CD19;PDGFB;PDGFRA;NRG4;PDGFRB;NR4A1;HBEGF;BAG4;RBPJ;ESRP1;MAMLD1;MAML1;FGA;FGB;GAB2;FGF1;FGF2;NOX4;KDR;BIN2;FGFR1;FGG;LCK;CNKSR1;ADAM10;KIT;DLL4;HDAC7;VAV1;NEURL1B;APBB1IP;IQGAP1;CHUK;EREG,274 (274),0.114,0.449,0,,18 (71),1,1,0.362,0.989
Interleukin receptor SHC signaling,Reactome,4,IL2RB;INPP5D;IL3RA;GAB2,27 (27),0.499,0.995,0,,0 (0),1,1,0.499,0.995
FGFR2 alternative splicing,Reactome,4,POLR2D;ESRP2;ESRP1;POLR2A,27 (27),0.499,0.995,0,,0 (1),1,1,0.499,0.995
Neurexins and neuroligins,Reactome,8,EPB41L3;STXBP1;EPB41L5;SYT1;SHANK3;EPB41L1;DLG4;BEGAIN,57 (57),0.503,0.995,0,,0 (0),1,1,0.503,0.995
Interleukin-1 processing,Reactome,1,IL1B,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Sulindac Metabolic Pathway,Wikipathways,1,CYP1B1,5 (5),0.513,0.995,0,,0 (2),1,1,0.513,0.995
SARS-CoV-2 altering angiogenesis via NRP1,Wikipathways,1,KDR,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
GRB7 events in ERBB2 signaling,Reactome,1,ERBB2,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
MET interacts with TNS proteins,Reactome,1,HGF,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Interleukin-37 signaling,Reactome,1,SMAD3,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,Reactome,1,CCDC88C,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
MET activates PTPN11,Reactome,1,HGF,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Physiological factors,Reactome,1,NPR1,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Activation of NOXA and translocation to mitochondria,Reactome,1,PMAIP1,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Aurora C signaling,PID,1,INCENP,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Class IB PI3K non-lipid kinase events,PID,1,PDE3B,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
FLT3 signaling through SRC family kinases,Reactome,1,LCK,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
WNT5A-dependent internalization of FZD2_ FZD5 and ROR2,Reactome,1,ROR2,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
ifn gamma signaling pathway,BioCarta,1,IFNGR1,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
hiv-1 defeats host-mediated resistance by cem15,BioCarta,1,CXCR4,5 (5),0.513,0.995,0,,0 (0),1,1,0.513,0.995
acetylation and deacetylation of rela in nucleus,BioCarta,1,NFKBIA,5 (5),0.513,0.995,0,,0 (1),1,1,0.513,0.995
Cross-presentation of soluble exogenous antigens (endosomes),Reactome,1,MRC2,5 (5),0.513,0.995,0,,0 (1),1,1,0.513,0.995
Interactions between immune cells and microRNAs in tumor microenvironment,Wikipathways,7,TGFB2;TGFB3;TGFBR2;CCL2;IL2RB;CTLA4;TLR4,50 (50),0.513,0.995,0,,0 (1),1,1,0.513,0.995
Inflammatory bowel disease - Homo sapiens (human),KEGG,9,IL1B;TGFB2;IFNGR1;TGFB3;IL21R;SMAD3;TLR4;TLR5;MAF,65 (65),0.513,0.995,0,,0 (0),1,1,0.513,0.995
Receptor-type tyrosine-protein phosphatases,Reactome,3,PTPRF;PPFIA2;PTPRD,20 (20),0.514,0.995,0,,0 (0),1,1,0.514,0.995
Regulation of cytoplasmic and nuclear SMAD2/3 signaling,PID,3,SMAD3;CTDSPL;MAP3K1,20 (20),0.514,0.995,0,,0 (0),1,1,0.514,0.995
TP53 network,Wikipathways,3,ABL1;BCL2;PMAIP1,20 (20),0.514,0.995,0,,0 (0),1,1,0.514,0.995
Signaling by VEGF,Reactome,18,MAPK11;VEGFC;PAK1;PAK3;NRP2;CDH5;NOS3;KDR;NCF2;VAV1;WASF2;FLT4;SH2D2A;CAV1;WASF3;BCAR1;ITPR3;SHC2,100 (100),0.116,0.456,0,,25 (26),1,1,0.366,0.999
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling,Reactome,18,CD19;PDGFB;PDGFRA;NRG4;FGF1;KIT;HGF;PDGFRB;HBEGF;ERBB2;VAV1;FGFR1;EREG;GAB2;PIP4K2A;LCK;FGF2;KLB,100 (100),0.116,0.456,0,,7 (12),1,1,0.366,0.999
Phosphatidylcholine catabolism,Wikipathways,0,,0 (0),1,1,2,HMDB0010404;HMDB0013461,6 (9),0.000907,1,0.000907,1
Oligodendrocyte specification and differentiation_ leading to myelin components for CNS,Wikipathways,0,,0 (0),1,1,1,HMDB0013461,8 (11),0.0627,1,0.0627,1
Pyrimidine metabolism and related diseases,Wikipathways,0,,0 (0),1,1,1,HMDB0000273,14 (37),0.107,1,0.107,1
Biomarkers for pyrimidine metabolism disorders,Wikipathways,0,,0 (0),1,1,1,HMDB0000273,15 (34),0.114,1,0.114,1
Urea cycle and metabolism of amino groups,Wikipathways,0,,0 (0),1,1,1,HMDB0000128,28 (32),0.203,1,0.203,1
Fc-epsilon receptor I signaling in mast cells,PID,12,LAT;FCGR2B;PLPP1;DOK1;NFATC2;GAB2;VAV1;INPP5D;MAP3K1;DUSP1;CHUK;IKBKG,62 (62),0.119,0.465,0,,6 (8),1,1,0.373,1
One carbon pool by folate - Homo sapiens (human),KEGG,5,ALDH1L1;MTHFD1;AMT;SHMT1;DHFR,20 (20),0.12,0.465,0,,9 (9),1,1,0.373,1
Cellular hexose transport,Reactome,5,SLC2A2;SLC5A1;SLC2A4;SLC2A9;SLC2A10,20 (20),0.12,0.465,0,,4 (7),1,1,0.373,1
S1P1 pathway,PID,5,PDGFRB;GNAI1;PDGFB;KDR;PTGS2,20 (20),0.12,0.465,0,,4 (4),1,1,0.373,1
Aminosugars metabolism,INOH,5,PFKFB2;PFKFB4;GNE;PGM3;PFKFB1,20 (20),0.12,0.465,0,,30 (32),1,1,0.373,1
Aflatoxin activation and detoxification,Reactome,5,DPEP1;MGST1;GGT1;GGT7;GGT6,20 (20),0.12,0.465,0,,13 (25),1,1,0.373,1
D-<i>myo</i>-inositol-5-phosphate metabolism,HumanCyc,5,PLCG2;PIP4K2A;PLCD3;PLCB4;PLCD1,20 (20),0.12,0.465,0,,7 (8),1,1,0.373,1
Thromboxane A2 receptor signaling,PID,11,BLK;MAPK11;LCK;PTGIR;NOS3;PRKCH;PRKCQ;GNB5;ARRB2;GNG2;FGR,56 (56),0.122,0.475,0,,12 (12),1,1,0.379,1
GPCR signaling-G alpha i,INOH,42,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;ADCY4;EREG;RGS19;FZD8;PDGFB;ADORA1;BMP10;DLL4;INHBC;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;TGFB3;HGF;NGF;FZD4;FGF2;GNAI1;GNB5;WNT9B;NRG4;IL1B;GDF2;GDF10;GNGT2;ADCY2;RGS3;RGS10;ADCY9;KNG1,262 (262),0.123,0.476,0,,2 (2),1,1,0.38,1
GPCR signaling-pertussis toxin,INOH,42,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;ADCY4;EREG;RGS19;FZD8;PDGFB;ADORA1;BMP10;DLL4;INHBC;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;TGFB3;HGF;NGF;FZD4;FGF2;GNAI1;GNB5;WNT9B;NRG4;IL1B;GDF2;GDF10;GNGT2;ADCY2;RGS3;RGS10;ADCY9;KNG1,262 (262),0.123,0.476,0,,2 (2),1,1,0.38,1
16p11.2 proximal deletion syndrome,Wikipathways,6,ALDOA;SPN;CORO1A;QPRT;PPP4R4;MSN,79 (79),0.963,1,1,HMDB0010404,17 (40),0.129,1,0.383,1
GPCR Dopamine D1like receptor,INOH,10,PRKAR1B;CACNA1C;CACNA1D;GNGT2;CACNA1S;CACNA2D1;CACNB1;PRKAR2A;CACNG1;GNB5,50 (50),0.125,0.482,0,,4 (4),1,1,0.384,1
A tetrasaccharide linker sequence is required for GAG synthesis,Reactome,6,SDC3;HSPG2;SDC1;SDC2;VCAN;GPC3,26 (26),0.125,0.482,0,,5 (6),1,1,0.386,1
Vitamin A (retinol) metabolism,EHMN,6,UGT1A1;CYP1A1;ATP8B2;UGT1A5;CYP26A1;CYP26B1,26 (26),0.125,0.482,0,,23 (28),1,1,0.386,1
Vitamin B9 (folate) metabolism,EHMN,6,SLC25A4;SHMT1;SLC25A22;MTHFD1;AMT;SLC25A13,26 (26),0.125,0.482,0,,31 (35),1,1,0.386,1
Endogenous TLR signaling,PID,6,HSPD1;TLR4;IKBKG;VCAN;TLR1;CHUK,26 (26),0.125,0.482,0,,2 (2),1,1,0.386,1
Metal ion SLC transporters,Reactome,6,SLC11A1;CP;SLC39A5;HEPH;SLC30A10;SLC41A1,26 (26),0.125,0.482,0,,6 (8),1,1,0.386,1
Platelet calcium homeostasis,Reactome,6,P2RX7;P2RX6;ATP2A3;ATP2A1;ATP2B4;ITPR3,26 (26),0.125,0.482,0,,6 (7),1,1,0.386,1
Galactose metabolism,EHMN,9,B4GALT2;SLC2A10;MGAM;SLC35B4;SLC2A2;SLC35A3;SLC2A4;SLC5A1;SLC2A9,44 (44),0.127,0.485,0,,43 (47),1,1,0.388,1
Ion homeostasis,Reactome,9,DMPK;FXYD6;ATP2A1;ATP2A3;ATP2B4;RYR1;TRDN;ATP1A2;ITPR3,44 (44),0.127,0.485,0,,10 (11),1,1,0.388,1
nfat and hypertrophy of the heart ,BioCarta,9,GATA4;ATP2A1;LIF;ATP2A3;HBEGF;MEF2C;MYL2;ACTA1;CAMKK1,44 (44),0.127,0.485,0,,3 (5),1,1,0.388,1
Oncogenic MAPK signaling,Reactome,13,FGA;FGB;IQGAP1;KSR1;ESRP1;CNKSR1;APBB1IP;ARRB1;ARRB2;VWF;CAMK2A;FGG;FN1,69 (69),0.127,0.485,0,,8 (17),1,1,0.389,1
Adipocytokine signaling pathway - Homo sapiens (human),KEGG,13,CHUK;ACSL1;IKBKG;PCK1;CPT1C;ADIPOR2;PRKCQ;PRKAG2;NFKBIA;PPARA;PRKAA2;CPT1A;SLC2A4,69 (69),0.127,0.485,0,,3 (7),1,1,0.389,1
16p11.2 distal deletion syndrome,Wikipathways,7,LAT;CD19;CR2;NFATC2;ATP2A1;C3;KDR,32 (32),0.128,0.486,0,,3 (4),1,1,0.39,1
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,25,GABRB3;DAGLB;CACNA1C;GABRP;CACNA1S;ADCY4;MAPK12;CACNA1D;GNB5;GNG2;ABHD6;SLC17A8;MGLL;GNAI1;PLCB4;MAPK11;MAPK13;GNG11;GNGT2;DAGLA;ADCY2;PTGS2;ADCY9;GABRA3;ITPR3,148 (148),0.13,0.486,0,,17 (19),1,1,0.396,1
Phytochemical activity on NRF2 transcriptional activation,Wikipathways,4,NQO1;EPHB2;GCLM;MAF,15 (15),0.131,0.486,0,,2 (3),1,1,0.397,1
GPR40 Pathway,Wikipathways,4,PLCG2;PLCD3;PLCD1;ITPR3,15 (15),0.131,0.486,0,,3 (3),1,1,0.397,1
Biopterin metabolism,EHMN,4,SLC38A4;SLC16A10;SLC7A1;SLC43A2,15 (15),0.131,0.486,0,,23 (24),1,1,0.397,1
ERBB2 Regulates Cell Motility,Reactome,4,NRG4;ERBB2;EREG;HBEGF,15 (15),0.131,0.486,0,,1 (1),1,1,0.397,1
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,4,INPP5D;ITPKA;SYNJ2;ITPKC,15 (15),0.131,0.486,0,,8 (8),1,1,0.397,1
Phase 2 - plateau phase,Reactome,4,KCNE3;KCNQ1;CACNB1;CACNA1C,15 (15),0.131,0.486,0,,2 (2),1,1,0.397,1
Mercaptopurine Metabolism Pathway,SMPDB,4,SLC28A2;ADK;TPMT;ABCC4,15 (15),0.131,0.486,0,,21 (24),1,1,0.397,1
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,4,INPP5D;ITPKA;SYNJ2;ITPKC,15 (15),0.131,0.486,0,,11 (11),1,1,0.397,1
Pyrimidine nucleotides nucleosides metabolism,INOH,8,ABAT;DPYD;DPYS;CDA;UPB1;CPS1;AK3;ENTPD5,51 (51),0.375,0.868,1,HMDB0000273,53 (56),0.351,1,0.399,1
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,14,FGD2;OBSCN;NGF;NGFR;FGD1;BEX3;PREX1;ARHGEF2;VAV1;ARHGEF6;FGD3;ARHGEF17;ARHGEF7;MCF2L,76 (76),0.133,0.486,0,,4 (4),1,1,0.402,1
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,18,SLC7A6;SLC1A3;SLC7A8;SLC17A8;SLC43A2;SLC17A1;SLC1A1;SLC1A2;SLC6A12;SLC26A1;SLC1A5;SLC7A1;SLC38A4;SLC25A22;SLC17A5;SLC15A2;SLC4A4;SLC16A10,102 (102),0.133,0.486,0,,46 (55),1,1,0.402,1
Metabolism of Dichloroethylene by CYP450,Wikipathways,1,CYP2E1,1 (1),0.134,0.486,0,,9 (10),1,1,0.403,1
Acrylamide Biotransformation and Exposure Biomarkers,Wikipathways,1,CYP2E1,1 (1),0.134,0.486,0,,3 (4),1,1,0.403,1
sulfite oxidation,HumanCyc,1,SUOX,1 (1),0.134,0.486,0,,4 (5),1,1,0.403,1
Conversion of Angiotensinogen to Angiotensin II,Wikipathways,1,ACE,1 (1),0.134,0.486,0,,2 (3),1,1,0.403,1
Riboflavin and CoQ disorders,Wikipathways,1,ETFDH,1 (1),0.134,0.486,0,,19 (26),1,1,0.403,1
Oleoyl-phe metabolism,Reactome,1,PM20D1,1 (1),0.134,0.486,0,,2 (4),1,1,0.403,1
adenine and adenosine salvage II,HumanCyc,1,ADK,1 (1),0.134,0.486,0,,5 (5),1,1,0.403,1
NADPH regeneration,Reactome,1,IDH1,1 (1),0.134,0.486,0,,7 (8),1,1,0.403,1
Signaling by kinase domain mutants of KIT,Reactome,1,KIT,1 (1),0.134,0.486,0,,2 (2),1,1,0.403,1
Signaling by juxtamembrane domain KIT mutants,Reactome,1,KIT,1 (1),0.134,0.486,0,,2 (2),1,1,0.403,1
Signaling by extracellular domain mutants of KIT,Reactome,1,KIT,1 (1),0.134,0.486,0,,2 (2),1,1,0.403,1
Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Reactome,1,ALOX12,1 (1),0.134,0.486,0,,7 (10),1,1,0.403,1
glutamine biosynthesis,HumanCyc,1,GLUL,1 (1),0.134,0.486,0,,7 (7),1,1,0.403,1
Biosynthesis of DPAn-3-derived 13-series resolvins,Reactome,1,ALOX5,1 (1),0.134,0.486,0,,1 (6),1,1,0.403,1
L-serine degradation,HumanCyc,1,SDSL,1 (1),0.134,0.486,0,,6 (7),1,1,0.403,1
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Reactome,1,IDH1,1 (1),0.134,0.486,0,,5 (5),1,1,0.403,1
Diseases of metabolism,Reactome,1,IDH1,1 (1),0.134,0.486,0,,5 (5),1,1,0.403,1
thiamin salvage III,HumanCyc,1,TPK1,1 (1),0.134,0.486,0,,5 (5),1,1,0.403,1
Vitamin E,Reactome,1,TTPA,1 (1),0.134,0.486,0,,1 (1),1,1,0.403,1
Signaling by FGFR1 amplification mutants,Reactome,1,FGFR1,1 (1),0.134,0.486,0,,2 (11),1,1,0.403,1
Quinapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,4 (4),1,1,0.403,1
Ramipril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (4),1,1,0.403,1
Fosinopril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (4),1,1,0.403,1
Moexipril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (3),1,1,0.403,1
Cilazapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (4),1,1,0.403,1
Enalapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,4 (4),1,1,0.403,1
Benazepril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,4 (4),1,1,0.403,1
Spirapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (3),1,1,0.403,1
Trandolapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,3 (3),1,1,0.403,1
sorbitol degradation I,HumanCyc,1,SORD,1 (1),0.134,0.486,0,,4 (5),1,1,0.403,1
Tandem pore domain halothane-inhibited K+ channel (THIK),Reactome,1,KCNK13,1 (1),0.134,0.486,0,,1 (1),1,1,0.403,1
4-hydroxybenzoate biosynthesis,HumanCyc,1,TAT,1 (1),0.134,0.486,0,,17 (17),1,1,0.403,1
Dipyridamole (Antiplatelet) Action Pathway,SMPDB,1,PDE4D,1 (1),0.134,0.486,0,,1 (2),1,1,0.403,1
Cilostazol Action Pathway,SMPDB,1,PDE4D,1 (1),0.134,0.486,0,,1 (2),1,1,0.403,1
Temocapril Metabolism Pathway,SMPDB,1,ACE,1 (1),0.134,0.486,0,,1 (1),1,1,0.403,1
Caffeine metabolism - Homo sapiens (human),KEGG,0,,6 (6),1,1,1,HMDB0001860,18 (22),0.136,1,0.407,1
D-Glutamine and D-glutamate metabolism - Homo sapiens (human),KEGG,2,DGLUCY;GLUD1,5 (5),0.136,0.486,0,,7 (13),1,1,0.408,1
dTMP <i>de novo</i> biosynthesis (mitochondrial),HumanCyc,2,SHMT1;DHFR,5 (5),0.136,0.486,0,,11 (11),1,1,0.408,1
Vitamin B2 (riboflavin) metabolism,EHMN,2,ACP6;ENPP1,5 (5),0.136,0.486,0,,14 (14),1,1,0.408,1
Adenosine P1 receptors,Reactome,2,ADORA2B;ADORA1,5 (5),0.136,0.486,0,,1 (1),1,1,0.408,1
Abacavir transmembrane transport,Reactome,2,SLC22A1;ABCG2,5 (5),0.136,0.486,0,,4 (4),1,1,0.408,1
Abacavir metabolism,Reactome,2,PCK1;ADAL,5 (5),0.136,0.486,0,,14 (18),1,1,0.408,1
Beta oxidation of butanoyl-CoA to acetyl-CoA,Reactome,2,ACSM3;HADH,5 (5),0.136,0.486,0,,14 (14),1,1,0.408,1
folate polyglutamylation,HumanCyc,2,MTHFD1;SHMT1,5 (5),0.136,0.486,0,,13 (13),1,1,0.408,1
lactate fermentation (reoxidation of cytosolic NADH),HumanCyc,2,LDHB;LDHA,5 (5),0.136,0.486,0,,5 (5),1,1,0.408,1
creatine-phosphate biosynthesis,HumanCyc,2,CKMT2;CKM,5 (5),0.136,0.486,0,,5 (5),1,1,0.408,1
Threonine catabolism,Reactome,2,SDS;SDSL,5 (5),0.136,0.486,0,,12 (14),1,1,0.408,1
Propionyl-CoA catabolism,Reactome,2,PCCB;PCCA,5 (5),0.136,0.486,0,,7 (9),1,1,0.408,1
Vitamin B1 (thiamin) metabolism,Reactome,2,TPK1;THTPA,5 (5),0.136,0.486,0,,9 (10),1,1,0.408,1
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde,HumanCyc,2,QPRT;NADSYN1,5 (5),0.136,0.486,0,,14 (14),1,1,0.408,1
malate-aspartate shuttle,HumanCyc,2,GOT1;GOT2,5 (5),0.136,0.486,0,,8 (8),1,1,0.408,1
Acetylcholine inhibits contraction of outer hair cells,Reactome,2,KCNMB1;KCNN2,5 (5),0.136,0.486,0,,3 (3),1,1,0.408,1
VLDL assembly,Reactome,2,APOB;MTTP,5 (5),0.136,0.486,0,,3 (4),1,1,0.408,1
HDL clearance,Reactome,2,HDLBP;SCARB1,5 (5),0.136,0.486,0,,3 (4),1,1,0.408,1
Pyruvate Carboxylase Deficiency,SMPDB,2,GPT;AGXT,5 (5),0.136,0.486,0,,16 (17),1,1,0.408,1
Primary Hyperoxaluria Type I,SMPDB,2,GPT;AGXT,5 (5),0.136,0.486,0,,16 (17),1,1,0.408,1
Lactic Acidemia,SMPDB,2,GPT;AGXT,5 (5),0.136,0.486,0,,16 (17),1,1,0.408,1
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,Reactome,2,PCK1;NRIP1,5 (5),0.136,0.486,0,,3 (4),1,1,0.408,1
Alanine Metabolism,SMPDB,2,GPT;AGXT,5 (5),0.136,0.486,0,,16 (17),1,1,0.408,1
Taurine and Hypotaurine Metabolism,SMPDB,2,CDO1;GGT6,5 (5),0.136,0.486,0,,11 (12),1,1,0.408,1
Tight junction - Homo sapiens (human),KEGG,28,PARD6B;CACNA1D;ERBB2;MYL2;WAS;MICALL2;EPB41L4B;ARHGEF2;CLDN1;AMOTL1;PRKAA2;GATA4;IGSF5;ACTG1;CLDN5;CLDN4;CLDN7;CGNL1;RUNX1;PRKAG2;PARD3;TUBA1A;VASP;CLDN2;JAM3;MSN;MAP3K1;JAM2,169 (169),0.136,0.486,0,,1 (1),1,1,0.408,1
Inositol phosphate metabolism,Reactome,10,PLCD3;PPIP5K1;ITPKC;INPP5D;PLCB4;INPP4B;PLCG2;ITPKA;PPIP5K2;PLCD1,51 (51),0.138,0.489,0,,31 (44),1,1,0.41,1
superpathway of inositol phosphate compounds,HumanCyc,13,PLCD3;PI4K2B;SYNJ2;PIK3C2G;PPIP5K1;ITPKC;INPP5D;PLCB4;PLCD1;PLCG2;PIP4K2A;ITPKA;PPIP5K2,70 (70),0.138,0.489,0,,18 (26),1,1,0.411,1
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,13,MGST1;UGT1A1;CYP2E1;GSTK1;MAOB;UGT2A3;UGT1A5;FMO1;FMO2;FMO3;FMO4;FMO5;ADH4,70 (72),0.138,0.489,0,,83 (88),1,1,0.411,1
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,13,PKM;PDGFRA;PDGFRB;PGAM2;HKDC1;KIT;SLC1A5;ERBB2;SLC2A2;LDHA;FGFR1;LDHB;IDH1,70 (70),0.138,0.489,0,,35 (37),1,1,0.411,1
TCA cycle in senescence,Wikipathways,3,ME2;GOT1;ME1,10 (10),0.14,0.493,0,,10 (13),1,1,0.416,1
mevalonate pathway,HumanCyc,3,IDI1;ACAT1;HMGCS2,10 (10),0.14,0.493,0,,17 (17),1,1,0.416,1
PI3K events in ERBB4 signaling,Reactome,3,HBEGF;EREG;NRG4,10 (10),0.14,0.493,0,,3 (4),1,1,0.416,1
Adenylate cyclase activating pathway,Reactome,3,ADCY9;ADCY4;ADCY2,10 (10),0.14,0.493,0,,7 (7),1,1,0.416,1
Gamma-carboxylation of protein precursors,Reactome,3,PROZ;GAS6;F9,10 (10),0.14,0.493,0,,4 (6),1,1,0.416,1
Activation of SMO,Reactome,3,ARRB1;ARRB2;EVC2,10 (10),0.14,0.493,0,,2 (2),1,1,0.416,1
acetone degradation I (to methylglyoxal),HumanCyc,3,AKR1B10;CYP2S1;CYP2E1,10 (10),0.14,0.493,0,,11 (11),1,1,0.416,1
Reduction of cytosolic Ca++ levels,Reactome,3,ATP2A3;ATP2B4;ATP2A1,10 (10),0.14,0.493,0,,3 (3),1,1,0.416,1
Vitamin D Metabolism,Wikipathways,3,CYP2R1;VDR;GC,10 (10),0.14,0.493,0,,9 (9),1,1,0.416,1
Tamoxifen metabolism,Wikipathways,5,FMO3;CYP1B1;CYP2E1;FMO1;CYP1A1,21 (21),0.141,0.493,0,,9 (16),1,1,0.416,1
nf-kb signaling pathway,BioCarta,5,NFKBIA;CHUK;TLR4;IKBKG;MAP3K1,21 (21),0.141,0.493,0,,1 (1),1,1,0.416,1
downregulated of mta-3 in er-negative breast tumors,BioCarta,5,ALDOA;HSPB1;PDZK1;TUBA1A;SNAI1,21 (21),0.141,0.493,0,,2 (2),1,1,0.416,1
Transcriptional regulation of granulopoiesis,Reactome,6,SPI1;GATA2;TAL1;FLI1;KLF5;RUNX1,27 (27),0.144,0.502,0,,1 (1),1,1,0.423,1
corticosteroids and cardioprotection,BioCarta,6,NOS3;BDKRB2;KNG1;CCL11;CAV1;ADRB2,27 (27),0.144,0.502,0,,7 (8),1,1,0.423,1
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis,HumanCyc,6,PLCD3;PI4K2B;PLCB4;PLCD1;PLCG2;PIP4K2A,27 (27),0.144,0.502,0,,8 (13),1,1,0.423,1
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),Wikipathways,7,PRLR;ERBB2;GJB2;TTC9;TNFRSF11A;CAV1;CHUK,33 (33),0.144,0.502,0,,2 (3),1,1,0.424,1
Prion disease pathway,Wikipathways,7,SPI1;POU2F2;MEF2C;BCL2;CASP12;PAX5;FGFR1,33 (33),0.144,0.502,0,,1 (2),1,1,0.424,1
Glucagon signaling in metabolic regulation,Reactome,7,GNG11;ADCY4;PRKAR1B;ADCY2;PRKAR2A;ADCY9;GNG2,33 (33),0.144,0.502,0,,6 (6),1,1,0.424,1
Signaling by NOTCH2,Reactome,7,MAML1;ADAM10;DLL4;NEURL1B;GZMB;RBPJ;MAMLD1,33 (33),0.144,0.502,0,,1 (1),1,1,0.424,1
Cargo concentration in the ER,Reactome,7,F5;F8;MIA3;SEC24A;SEC23A;MIA2;LMAN1,33 (33),0.144,0.502,0,,1 (6),1,1,0.424,1
retinol biosynthesis,HumanCyc,1,CES4A,19 (19),0.935,1,1,HMDB0002183,21 (37),0.157,1,0.428,1
Xenobiotics,Reactome,3,CYP2S1;CYP2E1;CYP1A1,21 (21),0.548,1,1,HMDB0001860,39 (51),0.272,1,0.433,1
GPCR signaling-G alpha q,INOH,43,VEGFC;TGFB2;FGF1;IL11;FZD9;LIF;BMP2;BMP5;BMP6;INHBE;TGFB3;EREG;RGS19;FZD8;PDGFB;ADORA1;BMP10;DLL4;INHBC;HBEGF;ADORA2B;FGF21;WNT7B;WNT11;WNT9B;HGF;NGF;FZD4;FGF2;PRKCH;GNAI1;PRKCQ;GNB5;NRG4;IL1B;GDF2;GDF10;GNGT2;RGS3;RGS10;KNG1;PLCB4;ITPR3,274 (274),0.151,0.524,0,,5 (6),1,1,0.436,1
Brain-derived neurotrophic factor (BDNF) signaling pathway,Wikipathways,24,GABRB3;BMP2;KSR1;DPYSL2;KCNN2;PTPRF;EGR1;NFATC4;CAMK2A;NTRK2;NFKBIA;PRKAA2;NGF;NGFR;IKBKG;SHC2;NCF2;SIRPA;MAPK7;SH2B2;MEF2C;SPP1;MAP3K1;CHUK,144 (144),0.151,0.524,0,,4 (4),1,1,0.437,1
Type II diabetes mellitus - Homo sapiens (human),KEGG,9,PKLR;SOCS2;CACNA1C;CACNA1D;HKDC1;SLC2A2;PKM;SLC2A4;MAFA,46 (46),0.155,0.537,0,,4 (6),1,1,0.444,1
FOXA2 pathway,Wikipathways,4,ABCC4;MTTP;ABCC2;SLC27A5,16 (16),0.157,0.541,0,,1 (1),1,1,0.448,1
GRB2 events in ERBB2 signaling,Reactome,4,ERBB2;EREG;NRG4;HBEGF,16 (16),0.157,0.541,0,,2 (2),1,1,0.448,1
PI3K events in ERBB2 signaling,Reactome,4,ERBB2;HBEGF;NRG4;EREG,16 (16),0.157,0.541,0,,3 (4),1,1,0.448,1
Sema3A PAK dependent Axon repulsion,Reactome,4,PLXNA4;LIMK1;PAK1;PAK3,16 (16),0.157,0.541,0,,3 (3),1,1,0.448,1
TRAF6 mediated NF-kB activation,Reactome,4,NFKBIA;CHUK;IKBKG;MAP3K1,16 (16),0.157,0.541,0,,2 (5),1,1,0.448,1
Rap1 signalling,Reactome,4,RAPGEF3;RAP1GAP2;RAPGEF4;SIPA1,16 (16),0.157,0.541,0,,7 (8),1,1,0.448,1
Cori Cycle,Wikipathways,4,GPT;SLC2A2;LDHA;SLC2A4,16 (16),0.157,0.541,0,,18 (25),1,1,0.448,1
C-MYB transcription factor network,PID,15,SPI1;ANPEP;SMARCA2;ADA;ETS2;KIT;ADORA2B;MCM4;PTGS2;CD34;BCL2;COL1A2;PAX5;IQGAP1;MAF,85 (85),0.16,0.549,0,,2 (2),1,1,0.453,1
RAC2 GTPase cycle,Reactome,15,NCF2;PAK1;BAIAP2L1;ARHGAP1;PREX1;MCAM;ARHGAP35;SYDE1;VAV1;WASF2;CAV1;LBR;DEF6;IQGAP1;LMAN1,85 (85),0.16,0.549,0,,4 (4),1,1,0.453,1
Alpha4 beta1 integrin signaling events,PID,7,PRKAR1B;SPP1;MYH2;THBS1;BCAR1;JAM2;FN1,34 (34),0.162,0.553,0,,4 (4),1,1,0.457,1
RHOU GTPase cycle,Reactome,7,PAK1;MYO6;PAK3;ARHGEF7;DLG5;ARHGEF6;IQGAP1,34 (34),0.162,0.553,0,,2 (2),1,1,0.457,1
Fatty Acid Biosynthesis,Wikipathways,5,PECR;DECR1;ACSL1;ECHDC1;HADH,22 (22),0.163,0.553,0,,4 (14),1,1,0.459,1
Glycerolipids and Glycerophospholipids,Wikipathways,5,DGAT2;CHPT1;PNPLA3;GPAT4;GPAM,22 (22),0.163,0.553,0,,10 (11),1,1,0.459,1
NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence,Wikipathways,5,SIRT5;IL1B;GOT1;GOT2;SLC2A4,22 (22),0.163,0.553,0,,8 (12),1,1,0.459,1
Triglyceride catabolism,Reactome,5,FABP2;FABP3;FABP4;FABP7;MGLL,22 (22),0.163,0.553,0,,14 (19),1,1,0.459,1
ADP signalling through P2Y purinoceptor 12,Reactome,5,GNGT2;GNB5;GNAI1;GNG2;GNG11,22 (22),0.163,0.553,0,,3 (3),1,1,0.459,1
VEGFR2 mediated vascular permeability,Reactome,6,PAK1;PAK3;CDH5;NOS3;VAV1;CAV1,28 (28),0.164,0.555,0,,16 (16),1,1,0.46,1
GPCR GroupI metabotropic glutamate receptor,INOH,6,GNGT2;PRKCQ;PRKCH;PLCB4;GNB5;ITPR3,28 (28),0.164,0.555,0,,5 (6),1,1,0.46,1
Nucleobase catabolism,Reactome,6,AGXT2;UPP2;DPYD;DPYS;UPB1;ENTPD5,36 (36),0.351,0.834,1,HMDB0000273,78 (99),0.473,1,0.464,1
Growth hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,20,MAPK11;GHR;SOCS2;CACNA1C;CACNA1D;ADCY4;CACNA1S;ADCY2;MAPK13;IGFALS;GNAI1;ADCY9;PLCB4;MAP3K1;PLCG2;BCAR1;CREB3L3;MAPK12;ITPR3;SHC2,119 (119),0.168,0.568,0,,4 (4),1,1,0.468,1
Pathways in cancer - Homo sapiens (human),KEGG,79,VEGFC;FZD4;TGFB3;PLCB4;FZD8;FZD9;TGFBR2;BMP2;KIT;COL4A1;HHIP;ERBB2;ADCY4;FLT4;LAMA5;IGF1R;ABL1;KNG1;TGFB2;FN1;SPI1;MGST1;ITGA3;PDGFB;PDGFRA;COL4A4;COL4A2;PDGFRB;LAMA4;ITGA6;CXCR4;CAMK2A;FGF21;RASGRP3;RUNX1T1;NFKBIA;GNB5;GNG2;WNT9B;HGF;WNT7B;NQO1;BAK1;LAMA2;IKBKG;FGF1;FGF2;LAMB1;LAMB2;LAMB3;LAMC1;IFNGR1;LAMC2;LAMC3;CTBP2;GNAI1;FGFR1;WNT11;PLCG2;MMP2;PPARD;RUNX1;MMP9;NCOA4;ARNT2;GNG11;IL2RB;GNGT2;DLL4;ADCY2;PTGS2;BDKRB2;ADCY9;PMAIP1;NOTCH4;SMAD3;BCL2;CHUK;IL3RA,531 (531),0.171,0.576,0,,26 (31),1,1,0.472,1
CXCR4-mediated signaling events,PID,15,BLK;PAK1;UBQLN1;BCAR1;CXCR4;CD3D;LIMK1;VAV1;GNAI1;INPP5D;FGR;ARRB2;GNG2;LCK;MMP9,86 (86),0.171,0.579,0,,4 (4),1,1,0.474,1
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,12,MGST1;UGT1A1;CYP2E1;GSTK1;CYP1A1;CYP1B1;CBR3;UGT1A5;UGT2A3;CYP2S1;DHDH;ADH4,76 (78),0.317,0.815,1,HMDB0060326,95 (121),0.542,1,0.475,1
Inositol phosphate metabolism - Homo sapiens (human),KEGG,13,PLCD3;PI4K2B;SYNJ2;PIK3C2G;ALDH6A1;ITPKC;INPP5D;PLCB4;PLCD1;PLCG2;PIP4K2A;ITPKA;INPP4B,73 (73),0.173,0.583,0,,25 (47),1,1,0.477,1
Lysine metabolism,EHMN,11,PIPOX;SHMT1;CERCAM;AASS;DLST;SLC25A21;ALDH7A1;NUP35;GCDH;AADAT;ALDH9A1,60 (60),0.173,0.583,0,,42 (53),1,1,0.477,1
folate transformations,HumanCyc,3,ALDH1L1;MTHFD1;SHMT1,11 (11),0.174,0.583,0,,21 (21),1,1,0.479,1
Dermatan sulfate biosynthesis,Reactome,3,CHST14;DSEL;VCAN,11 (11),0.174,0.583,0,,2 (2),1,1,0.479,1
Glycogen synthesis,Reactome,3,UGP2;GBE1;GYS2,11 (11),0.174,0.583,0,,9 (10),1,1,0.479,1
Signaling by activated point mutants of FGFR1,Reactome,3,FGFR1;FGF1;FGF2,11 (11),0.174,0.583,0,,3 (3),1,1,0.479,1
Gamma-carboxylation_ transport_ and amino-terminal cleavage of proteins,Reactome,3,PROZ;GAS6;F9,11 (11),0.174,0.583,0,,4 (6),1,1,0.479,1
Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human),KEGG,3,NQO1;HPD;TAT,11 (11),0.174,0.583,0,,29 (71),1,1,0.479,1
pertussis toxin-insensitive ccr5 signaling in macrophage,BioCarta,3,CCR5;CCL2;CXCR4,11 (11),0.174,0.583,0,,1 (2),1,1,0.479,1
Lactose Degradation,SMPDB,3,SLC2A2;SLC5A1;ATP1A2,11 (11),0.174,0.583,0,,8 (9),1,1,0.479,1
Lactose Intolerance,SMPDB,3,SLC2A2;SLC5A1;ATP1A2,11 (11),0.174,0.583,0,,8 (9),1,1,0.479,1
Cholinergic synapse - Homo sapiens (human),KEGG,19,GNB5;CREB3L3;ADCY4;GNG11;KCNQ1;ADCY2;CACNA1C;KCNQ4;CACNA1S;CAMK2A;CACNA1D;GNAI1;ADCY9;BCL2;GNGT2;KCNJ12;PLCB4;GNG2;ITPR3,113 (113),0.175,0.585,0,,11 (12),1,1,0.48,1
Inositol phosphate metabolism,INOH,8,PLCD3;SYNJ2;PLCB4;INPP4B;PLCG2;PIP4K2A;ITPKA;PLCD1,41 (41),0.176,0.585,0,,19 (25),1,1,0.481,1
PDGFR-beta signaling pathway,PID,21,BLK;SRF;PDGFB;DOK1;IQGAP1;GRB10;TAGLN;BCAR1;PDGFRB;KSR1;PAK1;ASB15;EPS8;WASF2;FGR;ABL1;SFN;ACTA2;LCK;ARHGAP35;SIPA1,127 (127),0.18,0.585,0,,6 (6),1,1,0.489,1
Arf6 signaling events,PID,7,HGF;ACAP1;IPCEF1;ARRB2;ARRB1;ADAP1;ADRB2,35 (35),0.181,0.585,0,,4 (4),1,1,0.49,1
toll-like receptor pathway,BioCarta,7,TLR4;IKBKG;MAP3K1;NFKBIA;PPARA;TLR9;CHUK,35 (35),0.181,0.585,0,,1 (1),1,1,0.49,1
Inwardly rectifying K+ channels,Reactome,7,GABBR2;GNG11;GNGT2;KCNJ10;KCNJ12;GNB5;GNG2,35 (35),0.181,0.585,0,,2 (2),1,1,0.49,1
Negative regulation of the PI3K/AKT network,Reactome,18,CD19;PDGFB;PDGFRA;NRG4;FGF1;KIT;HGF;PDGFRB;HBEGF;ERBB2;VAV1;FGFR1;EREG;GAB2;PIP4K2A;LCK;FGF2;KLB,107 (107),0.182,0.585,0,,8 (14),1,1,0.493,1
Myogenesis,Reactome,6,MAPK11;BOC;MEF2C;ABL1;CDON;MAPK12,29 (29),0.185,0.585,0,,3 (3),1,1,0.496,1
Acyl chain remodelling of PE,Reactome,6,PLA2G4E;LPCAT4;PLA2G6;PNPLA8;PLA2G4F;MBOAT1,29 (29),0.185,0.585,0,,5 (13),1,1,0.496,1
Regulation of Wnt-B-catenin Signaling by Small Molecule Compounds,Wikipathways,4,SFRP4;DKK3;MBOAT1;FZD8,17 (17),0.185,0.585,0,,2 (12),1,1,0.497,1
Simplified Depiction of MYD88 Distinct Input-Output Pathway,Wikipathways,4,TLR1;TLR9;TLR4;TLR5,17 (17),0.185,0.585,0,,1 (1),1,1,0.497,1
Heme degradation,Reactome,4,UGT1A1;ABCC2;ABCG2;ALB,17 (17),0.185,0.585,0,,18 (19),1,1,0.497,1
Signaling by NTRK1 (TRKA),Reactome,19,MAPK11;LYL1;NGF;ARC;EGR1;ID4;SRF;SGK1;MEF2C;EGR3;FOSB;NTRK2;RPS6KA2;DUSP4;DUSP7;RRAD;FOSL1;MAPK7;SHC2,114 (114),0.185,0.585,0,,10 (12),1,1,0.497,1
Thyroid hormones production and their peripheral downstream signaling effects,Wikipathways,13,DIO1;PRDM16;MAFA;MGLL;FGF21;FGFR1;PFKFB2;DUOXA2;IYD;SLC16A10;THRB;TBC1D4;KLB,74 (74),0.186,0.585,0,,17 (25),1,1,0.499,1
Digestion,Reactome,2,PIR;MGAM,22 (22),0.815,1,1,HMDB0000036,32 (42),0.229,1,0.5,1
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,9,MAPK11;MAPK13;IKBKG;CARD9;P2RX7;BCL2;PYCARD;CHUK;MAPK12,48 (48),0.187,0.585,0,,3 (7),1,1,0.5,1
Nicotinate Nicotinamide metabolism,INOH,5,ENPP1;BST1;QPRT;NNMT;NADSYN1,23 (23),0.187,0.585,0,,26 (26),1,1,0.5,1
TLR ECSIT MEKK1 p38,INOH,5,MAPK11;MAPK13;MAPK12;TLR4;MAP3K1,23 (23),0.187,0.585,0,,1 (1),1,1,0.5,1
Renin-angiotensin system - Homo sapiens (human),KEGG,5,ANPEP;CPA3;ACE;MME;CMA1,23 (23),0.187,0.585,0,,4 (11),1,1,0.5,1
Proximal tubule bicarbonate reclamation - Homo sapiens (human),KEGG,5,PCK1;GLUD1;ATP1A2;AQP1;SLC4A4,23 (23),0.187,0.585,0,,15 (17),1,1,0.5,1
Adrenaline_noradrenaline inhibits insulin secretion,Reactome,5,GNGT2;GNB5;GNAI1;GNG2;GNG11,23 (23),0.187,0.585,0,,4 (4),1,1,0.5,1
ccr3 signaling in eosinophils,BioCarta,5,LIMK1;MYL2;DECR1;PIK3C2G;CCL11,23 (23),0.187,0.585,0,,1 (1),1,1,0.5,1
eicosanoid metabolism,BioCarta,5,ALOX5;PTGES;PTGIR;PTGIS;EPHX2,23 (23),0.187,0.585,0,,8 (9),1,1,0.5,1
SCFA and skeletal muscle substrate metabolism,Wikipathways,2,PPARD;SLC2A4,6 (6),0.187,0.585,0,,3 (4),1,1,0.5,1
Mitochondrial fatty acid synthesis pathway,Wikipathways,2,HSD17B12;OXSM,6 (6),0.187,0.585,0,,8 (13),1,1,0.5,1
Fluoroacetic acid toxicity,Wikipathways,2,ALDH3A2;ALDH9A1,6 (6),0.187,0.585,0,,2 (6),1,1,0.5,1
methionine degradation,HumanCyc,2,AHCY;MAT1A,6 (6),0.187,0.585,0,,11 (11),1,1,0.5,1
Activation of TRKA receptors,Reactome,2,NTRK2;NGF,6 (6),0.187,0.585,0,,3 (3),1,1,0.5,1
Biosynthesis of EPA-derived SPMs,Reactome,2,ALOX5;PTGS2,6 (6),0.187,0.585,0,,13 (28),1,1,0.5,1
Mitochondrial Uncoupling,Reactome,2,UCP3;PM20D1,6 (6),0.187,0.585,0,,3 (7),1,1,0.5,1
Vitamin H (biotin) metabolism,EHMN,2,SLC25A15;SLC16A1,6 (6),0.187,0.585,0,,11 (11),1,1,0.5,1
Transport and synthesis of PAPS,Reactome,2,PAPSS2;SLC26A1,6 (6),0.187,0.585,0,,7 (7),1,1,0.5,1
VLDL clearance,Reactome,2,APOB;VLDLR,6 (6),0.187,0.585,0,,3 (4),1,1,0.5,1
Methionine salvage pathway,Reactome,2,ADI1;GOT1,6 (6),0.187,0.585,0,,11 (19),1,1,0.5,1
Conjugation of benzoate with glycine,Reactome,2,GLYAT;ACSM1,6 (6),0.187,0.585,0,,7 (8),1,1,0.5,1
selenocysteine biosynthesis,HumanCyc,2,SEPHS2;SEPSECS,6 (6),0.187,0.585,0,,9 (10),1,1,0.5,1
Phosphonate and phosphinate metabolism - Homo sapiens (human),KEGG,2,SELENOI;CHPT1,6 (6),0.187,0.585,0,,14 (56),1,1,0.5,1
Synthesis of Lipoxins (LX),Reactome,2,ALOX5;ALOX12,6 (6),0.187,0.585,0,,17 (20),1,1,0.5,1
leukotriene biosynthesis,HumanCyc,2,ALOX5;DPEP1,6 (6),0.187,0.585,0,,29 (30),1,1,0.5,1
mechanism of acetaminophen activity and toxicity,BioCarta,2,NR1I3;CYP2E1,6 (6),0.187,0.585,0,,3 (3),1,1,0.5,1
multi-drug resistance factors,BioCarta,2,ABCB4;ABCB11,6 (6),0.187,0.585,0,,2 (2),1,1,0.5,1
Lipid particle organization,Reactome,2,HILPDA;FITM2,6 (6),0.187,0.585,0,,2 (3),1,1,0.5,1
Glibenclamide Action Pathway,SMPDB,2,SLC2A2;CACNB1,6 (6),0.187,0.585,0,,4 (5),1,1,0.5,1
Gliclazide Action Pathway,SMPDB,2,SLC2A2;CACNB1,6 (6),0.187,0.585,0,,3 (5),1,1,0.5,1
Pancreas Function,SMPDB,2,SLC2A2;CACNB1,6 (6),0.187,0.585,0,,3 (4),1,1,0.5,1
Repaglinide Action Pathway,SMPDB,2,SLC2A2;CACNB1,6 (6),0.187,0.585,0,,4 (5),1,1,0.5,1
Nateglinide Action Pathway,SMPDB,2,SLC2A2;CACNB1,6 (6),0.187,0.585,0,,4 (5),1,1,0.5,1
Coregulation of Androgen receptor activity,PID,11,XRCC5;TGFB1I1;FHL2;KDM4C;NRIP1;SRF;HIP1;GSN;SVIL;ZMIZ1;NCOA4,61 (61),0.188,0.585,0,,2 (2),1,1,0.501,1
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,1,ACER2,9 (9),0.726,1,1,HMDB0002183,37 (59),0.26,1,0.504,1
Stabilization and expansion of the E-cadherin adherens junction,PID,8,MYO6;HGF;ZYX;VASP;KIFC3;IGF1R;MYL2;ENAH,42 (42),0.193,0.602,0,,3 (3),1,1,0.511,1
DAG and IP3 signaling,Reactome,8,ADCY9;PRKAR1B;PRKAR2A;ADCY2;CAMK2A;ADCY4;CAMKK1;ITPR3,42 (42),0.193,0.602,0,,10 (11),1,1,0.511,1
Retinol metabolism - Homo sapiens (human),KEGG,12,RDH16;UGT1A1;RETSAT;CYP1A1;UGT1A5;ALDH1A2;UGT2A3;CYP26A1;CYP2S1;CYP26B1;BCO1;ADH4,68 (68),0.194,0.603,0,,18 (25),1,1,0.512,1
Selenoamino acid metabolism,EHMN,7,CBS;FMO1;FMO2;FMO3;NUP35;FMO5;FMO4,36 (36),0.2,0.621,0,,31 (38),1,1,0.522,1
African trypanosomiasis - Homo sapiens (human),KEGG,7,IL1B;LAMA4;F2RL1;IDO2;KNG1;PLCB4;TLR9,36 (37),0.2,0.621,0,,8 (8),1,1,0.522,1
GPCR Adenosine A2A receptor,INOH,7,ADCY9;PRKAR1B;PRKAR2A;GNGT2;ADCY2;ADCY4;GNB5,36 (36),0.2,0.621,0,,4 (4),1,1,0.522,1
p53 signaling pathway - Homo sapiens (human),KEGG,10,PERP;EI24;SESN3;SESN1;THBS1;SESN2;BCL2;PMAIP1;SFN;TNFRSF10B,73 (73),0.523,1,0,,0 (0),1,1,0.523,1
Notch,NetPath,8,FHL1;MAML1;DTX1;MFNG;LFNG;NOTCH4;RBPJ;APP,58 (58),0.524,1,0,,0 (0),1,1,0.524,1
Longevity regulating pathway - multiple species - Homo sapiens (human),KEGG,11,CRYAB;ADCY9;HSPA1A;HSPA1B;HSPA1L;ADCY2;CAT;ADCY4;IGF1R;PRKAA2;PRKAG2,62 (62),0.202,0.627,0,,2 (2),1,1,0.526,1
Calcineurin-regulated NFAT-dependent transcription in lymphocytes,PID,9,RNF128;EGR1;EGR3;PTGS2;PRKCQ;CTLA4;FOSL1;MAF;NFATC2,49 (49),0.203,0.629,0,,1 (1),1,1,0.527,1
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,1,CDA,17 (17),0.914,1,1,HMDB0000273,31 (31),0.223,1,0.527,1
Reelin signaling pathway,PID,4,MAP1B;ITGA3;VLDLR;ARHGEF2,28 (28),0.528,1,0,,0 (0),1,1,0.528,1
IL3-mediated signaling events,PID,4,CNKSR1;INPP5D;IL3RA;GAB2,28 (28),0.528,1,0,,0 (0),1,1,0.528,1
influence of ras and rho proteins on g1 to s transition,BioCarta,4,NFKBIA;PAK1;CHUK;IKBKG,28 (28),0.528,1,0,,0 (0),1,1,0.528,1
The role of Nef in HIV-1 replication and disease pathogenesis,Reactome,4,AP1S2;PACS1;LCK;AP1M2,28 (28),0.528,1,0,,0 (1),1,1,0.528,1
Biochemical Pathways Part I,Wikipathways,0,,0 (0),1,1,4,HMDB0000036;HMDB0000128;HMDB0000273;HMDB0001290,465 (469),0.53,1,0.53,1
Citrate cycle (TCA cycle) - Homo sapiens (human),KEGG,6,SUCLG2;SUCLG1;DLST;ACO1;PCK1;IDH1,30 (30),0.206,0.637,0,,17 (20),1,1,0.532,1
-arrestins in gpcr desensitization,BioCarta,6,CXCR4;CCR5;CCL11;ARRB1;PPARA;ADRB2,30 (30),0.206,0.637,0,,3 (4),1,1,0.532,1
Fructose Mannose metabolism,INOH,6,ALDOA;ALDOB;PFKFB1;PFKFB2;PFKFB4;SORD,30 (30),0.206,0.637,0,,28 (33),1,1,0.532,1
PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human),KEGG,15,LAT;MAPK11;IFNGR1;NFATC2;LCK;TLR4;MAPK13;CD3D;PRKCQ;MAP3K3;NFKBIA;TLR9;CHUK;MAPK12;IKBKG,89 (89),0.207,0.64,0,,4 (4),1,1,0.534,1
EDA signaling in hair follicle development,Wikipathways,2,LTB;RELB,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
Transcriptional cascade regulating adipogenesis,Wikipathways,2,GATA2;KLF5,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
Development of pulmonary dendritic cells and macrophage subsets,Wikipathways,2,SPI1;IRF8,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
BMAL1:CLOCK_NPAS2 activates circadian gene expression,Reactome,2,PPARA;BHLHE41,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
Non-homologous end-joining - Homo sapiens (human),KEGG,2,XRCC5;RAD50,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
p53 signaling pathway,BioCarta,2,BCL2;TIMP3,13 (13),0.536,1,0,,0 (0),1,1,0.536,1
Toll-like Receptor Cascades,Reactome,21,MAPK11;CHUK;ITGAM;IKBKG;RIPK3;ITGB2;MAP3K1;MEF2C;TLR1;APOB;FGA;RPS6KA2;DUSP4;DUSP7;NFKBIA;FGB;TLR9;TLR4;TLR5;FGG;MAPK7,130 (130),0.21,0.643,0,,10 (31),1,1,0.538,1
Androgen receptor signaling pathway,Wikipathways,12,TGFB1I1;FHL2;PLPP1;ETV5;KAT7;FLNA;SMAD3;CAV1;ZMIZ1;BMF;PAK6;NCOA4,89 (89),0.539,1,0,,0 (0),1,1,0.539,1
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,3,HMGCS2;IDI1;ACAT1,12 (12),0.211,0.643,0,,20 (21),1,1,0.539,1
Pre-NOTCH Processing in Golgi,Reactome,3,MFNG;LFNG;NOTCH4,12 (12),0.211,0.643,0,,5 (5),1,1,0.539,1
Early Phase of HIV Life Cycle,Reactome,3,XRCC5;CCR5;CXCR4,12 (12),0.211,0.643,0,,1 (5),1,1,0.539,1
FGFR1c ligand binding and activation,Reactome,3,FGFR1;FGF1;FGF2,12 (12),0.211,0.643,0,,3 (3),1,1,0.539,1
Trehalose Degradation,SMPDB,3,SLC2A2;SLC5A1;ATP1A2,12 (12),0.211,0.643,0,,10 (10),1,1,0.539,1
Eicosanoids,Reactome,3,CYP4B1;PTGIS;CYP8B1,12 (12),0.211,0.643,0,,10 (13),1,1,0.539,1
Regulation of glycolysis by fructose 2_6-bisphosphate metabolism,Reactome,3,PFKFB2;PFKFB4;PFKFB1,12 (12),0.211,0.643,0,,6 (6),1,1,0.539,1
PECAM1 interactions,Reactome,3,INPP5D;LCK;PECAM1,12 (12),0.211,0.643,0,,2 (2),1,1,0.539,1
ERKs are inactivated,Reactome,3,DUSP7;DUSP4;MAPK7,12 (12),0.211,0.643,0,,2 (2),1,1,0.539,1
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,3,CYP17A1;SRD5A1;AKR1D1,12 (12),0.211,0.643,0,,32 (32),1,1,0.539,1
Tandem pore domain potassium channels,Reactome,3,KCNK6;KCNK13;KCNK1,12 (12),0.211,0.643,0,,1 (1),1,1,0.539,1
Androgen and Estrogen Metabolism,SMPDB,3,CYP17A1;SRD5A1;AKR1D1,12 (12),0.211,0.643,0,,32 (32),1,1,0.539,1
Aromatase deficiency,SMPDB,3,CYP17A1;SRD5A1;AKR1D1,12 (12),0.211,0.643,0,,32 (32),1,1,0.539,1
FGF signaling pathway,PID,10,IL17RD;FGF1;FGF2;SPP1;HGF;SDC2;FGFR1;CAMK2A;MMP9;KLB,56 (56),0.211,0.643,0,,3 (4),1,1,0.54,1
t cell receptor signaling pathway,BioCarta,10,LAT;ARHGAP1;ARHGAP4;NCF2;VAV1;PTPN7;CD3D;MAP3K1;NFKBIA;LCK,56 (56),0.211,0.643,0,,3 (5),1,1,0.54,1
Pathogenic Escherichia coli infection,Wikipathways,10,TUBB1;TUBA1A;ACTG1;CLDN1;TUBB2B;ABL1;TLR4;TLR5;ARHGEF2;WAS,56 (56),0.211,0.643,0,,1 (1),1,1,0.54,1
Sphingolipid Metabolism (integrated pathway),Wikipathways,5,CERS5;CERS4;CERS2;CERK;SGMS1,24 (24),0.212,0.643,0,,7 (10),1,1,0.54,1
Fas ligand pathway and stress induction of heat shock proteins,Wikipathways,8,LMNB1;PAK1;ACTG1;ARHGDIB;HSPB1;BCL2;MAP3K1;ACTA1,43 (43),0.212,0.643,0,,4 (4),1,1,0.54,1
RND2 GTPase cycle,Reactome,8,ALDH3A2;ARHGAP1;DLG5;KIF14;CAV1;PLXND1;CKAP4;ARHGAP35,43 (43),0.212,0.643,0,,1 (1),1,1,0.54,1
Chronic myeloid leukemia - Homo sapiens (human),KEGG,13,TGFB2;TGFB3;IKBKG;TGFBR2;BAK1;CTBP2;SMAD3;GAB2;NFKBIA;ABL1;CHUK;RUNX1;SHC2,76 (76),0.213,0.645,0,,1 (1),1,1,0.542,1
Pertussis - Homo sapiens (human),KEGG,13,MAPK11;IL1B;IRF8;MAPK13;ITGAM;CXCL5;ITGB2;C3;GNAI1;PYCARD;TLR4;MAPK12;ITGA5,76 (76),0.213,0.645,0,,7 (10),1,1,0.542,1
Gastric acid secretion - Homo sapiens (human),KEGG,13,ADCY9;MYLK2;ACTG1;KCNQ1;ADCY2;CAMK2A;GNAI1;ADCY4;PLCB4;KCNJ10;ATP1A2;ITPR3;MYLK3,76 (76),0.213,0.645,0,,13 (14),1,1,0.542,1
G alpha (q) signalling events,Reactome,29,DAGLB;PROK2;ADRA1A;RGS19;P2RY6;AVPR1A;HBEGF;RPS6KA2;GNB5;NTS;GNG2;ABHD6;P2RY10;MGLL;PRKCQ;PRKCH;MAPK7;APP;ARHGEF25;F2RL1;GNG11;GNGT2;DAGLA;RGS3;BDKRB2;KNG1;PLCB4;FFAR4;ITPR3,221 (221),0.58,1,1,HMDB0002183,56 (64),0.367,1,0.542,1
Estrogen metabolism,Wikipathways,4,NQO1;CYP1B1;UGT1A1;CYP1A1,18 (18),0.214,0.646,0,,19 (23),1,1,0.544,1
Proteoglycan biosynthesis,Wikipathways,4,CHSY1;PAPSS2;CHST3;CHST14,18 (18),0.214,0.646,0,,13 (17),1,1,0.544,1
Activation of NF-kappaB in B cells,Reactome,4,NFKBIA;CARD11;CHUK;IKBKG,18 (18),0.214,0.646,0,,4 (5),1,1,0.544,1
Fructose intolerance_ hereditary,SMPDB,4,ALDOA;SORD;ALDOB;PFKFB1,18 (18),0.214,0.646,0,,28 (31),1,1,0.544,1
LDL clearance,Reactome,4,NPC1;NCEH1;APOB;LIPA,18 (18),0.214,0.646,0,,5 (9),1,1,0.544,1
Fructose and Mannose Degradation,SMPDB,4,ALDOA;SORD;ALDOB;PFKFB1,18 (18),0.214,0.646,0,,28 (31),1,1,0.544,1
Tie2 Signaling,Reactome,4,GRB14;TEK;ANGPT1;DOK2,18 (18),0.214,0.646,0,,4 (4),1,1,0.544,1
Norepinephrine Neurotransmitter Release Cycle,Reactome,4,STXBP1;PPFIA2;SLC22A1;SYT1,18 (18),0.214,0.646,0,,8 (8),1,1,0.544,1
Fructosuria,SMPDB,4,ALDOA;SORD;ALDOB;PFKFB1,18 (18),0.214,0.646,0,,28 (31),1,1,0.544,1
G beta:gamma signalling through BTK,Reactome,4,GNB5;GNGT2;GNG2;GNG11,18 (18),0.214,0.646,0,,1 (1),1,1,0.544,1
GPCR ligand binding,Reactome,58,FZD4;PROK2;FZD8;FZD9;ADORA2B;CCR2;CXCR3;PXMP2;ADRA1A;RAMP2;CYP26B1;ADRB2;CXCL2;ADORA1;P2RY4;CXCR6;AVPR1A;GPR35;CXCR4;ACKR3;WNT7B;WNT11;NTS;PENK;WNT9B;CXCL13;CD55;P2RY10;P2RY6;SCTR;GPR55;CCL2;C3;C3AR1;ADGRE5;CCR5;CCL11;S1PR2;ACKR2;GNB5;CMKLR1;APP;GABBR2;GNG2;CXCL5;F2RL1;GNG11;CX3CL1;CXCL3;PTGIR;C5AR1;BDKRB2;PTH1R;KNG1;CNR2;GNGT2;S1PR4;FFAR4,476 (476),0.805,1,2,HMDB0034927;HMDB0002183,125 (168),0.266,1,0.545,1
LncRNA involvement in canonical Wnt signaling and colorectal cancer,Wikipathways,13,CTBP2;FZD8;FZD9;CSNK1E;CHD8;ROR2;ATF3;WNT7B;SFRP1;WNT11;SFRP4;SFRP5;FOSL1,97 (97),0.546,1,0,,0 (0),1,1,0.546,1
Pyrimidine metabolism - Homo sapiens (human),KEGG,7,UPP2;DPYD;DPYS;CDA;UPB1;ENPP1;ENTPD5,57 (57),0.657,1,1,HMDB0000273,49 (65),0.329,1,0.548,1
Galanin receptor pathway,Wikipathways,3,KRT19;CRP;SLC2A4,21 (21),0.548,1,0,,0 (0),1,1,0.548,1
the co-stimulatory signal during t-cell activation,BioCarta,3,CD3D;LCK;CTLA4,21 (21),0.548,1,0,,0 (0),1,1,0.548,1
Fatty acyl-CoA biosynthesis,Reactome,7,ELOVL5;ACSL1;HACD3;HSD17B12;ACSF3;ELOVL2;ELOVL7,37 (37),0.22,0.659,0,,29 (42),1,1,0.554,1
Hedgehog _on_ state,Reactome,7,BOC;HHIP;EVC2;ARRB2;ARRB1;CDON;GAS1,37 (37),0.22,0.659,0,,2 (2),1,1,0.554,1
Calmodulin induced events,Reactome,7,ADCY9;PRKAR1B;PRKAR2A;ADCY2;CAMK2A;ADCY4;CAMKK1,37 (37),0.22,0.659,0,,8 (8),1,1,0.554,1
CaM pathway,Reactome,7,ADCY9;PRKAR1B;PRKAR2A;ADCY2;CAMK2A;ADCY4;CAMKK1,37 (37),0.22,0.659,0,,8 (8),1,1,0.554,1
trefoil factors initiate mucosal healing,BioCarta,7,GHR;IKBKG;ERBB2;TFF1;NFKBIA;TFF3;CHUK,37 (37),0.22,0.659,0,,2 (2),1,1,0.554,1
RHOH GTPase cycle,Reactome,7,PAK1;PAK6;ARHGDIB;SLC1A5;CAV1;LCK;DBT,37 (37),0.22,0.659,0,,1 (1),1,1,0.554,1
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,21,MAPK11;ABCG8;PIK3C2G;MAPK13;SESN3;SLC16A2;MAP3K6;THRB;CYP7A1;MAP4K1;PRKAG2;PCK1;SLC2A4;MAP3K1;MAP3K3;RPS6KA2;PRKAA2;MAPK12;ABCG5;MAPK7;SHC2,131 (131),0.221,0.659,0,,5 (9),1,1,0.554,1
FoxO signaling pathway - Homo sapiens (human),KEGG,21,MAPK11;TGFB2;TGFB3;IGF1R;SGK2;PCK1;CDKN2D;SMAD3;SGK1;CAT;PLK2;TGFBR2;MAPK13;SLC2A4;CSNK1E;BNIP3;S1PR4;CHUK;MAPK12;PRKAA2;PRKAG2,131 (131),0.221,0.659,0,,4 (5),1,1,0.554,1
Prostate cancer - Homo sapiens (human),KEGG,16,PDGFB;SPINT1;IKBKG;CREB3L3;ETV5;PDGFRB;ERBB2;IGF1R;BCL2;MMP9;PDGFD;NFKBIA;FGFR1;CHUK;ERG;PDGFRA,97 (97),0.223,0.666,0,,11 (11),1,1,0.557,1
Phagosome - Homo sapiens (human),KEGG,20,C3;MSR1;TUBB1;ITGAM;FCGR2B;TUBA1A;ACTG1;ITGB2;MARCO;MRC2;CORO1A;NCF2;THBS1;TUBB2B;RAB7B;SCARB1;ATP6V0E2;TLR4;ITGA5;COMP,151 (152),0.56,1,0,,0 (1),1,1,0.56,1
Type II interferon signaling (IFNG),Wikipathways,5,SPI1;IL1B;IRF8;IFNGR1;CIITA,37 (37),0.565,1,0,,0 (0),1,1,0.565,1
Ethanol effects on histone modifications,Wikipathways,6,CYP2E1;HDAC7;MAT1A;ALDH1A2;DHFR;AHCY,31 (31),0.229,0.681,0,,16 (21),1,1,0.567,1
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,BioCarta,6,ZYX;GSN;ACTN2;ACTN3;ACTA1;BCAR1,31 (31),0.229,0.681,0,,1 (1),1,1,0.567,1
activation of camp-dependent protein kinase pka,BioCarta,6,PRKAR1B;PRKAR2A;CXCR4;CCR5;CCL11;ADRB2,31 (31),0.229,0.681,0,,5 (6),1,1,0.567,1
Adherens junctions interactions,Reactome,6,CDH3;CDH5;CDH11;CDH13;CDH17;PVR,31 (31),0.229,0.681,0,,1 (2),1,1,0.567,1
MAPK targets/ Nuclear events mediated by MAP kinases,Reactome,6,MAPK11;MEF2C;RPS6KA2;DUSP4;DUSP7;MAPK7,31 (31),0.229,0.681,0,,4 (4),1,1,0.567,1
Activated NOTCH1 Transmits Signal to the Nucleus,Reactome,6,ADAM10;DLL4;DTX1;ARRB1;ARRB2;NEURL1B,31 (31),0.229,0.681,0,,1 (1),1,1,0.567,1
C-type lectin receptors (CLRs),Reactome,14,IL1B;PAK1;IKBKG;MUC1;PAK3;CARD9;NFKBIA;PLCG2;RELB;PYCARD;ICAM2;CHUK;ITPR3;NFATC2,84 (84),0.23,0.684,0,,12 (18),1,1,0.568,1
Prostaglandin Synthesis and Regulation,Wikipathways,8,PTGES;PTGFRN;PTGIR;PTGIS;ANXA2;PTGS2;ABCC4;ANXA3,44 (44),0.231,0.684,0,,10 (12),1,1,0.569,1
G Protein Signaling Pathways,Wikipathways,15,AKAP6;PRKD3;GNG11;ADCY4;GNGT2;PRKAR1B;ADCY2;PRKCH;PRKAR2A;GNAI1;ADCY9;PRKCQ;PDE4B;PDE4D;GNB5,91 (91),0.233,0.689,0,,4 (4),1,1,0.573,1
Class B/2 (Secretin family receptors),Reactome,15,FZD4;CD55;FZD8;FZD9;GNG11;SCTR;GNGT2;ADGRE5;PTH1R;WNT7B;WNT11;GNB5;RAMP2;GNG2;WNT9B,91 (91),0.233,0.689,0,,2 (2),1,1,0.573,1
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Reactome,15,MAPK11;TLR4;FGB;IKBKG;MEF2C;TLR1;FGA;RPS6KA2;DUSP4;NFKBIA;DUSP7;FGG;CHUK;MAP3K1;MAPK7,91 (91),0.233,0.689,0,,6 (14),1,1,0.573,1
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,15,MAPK11;TLR4;FGB;IKBKG;MEF2C;TLR1;FGA;RPS6KA2;DUSP4;NFKBIA;DUSP7;FGG;CHUK;MAP3K1;MAPK7,91 (91),0.233,0.689,0,,6 (14),1,1,0.573,1
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,15,MAPK11;TLR4;FGB;IKBKG;MEF2C;TLR1;FGA;RPS6KA2;DUSP4;NFKBIA;DUSP7;FGG;CHUK;MAP3K1;MAPK7,91 (91),0.233,0.689,0,,6 (14),1,1,0.573,1
Toll Like Receptor 2 (TLR2) Cascade,Reactome,15,MAPK11;TLR4;FGB;IKBKG;MEF2C;TLR1;FGA;RPS6KA2;DUSP4;NFKBIA;DUSP7;FGG;CHUK;MAP3K1;MAPK7,91 (91),0.233,0.689,0,,6 (14),1,1,0.573,1
Pyrimidine metabolism,Wikipathways,7,DPYD;DPYS;CDA;UPB1;POLR2A;POLR2D;ENPP1,84 (84),0.945,1,1,HMDB0000273,35 (40),0.248,1,0.574,1
cAMP signaling pathway - Homo sapiens (human),KEGG,33,ADORA1;CACNA1C;CACNA1D;CACNA1S;HHIP;ABCC4;ADCY4;PDE3B;PDE4B;PDE4D;ADRB2;ARAP3;RAPGEF3;CAMK2A;ACOX1;NFKBIA;RAPGEF4;GABBR2;PAK1;GNAI1;PPARA;CREB3L3;ATP1A2;PDE10A;PDE3A;NPR1;ATP2A3;ATP2A1;ADCY2;ATP2B4;VAV1;ADCY9;ACOX3,216 (216),0.234,0.692,0,,22 (25),1,1,0.574,1
Prolactin Signaling Pathway,Wikipathways,10,PAK1;SOCS2;FLNA;ERBB2;VAV1;PRLR;RPS6KA2;SIRPA;GAB2;NFKBIA,76 (76),0.576,1,0,,0 (0),1,1,0.576,1
Somatic sex determination,Wikipathways,2,GATA4;WT1,14 (14),0.578,1,0,,0 (0),1,1,0.578,1
akap95 role in mitosis and chromosome dynamics,BioCarta,2,PRKAR2A;NCAPD2,14 (14),0.578,1,0,,0 (0),1,1,0.578,1
lck and fyn tyrosine kinases in initiation of tcr activation,BioCarta,2,CD3D;LCK,14 (14),0.578,1,0,,0 (0),1,1,0.578,1
il 2 signaling pathway,BioCarta,2,IL2RB;LCK,14 (14),0.578,1,0,,0 (0),1,1,0.578,1
exRNA mechanism of action and biogenesis,Wikipathways,1,DROSHA,6 (6),0.578,1,0,,0 (1),1,1,0.578,1
mir-124 predicted interactions with cell cycle and differentiation,Wikipathways,1,STRADB,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
Somatroph axis (GH) and its relationship to dietary restriction and aging,Wikipathways,1,IGF1R,6 (6),0.578,1,0,,0 (1),1,1,0.578,1
MED and Pseudoachondroplasia genes,Wikipathways,1,COMP,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
Robo4 and VEGF Signaling Pathways Crosstalk,Wikipathways,1,KDR,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
TLR3-mediated TICAM1-dependent programmed cell death,Reactome,1,RIPK3,6 (6),0.578,1,0,,0 (2),1,1,0.578,1
Regulation of ornithine decarboxylase (ODC),Reactome,1,NQO1,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
IFN gamma signaling,INOH,1,IFNGR1,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
Activation of C3 and C5,Reactome,1,C3,6 (6),0.578,1,0,,0 (2),1,1,0.578,1
proteolysis and signaling pathway of notch,BioCarta,1,RBPJ,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
d4gdi signaling pathway,BioCarta,1,ARHGDIB,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
Vasopressin-like receptors,Reactome,1,AVPR1A,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
TNFR1-mediated ceramide production,Reactome,1,SMPD3,6 (6),0.578,1,0,,0 (0),1,1,0.578,1
gluconeogenesis,HumanCyc,5,PGAM2;PCK1;ALDOA;ENO3;ALDOB,25 (26),0.237,0.696,0,,22 (26),1,1,0.579,1
Cytosolic sulfonation of small molecules,Reactome,5,PODXL2;BPNT1;SULT1B1;PAPSS2;SLC26A1,25 (25),0.237,0.696,0,,35 (47),1,1,0.579,1
Toll Like Receptor 4 (TLR4) Cascade,Reactome,18,MAPK11;CHUK;ITGAM;IKBKG;RIPK3;ITGB2;MEF2C;TLR1;FGA;RPS6KA2;DUSP4;DUSP7;NFKBIA;FGB;FGG;TLR4;MAP3K1;MAPK7,112 (112),0.239,0.696,0,,6 (14),1,1,0.581,1
IGF-Core,Signalink,3,IGF1R;SOCS2;GRAP,22 (22),0.581,1,0,,0 (0),1,1,0.581,1
Glycolysis in senescence,Wikipathways,2,LDHA;PKM,7 (7),0.239,0.696,0,,3 (7),1,1,0.581,1
phosphatidylethanolamine biosynthesis II,HumanCyc,2,ETNK2;SELENOI,7 (7),0.239,0.696,0,,11 (12),1,1,0.581,1
dopamine degradation,HumanCyc,2,ALDH3A2;MAOB,7 (7),0.239,0.696,0,,17 (17),1,1,0.581,1
serine and glycine biosynthesis,HumanCyc,2,SRR;SHMT1,7 (7),0.239,0.696,0,,15 (15),1,1,0.581,1
Neurofascin interactions,Reactome,2,CNTNAP1;ANK1,7 (7),0.239,0.696,0,,2 (3),1,1,0.581,1
inositol pyrophosphates biosynthesis,HumanCyc,2,PPIP5K1;PPIP5K2,7 (7),0.239,0.696,0,,7 (10),1,1,0.581,1
LTC4-CYSLTR mediated IL4 production,Reactome,2,DPEP1;GGT1,7 (7),0.239,0.696,0,,7 (7),1,1,0.581,1
Glycerophospholipid catabolism,Reactome,2,GDPD5;GDPD1,7 (7),0.239,0.696,0,,6 (11),1,1,0.581,1
metabolism of anandamide an endogenous cannabinoid,BioCarta,2,BAAT;CNR2,7 (7),0.239,0.696,0,,5 (6),1,1,0.581,1
androgen biosynthesis,HumanCyc,2,CYP17A1;SRD5A1,7 (7),0.239,0.696,0,,14 (15),1,1,0.581,1
Tramadol Metabolism Pathway,SMPDB,2,ABCC2;SLC22A1,7 (7),0.239,0.696,0,,12 (12),1,1,0.581,1
Neurotrophin signaling pathway - Homo sapiens (human),KEGG,19,MAPK11;NGF;NGFR;BEX3;SH2B2;MAPK13;ARHGDIB;CAMK2A;PLCG2;NTRK2;BCL2;MAP3K1;MAP3K3;NFKBIA;ABL1;SHC2;MAPK12;MAPK7;RPS6KA2,119 (119),0.24,0.698,0,,5 (5),1,1,0.583,1
Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,1,GABBR2,40 (40),0.997,1,1,HMDB0034927,34 (54),0.242,1,0.584,1
Notch Signaling Pathway Netpath,Wikipathways,8,FHL1;MAML1;NUMBL;DLL4;RBPJ;DTX1;NOTCH4;LCK,61 (61),0.584,1,0,,0 (0),1,1,0.584,1
CXCR3-mediated signaling events,PID,7,MAPK11;CXCL13;CXCR3;GNAI1;CCL11;ARRB1;GNG2,38 (38),0.241,0.699,0,,3 (3),1,1,0.584,1
Wnt,NetPath,9,FZD4;NFATC2;FZD9;CSNK1E;SFRP1;SMAD1;ROR2;ARRB2;FZD8,69 (69),0.589,1,0,,0 (0),1,1,0.589,1
Small Ligand GPCRs,Wikipathways,4,S1PR4;PTGIR;CNR2;S1PR2,19 (19),0.245,0.699,0,,1 (3),1,1,0.589,1
Phase 4 - resting membrane potential,Reactome,4,KCNJ12;KCNK6;KCNK13;KCNK1,19 (19),0.245,0.699,0,,1 (1),1,1,0.589,1
CD209 (DC-SIGN) signaling,Reactome,4,ICAM2;PAK1;RELB;PAK3,19 (19),0.245,0.699,0,,6 (7),1,1,0.589,1
TCA cycle,HumanCyc,4,ACO1;SUCLG2;SUCLG1;DLST,19 (19),0.245,0.699,0,,23 (23),1,1,0.589,1
Globo Sphingolipid Metabolism,Wikipathways,4,ST3GAL2;ST6GALNAC4;A4GALT;FUT2,19 (19),0.245,0.699,0,,3 (3),1,1,0.589,1
mBDNF and proBDNF regulation of GABA neurotransmission,Wikipathways,5,GABRP;GABRA3;GABRB3;NTRK2;NGFR,38 (38),0.59,1,0,,0 (0),1,1,0.59,1
VEGFA-VEGFR2 Pathway,Reactome,15,MAPK11;PAK1;PAK3;CDH5;NOS3;KDR;NCF2;VAV1;WASF2;SH2D2A;CAV1;WASF3;BCAR1;ITPR3;SHC2,92 (92),0.246,0.699,0,,25 (26),1,1,0.592,1
Metabolism of RNA,Reactome,24,TRMT9B;IGF2BP2;A1CF;NDC1;POM121;MAGOHB;GEMIN2;RPP40;POLR2A;POLR2D;TPRKB;SMG9;GEMIN5;HSD17B10;MAPK11;MTERF4;HSPA1A;HSPA1B;RPL3L;ADARB1;HSPB1;NUP35;TRDMT1;XPOT,583 (584),1,1,1,HMDB0001107,35 (77),0.248,1,0.593,1
the visual cycle I (vertebrates),HumanCyc,0,,16 (16),1,1,1,HMDB0002183,35 (58),0.248,1,0.593,1
Bacterial invasion of epithelial cells - Homo sapiens (human),KEGG,10,ACTG1;ARHGAP10;WASF2;ELMO3;CAV1;CAV2;FN1;BCAR1;ITGA5;SHC2,77 (77),0.594,1,0,,0 (0),1,1,0.594,1
Dopamine metabolism,Wikipathways,3,NQO1;MAOB;DDC,13 (13),0.248,0.699,0,,29 (33),1,1,0.594,1
Cell-type Dependent Selectivity of CCK2R Signaling,Wikipathways,3,GNAI1;DAGLA;RYR1,13 (13),0.248,0.699,0,,3 (7),1,1,0.594,1
NO metabolism in cystic fibrosis,Wikipathways,3,DDAH1;DDAH2;NOS3,13 (13),0.248,0.699,0,,5 (9),1,1,0.594,1
Activation of RAC1,Reactome,3,PAK1;PAK6;PAK3,13 (13),0.248,0.699,0,,2 (2),1,1,0.594,1
Organic cation/anion/zwitterion transport,Reactome,3,SLC22A5;SLC22A18;SLC22A1,13 (13),0.248,0.699,0,,30 (35),1,1,0.594,1
noradrenaline and adrenaline degradation,HumanCyc,3,ALDH3A2;MAOB;ADH4,13 (13),0.248,0.699,0,,20 (20),1,1,0.594,1
FGFR3c ligand binding and activation,Reactome,3,GALNT3;FGF1;FGF2,13 (13),0.248,0.699,0,,5 (5),1,1,0.594,1
FGFR3 ligand binding and activation,Reactome,3,GALNT3;FGF1;FGF2,13 (13),0.248,0.699,0,,5 (5),1,1,0.594,1
Assembly of active LPL and LIPC lipase complexes,Reactome,3,ANGPTL3;CREB3L3;PCSK6,13 (13),0.248,0.699,0,,3 (6),1,1,0.594,1
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,3,ALDH1L1;MTHFD1;DHFR,13 (13),0.248,0.699,0,,28 (28),1,1,0.594,1
Folate malabsorption_ hereditary,SMPDB,3,ALDH1L1;MTHFD1;DHFR,13 (13),0.248,0.699,0,,28 (28),1,1,0.594,1
Methotrexate Action Pathway,SMPDB,3,ALDH1L1;MTHFD1;DHFR,13 (13),0.248,0.699,0,,29 (29),1,1,0.594,1
Folate Metabolism,SMPDB,3,ALDH1L1;MTHFD1;DHFR,13 (13),0.248,0.699,0,,28 (28),1,1,0.594,1
NF-kB is activated and signals survival,Reactome,3,NFKBIA;NGF;NGFR,13 (13),0.248,0.699,0,,2 (2),1,1,0.594,1
ErbB1 downstream signaling,PID,17,SRF;CHN2;IQGAP1;EGR1;MYLPF;RIN1;EPS8;KSR1;MAP3K1;MEF2C;WASF2;SMAD1;SH2D2A;DUSP1;SFN;ASB15;MAPK7,106 (106),0.25,0.699,0,,7 (7),1,1,0.596,1
Integrin-linked kinase signaling,PID,8,PPP1R14A;ARHGEF7;ZYX;ARHGEF6;PARVB;SNAI1;IQGAP1;PPP1R14C,45 (45),0.25,0.699,0,,3 (3),1,1,0.597,1
Felbamate Metabolism,Wikipathways,1,CYP2E1,2 (2),0.25,0.699,0,,4 (4),1,1,0.597,1
Disorders of Folate Metabolism and Transport,Wikipathways,1,MTHFD1,2 (2),0.25,0.699,0,,23 (26),1,1,0.597,1
purine deoxyribonucleosides degradation,HumanCyc,1,ADA,2 (2),0.25,0.699,0,,9 (10),1,1,0.597,1
TRKA activation by NGF,Reactome,1,NGF,2 (2),0.25,0.699,0,,2 (2),1,1,0.597,1
Biosynthesis of DPAn-3-derived protectins and resolvins,Reactome,1,ALOX5,2 (2),0.25,0.699,0,,5 (16),1,1,0.597,1
NTF4 activates NTRK2 (TRKB) signaling,Reactome,1,NTRK2,2 (2),0.25,0.699,0,,2 (2),1,1,0.597,1
Transport of glycerol from adipocytes to the liver by Aquaporins,Reactome,1,AQP9,2 (2),0.25,0.699,0,,1 (1),1,1,0.597,1
glycerol-3-phosphate shuttle,HumanCyc,1,GPD1,2 (2),0.25,0.699,0,,8 (9),1,1,0.597,1
Fructose biosynthesis,Reactome,1,SORD,2 (2),0.25,0.699,0,,8 (10),1,1,0.597,1
Biosynthesis of DPAn-6 SPMs,Reactome,1,ALOX12,2 (2),0.25,0.699,0,,3 (7),1,1,0.597,1
BDNF activates NTRK2 (TRKB) signaling,Reactome,1,NTRK2,2 (2),0.25,0.699,0,,2 (2),1,1,0.597,1
Signalling to ERK5,Reactome,1,MAPK7,2 (2),0.25,0.699,0,,2 (2),1,1,0.597,1
Pyrophosphate hydrolysis,Reactome,1,PPA1,2 (2),0.25,0.699,0,,3 (3),1,1,0.597,1
glycine/serine biosynthesis,HumanCyc,1,SHMT1,2 (2),0.25,0.699,0,,5 (5),1,1,0.597,1
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Reactome,1,MAOB,2 (2),0.25,0.699,0,,11 (11),1,1,0.597,1
histamine degradation,HumanCyc,1,HNMT,2 (2),0.25,0.699,0,,13 (13),1,1,0.597,1
C6 deamination of adenosine,Reactome,1,ADARB1,2 (2),0.25,0.699,0,,2 (4),1,1,0.597,1
mRNA Editing: A to I Conversion,Reactome,1,ADARB1,2 (2),0.25,0.699,0,,2 (4),1,1,0.597,1
NAD phosphorylation and dephosphorylation,HumanCyc,1,NNT,2 (2),0.25,0.699,0,,7 (7),1,1,0.597,1
Conjugation of phenylacetate with glutamine,Reactome,1,ACSM1,2 (2),0.25,0.699,0,,7 (9),1,1,0.597,1
PDE3B signalling,Reactome,1,PDE3B,2 (2),0.25,0.699,0,,6 (6),1,1,0.597,1
PKB-mediated events,Reactome,1,PDE3B,2 (2),0.25,0.699,0,,6 (6),1,1,0.597,1
aspartate biosynthesis,HumanCyc,1,GOT1,2 (2),0.25,0.699,0,,4 (4),1,1,0.597,1
NOSIP mediated eNOS trafficking,Reactome,1,NOS3,2 (2),0.25,0.699,0,,4 (4),1,1,0.597,1
UDP-D-xylose and UDP-D-glucuronate biosynthesis,HumanCyc,1,UGDH,2 (2),0.25,0.699,0,,7 (8),1,1,0.597,1
Influenza A virus infection,Wikipathways,1,BCL2,2 (2),0.25,0.699,0,,2 (2),1,1,0.597,1
sulfate activation for sulfonation,HumanCyc,1,PAPSS2,2 (2),0.25,0.699,0,,7 (7),1,1,0.597,1
Thrombin signalling through proteinase activated receptors (PARs),Reactome,6,GNG11;GNGT2;GNB5;ARRB1;ARRB2;GNG2,32 (32),0.252,0.704,0,,3 (3),1,1,0.6,1
Activation of kainate receptors upon glutamate binding,Reactome,6,GNG11;GNGT2;DLG4;NCALD;GNB5;GNG2,32 (32),0.252,0.704,0,,4 (4),1,1,0.6,1
G-protein beta:gamma signalling,Reactome,6,PAK1;GNG11;GNGT2;ARHGEF6;GNB5;GNG2,32 (32),0.252,0.704,0,,5 (7),1,1,0.6,1
Metabolism of nucleotides,Reactome,15,AK1;ADA;AGXT2;UPP2;LHPP;AMPD1;DPYS;AMPD3;CDA;PAICS;DPYD;ADK;ADAL;ENTPD5;UPB1,102 (102),0.392,0.901,1,HMDB0000273,125 (154),0.645,1,0.6,1
Signaling by NTRKs,Reactome,20,MAPK11;LYL1;NGF;PCSK6;EGR1;ID4;NTRK2;SRF;SGK1;MEF2C;ARC;FOSB;EGR3;RPS6KA2;DUSP4;DUSP7;RRAD;FOSL1;MAPK7;SHC2,127 (127),0.253,0.704,0,,11 (13),1,1,0.601,1
Glycolysis,Reactome,12,PKLR;ALDOA;PKM;ALDOB;PGAM2;ENO3;PFKFB1;PFKFB2;NUP35;NDC1;POM121;PFKFB4,72 (73),0.253,0.704,0,,21 (27),1,1,0.601,1
Cushing syndrome - Homo sapiens (human),KEGG,24,FZD4;FZD8;FZD9;CACNA1C;CACNA1D;CACNA1S;ADCY4;CAMK2A;CYP17A1;WNT7B;WNT11;WNT9B;SCARB1;AHR;RASD1;CACNA1I;NCEH1;GNAI1;PLCB4;CREB3L3;NR4A1;ADCY2;ADCY9;ITPR3,155 (155),0.254,0.707,0,,12 (13),1,1,0.602,1
Signaling events mediated by Stem cell factor receptor (c-Kit),PID,9,DOK1;GRB10;SH2B2;KIT;MAP4K1;VAV1;BCL2;GRAP2;SPRED2,52 (52),0.257,0.713,0,,2 (2),1,1,0.606,1
RIG-I-like receptor signaling pathway - Homo sapiens (human),KEGG,9,MAPK11;MAPK13;IKBKG;CHUK;MAP3K1;TKFC;NFKBIA;TBKBP1;MAPK12,70 (70),0.607,1,0,,0 (0),1,1,0.607,1
Notch,INOH,10,MAML1;ADAM10;DLL4;PSMD1;DTX1;MFNG;DTX3;NOTCH4;LFNG;RBPJ,78 (78),0.611,1,0,,0 (0),1,1,0.611,1
Aurora A signaling,PID,4,NFKBIA;AJUBA;PAK1;ARHGEF7,31 (31),0.612,1,0,,0 (0),1,1,0.612,1
RANKL,NetPath,3,TNFRSF11A;SPI1;CHUK,23 (23),0.612,1,0,,0 (0),1,1,0.612,1
Energy Metabolism,Wikipathways,6,PRKAA2;MEF2C;UCP3;PPARA;PPARD;PRKAG2,47 (47),0.616,1,0,,0 (1),1,1,0.616,1
let-7 inhibition of ES cell reprogramming,Wikipathways,2,KLF4;EGR1,15 (15),0.617,1,0,,0 (0),1,1,0.617,1
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,Wikipathways,2,SOX4;PMAIP1,15 (15),0.617,1,0,,0 (0),1,1,0.617,1
COVID-19 adverse outcome pathway,Wikipathways,2,IL1B;CCL2,15 (15),0.617,1,0,,0 (0),1,1,0.617,1
il12 and stat4 dependent signaling pathway in th1 development,BioCarta,2,CCR5;ETV5,15 (15),0.617,1,0,,0 (0),1,1,0.617,1
il-7 signal transduction,BioCarta,2,LCK;BCL2,15 (15),0.617,1,0,,0 (0),1,1,0.617,1
IL4,NetPath,8,SPI1;MAPK11;CXCR4;NFKBIA;INPP5D;DOK2;PLCG2;CHUK,63 (63),0.622,1,0,,0 (0),1,1,0.622,1
Primary focal segmental glomerulosclerosis (FSGS),Wikipathways,12,WT1;ITGA3;COL4A4;LAMA5;LAMB2;VIM;PODXL;ITGB4;CLDN1;MME;VTN;TLR4,73 (73),0.269,0.743,0,,1 (4),1,1,0.622,1
activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,BioCarta,8,PRKAR1B;PRKAR2A;CXCR4;CCR5;CD3D;CCL11;ADRB2;LCK,46 (46),0.27,0.744,0,,5 (6),1,1,0.624,1
RAC3 GTPase cycle,Reactome,15,NCF2;MCAM;BAIAP2L1;ARHGAP1;PREX1;PAK1;SLC1A5;ARHGDIB;SYDE1;WASF2;CAV1;LBR;ARAP3;ARHGAP35;LMAN1,94 (94),0.274,0.744,0,,6 (6),1,1,0.629,1
Salmonella infection - Homo sapiens (human),KEGG,37,TUBB1;FLNA;PAK1;FLNC;MYL2;RIPK3;MAPK12;RHOJ;MYO6;PIK3C2G;MYLPF;PODXL;ANXA2;AHNAK;PYCARD;FHOD1;NFKBIA;WASF3;TLR4;TLR5;VPS41;BAK1;IKBKG;ACTG1;RAB7B;BCL2;TUBB2B;TLR9;TNFRSF10B;MAPK11;IL1B;MAPK13;TUBA1A;PAK3;CYTH4;SNX33;CHUK,249 (249),0.274,0.744,0,,2 (5),1,1,0.629,1
Apoptosis,Wikipathways,11,PMAIP1;BAK1;TNFRSF10B;IKBKG;PRF1;NFKBIA;BCL2;MAP3K1;IGF1R;GZMB;CHUK,87 (87),0.631,1,0,,0 (0),1,1,0.631,1
Validated targets of C-MYC transcriptional activation,PID,11,HSPD1;LDHA;SHMT1;BCAT1;GPAM;MYCT1;PMAIP1;SNAI1;SMAD3;FOSL1;MMP9,87 (87),0.631,1,0,,0 (0),1,1,0.631,1
keratinocyte differentiation,BioCarta,9,ETS2;MAPK13;IKBKG;PRKCH;BCL2;MAP3K1;NFKBIA;PRKCQ;CHUK,53 (53),0.275,0.744,0,,3 (3),1,1,0.631,1
Nanomaterial induced apoptosis,Wikipathways,4,BAK1;AIFM1;BCL2;PRF1,20 (20),0.276,0.744,0,,1 (2),1,1,0.631,1
Signaling by PDGFR in disease,Reactome,4,BIN2;PDGFRA;KANK1;KDR,20 (20),0.276,0.744,0,,5 (12),1,1,0.631,1
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,4,INPP5D;ITPKA;SYNJ2;ITPKC,20 (20),0.276,0.744,0,,11 (11),1,1,0.631,1
G beta:gamma signalling through PLC beta,Reactome,4,GNB5;GNGT2;GNG2;GNG11,20 (20),0.276,0.744,0,,1 (3),1,1,0.631,1
Lysinuric protein intolerance (LPI),SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Downstream signaling events of B Cell Receptor (BCR),Reactome,6,NFATC2;CARD11;RASGRP3;NFKBIA;CHUK;IKBKG,33 (33),0.276,0.744,0,,8 (10),1,1,0.632,1
Polythiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Spironolactone Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Quinethazone Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Bendroflumethiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Netrin-mediated signaling events,PID,6,PAK1;MAP1B;UNC5A;CAMK2A;BCAR1;ASB15,33 (33),0.276,0.744,0,,5 (5),1,1,0.632,1
Lysinuric Protein Intolerance,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
EPHA forward signaling,PID,6,BLK;LCK;EPHA3;EPHA4;FGR;EPHA7,33 (33),0.276,0.744,0,,2 (2),1,1,0.632,1
Cyclothiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Methyclothiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Bumetanide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Eplerenone Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Triamterene Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Amiloride Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Ethacrynic Acid Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Chlorthalidone Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Trichlormethiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Iminoglycinuria,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Blue diaper syndrome,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Cystinuria,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Indapamide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Furosemide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Torsemide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Hartnup Disorder,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Glucose Transporter Defect (SGLT2),SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Kidney Function,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Glucose Transporter Defect (SGLT2),SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (8),1,1,0.632,1
Metolazone Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,7 (9),1,1,0.632,1
Hydrochlorothiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Hydroflumethiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
Chlorothiazide Action Pathway,SMPDB,6,SLC7A6;SLC7A8;AQP1;SLC1A1;SLC38A4;ATP1A2,33 (33),0.276,0.744,0,,8 (9),1,1,0.632,1
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma,Wikipathways,1,VEGFC,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
RUNX3 regulates YAP1-mediated transcription,Reactome,1,RUNX3,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
IL-2 signaling,INOH,1,IL2RB,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
IL-3 signaling,INOH,1,IL3RA,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
TRAIL  signaling,Reactome,1,TNFRSF10B,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
2-LTR circle formation,Reactome,1,XRCC5,7 (7),0.635,1,0,,0 (1),1,1,0.635,1
Nectin/Necl  trans heterodimerization,Reactome,1,PVR,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Reactome,1,HSPD1,7 (7),0.635,1,0,,0 (0),1,1,0.635,1
Bladder cancer,Wikipathways,5,ERBB2;THBS1;MMP2;MMP9;HBEGF,40 (40),0.637,1,0,,0 (0),1,1,0.637,1
Development and heterogeneity of the ILC family,Wikipathways,4,IL1B;BCL11B;AHR;HNF1A,32 (32),0.638,1,0,,0 (0),1,1,0.638,1
Apoptosis - multiple species - Homo sapiens (human),KEGG,4,BCL2;BAK1;NGFR;PMAIP1,32 (32),0.638,1,0,,0 (0),1,1,0.638,1
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,11,LAT;MAPK11;MAPK13;PLA2G4E;ALOX5;VAV1;INPP5D;PLA2G4F;GAB2;PLCG2;MAPK12,67 (68),0.282,0.759,0,,11 (11),1,1,0.639,1
tumor suppressor arf inhibits ribosomal biogenesis,BioCarta,3,HSPA1B;ABL1;HSPA1A,24 (24),0.642,1,0,,0 (0),1,1,0.642,1
Neuroinflammation,Wikipathways,3,NFKBIA;CHUK;TLR4,14 (14),0.287,0.763,0,,9 (11),1,1,0.645,1
P2Y receptors,Reactome,3,P2RY10;P2RY4;P2RY6,14 (14),0.287,0.763,0,,8 (11),1,1,0.645,1
SHC1 events in ERBB4 signaling,Reactome,3,NRG4;EREG;HBEGF,14 (14),0.287,0.763,0,,4 (4),1,1,0.645,1
Response of EIF2AK1 (HRI) to heme deficiency,Reactome,3,ATF5;ATF3;CHAC1,14 (14),0.287,0.763,0,,2 (3),1,1,0.645,1
Vitamin B5 (pantothenate) metabolism,Reactome,3,PANK1;VNN1;SLC25A16,14 (14),0.287,0.763,0,,17 (17),1,1,0.645,1
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,3,PDP1;GSTZ1;PDK4,14 (14),0.287,0.763,0,,9 (10),1,1,0.645,1
FGFR4 ligand binding and activation,Reactome,3,KLB;FGF1;FGF2,14 (14),0.287,0.763,0,,3 (3),1,1,0.645,1
Membrane binding and targetting of GAG proteins,Reactome,3,VPS37A;NMT2;MVB12B,14 (14),0.287,0.763,0,,2 (2),1,1,0.645,1
Synthesis And Processing Of GAG_ GAGPOL Polyproteins,Reactome,3,VPS37A;NMT2;MVB12B,14 (14),0.287,0.763,0,,2 (2),1,1,0.645,1
stress induction of hsp regulation,BioCarta,3,ACTA1;HSPB1;BCL2,14 (14),0.287,0.763,0,,1 (1),1,1,0.645,1
Inositol Phosphate Metabolism,SMPDB,3,ITPKA;PPIP5K1;INPP4B,14 (14),0.287,0.763,0,,23 (23),1,1,0.645,1
Hypoacetylaspartia,SMPDB,3,DDO;ABAT;ASPA,14 (14),0.287,0.763,0,,34 (34),1,1,0.645,1
Aspartate Metabolism,SMPDB,3,DDO;ABAT;ASPA,14 (14),0.287,0.763,0,,34 (34),1,1,0.645,1
Canavan Disease,SMPDB,3,DDO;ABAT;ASPA,14 (14),0.287,0.763,0,,34 (34),1,1,0.645,1
Pancreatic secretion - Homo sapiens (human),KEGG,16,ATP2A1;CPB2;KCNQ1;ADCY4;BST1;ADCY2;ATP2B4;CPA3;SCTR;RAB27B;ADCY9;PLCB4;ATP2A3;ATP1A2;ITPR3;SLC4A4,102 (102),0.289,0.763,0,,12 (15),1,1,0.647,1
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,8,ART1;ART3;ART5;NNT;BST1;ENPP1;NUP35;NUDT12,47 (47),0.29,0.763,0,,33 (36),1,1,0.649,1
NR1H2 and NR1H3-mediated signaling,Reactome,8,ANGPTL3;PCK1;ARL4C;NRIP1;ABCG5;ABCG8;KDM1B;APOD,47 (47),0.29,0.763,0,,3 (4),1,1,0.649,1
Arf6 trafficking events,PID,8,ITGA8;ITGA6;ACAP1;CPE;SLC2A4;ADRB2;ITGA3;ITGA5,47 (47),0.29,0.763,0,,6 (6),1,1,0.649,1
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,8,CACNA1D;HKDC1;MGAM;SLC37A4;SLC2A2;PLCB4;SLC5A1;ATP1A2,47 (47),0.29,0.763,0,,19 (27),1,1,0.649,1
Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human),KEGG,5,B4GALT2;B3GNT5;B3GNT3;FUT2;A4GALT,27 (27),0.291,0.763,0,,1 (54),1,1,0.651,1
The oncogenic action of 2-hydroxyglutarate,SMPDB,5,ACO1;SUCLG2;SUCLG1;IDH1;DLST,27 (27),0.291,0.763,0,,38 (40),1,1,0.651,1
Thiamine metabolic pathways,Wikipathways,2,TPK1;BCKDK,8 (8),0.292,0.763,0,,13 (21),1,1,0.652,1
RUNX3 regulates p14-ARF,Reactome,2,RUNX3;RUNX1,8 (8),0.292,0.763,0,,4 (4),1,1,0.652,1
Sema4D mediated inhibition of cell attachment and migration,Reactome,2,SEMA4D;ARHGAP35,8 (8),0.292,0.763,0,,6 (6),1,1,0.652,1
Coenzyme A biosynthesis,Reactome,2,PANK1;SLC25A16,8 (8),0.292,0.763,0,,13 (13),1,1,0.652,1
Dectin-1 mediated noncanonical NF-kB signaling,Reactome,2,RELB;CHUK,8 (8),0.292,0.763,0,,2 (2),1,1,0.652,1
Galactosemia III,SMPDB,2,UGP2;UGDH,8 (8),0.292,0.763,0,,19 (20),1,1,0.652,1
Conjugation of salicylate with glycine,Reactome,2,GLYAT;ACSM5,8 (8),0.292,0.763,0,,7 (8),1,1,0.652,1
Rapid glucocorticoid signaling,PID,2,MAPK11;GNG2,8 (8),0.292,0.763,0,,3 (3),1,1,0.652,1
NIK-->noncanonical NF-kB signaling,Reactome,2,RELB;CHUK,8 (8),0.292,0.763,0,,2 (2),1,1,0.652,1
Phase 3 - rapid repolarisation,Reactome,2,KCNE3;KCNQ1,8 (8),0.292,0.763,0,,1 (1),1,1,0.652,1
ca-calmodulin-dependent protein kinase activation,BioCarta,2,CAMKK1;CAMK2A,8 (8),0.292,0.763,0,,1 (1),1,1,0.652,1
Thyroxine biosynthesis,Reactome,2,IYD;DIO1,8 (8),0.292,0.763,0,,16 (17),1,1,0.652,1
Galactosemia II (GALK),SMPDB,2,UGP2;UGDH,8 (8),0.292,0.763,0,,19 (20),1,1,0.652,1
Nucleotide Sugars Metabolism,SMPDB,2,UGP2;UGDH,8 (8),0.292,0.763,0,,19 (20),1,1,0.652,1
Effects of nitric oxide,Wikipathways,2,NOS3;MB,8 (8),0.292,0.763,0,,7 (7),1,1,0.652,1
Interactome of polycomb repressive complex 2 (PRC2),Wikipathways,2,TRIM35;MTF2,16 (16),0.653,1,0,,0 (0),1,1,0.653,1
MAP3K1 role in promoting and blocking gonadal determination,Wikipathways,2,MAPK11;MAP3K1,16 (16),0.653,1,0,,0 (0),1,1,0.653,1
ID signaling pathway,Wikipathways,2,ELK3;PAX5,16 (16),0.653,1,0,,0 (0),1,1,0.653,1
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Reactome,2,ERBB2;KIT,16 (16),0.653,1,0,,0 (0),1,1,0.653,1
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,9,HS3ST3A1;HS3ST1;HPSE;SDC3;HSPG2;SDC1;SDC2;VCAN;GPC3,54 (54),0.294,0.768,0,,21 (34),1,1,0.655,1
Wnt signaling pathway - Homo sapiens (human),KEGG,25,FZD4;FZD8;RSPO3;SFRP1;SFRP4;SFRP5;PRICKLE1;PRICKLE3;NFATC4;CSNK1E;CAMK2A;WNT7B;ROR2;WNT11;WNT9B;FZD9;BAMBI;CHD8;PLCB4;PPARD;MMP7;NFATC2;CTBP2;SMAD3;FOSL1,166 (166),0.296,0.773,0,,1 (1),1,1,0.657,1
Bladder cancer - Homo sapiens (human),KEGG,5,ERBB2;THBS1;MMP2;MMP9;HBEGF,41 (41),0.659,1,0,,0 (0),1,1,0.659,1
Sterol regulatory element-binding proteins (SREBP) signaling,Wikipathways,11,INSIG2;AMFR;GPAM;PRKAG2;SEC24A;FGF21;SEC23A;SCARB1;ACSS1;PRKAA2;IDI1,68 (68),0.299,0.78,0,,3 (5),1,1,0.661,1
AMP-activated protein kinase (AMPK) signaling,Wikipathways,11,HNF4A;CAMKK1;STRADB;PRKAG2;CPT1C;ADIPOR2;ADRA1A;SLC2A4;GYS2;PRKAA2;CPT1A,68 (68),0.299,0.78,0,,7 (7),1,1,0.661,1
Thyroid hormone synthesis - Homo sapiens (human),KEGG,12,ADCY9;SERPINA7;ADCY2;ADCY4;PLCB4;ITPR3;DUOXA2;IYD;CREB3L3;ATP1A2;GPX3;ALB,75 (75),0.301,0.783,0,,20 (21),1,1,0.662,1
Porphyrin metabolism,EHMN,6,UGT1A1;ALAS1;SLC1A5;SLC38A4;UGT1A5;CPOX,34 (34),0.301,0.783,0,,43 (48),1,1,0.662,1
NOD1/2 Signaling Pathway,Reactome,6,MAPK11;MAPK13;IKBKG;CARD9;CHUK;MAPK12,34 (34),0.301,0.783,0,,2 (5),1,1,0.662,1
Pregnane X receptor pathway,Wikipathways,4,ABCC4;UGT1A1;NRIP1;ABCC2,33 (33),0.663,1,0,,0 (1),1,1,0.663,1
Signaling by TGFB family members,Reactome,15,PARD3;GDF2;SMAD6;BMP10;TGFBR2;BMP2;CHRDL1;BAMBI;WWTR1;SMAD1;SMAD3;ACVR1B;SMAD9;ACVRL1;FSTL1,96 (96),0.302,0.786,0,,7 (8),1,1,0.664,1
JAK STAT pathway and regulation,INOH,45,GHR;IFNGR1;IL11;LIF;LIFR;FLT4;IGF1R;RIPK3;MAPK12;ACVR1B;PDGFRA;PDGFRB;LCK;PRLR;CSNK1E;CAMK2A;TGFBR2;RPS6KA2;ACVRL1;MAPK7;PRKAA2;PAK1;NGFR;IKBKG;PRKAR1B;PRKAR2A;PSMD1;KDR;FGFR1;PRKCH;PAK6;PRKAG2;MAPK11;IL1B;MAPK13;KIT;IL2RB;IL3RA;MAP3K3;GFRA1;MAP3K1;CNTFR;PRKCQ;CHUK;IL9R,310 (310),0.305,0.791,0,,2 (2),1,1,0.667,1
Putative anti-Inflammatory metabolites formation from EPA,EHMN,7,EPHX2;CBR3;CBS;PTGS2;ALOX5;ACOX2;NUP35,41 (41),0.307,0.795,0,,8 (10),1,1,0.67,1
cell cycle: g1/s check point,BioCarta,3,SMAD3;ABL1;DHFR,25 (25),0.67,1,0,,0 (0),1,1,0.67,1
Assembly and cell surface presentation of NMDA receptors,Reactome,3,ACTN2;DLG4;CAMK2A,25 (25),0.67,1,0,,0 (1),1,1,0.67,1
STING pathway in Kawasaki-like disease and COVID-19,Wikipathways,4,NFKBIA;IL1B;CHUK;IKBKG,21 (21),0.308,0.795,0,,4 (4),1,1,0.671,1
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,4,ALOX5;DPEP1;CYP4B1;GGT1,21 (21),0.308,0.795,0,,26 (32),1,1,0.671,1
regulation of pgc-1a,BioCarta,4,MEF2C;PPARA;CAMKK1;CAMK2A,21 (21),0.308,0.795,0,,1 (1),1,1,0.671,1
Kallmann_s Syndrome,Wikipathways,4,PROK2;FGFR1;TMEM98;SOX10,21 (21),0.308,0.795,0,,6 (11),1,1,0.671,1
Presynaptic function of Kainate receptors,Reactome,4,GNB5;GNGT2;GNG2;GNG11,21 (21),0.308,0.795,0,,2 (2),1,1,0.671,1
Nicotine Activity on Dopaminergic Neurons,Wikipathways,4,ADCY2;GNAI1;GNG2;DDC,21 (21),0.308,0.795,0,,9 (9),1,1,0.671,1
Diabetic cardiomyopathy - Homo sapiens (human),KEGG,30,COL3A1;TGFB2;TGFB3;TGFBR2;MMP2;TBC1D4;MAPK12;SLC25A4;PDK4;CAMK2A;GYS2;COX6A2;CMA1;MAPK11;COX7A1;NCF2;PLCB4;PPARA;UQCRC2;MMP9;CPT2;MAPK13;ACE;ATP2A1;ATP2A3;NOS3;SLC2A4;SMAD3;COL1A1;COL1A2,203 (203),0.311,0.802,0,,26 (39),1,1,0.674,1
Differentiation Pathway,Wikipathways,8,TGFB3;IL11;FGF1;KIT;HGF;FGF2;PDGFB;WNT7B,48 (48),0.311,0.802,0,,8 (12),1,1,0.674,1
RANKL-RANK signaling pathway,Wikipathways,9,SPI1;FHL2;PAPSS2;IKBKG;NFKBIA;RELB;GAB2;TNFRSF11A;CHUK,55 (55),0.314,0.809,0,,1 (2),1,1,0.678,1
FOXO-mediated transcription,Reactome,10,PLXNA4;KLF4;ABCA6;CAT;PCK1;CAV1;SMAD3;TRIM63;SFN;IGFBP1,62 (62),0.316,0.812,0,,10 (12),1,1,0.68,1
Signaling events mediated by focal adhesion kinase,PID,10,PAK1;ARHGEF7;ARHGAP35;ACTN2;ACTN3;ACTA1;ARHGEF28;BCAR1;ASB15;ITGA5,62 (62),0.316,0.812,0,,3 (3),1,1,0.68,1
Post NMDA receptor activation events,Reactome,10,PRKAR1B;PRKAR2A;ARHGEF7;DLG4;CAMK2A;RPS6KA2;CAMKK1;ACTN2;PRKAA2;PRKAG2,62 (62),0.316,0.812,0,,11 (13),1,1,0.68,1
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,15,PPIP5K2;PLCD3;PI4K2B;SYNJ2;PIK3C2G;PPIP5K1;ITPKC;INPP5D;PLCB4;INPP4B;PLCG2;PIP4K2A;ITPKA;ITPR3;PLCD1,97 (97),0.317,0.815,0,,19 (29),1,1,0.681,1
adp-ribosylation factor,BioCarta,5,CYTH4;ARHGAP1;NCF2;GPLD1;ARHGAP4,28 (28),0.319,0.818,0,,2 (2),1,1,0.684,1
Dual hijack model of Vif in HIV infection,Wikipathways,1,RUNX1,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,Reactome,1,RUNX1,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
LDLRAD4 and what we know about it,Wikipathways,1,TGFBR2,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
Formation of the Editosome,Reactome,1,A1CF,8 (8),0.684,1,0,,0 (1),1,1,0.684,1
CREB3 factors activate genes,Reactome,1,CREB3L3,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
Interleukin-15 signaling,Reactome,1,IL2RB,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
RUNX3 regulates WNT signaling,Reactome,1,RUNX3,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
Regulation of commissural axon pathfinding by SLIT and ROBO,Reactome,1,SLIT3,8 (8),0.684,1,0,,0 (1),1,1,0.684,1
Nef and signal transduction,Reactome,1,LCK,8 (8),0.684,1,0,,0 (1),1,1,0.684,1
g-secretase mediated erbb4 signaling pathway,BioCarta,1,NRG4,8 (8),0.684,1,0,,0 (0),1,1,0.684,1
tnfr1 signaling pathway,BioCarta,2,LMNB1;BAG4,17 (17),0.686,1,0,,0 (0),1,1,0.686,1
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,20,FHL1;GHR;PDGFB;PDGFRA;IL11;PDGFRB;LIF;LIFR;CNTFR;IFNGR1;GFAP;IL2RB;PRLR;SOCS2;BCL2;SOCS5;IL21R;IL27RA;IL9R;IL3RA,162 (162),0.689,1,0,,0 (0),1,1,0.689,1
EPHB-mediated forward signaling,Reactome,6,PAK1;ACTG1;SDC2;LIMK1;ARHGEF28;ASB15,35 (35),0.326,0.826,0,,8 (10),1,1,0.691,1
N-Glycan antennae elongation,Reactome,3,B4GALT2;B4GALT6;ST8SIA3,15 (15),0.326,0.826,0,,2 (6),1,1,0.691,1
Constitutive Signaling by NOTCH1 HD Domain Mutants,Reactome,3,NEURL1B;ADAM10;DLL4,15 (15),0.326,0.826,0,,1 (1),1,1,0.691,1
Signaling by NOTCH1 HD Domain Mutants in Cancer,Reactome,3,NEURL1B;ADAM10;DLL4,15 (15),0.326,0.826,0,,1 (1),1,1,0.691,1
DCC mediated attractive signaling,Reactome,3,ABLIM2;ABLIM3;ASB15,15 (15),0.326,0.826,0,,4 (5),1,1,0.691,1
Inflammasomes,Reactome,3,BCL2;P2RX7;PYCARD,15 (15),0.326,0.826,0,,2 (5),1,1,0.691,1
Phospholipase C-mediated cascade; FGFR4,Reactome,3,KLB;FGF1;FGF2,15 (15),0.326,0.826,0,,4 (4),1,1,0.691,1
telomeres telomerase cellular aging and immortality,BioCarta,3,XRCC5;BCL2;POLR2A,15 (15),0.326,0.826,0,,1 (3),1,1,0.691,1
repression of pain sensation by the transcriptional regulator dream,BioCarta,3,PRKAR2A;POLR2A;PRKAR1B,15 (15),0.326,0.826,0,,1 (1),1,1,0.691,1
Thiamine metabolism - Homo sapiens (human),KEGG,3,TPK1;AK1;THTPA,15 (16),0.326,0.826,0,,14 (31),1,1,0.691,1
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human),KEGG,3,ST3GAL2;FUT2;A4GALT,15 (15),0.326,0.826,0,,3 (23),1,1,0.691,1
Histidine Metabolism,SMPDB,3,HNMT;HAL;UROC1,15 (15),0.326,0.826,0,,40 (40),1,1,0.691,1
Histidinemia,SMPDB,3,HNMT;HAL;UROC1,15 (15),0.326,0.826,0,,40 (40),1,1,0.691,1
Cholesterol Biosynthesis Pathway,Wikipathways,3,NSDHL;SC5D;IDI1,15 (15),0.326,0.826,0,,14 (14),1,1,0.691,1
Fatty Acid Omega Oxidation,Wikipathways,3,CYP2E1;ADH4;CYP1A1,15 (15),0.326,0.826,0,,2 (4),1,1,0.691,1
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,7,UGT1A1;ALAS1;HEPH;CP;UGT1A5;UGT2A3;CPOX,42 (42),0.33,0.834,0,,41 (143),1,1,0.696,1
RHOF GTPase cycle,Reactome,7,LMNB1;MCAM;BAIAP2L1;ARHGAP1;RHOF;SYDE1;CAV1,42 (42),0.33,0.834,0,,4 (4),1,1,0.696,1
Wnt Signaling Pathway,Wikipathways,6,TEK;NFATC2;GJA1;CSNK1E;ROR2;ARRB2,51 (51),0.696,1,0,,0 (0),1,1,0.696,1
IL3,NetPath,6,SOCS2;DOK1;IL3RA;INPP5D;BCL2;GAB2,51 (51),0.696,1,0,,0 (0),1,1,0.696,1
EGFR Tyrosine Kinase Inhibitor Resistance,Wikipathways,13,PDGFB;PDGFRA;PDGFRB;HGF;FGF2;KDR;ERBB2;IGF1R;BCL2;PDGFD;PLCG2;GAS6;SHC2,84 (84),0.334,0.834,0,,3 (5),1,1,0.7,1
Hedgehog signaling pathway - Homo sapiens (human),KEGG,9,BOC;CSNK1E;HHIP;BCL2;EVC2;CDON;ARRB1;ARRB2;GAS1,56 (56),0.334,0.834,0,,1 (1),1,1,0.7,1
Neurotrophic factor-mediated Trk receptor signaling,PID,10,NGF;NGFR;DNAJA3;SH2B2;RGS19;NTRK2;GAB2;ABL1;SHC2;MCF2L,63 (63),0.334,0.834,0,,2 (2),1,1,0.7,1
LPA receptor mediated events,PID,10,ADCY4;ADCY2;HBEGF;GNAI1;ADCY9;NFKBIA;MMP2;GNG2;BCAR1;MMP9,63 (63),0.334,0.834,0,,5 (5),1,1,0.7,1
Leptin signaling pathway,Wikipathways,9,IL1B;PRKAA2;IKBKG;NOS3;ERBB2;SOCS2;PDE3B;PLCG2;CHUK,76 (76),0.706,1,0,,0 (0),1,1,0.706,1
Regulation of Complement cascade,Reactome,19,CFI;CFH;CD55;CFHR1;CPB2;CR2;CD19;C3;C3AR1;VTN;IGLC2;CD46;C5AR1;C6;CPN2;C8A;C8B;C7;C9,127 (127),0.34,0.834,0,,2 (6),1,1,0.707,1
PI3K-AKT-mTOR - VitD3 signaling,Wikipathways,4,LDHA;PFKFB4;PRKAA2;VDR,22 (22),0.34,0.834,0,,7 (8),1,1,0.707,1
SHC1 events in ERBB2 signaling,Reactome,4,ERBB2;HBEGF;NRG4;EREG,22 (22),0.34,0.834,0,,7 (8),1,1,0.707,1
Signaling by ERBB2 TMD/JMD mutants,Reactome,4,ERBB2;HBEGF;NRG4;EREG,22 (22),0.34,0.834,0,,5 (6),1,1,0.707,1
Interleukin-6 family signaling,Reactome,4,LIF;LIFR;IL11;CNTFR,22 (22),0.34,0.834,0,,2 (2),1,1,0.707,1
glutathione-mediated detoxification,HumanCyc,4,MGST1;ANPEP;GSTK1;GSTZ1,22 (22),0.34,0.834,0,,14 (14),1,1,0.707,1
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,4,PCYOX1;IDI1;HMGCS2;ACAT1,22 (22),0.34,0.834,0,,20 (45),1,1,0.707,1
cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,BioCarta,4,PRKAR2A;ADRB2;CCL11;PRKAR1B,22 (22),0.34,0.834,0,,5 (7),1,1,0.707,1
Type II diabetes mellitus,Wikipathways,4,SLC2A2;MAFA;SLC2A4;GK,22 (22),0.34,0.834,0,,4 (4),1,1,0.707,1
Overview of leukocyte-intrinsic Hippo pathway functions,Wikipathways,4,CD19;ITGAL;FERMT3;PRDM1,35 (35),0.709,1,0,,0 (0),1,1,0.709,1
Class I PI3K signaling events mediated by Akt,PID,4,SFN;TBC1D4;CHUK;SLC2A4,35 (35),0.709,1,0,,0 (0),1,1,0.709,1
HIV-1 Nef: Negative effector of Fas and TNF-alpha,PID,4,NFKBIA;BAG4;CHUK;BCL2,35 (35),0.709,1,0,,0 (0),1,1,0.709,1
EGFR interacts with phospholipase C-gamma,Reactome,2,EREG;HBEGF,9 (9),0.345,0.834,0,,2 (2),1,1,0.712,1
ApoE and miR-146 in inflammation and atherosclerosis,Wikipathways,2,SPI1;TLR4,9 (9),0.345,0.834,0,,1 (3),1,1,0.712,1
Ethanol metabolism resulting in production of ROS by CYP2E1,Wikipathways,2,CYP2E1;MAFF,9 (9),0.345,0.834,0,,13 (16),1,1,0.712,1
Heme Biosynthesis,Wikipathways,2,CPOX;ALAS1,9 (9),0.345,0.834,0,,16 (16),1,1,0.712,1
STAT5 activation downstream of FLT3 ITD mutants,Reactome,2,NOX4;GAB2,9 (9),0.345,0.834,0,,7 (7),1,1,0.712,1
glycogenolysis,HumanCyc,2,PYGB;PYGL,9 (9),0.345,0.834,0,,6 (7),1,1,0.712,1
retinoate biosynthesis I,HumanCyc,2,RDH16;ALDH1A2,9 (9),0.345,0.834,0,,5 (6),1,1,0.712,1
Maturation of protein 3a,Reactome,2,ST6GALNAC4;ST3GAL2,9 (9),0.345,0.834,0,,4 (5),1,1,0.712,1
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II,HumanCyc,2,HKDC1;PGM3,9 (9),0.345,0.834,0,,13 (16),1,1,0.712,1
Benzo(a)pyrene metabolism,Wikipathways,2,CYP1B1;CYP1A1,9 (9),0.345,0.834,0,,1 (5),1,1,0.712,1
TRIF-mediated programmed cell death,Reactome,2,RIPK3;TLR4,9 (9),0.345,0.834,0,,1 (1),1,1,0.712,1
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Reactome,2,ANGPTL3;NRIP1,9 (9),0.345,0.834,0,,3 (4),1,1,0.712,1
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Reactome,2,CYP1B1;CYP1A1,9 (9),0.345,0.834,0,,9 (11),1,1,0.712,1
Effects of Botulinum toxin,PID,2,SYT1;STXBP1,9 (9),0.345,0.834,0,,1 (2),1,1,0.712,1
p75NTR recruits signalling complexes,Reactome,2,NGF;NGFR,9 (9),0.345,0.834,0,,2 (3),1,1,0.712,1
Glucocorticoid biosynthesis,Reactome,2,CYP17A1;SERPINA6,9 (9),0.345,0.834,0,,17 (17),1,1,0.712,1
reversal of insulin resistance by leptin,BioCarta,2,PRKAA2;PRKAG2,9 (9),0.345,0.834,0,,1 (2),1,1,0.712,1
Chylomicron remodeling,Reactome,2,APOA4;APOB,9 (9),0.345,0.834,0,,4 (7),1,1,0.712,1
heme biosynthesis,HumanCyc,2,CPOX;ALAS1,9 (9),0.345,0.834,0,,18 (18),1,1,0.712,1
Serine biosynthesis,Reactome,2,SRR;SERINC2,9 (9),0.345,0.834,0,,13 (15),1,1,0.712,1
p75NTR regulates axonogenesis,Reactome,2,NGF;NGFR,9 (9),0.345,0.834,0,,2 (3),1,1,0.712,1
Adrenoceptors,Reactome,2,ADRB2;ADRA1A,9 (9),0.345,0.834,0,,15 (23),1,1,0.712,1
Activation of RAC1 downstream of NMDARs,Reactome,2,ARHGEF7;CAMKK1,9 (9),0.345,0.834,0,,5 (5),1,1,0.712,1
Maturation of protein 3a,Reactome,2,ST6GALNAC4;ST3GAL2,9 (9),0.345,0.834,0,,4 (5),1,1,0.712,1
Attenuation phase,Reactome,5,SERPINH1;HSPA1L;HSPB1;HSPA1B;HSPA1A,29 (29),0.347,0.834,0,,2 (2),1,1,0.715,1
Lipid Metabolism Pathway,Wikipathways,5,PRKAR2A;PRKAA2;PRKAR1B;PRKAG2;HILPDA,29 (29),0.347,0.834,0,,8 (14),1,1,0.715,1
Energy dependent regulation of mTOR by LKB1-AMPK,Reactome,5,RRAGD;CAB39L;PRKAA2;STRADB;PRKAG2,29 (29),0.347,0.834,0,,7 (7),1,1,0.715,1
Synthesis of PC,Reactome,5,SLC44A2;CHPT1;ABHD3;BCHE;MFSD2A,29 (29),0.347,0.834,0,,22 (28),1,1,0.715,1
Downregulation of ERBB2 signaling,Reactome,5,ERBB2;PTPN18;HBEGF;NRG4;EREG,29 (29),0.347,0.834,0,,4 (4),1,1,0.715,1
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,27,GABRB3;ADCY4;NCALD;CAMKK1;MYO6;ARHGEF7;CAMK2A;RPS6KA2;KCNJ10;KCNJ12;GNB5;PRKAA2;PRKAR1B;PRKAR2A;DLG4;GNAI1;ACTN2;PRKAG2;GABBR2;GNG2;GNG11;GNGT2;ADCY2;CHRNA2;ADCY9;EPB41L1;GABRA3,185 (185),0.348,0.834,0,,21 (24),1,1,0.715,1
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,Wikipathways,2,SOX4;IL11,18 (18),0.716,1,0,,0 (0),1,1,0.716,1
oxidative stress induced gene expression via nrf2,BioCarta,2,MAFF;CRYZ,18 (18),0.716,1,0,,0 (0),1,1,0.716,1
atm signaling pathway,BioCarta,2,NFKBIA;ABL1,18 (18),0.716,1,0,,0 (0),1,1,0.716,1
cdk regulation of dna replication,BioCarta,2,MCM3;MCM4,18 (18),0.716,1,0,,0 (0),1,1,0.716,1
TNFR1-induced NFkappaB signaling pathway,Reactome,2,CHUK;IKBKG,18 (18),0.716,1,0,,0 (1),1,1,0.716,1
Vitamins A and D - action mechanisms,Wikipathways,1,VDR,3 (3),0.351,0.834,0,,7 (10),1,1,0.718,1
2-oxoglutarate decarboxylation to succinyl-CoA,HumanCyc,1,DLST,3 (3),0.351,0.834,0,,7 (7),1,1,0.718,1
S-adenosyl-L-methionine biosynthesis,HumanCyc,1,MAT1A,3 (3),0.351,0.834,0,,6 (6),1,1,0.718,1
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Reactome,1,ADAM10,3 (3),0.351,0.834,0,,1 (1),1,1,0.718,1
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Reactome,1,ADAM10,3 (3),0.351,0.834,0,,1 (1),1,1,0.718,1
fatty acid &alpha;-oxidation III,HumanCyc,1,ALDH3A2,3 (3),0.351,0.834,0,,18 (23),1,1,0.718,1
Signaling by MST1,Reactome,1,MST1R,3 (3),0.351,0.834,0,,3 (3),1,1,0.718,1
Signalling to STAT3,Reactome,1,NGF,3 (3),0.351,0.834,0,,2 (2),1,1,0.718,1
The NLRP1 inflammasome,Reactome,1,BCL2,3 (3),0.351,0.834,0,,1 (2),1,1,0.718,1
Chylomicron clearance,Reactome,1,APOB,3 (3),0.351,0.834,0,,3 (4),1,1,0.718,1
Vitamin C metabolism,EHMN,1,SLC2A4,3 (3),0.351,0.834,0,,11 (13),1,1,0.718,1
glutathione biosynthesis,HumanCyc,1,GCLM,3 (3),0.351,0.834,0,,9 (9),1,1,0.718,1
adenine and adenosine salvage III,HumanCyc,1,ADA,3 (3),0.351,0.834,0,,12 (12),1,1,0.718,1
thyroid hormone metabolism I (via deiodination),HumanCyc,1,DIO1,3 (3),0.351,0.834,0,,5 (11),1,1,0.718,1
biotin-carboxyl carrier protein assembly,HumanCyc,1,HLCS,3 (3),0.351,0.834,0,,9 (11),1,1,0.718,1
Vitamins B6 activation to pyridoxal phosphate,Reactome,1,PNPO,3 (3),0.351,0.834,0,,16 (18),1,1,0.718,1
Biosynthesis of aspirin-triggered D-series resolvins,Reactome,1,ALOX5,3 (3),0.351,0.834,0,,7 (21),1,1,0.718,1
Regulation of gap junction activity,Reactome,1,GJA1,3 (3),0.351,0.834,0,,2 (2),1,1,0.718,1
asparagine biosynthesis,HumanCyc,1,GOT1,3 (3),0.351,0.834,0,,11 (11),1,1,0.718,1
glutamate dependent acid resistance,HumanCyc,1,GLUL,3 (3),0.351,0.834,0,,4 (4),1,1,0.718,1
Potassium transport channels,Reactome,1,KCNJ10,3 (3),0.351,0.834,0,,1 (1),1,1,0.718,1
Regulation of thyroid hormone activity,Reactome,1,DIO1,3 (3),0.351,0.834,0,,5 (6),1,1,0.718,1
FGFR1c and Klotho ligand binding and activation,Reactome,1,FGFR1,3 (3),0.351,0.834,0,,3 (3),1,1,0.718,1
1_25-dihydroxyvitamin D<sub>3</sub> biosynthesis,HumanCyc,1,CYP2R1,3 (3),0.351,0.834,0,,10 (10),1,1,0.718,1
Activation of BMF and translocation to mitochondria,Reactome,1,BMF,3 (3),0.351,0.834,0,,2 (3),1,1,0.718,1
betaKlotho-mediated ligand binding,Reactome,1,KLB,3 (3),0.351,0.834,0,,3 (3),1,1,0.718,1
glutamate biosynthesis/degradation,HumanCyc,1,GLUD1,3 (3),0.351,0.834,0,,9 (9),1,1,0.718,1
PLC-gamma1 signalling,Reactome,1,NGF,3 (3),0.351,0.834,0,,2 (2),1,1,0.718,1
inosine-5_-phosphate biosynthesis,HumanCyc,1,PAICS,3 (3),0.351,0.834,0,,16 (16),1,1,0.718,1
ABO blood group biosynthesis,Reactome,1,FUT2,3 (3),0.351,0.834,0,,6 (15),1,1,0.718,1
Toxicity of botulinum toxin type G (botG),Reactome,1,SYT1,3 (3),0.351,0.834,0,,1 (2),1,1,0.718,1
Uptake and function of diphtheria toxin,Reactome,1,HBEGF,3 (3),0.351,0.834,0,,2 (2),1,1,0.718,1
LDL remodeling,Reactome,1,APOB,3 (3),0.351,0.834,0,,3 (4),1,1,0.718,1
Toxicity of botulinum toxin type B (botB),Reactome,1,SYT1,3 (3),0.351,0.834,0,,1 (2),1,1,0.718,1
taurine biosynthesis,HumanCyc,1,CDO1,3 (3),0.351,0.834,0,,11 (11),1,1,0.718,1
MTF1 activates gene expression,Reactome,1,CSRP1,3 (3),0.351,0.834,0,,1 (1),1,1,0.718,1
MET activates STAT3,Reactome,1,HGF,3 (3),0.351,0.834,0,,2 (2),1,1,0.718,1
glucocorticoid biosynthesis,HumanCyc,1,CYP17A1,3 (3),0.351,0.834,0,,9 (9),1,1,0.718,1
tetrahydrofolate salvage from 5_10-methenyltetrahydrofolate,HumanCyc,1,MTHFD1,3 (3),0.351,0.834,0,,7 (7),1,1,0.718,1
purine ribonucleosides degradation to ribose-1-phosphate,HumanCyc,1,ADA,3 (3),0.351,0.834,0,,14 (15),1,1,0.718,1
Glycerol Phosphate Shuttle,SMPDB,1,GPD1,3 (3),0.351,0.834,0,,9 (10),1,1,0.718,1
thyronamine and iodothyronamine metabolism,HumanCyc,1,DIO1,3 (3),0.351,0.834,0,,2 (11),1,1,0.718,1
Erlotinib Action Pathway,SMPDB,1,ABCG2,3 (3),0.351,0.834,0,,4 (5),1,1,0.718,1
Biotin Metabolism,SMPDB,1,HLCS,3 (3),0.351,0.834,0,,7 (7),1,1,0.718,1
Multiple carboxylase deficiency_ neonatal or early onset form,SMPDB,1,HLCS,3 (3),0.351,0.834,0,,7 (7),1,1,0.718,1
Biotinidase Deficiency,SMPDB,1,HLCS,3 (3),0.351,0.834,0,,7 (7),1,1,0.718,1
Glycine Metabolism,Wikipathways,1,SHMT1,3 (3),0.351,0.834,0,,6 (10),1,1,0.718,1
Glycogen Synthesis and Degradation,Wikipathways,6,UGP2;GBE1;PHKG1;PYGB;PYGL;GYS2,36 (36),0.351,0.834,0,,5 (6),1,1,0.718,1
N-cadherin signaling events,PID,6,DAGLB;GJA1;DAGLA;FGFR1;GSN;MYL2,36 (36),0.351,0.834,0,,5 (5),1,1,0.718,1
roles of  arrestin dependent recruitment of src kinases in gpcr signaling,BioCarta,6,CXCR4;CCR5;CCL11;ARRB1;ADRB2;FGR,36 (36),0.351,0.834,0,,3 (4),1,1,0.718,1
Target Of Rapamycin (TOR) Signaling,Wikipathways,6,RRAGD;DDIT4L;DDIT4;PRKAG2;PRKAA2;IDI1,36 (36),0.351,0.834,0,,1 (1),1,1,0.718,1
Synaptic vesicle cycle - Homo sapiens (human),KEGG,12,SLC1A3;SLC17A8;SLC6A9;SYT1;SLC18A1;SLC6A12;SLC6A13;SLC1A1;ATP6V0E2;STXBP1;SLC1A2;CPLX2,78 (78),0.351,0.834,0,,11 (12),1,1,0.718,1
CDC42 signaling events,PID,11,PAK1;ENAH;ARHGEF7;EPS8;LIMK1;ARHGEF6;MAP3K1;MYL2;IQGAP1;BCAR1;ASB15,71 (71),0.352,0.836,0,,6 (6),1,1,0.72,1
Voltage gated Potassium channels,Reactome,7,KCNB1;KCNAB2;KCNQ1;KCNAB1;KCNQ4;KCNG4;KCNA7,43 (43),0.353,0.836,0,,1 (1),1,1,0.72,1
PAR1-mediated thrombin signaling events,PID,7,NOS3;ZYX;VASP;GNAI1;ARRB1;MYL2;GNG2,43 (43),0.353,0.836,0,,4 (4),1,1,0.72,1
Structural Pathway of Interleukin 1 (IL-1),Wikipathways,5,MAPK11;MBP;CHUK;MAP3K1;MAP3K3,44 (44),0.721,1,0,,0 (0),1,1,0.721,1
WNT-Core,Signalink,5,SMAD3;FZD4;FZD8;FZD9;HNF1A,44 (44),0.721,1,0,,0 (0),1,1,0.721,1
CD4 T cell receptor signaling-JNK cascade,INOH,9,LAT;CD3D;FOSB;FOSL2;PRKCQ;PLCG2;LCK;FOSL1;ITPR3,57 (57),0.353,0.837,0,,5 (6),1,1,0.721,1
Peptide hormone metabolism,Reactome,8,ANPEP;ACE;BCHE;CPA3;CPB2;CPE;MME;CMA1,50 (50),0.353,0.837,0,,15 (31),1,1,0.721,1
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,18,GATA4;ATP2A1;DIO1;ACTG1;ATP2A3;SLC16A2;PLCD3;ATP1A2;MYH7;PLCB4;PLCD1;NOTCH4;PLCG2;TBC1D4;THRB;MED13L;PFKFB2;SLC16A10,121 (121),0.355,0.841,0,,10 (11),1,1,0.723,1
Wnt signaling,Wikipathways,17,CTBP2;NFATC2;FZD9;NFATC4;CSNK1E;CAMK2A;CHD8;ROR2;PRICKLE1;PLCB4;WNT7B;SFRP1;WNT11;SFRP4;SFRP5;FOSL1;FZD8,114 (114),0.358,0.845,0,,1 (1),1,1,0.725,1
MicroRNA network associated with chronic lymphocytic leukemia,Wikipathways,1,BCL2,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
Downregulation of ERBB4 signaling,Reactome,1,WWP1,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
Integration of provirus,Reactome,1,XRCC5,9 (9),0.726,1,0,,0 (1),1,1,0.726,1
Formation of annular gap junctions,Reactome,1,GJA1,9 (9),0.726,1,0,,0 (1),1,1,0.726,1
YAP1- and WWTR1 (TAZ)-stimulated gene expression,Reactome,1,WWTR1,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
Displacement of DNA glycosylase by APEX1,Reactome,1,MBD4,9 (9),0.726,1,0,,0 (1),1,1,0.726,1
Nef Mediated CD4 Down-regulation,Reactome,1,LCK,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
btg family proteins and cell cycle regulation,BioCarta,1,BTG2,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
sodd/tnfr1 signaling pathway,BioCarta,1,BAG4,9 (9),0.726,1,0,,0 (0),1,1,0.726,1
DNA damage response (only ATM dependent),Wikipathways,13,BAK1;PMAIP1;SCP2;PIK3C2G;CAT;ERBB2;BCL2;WNT7B;MAP3K1;WNT11;SMAD3;ABL1;FOSL1,110 (110),0.729,1,0,,0 (0),1,1,0.729,1
IL1-mediated signaling events,PID,4,IL1B;CHUK;IKBKG;MAP3K3,36 (36),0.73,1,0,,0 (0),1,1,0.73,1
Intracellular signaling by second messengers,Reactome,37,MAF1;ADCY2;HGF;USP13;ERBB2;ADCY4;EREG;CAMK2A;CAMKK1;RRAGD;CD19;PDGFB;PDGFRA;NRG4;EGR1;PDGFRB;NR4A1;CBX6;PRKAR1B;HBEGF;PREX2;ATN1;PIP4K2A;FGF1;FGF2;PRKAR2A;FGFR1;SNAI1;LCK;KIT;HDAC7;VAV1;ADCY9;GAB2;CHUK;ITPR3;KLB,259 (259),0.364,0.856,0,,22 (28),1,1,0.732,1
Regulation of KIT signaling,Reactome,3,SH2B2;LCK;KIT,16 (16),0.365,0.856,0,,2 (2),1,1,0.733,1
CRMPs in Sema3A signaling,Reactome,3,DPYSL2;DPYSL3;PLXNA4,16 (16),0.365,0.856,0,,2 (2),1,1,0.733,1
Steroids metabolism,INOH,3,CYP7A1;IDI1;SC5D,16 (16),0.365,0.856,0,,27 (31),1,1,0.733,1
FGFR1 ligand binding and activation,Reactome,3,FGFR1;FGF1;FGF2,16 (16),0.365,0.856,0,,3 (3),1,1,0.733,1
cGMP effects,Reactome,3,PDE9A;KCNMB1;PDE10A,16 (16),0.365,0.856,0,,2 (2),1,1,0.733,1
LPA4-mediated signaling events,PID,3,ADCY4;ADCY9;ADCY2,16 (16),0.365,0.856,0,,1 (1),1,1,0.733,1
Metabolism of amine-derived hormones,Reactome,3,IYD;DDC;DIO1,16 (16),0.365,0.856,0,,34 (39),1,1,0.733,1
Phospholipase C-mediated cascade: FGFR1,Reactome,3,FGFR1;FGF1;FGF2,16 (16),0.365,0.856,0,,4 (4),1,1,0.733,1
Elevation of cytosolic Ca2+ levels,Reactome,3,P2RX7;ITPR3;P2RX6,16 (16),0.365,0.856,0,,5 (6),1,1,0.733,1
p75NTR signals via NF-kB,Reactome,3,NFKBIA;NGF;NGFR,16 (16),0.365,0.856,0,,2 (3),1,1,0.733,1
Osteoclast Signaling,Wikipathways,3,TNFRSF11A;SPP1;PDGFB,16 (16),0.365,0.856,0,,3 (4),1,1,0.733,1
Signaling by Hedgehog,Reactome,12,BOC;PRKAR1B;ADCY4;ADCY2;HHIP;PRKAR2A;ADCY9;EVC2;CDON;ARRB1;ARRB2;GAS1,79 (79),0.368,0.863,0,,10 (11),1,1,0.736,1
Melanoma - Homo sapiens (human),KEGG,11,BAK1;PDGFB;PDGFRA;FGF1;PDGFRB;HGF;FGF2;FGF21;FGFR1;PDGFD;IGF1R,72 (72),0.37,0.865,0,,1 (1),1,1,0.738,1
RAGE,NetPath,5,NFKBIA;CHUK;AIFM1;MAPK7;MSN,45 (45),0.739,1,0,,0 (0),1,1,0.739,1
TGF-Ncore,Signalink,5,ROR2;WWP1;BAMBI;MAP3K1;SMAD6,45 (45),0.739,1,0,,0 (0),1,1,0.739,1
Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,10,FZD4;FZD8;FZD9;NEFH;PAK1;ERBB2;MYL1;WNT11;ACTA1;FN1,65 (65),0.372,0.865,0,,9 (9),1,1,0.74,1
Signaling by ROBO receptors,Reactome,10,PAK1;PAK3;PRKAR2A;ENAH;CXCR4;VASP;ABL1;SLIT3;PAK6;HOXA2,65 (65),0.372,0.865,0,,6 (9),1,1,0.74,1
Sphingolipid Metabolism (general overview),Wikipathways,4,CERS4;CERS2;CERK;SGMS1,23 (23),0.372,0.865,0,,7 (10),1,1,0.74,1
Nephrin family interactions,Reactome,4,ACTN2;ACTN3;IQGAP1;ASB15,23 (23),0.372,0.865,0,,2 (3),1,1,0.74,1
Signaling events mediated by PRL,PID,4,ATF5;PTP4A3;BCAR1;EGR1,23 (23),0.372,0.865,0,,1 (1),1,1,0.74,1
Abortive elongation of HIV-1 transcript in the absence of Tat,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,23 (23),0.372,0.865,0,,4 (5),1,1,0.74,1
how progesterone initiates the oocyte maturation,BioCarta,4,PRKAR2A;GNAI1;PAQR5;PRKAR1B,23 (23),0.372,0.865,0,,5 (5),1,1,0.74,1
RHO GTPases activate PAKs,Reactome,4,LIMK1;PAK1;FLNA;PAK3,23 (23),0.372,0.865,0,,6 (6),1,1,0.74,1
Irinotecan Action Pathway,SMPDB,4,UGT1A1;ABCC2;ABCG2;BCHE,23 (23),0.372,0.865,0,,11 (12),1,1,0.74,1
Irinotecan Metabolism Pathway,SMPDB,4,UGT1A1;ABCC2;ABCG2;BCHE,23 (23),0.372,0.865,0,,11 (12),1,1,0.74,1
Toll-like Receptor Signaling Pathway,Wikipathways,12,MAPK11;IL1B;MAPK13;IKBKG;SPP1;TLR5;TLR4;NFKBIA;TLR1;TLR9;CHUK;MAPK12,103 (103),0.742,1,0,,0 (5),1,1,0.742,1
RHOD GTPase cycle,Reactome,8,LMNB1;MCAM;ARHGAP1;CAV1;LBR;PAK6;ARHGAP35;LMAN1,51 (51),0.375,0.868,0,,4 (4),1,1,0.743,1
Synaptic Vesicle Pathway,Wikipathways,8,SLC25A4;SLC17A8;SYT1;SLC18A1;SLC1A3;STXBP1;ATP1A2;CPLX2,51 (51),0.375,0.868,0,,6 (7),1,1,0.743,1
Proteoglycan biosynthesis,EHMN,5,SLC35B4;CHSY1;CHST11;CHST3;CHST12,30 (30),0.375,0.868,0,,9 (19),1,1,0.743,1
Pentose phosphate pathway - Homo sapiens (human),KEGG,5,RGN;ALDOA;GLYCTK;RPIA;ALDOB,30 (30),0.375,0.868,0,,25 (35),1,1,0.743,1
fmlp induced chemokine gene expression in hmc-1 cells,BioCarta,5,PIK3C2G;NFKBIA;PAK1;NCF2;CAMKK1,30 (30),0.375,0.868,0,,1 (3),1,1,0.743,1
Signaling by NOTCH3,Reactome,7,MAML1;ADAM10;DLL4;NEURL1B;PLXND1;RBPJ;MAMLD1,44 (44),0.376,0.868,0,,3 (3),1,1,0.744,1
PI3K Cascade,Reactome,7,FGF1;FGF2;PDE3B;GAB2;FGFR1;TLR9;KLB,44 (44),0.376,0.868,0,,7 (10),1,1,0.744,1
HSF1-dependent transactivation,Reactome,6,SERPINH1;HSPA1B;HSPA1L;HSPA1A;CAMK2A;HSPB1,37 (37),0.376,0.868,0,,4 (4),1,1,0.744,1
Wnt signaling in kidney disease,Wikipathways,6,FZD4;FZD8;FZD9;WNT7B;WNT11;WNT9B,37 (37),0.376,0.868,0,,1 (1),1,1,0.744,1
Retinol Metabolism,SMPDB,6,RDH16;UGT1A1;RETSAT;ALDH1A2;CYP26A1;BCO1,37 (37),0.376,0.868,0,,31 (32),1,1,0.744,1
RHO GTPases Activate WASPs and WAVEs,Reactome,6,ACTG1;WASF2;ABL1;WASF3;ASB15;WAS,37 (37),0.376,0.868,0,,4 (6),1,1,0.744,1
Vitamin A Deficiency,SMPDB,6,RDH16;UGT1A1;RETSAT;ALDH1A2;CYP26A1;BCO1,37 (37),0.376,0.868,0,,31 (32),1,1,0.744,1
Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex,Wikipathways,2,GZMB;BCL2,19 (19),0.744,1,0,,0 (0),1,1,0.744,1
Cytokines and Inflammatory Response,Wikipathways,3,CXCL2;IL1B;IL11,28 (29),0.745,1,0,,0 (0),1,1,0.745,1
Transcriptional regulation of pluripotent stem cells,Reactome,3,KLF4;GATA6;FGF2,28 (28),0.745,1,0,,0 (0),1,1,0.745,1
Complement cascade,Reactome,20,CFI;CFH;CD55;CFHR1;CPB2;CR2;CD19;MASP2;C3;C3AR1;VTN;IGLC2;CD46;C5AR1;C6;CPN2;C8A;C8B;C7;C9,137 (137),0.377,0.869,0,,4 (12),1,1,0.745,1
Estrogen signaling pathway - Homo sapiens (human),KEGG,20,KRT17;HBEGF;HSPA1A;ADCY4;HSPA1L;TFF1;ADCY2;NOS3;KRT19;HSPA1B;GNAI1;ADCY9;BCL2;MMP9;MMP2;PLCB4;CREB3L3;GABBR2;ITPR3;SHC2,137 (138),0.377,0.869,0,,8 (8),1,1,0.745,1
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies,Wikipathways,6,MAOB;TGFB2;SPP1;BMP2;WNT7B;SMAD3,54 (54),0.748,1,0,,0 (1),1,1,0.748,1
Interactions of Vpr with host cellular proteins,Reactome,4,NUP35;NDC1;SLC25A4;POM121,37 (37),0.75,1,0,,0 (1),1,1,0.75,1
IL23-mediated signaling events,PID,4,NFKBIA;IL1B;ITGA3;CCL2,37 (37),0.75,1,0,,0 (0),1,1,0.75,1
Wnt Canonical,INOH,14,FZD4;HSPG2;FZD8;FZD9;SDC3;PSMD1;SDC1;SDC2;DKK3;WNT7B;CSNK1E;SFRP4;WNT11;WNT9B,120 (120),0.752,1,0,,0 (0),1,1,0.752,1
Wnt Mammals,INOH,14,FZD4;HSPG2;FZD8;FZD9;SDC3;PSMD1;SDC1;SDC2;DKK3;WNT7B;CSNK1E;SFRP4;WNT11;WNT9B,120 (120),0.752,1,0,,0 (0),1,1,0.752,1
Toll-like receptor signaling pathway - Homo sapiens (human),KEGG,12,MAPK11;IL1B;TLR4;IKBKG;SPP1;TLR5;TLR1;MAPK13;NFKBIA;TLR9;CHUK;MAPK12,104 (104),0.754,1,0,,0 (0),1,1,0.754,1
JAK-STAT-Core,Signalink,12,IL1B;GHR;IFNGR1;IL11;LIF;LIFR;CNTFR;PRLR;IL21R;IL27RA;IL9R;IL3RA,104 (104),0.754,1,0,,0 (0),1,1,0.754,1
Male infertility,Wikipathways,21,XRCC5;NQO1;BHMT;AHR;SHMT1;CYP1A1;PON1;MTHFD1;ETV5;APOB;NOS3;CAT;THBS1;CTCFL;CYP17A1;BCL2;SIRPA;MMP2;CYP26B1;SLC16A7;MMP9,145 (145),0.387,0.891,0,,4 (4),1,1,0.754,1
Transcriptional regulation by RUNX2,Reactome,11,MMP13;SMAD1;ITGBL1;WWTR1;WWP1;MAF;LGALS3;SMAD6;COL1A1;ITGA5;HIVEP3,73 (73),0.388,0.892,0,,11 (13),1,1,0.755,1
HIF-1 signaling pathway - Homo sapiens (human),KEGG,16,ALDOA;LDHA;ALDOB;HKDC1;ENO3;TEK;NOS3;CAMK2A;ERBB2;IGF1R;IFNGR1;BCL2;LDHB;PLCG2;TLR4;ANGPT1,109 (109),0.389,0.894,0,,13 (15),1,1,0.756,1
BDNF,NetPath,5,NFKBIA;NTRK2;SH2B2;NGFR;NGF,46 (46),0.757,1,0,,0 (0),1,1,0.757,1
Presenilin action in Notch and Wnt signaling,PID,5,DTX1;PPARD;RBPJ;ADAM10;HNF1A,46 (46),0.757,1,0,,0 (0),1,1,0.757,1
Leptin and adiponectin,Wikipathways,2,ADIPOR2;CPT1A,10 (10),0.396,0.902,0,,2 (4),1,1,0.763,1
mRNA Editing,Reactome,2,ADARB1;A1CF,10 (10),0.396,0.902,0,,2 (4),1,1,0.763,1
Pexophagy,Reactome,2,NBR1;PEX5,10 (10),0.396,0.902,0,,1 (1),1,1,0.763,1
The NLRP3 inflammasome,Reactome,2,P2RX7;PYCARD,10 (10),0.396,0.902,0,,2 (3),1,1,0.763,1
Neurotransmitter clearance,Reactome,2,SLC22A1;BCHE,10 (10),0.396,0.902,0,,31 (33),1,1,0.763,1
Hyaluronan uptake and degradation,Reactome,2,CHP1;LYVE1,10 (10),0.396,0.902,0,,5 (7),1,1,0.763,1
FGFR2b ligand binding and activation,Reactome,2,FGF1;FGF2,10 (10),0.396,0.902,0,,3 (4),1,1,0.763,1
Vincristine Action Pathway,SMPDB,2,TUBB1;ABCC2,10 (10),0.396,0.902,0,,5 (5),1,1,0.763,1
putrescine degradation III,HumanCyc,2,ALDH3A2;MAOB,10 (10),0.396,0.902,0,,15 (15),1,1,0.763,1
Synthesis of pyrophosphates in the cytosol,Reactome,2,PPIP5K1;PPIP5K2,10 (10),0.396,0.902,0,,11 (19),1,1,0.763,1
Vindesine Action Pathway,SMPDB,2,TUBB1;ABCC2,10 (10),0.396,0.902,0,,5 (5),1,1,0.763,1
Tamoxifen Action Pathway,SMPDB,2,FMO3;FMO1,10 (10),0.396,0.902,0,,20 (20),1,1,0.763,1
Tamoxifen Metabolism Pathway,SMPDB,2,FMO3;FMO1,10 (10),0.396,0.902,0,,20 (20),1,1,0.763,1
Mammary gland development pathway - Involution (Stage 4 of 4),Wikipathways,1,MMP9,10 (10),0.763,1,0,,0 (1),1,1,0.763,1
Non-homologous end joining,Wikipathways,1,XRCC5,10 (10),0.763,1,0,,0 (0),1,1,0.763,1
Interleukin-27 signaling,Reactome,1,IL27RA,10 (10),0.763,1,0,,0 (0),1,1,0.763,1
Dimerization of procaspase-8,Reactome,1,TNFRSF10B,10 (10),0.763,1,0,,0 (0),1,1,0.763,1
Alpha-defensins,Reactome,1,ART1,10 (10),0.763,1,0,,0 (1),1,1,0.763,1
VLDLR internalisation and degradation,Reactome,1,VLDLR,10 (10),0.763,1,0,,0 (0),1,1,0.763,1
Calcitonin-like ligand receptors,Reactome,1,RAMP2,10 (10),0.763,1,0,,0 (0),1,1,0.763,1
IRS-related events triggered by IGF1R,Reactome,8,FGF1;FGF2;PDE3B;GAB2;IGF1R;FGFR1;TLR9;KLB,52 (52),0.396,0.902,0,,9 (12),1,1,0.763,1
Downstream TCR signaling,Reactome,8,IKBKG;CARD11;INPP5D;CD3D;PRKCQ;NFKBIA;CHUK;LCK,52 (52),0.396,0.902,0,,6 (9),1,1,0.763,1
PDGF,INOH,7,PAK1;PDGFB;PDGFRA;PDGFRB;ARHGEF6;MAP3K1;SHC2,45 (45),0.399,0.903,0,,5 (6),1,1,0.766,1
Gastric Cancer Network 1,Wikipathways,3,KIF20B;MCM4;SMOC2,29 (29),0.766,1,0,,0 (0),1,1,0.766,1
Hedgehog,INOH,8,BOC;PRKAR1B;CDKN2D;PSMD1;HHIP;PRKAR2A;CDON;ARRB2,72 (72),0.767,1,0,,0 (0),1,1,0.767,1
Human T-cell leukemia virus 1 infection - Homo sapiens (human),KEGG,31,TGFB2;TGFB3;TGFBR2;ETS2;CRTC3;ADCY4;ANAPC10;SPI1;SLC25A4;NFATC2;EGR1;NFATC4;LCK;NFKBIA;SRF;IKBKG;CD3D;RELB;CREB3L3;MMP7;TNFRSF13C;ITGAL;IL2RB;ITGB2;ADCY2;ADCY9;MAP3K1;MAP3K3;SMAD3;CHUK;FOSL1,219 (219),0.401,0.903,0,,5 (5),1,1,0.768,1
1q21.1 copy number variation syndrome,Wikipathways,6,ACP6;GJA1;GJA5;FMO5;PRKAA2;PRKAG2,38 (38),0.402,0.903,0,,7 (10),1,1,0.768,1
Signaling events mediated by HDAC Class II,PID,6,GATA2;BCOR;SRF;HDAC7;MEF2C;GNG2,38 (38),0.402,0.903,0,,1 (1),1,1,0.768,1
Oncostatin_M,NetPath,4,ERBB2;NFKBIA;EGR1;LIFR,38 (38),0.769,1,0,,0 (0),1,1,0.769,1
Regulation of HSF1-mediated heat shock response,Reactome,12,SERPINH1;HSPA12B;HSPA1A;HSPA1B;HSPA1L;HSPA9;HSPA12A;HSPB1;NUP35;NDC1;POM121;BAG4,81 (81),0.402,0.903,0,,6 (7),1,1,0.769,1
Galactose metabolism - Homo sapiens (human),KEGG,5,B4GALT2;AKR1B10;MGAM;UGP2;HKDC1,31 (31),0.404,0.903,0,,30 (46),1,1,0.77,1
RUNX2 regulates bone development,Reactome,5,WWTR1;SMAD6;COL1A1;SMAD1;MAF,31 (31),0.404,0.903,0,,5 (6),1,1,0.77,1
Nuclear signaling by ERBB4,Reactome,5,ADAP1;HBEGF;NRG4;GFAP;EREG,31 (31),0.404,0.903,0,,1 (2),1,1,0.77,1
Metabolism of steroid hormones,Reactome,5,HSD17B12;HSD17B11;CYP17A1;SRD5A1;SERPINA6,31 (31),0.404,0.903,0,,33 (35),1,1,0.77,1
Circadian rhythm - Homo sapiens (human),KEGG,5,PRKAG2;PRKAA2;BHLHE41;CSNK1E;PER3,31 (31),0.404,0.903,0,,2 (2),1,1,0.77,1
FGFR1 mutant receptor activation,Reactome,5,BAG4;FGFR1;GAB2;FGF1;FGF2,31 (31),0.404,0.903,0,,4 (15),1,1,0.77,1
The oncogenic action of Succinate,SMPDB,5,ACO1;SUCLG2;SUCLG1;IDH1;DLST,31 (31),0.404,0.903,0,,38 (41),1,1,0.77,1
The oncogenic action of Fumarate,SMPDB,5,ACO1;SUCLG2;SUCLG1;IDH1;DLST,31 (31),0.404,0.903,0,,38 (42),1,1,0.77,1
dermatan sulfate biosynthesis,HumanCyc,3,CHSY1;CHST15;CHST14,17 (17),0.404,0.903,0,,7 (8),1,1,0.77,1
Acetylcholine Neurotransmitter Release Cycle,Reactome,3,SYT1;PPFIA2;STXBP1,17 (17),0.404,0.903,0,,7 (7),1,1,0.77,1
Glycogen breakdown (glycogenolysis),Reactome,3,PHKG1;PYGB;PYGL,17 (17),0.404,0.903,0,,9 (11),1,1,0.77,1
TCA Cycle (aka Krebs or citric acid cycle),Wikipathways,3,SUCLG2;SUCLG1;DLST,17 (17),0.404,0.903,0,,24 (24),1,1,0.77,1
Sialuria or French Type Sialuria,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
Assembly Of The HIV Virion,Reactome,3,VPS37A;NMT2;MVB12B,17 (17),0.404,0.903,0,,2 (3),1,1,0.77,1
Plasma lipoprotein assembly,Reactome,3,APOA4;APOB;MTTP,17 (17),0.404,0.903,0,,10 (11),1,1,0.77,1
Nitrogen metabolism - Homo sapiens (human),KEGG,3,GLUL;GLUD1;CPS1,17 (17),0.404,0.903,0,,16 (19),1,1,0.77,1
ucalpain and friends in cell spread,BioCarta,3,ACTN2;ACTN3;ACTA1,17 (17),0.404,0.903,0,,1 (1),1,1,0.77,1
Sialuria or French Type Sialuria,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
Amino Sugar Metabolism,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
Tay-Sachs Disease,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
Platelet sensitization by LDL,Reactome,3,APOB;FGR;PECAM1,17 (17),0.404,0.903,0,,5 (6),1,1,0.77,1
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,3,GNE;PGM3;SLC17A5,17 (17),0.404,0.903,0,,31 (32),1,1,0.77,1
Assembly of the pre-replicative complex,Reactome,2,MCM3;MCM4,20 (20),0.77,1,0,,0 (1),1,1,0.77,1
TICAM1_ RIP1-mediated IKK complex recruitment,Reactome,2,CHUK;IKBKG,20 (20),0.77,1,0,,0 (3),1,1,0.77,1
Thromboxane signalling through TP receptor,Reactome,4,GNB5;GNGT2;GNG2;GNG11,24 (24),0.405,0.903,0,,3 (3),1,1,0.771,1
Sema4D in semaphorin signaling,Reactome,4,LIMK1;ERBB2;SEMA4D;ARHGAP35,24 (24),0.405,0.903,0,,6 (6),1,1,0.771,1
ADP signalling through P2Y purinoceptor 1,Reactome,4,GNB5;GNGT2;GNG2;GNG11,24 (24),0.405,0.903,0,,4 (4),1,1,0.771,1
G-protein activation,Reactome,4,GNB5;GNGT2;GNG2;GNG11,24 (24),0.405,0.903,0,,2 (2),1,1,0.771,1
Vitamin digestion and absorption - Homo sapiens (human),KEGG,4,APOA4;APOB;SLC23A1;SCARB1,24 (24),0.405,0.903,0,,29 (39),1,1,0.771,1
Physiological and pathological hypertrophy of the heart,Wikipathways,4,MAPK11;LIFR;GATA4;NFATC4,24 (24),0.405,0.903,0,,2 (2),1,1,0.771,1
RHOG GTPase cycle,Reactome,11,MCAM;IQGAP2;ARHGAP1;PREX1;ARHGDIB;VAV1;CAV1;LBR;ARHGAP35;LMAN1;MCF2L,74 (74),0.406,0.905,0,,4 (4),1,1,0.772,1
Dopaminergic synapse - Homo sapiens (human),KEGG,19,MAPK11;MAOB;CREB3L3;GNG11;CACNA1D;GNGT2;SLC18A1;CACNA1C;DDC;CAMK2A;GNAI1;MAPK13;PLCB4;GNB5;ARRB1;ARRB2;GNG2;MAPK12;ITPR3,132 (132),0.407,0.906,0,,12 (12),1,1,0.773,1
Visual phototransduction,Reactome,15,RDH16;RETSAT;SDC3;HSPG2;SDC1;SDC2;APOA4;APOB;PRKCQ;NMT2;AKR1B10;GNB5;GNAT1;BCO1;GPC3,103 (103),0.407,0.907,0,,48 (68),1,1,0.773,1
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway,Wikipathways,5,NFKBIA;CCL11;RELB;LCK;GAB2,47 (47),0.774,1,0,,0 (0),1,1,0.774,1
Class A/1 (Rhodopsin-like receptors),Reactome,42,PROK2;ADORA1;ADORA2B;CCR2;CXCR3;PXMP2;ADRA1A;ADRB2;CYP26B1;P2RY4;CXCR6;AVPR1A;GPR35;CXCR4;ACKR3;P2RY6;NTS;PENK;CXCL13;P2RY10;GPR55;CCL2;C3;C3AR1;CCR5;CCL11;S1PR2;ACKR2;CMKLR1;APP;CXCL5;F2RL1;CX3CL1;CXCL3;PTGIR;C5AR1;BDKRB2;CXCL2;KNG1;CNR2;S1PR4;FFAR4,346 (346),0.78,1,1,HMDB0002183,90 (113),0.523,1,0.774,1
Long-term depression - Homo sapiens (human),KEGG,9,PLA2G4E;GUCY1A1;GUCY1B1;GNAI1;PLCB4;RYR1;IGF1R;ITPR3;PLA2G4F,60 (60),0.414,0.921,0,,8 (9),1,1,0.779,1
Hepatitis C and Hepatocellular Carcinoma,Wikipathways,6,COL4A2;PODXL;MYOF;PTGS2;SMAD3;HNF1A,56 (56),0.78,1,0,,0 (0),1,1,0.78,1
JAK STAT MolecularVariation 1,INOH,11,IL1B;GHR;IFNGR1;IL11;LIF;LIFR;IL3RA;IL2RB;PRLR;CNTFR;IL9R,98 (98),0.78,1,0,,0 (0),1,1,0.78,1
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,8,TUBB1;TUBA1A;HSPA1A;HSPA1B;HSPA1L;PSMD1;HSPA9;TUBB2B,73 (73),0.78,1,0,,0 (0),1,1,0.78,1
Pancreatic adenocarcinoma pathway,Wikipathways,13,PAK1;TGFB2;TGFB3;IKBKG;PAK3;TGFBR2;BAK1;ERBB2;ARHGEF6;RIPK4;SMAD3;CHUK;PAK6,89 (89),0.415,0.924,0,,1 (2),1,1,0.78,1
IGF1R signaling cascade,Reactome,8,FGF1;FGF2;PDE3B;GAB2;IGF1R;FGFR1;TLR9;KLB,53 (53),0.418,0.927,0,,9 (12),1,1,0.783,1
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Reactome,8,FGF1;FGF2;PDE3B;GAB2;IGF1R;FGFR1;TLR9;KLB,53 (53),0.418,0.927,0,,9 (12),1,1,0.783,1
Signaling by Nuclear Receptors,Reactome,41,ALDH8A1;ARL4C;NRIP1;EREG;ALDH1A2;MMP2;CYP26B1;RARG;RDH16;PPARD;ABCG8;PDK4;HBEGF;FOSB;CPT1A;POLR2A;CYP26A1;GNB5;GNG2;ANGPTL3;SRF;ZDHHC7;GPAM;GNAI1;BCL2;POLR2D;KDM1B;CAV1;CAV2;APOD;MMP7;RUNX1;MMP9;GNG11;GNGT2;NOS3;ABCG5;PCK1;TFF1;TFF3;ADH4,294 (295),0.418,0.927,0,,42 (49),1,1,0.783,1
Oncostatin M Signaling Pathway,Wikipathways,7,MMP13;TIMP3;EGR1;LIFR;CCL2;PRKCH;NFKBIA,65 (65),0.786,1,0,,0 (0),1,1,0.786,1
Various types of N-glycan biosynthesis - Homo sapiens (human),KEGG,4,B4GALT2;FUT8;ALG13;MAN1C1,39 (39),0.786,1,0,,0 (31),1,1,0.786,1
TNF receptor signaling pathway ,PID,7,TNIK;IKBKG;MAP3K1;MAP3K3;CAV1;BAG4;CHUK,46 (46),0.422,0.927,0,,1 (1),1,1,0.786,1
Insulin Pathway,PID,7,DOK1;GRB10;GRB14;SH2B2;SGK1;INPP5D;CAV1,46 (46),0.422,0.927,0,,5 (5),1,1,0.786,1
Pyrimidine metabolism,EHMN,11,SLC28A2;PKM;UPP2;ENPP1;CDA;SLC29A3;POLR2A;POLR2D;AK3;NUP35;ENTPD5,135 (135),0.979,1,1,HMDB0000273,69 (77),0.432,1,0.787,1
MAPK6/MAPK4 signaling,Reactome,6,PAK1;PAK3;CDC42EP3;CDC14A;HSPB1;MMP2,39 (39),0.427,0.927,0,,5 (6),1,1,0.79,1
Kisspeptin-kisspeptin receptor system in the ovary,Wikipathways,6,PLCB4;PRKCH;PRKCQ;ARRB1;ARRB2;MMP9,39 (39),0.427,0.927,0,,5 (6),1,1,0.79,1
Downstream signaling in na&#xef;ve CD8+ T cells,PID,10,NFATC2;EGR1;IL2RB;FOSL1;PTPN7;CD3D;PRKCQ;GZMB;PRF1;CD8A,68 (68),0.429,0.927,0,,2 (2),1,1,0.792,1
Signaling events mediated by VEGFR1 and VEGFR2,PID,10,MAPK11;GRB10;CDH5;MYOF;NOS3;KDR;SH2D2A;VTN;CAV1;IQGAP1,68 (68),0.429,0.927,0,,8 (8),1,1,0.792,1
TSLP,NetPath,2,NFKBIA;RELB,21 (21),0.793,1,0,,0 (0),1,1,0.793,1
cell cycle: g2/m checkpoint,BioCarta,2,CDKN2D;SFN,21 (21),0.793,1,0,,0 (0),1,1,0.793,1
igf-1 signaling pathway,BioCarta,2,IGF1R;SRF,21 (21),0.793,1,0,,0 (0),1,1,0.793,1
Signal amplification,Reactome,5,GNGT2;GNB5;GNAI1;GNG2;GNG11,32 (32),0.432,0.927,0,,5 (5),1,1,0.794,1
miRNA regulation of p53 pathway in prostate cancer,Wikipathways,5,PERP;EI24;TNFRSF10B;PMAIP1;SESN3,32 (32),0.432,0.927,0,,1 (2),1,1,0.794,1
Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,5,NFKBIA;NFATC4;HDAC7;NFATC2;NELFA,32 (32),0.432,0.927,0,,1 (1),1,1,0.794,1
Noncanonical Wnt signaling pathway,PID,5,ROR2;ARRB2;FLNA;NFATC2;CAMK2A,32 (32),0.432,0.927,0,,3 (3),1,1,0.794,1
FLT3 Signaling,Reactome,5,GRAP2;SOCS2;LCK;GAB2;GRB10,32 (32),0.432,0.927,0,,6 (9),1,1,0.794,1
role of -arrestins in the activation and targeting of map kinases,BioCarta,5,ARRB1;CXCR4;ADRB2;CCL11;CCR5,32 (32),0.432,0.927,0,,3 (4),1,1,0.794,1
bcr signaling pathway,BioCarta,5,BLNK;VAV1;CD79A;CD79B;MAP3K1,32 (32),0.432,0.927,0,,3 (3),1,1,0.794,1
CD28 co-stimulation,Reactome,5,VAV1;GRAP2;LCK;PAK1;PAK3,32 (32),0.432,0.927,0,,5 (6),1,1,0.794,1
IL-5 signaling,INOH,1,SHC2,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
POU5F1 (OCT4)_ SOX2_ NANOG repress genes related to differentiation,Reactome,1,GATA6,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
Regulation by c-FLIP,Reactome,1,TNFRSF10B,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
CASP8 activity is inhibited,Reactome,1,TNFRSF10B,11 (11),0.795,1,0,,0 (1),1,1,0.795,1
Apoptotic cleavage of cell adhesion  proteins,Reactome,1,DSP,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
Activation of the TFAP2 (AP-2) family of transcription factors,Reactome,1,CITED4,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
NOTCH-Core,Signalink,1,RBPJ,11 (11),0.795,1,0,,0 (0),1,1,0.795,1
Mammalian disorder of sexual development,Wikipathways,4,MAPK11;WT1;SRD5A1;GATA4,25 (25),0.436,0.927,0,,3 (3),1,1,0.798,1
Signaling by ERBB2 KD Mutants,Reactome,4,ERBB2;HBEGF;NRG4;EREG,25 (25),0.436,0.927,0,,6 (10),1,1,0.798,1
WNT ligand biogenesis and trafficking,Reactome,4,WNT11;WLS;WNT9B;WNT7B,25 (25),0.436,0.927,0,,2 (2),1,1,0.798,1
G beta:gamma signalling through PI3Kgamma,Reactome,4,GNB5;GNGT2;GNG2;GNG11,25 (25),0.436,0.927,0,,3 (4),1,1,0.798,1
Signaling by ERBB2 in Cancer,Reactome,4,ERBB2;HBEGF;NRG4;EREG,25 (25),0.436,0.927,0,,6 (10),1,1,0.798,1
TRAIL signaling pathway,PID,4,TNFRSF10B;CHUK;IKBKG;MAP3K1,25 (25),0.436,0.927,0,,2 (2),1,1,0.798,1
Lipid and atherosclerosis - Homo sapiens (human),KEGG,30,HSPD1;CYP1A1;VLDLR;CXCL2;MAPK12;NFATC2;CAMK2A;PYCARD;NFKBIA;TLR4;IKBKG;CCL2;POU2F2;NCF2;APOA4;APOB;PLCB4;TNFRSF10B;MMP9;MAPK11;IL1B;MAPK13;HSPA1A;HSPA1B;HSPA1L;NOS3;VAV1;CXCL3;BCL2;CHUK,215 (215),0.436,0.927,0,,9 (14),1,1,0.798,1
Composition of Lipid Particles,Wikipathways,1,LCAT,4 (4),0.438,0.927,0,,4 (10),1,1,0.799,1
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione_ including diseases,Wikipathways,1,GGT1,4 (4),0.438,0.927,0,,6 (12),1,1,0.799,1
Drug-mediated inhibition of ERBB2 signaling,Reactome,1,ERBB2,4 (4),0.438,0.927,0,,1 (3),1,1,0.799,1
Amino acid conjugation of benzoic acid,Wikipathways,1,GLYAT,4 (4),0.438,0.927,0,,9 (11),1,1,0.799,1
PLCG1 events in ERBB2 signaling,Reactome,1,ERBB2,4 (4),0.438,0.927,0,,2 (2),1,1,0.799,1
<i>trans_ trans</i>-farnesyl diphosphate biosynthesis,HumanCyc,1,IDI1,4 (4),0.438,0.927,0,,4 (5),1,1,0.799,1
heme biosynthesis from uroporphyrinogen-III I,HumanCyc,1,CPOX,4 (4),0.438,0.927,0,,11 (11),1,1,0.799,1
Activated NTRK2 signals through PLCG1,Reactome,1,NTRK2,4 (4),0.438,0.927,0,,2 (2),1,1,0.799,1
Activated NTRK2 signals through FYN,Reactome,1,NTRK2,4 (4),0.438,0.927,0,,2 (2),1,1,0.799,1
MET Receptor Activation,Reactome,1,HGF,4 (4),0.438,0.927,0,,3 (3),1,1,0.799,1
catecholamine biosynthesis,HumanCyc,1,DDC,4 (4),0.438,0.927,0,,14 (16),1,1,0.799,1
MET activates PTK2 signaling,Reactome,1,HGF,4 (4),0.438,0.927,0,,2 (2),1,1,0.799,1
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Reactome,1,PAPSS2,4 (4),0.438,0.927,0,,15 (19),1,1,0.799,1
4-hydroxyproline degradation,HumanCyc,1,GOT2,4 (4),0.438,0.927,0,,15 (17),1,1,0.799,1
proline biosynthesis,HumanCyc,1,ALDH18A1,4 (4),0.438,0.927,0,,13 (14),1,1,0.799,1
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes),HumanCyc,1,GNE,4 (4),0.438,0.927,0,,13 (15),1,1,0.799,1
Amine Oxidase reactions,Reactome,1,MAOB,4 (4),0.438,0.927,0,,18 (18),1,1,0.799,1
Biosynthesis of E-series 18(R)-resolvins,Reactome,1,ALOX5,4 (4),0.438,0.927,0,,8 (15),1,1,0.799,1
phenylalanine degradation/tyrosine biosynthesis,HumanCyc,1,PAH,4 (4),0.438,0.927,0,,10 (11),1,1,0.799,1
Synthesis of PIPs in the nucleus,Reactome,1,PIP4K2A,4 (4),0.438,0.927,0,,4 (6),1,1,0.799,1
trehalose degradation,HumanCyc,1,HKDC1,4 (4),0.438,0.927,0,,8 (8),1,1,0.799,1
pyrimidine ribonucleosides salvage I,HumanCyc,1,CDA,4 (4),0.438,0.927,0,,9 (9),1,1,0.799,1
arsenate detoxification I (glutaredoxin),HumanCyc,1,AS3MT,4 (4),0.438,0.927,0,,21 (24),1,1,0.799,1
Vitamin B6 metabolism,INOH,1,PNPO,4 (4),0.438,0.927,0,,17 (17),1,1,0.799,1
Lidocaine (Local Anaesthetic) Metabolism Pathway,SMPDB,1,SCN1B,4 (4),0.438,0.927,0,,17 (17),1,1,0.799,1
Trandolapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Lipoic acid metabolism - Homo sapiens (human),KEGG,1,ACSM1,4 (4),0.438,0.927,0,,5 (13),1,1,0.799,1
Ramipril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (8),1,1,0.799,1
Quinapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,8 (8),1,1,0.799,1
Lisinopril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Rapoport-Luebering glycolytic shunt,HumanCyc,1,PGAM2,4 (5),0.438,0.927,0,,7 (7),1,1,0.799,1
Biosynthesis of D-series resolvins,Reactome,1,ALOX5,4 (4),0.438,0.927,0,,10 (25),1,1,0.799,1
Biosynthesis of protectins,Reactome,1,CYP1A1,4 (4),0.438,0.927,0,,7 (14),1,1,0.799,1
<i>S</i>-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,1,ADI1,4 (4),0.438,0.927,0,,34 (35),1,1,0.799,1
Fosinopril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (8),1,1,0.799,1
Enalapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,8 (8),1,1,0.799,1
Alternative complement activation,Reactome,1,C3,4 (4),0.438,0.927,0,,1 (3),1,1,0.799,1
Classical Kir channels,Reactome,1,KCNJ12,4 (4),0.438,0.927,0,,1 (1),1,1,0.799,1
Tyrosine hydroxylase deficiency,SMPDB,1,DDC,4 (4),0.438,0.927,0,,16 (18),1,1,0.799,1
Temocapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Vitamin K Metabolism,SMPDB,1,NQO1,4 (4),0.438,0.927,0,,12 (13),1,1,0.799,1
Olmesartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Losartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Irbesartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Forasartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Valsartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,6 (7),1,1,0.799,1
Telmisartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Malate-Aspartate Shuttle,SMPDB,1,GOT2,4 (4),0.438,0.927,0,,9 (10),1,1,0.799,1
Angiotensin Metabolism,SMPDB,1,ACE,4 (4),0.438,0.927,0,,6 (6),1,1,0.799,1
Catecholamine Biosynthesis,SMPDB,1,DDC,4 (4),0.438,0.927,0,,16 (18),1,1,0.799,1
Spirapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Rescinnamine Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Perindopril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,8 (8),1,1,0.799,1
Moexipril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Candesartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Eprosartan Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (7),1,1,0.799,1
Felbamate Metabolism Pathway,SMPDB,1,CYP2E1,4 (4),0.438,0.927,0,,18 (18),1,1,0.799,1
Catecholamine biosynthesis,Reactome,1,DDC,4 (4),0.438,0.927,0,,15 (19),1,1,0.799,1
Benazepril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,8 (8),1,1,0.799,1
Cilazapril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,7 (8),1,1,0.799,1
Captopril Action Pathway,SMPDB,1,ACE,4 (4),0.438,0.927,0,,6 (7),1,1,0.799,1
Proton/oligopeptide cotransporters,Reactome,1,SLC15A2,4 (4),0.438,0.927,0,,2 (5),1,1,0.799,1
Aromatic L-Aminoacid Decarboxylase Deficiency,SMPDB,1,DDC,4 (4),0.438,0.927,0,,16 (18),1,1,0.799,1
Nicotine Activity on Chromaffin Cells,Wikipathways,1,CACNA1C,4 (4),0.438,0.927,0,,5 (5),1,1,0.799,1
Apoptosis,Reactome,18,SATB1;LMNB1;BAK1;BMF;PMAIP1;VIM;DSP;UNC5A;ARHGAP10;HMGB2;OPA1;TNFRSF10B;BCL2;GSN;PRKCQ;SFN;TLR4;GZMB,127 (127),0.438,0.927,0,,5 (8),1,1,0.8,1
Cardiac Hypertrophic Response,Wikipathways,8,IKBKG;FGF2;HDAC7;MAP4K1;MAP3K1;CHUK;MAPK7;NFATC2,54 (54),0.439,0.927,0,,4 (5),1,1,0.801,1
Insulin receptor signalling cascade,Reactome,8,FGF1;GRB10;FGF2;PDE3B;GAB2;FGFR1;TLR9;KLB,54 (54),0.439,0.927,0,,10 (14),1,1,0.801,1
IL2-mediated signaling events,PID,8,MAPK11;IKZF3;SOCS2;DOK2;IL2RB;BCL2;GAB2;LCK,54 (54),0.439,0.927,0,,2 (2),1,1,0.801,1
Glycosphingolipid biosynthesis - globoseries,EHMN,3,B4GALT6;ST3GAL2;FUT2,18 (18),0.441,0.927,0,,14 (22),1,1,0.802,1
Synthesis of PIPs at the Golgi membrane,Reactome,3,PIK3C2G;TPTE;PI4K2B,18 (18),0.441,0.927,0,,8 (15),1,1,0.802,1
Acyl chain remodelling of PG,Reactome,3,LPCAT4;PLA2G4F;LPGAT1,18 (18),0.441,0.927,0,,3 (8),1,1,0.802,1
Signalling to RAS,Reactome,3,MAPK11;NGF;SHC2,18 (18),0.441,0.927,0,,5 (5),1,1,0.802,1
Fatty acid biosynthesis - Homo sapiens (human),KEGG,3,ACSF3;OXSM;ACSL1,18 (18),0.441,0.927,0,,10 (58),1,1,0.802,1
EPHA2 forward signaling,PID,3,PAK1;BCAR1;ARHGAP35,18 (18),0.441,0.927,0,,3 (3),1,1,0.802,1
Serotonin Neurotransmitter Release Cycle,Reactome,3,SYT1;PPFIA2;STXBP1,18 (18),0.441,0.927,0,,1 (1),1,1,0.802,1
AMPK signaling pathway - Homo sapiens (human),KEGG,17,PRKAA2;HNF4A;PCK1;CPT1C;STRADB;PFKFB2;CAB39L;ADRA1A;CPT1A;GYS2;PFKFB1;IGF1R;ADIPOR2;PFKFB4;CREB3L3;PRKAG2;SLC2A4,120 (120),0.443,0.927,0,,17 (23),1,1,0.804,1
IL-3 signaling pathway,Wikipathways,5,VAV1;INPP5D;BCL2;GAB2;IL3RA,49 (49),0.804,1,0,,0 (0),1,1,0.804,1
IL12 signaling mediated by STAT4,PID,3,ETV5;CD3D;PRF1,31 (31),0.805,1,0,,0 (0),1,1,0.805,1
p38 mapk signaling pathway,BioCarta,3,MEF2C;HSPB1;MAP3K1,31 (31),0.805,1,0,,0 (0),1,1,0.805,1
PDGF Pathway,Wikipathways,2,PDGFB;PDGFRB,11 (11),0.445,0.927,0,,7 (8),1,1,0.805,1
Steroidogenesis,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
superoxide radicals degradation,HumanCyc,2,GPX3;CAT,11 (11),0.445,0.927,0,,10 (11),1,1,0.805,1
MET activates RAS signaling,Reactome,2,HGF;RANBP10,11 (11),0.445,0.927,0,,4 (4),1,1,0.805,1
CYP2E1 reactions,Reactome,2,CYP2S1;CYP2E1,11 (11),0.445,0.927,0,,14 (20),1,1,0.805,1
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Apparent mineralocorticoid excess syndrome,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
3-Beta-Hydroxysteroid Dehydrogenase Deficiency,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Vinblastine Action Pathway,SMPDB,2,TUBB1;ABCC2,11 (11),0.445,0.927,0,,6 (6),1,1,0.805,1
Vinorelbine Action Pathway,SMPDB,2,TUBB1;ABCC2,11 (11),0.445,0.927,0,,5 (6),1,1,0.805,1
21-hydroxylase deficiency (CYP21),SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Corticosterone methyl oxidase I deficiency (CMO I),SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Corticosterone methyl oxidase II deficiency - CMO II,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
17-alpha-hydroxylase deficiency (CYP17),SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
11-beta-hydroxylase deficiency (CYP11B1),SMPDB,2,CYP17A1;AKR1D1,11 (11),0.445,0.927,0,,40 (42),1,1,0.805,1
Serotonin Transporter Activity,Wikipathways,2,TGFB1I1;IL1B,11 (11),0.445,0.927,0,,3 (3),1,1,0.805,1
Microglia Pathogen Phagocytosis Pathway,Wikipathways,6,LAT;ITGAM;ITGB2;NCF2;VAV1;PLCG2,40 (40),0.452,0.939,0,,2 (2),1,1,0.811,1
Interleukin-2 family signaling,Reactome,6,IL2RB;IL3RA;INPP5D;GAB2;LCK;IL9R,40 (40),0.452,0.939,0,,2 (2),1,1,0.811,1
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,BioCarta,6,TLR4;IKBKG;GJA1;EHHADH;NFKBIA;CHUK,40 (40),0.452,0.939,0,,2 (2),1,1,0.811,1
Transcription factor regulation in adipogenesis,Wikipathways,2,NRIP1;SLC2A4,22 (22),0.815,1,0,,0 (1),1,1,0.815,1
inhibition of cellular proliferation by gleevec,BioCarta,2,BCL2;MAP3K1,22 (22),0.815,1,0,,0 (0),1,1,0.815,1
erk1/erk2 mapk signaling pathway,BioCarta,2,NGF;NGFR,22 (22),0.815,1,0,,0 (1),1,1,0.815,1
IL2,NetPath,8,ETS2;VIL1;IL2RB;SGK1;VAV1;BCL2;GAB2;LCK,76 (76),0.816,1,0,,0 (0),1,1,0.816,1
MAPK Cascade,Wikipathways,5,MBP;MAPK12;MAP3K1;SIPA1;MAP3K3,33 (33),0.459,0.952,0,,2 (2),1,1,0.817,1
Circadian Clock,Reactome,5,PPARA;NRIP1;CPT1A;CSNK1E;BHLHE41,33 (33),0.459,0.952,0,,2 (3),1,1,0.817,1
GPVI-mediated activation cascade,Reactome,5,PLCG2;LAT;CLEC1B;LCK;VAV1,33 (33),0.459,0.952,0,,6 (9),1,1,0.817,1
Sialic acid metabolism,Reactome,5,ST6GALNAC4;ST3GAL2;GNE;ST8SIA3;SLC17A5,33 (33),0.459,0.952,0,,18 (27),1,1,0.817,1
Regulation of Ras family activation,PID,5,RASGRP3;DAB2IP;LGALS1;RIN1;LGALS3,33 (33),0.459,0.952,0,,5 (5),1,1,0.817,1
Glucagon-type ligand receptors,Reactome,5,SCTR;GNB5;GNGT2;GNG2;GNG11,33 (33),0.459,0.952,0,,1 (1),1,1,0.817,1
Toll Like Receptor 10 (TLR10) Cascade,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;CHUK;TLR5;MAPK7;IKBKG,77 (77),0.46,0.952,0,,4 (8),1,1,0.817,1
Toll Like Receptor 5 (TLR5) Cascade,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;CHUK;TLR5;MAPK7;IKBKG,77 (77),0.46,0.952,0,,4 (8),1,1,0.817,1
MyD88 cascade initiated on plasma membrane,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;CHUK;TLR5;MAPK7;IKBKG,77 (77),0.46,0.952,0,,4 (8),1,1,0.817,1
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,11,MAPK11;IKBKG;MEF2C;RPS6KA2;DUSP4;NFKBIA;DUSP7;TLR9;CHUK;MAP3K1;MAPK7,77 (77),0.46,0.952,0,,5 (11),1,1,0.817,1
Ca2+ pathway,Reactome,8,FZD4;GNG11;GNGT2;CAMK2A;WNT11;GNB5;GNG2;ITPR3,55 (55),0.461,0.953,0,,13 (16),1,1,0.818,1
Apoptosis - Homo sapiens (human),KEGG,19,LMNB1;DAB2IP;CHUK;PMAIP1;TUBA1A;ACTG1;AIFM1;IL3RA;BAK1;PRF1;CTSW;NGF;BCL2;CASP12;NFKBIA;GZMB;TNFRSF10B;ITPR3;IKBKG,136 (136),0.461,0.953,0,,4 (4),1,1,0.818,1
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Reactome,4,ERBB2;HSPD1;CITED4;KIT,41 (41),0.818,1,0,,0 (0),1,1,0.818,1
Pre-implantation embryo,Wikipathways,6,GATA2;KLF4;ZFP36L2;EGR1;AQP9;FOSB,59 (59),0.821,1,0,,0 (0),1,1,0.821,1
SARS-CoV-2 innate immunity evasion and cell-specific immune response,Wikipathways,6,CXCL13;CXCL5;CXCL2;CXCL3;CCL2;SMAD3,59 (60),0.821,1,0,,0 (0),1,1,0.821,1
Regulation of Glucokinase by Glucokinase Regulatory Protein,Reactome,3,NUP35;NDC1;POM121,32 (32),0.822,1,0,,0 (0),1,1,0.822,1
IL17 signaling pathway,Wikipathways,3,IL17RD;IL17RB;IKBKG,32 (32),0.822,1,0,,0 (0),1,1,0.822,1
IL9,NetPath,1,IL9R,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
FOXP3 in COVID-19,Wikipathways,1,IL2RB,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
Regulation of signaling by NODAL,Reactome,1,ACVR1B,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
POU5F1 (OCT4)_ SOX2_ NANOG activate genes related to proliferation,Reactome,1,FGF2,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
TP53 Regulates Transcription of Death Receptors and Ligands,Reactome,1,TNFRSF10B,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
il 3 signaling pathway,BioCarta,1,IL3RA,12 (12),0.822,1,0,,0 (0),1,1,0.822,1
protein kinase a at the centrosome,BioCarta,1,PRKAR2A,12 (12),0.822,1,0,,0 (1),1,1,0.822,1
Prolactin signaling pathway - Homo sapiens (human),KEGG,10,MAPK11;SOCS2;SLC2A2;PRLR;CYP17A1;MAPK13;SOCS5;TNFRSF11A;MAPK12;SHC2,70 (70),0.467,0.961,0,,10 (11),1,1,0.822,1
Surfactant metabolism,Reactome,4,ADORA2B;CKAP4;LMCD1;GATA6,26 (26),0.468,0.961,0,,12 (13),1,1,0.823,1
N-glycan antennae elongation in the medial/trans-Golgi,Reactome,4,B4GALT2;FUT8;B4GALT6;ST8SIA3,26 (26),0.468,0.961,0,,10 (22),1,1,0.823,1
DARPP-32 events,Reactome,4,PDE4D;PRKAR2A;PDE4B;PRKAR1B,26 (26),0.468,0.961,0,,11 (13),1,1,0.823,1
S1P3 pathway,PID,4,GNAI1;PDGFB;CXCR4;PDGFRB,26 (26),0.468,0.961,0,,4 (4),1,1,0.823,1
S1P2 pathway,PID,4,GNAI1;CDH5;PAK1;S1PR2,26 (26),0.468,0.961,0,,4 (4),1,1,0.823,1
IRS-mediated signalling,Reactome,7,FGF1;FGF2;PDE3B;GAB2;FGFR1;TLR9;KLB,48 (48),0.468,0.961,0,,9 (12),1,1,0.823,1
Ceramide signaling pathway,PID,7,AIFM1;KSR1;NFKBIA;BCL2;MAP3K1;SMPD3;BAG4,48 (48),0.468,0.961,0,,3 (3),1,1,0.823,1
Regulation of nuclear SMAD2/3 signaling,PID,8,RUNX3;HNF4A;LAMC1;RUNX1;MEF2C;SMAD3;VDR;COL1A2,77 (77),0.827,1,0,,0 (0),1,1,0.827,1
Basal cell carcinoma - Homo sapiens (human),KEGG,9,FZD4;FZD8;FZD9;BMP2;BAK1;HHIP;WNT7B;WNT11;WNT9B,63 (63),0.474,0.972,0,,1 (1),1,1,0.828,1
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,6,F8;F9;ARSG;FN3KRP;PROZ;GAS6,41 (41),0.477,0.976,0,,24 (34),1,1,0.83,1
Aurora B signaling,PID,6,INCENP;EVI5;VIM;DES;KIF23;NCAPD2,41 (41),0.477,0.976,0,,2 (2),1,1,0.83,1
MyD88 dependent cascade initiated on endosome,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;TLR9;CHUK;MAPK7;IKBKG,78 (78),0.478,0.976,0,,5 (11),1,1,0.831,1
Gastrin-CREB signalling pathway via PKC and MAPK,Reactome,3,RPS6KA2;MAPK7;HBEGF,19 (19),0.478,0.976,0,,4 (5),1,1,0.831,1
Asymmetric localization of PCP proteins,Reactome,3,FZD4;PRICKLE1;FZD8,19 (19),0.478,0.976,0,,2 (3),1,1,0.831,1
gata3 participate in activating the th2 cytokine genes expression,BioCarta,3,PRKAR2A;MAF;PRKAR1B,19 (19),0.478,0.976,0,,3 (5),1,1,0.831,1
nitric oxide signaling pathway,BioCarta,3,PRKAR2A;DLG4;PRKAR1B,19 (19),0.478,0.976,0,,5 (5),1,1,0.831,1
IL-2 signaling pathway,Wikipathways,4,IL2RB;LCK;BCL2;GAB2,42 (42),0.833,1,0,,0 (0),1,1,0.833,1
Salivary secretion - Homo sapiens (human),KEGG,13,GUCY1A1;KCNN4;ADCY4;BST1;ADCY2;ATP2B4;ADCY9;ADRA1A;GUCY1B1;PLCB4;ADRB2;ATP1A2;ITPR3,93 (93),0.481,0.982,0,,15 (17),1,1,0.833,1
Role of Calcineurin-dependent NFAT signaling in lymphocytes,PID,8,NFATC2;PRKCH;PRKCQ;MAP3K1;BCL2;SFN;NR4A1;CHP1,56 (56),0.482,0.982,0,,1 (2),1,1,0.834,1
Hippo-Yap signaling pathway,Wikipathways,2,MAP4K1;TNIK,23 (23),0.834,1,0,,0 (0),1,1,0.834,1
IL11,NetPath,2,CHUK;IL11,23 (23),0.834,1,0,,0 (0),1,1,0.834,1
induction of apoptosis through dr3 and dr4/5 death receptors,BioCarta,2,ACTA1;TNFRSF10B,23 (23),0.834,1,0,,0 (0),1,1,0.834,1
Factors involved in megakaryocyte development and platelet production,Reactome,20,GATA2;GATA4;GATA6;PRKAR1B;KIF21B;CENPE;RBSN;PRKAR2A;KIF26A;DOCK11;SH2B2;KIF20B;MAFF;KIF21A;ZFPM2;KIF1B;AK3;ABL1;EHD2;KIF23,145 (145),0.482,0.983,0,,10 (13),1,1,0.834,1
Signaling by Rho GTPases,Reactome,93,STARD13;CCP110;DLG5;PLXND1;ABL1;STARD8;INCENP;IQGAP2;RHOJ;MYO6;KDM4C;DOCK11;TEX2;ASB15;WASF3;OBSCN;SRF;MCAM;ACTG1;SKA2;NCF2;ARHGEF17;PAK6;DBT;CHN2;IQGAP1;FARP2;PLEKHG1;GJA1;DLC1;CDC42SE2;BAIAP2L1;GFOD1;ARHGEF7;WAS;ABCD3;FGD1;KIF14;DLG4;FGD5;ARHGAP25;CKAP4;MCF2L;ALDH3A2;CENPE;PREX1;RHOF;FMNL1;VAV1;ARHGEF6;FGD3;MYO9A;SFN;VIM;FLNA;ARHGEF28;SH3RF1;FGD2;DSP;ARHGAP10;STK10;ACBD5;ARHGAP9;ARHGDIB;CAV1;LBR;LCK;ARHGAP35;ARHGEF25;CDC42EP3;SLC1A5;SYDE1;PREX2;FMNL3;ARHGAP1;ARHGAP4;PPP1R14A;LIMK1;ARAP3;LMAN1;FAM13A;LMNB1;WASF2;DEF6;PAK1;PAK3;CAVIN1;ARHGAP27;ARHGEF2;MAPK11;ARHGAP45;PCDH7;ARHGAP31,688 (689),0.483,0.984,0,,24 (29),1,1,0.834,1
Melatonin metabolism and effects,Wikipathways,5,CYP1B1;PER3;CSNK1E;CAMK2A;CYP1A1,34 (34),0.487,0.989,0,,12 (15),1,1,0.837,1
Type 2 papillary renal cell carcinoma,Wikipathways,5,PDGFB;TGFB2;TGFB3;ARNT2;TFEB,34 (34),0.487,0.989,0,,3 (3),1,1,0.837,1
Translocation of SLC2A4 (GLUT4) to the plasma membrane,Reactome,5,TBC1D4;PRKAA2;RALGAPB;SFN;PRKAG2,34 (34),0.487,0.989,0,,7 (8),1,1,0.837,1
IL8- and CXCR2-mediated signaling events,PID,5,VASP;ARRB2;ARRB1;GNG2;FGR,34 (34),0.487,0.989,0,,4 (4),1,1,0.837,1
Role of Osx and miRNAs in tooth development,Wikipathways,3,KLF4;NOTCH4;HNF1A,33 (33),0.838,1,0,,0 (1),1,1,0.838,1
Host-pathogen interaction of human coronaviruses - interferon induction,Wikipathways,3,NFKBIA;CHUK;IKBKG,33 (33),0.838,1,0,,0 (0),1,1,0.838,1
Melanogenesis - Homo sapiens (human),KEGG,14,FZD4;FZD8;FZD9;KIT;ADCY4;ADCY2;CAMK2A;GNAI1;ADCY9;PLCB4;WNT7B;WNT11;CREB3L3;WNT9B,101 (101),0.491,0.989,0,,6 (6),1,1,0.84,1
Transcriptional regulation by RUNX3,Reactome,7,RUNX3;MAML1;ITGAL;SMAD3;RBPJ;RUNX1;MAMLD1,49 (49),0.491,0.989,0,,6 (6),1,1,0.84,1
Cocaine addiction - Homo sapiens (human),KEGG,7,MAOB;SLC18A1;DDC;FOSB;DLG4;GNAI1;CREB3L3,49 (49),0.491,0.989,0,,8 (8),1,1,0.84,1
melatonin degradation I,HumanCyc,2,CYP2S1;CYP1B1,12 (12),0.492,0.989,0,,10 (13),1,1,0.841,1
Signaling by Activin,Reactome,2,SMAD3;ACVR1B,12 (12),0.492,0.989,0,,2 (3),1,1,0.841,1
Interleukin-2 signaling,Reactome,2,IL2RB;LCK,12 (12),0.492,0.989,0,,2 (2),1,1,0.841,1
Presynaptic depolarization and calcium channel opening,Reactome,2,CACNA2D1;CACNB1,12 (12),0.492,0.989,0,,1 (1),1,1,0.841,1
Hyaluronan metabolism,Reactome,2,CHP1;LYVE1,12 (12),0.492,0.989,0,,5 (7),1,1,0.841,1
Signaling by activated point mutants of FGFR3,Reactome,2,FGF1;FGF2,12 (12),0.492,0.989,0,,3 (3),1,1,0.841,1
Ionotropic activity of kainate receptors,Reactome,2,NCALD;DLG4,12 (12),0.492,0.989,0,,4 (4),1,1,0.841,1
CLEC7A (Dectin-1) induces NFAT activation,Reactome,2,NFATC2;ITPR3,12 (12),0.492,0.989,0,,4 (5),1,1,0.841,1
FGFR3 mutant receptor activation,Reactome,2,FGF1;FGF2,12 (12),0.492,0.989,0,,3 (13),1,1,0.841,1
Ethanol oxidation,Reactome,2,ACSS1;ADH4,12 (12),0.492,0.989,0,,15 (15),1,1,0.841,1
IRAK1 recruits IKK complex,Reactome,2,CHUK;IKBKG,12 (12),0.492,0.989,0,,2 (3),1,1,0.841,1
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Reactome,2,CHUK;IKBKG,12 (12),0.492,0.989,0,,1 (4),1,1,0.841,1
Miscellaneous substrates,Reactome,2,CYP2S1;CYP4B1,12 (12),0.492,0.989,0,,12 (15),1,1,0.841,1
CaMK IV-mediated phosphorylation of CREB,Reactome,2,CAMKK1;CAMK2A,12 (12),0.492,0.989,0,,3 (3),1,1,0.841,1
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Reactome,2,NOS3;DHFR,12 (12),0.492,0.989,0,,21 (27),1,1,0.841,1
carm1 and regulation of the estrogen receptor,BioCarta,2,MEF2C;POLR2A,12 (12),0.492,0.989,0,,1 (1),1,1,0.841,1
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Reactome,2,CHUK;IKBKG,12 (12),0.492,0.989,0,,2 (3),1,1,0.841,1
Activation of Ca-permeable Kainate Receptor,Reactome,2,NCALD;DLG4,12 (12),0.492,0.989,0,,3 (3),1,1,0.841,1
Purine ribonucleoside monophosphate biosynthesis,Reactome,2,LHPP;PAICS,12 (12),0.492,0.989,0,,36 (37),1,1,0.841,1
Activation of AMPK downstream of NMDARs,Reactome,2,PRKAA2;PRKAG2,12 (12),0.492,0.989,0,,3 (4),1,1,0.841,1
Iron metabolism in placenta,Wikipathways,2,ACO1;TFR2,12 (12),0.492,0.989,0,,2 (2),1,1,0.841,1
Endothelins,PID,9,COL3A1;ADCY4;ADCY2;PRKCH;GNAI1;ADCY9;PRKCQ;BCAR1;COL1A2,64 (64),0.494,0.991,0,,5 (5),1,1,0.842,1
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;TLR9;CHUK;MAPK7;IKBKG,79 (79),0.496,0.995,0,,5 (11),1,1,0.844,1
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,13,PLET1;ART3;GPLD1;MDGA1;BST1;VNN1;FOLR2;PIGL;RECK;IZUMO1R;VNN3;PGAP1;THY1,94 (94),0.498,0.995,0,,12 (22),1,1,0.845,1
Control of immune tolerance by vasoactive intestinal peptide,Wikipathways,1,CTLA4,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
Apoptosis induced DNA fragmentation,Reactome,1,HMGB2,13 (13),0.846,1,0,,0 (3),1,1,0.846,1
Homologous recombination,Wikipathways,1,RAD50,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
Trafficking and processing of endosomal TLR,Reactome,1,TLR9,13 (13),0.846,1,0,,0 (2),1,1,0.846,1
erythropoietin mediated neuroprotection through nf-kb,BioCarta,1,NFKBIA,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation,BioCarta,1,IGF1R,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
il 6 signaling pathway,BioCarta,1,LRPPRC,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
the 41bb-dependent immune response,BioCarta,1,TNFSF9,13 (13),0.846,1,0,,0 (0),1,1,0.846,1
RND1 GTPase cycle,Reactome,6,ALDH3A2;DSP;DLG5;KIF14;CAV1;ARHGAP35,42 (42),0.501,0.995,0,,1 (1),1,1,0.847,1
p73 transcription factor network,PID,8,MAPK11;WT1;PLPP1;ADA;TUBA1A;BAK1;ABL1;SFN,79 (79),0.848,1,0,,0 (0),1,1,0.848,1
segmentation clock,BioCarta,2,LFNG;RBPJ,24 (24),0.851,1,0,,0 (0),1,1,0.851,1
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,20,PLA2G4E;PDGFB;PDGFRA;PDGFD;PDGFRB;AVPR1A;ADCY4;RAPGEF3;ADCY2;PLPP1;KIT;CYTH4;ADCY9;PLCB4;PLA2G4F;GAB2;PLCG2;PLPP2;RAPGEF4;SHC2,147 (148),0.508,0.995,0,,9 (11),1,1,0.852,1
Signaling of Hepatocyte Growth Factor Receptor,Wikipathways,3,MAP4K1;PAK1;HGF,34 (34),0.853,1,0,,0 (0),1,1,0.853,1
p38 MAPK Signaling Pathway,Wikipathways,3,TGFB2;HSPB1;MAP3K1,34 (34),0.853,1,0,,0 (0),1,1,0.853,1
Vpr-mediated nuclear import of PICs,Reactome,3,NUP35;NDC1;POM121,34 (34),0.853,1,0,,0 (1),1,1,0.853,1
Biosynthesis of E-series 18(S)-resolvins,Reactome,1,ALOX5,5 (5),0.513,0.995,0,,11 (20),1,1,0.856,1
spermine and spermidine degradation I,HumanCyc,1,AOC3,5 (5),0.513,0.995,0,,13 (13),1,1,0.856,1
The proton buffering model,Reactome,1,UCP3,5 (5),0.513,0.995,0,,1 (1),1,1,0.856,1
citrulline-nitric oxide cycle,HumanCyc,1,NOS3,5 (5),0.513,0.995,0,,14 (14),1,1,0.856,1
glycerol degradation,HumanCyc,1,GK,5 (5),0.513,0.995,0,,9 (10),1,1,0.856,1
PKA-mediated phosphorylation of key metabolic factors,Reactome,1,PFKFB1,5 (5),0.513,0.995,0,,2 (2),1,1,0.856,1
The fatty acid cycling model,Reactome,1,UCP3,5 (5),0.513,0.995,0,,1 (3),1,1,0.856,1
Estrogen biosynthesis,Reactome,1,HSD17B11,5 (5),0.513,0.995,0,,10 (10),1,1,0.856,1
pyridoxal 5_-phosphate salvage,HumanCyc,1,PNPO,5 (5),0.513,0.995,0,,14 (14),1,1,0.856,1
Serotonin and melatonin biosynthesis,Reactome,1,DDC,5 (5),0.513,0.995,0,,14 (16),1,1,0.856,1
serotonin and melatonin biosynthesis,HumanCyc,1,DDC,5 (5),0.513,0.995,0,,14 (15),1,1,0.856,1
Activation of RAS in B cells,Reactome,1,RASGRP3,5 (5),0.513,0.995,0,,2 (3),1,1,0.856,1
Extrinsic Pathway of Fibrin Clot Formation,Reactome,1,F9,5 (5),0.513,0.995,0,,1 (1),1,1,0.856,1
Ficolins bind to repetitive carbohydrate structures on the target cell surface,Reactome,1,MASP2,5 (5),0.513,0.995,0,,3 (8),1,1,0.856,1
bupropion degradation,HumanCyc,1,CYP2S1,5 (5),0.513,0.995,0,,5 (10),1,1,0.856,1
protein citrullination,HumanCyc,1,PADI2,5 (5),0.513,0.995,0,,2 (2),1,1,0.856,1
Tenofovir Metabolism Pathway,SMPDB,1,AK1,5 (5),0.513,0.995,0,,3 (4),1,1,0.856,1
Sulfide oxidation to sulfate,Reactome,1,SUOX,5 (5),0.513,0.995,0,,12 (15),1,1,0.856,1
asparagine degradation,HumanCyc,1,GOT1,5 (5),0.513,0.995,0,,10 (10),1,1,0.856,1
Capecitabine Action Pathway,SMPDB,1,CDA,5 (5),0.513,0.995,0,,9 (9),1,1,0.856,1
Reelin signalling pathway,Reactome,1,VLDLR,5 (5),0.513,0.995,0,,2 (2),1,1,0.856,1
Synthesis of PIPs at the ER membrane,Reactome,1,PI4K2B,5 (5),0.513,0.995,0,,4 (9),1,1,0.856,1
Neomycin_ kanamycin and gentamicin biosynthesis - Homo sapiens (human),KEGG,1,HKDC1,5 (5),0.513,0.995,0,,8 (81),1,1,0.856,1
Sodium-coupled sulphate_ di- and tri-carboxylate transporters,Reactome,1,SLC13A3,5 (5),0.513,0.995,0,,4 (4),1,1,0.856,1
tetrapyrrole biosynthesis,HumanCyc,1,ALAS1,5 (5),0.513,0.995,0,,11 (11),1,1,0.856,1
N-glycan trimming and elongation in the cis-Golgi,Reactome,1,MAN1C1,5 (5),0.513,0.995,0,,3 (13),1,1,0.856,1
fosb gene expression and drug abuse,BioCarta,1,FOSB,5 (5),0.513,0.995,0,,5 (7),1,1,0.856,1
Formation of xylulose-5-phosphate,Reactome,1,SORD,5 (5),0.513,0.995,0,,15 (17),1,1,0.856,1
NGF-independant TRKA activation,Reactome,1,NTRK2,5 (5),0.513,0.995,0,,3 (3),1,1,0.856,1
Hypophosphatasia,SMPDB,1,PNPO,5 (5),0.513,0.995,0,,19 (20),1,1,0.856,1
Degradation of Superoxides,SMPDB,1,CAT,5 (5),0.513,0.995,0,,10 (10),1,1,0.856,1
Adefovir Dipivoxil Metabolism Pathway,SMPDB,1,AK1,5 (5),0.513,0.995,0,,4 (5),1,1,0.856,1
Capecitabine Metabolism Pathway,SMPDB,1,CDA,5 (5),0.513,0.995,0,,9 (9),1,1,0.856,1
Plasmalogen Synthesis,SMPDB,1,PLPP1,5 (5),0.513,0.995,0,,14 (14),1,1,0.856,1
Vitamin B6 Metabolism,SMPDB,1,PNPO,5 (5),0.513,0.995,0,,19 (20),1,1,0.856,1
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,1,PGM3,5 (5),0.513,0.995,0,,9 (11),1,1,0.856,1
Riboflavin Metabolism,SMPDB,1,ENPP1,5 (5),0.513,0.995,0,,19 (19),1,1,0.856,1
miRNA Biogenesis,Wikipathways,1,DROSHA,5 (5),0.513,0.995,0,,1 (1),1,1,0.856,1
Synaptic signaling pathways associated with autism spectrum disorder,Wikipathways,7,ARC;CACNA1C;SHANK3;NTRK2;DLG4;PRKAA2;PRKAG2,50 (50),0.513,0.995,0,,4 (4),1,1,0.856,1
TNFR2 non-canonical NF-kB pathway,Reactome,7,TNFRSF13C;TNFSF9;EDA2R;LTB;RELB;TNFRSF11A;CHUK,50 (50),0.513,0.995,0,,2 (2),1,1,0.856,1
Detoxification of Reactive Oxygen Species,Reactome,5,NCF2;NOX4;PRDX6;GPX3;CAT,35 (35),0.513,0.995,0,,20 (24),1,1,0.856,1
Signaling mediated by p38-alpha and p38-beta,PID,5,MEF2C;KRT19;HSPB1;MAPK11;PTGS2,35 (35),0.513,0.995,0,,1 (1),1,1,0.856,1
Toll Like Receptor 9 (TLR9) Cascade,Reactome,11,MAPK11;DUSP4;MEF2C;RPS6KA2;MAP3K1;NFKBIA;DUSP7;TLR9;CHUK;MAPK7;IKBKG,80 (80),0.514,0.995,0,,5 (11),1,1,0.856,1
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,11,MGST1;UGT1A1;CYP2E1;TPMT;UPP2;DPYD;DPYS;CDA;UGT1A5;UPB1;UGT2A3,80 (80),0.514,0.995,0,,39 (52),1,1,0.856,1
3-phosphoinositide degradation,HumanCyc,3,INPP5D;INPP4B;SYNJ2,20 (20),0.514,0.995,0,,2 (5),1,1,0.856,1
HSP90 chaperone cycle for steroid hormone receptors (SHR),Reactome,3,HSPA1B;HSPA1L;HSPA1A,20 (20),0.514,0.995,0,,10 (12),1,1,0.856,1
Heme signaling,Reactome,3,APOB;TLR4;CLEC1B,20 (20),0.514,0.995,0,,6 (10),1,1,0.856,1
Signaling by NODAL,Reactome,3,SMAD3;ACVR1B;PCSK6,20 (20),0.514,0.995,0,,2 (3),1,1,0.856,1
Sema4D induced cell migration and growth-cone collapse,Reactome,3,ERBB2;LIMK1;SEMA4D,20 (20),0.514,0.995,0,,4 (4),1,1,0.856,1
Unblocking of NMDA receptors_ glutamate binding and activation,Reactome,3,ACTN2;DLG4;CAMK2A,20 (20),0.514,0.995,0,,6 (6),1,1,0.856,1
SHC-mediated cascade:FGFR4,Reactome,3,KLB;FGF1;FGF2,20 (20),0.514,0.995,0,,5 (5),1,1,0.856,1
PI-3K cascade:FGFR4,Reactome,3,KLB;FGF1;FGF2,20 (20),0.514,0.995,0,,4 (5),1,1,0.856,1
sprouty regulation of tyrosine kinase signals,BioCarta,3,SPRY4;PTPRB;SPRY1,20 (20),0.514,0.995,0,,3 (4),1,1,0.856,1
Mitochondrial Electron Transport Chain,SMPDB,3,GPD1;SLC25A4;SLC37A4,20 (20),0.514,0.995,0,,17 (18),1,1,0.856,1
MECP2 and Associated Rett Syndrome,Wikipathways,10,FUT8;MBP;FGF2;SGK1;CAMK2A;MEF2C;CDON;IGF1R;CSRP1;RBFOX1,73 (73),0.523,1,0,,9 (11),1,1,0.862,1
Signaling by ERBB4,Reactome,8,GABRB3;NRG4;GFAP;HBEGF;WWP1;DLG4;ADAP1;EREG,58 (58),0.524,1,0,,7 (9),1,1,0.862,1
Recycling pathway of L1,Reactome,4,DPYSL2;SHTN1;RPS6KA2;MSN,28 (28),0.528,1,0,,5 (7),1,1,0.865,1
IL8- and CXCR1-mediated signaling events,PID,4,ARRB1;ARRB2;GNG2;FGR,28 (28),0.528,1,0,,4 (4),1,1,0.865,1
Pathways affected in adenoid cystic carcinoma,Wikipathways,6,BCOR;SMARCA2;IL17RD;UHRF1;ERBB2;KDM6B,63 (63),0.865,1,0,,0 (0),1,1,0.865,1
Cytosolic DNA-sensing pathway - Homo sapiens (human),KEGG,6,IL1B;CHUK;IKBKG;PYCARD;NFKBIA;RIPK3,63 (63),0.865,1,0,,0 (1),1,1,0.865,1
SUMOylation of SUMOylation proteins,Reactome,3,NUP35;NDC1;POM121,35 (35),0.866,1,0,,0 (0),1,1,0.866,1
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,Reactome,1,E2F8,14 (14),0.867,1,0,,0 (0),1,1,0.867,1
apoptotic signaling in response to dna damage,BioCarta,1,BCL2,14 (14),0.867,1,0,,0 (0),1,1,0.867,1
Repression of WNT target genes,Reactome,1,CTBP2,14 (14),0.867,1,0,,0 (0),1,1,0.867,1
Hedgehog,NetPath,2,ARRB2;HHIP,25 (25),0.867,1,0,,0 (0),1,1,0.867,1
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,11,PAK1;GAB2;EGR1;HGF;INPP5D;MAP3K1;SNAI1;RANBP10;BCAR1;ASB15;DEPTOR,81 (81),0.531,1,0,,4 (4),1,1,0.867,1
Tuberculosis - Homo sapiens (human),KEGG,24,HSPD1;TGFB2;TGFB3;KSR1;CORO1A;IFNGR1;MAPK12;CIITA;CARD9;MRC2;CAMK2A;TLR1;TLR4;C3;BCL2;TLR9;FCGR2B;MAPK11;IL1B;MAPK13;ITGAM;ITGB2;HSPA9;VDR,179 (180),0.533,1,0,,5 (18),1,1,0.869,1
MFAP5-mediated ovarian cancer cell motility and invasiveness,Wikipathways,2,PRKCQ;ITPR3,13 (13),0.536,1,0,,3 (3),1,1,0.87,1
GRB2 events in EGFR signaling,Reactome,2,EREG;HBEGF,13 (13),0.536,1,0,,2 (2),1,1,0.87,1
superpathway of melatonin degradation,HumanCyc,2,CYP2S1;CYP1B1,13 (13),0.536,1,0,,19 (24),1,1,0.87,1
Erythrocytes take up carbon dioxide and release oxygen,Reactome,2,AQP1;CYB5RL,13 (13),0.536,1,0,,9 (11),1,1,0.87,1
Phospholipase C-mediated cascade; FGFR3,Reactome,2,FGF1;FGF2,13 (13),0.536,1,0,,4 (4),1,1,0.87,1
Galactose metabolism,INOH,2,UGP2;B4GALT2,13 (13),0.536,1,0,,14 (15),1,1,0.87,1
O2/CO2 exchange in erythrocytes,Reactome,2,AQP1;CYB5RL,13 (13),0.536,1,0,,9 (11),1,1,0.87,1
FGFRL1 modulation of FGFR1 signaling,Reactome,2,SPRED2;FGF2,13 (13),0.536,1,0,,1 (1),1,1,0.87,1
FGFR2c ligand binding and activation,Reactome,2,FGF1;FGF2,13 (13),0.536,1,0,,3 (4),1,1,0.87,1
activation of pkc through g-protein coupled receptors,BioCarta,2,PPP1R14A;CCL11,13 (13),0.536,1,0,,2 (3),1,1,0.87,1
RHO GTPases activate IQGAPs,Reactome,2,IQGAP1;IQGAP2,13 (13),0.536,1,0,,2 (3),1,1,0.87,1
melanocyte development and pigmentation pathway,BioCarta,2,BCL2;KIT,13 (13),0.536,1,0,,2 (2),1,1,0.87,1
hemoglobins chaperone,BioCarta,2,CPOX;ALAS1,13 (13),0.536,1,0,,3 (3),1,1,0.87,1
Ganglio Sphingolipid Metabolism,Wikipathways,2,ST3GAL2;ST8SIA3,13 (13),0.536,1,0,,8 (19),1,1,0.87,1
Longevity regulating pathway - Homo sapiens (human),KEGG,12,PRKAA2;SESN3;ADCY4;SESN1;ADCY2;CAT;ADIPOR2;ADCY9;SESN2;IGF1R;CREB3L3;PRKAG2,89 (89),0.539,1,0,,8 (8),1,1,0.872,1
Trk receptor signaling mediated by PI3K and PLC-gamma,PID,5,SFN;NGF;EPB41L1;EGR1;CAMK2A,36 (36),0.54,1,0,,3 (3),1,1,0.872,1
Citalopram Action Pathway,SMPDB,5,MAOB;ADRA1A;SCN1B;ATP1A2;CACNB1,36 (36),0.54,1,0,,26 (27),1,1,0.872,1
Nicotine Action Pathway,SMPDB,5,FMO3;ADRA1A;SCN1B;ATP1A2;CACNB1,36 (36),0.54,1,0,,29 (31),1,1,0.872,1
Head and Neck Squamous Cell Carcinoma,Wikipathways,10,AJUBA;TGFBR2;SESN1;DDIT4;MAML1;ERBB2;SESN2;FGFR1;IGF1R;PRKAA2,74 (74),0.541,1,0,,2 (4),1,1,0.873,1
Signaling by NOTCH1,Reactome,10,MAML1;ADAM10;DLL4;RBPJ;HDAC7;DTX1;ARRB1;ARRB2;NEURL1B;MAMLD1,74 (74),0.541,1,0,,3 (3),1,1,0.873,1
Programmed Cell Death,Reactome,19,RIPK3;LMNB1;BAK1;BMF;PMAIP1;VIM;DSP;UNC5A;ARHGAP10;SATB1;HMGB2;OPA1;TNFRSF10B;BCL2;GSN;PRKCQ;SFN;TLR4;GZMB,142 (142),0.541,1,0,,11 (21),1,1,0.873,1
Cellular response to heat stress,Reactome,13,HSPA12B;HSPA1A;HSPA1B;HSPA1L;SERPINH1;HSPA9;CAMK2A;HSPA12A;HSPB1;NUP35;NDC1;POM121;BAG4,97 (97),0.546,1,0,,8 (10),1,1,0.876,1
E-cadherin signaling in keratinocytes,PID,3,VASP;AJUBA;ZYX,21 (21),0.548,1,0,,4 (4),1,1,0.878,1
Glycosphingolipid biosynthesis - ganglioseries,EHMN,3,ST6GALNAC4;ST3GAL2;GAL3ST1,21 (21),0.548,1,0,,18 (38),1,1,0.878,1
Citric Acid Cycle,SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
SHC-mediated cascade:FGFR1,Reactome,3,FGFR1;FGF1;FGF2,21 (21),0.548,1,0,,5 (5),1,1,0.878,1
PI-3K cascade:FGFR1,Reactome,3,FGFR1;FGF1;FGF2,21 (21),0.548,1,0,,4 (5),1,1,0.878,1
Pyruvate dehydrogenase deficiency (E3),SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
Sphingosine 1-phosphate (S1P) pathway,PID,3,S1PR4;GNAI1;S1PR2,21 (21),0.548,1,0,,4 (5),1,1,0.878,1
pkc-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,BioCarta,3,MYL2;PPP1R14A;VAV1,21 (21),0.548,1,0,,1 (3),1,1,0.878,1
Metabolism of cofactors,Reactome,3,IDH1;NOS3;DHFR,21 (21),0.548,1,0,,41 (48),1,1,0.878,1
Regulation of FZD by ubiquitination,Reactome,3,FZD4;FZD8;RSPO3,21 (21),0.548,1,0,,1 (1),1,1,0.878,1
Pyruvate dehydrogenase deficiency (E2),SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
2-ketoglutarate dehydrogenase complex deficiency,SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
Mitochondrial complex II deficiency,SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
Fumarase deficiency,SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
Congenital lactic acidosis,SMPDB,3,SUCLG2;SUCLG1;DLST,21 (21),0.548,1,0,,31 (33),1,1,0.878,1
Synaptic adhesion-like molecules,Reactome,3,PTPRF;PTPRD;DLG4,21 (21),0.548,1,0,,2 (2),1,1,0.878,1
PIP3 activates AKT signaling,Reactome,29,MAF1;HGF;USP13;ERBB2;EREG;ATN1;RRAGD;CD19;PDGFB;PDGFRA;NRG4;EGR1;PDGFRB;NR4A1;CBX6;HBEGF;PIP4K2A;FGF1;FGF2;FGFR1;SNAI1;LCK;KIT;HDAC7;VAV1;PREX2;GAB2;CHUK;KLB,218 (218),0.549,1,0,,15 (21),1,1,0.878,1
Renin-angiotensin-aldosterone system (RAAS),Wikipathways,6,ACE;CAMK2A;CAMK1D;CREB3L3;ITPR3;CMA1,44 (44),0.549,1,0,,11 (12),1,1,0.878,1
Interleukin-3_ Interleukin-5 and GM-CSF signaling,Reactome,6,BLNK;IL2RB;IL3RA;VAV1;INPP5D;GAB2,44 (44),0.549,1,0,,2 (3),1,1,0.878,1
Cargo recognition for clathrin-mediated endocytosis,Reactome,14,REPS2;FZD4;SYT1;FCHO1;HBEGF;APOB;CD3D;EREG;ARRB2;ARRB1;EPN2;ADRB2;UBQLN1;STON1,105 (105),0.552,1,0,,8 (10),1,1,0.88,1
IL27-mediated signaling events,PID,2,IL1B;IL27RA,26 (26),0.881,1,0,,0 (0),1,1,0.881,1
TSH,NetPath,2,IGF1R;GNAI1,26 (26),0.881,1,0,,0 (0),1,1,0.881,1
G alpha (s) signalling events,Reactome,19,PDE3A;ADCY9;GNG11;ADORA2B;GNGT2;PTGIR;ADCY2;PTH1R;ADCY4;PDE3B;PDE4D;ARRB2;ARRB1;GNB5;ADRB2;GNG2;SCTR;RAMP2;PDE10A,143 (143),0.554,1,0,,25 (25),1,1,0.881,1
Apoptotic execution phase,Reactome,7,SATB1;LMNB1;VIM;DSP;HMGB2;PRKCQ;GSN,52 (52),0.557,1,0,,2 (5),1,1,0.883,1
Hydromorphone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Dezocine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Levomethadyl Acetate Action Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Naloxone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Linoleic acid metabolism - Homo sapiens (human),KEGG,4,PLA2G4E;CYP2E1;PLA2G4F;PLA2G6,29 (29),0.557,1,0,,19 (28),1,1,0.883,1
Insulin-mediated glucose transport,PID,4,SFN;TBC1D4;SLC2A4;PPP1R3A,29 (29),0.557,1,0,,3 (3),1,1,0.883,1
p38 MAPK signaling pathway,PID,4,MAPK11;MAP3K6;MAP3K1;MAP3K3,29 (29),0.557,1,0,,1 (1),1,1,0.883,1
VEGFR1 specific signals,PID,4,CAV1;NRP2;NOS3;SHC2,29 (29),0.557,1,0,,6 (6),1,1,0.883,1
Anileridine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,10 (11),1,1,0.883,1
DAP12 signaling,Reactome,4,PLCG2;LAT;GRAP2;LCK,29 (29),0.557,1,0,,5 (6),1,1,0.883,1
Calcium signaling in the CD4+ TCR pathway,PID,4,PTGS2;CHP1;NFATC2;FOSL1,29 (29),0.557,1,0,,1 (2),1,1,0.883,1
3-Methylthiofentanyl Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Escitalopram Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,10 (11),1,1,0.883,1
Levallorphan Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Dimethylthiambutene Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Ethylmorphine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Pentazocine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Naltrexone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Buprenorphine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Alvimopan Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Dihydromorphine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Ketobemidone  Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Mepivacaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Chloroprocaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Cocaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Dibucaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Levobupivacaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Benzocaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Bupivacaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Levorphanol Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Propoxyphene Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Tramadol Action Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Diphenoxylate Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Oxycodone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Oxybuprocaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,10 (11),1,1,0.883,1
Prilocaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Procaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Proparacaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Ropivacaine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Alfentanil Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Oxymorphone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Hydrocodone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Sufentanil Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Remifentanil Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Fentanyl Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,10 (11),1,1,0.883,1
Carfentanil Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,10 (11),1,1,0.883,1
Methadyl Acetate Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,29 (29),0.557,1,0,,11 (11),1,1,0.883,1
Activation of NMDA receptors and postsynaptic events,Reactome,10,PRKAR1B;PRKAR2A;ARHGEF7;DLG4;CAMK2A;RPS6KA2;CAMKK1;ACTN2;PRKAA2;PRKAG2,75 (75),0.559,1,0,,15 (17),1,1,0.884,1
Regulation of sister chromatid separation at the metaphase-anaphase transition,Wikipathways,1,CENPE,15 (15),0.885,1,0,,0 (0),1,1,0.885,1
Cancer immunotherapy by CTLA4 blockade,Wikipathways,1,CTLA4,15 (15),0.885,1,0,,0 (0),1,1,0.885,1
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Reactome,1,SFRP1,15 (15),0.885,1,0,,0 (0),1,1,0.885,1
pten dependent cell cycle arrest and apoptosis,BioCarta,1,BCAR1,15 (15),0.885,1,0,,0 (0),1,1,0.885,1
Squalene and cholesterol biosynthesis,EHMN,5,NUP35;NSDHL;TM7SF2;SC5D;IDI1,37 (37),0.565,1,0,,38 (42),1,1,0.888,1
IL2 signaling events mediated by PI3K,PID,5,IL2RB;LCK;BCL2;GAB2;SGMS1,37 (37),0.565,1,0,,7 (7),1,1,0.888,1
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Reactome,5,KDM1B;ABCG8;APOD;ARL4C;ABCG5,37 (37),0.565,1,0,,3 (4),1,1,0.888,1
Chemical carcinogenesis - Homo sapiens (human),KEGG,11,MGST1;UGT1A1;CYP2E1;GSTK1;CYP1A1;CYP1B1;KYAT3;PTGS2;UGT1A5;UGT2A3;ADH4,83 (83),0.565,1,0,,57 (99),1,1,0.888,1
Intra-Golgi traffic,Reactome,6,COG5;GOLIM4;RAB36;MAN1C1;RAB30;CYTH4,45 (45),0.572,1,0,,4 (4),1,1,0.891,1
RhoA signaling pathway,PID,6,SRF;LIMK1;MYL2;ACTA1;MAPK12;MSN,45 (45),0.572,1,0,,1 (1),1,1,0.891,1
DAP12 interactions,Reactome,6,LAT;CD300E;CD300LB;PLCG2;GRAP2;LCK,45 (45),0.572,1,0,,5 (7),1,1,0.891,1
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,47 (47),0.892,1,0,,0 (1),1,1,0.892,1
Hepatitis B infection,Wikipathways,20,MAPK11;EGR3;TGFB2;TGFB3;IKBKG;CREB3L3;TGFBR2;HSPG2;TLR4;NFATC4;MAPK13;BCL2;MAP3K1;SMAD3;SLC10A1;CHUK;MAPK12;CASP12;MMP9;NFATC2,152 (152),0.572,1,0,,1 (1),1,1,0.892,1
Thyroid stimulating hormone (TSH) signaling pathway,Wikipathways,6,EGR1;ADCY2;PDE4D;GNAI1;IGF1R;GNG2,66 (66),0.893,1,0,,0 (0),1,1,0.893,1
Insulin signaling pathway - Homo sapiens (human),KEGG,18,PTPRF;PKLR;PPP1R3A;SOCS2;PRKAR1B;PRKAR2A;PYGL;PYGB;SH2B2;PHKG1;PCK1;PDE3B;SLC2A4;GYS2;HKDC1;PRKAA2;PRKAG2;SHC2,137 (137),0.575,1,0,,2 (4),1,1,0.893,1
S1P4 pathway,PID,2,S1PR4;GNAI1,14 (14),0.578,1,0,,3 (3),1,1,0.895,1
Kennedy pathway from sphingolipids,Wikipathways,2,ETNK2;CHPT1,14 (14),0.578,1,0,,16 (18),1,1,0.895,1
CREB1 phosphorylation through the activation of Adenylate Cyclase,Reactome,2,PRKAR2A;PRKAR1B,14 (14),0.578,1,0,,5 (5),1,1,0.895,1
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,2,ALDOA;RPIA,14 (14),0.578,1,0,,26 (29),1,1,0.895,1
PTK6 Regulates RHO GTPases_ RAS GTPase and MAP kinases,Reactome,2,BCAR1;ARHGAP35,14 (14),0.578,1,0,,5 (5),1,1,0.895,1
Advanced glycosylation endproduct receptor signaling,Reactome,2,LGALS3;APP,14 (14),0.578,1,0,,1 (3),1,1,0.895,1
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Reactome,2,PLXNA4;FARP2,14 (14),0.578,1,0,,5 (5),1,1,0.895,1
Synthesis of PE,Reactome,2,ETNK2;SELENOI,14 (14),0.578,1,0,,19 (21),1,1,0.895,1
SHC1 events in EGFR signaling,Reactome,2,EREG;HBEGF,14 (14),0.578,1,0,,4 (4),1,1,0.895,1
Ribose-5-phosphate isomerase deficiency,SMPDB,2,ALDOA;RPIA,14 (14),0.578,1,0,,26 (29),1,1,0.895,1
ER-Phagosome pathway,Reactome,2,CHUK;IKBKG,14 (14),0.578,1,0,,4 (7),1,1,0.895,1
Lysosphingolipid and LPA receptors,Reactome,2,S1PR4;S1PR2,14 (14),0.578,1,0,,3 (5),1,1,0.895,1
Pentose Phosphate Pathway,SMPDB,2,ALDOA;RPIA,14 (14),0.578,1,0,,26 (29),1,1,0.895,1
Transaldolase deficiency,SMPDB,2,ALDOA;RPIA,14 (14),0.578,1,0,,26 (29),1,1,0.895,1
Mitochondrial biogenesis,Reactome,7,MAPK11;SIRT5;ALAS1;GLUD1;PRKAA2;MAPK12;PRKAG2,53 (53),0.578,1,0,,7 (8),1,1,0.895,1
Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human),KEGG,7,ATP2B4;VDR;BDKRB2;PTH1R;ADCY9;PLCB4;ATP1A2,53 (53),0.578,1,0,,8 (8),1,1,0.895,1
Synthesis of PIPs at the plasma membrane,Reactome,7,PI4K2B;SYNJ2;PIK3C2G;INPP5D;PLEKHA8;PIP4K2A;INPP4B,53 (53),0.578,1,0,,9 (17),1,1,0.895,1
chondroitin and dermatan biosynthesis,HumanCyc,1,CHSY1,6 (6),0.578,1,0,,3 (4),1,1,0.895,1
Metabolic pathway of LDL_ HDL and TG_ including diseases,Wikipathways,1,LCAT,6 (6),0.578,1,0,,1 (5),1,1,0.895,1
Signalling to p38 via RIT and RIN,Reactome,1,NGF,6 (6),0.578,1,0,,3 (4),1,1,0.895,1
Activated NTRK2 signals through FRS2 and FRS3,Reactome,1,NTRK2,6 (6),0.578,1,0,,2 (2),1,1,0.895,1
MET activates PI3K/AKT signaling,Reactome,1,HGF,6 (6),0.578,1,0,,3 (4),1,1,0.895,1
Activated NTRK2 signals through CDK5,Reactome,1,NTRK2,6 (6),0.578,1,0,,4 (4),1,1,0.895,1
pentose phosphate pathway (non-oxidative branch),HumanCyc,1,RPIA,6 (6),0.578,1,0,,6 (8),1,1,0.895,1
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,1,PTGS2,6 (6),0.578,1,0,,16 (18),1,1,0.895,1
CD163 mediating an anti-inflammatory response,Reactome,1,PLK2,6 (6),0.578,1,0,,3 (3),1,1,0.895,1
Pre-NOTCH Processing in the Endoplasmic Reticulum,Reactome,1,NOTCH4,6 (6),0.578,1,0,,4 (4),1,1,0.895,1
rRNA processing in the mitochondrion,Reactome,1,MTERF4,6 (6),0.578,1,0,,2 (5),1,1,0.895,1
tRNA modification in the mitochondrion,Reactome,1,HSD17B10,6 (6),0.578,1,0,,4 (8),1,1,0.895,1
allopregnanolone biosynthesis,HumanCyc,1,SRD5A1,6 (6),0.578,1,0,,8 (8),1,1,0.895,1
Vitamin B6 metabolism - Homo sapiens (human),KEGG,1,PNPO,6 (6),0.578,1,0,,19 (29),1,1,0.895,1
Glypican 3 network,PID,1,GPC3,6 (6),0.578,1,0,,1 (1),1,1,0.895,1
Scavenging by Class F Receptors,Reactome,1,APOB,6 (6),0.578,1,0,,3 (9),1,1,0.895,1
rRNA modification in the mitochondrion,Reactome,1,MTERF4,6 (6),0.578,1,0,,2 (5),1,1,0.895,1
PTK6 promotes HIF1A stabilization,Reactome,1,HBEGF,6 (6),0.578,1,0,,2 (2),1,1,0.895,1
Sensing of DNA Double Strand Breaks,Reactome,1,RAD50,6 (6),0.578,1,0,,4 (5),1,1,0.895,1
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,SMPDB,1,ADCY2,6 (6),0.578,1,0,,7 (7),1,1,0.895,1
Dopamine Activation of Neurological Reward System,SMPDB,1,ADCY2,6 (6),0.578,1,0,,7 (7),1,1,0.895,1
Nicotine Metabolism,Wikipathways,1,FMO3,6 (6),0.578,1,0,,10 (10),1,1,0.895,1
Signaling by Rho GTPases_ Miro GTPases and RHOBTB3,Reactome,93,STARD13;CCP110;DLG5;PLXND1;ABL1;STARD8;INCENP;IQGAP2;RHOJ;MYO6;KDM4C;DOCK11;TEX2;ASB15;WASF3;OBSCN;SRF;MCAM;ACTG1;SKA2;NCF2;ARHGEF17;PAK6;DBT;CHN2;IQGAP1;FARP2;PLEKHG1;GJA1;DLC1;CDC42SE2;BAIAP2L1;GFOD1;ARHGEF7;WAS;ABCD3;FGD1;KIF14;DLG4;FGD5;ARHGAP25;CKAP4;MCF2L;ALDH3A2;CENPE;PREX1;RHOF;FMNL1;VAV1;ARHGEF6;FGD3;MYO9A;SFN;VIM;FLNA;ARHGEF28;SH3RF1;FGD2;DSP;ARHGAP10;STK10;ACBD5;ARHGAP9;ARHGDIB;CAV1;LBR;LCK;ARHGAP35;ARHGEF25;CDC42EP3;SLC1A5;SYDE1;PREX2;FMNL3;ARHGAP1;ARHGAP4;PPP1R14A;LIMK1;ARAP3;LMAN1;FAM13A;LMNB1;WASF2;DEF6;PAK1;PAK3;CAVIN1;ARHGAP27;ARHGEF2;MAPK11;ARHGAP45;PCDH7;ARHGAP31,704 (705),0.58,1,0,,24 (29),1,1,0.896,1
Post-chaperonin tubulin folding pathway,Reactome,3,TUBB1;TUBB2B;TUBA1A,22 (22),0.581,1,0,,2 (2),1,1,0.897,1
NOTCH2 Activation and Transmission of Signal to the Nucleus,Reactome,3,NEURL1B;ADAM10;DLL4,22 (22),0.581,1,0,,1 (1),1,1,0.897,1
PDGFR-alpha signaling pathway,PID,3,CAV1;SRF;PDGFRA,22 (22),0.581,1,0,,2 (2),1,1,0.897,1
FRS-mediated FGFR4 signaling,Reactome,3,FGF2;FGF1;KLB,22 (22),0.581,1,0,,5 (5),1,1,0.897,1
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Reactome,3,NFKBIA;CHUK;IKBKG,22 (22),0.581,1,0,,2 (5),1,1,0.897,1
Ras activation upon Ca2+ influx through NMDA receptor,Reactome,3,ACTN2;DLG4;CAMK2A,22 (22),0.581,1,0,,6 (6),1,1,0.897,1
Signal transduction by L1,Reactome,3,PAK1;FGFR1;ITGA5,22 (22),0.581,1,0,,4 (4),1,1,0.897,1
PI Metabolism,Reactome,11,GDPD1;PI4K2B;SYNJ2;GDPD5;TPTE;PIK3C2G;INPP5D;PLEKHA8;TNFAIP8;PIP4K2A;INPP4B,84 (84),0.582,1,0,,15 (29),1,1,0.897,1
EGFR downregulation,Reactome,4,ARHGEF7;SPRY1;EREG;HBEGF,30 (30),0.585,1,0,,5 (6),1,1,0.899,1
Trafficking of AMPA receptors,Reactome,4,EPB41L1;MYO6;DLG4;CAMK2A,30 (30),0.585,1,0,,5 (6),1,1,0.899,1
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,4,EPB41L1;MYO6;DLG4;CAMK2A,30 (30),0.585,1,0,,7 (8),1,1,0.899,1
Activation of BH3-only proteins,Reactome,4,SFN;BMF;BCL2;PMAIP1,30 (30),0.585,1,0,,4 (5),1,1,0.899,1
Nalbuphine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,30 (30),0.585,1,0,,11 (11),1,1,0.899,1
Downstream signal transduction,Reactome,4,PDGFRA;PDGFB;BCAR1;PDGFRB,30 (30),0.585,1,0,,5 (6),1,1,0.899,1
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Reactome,4,ACTN2;RPS6KA2;DLG4;CAMK2A,30 (30),0.585,1,0,,9 (10),1,1,0.899,1
Desipramine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,30 (30),0.585,1,0,,16 (16),1,1,0.899,1
Acetaminophen Metabolism Pathway,SMPDB,4,ABCC4;UGT1A1;CYP2E1;ABCG2,30 (30),0.585,1,0,,16 (16),1,1,0.899,1
Mitochondrial complex III assembly,Wikipathways,1,UQCRC2,16 (16),0.9,1,0,,0 (2),1,1,0.9,1
TLR4 Signaling and Tolerance,Wikipathways,1,TLR4,16 (16),0.9,1,0,,0 (0),1,1,0.9,1
chromatin remodeling by hswi/snf atp-dependent complexes,BioCarta,1,POLR2A,16 (16),0.9,1,0,,0 (0),1,1,0.9,1
Late endosomal microautophagy,Reactome,1,PLIN2,16 (16),0.9,1,0,,0 (2),1,1,0.9,1
human cytomegalovirus and map kinase pathways,BioCarta,1,MAP3K1,16 (16),0.9,1,0,,0 (0),1,1,0.9,1
Amphetamine addiction - Homo sapiens (human),KEGG,9,MAOB;ARC;CACNA1C;CACNA1D;SLC18A1;DDC;CAMK2A;FOSB;CREB3L3,69 (69),0.589,1,0,,10 (10),1,1,0.901,1
IL5,NetPath,4,ALOX5;NFKBIA;SOX4;IL2RB,48 (48),0.901,1,0,,0 (0),1,1,0.901,1
Signaling by FGFR1 in disease,Reactome,5,BAG4;FGFR1;GAB2;FGF1;FGF2,38 (38),0.59,1,0,,6 (17),1,1,0.901,1
TBC/RABGAPs,Reactome,5,SYTL1;RAB6B;TBC1D10A;OPTN;RAB7B,38 (38),0.59,1,0,,4 (4),1,1,0.901,1
Signaling events mediated by TCPTP,PID,5,PDGFRB;HGF;PDGFB;LMAN1;KDR,38 (38),0.59,1,0,,1 (1),1,1,0.901,1
Peptide ligand-binding receptors,Reactome,27,PROK2;CCR2;CXCR3;PXMP2;CYP26B1;CXCR6;AVPR1A;CXCR4;ACKR3;NTS;PENK;CXCL13;CCL2;C3;C3AR1;CCR5;CCL11;ACKR2;C5AR1;APP;F2RL1;CXCL5;CXCL2;CXCL3;BDKRB2;CX3CL1;KNG1,207 (207),0.593,1,0,,9 (13),1,1,0.903,1
ErbB signaling pathway - Homo sapiens (human),KEGG,11,PAK1;NRG4;PAK3;CAMK2A;ERBB2;EREG;PLCG2;ABL1;HBEGF;PAK6;SHC2,85 (85),0.599,1,0,,4 (4),1,1,0.906,1
Signaling by NOTCH1 PEST Domain Mutants in Cancer,Reactome,7,MAML1;ADAM10;DLL4;RBPJ;HDAC7;NEURL1B;MAMLD1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Reactome,7,MAML1;ADAM10;DLL4;RBPJ;HDAC7;NEURL1B;MAMLD1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
Signaling by NOTCH1 in Cancer,Reactome,7,MAML1;ADAM10;DLL4;RBPJ;HDAC7;NEURL1B;MAMLD1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Reactome,7,MAML1;ADAM10;DLL4;RBPJ;HDAC7;NEURL1B;MAMLD1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
Signaling by PTK6,Reactome,7,DOK1;NRG4;HBEGF;ERBB2;EREG;BCAR1;ARHGAP35,54 (54),0.599,1,0,,10 (10),1,1,0.906,1
Signaling by Non-Receptor Tyrosine Kinases,Reactome,7,DOK1;NRG4;HBEGF;ERBB2;EREG;BCAR1;ARHGAP35,54 (54),0.599,1,0,,10 (10),1,1,0.906,1
Constitutive Signaling by NOTCH1 PEST Domain Mutants,Reactome,7,MAML1;ADAM10;DLL4;RBPJ;HDAC7;NEURL1B;MAMLD1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
RAC1 signaling pathway,PID,7,NCF2;PAK1;LIMK1;WASF2;MAP3K1;IQGAP1;BCAR1,54 (54),0.599,1,0,,3 (3),1,1,0.906,1
Hepatitis B - Homo sapiens (human),KEGG,21,MAPK11;EGR3;TGFB2;CREB3L3;NFATC2;NFATC4;HSPG2;TLR4;MAPK13;TGFBR2;TGFB3;BCL2;SMAD3;CASP12;NFKBIA;SLC10A1;CHUK;MAPK12;MAP3K1;MMP9;IKBKG,162 (162),0.601,1,0,,1 (1),1,1,0.907,1
Regulation of Telomerase,PID,6,XRCC5;WT1;NR2F2;SMAD3;ABL1;RAD50,68 (68),0.908,1,0,,0 (0),1,1,0.908,1
SUMOylation of DNA replication proteins,Reactome,3,NUP35;NDC1;POM121,39 (39),0.91,1,0,,0 (0),1,1,0.91,1
SUMOylation of ubiquitinylation proteins,Reactome,3,NUP35;NDC1;POM121,39 (39),0.91,1,0,,0 (0),1,1,0.91,1
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,4,NUP35;SLC25A16;VNN1;ENPP1,31 (31),0.612,1,0,,21 (21),1,1,0.913,1
Lissencephaly gene (LIS1) in neuronal migration and development,PID,4,ABL1;IQGAP1;MAP1B;VLDLR,31 (31),0.612,1,0,,1 (1),1,1,0.913,1
role of mef2d in t-cell apoptosis,BioCarta,4,LAT;LCK;CD3D;NR4A1,31 (31),0.612,1,0,,1 (1),1,1,0.913,1
Regulation of cholesterol biosynthesis by SREBP (SREBF),Reactome,4,IDI1;TM7SF2;SC5D;GPAM,31 (31),0.612,1,0,,1 (1),1,1,0.913,1
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,31 (31),0.612,1,0,,26 (26),1,1,0.913,1
FGF23 signaling in hypophosphatemic rickets and related disorders,Wikipathways,3,SPP1;ENPP1;GALNT3,23 (23),0.612,1,0,,3 (4),1,1,0.913,1
FRS-mediated FGFR1 signaling,Reactome,3,FGFR1;FGF1;FGF2,23 (23),0.612,1,0,,5 (5),1,1,0.913,1
Dopamine Neurotransmitter Release Cycle,Reactome,3,SYT1;PPFIA2;STXBP1,23 (23),0.612,1,0,,1 (1),1,1,0.913,1
Estrogen signaling pathway,Wikipathways,3,CHUK;BCL2;IKBKG,23 (23),0.612,1,0,,2 (2),1,1,0.913,1
Regulation of RAS by GAPs,Reactome,3,DAB2IP;RASAL3;SPRED2,23 (23),0.612,1,0,,2 (2),1,1,0.913,1
RAS processing,Reactome,3,ZDHHC9;PRKCQ;LYPLA1,23 (23),0.612,1,0,,15 (19),1,1,0.913,1
IKK complex recruitment mediated by RIP1,Reactome,3,CHUK;TLR4;IKBKG,23 (23),0.612,1,0,,1 (2),1,1,0.913,1
Canonical NF-kappaB pathway,PID,3,NFKBIA;CHUK;IKBKG,23 (23),0.612,1,0,,1 (1),1,1,0.913,1
RUNX2 regulates osteoblast differentiation,Reactome,3,WWTR1;COL1A1;MAF,23 (23),0.612,1,0,,5 (6),1,1,0.913,1
Uptake and actions of bacterial toxins,Reactome,3,ANTXR1;SYT1;HBEGF,23 (23),0.612,1,0,,9 (11),1,1,0.913,1
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Reactome,3,BTG2;PLK2;RGCC,23 (23),0.612,1,0,,2 (2),1,1,0.913,1
growth hormone signaling pathway,BioCarta,3,GHR;SRF;HNF1A,23 (23),0.612,1,0,,1 (1),1,1,0.913,1
Long-term potentiation,Reactome,3,ACTN2;DLG4;CAMK2A,23 (23),0.612,1,0,,6 (6),1,1,0.913,1
Negative regulation of NMDA receptor-mediated neuronal transmission,Reactome,3,ACTN2;DLG4;CAMK2A,23 (23),0.612,1,0,,6 (6),1,1,0.913,1
EPHB forward signaling,PID,5,EPHB2;EPHB4;PAK1;EFNB2;ASB15,39 (39),0.614,1,0,,2 (2),1,1,0.913,1
Signaling events regulated by Ret tyrosine kinase,PID,5,DOK1;GFRA1;BCAR1;SHANK3;GRB10,39 (39),0.614,1,0,,2 (2),1,1,0.913,1
G1/S-Specific Transcription,Reactome,1,DHFR,17 (17),0.914,1,0,,0 (0),1,1,0.914,1
role of nicotinic acetylcholine receptors in the regulation of apoptosis,BioCarta,1,CHRNB1,17 (17),0.914,1,0,,0 (0),1,1,0.914,1
IL-9 signaling pathway,Wikipathways,1,IL9R,17 (17),0.914,1,0,,0 (0),1,1,0.914,1
PCP/CE pathway,Reactome,6,FZD4;PRICKLE1;WNT11;ROR2;ARRB2;FZD8,47 (47),0.616,1,0,,6 (8),1,1,0.914,1
IL6-mediated signaling events,PID,6,MAPK11;VAV1;GAB2;CRP;FGG;PTPRE,47 (47),0.616,1,0,,2 (2),1,1,0.914,1
Biogenic Amine Synthesis,Wikipathways,2,DDC;PAH,15 (15),0.617,1,0,,17 (18),1,1,0.915,1
Pentose phosphate pathway,Reactome,2,SHPK;RPIA,15 (15),0.617,1,0,,27 (31),1,1,0.915,1
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,2,ST6GALNAC4;ST3GAL2,15 (15),0.617,1,0,,7 (31),1,1,0.915,1
Signaling by FLT3 ITD and TKD mutants,Reactome,2,NOX4;GAB2,15 (15),0.617,1,0,,9 (9),1,1,0.915,1
Activation of BAD and translocation to mitochondria ,Reactome,2,SFN;BCL2,15 (15),0.617,1,0,,4 (4),1,1,0.915,1
Hereditary Coproporphyria (HCP),SMPDB,2,CPOX;ALAS1,15 (15),0.617,1,0,,39 (39),1,1,0.915,1
Porphyria Variegata (PV),SMPDB,2,CPOX;ALAS1,15 (15),0.617,1,0,,39 (39),1,1,0.915,1
PAR4-mediated thrombin signaling events,PID,2,MYL2;GNG2,15 (15),0.617,1,0,,4 (4),1,1,0.915,1
Nucleobase biosynthesis,Reactome,2,LHPP;PAICS,15 (15),0.617,1,0,,46 (48),1,1,0.915,1
gamma-aminobutyric acid receptor life cycle pathway,BioCarta,2,UBQLN1;GABRA3,15 (15),0.617,1,0,,1 (1),1,1,0.915,1
WNT5A-dependent internalization of FZD4,Reactome,2,ARRB2;FZD4,15 (15),0.617,1,0,,4 (5),1,1,0.915,1
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,SMPDB,2,CPOX;ALAS1,15 (15),0.617,1,0,,39 (39),1,1,0.915,1
Acute Intermittent Porphyria,SMPDB,2,CPOX;ALAS1,15 (15),0.617,1,0,,39 (39),1,1,0.915,1
Porphyrin Metabolism,SMPDB,2,CPOX;ALAS1,15 (15),0.617,1,0,,39 (39),1,1,0.915,1
Beta-catenin independent WNT signaling,Reactome,12,FZD4;PRICKLE1;GNG11;GNGT2;CAMK2A;ARRB2;ROR2;GNB5;GNG2;WNT11;ITPR3;FZD8,94 (94),0.618,1,0,,14 (18),1,1,0.916,1
IL-1 signaling pathway,Wikipathways,7,IL1B;IKBKG;CCL2;MAP3K1;MAP3K3;NFKBIA;CHUK,55 (55),0.619,1,0,,1 (1),1,1,0.916,1
TNFs bind their physiological receptors,Reactome,2,TNFSF9;EDA2R,29 (29),0.916,1,0,,0 (0),1,1,0.916,1
BARD1 signaling events,PID,2,XRCC5;RAD50,29 (29),0.916,1,0,,0 (0),1,1,0.916,1
22q11.2 copy number variation syndrome,Wikipathways,19,SRF;ACTA2;FGFR1;ALDH1A2;P2RX6;SERPIND1;OAT;CLDN5;TBX1;BCL2;SLC2A4;POLR2A;DROSHA;CYP26A1;CLDN1;VWF;CYP26B1;GLUD1;FOXC2,149 (149),0.63,1,0,,20 (30),1,1,0.921,1
Gastric cancer - Homo sapiens (human),KEGG,19,FZD8;BAK1;TGFB3;FGF1;FZD9;FGF2;TGFBR2;HGF;FZD4;ERBB2;FGF21;BCL2;WNT7B;CDH17;SMAD3;WNT11;WNT9B;TGFB2;SHC2,149 (149),0.63,1,0,,3 (4),1,1,0.921,1
Signaling by the B Cell Receptor (BCR),Reactome,16,BLK;BLNK;CD19;NFATC2;CARD11;VAV1;CD79A;CD79B;NFKBIA;IGLC2;RASGRP3;PLCG2;CD22;CHUK;ITPR3;IKBKG,126 (126),0.632,1,0,,10 (14),1,1,0.922,1
SARS-CoV-2 and angiotensin-converting enzyme 2 receptor- molecular mechanisms,Wikipathways,1,ACE,7 (7),0.635,1,0,,2 (6),1,1,0.923,1
Arachidonate Epoxygenase - Epoxide Hydrolase,Wikipathways,1,EPHX2,7 (7),0.635,1,0,,11 (11),1,1,0.923,1
Attachment of GPI anchor to uPAR,Reactome,1,PGAP1,7 (7),0.635,1,0,,1 (3),1,1,0.923,1
Erythropoietin activates Phospholipase C gamma (PLCG),Reactome,1,PLCG2,7 (7),0.635,1,0,,5 (6),1,1,0.923,1
CS/DS degradation,Reactome,1,HYAL1,7 (7),0.635,1,0,,4 (15),1,1,0.923,1
Porphyrin metabolism,INOH,1,CPOX,7 (7),0.635,1,0,,15 (16),1,1,0.923,1
coenzyme A biosynthesis,HumanCyc,1,PANK1,7 (7),0.635,1,0,,13 (13),1,1,0.923,1
PP2A-mediated dephosphorylation of key metabolic factors,Reactome,1,PFKFB1,7 (7),0.635,1,0,,2 (2),1,1,0.923,1
phosphatidylcholine biosynthesis,HumanCyc,1,CHPT1,7 (7),0.635,1,0,,11 (12),1,1,0.923,1
Glycosphingolipid biosynthesis - lactoseries,EHMN,1,FUT2,7 (7),0.635,1,0,,7 (19),1,1,0.923,1
thyroid hormone metabolism II (via conjugation and/or degradation),HumanCyc,1,DIO1,7 (7),0.635,1,0,,9 (22),1,1,0.923,1
Synthesis of 12-eicosatetraenoic acid derivatives,Reactome,1,ALOX12,7 (7),0.635,1,0,,11 (13),1,1,0.923,1
STAT5 Activation,Reactome,1,GAB2,7 (7),0.635,1,0,,2 (2),1,1,0.923,1
DSCAM interactions,Reactome,1,PAK1,7 (7),0.635,1,0,,3 (3),1,1,0.923,1
FGFR3b ligand binding and activation,Reactome,1,FGF1,7 (7),0.635,1,0,,3 (3),1,1,0.923,1
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Reactome,1,TLR9,7 (7),0.635,1,0,,3 (6),1,1,0.923,1
Vitamin B2 (riboflavin) metabolism,Reactome,1,ENPP1,7 (7),0.635,1,0,,10 (10),1,1,0.923,1
chondroitin sulfate degradation (metazoa),HumanCyc,1,HYAL1,7 (7),0.635,1,0,,70 (131),1,1,0.923,1
dermatan sulfate degradation (metazoa),HumanCyc,1,HYAL1,7 (7),0.635,1,0,,70 (131),1,1,0.923,1
RSK activation,Reactome,1,RPS6KA2,7 (7),0.635,1,0,,3 (4),1,1,0.923,1
Corticotropin Activation of Cortisol Production,SMPDB,1,ADCY2,7 (7),0.635,1,0,,7 (7),1,1,0.923,1
Vasopressin Regulation of Water Homeostasis,SMPDB,1,ADCY2,7 (7),0.635,1,0,,7 (7),1,1,0.923,1
Pentose Phosphate Metabolism,Wikipathways,1,RPIA,7 (7),0.635,1,0,,9 (9),1,1,0.923,1
Cytosolic sensors of pathogen-associated DNA ,Reactome,5,XRCC5;RIPK3;CHUK;NFKBIA;IKBKG,40 (40),0.637,1,0,,6 (10),1,1,0.924,1
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,6,UGP2;GNE;HKDC1;PGM3;UGDH;CYB5RL,48 (48),0.637,1,0,,49 (108),1,1,0.924,1
Notch-mediated HES/HEY network,PID,6,GATA4;GATA6;GHR;KDR;MAML1;RBPJ,48 (48),0.637,1,0,,3 (3),1,1,0.924,1
White fat cell differentiation,Wikipathways,4,GATA2;KLF5;KLF4;NR2F2,32 (32),0.638,1,0,,1 (2),1,1,0.925,1
Alpha-synuclein signaling,PID,4,BLK;LCK;FGR;MAOB,32 (32),0.638,1,0,,2 (3),1,1,0.925,1
Codeine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,32 (32),0.638,1,0,,21 (21),1,1,0.925,1
Clathrin-mediated endocytosis,Reactome,18,ARRB2;REPS2;FZD4;STON1;SYNJ2;SYT1;FCHO1;HBEGF;APOB;CD3D;HIP1;EREG;PACSIN1;ARRB1;EPN2;ADRB2;UBQLN1;ASB15,142 (142),0.639,1,0,,12 (17),1,1,0.925,1
Budding and maturation of HIV virion,Reactome,2,VPS37A;MVB12B,30 (30),0.925,1,0,,0 (2),1,1,0.925,1
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,Reactome,1,SFN,18 (18),0.925,1,0,,0 (0),1,1,0.925,1
er associated degradation (erad) pathway,BioCarta,1,MAN1C1,18 (18),0.925,1,0,,0 (0),1,1,0.925,1
SREBF and miR33 in cholesterol and lipid homeostasis,Wikipathways,1,PPARA,18 (18),0.925,1,0,,0 (0),1,1,0.925,1
Pentose phosphate cycle,INOH,3,ALDOA;ALDOB;RPIA,24 (24),0.642,1,0,,28 (31),1,1,0.927,1
regulation of ck1/cdk5 by type 1 glutamate receptors,BioCarta,3,PRKAR2A;NCS1;PRKAR1B,24 (24),0.642,1,0,,6 (7),1,1,0.927,1
Fragile X Syndrome,Wikipathways,15,ALDH3A2;ABCD3;MAP1B;ARC;SLC16A1;ALDH5A1;DLG4;CAMK2A;ABAT;NTRK2;MMP9;DEPTOR;EPHA4;CPT1A;APP,119 (119),0.642,1,0,,3 (6),1,1,0.927,1
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,27,PAK1;LIMK1;CD3D;MAPK12;IKBKG;NFATC2;NFATC4;CXCR4;NFKBIA;GNB5;GNG2;BAK1;AP1M2;PAK3;AP1S2;CCR5;MAPK13;BCL2;PLCG2;PAK6;MAPK11;TLR4;GNG11;GNGT2;GNAI1;CHUK;ITPR3,212 (212),0.644,1,0,,4 (5),1,1,0.927,1
Protein-protein interactions at synapses,Reactome,11,EPB41L3;PTPRF;EPB41L5;BEGAIN;DLG4;PPFIA2;EPB41L1;SHANK3;SYT1;STXBP1;PTPRD,88 (88),0.646,1,0,,2 (2),1,1,0.928,1
Caspase activation via Death Receptors in the presence of ligand,Reactome,2,TNFRSF10B;TLR4,16 (16),0.653,1,0,,1 (1),1,1,0.931,1
Codeine and Morphine Metabolism,Wikipathways,2,UGT1A1;ABCC2,16 (16),0.653,1,0,,7 (7),1,1,0.931,1
Synthesis of PIPs at the early endosome membrane,Reactome,2,PI4K2B;INPP4B,16 (16),0.653,1,0,,8 (16),1,1,0.931,1
hypoxia-inducible factor in the cardivascular system,BioCarta,2,LDHA;NOS3,16 (16),0.653,1,0,,2 (3),1,1,0.931,1
the igf-1 receptor and longevity,BioCarta,2,IGF1R;CAT,16 (16),0.653,1,0,,2 (2),1,1,0.931,1
Acyl chain remodelling of PI,Reactome,2,PLA2G4E;PLA2G4F,16 (16),0.653,1,0,,3 (8),1,1,0.931,1
MAP3K8 (TPL2)-dependent MAPK1/3 activation,Reactome,2,CHUK;IKBKG,16 (16),0.653,1,0,,2 (2),1,1,0.931,1
Mycophenolic Acid Metabolism Pathway,SMPDB,2,ABCC2;ABCG2,16 (16),0.653,1,0,,16 (16),1,1,0.931,1
NRIF signals cell death from the nucleus,Reactome,2,NGF;NGFR,16 (16),0.653,1,0,,2 (2),1,1,0.931,1
RHO GTPases activate CIT,Reactome,2,KIF14;DLG4,16 (16),0.653,1,0,,3 (3),1,1,0.931,1
Iron uptake and transport,Reactome,7,CP;ACO1;HEPH;ABCG2;FLVCR1;ATP6V0E2;TFR2,57 (57),0.657,1,0,,18 (23),1,1,0.933,1
Interleukin-17 signaling,Reactome,8,MAPK11;IKBKG;MEF2C;RPS6KA2;DUSP4;DUSP7;CHUK;MAPK7,65 (65),0.658,1,0,,4 (7),1,1,0.933,1
MAP kinase activation,Reactome,8,MAPK11;IKBKG;MEF2C;RPS6KA2;DUSP4;DUSP7;CHUK;MAPK7,65 (65),0.658,1,0,,4 (7),1,1,0.933,1
Hedgehog signaling events mediated by Gli proteins,PID,6,CSNK1E;GNAI1;LGALS3;ARRB2;GNG2;MTSS1,49 (49),0.658,1,0,,3 (3),1,1,0.933,1
RNA polymerase - Homo sapiens (human),KEGG,2,POLR2D;POLR2A,31 (31),0.933,1,0,,0 (0),1,1,0.933,1
wnt signaling pathway,BioCarta,2,PPARD;HNF1A,31 (31),0.933,1,0,,0 (0),1,1,0.933,1
Transport to the Golgi and subsequent modification,Reactome,21,B4GALT2;FUT8;CD55;ST8SIA3;USO1;F5;SEC16B;F8;MAN1C1;SEC22C;MIA3;SEC24A;B4GALT6;SEC23A;ANK1;SPTB;SPTBN2;COG5;MIA2;LMAN1;ANK2,167 (167),0.659,1,0,,15 (37),1,1,0.934,1
MTOR signalling,Reactome,5,RRAGD;CAB39L;PRKAA2;STRADB;PRKAG2,41 (41),0.659,1,0,,9 (9),1,1,0.934,1
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,11,MAPK11;TLR4;IKBKG;RIPK3;MEF2C;RPS6KA2;DUSP4;NFKBIA;DUSP7;CHUK;MAPK7,89 (89),0.661,1,0,,5 (8),1,1,0.935,1
Degradation of beta catenin,PID,1,CSNK1E,19 (19),0.935,1,0,,0 (0),1,1,0.935,1
ATM Signaling Pathway,Wikipathways,1,ABL1,19 (19),0.935,1,0,,0 (0),1,1,0.935,1
HH-Core,Signalink,1,GLIS2,19 (19),0.935,1,0,,0 (0),1,1,0.935,1
BDNF-TrkB Signaling,Wikipathways,4,DLG4;NTRK2;ARC;GAB2,33 (33),0.663,1,0,,2 (2),1,1,0.935,1
Formation of the HIV-1 Early Elongation Complex,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,33 (33),0.663,1,0,,4 (5),1,1,0.935,1
Formation of the Early Elongation Complex,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,33 (33),0.663,1,0,,4 (5),1,1,0.935,1
Trk receptor signaling mediated by the MAPK pathway,PID,4,MEF2C;SRF;EGR1;MAPK7,33 (33),0.663,1,0,,1 (1),1,1,0.935,1
Imipramine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,33 (33),0.663,1,0,,20 (20),1,1,0.935,1
NOTCH3 Activation and Transmission of Signal to the Nucleus,Reactome,3,NEURL1B;ADAM10;DLL4,25 (25),0.67,1,0,,3 (3),1,1,0.938,1
IL-6 signaling pathway,Wikipathways,3,CRP;VAV1;PRDM1,43 (43),0.94,1,0,,0 (0),1,1,0.94,1
LKB1 signaling events,PID,3,SFN;STRADB;SIK1,43 (43),0.94,1,0,,0 (0),1,1,0.94,1
MyD88-independent TLR4 cascade ,Reactome,11,MAPK11;TLR4;IKBKG;RIPK3;MEF2C;RPS6KA2;DUSP4;NFKBIA;DUSP7;CHUK;MAPK7,90 (90),0.676,1,0,,5 (8),1,1,0.941,1
Hedgehog _off_ state,Reactome,5,ADCY4;PRKAR2A;ADCY9;ADCY2;PRKAR1B,42 (42),0.681,1,0,,5 (6),1,1,0.942,1
RND3 GTPase cycle,Reactome,5,DSP;CAV1;CKAP4;ARHGAP35;DLG5,42 (42),0.681,1,0,,1 (1),1,1,0.942,1
IL-1 NFkB,INOH,5,NFKBIA;IL1B;PSMD1;CHUK;IKBKG,64 (64),0.943,1,0,,0 (0),1,1,0.943,1
Defensins,Reactome,4,DEFB1;ART1;TLR1;CCR2,54 (54),0.943,1,0,,0 (2),1,1,0.943,1
IL1,NetPath,4,NFKBIA;IL1B;CHUK;DOK1,54 (54),0.943,1,0,,0 (0),1,1,0.943,1
IL6,NetPath,6,SGK1;ERBB2;VAV1;HSPB1;GAB2;FGR,74 (74),0.943,1,0,,0 (0),1,1,0.943,1
Hypothetical Craniofacial Development Pathway,Wikipathways,1,TGFB3,8 (8),0.684,1,0,,2 (2),1,1,0.944,1
The alternative pathway of fetal androgen synthesis,Wikipathways,1,CYP17A1,8 (8),0.684,1,0,,12 (17),1,1,0.944,1
Transport of fatty acids,Reactome,1,APOD,8 (8),0.684,1,0,,9 (10),1,1,0.944,1
ARMS-mediated activation,Reactome,1,NGF,8 (8),0.684,1,0,,5 (5),1,1,0.944,1
Riboflavin metabolism - Homo sapiens (human),KEGG,1,ENPP1,8 (8),0.684,1,0,,14 (20),1,1,0.944,1
Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin ,SMPDB,1,ADCY2,8 (8),0.684,1,0,,8 (8),1,1,0.944,1
mRNA Editing: C to U Conversion,Reactome,1,A1CF,8 (8),0.684,1,0,,2 (3),1,1,0.944,1
Netrin mediated repulsion signals,Reactome,1,UNC5A,8 (8),0.684,1,0,,2 (2),1,1,0.944,1
Phosphate bond hydrolysis by NTPDase proteins,Reactome,1,ENTPD5,8 (8),0.684,1,0,,22 (26),1,1,0.944,1
Lectin pathway of complement activation,Reactome,1,MASP2,8 (8),0.684,1,0,,3 (9),1,1,0.944,1
Role of ABL in ROBO-SLIT signaling,Reactome,1,ABL1,8 (8),0.684,1,0,,2 (2),1,1,0.944,1
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin ,SMPDB,1,ADCY2,8 (8),0.684,1,0,,8 (8),1,1,0.944,1
OAS antiviral response,Reactome,1,FLNA,8 (8),0.684,1,0,,2 (6),1,1,0.944,1
Phenylalanine metabolism,Reactome,1,PAH,8 (8),0.684,1,0,,20 (22),1,1,0.944,1
S1P5 pathway,PID,1,GNAI1,8 (8),0.684,1,0,,3 (3),1,1,0.944,1
a4b7 Integrin signaling,PID,1,ITGB7,8 (8),0.684,1,0,,1 (1),1,1,0.944,1
Cross-presentation of particulate exogenous antigens (phagosomes),Reactome,1,NCF2,8 (8),0.684,1,0,,5 (6),1,1,0.944,1
Sulfur relay system - Homo sapiens (human),KEGG,1,MPST,8 (8),0.684,1,0,,7 (11),1,1,0.944,1
Synthesis of UDP-N-acetyl-glucosamine,Reactome,1,PGM3,8 (8),0.684,1,0,,18 (21),1,1,0.944,1
Axonal growth inhibition (RHOA activation),Reactome,1,NGFR,8 (8),0.684,1,0,,2 (3),1,1,0.944,1
CREB phosphorylation,Reactome,1,RPS6KA2,8 (8),0.684,1,0,,2 (2),1,1,0.944,1
Vitamin C (ascorbate) metabolism,Reactome,1,SLC23A1,8 (8),0.684,1,0,,13 (18),1,1,0.944,1
Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMPDB,1,ADCY2,8 (8),0.684,1,0,,8 (8),1,1,0.944,1
Citalopram Metabolism Pathway,SMPDB,1,MAOB,8 (8),0.684,1,0,,17 (18),1,1,0.944,1
Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,1,ADCY2,8 (8),0.684,1,0,,8 (8),1,1,0.944,1
Celecoxib Metabolism Pathway,SMPDB,1,PTGS2,8 (8),0.684,1,0,,10 (11),1,1,0.944,1
SUMOylation of transcription factors,Reactome,1,HIC1,20 (20),0.944,1,0,,0 (0),1,1,0.944,1
Canonical Wnt signaling pathway,PID,1,CAV1,20 (20),0.944,1,0,,0 (0),1,1,0.944,1
lissencephaly gene (lis1) in neuronal migration and development,BioCarta,1,ABL1,20 (20),0.944,1,0,,0 (0),1,1,0.944,1
Serotonin and anxiety,Wikipathways,2,ADRA1A;ARC,17 (17),0.686,1,0,,2 (4),1,1,0.944,1
Glycosaminoglycan degradation,Wikipathways,2,HYAL1;HPSE,17 (17),0.686,1,0,,3 (5),1,1,0.944,1
Sulfation Biotransformation Reaction,Wikipathways,2,SULT1B1;PAPSS2,17 (17),0.686,1,0,,10 (10),1,1,0.944,1
GAB1 signalosome,Reactome,2,EREG;HBEGF,17 (17),0.686,1,0,,5 (6),1,1,0.944,1
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Reactome,2,PARD3;TGFBR2,17 (17),0.686,1,0,,3 (3),1,1,0.944,1
Activated point mutants of FGFR2,Reactome,2,FGF1;FGF2,17 (17),0.686,1,0,,3 (12),1,1,0.944,1
endocytotic role of ndk phosphins and dynamin,BioCarta,2,BIN2;SYNJ2,17 (17),0.686,1,0,,3 (3),1,1,0.944,1
FGFR2 mutant receptor activation,Reactome,2,FGF1;FGF2,17 (17),0.686,1,0,,3 (13),1,1,0.944,1
TNF signaling,Reactome,4,SMPD3;BAG4;CHUK;IKBKG,34 (34),0.686,1,0,,3 (4),1,1,0.945,1
Fluoxetine Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,34 (34),0.686,1,0,,15 (16),1,1,0.945,1
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,24,IFNGR1;MAPK12;PDGFB;NFATC2;NFATC4;NFKBIA;GNB5;GNG2;BAK1;IKBKG;FGF2;C3;CCR5;PLCG2;MAPK11;MAPK13;GNG11;CXCL2;CXCL3;PREX1;PTGS2;GNGT2;CHUK;ITPR3,193 (193),0.687,1,0,,5 (5),1,1,0.945,1
mTOR signaling pathway - Homo sapiens (human),KEGG,19,RRAGD;FZD4;PRKAA2;IGF1R;FZD8;FZD9;GRB10;STRADB;SGK1;DDIT4;CAB39L;SESN2;RPS6KA2;WNT7B;CASTOR2;WNT11;CHUK;WNT9B;DEPTOR,154 (155),0.688,1,0,,4 (4),1,1,0.945,1
The citric acid (TCA) cycle and respiratory electron transport,Reactome,20,NUBPL;SUCLG2;SUCLG1;LDHA;SLC16A1;ME1;L2HGDH;LDHB;GSTZ1;PM20D1;PDK4;DLST;ADHFE1;ME2;PDP1;ME3;UCP3;UQCRC2;NNT;ETFDH,162 (162),0.689,1,0,,46 (59),1,1,0.946,1
Beta defensins,Reactome,3,DEFB1;TLR1;CCR2,44 (44),0.946,1,0,,0 (0),1,1,0.946,1
Interleukin-11 Signaling Pathway,Wikipathways,3,CHUK;BCL2;IL11,44 (44),0.946,1,0,,0 (0),1,1,0.946,1
Formation of the cornified envelope,Reactome,9,DSC2;PERP;PKP2;DSP;EVPL;ST14;PKP3;PCSK6;SPINK5,75 (75),0.691,1,0,,6 (10),1,1,0.946,1
Glioma - Homo sapiens (human),KEGG,9,BAK1;PDGFB;PDGFRA;PDGFRB;CAMK2A;IGF1R;PLCG2;CAMK1D;SHC2,75 (75),0.691,1,0,,4 (4),1,1,0.946,1
Peptide GPCRs,Wikipathways,9,CXCR6;AVPR1A;CXCR4;CCR2;C3AR1;BDKRB2;CXCR3;CCR5;C5AR1,75 (75),0.691,1,0,,2 (2),1,1,0.946,1
Acute myeloid leukemia - Homo sapiens (human),KEGG,8,SPI1;CHUK;ITGAM;IKBKG;KIT;PPARD;RUNX1;RUNX1T1,67 (67),0.691,1,0,,1 (1),1,1,0.947,1
Mineral absorption - Homo sapiens (human),KEGG,7,ATP2B4;VDR;HEPH;ATP7A;SLC5A1;ATP7B;ATP1A2,59 (59),0.693,1,0,,27 (29),1,1,0.947,1
Human cytomegalovirus infection - Homo sapiens (human),KEGG,28,ADCY4;MAPK12;PDGFRA;NFATC2;NFATC4;CXCR4;NFKBIA;GNB5;GNG2;BAK1;IKBKG;CCL2;GNAI1;PLCB4;CREB3L3;BCAR1;MAPK11;IL1B;MAPK13;GNG11;CX3CL1;GNGT2;ADCY2;CCR5;PTGS2;ADCY9;CHUK;ITPR3,225 (225),0.694,1,0,,5 (6),1,1,0.948,1
Aminosugars metabolism,EHMN,6,SLC17A5;SLC1A5;SLC38A4;SLC2A2;SLC2A4;NUP35,51 (51),0.696,1,0,,37 (43),1,1,0.948,1
Termination of O-glycan biosynthesis,Reactome,3,ST6GALNAC4;ST3GAL2;MUC1,26 (26),0.697,1,0,,2 (2),1,1,0.948,1
Folate biosynthesis - Homo sapiens (human),KEGG,3,AKR1B10;PAH;DHFR,26 (26),0.697,1,0,,32 (58),1,1,0.948,1
TLR ECSIT MEKK1 JNK,INOH,3,IL1B;TLR4;MAP3K1,26 (26),0.697,1,0,,1 (1),1,1,0.948,1
Downregulation of TGF-beta receptor signaling,Reactome,3,TGFBR2;SMAD3;BAMBI,26 (26),0.697,1,0,,2 (2),1,1,0.948,1
Caspase activation via extrinsic apoptotic signalling pathway,Reactome,3,UNC5A;TNFRSF10B;TLR4,26 (26),0.697,1,0,,3 (3),1,1,0.948,1
Formation of tubulin folding intermediates by CCT/TriC,Reactome,3,TUBB1;TUBB2B;TUBA1A,26 (26),0.697,1,0,,4 (4),1,1,0.948,1
Fertilization,Reactome,3,HVCN1;CATSPER2;CATSPERD,26 (26),0.697,1,0,,5 (5),1,1,0.948,1
signaling pathway from g-protein families,BioCarta,3,PRKAR2A;GNAI1;PRKAR1B,26 (26),0.697,1,0,,3 (3),1,1,0.948,1
links between pyk2 and map kinases,BioCarta,3,PAK1;BCAR1;MAP3K1,26 (26),0.697,1,0,,2 (2),1,1,0.948,1
Breast cancer - Homo sapiens (human),KEGG,18,FZD8;DLL4;BAK1;FZD9;FGF1;FGF2;KIT;FZD4;ERBB2;FGF21;FGFR1;WNT7B;NOTCH4;IGF1R;FLT4;WNT9B;WNT11;SHC2,147 (147),0.697,1,0,,3 (3),1,1,0.949,1
De novo fatty acid biosynthesis,EHMN,5,NUP35;ACOT4;ACOT1;BAAT;ACOT2,43 (43),0.701,1,0,,24 (59),1,1,0.95,1
Type I diabetes mellitus - Homo sapiens (human),KEGG,5,IL1B;HSPD1;GZMB;CPE;PRF1,43 (43),0.701,1,0,,3 (3),1,1,0.95,1
Progesterone-mediated oocyte maturation - Homo sapiens (human),KEGG,12,MAPK11;MAPK13;ADCY4;STK10;ADCY2;GNAI1;ADCY9;RPS6KA2;IGF1R;ANAPC10;MAPK12;PDE3B,100 (100),0.704,1,0,,3 (4),1,1,0.951,1
ErbB signaling pathway,Wikipathways,11,PAK1;NRG4;PAK3;CAMK2A;ERBB2;EREG;PLCG2;ABL1;HBEGF;PAK6;SHC2,92 (92),0.704,1,0,,4 (5),1,1,0.951,1
Phosphorylation of the APC/C,Reactome,1,ANAPC10,21 (21),0.951,1,0,,0 (0),1,1,0.951,1
Other interleukin signaling,Reactome,1,SDC1,21 (21),0.951,1,0,,0 (0),1,1,0.951,1
Basal transcription factors - Homo sapiens (human),KEGG,3,TAF9B;GTF2I;TAF3,45 (45),0.952,1,0,,0 (0),1,1,0.952,1
Pancreatic cancer - Homo sapiens (human),KEGG,9,TGFB2;TGFB3;IKBKG;TGFBR2;BAK1;ERBB2;ARHGEF6;SMAD3;CHUK,76 (76),0.706,1,0,,2 (2),1,1,0.952,1
IL-1 p38,INOH,5,MAPK11;IL1B;PSMD1;MAPK13;MAPK12,66 (66),0.952,1,0,,0 (0),1,1,0.952,1
COPII-mediated vesicle transport,Reactome,8,USO1;F5;SEC16B;F8;SEC24A;SEC23A;SEC22C;LMAN1,68 (68),0.708,1,0,,6 (11),1,1,0.952,1
Amyotrophic lateral sclerosis (ALS),Wikipathways,4,NEFH;BCL2;CASP12;CAT,35 (35),0.709,1,0,,10 (11),1,1,0.953,1
ROS and RNS production in phagocytes,Reactome,4,NCF2;ATP6V0E2;SLC11A1;NOS3,35 (35),0.709,1,0,,28 (50),1,1,0.953,1
Tat-mediated HIV elongation arrest and recovery,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,35 (35),0.709,1,0,,4 (5),1,1,0.953,1
Pausing and recovery of Tat-mediated HIV elongation,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,35 (35),0.709,1,0,,4 (5),1,1,0.953,1
FAS (CD95) signaling pathway,PID,4,MAPK11;CHUK;IKBKG;MAP3K1,35 (35),0.709,1,0,,1 (2),1,1,0.953,1
angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling,BioCarta,4,MEF2C;PAK1;BCAR1;MAP3K1,35 (35),0.709,1,0,,3 (3),1,1,0.953,1
Lysosome Vesicle Biogenesis,Reactome,4,ARRB1;AP1S2;AP1M2;APP,35 (35),0.709,1,0,,5 (6),1,1,0.953,1
ATM pathway,PID,2,ABL1;RAD50,34 (34),0.953,1,0,,0 (0),1,1,0.953,1
Regulation of PTEN gene transcription,Reactome,7,RRAGD;EGR1;MAF1;CBX6;HDAC7;SNAI1;ATN1,60 (60),0.71,1,0,,8 (8),1,1,0.953,1
Intrinsic Pathway for Apoptosis,Reactome,6,BAK1;BCL2;PMAIP1;GZMB;BMF;SFN,52 (52),0.714,1,0,,4 (5),1,1,0.955,1
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,Wikipathways,2,MYL2;PRKCQ,18 (18),0.716,1,0,,1 (1),1,1,0.955,1
Phospholipase C-mediated cascade; FGFR2,Reactome,2,FGF1;FGF2,18 (18),0.716,1,0,,4 (5),1,1,0.955,1
Signaling by FLT3 fusion proteins,Reactome,2,NOX4;GAB2,18 (18),0.716,1,0,,9 (9),1,1,0.955,1
SHC-mediated cascade:FGFR3,Reactome,2,FGF1;FGF2,18 (18),0.716,1,0,,5 (5),1,1,0.955,1
Regulation of signaling by CBL,Reactome,2,BLNK;VAV1,18 (18),0.716,1,0,,2 (2),1,1,0.955,1
Lewis blood group biosynthesis,Reactome,2,FUT2;FUT10,18 (18),0.716,1,0,,7 (21),1,1,0.955,1
nerve growth factor pathway (ngf),BioCarta,2,NGF;NGFR,18 (18),0.716,1,0,,2 (2),1,1,0.955,1
PI-3K cascade:FGFR3,Reactome,2,FGF1;FGF2,18 (18),0.716,1,0,,4 (5),1,1,0.955,1
TNF,INOH,5,RIPK3;NFKBIA;PSMD1;CHUK;IKBKG,67 (67),0.956,1,0,,0 (0),1,1,0.956,1
FOXA1 transcription factor network,PID,5,VTN;APOB;NRIP1;NR2F2;TFF1,44 (44),0.721,1,0,,3 (3),1,1,0.957,1
CD4 T cell receptor signaling-ERK cascade,INOH,5,PLCG2;LAT;CD3D;LCK;ITPR3,44 (44),0.721,1,0,,4 (5),1,1,0.957,1
Morphine Action Pathway,SMPDB,5,ADRA1A;UGT1A1;SCN1B;ATP1A2;CACNB1,44 (44),0.721,1,0,,16 (16),1,1,0.957,1
Ion channel transport,Reactome,20,FXYD6;ANO1;ASIC5;ATP8B2;ATP2A1;TRDN;ATP11C;ATP2B4;SGK1;ATP1A2;ATP2A3;WWP1;RYR1;TTYH3;ATP7A;ATP9A;ATP7B;TPCN1;SGK2;ATP6V0E2,165 (165),0.721,1,0,,16 (22),1,1,0.957,1
Transcriptional activation of mitochondrial biogenesis,Reactome,3,SIRT5;GLUD1;ALAS1,27 (27),0.721,1,0,,6 (7),1,1,0.957,1
Downstream signaling of activated FGFR4,Reactome,3,FGF2;FGF1;KLB,27 (27),0.721,1,0,,6 (7),1,1,0.957,1
role of erk5 in neuronal survival pathway,BioCarta,3,MEF2C;NGF;MAPK7,27 (27),0.721,1,0,,2 (2),1,1,0.957,1
transcription factor creb and its extracellular signals,BioCarta,3,PRKAR2A;PRKAR1B;CAMK2A,27 (27),0.721,1,0,,5 (5),1,1,0.957,1
pdgf signaling pathway,BioCarta,3,SRF;PDGFRA;MAP3K1,27 (27),0.721,1,0,,3 (3),1,1,0.957,1
Renal cell carcinoma - Homo sapiens (human),KEGG,8,TGFB2;PDGFB;PAK3;HGF;PAK1;TGFB3;ARNT2;PAK6,69 (69),0.723,1,0,,3 (3),1,1,0.958,1
Immune response to tuberculosis,Wikipathways,1,IFNGR1,22 (22),0.958,1,0,,0 (0),1,1,0.958,1
Inactivation of APC/C via direct inhibition of the APC/C complex,Reactome,1,ANAPC10,22 (22),0.958,1,0,,0 (0),1,1,0.958,1
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Reactome,1,ANAPC10,22 (22),0.958,1,0,,0 (0),1,1,0.958,1
role of brca1 brca2 and atr in cancer susceptibility,BioCarta,1,RAD50,22 (22),0.958,1,0,,0 (0),1,1,0.958,1
HIF-2-alpha transcription factor network,PID,2,ABCG2;KDR,35 (35),0.959,1,0,,0 (0),1,1,0.959,1
Interleukin-1 Induced Activation of NF-kappa-B,Wikipathways,1,AJUBA,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
Uptake and function of anthrax toxins,Reactome,1,ANTXR1,9 (9),0.726,1,0,,5 (5),1,1,0.959,1
Interleukin-9 signaling,Reactome,1,IL9R,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
Activated NTRK2 signals through RAS,Reactome,1,NTRK2,9 (9),0.726,1,0,,4 (4),1,1,0.959,1
Prostanoid ligand receptors,Reactome,1,PTGIR,9 (9),0.726,1,0,,5 (5),1,1,0.959,1
Bicarbonate transporters,Reactome,1,SLC4A4,9 (9),0.726,1,0,,3 (4),1,1,0.959,1
Prevention of phagosomal-lysosomal fusion,Reactome,1,CORO1A,9 (9),0.726,1,0,,4 (8),1,1,0.959,1
Multifunctional anion exchangers,Reactome,1,SLC26A1,9 (9),0.726,1,0,,8 (10),1,1,0.959,1
SHC-related events triggered by IGF1R,Reactome,1,IGF1R,9 (9),0.726,1,0,,4 (4),1,1,0.959,1
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Reactome,1,DOK1,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
ROBO receptors bind AKAP5,Reactome,1,PRKAR2A,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
Pterine Biosynthesis,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
MET activates RAP1 and RAC1,Reactome,1,HGF,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
CHL1 interactions,Reactome,1,ANK1,9 (9),0.726,1,0,,1 (1),1,1,0.959,1
PI3K/AKT activation,Reactome,1,NGF,9 (9),0.726,1,0,,3 (4),1,1,0.959,1
signal dependent regulation of myogenesis by corepressor mitr,BioCarta,1,MEF2C,9 (9),0.726,1,0,,1 (1),1,1,0.959,1
Highly calcium permeable nicotinic acetylcholine receptors,Reactome,1,CHRNA2,9 (9),0.726,1,0,,2 (2),1,1,0.959,1
adenosine nucleotides degradation,HumanCyc,1,ADA,9 (9),0.726,1,0,,13 (13),1,1,0.959,1
Erythrocytes take up oxygen and release carbon dioxide,Reactome,1,AQP1,9 (9),0.726,1,0,,7 (8),1,1,0.959,1
PI5P Regulates TP53 Acetylation,Reactome,1,PIP4K2A,9 (9),0.726,1,0,,6 (8),1,1,0.959,1
Segawa syndrome,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Reactome,1,CAMKK1,9 (9),0.726,1,0,,3 (3),1,1,0.959,1
glutathione redox reactions I,HumanCyc,1,GPX3,9 (9),0.726,1,0,,62 (100),1,1,0.959,1
Sepiapterin reductase deficiency,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
Clopidogrel Metabolism Pathway,SMPDB,1,PON1,9 (9),0.726,1,0,,9 (9),1,1,0.959,1
Transfer of Acetyl Groups into Mitochondria,SMPDB,1,ME1,9 (9),0.726,1,0,,20 (22),1,1,0.959,1
Thyroid hormone synthesis,SMPDB,1,NOX4,9 (9),0.726,1,0,,13 (13),1,1,0.959,1
Nicotine Metabolism Pathway,SMPDB,1,FMO3,9 (9),0.726,1,0,,20 (22),1,1,0.959,1
Clopidogrel Action Pathway,SMPDB,1,PON1,9 (9),0.726,1,0,,9 (9),1,1,0.959,1
Dopa-responsive dystonia,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
Hyperphenylalaninemia due to dhpr-deficiency,SMPDB,1,DHFR,9 (9),0.726,1,0,,19 (20),1,1,0.959,1
IGF signaling,INOH,4,IGF1R;IGFBP6;IGFBP1;SHC2,36 (36),0.73,1,0,,3 (4),1,1,0.96,1
Inactivation_ recovery and regulation of the phototransduction cascade,Reactome,4,GNB5;GNAT1;PRKCQ;NMT2,36 (36),0.73,1,0,,16 (18),1,1,0.96,1
E-cadherin signaling in the nascent adherens junction,PID,4,IQGAP1;WASF2;ENAH;ITGB7,36 (36),0.73,1,0,,3 (3),1,1,0.96,1
Methadone Action Pathway,SMPDB,4,ADRA1A;SCN1B;ATP1A2;CACNB1,36 (36),0.73,1,0,,17 (17),1,1,0.96,1
Mitophagy - animal - Homo sapiens (human),KEGG,5,BNIP3;RAB7B;OPTN;TFEB;NBR1,68 (68),0.96,1,0,,0 (0),1,1,0.96,1
Notch signaling pathway,PID,6,MAML1;LNX1;ADAM10;DLL4;NOTCH4;RBPJ,53 (53),0.732,1,0,,1 (1),1,1,0.96,1
Signaling by Insulin receptor,Reactome,9,FGF1;GRB10;FGF2;PDE3B;GAB2;FGFR1;TLR9;ATP6V0E2;KLB,78 (78),0.735,1,0,,11 (15),1,1,0.961,1
Regulation of toll-like receptor signaling pathway,Wikipathways,13,MAPK11;IL1B;MAPK13;IKBKG;SPP1;TLR5;TLR4;SMAD6;NFKBIA;TLR1;TLR9;CHUK;MAPK12,145 (145),0.962,1,0,,0 (2),1,1,0.962,1
p75(NTR)-mediated signaling,PID,8,NGF;NGFR;IKBKG;PLG;BEX3;CHUK;MMP7;APP,70 (70),0.738,1,0,,3 (3),1,1,0.962,1
The influence of laminopathies on Wnt signaling,Wikipathways,2,SPP1;SLC2A4,36 (36),0.963,1,0,,0 (1),1,1,0.963,1
DNA replication - Homo sapiens (human),KEGG,2,MCM3;MCM4,36 (36),0.963,1,0,,0 (0),1,1,0.963,1
Autodegradation of Cdh1 by Cdh1:APC/C,Reactome,1,ANAPC10,23 (23),0.964,1,0,,0 (0),1,1,0.964,1
cyclins and cell cycle regulation,BioCarta,1,CDKN2D,23 (23),0.964,1,0,,0 (0),1,1,0.964,1
Initiation of Nuclear Envelope (NE) Reformation,Reactome,2,LMNB1;LBR,19 (19),0.744,1,0,,6 (9),1,1,0.964,1
Growth hormone receptor signaling,Reactome,2,GHR;SOCS2,19 (19),0.744,1,0,,4 (4),1,1,0.964,1
Glycosaminoglycan degradation - Homo sapiens (human),KEGG,2,HYAL1;HPSE,19 (19),0.744,1,0,,5 (27),1,1,0.964,1
Etoposide Action Pathway,SMPDB,2,UGT1A1;PTGS2,19 (19),0.744,1,0,,14 (14),1,1,0.964,1
Serotonin Receptor 4-6-7 and NR3C Signaling,Wikipathways,2,SRF;EGR1,19 (19),0.744,1,0,,2 (2),1,1,0.964,1
Etoposide Metabolism Pathway,SMPDB,2,UGT1A1;PTGS2,19 (19),0.744,1,0,,14 (14),1,1,0.964,1
Postmitotic nuclear pore complex (NPC) reformation,Reactome,3,NUP35;NDC1;POM121,28 (28),0.745,1,0,,4 (5),1,1,0.964,1
Prefoldin mediated transfer of substrate  to CCT/TriC,Reactome,3,TUBB1;TUBB2B;TUBA1A,28 (28),0.745,1,0,,1 (1),1,1,0.964,1
SUMOylation of intracellular receptors,Reactome,3,PPARA;THRB;VDR,28 (28),0.745,1,0,,6 (7),1,1,0.964,1
EGF,INOH,3,SFN;MAP3K1;SHC2,28 (28),0.745,1,0,,2 (2),1,1,0.964,1
Toll Like Receptor 3 (TLR3) Cascade,Reactome,10,MAPK11;RIPK3;IKBKG;MEF2C;RPS6KA2;DUSP4;NFKBIA;DUSP7;CHUK;MAPK7,87 (87),0.746,1,0,,4 (9),1,1,0.965,1
Coronavirus disease - COVID-19 - Homo sapiens (human),KEGG,28,PLCG2;VWF;MAPK12;FGG;HBEGF;NFKBIA;TLR4;FGA;FGB;IKBKG;CCL2;C3;C3AR1;MAPK13;C5AR1;C6;C7;C8A;C8B;C9;MAPK11;IL1B;MASP2;ACE;RPL3L;F13A1;F13B;CHUK,231 (232),0.746,1,0,,6 (10),1,1,0.965,1
SUMOylation of RNA binding proteins,Reactome,3,NUP35;NDC1;POM121,48 (48),0.965,1,0,,0 (0),1,1,0.965,1
Copper homeostasis,Wikipathways,6,BACE1;ADAM10;MTF2;ATP7A;ATP7B;APP,54 (54),0.748,1,0,,1 (2),1,1,0.965,1
The phototransduction cascade,Reactome,4,GNB5;GNAT1;PRKCQ;NMT2,37 (37),0.75,1,0,,19 (22),1,1,0.966,1
HIV elongation arrest and recovery,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,37 (37),0.75,1,0,,4 (5),1,1,0.966,1
Pausing and recovery of HIV elongation,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,37 (37),0.75,1,0,,4 (5),1,1,0.966,1
GMCSF-mediated signaling events,PID,4,IRF8;INPP5D;CCL2;GAB2,37 (37),0.75,1,0,,2 (2),1,1,0.966,1
ER to Golgi Anterograde Transport,Reactome,16,COG5;CD55;USO1;F5;SEC16B;F8;SEC22C;MIA3;SEC24A;SEC23A;ANK1;SPTB;SPTBN2;MIA2;LMAN1;ANK2,136 (136),0.75,1,0,,6 (11),1,1,0.966,1
Retinoblastoma gene in cancer,Wikipathways,7,SMARCA2;HMGB2;MCM3;MCM4;MAPK13;DHFR;ABL1,90 (90),0.966,1,0,,0 (0),1,1,0.966,1
Thyroid cancer - Homo sapiens (human),KEGG,2,BAK1;NCOA4,37 (37),0.967,1,0,,0 (0),1,1,0.967,1
ATM Signaling Network in Development and Disease,Wikipathways,5,LBR;HSPB1;ATMIN;IKBKG;RAD50,46 (46),0.757,1,0,,1 (1),1,1,0.968,1
Signaling by FGFR,Reactome,10,ESRP2;FGF1;FGF2;FGFR1;POLR2A;POLR2D;GALNT3;ESRP1;SPRED2;KLB,88 (88),0.759,1,0,,9 (11),1,1,0.968,1
APC/C:Cdc20 mediated degradation of Securin,Reactome,1,ANAPC10,24 (24),0.969,1,0,,0 (0),1,1,0.969,1
Fas,INOH,1,SFN,24 (24),0.969,1,0,,0 (0),1,1,0.969,1
Cell cycle,Wikipathways,10,TGFB2;TGFB3;CDKN2D;CDC14A;MCM3;MCM4;ANAPC10;SMAD3;ABL1;SFN,120 (120),0.969,1,0,,0 (0),1,1,0.969,1
Glucocorticoid receptor regulatory network,PID,9,SPI1;KRT17;EGR1;SGK1;NR1I3;MAPK11;FGG;NR4A1;SFN,80 (80),0.762,1,0,,1 (1),1,1,0.969,1
GPCRs_ Other,Wikipathways,8,ADGRG1;GPR55;CXCR3;CCR5;ADGRF5;ADGRD1;ADRB2;ADGRV1,101 (101),0.969,1,0,,0 (0),1,1,0.969,1
15q11.2 copy number variation syndrome,Wikipathways,1,TUBGCP5,10 (10),0.763,1,0,,1 (1),1,1,0.969,1
WNT mediated activation of DVL,Reactome,1,CSNK1E,10 (10),0.763,1,0,,2 (4),1,1,0.969,1
Regulation of RUNX3 expression and activity,Reactome,1,RUNX3,10 (10),0.763,1,0,,2 (2),1,1,0.969,1
Activation of the AP-1 family of transcription factors,Reactome,1,MAPK11,10 (10),0.763,1,0,,2 (2),1,1,0.969,1
HDR through MMEJ (alt-NHEJ),Reactome,1,RAD50,10 (10),0.763,1,0,,4 (6),1,1,0.969,1
pentose phosphate pathway,HumanCyc,1,RPIA,10 (10),0.763,1,0,,14 (16),1,1,0.969,1
Caspase activation via Dependence Receptors in the absence of ligand,Reactome,1,UNC5A,10 (10),0.763,1,0,,2 (2),1,1,0.969,1
AKT phosphorylates targets in the nucleus,Reactome,1,NR4A1,10 (10),0.763,1,0,,2 (2),1,1,0.969,1
Insulin processing,Reactome,1,CPE,10 (10),0.763,1,0,,3 (3),1,1,0.969,1
Reactions specific to the complex N-glycan synthesis pathway,Reactome,1,FUT8,10 (10),0.763,1,0,,9 (19),1,1,0.969,1
nicotine degradation III,HumanCyc,1,CYP2S1,10 (10),0.763,1,0,,13 (24),1,1,0.969,1
Calcineurin activates NFAT,Reactome,1,NFATC2,10 (10),0.763,1,0,,3 (4),1,1,0.969,1
Constitutive Signaling by Overexpressed ERBB2,Reactome,1,ERBB2,10 (10),0.763,1,0,,5 (7),1,1,0.969,1
EGFR Transactivation by Gastrin,Reactome,1,HBEGF,10 (10),0.763,1,0,,2 (3),1,1,0.969,1
dolichyl-diphosphooligosaccharide biosynthesis,HumanCyc,1,ALG13,10 (10),0.763,1,0,,6 (7),1,1,0.969,1
TRAF6-mediated induction of TAK1 complex within TLR4 complex,Reactome,1,TLR4,10 (10),0.763,1,0,,3 (4),1,1,0.969,1
Activation of the phototransduction cascade,Reactome,1,GNAT1,10 (10),0.763,1,0,,8 (9),1,1,0.969,1
Signal attenuation,Reactome,1,GRB10,10 (10),0.763,1,0,,3 (4),1,1,0.969,1
Digestion of dietary carbohydrate,Reactome,1,MGAM,10 (10),0.763,1,0,,12 (17),1,1,0.969,1
Neurotoxicity of clostridium toxins,Reactome,1,SYT1,10 (10),0.763,1,0,,3 (5),1,1,0.969,1
overview of telomerase protein component gene htert transcriptional regulation,BioCarta,1,WT1,10 (10),0.763,1,0,,1 (1),1,1,0.969,1
Formyl peptide receptors bind formyl peptides and many other ligands,Reactome,1,APP,10 (10),0.763,1,0,,1 (2),1,1,0.969,1
Nanoparticle triggered regulated necrosis,Wikipathways,1,RIPK3,10 (10),0.763,1,0,,5 (8),1,1,0.969,1
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,SMPDB,1,ADCY2,10 (10),0.763,1,0,,7 (7),1,1,0.969,1
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,SMPDB,1,ADCY2,10 (10),0.763,1,0,,7 (7),1,1,0.969,1
Zinc influx into cells by the SLC39 gene family,Reactome,1,SLC39A5,10 (10),0.763,1,0,,1 (1),1,1,0.969,1
Prion disease - Homo sapiens (human),KEGG,33,TUBB1;CACNA1C;CACNA1D;CACNA1S;CAV1;UQCRC2;MAPK12;C7;SLC25A4;TUBA1A;COX6A2;COX7A1;LAMC1;C8A;PSMD1;NCAM2;NCF2;TUBB2B;C6;CAV2;CREB3L3;C8B;C9;MAPK11;IL1B;MAPK13;EGR1;HSPA1A;HSPA1B;HSPA1L;RYR1;CASP12;ITPR3,273 (273),0.766,1,0,,5 (5),1,1,0.97,1
Breast cancer pathway,Wikipathways,18,DLL4;BAK1;FGFR1;FZD8;FGF1;FGF2;KIT;ERBB2;SFRP4;FGF21;FLT4;WNT7B;NOTCH4;IGF1R;WNT11;SHC2;FZD9;RAD50,154 (154),0.769,1,0,,4 (4),1,1,0.971,1
Regucalcin in proximal tubule epithelial kidney cells,Wikipathways,2,BAK1;ACTA2,20 (20),0.77,1,0,,12 (22),1,1,0.971,1
VEGFR2 mediated cell proliferation,Reactome,2,ITPR3;KDR,20 (20),0.77,1,0,,9 (10),1,1,0.971,1
Serotonin Receptor 2 and ELK-SRF-GATA4 signaling,Wikipathways,2,SRF;GATA4,20 (20),0.77,1,0,,3 (3),1,1,0.971,1
Blood group systems biosynthesis,Reactome,2,FUT2;FUT10,20 (20),0.77,1,0,,8 (29),1,1,0.971,1
Signaling by phosphorylated juxtamembrane_ extracellular and kinase domain KIT mutants,Reactome,2,LCK;KIT,20 (20),0.77,1,0,,5 (6),1,1,0.971,1
Signaling by KIT in disease,Reactome,2,LCK;KIT,20 (20),0.77,1,0,,5 (12),1,1,0.971,1
Signaling by Hippo,Reactome,2,WWTR1;AMOTL1,20 (20),0.77,1,0,,2 (2),1,1,0.971,1
FGFR2 ligand binding and activation,Reactome,2,FGF1;FGF2,20 (20),0.77,1,0,,3 (4),1,1,0.971,1
FRS-mediated FGFR3 signaling,Reactome,2,FGF1;FGF2,20 (20),0.77,1,0,,5 (5),1,1,0.971,1
Arf1 pathway,PID,2,ARHGAP10;USO1,20 (20),0.77,1,0,,6 (7),1,1,0.971,1
ras signaling pathway,BioCarta,2,VAV1;CHUK,20 (20),0.77,1,0,,2 (2),1,1,0.971,1
fas signaling pathway (cd95),BioCarta,2,PAK1;MAP3K1,20 (20),0.77,1,0,,1 (1),1,1,0.971,1
Translation Factors,Wikipathways,3,EEF1A2;EIF4EBP3;CLUH,50 (50),0.972,1,0,,0 (0),1,1,0.972,1
Regulation of retinoblastoma protein,PID,7,SPI1;MAPK11;TGFB2;CKM;MEF2C;MYL1;ABL1,64 (64),0.772,1,0,,1 (1),1,1,0.972,1
Signaling by FGFR in disease,Reactome,5,BAG4;FGFR1;FGF1;GAB2;FGF2,47 (47),0.774,1,0,,6 (23),1,1,0.972,1
APC/C:Cdc20 mediated degradation of Cyclin B,Reactome,1,ANAPC10,25 (25),0.973,1,0,,0 (0),1,1,0.973,1
Golgi Associated Vesicle Biogenesis,Reactome,6,PUM1;AP1M2;AP1S2;SH3D19;ARRB1;TBC1D8B,56 (56),0.78,1,0,,5 (5),1,1,0.974,1
Chromosomal and microsatellite instability in colorectal cancer,Wikipathways,8,BAK1;TGFB3;TGFBR2;TGFB2;PTGS2;BCL2;PMAIP1;SMAD3,73 (73),0.78,1,0,,2 (2),1,1,0.974,1
Measles - Homo sapiens (human),KEGG,16,IL1B;BAK1;TLR4;FCGR2B;HSPA1A;HSPA1B;HSPA1L;IL2RB;CD46;BCL2;NFKBIA;TLR9;CHUK;CD3D;MSN;IKBKG,139 (139),0.78,1,0,,1 (1),1,1,0.974,1
Signaling events mediated by HDAC Class III,PID,2,FHL2;ACSS1,39 (39),0.974,1,0,,0 (0),1,1,0.974,1
RAB geranylgeranylation,Reactome,7,RAB6B;RAB36;RAB15;RAB27B;RAB7B;RAB30;RAB20,65 (65),0.786,1,0,,3 (3),1,1,0.975,1
Mitochondrial protein import,Reactome,7,HSPD1;SLC25A4;HSPA9;OTC;SLC25A13;GRPEL2;MTX2,65 (65),0.786,1,0,,4 (4),1,1,0.975,1
Viral Messenger RNA Synthesis,Reactome,3,NUP35;NDC1;POM121,30 (30),0.786,1,0,,1 (2),1,1,0.975,1
Influenza Viral RNA Transcription and Replication,Reactome,3,NUP35;NDC1;POM121,30 (30),0.786,1,0,,5 (6),1,1,0.975,1
Autophagy,Wikipathways,3,PRKAA2;PRKAG2;DEPTOR,30 (30),0.786,1,0,,1 (2),1,1,0.975,1
mcalpain and friends in cell motility,BioCarta,3,PRKAR2A;ACTA1;PRKAR1B,30 (30),0.786,1,0,,3 (3),1,1,0.975,1
Retinoic acid receptors-mediated signaling,PID,3,RARG;NRIP1;VDR,30 (30),0.786,1,0,,2 (2),1,1,0.975,1
IGF1 pathway,PID,3,IGF1R;BCAR1;GRB10,30 (30),0.786,1,0,,2 (2),1,1,0.975,1
Deactivation of the beta-catenin transactivating complex,Reactome,3,CHD8;SOX4;SOX7,30 (30),0.786,1,0,,2 (2),1,1,0.975,1
Regulation of mRNA stability by proteins that bind AU-rich elements,Reactome,4,MAPK11;HSPA1B;HSPB1;HSPA1A,39 (39),0.786,1,0,,3 (4),1,1,0.975,1
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Reactome,4,GNB5;GNGT2;GNG2;GNG11,39 (39),0.786,1,0,,3 (3),1,1,0.975,1
Signaling by EGFR,Reactome,5,ARHGEF7;SPRY1;EREG;ADAM10;HBEGF,48 (48),0.789,1,0,,8 (9),1,1,0.976,1
TNFalpha,NetPath,22,DOK1;FLNA;LRPPRC;GTF2I;RIPK3;TBKBP1;IQGAP2;MTIF2;NFKBIA;BAG4;PAK1;IKBKG;KCNQ1;PSMD1;RELB;SMPD3;CAV1;PEG3;HSPB1;MAP3K1;MAP3K3;CHUK,234 (234),0.976,1,0,,0 (0),1,1,0.976,1
ADORA2B mediated anti-inflammatory cytokines production,Reactome,15,ADCY9;PRKAR2A;PRKAR1B;GNG11;ADORA2B;GNGT2;PTGIR;ADCY2;PTH1R;ADCY4;GNB5;ADRB2;GNG2;SCTR;RAMP2,132 (132),0.791,1,0,,22 (22),1,1,0.977,1
CD4 T cell receptor signaling,INOH,15,LAT;IKBKG;CARD11;FOSL2;PSMD1;NFKBIA;FOSB;CD3D;PRKCQ;PLCG2;CHUK;LCK;FOSL1;ITPR3;VAV1,132 (132),0.791,1,0,,6 (7),1,1,0.977,1
Cell cycle - Homo sapiens (human),KEGG,10,TGFB2;TGFB3;CDKN2D;CDC14A;MCM3;MCM4;ANAPC10;SMAD3;ABL1;SFN,124 (124),0.977,1,0,,0 (0),1,1,0.977,1
FLT3 signaling in disease,Reactome,2,NOX4;GAB2,21 (21),0.793,1,0,,9 (12),1,1,0.977,1
Mitochondrial tRNA aminoacylation,Reactome,2,NARS2;IARS2,21 (21),0.793,1,0,,22 (65),1,1,0.977,1
NGF,INOH,2,NGF;SHC2,21 (21),0.793,1,0,,4 (5),1,1,0.977,1
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,Reactome,2,ANAPC10;CDC14A,21 (21),0.793,1,0,,2 (2),1,1,0.977,1
Signaling by EGFR in Cancer,Reactome,2,EREG;HBEGF,21 (21),0.793,1,0,,6 (19),1,1,0.977,1
activated TAK1 mediates p38 MAPK activation,Reactome,2,MAPK11;IKBKG,21 (21),0.793,1,0,,2 (5),1,1,0.977,1
CTLA4 inhibitory signaling,Reactome,2,LCK;CTLA4,21 (21),0.793,1,0,,4 (4),1,1,0.977,1
Autosomal recessive Osteopetrosis pathways,Wikipathways,1,TNFRSF11A,11 (11),0.795,1,0,,2 (2),1,1,0.977,1
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,Reactome,1,CHRNA2,11 (11),0.795,1,0,,2 (2),1,1,0.977,1
Synthesis_ secretion_ and deacylation of Ghrelin,Reactome,1,BCHE,11 (11),0.795,1,0,,3 (3),1,1,0.977,1
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Reactome,1,TLR4,11 (11),0.795,1,0,,3 (3),1,1,0.977,1
p38MAPK events,Reactome,1,MAPK11,11 (11),0.795,1,0,,5 (5),1,1,0.977,1
Depolymerisation of the Nuclear Lamina,Reactome,1,LMNB1,11 (11),0.795,1,0,,7 (7),1,1,0.977,1
Negative regulation of FLT3,Reactome,1,SOCS2,11 (11),0.795,1,0,,4 (4),1,1,0.977,1
cardiac protection against ros,BioCarta,1,GABRA3,11 (11),0.795,1,0,,6 (10),1,1,0.977,1
rho-selective guanine exchange factor akap13 mediates stress fiber formation,BioCarta,1,PRKAR2A,11 (11),0.795,1,0,,3 (3),1,1,0.977,1
Regulated proteolysis of p75NTR,Reactome,1,NGFR,11 (11),0.795,1,0,,1 (1),1,1,0.977,1
GLUT-1 deficiency syndrome,SMPDB,1,UGP2,11 (11),0.795,1,0,,17 (19),1,1,0.977,1
Congenital disorder of glycosylation CDG-IId,SMPDB,1,UGP2,11 (11),0.795,1,0,,17 (19),1,1,0.977,1
Lactose Synthesis,SMPDB,1,UGP2,11 (11),0.795,1,0,,17 (19),1,1,0.977,1
Glioblastoma signaling pathways,Wikipathways,9,PDGFRA;PDGFRB;PIK3C2G;PRKCH;ERBB2;IGF1R;FGFR1;PLCG2;PRKCQ,83 (83),0.799,1,0,,1 (3),1,1,0.978,1
Shigellosis - Homo sapiens (human),KEGG,29,PLCD3;BNIP3;MYL2;MAPK12;RRAGD;ACTG1;WASF2;PYCARD;NFKBIA;TLR4;TLR5;IKBKG;MYLPF;HKDC1;C3;PLCB4;PLCD1;PLCG2;BCAR1;ARHGEF2;ITGA5;MAPK11;IL1B;MAPK13;BCL2;CYTH4;PRKCQ;CHUK;ITPR3,246 (246),0.8,1,0,,9 (14),1,1,0.978,1
Purine metabolism,EHMN,26,ABCC4;SLC29A3;NPR1;GUCY1A1;GUCY1B1;SLC25A13;POLR2A;PRDX6;ENTPD5;SLC28A2;PKM;AK1;POLR2D;ATP1A2;ATP2A1;SLC1A1;SLC1A2;SLC1A3;ATP2B4;ADCY9;GFM2;ATP2A3;AK3;NUP35;SLC5A1;EEF1A2,222 (222),0.8,1,0,,86 (94),1,1,0.978,1
G1 to S cell cycle control,Wikipathways,4,CDKN2D;CREB3L3;MCM3;MCM4,64 (64),0.979,1,0,,0 (0),1,1,0.979,1
Ferroptosis,Wikipathways,4,ACSL1;GCLM;CP;NCOA4,40 (40),0.803,1,0,,19 (29),1,1,0.979,1
Antigen processing-Cross presentation,Reactome,4,NCF2;CHUK;IKBKG;MRC2,40 (40),0.803,1,0,,9 (14),1,1,0.979,1
Nicotine addiction - Homo sapiens (human),KEGG,4,GABRP;GABRB3;GABRA3;SLC17A8,40 (40),0.803,1,0,,7 (7),1,1,0.979,1
E2F transcription factor network,PID,5,CES4A;HIC1;SMARCA2;MCM3;DHFR,75 (75),0.979,1,0,,0 (0),1,1,0.979,1
Photodynamic therapy-induced unfolded protein response,Wikipathways,1,ATF3,27 (27),0.98,1,0,,0 (0),1,1,0.98,1
APC-Cdc20 mediated degradation of Nek2A,Reactome,1,ANAPC10,27 (27),0.98,1,0,,0 (0),1,1,0.98,1
Follicle Stimulating Hormone (FSH) signaling pathway,Wikipathways,1,SGK1,27 (27),0.98,1,0,,0 (0),1,1,0.98,1
Downstream signaling of activated FGFR1,Reactome,3,FGFR1;FGF1;FGF2,31 (31),0.805,1,0,,6 (7),1,1,0.98,1
Nongenotropic Androgen signaling,PID,3,PLCG2;GNAI1;GNG2,31 (31),0.805,1,0,,6 (6),1,1,0.98,1
Apoptosis Modulation and Signaling,Wikipathways,10,BLK;BAK1;TNFRSF10B;HSPA1A;AIFM1;NFKBIA;BCL2;PMAIP1;BNIP3;BMF,92 (92),0.806,1,0,,1 (1),1,1,0.98,1
Nonalcoholic fatty liver disease,Wikipathways,13,PKLR;BAK1;PRKAA2;IL1B;CCL2;COX7A1;CYP2E1;ADIPOR2;NR1H4;UQCRC2;PPARA;COX6A2;PRKAG2,155 (155),0.981,1,0,,0 (4),1,1,0.981,1
Long-term potentiation - Homo sapiens (human),KEGG,7,CACNA1C;RAPGEF3;CAMK2A;RPS6KA2;PPP1R1A;PLCB4;ITPR3,67 (67),0.812,1,0,,7 (7),1,1,0.981,1
Integrated breast cancer pathway,Wikipathways,7,AHR;DHTKD1;CERK;ITPKC;RASGRP3;ABL1;FOSL1,67 (67),0.812,1,0,,8 (19),1,1,0.981,1
Signaling by Interleukins,Reactome,28,IL11;LIF;LIFR;HGF;INPP5D;RPS6KA2;DUSP4;SOCS5;NFKBIA;DUSP7;BLNK;IKBKG;CNTFR;LCK;MAPK7;MAPK11;IL1B;IL2RB;IL3RA;SDC1;MEF2C;VAV1;GAB2;MAP3K3;SMAD3;IL27RA;CHUK;IL9R,240 (240),0.813,1,0,,4 (7),1,1,0.981,1
Wnt-beta-catenin signaling pathway in leukemia,Wikipathways,2,PPARD;RUNX1T1,22 (22),0.815,1,0,,1 (1),1,1,0.982,1
Signaling by FGFR3 in disease,Reactome,2,FGF1;FGF2,22 (22),0.815,1,0,,6 (17),1,1,0.982,1
Inositol Metabolism,SMPDB,2,ITPKA;PLCD3,22 (22),0.815,1,0,,27 (31),1,1,0.982,1
heparan sulfate biosynthesis (late stages),HumanCyc,2,HS3ST3A1;HS3ST1,22 (22),0.815,1,0,,8 (8),1,1,0.982,1
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Reactome,2,ALDH3A2;APP,22 (22),0.815,1,0,,2 (2),1,1,0.982,1
Cellular roles of Anthrax toxin,PID,2,ANTXR1;IL1B,22 (22),0.815,1,0,,4 (4),1,1,0.982,1
Regulation of necroptotic cell death,Reactome,2,RIPK3;TNFRSF10B,22 (22),0.815,1,0,,6 (10),1,1,0.982,1
Chaperone Mediated Autophagy,Reactome,2,PLIN2;GFAP,22 (22),0.815,1,0,,1 (2),1,1,0.982,1
RIPK1-mediated regulated necrosis,Reactome,2,RIPK3;TNFRSF10B,22 (22),0.815,1,0,,8 (14),1,1,0.982,1
Signaling by FGFR3 point mutants in cancer,Reactome,2,FGF1;FGF2,22 (22),0.815,1,0,,6 (17),1,1,0.982,1
TNF-alpha signaling pathway,Wikipathways,10,GLUL;CHUK;IKBKG;PYGL;CCL2;KSR1;MAP3K1;MAP3K3;NFKBIA;RIPK3,93 (93),0.816,1,0,,2 (3),1,1,0.982,1
Chaperonin-mediated protein folding,Reactome,10,TUBB1;TUBA1A;GNG11;LONP2;AP3M1;KIFC3;TUBB2B;GNGT2;GNB5;GNG2,93 (93),0.816,1,0,,4 (4),1,1,0.982,1
TP53 Regulates Metabolic Genes,Reactome,8,RRAGD;SESN3;SESN1;DDIT4;SESN2;SFN;PRKAA2;PRKAG2,76 (76),0.816,1,0,,22 (25),1,1,0.982,1
TWEAK,NetPath,1,NFKBIA,28 (28),0.982,1,0,,0 (0),1,1,0.982,1
Ferroptosis - Homo sapiens (human),KEGG,4,CP;GCLM;ACSL1;NCOA4,41 (41),0.818,1,0,,21 (31),1,1,0.982,1
Signaling by ERBB2,Reactome,5,ERBB2;PTPN18;HBEGF;NRG4;EREG,50 (50),0.818,1,0,,11 (15),1,1,0.982,1
Interleukin-1 signaling,Reactome,5,NFKBIA;IL1B;CHUK;IKBKG;MAP3K3,50 (50),0.818,1,0,,2 (5),1,1,0.982,1
Vibrio cholerae infection - Homo sapiens (human),KEGG,5,PLCG2;KCNQ1;ATP6V0E2;ADCY9;ACTG1,50 (50),0.818,1,0,,9 (9),1,1,0.982,1
FoxO family signaling,PID,5,SFN;CHUK;SGK1;CSNK1E;CAT,50 (50),0.818,1,0,,2 (2),1,1,0.982,1
Hepatocellular carcinoma - Homo sapiens (human),KEGG,19,NQO1;MGST1;BAK1;TGFB3;FZD8;FZD9;ACTG1;TGFBR2;HGF;SMAD3;FZD4;IGF1R;SMARCA2;WNT7B;PLCG2;WNT11;WNT9B;TGFB2;SHC2,168 (168),0.819,1,0,,9 (14),1,1,0.983,1
Monoamine Transport,Wikipathways,3,TGFB1I1;IL1B;TDO2,32 (32),0.822,1,0,,9 (13),1,1,0.983,1
TGF-beta receptor signaling activates SMADs,Reactome,3,TGFBR2;SMAD3;BAMBI,32 (32),0.822,1,0,,4 (4),1,1,0.983,1
Negative regulation of FGFR4 signaling,Reactome,3,FGF2;FGF1;KLB,32 (32),0.822,1,0,,4 (4),1,1,0.983,1
terminal <i>O</i>-glycans residues modification,HumanCyc,1,B4GALT2,12 (12),0.822,1,0,,7 (9),1,1,0.983,1
Signaling by PDGFRA transmembrane_ juxtamembrane and kinase domain mutants,Reactome,1,PDGFRA,12 (12),0.822,1,0,,5 (6),1,1,0.983,1
Presynaptic nicotinic acetylcholine receptors,Reactome,1,CHRNA2,12 (12),0.822,1,0,,3 (3),1,1,0.983,1
Negative regulation of NOTCH4 signaling,Reactome,1,NOTCH4,12 (12),0.822,1,0,,2 (2),1,1,0.983,1
Signaling by PDGFRA extracellular domain mutants,Reactome,1,PDGFRA,12 (12),0.822,1,0,,5 (6),1,1,0.983,1
Regulation of localization of FOXO transcription factors,Reactome,1,SFN,12 (12),0.822,1,0,,2 (2),1,1,0.983,1
Condensation of Prometaphase Chromosomes,Reactome,1,NCAPD2,12 (12),0.822,1,0,,4 (5),1,1,0.983,1
Scavenging of heme from plasma,Reactome,1,ALB,12 (12),0.822,1,0,,4 (6),1,1,0.983,1
purine nucleotides degradation,HumanCyc,1,ADA,12 (12),0.822,1,0,,19 (19),1,1,0.983,1
g-protein signaling through tubby proteins,BioCarta,1,CCL11,12 (12),0.822,1,0,,1 (2),1,1,0.983,1
how does salmonella hijack a cell,BioCarta,1,ASB15,12 (12),0.822,1,0,,2 (2),1,1,0.983,1
map kinase inactivation of smrt corepressor,BioCarta,1,MAP3K1,12 (12),0.822,1,0,,2 (2),1,1,0.983,1
MicroRNA (miRNA) biogenesis,Reactome,1,DROSHA,12 (12),0.822,1,0,,5 (6),1,1,0.983,1
Costimulation by the CD28 family,Reactome,8,PAK1;PAK3;BTLA;VAV1;CD3D;CTLA4;GRAP2;LCK,77 (77),0.827,1,0,,8 (10),1,1,0.984,1
Antigen processing and presentation - Homo sapiens (human),KEGG,5,HSPA1B;HSPA1L;HSPA1A;CD8A;CIITA,78 (78),0.984,1,0,,0 (0),1,1,0.984,1
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Reactome,1,ANAPC10,29 (29),0.985,1,0,,0 (0),1,1,0.985,1
the information processing pathway at the ifn beta enhancer,BioCarta,1,POLR2A,29 (29),0.985,1,0,,0 (0),1,1,0.985,1
TP53 Regulates Transcription of Cell Cycle Genes,Reactome,5,BTG2;PLK2;SFN;E2F8;RGCC,51 (51),0.832,1,0,,2 (2),1,1,0.985,1
Regulation of Androgen receptor activity,PID,5,PDE9A;SMARCA2;HDAC7;EGR1;KAT7,51 (51),0.832,1,0,,3 (3),1,1,0.985,1
Carboxyterminal post-translational modifications of tubulin,Reactome,4,TUBB1;TTLL7;TUBA1A;TUBB2B,42 (42),0.833,1,0,,9 (10),1,1,0.985,1
IFN-gamma pathway,PID,4,IL1B;IFNGR1;MAP3K1;CAMK2A,42 (42),0.833,1,0,,3 (3),1,1,0.985,1
SHC-mediated cascade:FGFR2,Reactome,2,FGF1;FGF2,23 (23),0.834,1,0,,5 (6),1,1,0.985,1
PI-3K cascade:FGFR2,Reactome,2,FGF1;FGF2,23 (23),0.834,1,0,,4 (6),1,1,0.985,1
Translation of structural proteins,Reactome,2,ST6GALNAC4;ST3GAL2,23 (23),0.834,1,0,,10 (11),1,1,0.985,1
Translation of structural proteins,Reactome,2,ST6GALNAC4;ST3GAL2,23 (23),0.834,1,0,,10 (11),1,1,0.985,1
Visual signal transduction: Cones,PID,2,GNGT2;GNB5,23 (23),0.834,1,0,,12 (14),1,1,0.985,1
RHOBTB1 GTPase cycle,Reactome,2,MYO6;VIM,23 (23),0.834,1,0,,1 (1),1,1,0.985,1
Ibuprofen Metabolism Pathway,SMPDB,2,UGT1A1;PTGS2,23 (23),0.834,1,0,,13 (13),1,1,0.985,1
Endocytosis - Homo sapiens (human),KEGG,29,EPN3;PARD6B;TGFBR2;ACAP1;RBSN;VPS37A;IGF1R;ARRB2;ARAP3;PDGFRA;CXCR4;FOLR2;WWP1;RAB11FIP5;CYTH4;CCR5;CAV1;CAV2;PARD3;ARRB1;IZUMO1R;HSPA1A;HSPA1B;HSPA1L;IL2RB;SMAD3;EPN2;MVB12B;EHD2,252 (252),0.838,1,0,,3 (6),1,1,0.986,1
Signalling to ERKs,Reactome,3,MAPK11;NGF;SHC2,33 (33),0.838,1,0,,6 (7),1,1,0.986,1
CAMKK2 Pathway,Wikipathways,3,ARHGEF7;NFATC2;MAF,33 (33),0.838,1,0,,7 (12),1,1,0.986,1
Sealing of the nuclear envelope (NE) by ESCRT-III,Reactome,3,TUBB1;TUBB2B;TUBA1A,33 (33),0.838,1,0,,7 (8),1,1,0.986,1
Activation of the pre-replicative complex,Reactome,3,MCM3;MCM10;MCM4,33 (33),0.838,1,0,,3 (5),1,1,0.986,1
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Reactome,3,TUBB1;TUBB2B;TUBA1A,33 (33),0.838,1,0,,4 (4),1,1,0.986,1
EPO signaling pathway,PID,3,PLCG2;INPP5D;BCL2,33 (33),0.838,1,0,,3 (3),1,1,0.986,1
role of egf receptor transactivation by gpcrs in cardiac hypertrophy,BioCarta,3,NFKBIA;CHUK;IKBKG,33 (33),0.838,1,0,,3 (3),1,1,0.986,1
Nuclear Envelope (NE) Reassembly,Reactome,8,LMNB1;TUBB1;TUBA1A;TUBB2B;NUP35;NDC1;POM121;LBR,78 (78),0.838,1,0,,9 (12),1,1,0.986,1
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Reactome,1,ANAPC10,30 (30),0.987,1,0,,0 (0),1,1,0.987,1
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Reactome,1,ANAPC10,30 (30),0.987,1,0,,0 (0),1,1,0.987,1
Neutrophil extracellular trap formation - Homo sapiens (human),KEGG,21,MAPK11;ITGAL;ITGAM;SELPLG;ACTG1;ITGB2;AQP9;HDAC7;C3;MAPK13;NCF2;C5AR1;FGA;PLCB4;SLC25A4;PLCG2;FGB;FGG;TLR4;MAPK12;VWF,188 (190),0.845,1,0,,9 (13),1,1,0.987,1
Natural killer cell mediated cytotoxicity - Homo sapiens (human),KEGG,14,LAT;PAK1;ITGAL;NFATC2;ITGB2;SHC2;PRF1;VAV1;IFNGR1;PLCG2;GZMB;TNFRSF10B;LCK;ICAM2,130 (131),0.846,1,0,,4 (4),1,1,0.987,1
Serotonin and anxiety-related events,Wikipathways,1,ARC,13 (13),0.846,1,0,,1 (2),1,1,0.988,1
Frs2-mediated activation,Reactome,1,NGF,13 (13),0.846,1,0,,5 (5),1,1,0.988,1
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,Reactome,1,SRF,13 (13),0.846,1,0,,2 (2),1,1,0.988,1
Galactose Metabolism,SMPDB,1,UGP2,13 (13),0.846,1,0,,31 (36),1,1,0.988,1
Metabolism of polyamines,Reactome,1,NQO1,13 (13),0.846,1,0,,20 (20),1,1,0.988,1
Platelet Adhesion to exposed collagen,Reactome,1,VWF,13 (13),0.846,1,0,,1 (2),1,1,0.988,1
Signal regulatory protein family interactions,Reactome,1,SIRPA,13 (13),0.846,1,0,,2 (3),1,1,0.988,1
Downregulation of ERBB2:ERBB3 signaling,Reactome,1,ERBB2,13 (13),0.846,1,0,,2 (2),1,1,0.988,1
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Reactome,1,SFN,13 (13),0.846,1,0,,2 (2),1,1,0.988,1
The activation of arylsulfatases,Reactome,1,ARSG,13 (13),0.846,1,0,,4 (4),1,1,0.988,1
DNA-PK pathway in nonhomologous end joining,PID,1,XRCC5,13 (13),0.846,1,0,,1 (1),1,1,0.988,1
Mitotic Telophase/Cytokinesis,Reactome,1,KIF23,13 (13),0.846,1,0,,2 (3),1,1,0.988,1
Suppression of phagosomal maturation,Reactome,1,CORO1A,13 (13),0.846,1,0,,4 (8),1,1,0.988,1
trka receptor signaling pathway,BioCarta,1,NGF,13 (13),0.846,1,0,,1 (1),1,1,0.988,1
D-<i>myo</i>-inositol (1_4_5)-trisphosphate degradation,HumanCyc,1,SYNJ2,13 (13),0.846,1,0,,6 (6),1,1,0.988,1
Galactosemia,SMPDB,1,UGP2,13 (13),0.846,1,0,,31 (36),1,1,0.988,1
Miscellaneous transport and binding events,Reactome,2,LRRC8A;NIPAL2,24 (24),0.851,1,0,,9 (11),1,1,0.988,1
RHO GTPases Activate NADPH Oxidases,Reactome,2,MAPK11;NCF2,24 (24),0.851,1,0,,12 (14),1,1,0.988,1
snRNP Assembly,Reactome,2,GEMIN5;GEMIN2,24 (24),0.851,1,0,,4 (4),1,1,0.988,1
Antigen Presentation: Folding_ assembly and peptide loading of class I MHC,Reactome,2,SEC24A;SEC23A,24 (24),0.851,1,0,,6 (10),1,1,0.988,1
Metabolism of non-coding RNA,Reactome,2,GEMIN5;GEMIN2,24 (24),0.851,1,0,,4 (4),1,1,0.988,1
Visual signal transduction: Rods,PID,2,GNB5;GNAT1,24 (24),0.851,1,0,,11 (13),1,1,0.988,1
Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human),KEGG,2,HS3ST3A1;HS3ST1,24 (24),0.851,1,0,,3 (7),1,1,0.988,1
RHOBTB2 GTPase cycle,Reactome,2,MYO6;ACTG1,24 (24),0.851,1,0,,1 (1),1,1,0.988,1
Cell Differentiation - Index expanded,Wikipathways,3,MEF2C;SRF;KLF4,58 (58),0.988,1,0,,0 (0),1,1,0.988,1
Recruitment of NuMA to mitotic centrosomes,Reactome,5,CCP110;TUBA1A;NINL;CSNK1E;TUBGCP5,81 (81),0.988,1,0,,0 (1),1,1,0.988,1
Base Excision Repair,Wikipathways,1,MBD4,31 (31),0.989,1,0,,0 (0),1,1,0.989,1
RNA Polymerase I Transcription Termination,Reactome,1,CAVIN1,31 (31),0.989,1,0,,0 (0),1,1,0.989,1
Rev-mediated nuclear export of HIV RNA,Reactome,3,NUP35;NDC1;POM121,34 (34),0.853,1,0,,3 (4),1,1,0.989,1
Negative regulation of FGFR1 signaling,Reactome,3,FGFR1;FGF1;FGF2,34 (34),0.853,1,0,,4 (4),1,1,0.989,1
CD40/CD40L signaling,PID,3,MAPK11;NFKBIA;MAP3K1,34 (34),0.853,1,0,,1 (1),1,1,0.989,1
NOD-like receptor signaling pathway - Homo sapiens (human),KEGG,20,MAPK11;IL1B;RIPK3;PLCB4;IKBKG;ANTXR1;CXCL3;CARD9;CCL2;TLR4;MAPK13;CXCL2;P2RX7;BCL2;CASP12;NFKBIA;PYCARD;CHUK;MAPK12;ITPR3,181 (181),0.853,1,0,,6 (6),1,1,0.989,1
MicroRNAs in cancer - Homo sapiens (human),KEGG,29,TPM1;TGFB2;SOX4;VIM;CYP1B1;DDIT4;ERBB2;THBS1;KIF23;ABL1;PDGFB;PDGFRA;TIMP3;PDGFRB;TNC;ITGA5;MAPK7;BMF;BAK1;SLC7A1;BCL2;PLCG2;MMP9;TNXB;PTGS2;ST14;RECK;ZFPM2;NOTCH4,310 (310),0.989,1,0,,0 (0),1,1,0.989,1
Recruitment of mitotic centrosome proteins and complexes,Reactome,5,CCP110;TUBA1A;NINL;CSNK1E;TUBGCP5,82 (82),0.99,1,0,,0 (0),1,1,0.99,1
PLK1 signaling events,PID,4,PAK1;INCENP;NINL;CENPE,44 (44),0.859,1,0,,1 (1),1,1,0.99,1
Vasopressin-regulated water reabsorption - Homo sapiens (human),KEGG,4,ADCY9;AQP4;CREB3L3;ARHGDIB,44 (44),0.859,1,0,,2 (2),1,1,0.99,1
APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,ANAPC10,32 (32),0.99,1,0,,0 (0),1,1,0.99,1
Gastric Cancer Network 2,Wikipathways,1,LBR,32 (32),0.99,1,0,,0 (0),1,1,0.99,1
Protein folding,Reactome,10,TUBB1;TUBA1A;GNG11;LONP2;AP3M1;KIFC3;TUBB2B;GNGT2;GNB5;GNG2,98 (98),0.863,1,0,,4 (4),1,1,0.99,1
Thermogenesis - Homo sapiens (human),KEGG,26,ACSL1;NPR1;ADCY4;SLC25A20;MAPK12;CPT1C;FGF21;RPS6KA2;PRKAG2;COX6A2;MAPK11;COX7A1;SMARCA2;ACTG1;MGLL;MAPK13;FGFR1;UQCRC2;CREB3L3;CPT1A;CPT2;PRKAA2;PRDM16;ADCY2;ADCY9;KLB,232 (232),0.863,1,0,,19 (23),1,1,0.99,1
Synthesis of substrates in N-glycan biosythesis,Reactome,6,GNE;ST8SIA3;SLC17A5;ST6GALNAC4;ST3GAL2;PGM3,63 (63),0.865,1,0,,56 (69),1,1,0.991,1
trans-Golgi Network Vesicle Budding,Reactome,7,PUM1;TBC1D8B;AP1S2;SH3D19;ARRB1;APP;AP1M2,72 (72),0.866,1,0,,5 (6),1,1,0.991,1
HGF,INOH,3,PLCG2;HGF;SHC2,35 (35),0.866,1,0,,2 (2),1,1,0.991,1
Regulation of nuclear beta catenin signaling and target gene transcription,PID,8,KLF4;INCENP;CHD8;TNIK;VCAN;MMP2;SFN;MMP9,81 (81),0.867,1,0,,2 (2),1,1,0.991,1
Regulation of IFNG signaling,Reactome,1,IFNGR1,14 (14),0.867,1,0,,2 (2),1,1,0.991,1
Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,Wikipathways,1,CYP17A1,14 (14),0.867,1,0,,21 (29),1,1,0.991,1
Erythropoietin activates RAS,Reactome,1,VAV1,14 (14),0.867,1,0,,4 (4),1,1,0.991,1
Retrograde neurotrophin signalling,Reactome,1,NGF,14 (14),0.867,1,0,,4 (4),1,1,0.991,1
MET promotes cell motility,Reactome,1,HGF,14 (14),0.867,1,0,,4 (4),1,1,0.991,1
Postsynaptic nicotinic acetylcholine receptors,Reactome,1,CHRNA2,14 (14),0.867,1,0,,3 (3),1,1,0.991,1
Acetylcholine binding and downstream events,Reactome,1,CHRNA2,14 (14),0.867,1,0,,3 (3),1,1,0.991,1
serotonin degradation,HumanCyc,1,ALDH3A2,14 (14),0.867,1,0,,16 (20),1,1,0.991,1
MAPK pathway in congenital thyroid cancer,Wikipathways,1,KSR1,14 (14),0.867,1,0,,2 (2),1,1,0.991,1
Golgi Cisternae Pericentriolar Stack Reorganization,Reactome,1,USO1,14 (14),0.867,1,0,,3 (3),1,1,0.991,1
Prolactin receptor signaling,Reactome,1,PRLR,14 (14),0.867,1,0,,3 (3),1,1,0.991,1
Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,1,INPP4B,14 (14),0.867,1,0,,18 (19),1,1,0.991,1
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Reactome,1,PERP,14 (14),0.867,1,0,,5 (7),1,1,0.991,1
Ras signaling in the CD4+ TCR pathway,PID,1,PTPN7,14 (14),0.867,1,0,,1 (1),1,1,0.991,1
AKT phosphorylates targets in the cytosol,Reactome,1,CHUK,14 (14),0.867,1,0,,2 (2),1,1,0.991,1
Relationship between inflammation_ COX-2 and EGFR,Wikipathways,2,PLA1A;PTGS2,25 (25),0.867,1,0,,1 (2),1,1,0.991,1
Signaling by Erythropoietin,Reactome,2,PLCG2;VAV1,25 (25),0.867,1,0,,8 (9),1,1,0.991,1
FRS-mediated FGFR2 signaling,Reactome,2,FGF1;FGF2,25 (25),0.867,1,0,,5 (6),1,1,0.991,1
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Reactome,2,SMAD3;WWTR1,25 (25),0.867,1,0,,2 (2),1,1,0.991,1
Downstream signaling of activated FGFR3,Reactome,2,FGF1;FGF2,25 (25),0.867,1,0,,6 (7),1,1,0.991,1
Regulation of PTEN stability and activity,Reactome,2,PREX2;USP13,25 (25),0.867,1,0,,5 (5),1,1,0.991,1
Regulation of TNFR1 signaling,Reactome,2,CHUK;IKBKG,25 (25),0.867,1,0,,2 (3),1,1,0.991,1
SUMOylation of chromatin organization proteins,Reactome,4,SATB1;NUP35;NDC1;POM121,72 (72),0.991,1,0,,0 (0),1,1,0.991,1
Ciliary landscape,Wikipathways,18,APMAP;POM121;IQGAP2;NINL;TBC1D4;VIM;RANBP10;CBS;MCM3;MCM4;CAMK2A;LRPPRC;CTBP2;DCAF11;IQGAP1;RMND5A;MCM10;RAB3IL1,213 (213),0.991,1,0,,0 (0),1,1,0.991,1
CD4 T cell receptor signaling-NFkB cascade,INOH,10,LAT;IKBKG;CARD11;PSMD1;NFKBIA;CD3D;PLCG2;CHUK;LCK;ITPR3,99 (99),0.871,1,0,,3 (4),1,1,0.991,1
FBXL10 enhancement of MAP-ERK signaling in diffuse large B-cell lymphoma,Wikipathways,1,BCOR,33 (33),0.991,1,0,,0 (0),1,1,0.991,1
Base excision repair - Homo sapiens (human),KEGG,1,MBD4,33 (33),0.991,1,0,,0 (0),1,1,0.991,1
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,ANAPC10,33 (33),0.991,1,0,,0 (0),1,1,0.991,1
Immune System,Reactome,230,A1BG;CFH;IL11;CFHR1;HGF;CPPED1;ABL1;ATP7A;CPN2;PLPP5;WASF3;IQGAP2;TNFSF9;ALOX5;TRIM35;CD300A;INPP5D;RPS6KA2;PECAM1;DOK3;BLNK;RAP1GAP2;ACTG1;FLNA;BPIFB1;PGRMC1;NCF2;PGLYRP2;CD46;KLHL41;SIRPA;TNFRSF11A;CR2;ADAM8;LGALS3;ITGAL;ITGAM;UBE2U;ADAM10;HPSE;ITGB2;ITGB7;MEF2C;CLEC4G;GAB2;MAP3K3;CEACAM1;FGL2;ITPR3;BLK;GHR;SOCS2;DEFB1;STK10;CD63;TNFRSF13C;CCR2;TRIM8;FGB;PTPRB;MAPK12;AHSG;FCGR2B;MGST1;PIGR;NFATC2;CARD9;BST1;VNN1;MRC2;HECW2;RASGRP3;WAS;CD300LB;NFKBIA;PVR;GRAP2;PKM;TRIM63;MAP3K1;AP1S2;PYGB;PYGL;C3;C3AR1;CREG1;BIN2;CD79B;MME;PLCG2;C6;C7;C8A;C8B;IQGAP1;MMP9;C9;CHUK;ALDOA;ASB4;LNX1;HSPA1A;HSPA1B;TLR5;IGLC2;NOS3;VASP;VAV1;SEC23A;CNTFR;CD200;IL27RA;KCTD7;CRISPLD2;MGAM;AMPD3;C5AR1;ADGRG3;VTN;TRIM2;RIPK3;CKAP4;SH3RF1;LTB;ANPEP;PJA1;FGA;DSP;FGR;SEC24A;ANXA2;CAMK2A;QSOX1;WWP1;DUSP4;ICAM2;DUSP7;UNC13D;RAPGEF4;SLC44A2;IRF8;IKBKG;GRB10;ARHGAP9;ORM2;BTLA;CPB2;APOB;RELB;RAPGEF3;IDH1;TLR9;LCK;ASB15;SIPA1;APP;XRCC5;CFI;NFAM1;ARHGAP45;HVCN1;COTL1;IL2RB;PRDX6;GSN;CD22;ARG1;IFNGR1;CD93;LIF;LIFR;TKFC;KCNAB2;RHOF;LIMK1;CD34;CD3D;SDC1;ANAPC10;CD55;SLC11A1;CD8A;AP1M2;LAT;ART1;CD19;P2RX7;TIMP2;EGR1;CNN2;PLEKHO2;WASF2;PYCARD;SOCS5;TLR1;SYNGR1;ATP6V0E2;TLR4;ENAH;SLPI;PAK1;PSMD1;PAK3;CD79A;CD300LG;ADGRE5;CARD11;CDA;PRKCQ;CTLA4;SLC27A2;FGG;CAT;ASB2;MAPK7;CIITA;MAPK11;IL1B;MAPK13;MUC1;PADI2;IL3RA;CD300E;IL9R;EDA2R;PRLR;SMAD3;BCL2;MASP2;ASB5,1827 (1828),0.873,1,0,,65 (147),1,1,0.992,1
Transcriptional Regulation by MECP2,Reactome,6,SGK1;CAMK2A;MEF2C;PVALB;LBR;RBFOX1,64 (64),0.875,1,0,,3 (4),1,1,0.992,1
mTOR signaling pathway,PID,6,RRAGD;DDIT4;SGK1;BNIP3;SFN;DEPTOR,64 (64),0.875,1,0,,6 (6),1,1,0.992,1
Nuclear Pore Complex (NPC) Disassembly,Reactome,3,NUP35;NDC1;POM121,36 (36),0.879,1,0,,2 (2),1,1,0.992,1
Nuclear import of Rev protein,Reactome,3,NUP35;NDC1;POM121,36 (36),0.879,1,0,,2 (3),1,1,0.992,1
RHOBTB GTPase Cycle,Reactome,3,ACTG1;MYO6;VIM,36 (36),0.879,1,0,,1 (1),1,1,0.992,1
Orc1 removal from chromatin,Reactome,2,MCM3;MCM4,26 (26),0.881,1,0,,2 (3),1,1,0.993,1
Cell Differentiation - Index,Wikipathways,2,MEF2C;SRF,49 (49),0.993,1,0,,0 (0),1,1,0.993,1
RNA Polymerase II Promoter Escape,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,46 (46),0.882,1,0,,5 (6),1,1,0.993,1
Alzheimer_s disease,Wikipathways,15,IL1B;ATP2A1;BACE1;ADAM10;CACNA1C;CACNA1D;ATP2A3;CACNA1S;PLCB4;CASP12;MME;HSD17B10;CHP1;ITPR3;APP,144 (144),0.884,1,0,,7 (7),1,1,0.993,1
ERK Pathway in Huntington_s Disease,Wikipathways,1,NTRK2,15 (15),0.885,1,0,,1 (1),1,1,0.993,1
Prolonged ERK activation events,Reactome,1,NGF,15 (15),0.885,1,0,,5 (5),1,1,0.993,1
Eicosanoid ligand-binding receptors,Reactome,1,PTGIR,15 (15),0.885,1,0,,10 (10),1,1,0.993,1
Unfolded Protein Response (UPR),Reactome,1,CREB3L3,15 (15),0.885,1,0,,2 (4),1,1,0.993,1
Fatty acids,Reactome,1,CYP4B1,15 (15),0.885,1,0,,12 (14),1,1,0.993,1
Interleukin-4 and Interleukin-13 signaling,Reactome,1,SOCS5,15 (15),0.885,1,0,,2 (2),1,1,0.993,1
Validated nuclear estrogen receptor beta network,PID,1,C3,15 (15),0.885,1,0,,1 (1),1,1,0.993,1
estrogen responsive protein efp controls cell cycle and breast tumors growth,BioCarta,1,SFN,15 (15),0.885,1,0,,1 (1),1,1,0.993,1
Response to metal ions,Reactome,1,CSRP1,15 (15),0.885,1,0,,3 (4),1,1,0.993,1
Sorafenib Metabolism Pathway,SMPDB,1,UGT1A1,15 (15),0.885,1,0,,6 (7),1,1,0.993,1
HDR through Single Strand Annealing (SSA),Reactome,3,ABL1;RMI2;RAD50,37 (37),0.89,1,0,,2 (3),1,1,0.994,1
Aldosterone-regulated sodium reabsorption - Homo sapiens (human),KEGG,3,SFN;ATP1A2;SGK1,37 (37),0.89,1,0,,8 (8),1,1,0.994,1
Activation of ATR in response to replication stress,Reactome,3,MCM3;MCM10;MCM4,37 (37),0.89,1,0,,2 (4),1,1,0.994,1
DNA Replication Pre-Initiation,Reactome,3,MCM3;MCM10;MCM4,37 (37),0.89,1,0,,3 (5),1,1,0.994,1
PTEN Regulation,Reactome,9,RRAGD;EGR1;MAF1;CBX6;HDAC7;USP13;PREX2;SNAI1;ATN1,93 (93),0.891,1,0,,11 (11),1,1,0.994,1
HIV Transcription Initiation,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,47 (47),0.892,1,0,,5 (6),1,1,0.994,1
RNA Polymerase II Transcription Initiation,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,47 (47),0.892,1,0,,5 (6),1,1,0.994,1
RNA Polymerase II Transcription Initiation And Promoter Clearance,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,47 (47),0.892,1,0,,7 (8),1,1,0.994,1
RNA Polymerase II HIV Promoter Escape,Reactome,4,TAF9B;POLR2D;TAF3;POLR2A,47 (47),0.892,1,0,,5 (6),1,1,0.994,1
Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,47 (47),0.892,1,0,,2 (3),1,1,0.994,1
Tat-mediated elongation of the HIV-1 transcript,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,47 (47),0.892,1,0,,5 (6),1,1,0.994,1
HIV Transcription Elongation,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,47 (47),0.892,1,0,,5 (6),1,1,0.994,1
Intestinal immune network for IgA production - Homo sapiens (human),KEGG,4,PIGR;TNFRSF13C;CXCR4;ITGB7,47 (49),0.892,1,0,,2 (2),1,1,0.994,1
Regulation of RUNX2 expression and activity,Reactome,2,WWP1;HIVEP3,27 (27),0.894,1,0,,6 (7),1,1,0.994,1
Constitutive Signaling by AKT1 E17K in Cancer,Reactome,2,CHUK;NR4A1,27 (27),0.894,1,0,,2 (6),1,1,0.994,1
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),Reactome,2,RMI2;RAD50,27 (27),0.894,1,0,,4 (6),1,1,0.994,1
RNA Pol II CTD phosphorylation and interaction with CE,Reactome,2,POLR2D;POLR2A,27 (27),0.894,1,0,,2 (3),1,1,0.994,1
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Reactome,2,POLR2D;POLR2A,27 (27),0.894,1,0,,2 (4),1,1,0.994,1
thrombin signaling and protease-activated receptors,BioCarta,2,CYTH4;GNAI1,27 (27),0.894,1,0,,3 (3),1,1,0.994,1
Signaling by FGFR2 in disease,Reactome,2,FGF1;FGF2,27 (27),0.894,1,0,,6 (17),1,1,0.994,1
Keratinization,Reactome,13,KRT17;PERP;PKP2;DSP;EVPL;KRT7;ST14;KRT19;PKP3;KRT80;PCSK6;SPINK5;DSC2,129 (129),0.897,1,0,,6 (10),1,1,0.995,1
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Reactome,9,BLK;BLNK;CD19;CD79A;CD79B;VAV1;IGLC2;PLCG2;ITPR3,94 (94),0.898,1,0,,5 (8),1,1,0.995,1
Stimuli-sensing channels,Reactome,9,ANO1;TRDN;SGK1;WWP1;RYR1;TTYH3;ASIC5;TPCN1;SGK2,94 (94),0.898,1,0,,9 (11),1,1,0.995,1
DroToll-like,INOH,3,GZMB;PSMD1;ADAM10,65 (65),0.995,1,0,,0 (1),1,1,0.995,1
NAD+ metabolism,Wikipathways,1,SIRT5,16 (16),0.9,1,0,,14 (14),1,1,0.995,1
Signaling by ERBB2 ECD mutants,Reactome,1,ERBB2,16 (16),0.9,1,0,,6 (8),1,1,0.995,1
Glycosphingolipid biosynthesis - neolactoseries,EHMN,1,FUT2,16 (16),0.9,1,0,,8 (48),1,1,0.995,1
control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk),BioCarta,1,MEF2C,16 (16),0.9,1,0,,1 (1),1,1,0.995,1
cadmium induces dna synthesis and proliferation in macrophages,BioCarta,1,NFKBIA,16 (16),0.9,1,0,,6 (9),1,1,0.995,1
KSRP (KHSRP) binds and destabilizes mRNA,Reactome,1,MAPK11,16 (16),0.9,1,0,,3 (4),1,1,0.995,1
Morphine Metabolism Pathway,SMPDB,1,UGT1A1,16 (16),0.9,1,0,,6 (6),1,1,0.995,1
Interactions of Rev with host cellular proteins,Reactome,3,NUP35;NDC1;POM121,38 (38),0.9,1,0,,3 (4),1,1,0.995,1
NOTCH1 Intracellular Domain Regulates Transcription,Reactome,4,RBPJ;MAML1;HDAC7;MAMLD1,48 (48),0.901,1,0,,2 (2),1,1,0.995,1
mRNA Splicing - Minor Pathway,Reactome,2,POLR2D;POLR2A,52 (52),0.995,1,0,,0 (2),1,1,0.995,1
Overview of interferons-mediated signaling pathway,Wikipathways,1,IFNGR1,37 (37),0.995,1,0,,0 (0),1,1,0.995,1
SUMOylation of DNA damage response and repair proteins,Reactome,4,NUP35;NDC1;POM121;HDAC7,78 (78),0.995,1,0,,0 (0),1,1,0.995,1
tRNA processing in the nucleus,Reactome,5,NUP35;NDC1;POM121;XPOT;RPP40,58 (58),0.904,1,0,,7 (10),1,1,0.995,1
Colorectal cancer - Homo sapiens (human),KEGG,8,TGFB2;TGFB3;TGFBR2;BAK1;BCL2;EREG;PMAIP1;SMAD3,86 (86),0.905,1,0,,1 (1),1,1,0.995,1
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,10,GATA4;IKBKG;FGF2;NFATC4;HDAC7;LIF;IGF1R;CHUK;MAPK7;MYLK3,104 (104),0.905,1,0,,3 (3),1,1,0.995,1
Translocation of ZAP-70 to Immunological synapse,Reactome,2,CD3D;LCK,28 (28),0.905,1,0,,4 (5),1,1,0.995,1
3-phosphoinositide biosynthesis,HumanCyc,2,PIK3C2G;PI4K2B,28 (28),0.905,1,0,,7 (11),1,1,0.995,1
role of erbb2 in signal transduction and oncology,BioCarta,2,LRPPRC;ERBB2,28 (28),0.905,1,0,,2 (2),1,1,0.995,1
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,7,GNE;ST8SIA3;SLC17A5;ST6GALNAC4;ST3GAL2;PGM3;ALG13,77 (77),0.906,1,0,,59 (82),1,1,0.995,1
ESR-mediated signaling,Reactome,23,EREG;MMP2;HBEGF;FOSB;POLR2A;GNB5;GNG2;SRF;ZDHHC7;GPAM;GNAI1;BCL2;POLR2D;CAV1;CAV2;MMP7;RUNX1;MMP9;GNG11;GNGT2;NOS3;TFF1;TFF3,216 (217),0.906,1,0,,27 (30),1,1,0.995,1
Melanoma,Wikipathways,6,BAK1;KIT;PAK1;KDR;PREX2;SHC2,68 (68),0.908,1,0,,2 (5),1,1,0.996,1
Interleukin-1 family signaling,Reactome,6,IL1B;IKBKG;NFKBIA;MAP3K3;SMAD3;CHUK,68 (68),0.908,1,0,,2 (5),1,1,0.996,1
DNA damage response,Wikipathways,6,SESN1;PMAIP1;ABL1;SFN;TNFRSF10B;RAD50,68 (68),0.908,1,0,,1 (2),1,1,0.996,1
RNA degradation - Homo sapiens (human),KEGG,4,BTG2;HSPD1;ENO3;HSPA9,79 (79),0.996,1,0,,0 (0),1,1,0.996,1
Formation of HIV elongation complex in the absence of HIV Tat,Reactome,4,POLR2D;NELFA;POLR2A;CTDP1,49 (49),0.909,1,0,,2 (3),1,1,0.996,1
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Reactome,3,CBX6;SMARCA2;RUNX1,39 (39),0.91,1,0,,2 (2),1,1,0.996,1
Association of TriC/CCT with target proteins during biosynthesis,Reactome,3,LONP2;AP3M1;KIFC3,39 (39),0.91,1,0,,1 (1),1,1,0.996,1
HIV Infection,Reactome,20,TAF9B;XRCC5;SLC25A4;AP1M2;VPS37A;AP1S2;PACS1;CXCR4;NELFA;CCR5;TAF3;NMT2;POLR2A;POLR2D;NUP35;NDC1;POM121;LCK;MVB12B;CTDP1,192 (192),0.912,1,0,,12 (19),1,1,0.996,1
Leptin Insulin Overlap,Wikipathways,1,SOCS2,17 (17),0.914,1,0,,1 (2),1,1,0.996,1
Circadian rhythm pathway,PID,1,CSNK1E,17 (17),0.914,1,0,,3 (4),1,1,0.996,1
Zinc transporters,Reactome,1,SLC39A5,17 (17),0.914,1,0,,1 (1),1,1,0.996,1
aspirin blocks signaling pathway involved in platelet activation,BioCarta,1,GNAI1,17 (17),0.914,1,0,,6 (6),1,1,0.996,1
Regulation of RUNX1 Expression and Activity,Reactome,1,RUNX1,17 (17),0.914,1,0,,4 (4),1,1,0.996,1
TLR NFkB,INOH,6,IL1B;CHUK;IKBKG;PSMD1;NFKBIA;TLR4,69 (69),0.915,1,0,,1 (1),1,1,0.996,1
Pentose phosphate pathway,EHMN,2,NUP35;ALDOB,29 (29),0.916,1,0,,35 (37),1,1,0.996,1
Dectin-2 family,Reactome,2,PLCG2;MUC1,29 (29),0.916,1,0,,3 (4),1,1,0.996,1
heparan sulfate biosynthesis,HumanCyc,2,HS3ST3A1;HS3ST1,29 (29),0.916,1,0,,10 (10),1,1,0.996,1
Nephrin/Neph1 signaling in the kidney podocyte,PID,2,ARRB2;ASB15,29 (29),0.916,1,0,,5 (5),1,1,0.996,1
mRNA Capping,Reactome,2,POLR2D;POLR2A,29 (29),0.916,1,0,,6 (9),1,1,0.996,1
Regulated Necrosis,Reactome,2,RIPK3;TNFRSF10B,29 (29),0.916,1,0,,8 (16),1,1,0.996,1
fc epsilon receptor i signaling in mast cells,BioCarta,2,VAV1;MAP3K1,29 (29),0.916,1,0,,1 (1),1,1,0.996,1
Fc epsilon receptor (FCERI) signaling,Reactome,15,LAT;PAK1;NFATC2;CARD11;VAV1;NFKBIA;IGLC2;PRKCQ;GAB2;PLCG2;GRAP2;CHUK;MAP3K1;ITPR3;IKBKG,150 (150),0.916,1,0,,11 (16),1,1,0.996,1
N-Glycan biosynthesis - Homo sapiens (human),KEGG,4,B4GALT2;FUT8;ALG13;MAN1C1,50 (50),0.917,1,0,,11 (38),1,1,0.996,1
HIV Life Cycle,Reactome,15,TAF9B;XRCC5;VPS37A;CXCR4;NELFA;CCR5;TAF3;NMT2;POLR2A;POLR2D;NUP35;NDC1;POM121;MVB12B;CTDP1,151 (151),0.921,1,0,,10 (16),1,1,0.997,1
IL-5 signaling pathway,Wikipathways,1,BCL2,40 (40),0.997,1,0,,0 (0),1,1,0.997,1
Rab regulation of trafficking,Reactome,11,RINL;TBC1D10A;DENND5B;RAB6B;RAB3IL1;RAB27B;RAB7B;DENND3;OPTN;RIN1;SYTL1,116 (116),0.922,1,0,,6 (6),1,1,0.997,1
B cell receptor signaling,INOH,13,BLNK;CD19;PSMD1;IKBKG;CARD11;NFKBIA;CD79A;CD79B;VAV1;PLCG2;CHUK;LCK;ITPR3,134 (134),0.923,1,0,,6 (7),1,1,0.997,1
Host Interactions of HIV factors,Reactome,8,SLC25A4;AP1M2;AP1S2;PACS1;NUP35;NDC1;POM121;LCK,89 (89),0.923,1,0,,5 (9),1,1,0.997,1
Signaling by FGFR1,Reactome,4,FGFR1;FGF1;SPRED2;FGF2,51 (51),0.925,1,0,,7 (8),1,1,0.997,1
Downstream signaling of activated FGFR2,Reactome,2,FGF1;FGF2,30 (30),0.925,1,0,,6 (8),1,1,0.997,1
Negative regulation of FGFR3 signaling,Reactome,2,FGF1;FGF2,30 (30),0.925,1,0,,4 (4),1,1,0.997,1
Regulation of TP53 Activity through Acetylation,Reactome,2,PIP4K2A;BRPF1,30 (30),0.925,1,0,,7 (9),1,1,0.997,1
Synthesis of glycosylphosphatidylinositol (GPI),Reactome,1,PIGL,18 (18),0.925,1,0,,10 (19),1,1,0.997,1
Interleukin-12 family signaling,Reactome,1,IL27RA,18 (18),0.925,1,0,,2 (2),1,1,0.997,1
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer_s disease models,Reactome,1,LMNB1,18 (18),0.925,1,0,,4 (4),1,1,0.997,1
Neurodegenerative Diseases,Reactome,1,LMNB1,18 (18),0.925,1,0,,4 (4),1,1,0.997,1
mets affect on macrophage differentiation,BioCarta,1,ETS2,18 (18),0.925,1,0,,2 (2),1,1,0.997,1
RHO GTPases Activate ROCKs,Reactome,1,LIMK1,18 (18),0.925,1,0,,5 (5),1,1,0.997,1
Signaling by cytosolic FGFR1 fusion mutants,Reactome,1,GAB2,18 (18),0.925,1,0,,3 (8),1,1,0.997,1
DDX58/IFIH1-mediated induction of interferon-alpha/beta,Reactome,5,NFKBIA;CHUK;IKBKG;MAP3K1;TKFC,61 (61),0.926,1,0,,3 (7),1,1,0.997,1
Signaling by FGFR3,Reactome,3,GALNT3;FGF1;FGF2,41 (41),0.926,1,0,,9 (10),1,1,0.997,1
tRNA modification in the nucleus and cytosol,Reactome,3,TPRKB;TRDMT1;TRMT9B,41 (41),0.926,1,0,,23 (48),1,1,0.997,1
Non-alcoholic fatty liver disease - Homo sapiens (human),KEGG,10,PKLR;COX7A1;CYP2E1;IL1B;ADIPOR2;PPARA;UQCRC2;COX6A2;PRKAA2;PRKAG2,150 (150),0.997,1,0,,0 (2),1,1,0.997,1
Eukaryotic Transcription Initiation,Wikipathways,1,POLR2A,41 (41),0.997,1,0,,0 (0),1,1,0.997,1
Homologous recombination - Homo sapiens (human),KEGG,1,RAD50,41 (41),0.997,1,0,,0 (0),1,1,0.997,1
RAB GEFs exchange GTP for GDP on RABs,Reactome,8,RINL;DENND5B;RAB6B;RIN1;RAB27B;RAB7B;DENND3;RAB3IL1,90 (90),0.929,1,0,,4 (4),1,1,0.997,1
Leishmania infection,Reactome,35,ADORA2B;PLK2;ADCY4;ABL1;RAMP2;ADRB2;WAS;P2RX7;VAV1;PRKAR1B;DPEP1;WASF2;PYCARD;GNB5;WASF3;GNG2;SCTR;ENTPD5;ACTG1;PRKAR2A;C3;C3AR1;IGLC2;PLCG2;FGR;ASB15;IL1B;GNG11;GNGT2;PTGIR;ADCY2;PTH1R;ADCY9;GGT1;ITPR3,323 (323),0.931,1,0,,46 (53),1,1,0.998,1
Formation of RNA Pol II elongation complex ,Reactome,5,POLR2D;MLLT3;NELFA;POLR2A;CTDP1,62 (62),0.932,1,0,,2 (4),1,1,0.998,1
RNA Polymerase II Transcription Elongation,Reactome,5,POLR2D;MLLT3;NELFA;POLR2A;CTDP1,62 (62),0.932,1,0,,5 (7),1,1,0.998,1
Transferrin endocytosis and recycling,Reactome,2,ATP6V0E2;TFR2,31 (31),0.933,1,0,,7 (9),1,1,0.998,1
Prostaglandin formation from dihomo gama-linoleic acid,EHMN,2,NUP35;PTGS2,31 (31),0.933,1,0,,6 (8),1,1,0.998,1
Phosphorylation of CD3 and TCR zeta chains,Reactome,2,CD3D;LCK,31 (31),0.933,1,0,,4 (5),1,1,0.998,1
SARS-CoV-1 Infection,Reactome,2,ST6GALNAC4;ST3GAL2,31 (31),0.933,1,0,,13 (25),1,1,0.998,1
Prader-Willi and Angelman Syndrome,Wikipathways,3,GABRB3;NGF;TUBGCP5,42 (43),0.934,1,0,,2 (3),1,1,0.998,1
DNA Replication,Wikipathways,3,MCM3;MCM10;MCM4,42 (42),0.934,1,0,,7 (7),1,1,0.998,1
N-Glycan biosynthesis,EHMN,3,B4GALT2;FUT8;MAN1C1,42 (42),0.934,1,0,,23 (51),1,1,0.998,1
tRNA Aminoacylation,Reactome,3,PPA1;NARS2;IARS2,42 (42),0.934,1,0,,22 (65),1,1,0.998,1
Signaling by FGFR4,Reactome,3,FGF2;FGF1;KLB,42 (42),0.934,1,0,,7 (8),1,1,0.998,1
Graft-versus-host disease - Homo sapiens (human),KEGG,3,IL1B;GZMB;PRF1,42 (42),0.934,1,0,,2 (2),1,1,0.998,1
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,3,LAT;INPP5D;GAB2,42 (42),0.934,1,0,,13 (13),1,1,0.998,1
Signaling by NOTCH,Reactome,19,ARRB2;MAML1;ADAM10;DLL4;NEURL1B;HDAC7;ELF3;DTX1;SMAD3;MFNG;LFNG;FLT4;NOTCH4;ARRB1;PLXND1;GZMB;RBPJ;RUNX1;MAMLD1,189 (190),0.934,1,0,,12 (13),1,1,0.998,1
Nucleotide metabolism,Wikipathways,1,DHFR,19 (19),0.935,1,0,,16 (18),1,1,0.998,1
ER Quality Control Compartment (ERQC),Reactome,1,AMFR,19 (19),0.935,1,0,,3 (13),1,1,0.998,1
COPI-dependent Golgi-to-ER retrograde traffic,Reactome,7,KIF21B;CENPE;KIF26A;KIF20B;KIF23;KIF1B;KIF21A,82 (82),0.936,1,0,,4 (5),1,1,0.998,1
Lysosome - Homo sapiens (human),KEGG,12,NPC1;AP1M2;SLC17A5;AP1S2;CD63;HYAL1;DNASE2B;CTSW;LIPA;ARSG;AP3M1;SLC11A1,128 (128),0.936,1,0,,3 (4),1,1,0.998,1
p53 pathway,PID,2,ABL1;CSNK1E,59 (59),0.998,1,0,,0 (0),1,1,0.998,1
Endometrial cancer,Wikipathways,5,ERBB2;BAK1;FGFR1;FGF1;FGF2,63 (63),0.937,1,0,,1 (4),1,1,0.998,1
TLR p38,INOH,5,MAPK11;PSMD1;MAPK13;MAPK12;TLR4,63 (63),0.937,1,0,,1 (1),1,1,0.998,1
Nuclear Envelope Breakdown,Reactome,4,LMNB1;NDC1;POM121;NUP35,53 (53),0.938,1,0,,7 (9),1,1,0.998,1
Cytosolic DNA-sensing pathway,Wikipathways,6,IL1B;CHUK;IKBKG;PYCARD;NFKBIA;RIPK3,73 (73),0.939,1,0,,1 (2),1,1,0.998,1
COPI-mediated anterograde transport,Reactome,7,COG5;CD55;USO1;SPTB;SPTBN2;ANK1;ANK2,83 (83),0.941,1,0,,4 (5),1,1,0.998,1
Cellular senescence - Homo sapiens (human),KEGG,15,MAPK11;GATA4;SLC25A4;NFATC2;ZFP36L2;NFATC4;TGFB2;MAPK13;CACNA1D;TGFBR2;TGFB3;SMAD3;MAPK12;ITPR3;RAD50,156 (156),0.941,1,0,,4 (5),1,1,0.998,1
Oncogene Induced Senescence,Reactome,2,CDKN2D;ETS2,32 (32),0.941,1,0,,2 (2),1,1,0.998,1
PD-1 signaling,Reactome,2,CD3D;LCK,32 (32),0.941,1,0,,3 (4),1,1,0.998,1
DNA strand elongation,Reactome,2,MCM3;MCM4,32 (32),0.941,1,0,,6 (8),1,1,0.998,1
SARS-CoV-2 Infection,Reactome,2,ST6GALNAC4;ST3GAL2,32 (32),0.941,1,0,,13 (24),1,1,0.998,1
Endosomal Sorting Complex Required For Transport (ESCRT),Reactome,2,VPS37A;MVB12B,32 (32),0.941,1,0,,4 (4),1,1,0.998,1
miRNAs involvement in the immune response in sepsis,Wikipathways,5,TLR4;RELB;GZMB;CHUK;IKBKG,64 (64),0.943,1,0,,1 (1),1,1,0.998,1
Validated nuclear estrogen receptor alpha network,PID,5,HSF2;CHUK;NRIP1;C3;TFF1,64 (64),0.943,1,0,,1 (1),1,1,0.998,1
Regulation of TP53 Activity through Phosphorylation,Reactome,8,MAPK11;TAF9B;NUAK1;TAF3;PRKAA2;RMI2;PRKAG2;RAD50,93 (93),0.943,1,0,,3 (4),1,1,0.998,1
Amyloid fiber formation,Reactome,8,TSPAN15;BACE1;ADAM10;HSPG2;TSPAN5;APP;SORL1;APCS,93 (94),0.943,1,0,,4 (7),1,1,0.998,1
Interferon type I signaling pathways,Wikipathways,4,VAV1;LCK;GAB2;MAP3K1,54 (54),0.943,1,0,,2 (2),1,1,0.998,1
Transcription of the HIV genome,Reactome,6,TAF9B;NELFA;TAF3;POLR2A;POLR2D;CTDP1,74 (74),0.943,1,0,,7 (10),1,1,0.998,1
Signaling by FGFR2,Reactome,6,ESRP2;FGF1;FGF2;POLR2A;POLR2D;ESRP1,74 (74),0.943,1,0,,7 (9),1,1,0.998,1
Signaling by NTRK2 (TRKB),Reactome,1,NTRK2,20 (20),0.944,1,0,,4 (4),1,1,0.998,1
Regulation of lipid metabolism by PPARalpha,Reactome,1,PPARA,20 (20),0.944,1,0,,6 (7),1,1,0.998,1
Regulation of expression of SLITs and ROBOs,Reactome,1,HOXA2,20 (20),0.944,1,0,,1 (1),1,1,0.998,1
Protein methylation,Reactome,1,ETFBKMT,20 (20),0.944,1,0,,2 (2),1,1,0.998,1
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Reactome,1,PMAIP1,20 (20),0.944,1,0,,3 (3),1,1,0.998,1
egf signaling pathway,BioCarta,1,MAP3K1,20 (20),0.944,1,0,,1 (1),1,1,0.998,1
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Reactome,1,IKBKG,20 (20),0.944,1,0,,2 (5),1,1,0.998,1
tRNA processing,Reactome,9,POM121;TRMT9B;RPP40;HSD17B10;NUP35;NDC1;TRDMT1;XPOT;TPRKB,103 (103),0.946,1,0,,26 (52),1,1,0.998,1
TP53 Regulates Transcription of Cell Death Genes,Reactome,3,PERP;TNFRSF10B;PMAIP1,44 (44),0.946,1,0,,8 (10),1,1,0.999,1
Influenza Infection,Reactome,3,NUP35;NDC1;POM121,44 (44),0.946,1,0,,8 (12),1,1,0.999,1
Disruption of postsynaptic signaling by CNV,Wikipathways,2,ARC;CAMK2A,33 (33),0.947,1,0,,1 (1),1,1,0.999,1
Resolution of D-loop Structures through Holliday Junction Intermediates,Reactome,2,RMI2;RAD50,33 (33),0.947,1,0,,4 (7),1,1,0.999,1
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,2,NGLY1;AMFR,33 (33),0.947,1,0,,4 (25),1,1,0.999,1
bioactive peptide induced signaling pathway,BioCarta,2,GNAI1;CAMK2A,33 (33),0.947,1,0,,3 (3),1,1,0.999,1
IL-1 JNK,INOH,2,IL1B;PSMD1,62 (62),0.999,1,0,,0 (0),1,1,0.999,1
Translation inhibitors in chronically activated PDGFRA cells,Wikipathways,1,RPS6KA2,46 (46),0.999,1,0,,0 (2),1,1,0.999,1
Proteasome - Homo sapiens (human),KEGG,1,PSMD1,46 (46),0.999,1,0,,0 (0),1,1,0.999,1
Fanconi anemia pathway,PID,1,RAD50,46 (46),0.999,1,0,,0 (0),1,1,0.999,1
RNA Polymerase II Pre-transcription Events,Reactome,7,TAF9B;MLLT3;NELFA;TAF3;POLR2A;POLR2D;CTDP1,85 (85),0.949,1,0,,4 (6),1,1,0.999,1
The canonical retinoid cycle in rods (twilight vision),Reactome,1,RDH16,21 (21),0.951,1,0,,21 (34),1,1,0.999,1
Negative regulation of MET activity,Reactome,1,HGF,21 (21),0.951,1,0,,4 (5),1,1,0.999,1
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Reactome,1,SMAD3,21 (21),0.951,1,0,,4 (4),1,1,0.999,1
CD28 dependent PI3K/Akt signaling,Reactome,1,LCK,21 (21),0.951,1,0,,3 (4),1,1,0.999,1
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Reactome,1,AJUBA,21 (21),0.951,1,0,,5 (7),1,1,0.999,1
SUMOylation of transcription cofactors,Reactome,1,NRIP1,47 (47),0.999,1,0,,0 (0),1,1,0.999,1
Taste transduction - Homo sapiens (human),KEGG,7,GABBR2;P2RY4;CACNA1C;ADCY4;PLCB4;GABRA3;ITPR3,86 (86),0.953,1,0,,27 (33),1,1,0.999,1
Monoamine GPCRs,Wikipathways,2,ADRB2;ADRA1A,34 (34),0.953,1,0,,7 (8),1,1,0.999,1
Regulation of MECP2 expression and activity,Reactome,2,LBR;CAMK2A,34 (34),0.953,1,0,,3 (3),1,1,0.999,1
RAF activation,Reactome,2,KSR1;CAMK2A,34 (34),0.953,1,0,,6 (6),1,1,0.999,1
Amino acids regulate mTORC1,Reactome,2,RRAGD;ATP6V0E2,34 (34),0.953,1,0,,4 (4),1,1,0.999,1
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,36,GABRB3;ADORA1;GABRP;GHR;ADRA1A;ADRB2;THRB;P2RX7;P2RY4;P2RY6;AVPR1A;GPR35;ADORA2B;P2RX6;NTS;PENK;PARD3;P2RY10;SCTR;S1PR2;C3AR1;C3;C5AR1;PLG;GABBR2;F2RL1;PTGIR;CHRNA2;BDKRB2;PTH1R;PRLR;KNG1;CHRNB1;CNR2;S1PR4;GABRA3,341 (341),0.954,1,0,,44 (52),1,1,0.999,1
Viral carcinogenesis - Homo sapiens (human),KEGG,14,BAK1;PKM;GSN;IKBKG;EGR3;HDAC7;SRF;C3;CCR5;PMAIP1;NFKBIA;CREB3L3;RBPJ;DNAJA3,203 (204),0.999,1,0,,0 (0),1,1,0.999,1
Asparagine N-linked glycosylation,Reactome,29,B4GALT2;SLC17A5;SEC16B;AMFR;MIA3;SEC22C;LMAN1;ANK2;GNE;USO1;MAN1C1;MIA2;SEC24A;ANK1;SPTB;SPTBN2;CD55;COG5;ST6GALNAC4;ST3GAL2;NGLY1;FUT8;ST8SIA3;F5;F8;B4GALT6;SEC23A;PGM3;ALG13,283 (283),0.956,1,0,,65 (121),1,1,0.999,1
Spinocerebellar ataxia - Homo sapiens (human),KEGG,13,PUM1;SLC25A4;ATP2A1;ATP2A3;PSMD1;VLDLR;OPA1;PLCB4;RYR1;ATXN10;SPTBN2;RBPJ;ITPR3,143 (143),0.956,1,0,,6 (7),1,1,0.999,1
Nanoparticle triggered autophagic cell death,Wikipathways,1,BCL2,22 (22),0.958,1,0,,1 (1),1,1,0.999,1
PKC-gamma calcium signaling pathway in ataxia,Wikipathways,1,PLCB4,22 (22),0.958,1,0,,4 (4),1,1,0.999,1
mTORC1-mediated signalling,Reactome,1,RRAGD,22 (22),0.958,1,0,,4 (4),1,1,0.999,1
Diseases of programmed cell death,Reactome,1,LMNB1,22 (22),0.958,1,0,,9 (11),1,1,0.999,1
Resolution of D-Loop Structures,Reactome,2,RMI2;RAD50,35 (35),0.959,1,0,,4 (7),1,1,0.999,1
Negative regulation of FGFR2 signaling,Reactome,2,FGF1;FGF2,35 (35),0.959,1,0,,4 (5),1,1,0.999,1
Signaling by TGF-beta Receptor Complex,Reactome,5,TGFBR2;WWTR1;PARD3;SMAD3;BAMBI,68 (68),0.96,1,0,,7 (7),1,1,0.999,1
Switching of origins to a post-replicative state,Reactome,3,ANAPC10;MCM3;MCM4,47 (47),0.961,1,0,,2 (3),1,1,0.999,1
Transcriptional regulation of white adipocyte differentiation,Reactome,3,CDK19;MED13L;FABP4,47 (47),0.961,1,0,,4 (4),1,1,0.999,1
Antimicrobial peptides,Reactome,8,ART1;DEFB1;BPIFB1;CCR2;PGLYRP2;TLR1;ATP7A;SLC11A1,98 (98),0.961,1,0,,14 (27),1,1,0.999,1
Cellular response to hypoxia,Reactome,1,AJUBA,23 (23),0.964,1,0,,5 (7),1,1,0.999,1
Mannose type O-glycan biosynthesis - Homo sapiens (human),KEGG,1,B4GALT2,23 (23),0.964,1,0,,2 (27),1,1,0.999,1
Response of Mtb to phagocytosis,Reactome,1,CORO1A,23 (23),0.964,1,0,,7 (11),1,1,0.999,1
Signaling by CSF3 (G-CSF),Reactome,1,GAB2,23 (23),0.964,1,0,,3 (3),1,1,0.999,1
il-2 receptor beta chain in t cell activation,BioCarta,3,IL2RB;BCL2;IKZF3,48 (48),0.965,1,0,,2 (2),1,1,0.999,1
Selective autophagy,Reactome,4,PLIN2;PRKAA2;NBR1;PEX5,59 (59),0.965,1,0,,3 (4),1,1,0.999,1
superpathway of purine nucleotide salvage,HumanCyc,4,AK3;ADA;AK1;ADK,59 (59),0.965,1,0,,30 (30),1,1,0.999,1
Epstein-Barr virus infection - Homo sapiens (human),KEGG,19,BLNK;RUNX3;BAK1;ITGAL;CR2;IKBKG;VIM;RBPJ;PSMD1;CD3D;MAPK13;PLCG2;RELB;BCL2;MAPK11;NFKBIA;CHUK;MAPK12;CD19,201 (202),0.966,1,0,,3 (3),1,1,0.999,1
Zinc homeostasis,Wikipathways,2,SLC30A10;SLC39A5,37 (37),0.967,1,0,,1 (1),1,1,0.999,1
Allograft rejection - Homo sapiens (human),KEGG,2,GZMB;PRF1,37 (38),0.967,1,0,,1 (1),1,1,0.999,1
Regulation of TP53 Expression and Degradation,Reactome,2,SGK1;PRDM1,37 (37),0.967,1,0,,5 (6),1,1,0.999,1
Oocyte meiosis - Homo sapiens (human),KEGG,11,MAPK11;MAPK13;ADCY4;ADCY2;CAMK2A;ADCY9;RPS6KA2;IGF1R;ANAPC10;MAPK12;ITPR3,129 (129),0.968,1,0,,4 (4),1,1,0.999,1
MHC class II antigen presentation,Reactome,4,AP1S2;SEC24A;SEC23A;AP1M2,60 (60),0.968,1,0,,3 (6),1,1,0.999,1
Calnexin/calreticulin cycle,Reactome,1,AMFR,24 (24),0.969,1,0,,4 (17),1,1,0.999,1
Cytosolic tRNA aminoacylation,Reactome,1,PPA1,24 (24),0.969,1,0,,22 (65),1,1,0.999,1
tRNA charging,HumanCyc,2,NARS2;IARS2,38 (38),0.971,1,0,,24 (24),1,1,1,1
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,2,SMAD3;WWTR1,38 (38),0.971,1,0,,6 (6),1,1,1,1
Ovarian tumor domain proteases,Reactome,2,IKBKG;RNF128,38 (38),0.971,1,0,,3 (9),1,1,1,1
adenosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,2,AK3;AK1,38 (38),0.971,1,0,,12 (12),1,1,1,1
Fanconi anemia pathway - Homo sapiens (human),KEGG,1,RMI2,54 (54),1,1,0,,0 (0),1,1,1,1
Transcriptional regulation by RUNX1,Reactome,18,BLK;SPI1;SMARCA2;NFATC2;TAL1;RSPO3;LIFR;CBX6;GPAM;THBS1;CLDN5;PRKCQ;CTLA4;LGALS3;PAX5;GATA2;ABL1;RUNX1,195 (196),0.971,1,0,,6 (7),1,1,1,1
Alcoholism - Homo sapiens (human),KEGG,17,PKIA;MAOB;CREB3L3;GNG11;ADORA2B;GNGT2;SLC18A1;DDC;FOSB;HDAC7;GNAI1;SLC29A3;GNB5;NTRK2;GNG2;CAMKK1;SHC2,186 (187),0.971,1,0,,10 (10),1,1,1,1
HDMs demethylate histones,Reactome,3,KDM1B;KDM4C;KDM6B,50 (50),0.972,1,0,,5 (5),1,1,1,1
Joubert Syndrome,Wikipathways,5,CCP110;RAD50;FLNA;MYO6;TMEM231,72 (72),0.972,1,0,,3 (9),1,1,1,1
mtor signaling pathway,BioCarta,1,GHR,25 (25),0.973,1,0,,3 (3),1,1,1,1
regulation of eif-4e and p70s6 kinase,BioCarta,1,GHR,25 (25),0.973,1,0,,1 (2),1,1,1,1
skeletal muscle hypertrophy is regulated via akt-mtor pathway,BioCarta,1,IGF1R,25 (25),0.973,1,0,,3 (3),1,1,1,1
Late Phase of HIV Life Cycle,Reactome,12,TAF9B;VPS37A;NELFA;TAF3;NMT2;POLR2A;POLR2D;NUP35;NDC1;POM121;MVB12B;CTDP1,141 (141),0.973,1,0,,10 (15),1,1,1,1
Presynaptic phase of homologous DNA pairing and strand exchange,Reactome,2,RMI2;RAD50,39 (39),0.974,1,0,,2 (3),1,1,1,1
Post-translational protein modification,Reactome,168,B4GALT2;GALNT15;THSD4;CCP110;NRIP1;VWA1;HIC1;DCAF6;ADRB2;GALNT3;B3GNT5;B3GNT3;SPP1;SPON1;ANKRD9;SEC24A;VNN3;SPTBN2;PENK;GAS6;CD55;PEX13;PSMD1;KLHL41;TUBB2B;USP13;IZUMO1R;GCNT4;ADAM10;F5;GALNT18;GALNT16;F8;F9;ITIH2;B4GALT6;PGM3;TUBB1;QSOX1;MFGE8;FBN1;PROZ;POM121;MIA2;GPC3;SATB1;HRC;TUBA1A;ADAMTS9;ASB5;BST1;VNN1;THSD7A;RAB30;PGAP1;NFKBIA;FN1;ADAMTS15;FGA;AHSG;PEX5;CHRDL1;DCUN1D4;C3;SPARCL1;RAB7B;CKAP4;COG5;RNF128;ADAMTSL4;ASB4;SDC2;SPSB3;FOXK1;RECK;KNG1;SEC23A;LTBP1;B3GNT7;VDR;ALB;KCTD7;GPLD1;SEC16B;AMFR;PIGL;MIA3;NGLY1;SOCS2;ADAMTSL1;FGG;ANK1;ANK2;GNE;ADAMTS2;ADAMTS1;APOA5;TNC;MAN1C1;FN3KRP;MXRA8;RCN1;OBSL1;IKBKG;LAMB1;LAMB2;LAMC1;CP;SEMA5A;GALNT12;APOB;ST3GAL2;ADAMTS8;ADAMTS5;PPARA;PRSS23;ASB15;APP;ST8SIA3;RAB6B;HDAC7;ETFBKMT;LGALS1;ARSG;NUP35;TTLL7;ADAMTS10;SLC17A5;TGFBR2;RAB36;THBS1;ARRB1;ARRB2;NDC1;THRB;SEC22C;THY1;FSTL1;TAF9B;IGFBP7;ART3;USO1;IGFBP1;RAB27B;FOLR2;LMAN1;VCAN;SOCS5;PLET1;DCAF11;RAB15;SERPINC1;ST6GALNAC4;SERPINA10;KDM1B;GALNT6;ASB2;SPTB;FUT8;MUC1;MDGA1;SERPIND1;RAB20;SMAD1;ADAMTSL2;SMAD3;ALG13;WDTC1,1425 (1425),0.975,1,0,,96 (182),1,1,1,1
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,15,BAK1;HSPA1A;HSPA1B;HSPA1L;AMFR;CRYAB;MAN1C1;SEC24A;BCL2;CASP12;NGLY1;SEC23A;CKAP4;UBQLN1;LMAN1,170 (171),0.975,1,0,,1 (6),1,1,1,1
DNA Damage/Telomere Stress Induced Senescence,Reactome,1,RAD50,26 (26),0.976,1,0,,4 (6),1,1,1,1
Interleukin-7 signaling,Reactome,1,HGF,26 (26),0.976,1,0,,2 (2),1,1,1,1
Insulin receptor recycling,Reactome,1,ATP6V0E2,26 (26),0.976,1,0,,2 (3),1,1,1,1
Genes related to primary cilium development (based on CRISPR),Wikipathways,4,SCLT1;TTC23;EVC2;TMEM231,103 (103),1,1,0,,0 (0),1,1,1,1
Autoimmune thyroid disease - Homo sapiens (human),KEGG,3,GZMB;CTLA4;PRF1,52 (53),0.977,1,0,,3 (4),1,1,1,1
ErbB2/ErbB3 signaling events,PID,2,ERBB2;NFATC4,40 (40),0.977,1,0,,4 (4),1,1,1,1
Influenza A - Homo sapiens (human),KEGG,15,IL1B;BAK1;TNFRSF10B;CIITA;ACTG1;CCL2;IFNGR1;TLR4;SLC25A4;PYCARD;NFKBIA;TPSB2;CHUK;PLG;IKBKG,172 (172),0.978,1,0,,3 (3),1,1,1,1
Vitamin D3 (cholecalciferol) metabolism,EHMN,1,NUP35,27 (27),0.98,1,0,,12 (12),1,1,1,1
Infection with Mycobacterium tuberculosis,Reactome,1,CORO1A,27 (27),0.98,1,0,,30 (55),1,1,1,1
Collecting duct acid secretion - Homo sapiens (human),KEGG,1,ATP6V0E2,27 (27),0.98,1,0,,7 (8),1,1,1,1
Interferon gamma signaling,Reactome,7,IRF8;TRIM8;CIITA;TRIM35;IFNGR1;TRIM2;CAMK2A,96 (96),0.98,1,0,,4 (5),1,1,1,1
Fcgamma receptor (FCGR) dependent phagocytosis,Reactome,13,PLPP5;PAK1;ACTG1;LIMK1;VAV1;IGLC2;WASF2;WAS;PLCG2;ABL1;WASF3;ASB15;ITPR3,155 (155),0.981,1,0,,13 (16),1,1,1,1
Pre-NOTCH Expression and Processing,Reactome,8,MAML1;ELF3;MFNG;LFNG;NOTCH4;RBPJ;RUNX1;MAMLD1,107 (108),0.981,1,0,,11 (12),1,1,1,1
Phototransduction - Homo sapiens (human),KEGG,1,GNAT1,28 (29),0.982,1,0,,8 (8),1,1,1,1
Homologous DNA Pairing and Strand Exchange,Reactome,2,RMI2;RAD50,42 (42),0.982,1,0,,2 (4),1,1,1,1
TP53 Regulates Transcription of DNA Repair Genes,Reactome,4,POLR2D;CTDP1;POLR2A;NELFA,66 (66),0.983,1,0,,2 (2),1,1,1,1
Selenoamino acid metabolism,Reactome,10,CBS;PAPSS2;NNMT;HNMT;RPL3L;MAT1A;SEPHS2;CTH;SEPSECS;AHCY,128 (128),0.983,1,0,,48 (63),1,1,1,1
Regulation of PLK1 Activity at G2/M Transition,Reactome,6,AJUBA;NINL;TUBA1A;CCP110;CSNK1E;OPTN,88 (88),0.983,1,0,,5 (5),1,1,1,1
Cellular response to chemical stress,Reactome,7,NOX4;CAT;NCF2;PRDX6;ALB;PPARA;GPX3,99 (99),0.984,1,0,,33 (41),1,1,1,1
Amine ligand-binding receptors,Reactome,2,ADRB2;ADRA1A,43 (43),0.984,1,0,,21 (29),1,1,1,1
insulin,INOH,5,SFN;PRKAA2;PRKAG2;GYS2;SHC2,78 (78),0.984,1,0,,4 (5),1,1,1,1
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Reactome,3,SKA2;INCENP;CENPE,96 (96),1,1,0,,0 (0),1,1,1,1
Amplification of signal from the kinetochores,Reactome,3,SKA2;INCENP;CENPE,96 (96),1,1,0,,0 (0),1,1,1,1
CDK-mediated phosphorylation and removal of Cdc6,Reactome,1,ANAPC10,29 (29),0.985,1,0,,2 (2),1,1,1,1
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Reactome,19,C3;CD19;ITGAL;FCGR2B;ITGB2;CD300LB;CD300A;CD300E;ITGB7;IGLC2;CD34;CD300LG;CD200;ICAM2;PVR;CD3D;CD8A;CLEC4G;CD22,215 (215),0.985,1,0,,6 (20),1,1,1,1
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Reactome,1,MBD4,64 (65),1,1,0,,0 (2),1,1,1,1
Cyclin D associated events in G1,Reactome,2,CDKN2D;ABL1,44 (44),0.986,1,0,,4 (4),1,1,1,1
G1 Phase,Reactome,2,CDKN2D;ABL1,44 (44),0.986,1,0,,4 (4),1,1,1,1
APC/C-mediated degradation of cell cycle proteins,Reactome,2,ANAPC10;CDC14A,44 (44),0.986,1,0,,4 (4),1,1,1,1
Regulation of mitotic cell cycle,Reactome,2,ANAPC10;CDC14A,44 (44),0.986,1,0,,4 (4),1,1,1,1
FCGR3A-mediated IL10 synthesis,Reactome,9,PRKAR1B;PRKAR2A;ADCY4;ADCY2;IGLC2;ADCY9;PLCG2;FGR;ITPR3,121 (121),0.986,1,0,,10 (13),1,1,1,1
Dopaminergic Neurogenesis,Wikipathways,1,DDC,30 (30),0.987,1,0,,1 (1),1,1,1,1
Asthma - Homo sapiens (human),KEGG,1,CCL11,30 (31),0.987,1,0,,5 (5),1,1,1,1
Cytokine Signaling in Immune system,Reactome,48,GHR;SOCS2;IL11;LIF;LIFR;HGF;FLNA;IRF8;IFNGR1;TRIM2;TRIM35;CIITA;EGR1;EDA2R;TNFSF9;CAMK2A;INPP5D;RPS6KA2;DUSP4;SOCS5;NFKBIA;DUSP7;GRAP2;BLNK;TNFRSF13C;TRIM8;IKBKG;GRB10;MAP3K3;LTB;RELB;TNFRSF11A;LCK;MAPK7;MAPK11;IL1B;IL2RB;IL3RA;SDC1;MEF2C;VAV1;PRLR;GAB2;CNTFR;SMAD3;IL27RA;CHUK;IL9R,471 (471),0.987,1,0,,9 (21),1,1,1,1
Mitotic Spindle Checkpoint,Reactome,4,ANAPC10;SKA2;INCENP;CENPE,114 (114),1,1,0,,0 (0),1,1,1,1
Loss of proteins required for interphase microtubule organization from the centrosome,Reactome,4,CCP110;NINL;CSNK1E;TUBA1A,70 (70),0.989,1,0,,2 (2),1,1,1,1
CD22 mediated BCR regulation,Reactome,4,IGLC2;CD22;CD79B;CD79A,70 (70),0.989,1,0,,2 (3),1,1,1,1
Loss of Nlp from mitotic centrosomes,Reactome,4,CCP110;NINL;CSNK1E;TUBA1A,70 (70),0.989,1,0,,2 (2),1,1,1,1
miRNAs involved in DNA damage response,Wikipathways,1,ABL1,67 (67),1,1,0,,0 (0),1,1,1,1
Anti-inflammatory response favouring Leishmania parasite infection,Reactome,22,ADORA2B;PLK2;ADCY4;RAMP2;ADRB2;DPEP1;PRKAR2A;GNB5;GNG2;PRKAR1B;SCTR;IGLC2;PLCG2;FGR;GNG11;GNGT2;PTGIR;ADCY2;PTH1R;ADCY9;GGT1;ITPR3,247 (247),0.989,1,0,,32 (35),1,1,1,1
Leishmania parasite growth and survival,Reactome,22,ADORA2B;PLK2;ADCY4;RAMP2;ADRB2;DPEP1;PRKAR2A;GNB5;GNG2;PRKAR1B;SCTR;IGLC2;PLCG2;FGR;GNG11;GNGT2;PTGIR;ADCY2;PTH1R;ADCY9;GGT1;ITPR3,247 (247),0.989,1,0,,32 (35),1,1,1,1
Signaling by MET,Reactome,2,HGF;RANBP10,46 (46),0.989,1,0,,7 (9),1,1,1,1
Centrosome maturation,Reactome,5,CCP110;TUBA1A;NINL;CSNK1E;TUBGCP5,82 (82),0.99,1,0,,2 (2),1,1,1,1
insulin Mam,INOH,5,SFN;PRKAA2;PRKAG2;GYS2;SHC2,82 (82),0.99,1,0,,6 (7),1,1,1,1
purine nucleotides <i>de novo</i> biosynthesis,HumanCyc,3,AK3;AK1;PAICS,59 (59),0.99,1,0,,37 (37),1,1,1,1
Parkinson_s disease pathway,Wikipathways,4,MAPK11;DDC;MAPK13;MAPK12,71 (71),0.99,1,0,,3 (4),1,1,1,1
15q13.3 copy number variation syndrome,Wikipathways,1,SERPINH1,32 (32),0.99,1,0,,1 (3),1,1,1,1
Interconversion of nucleotide di- and triphosphates,Reactome,1,AK1,32 (32),0.99,1,0,,44 (52),1,1,1,1
Cytoplasmic Ribosomal Proteins,Wikipathways,2,RPL3L;RPS6KA2,88 (88),1,1,0,,0 (0),1,1,1,1
Non-small cell lung cancer - Homo sapiens (human),KEGG,4,PLCG2;ERBB2;HGF;BAK1,72 (72),0.991,1,0,,6 (6),1,1,1,1
AURKA Activation by TPX2,Reactome,4,CCP110;NINL;CSNK1E;TUBA1A,73 (73),0.992,1,0,,2 (2),1,1,1,1
GPCRs_ Class A Rhodopsin-like,Wikipathways,23,ADORA1;ADORA2B;CCR2;CXCR3;ADRA1A;ADRB2;GPR174;P2RY4;P2RY6;AVPR1A;GPR35;CXCR4;ACKR3;GPR85;P2RY10;C3AR1;CCR5;ACKR2;CMKLR1;F2RL1;PTGIR;BDKRB2;CNR2,261 (261),0.992,1,0,,7 (11),1,1,1,1
RUNX1 regulates transcription of genes involved in differentiation of HSCs,Reactome,5,SPI1;ABL1;GATA2;RUNX1;TAL1,85 (86),0.992,1,0,,4 (4),1,1,1,1
Regulation of actin dynamics for phagocytic cup formation,Reactome,10,PAK1;ACTG1;LIMK1;VAV1;IGLC2;WASF2;ABL1;WASF3;ASB15;WAS,138 (138),0.992,1,0,,6 (9),1,1,1,1
Retrograde transport at the Trans-Golgi-Network,Reactome,2,RAB6B;COG5,49 (49),0.993,1,0,,6 (6),1,1,1,1
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,3,TCOF1;DROSHA;RPP40,108 (110),1,1,0,,0 (0),1,1,1,1
FCERI mediated MAPK activation,Reactome,7,LAT;PAK1;VAV1;IGLC2;MAP3K1;PLCG2;GRAP2,108 (108),0.993,1,0,,5 (7),1,1,1,1
FCERI mediated Ca+2 mobilization,Reactome,7,LAT;NFATC2;VAV1;IGLC2;PLCG2;GRAP2;ITPR3,108 (108),0.993,1,0,,9 (13),1,1,1,1
HCMV Early Events,Reactome,3,NUP35;NDC1;POM121,109 (109),1,1,0,,0 (2),1,1,1,1
Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,4,NUP35;NDC1;POM121;MAGOHB,75 (75),0.993,1,0,,3 (5),1,1,1,1
miRNA regulation of DNA damage response,Wikipathways,6,SESN1;PMAIP1;ABL1;SFN;TNFRSF10B;RAD50,98 (98),0.994,1,0,,1 (2),1,1,1,1
FCERI mediated NF-kB activation,Reactome,6,IKBKG;CARD11;IGLC2;PRKCQ;NFKBIA;CHUK,98 (98),0.994,1,0,,4 (6),1,1,1,1
RNA Polymerase I Transcription,Reactome,1,CAVIN1,35 (35),0.994,1,0,,7 (9),1,1,1,1
G1/S Transition,Reactome,4,MCM3;MCM10;MCM4;DHFR,76 (76),0.994,1,0,,4 (7),1,1,1,1
Regulation of TP53 Degradation,Reactome,1,SGK1,36 (36),0.994,1,0,,5 (6),1,1,1,1
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Reactome,4,ABL1;EYA2;EYA4;RAD50,77 (78),0.995,1,0,,7 (8),1,1,1,1
HCMV Infection,Reactome,3,NUP35;NDC1;POM121,113 (113),1,1,0,,0 (3),1,1,1,1
Regulation of TP53 Activity,Reactome,12,TAF9B;MAPK11;NUAK1;SGK1;TAF3;BRPF1;RAD50;PIP4K2A;PRKAA2;RMI2;PRKAG2;PRDM1,163 (163),0.995,1,0,,11 (15),1,1,1,1
Disease,Reactome,112,HGF;ERBB2;PLK2;EREG;ABL1;RAMP2;PDGFB;PDGFRA;NRG4;PDGFRB;WASF3;GNG2;ESRP1;FXYD6;ACTG1;NR4A1;CNKSR1;ADAM10;PTGIR;ADCY2;F8;F9;PTH1R;ADCY9;GGT1;IQGAP1;CHUK;ITPR3;ADORA2B;KSR1;KANK1;ADRB2;POM121;CXCR4;ANTXR1;NMT2;SYT1;NFKBIA;FGA;FGB;GAB2;FGF1;FGF2;SCTR;AP1S2;C3;C3AR1;CCR5;BIN2;FGFR1;PLCG2;FGG;KDR;FGR;GNG11;GNGT2;KLKB1;ST6GALNAC4;VAV1;APBB1IP;MVB12B;KLB;DPEP1;ADCY4;VPS37A;VWF;CAMK2A;WAS;FN1;SLC25A4;DLL4;NEURL1B;NELFA;HBEGF;POLR2A;POLR2D;BAG4;MAMLD1;AP1M2;NOX4;ST3GAL2;IDH1;TLR9;LCK;ASB15;XRCC5;KIT;HDAC7;NUP35;IFNGR1;PACS1;MAML1;CORO1A;TAF3;ARRB1;ARRB2;NDC1;TAF9B;LMNB1;CD19;P2RX7;WASF2;PYCARD;GNB5;RBPJ;ENTPD5;CTDP1;PRKAR1B;PRKAR2A;IGLC2;ATP1A2;IL1B,1029 (1029),0.995,1,0,,91 (198),1,1,1,1
Regulation of APC/C activators between G1/S and early anaphase,Reactome,1,ANAPC10,37 (37),0.995,1,0,,2 (2),1,1,1,1
Resolution of Abasic Sites (AP sites),Reactome,1,MBD4,37 (37),0.995,1,0,,6 (9),1,1,1,1
Antiviral mechanism by IFN-stimulated genes,Reactome,1,FLNA,37 (37),0.995,1,0,,3 (8),1,1,1,1
DNA Double Strand Break Response,Reactome,4,ABL1;EYA2;EYA4;RAD50,78 (79),0.995,1,0,,9 (10),1,1,1,1
Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,3,IARS2;SEPSECS;NARS2,66 (66),0.995,1,0,,23 (52),1,1,1,1
Autophagy,Reactome,7,RRAGD;PRKAA2;PEX5;NBR1;GFAP;PLIN2;PRKAG2,113 (113),0.996,1,0,,7 (13),1,1,1,1
Degradation of beta-catenin by the destruction complex,Reactome,1,CTBP2,38 (38),0.996,1,0,,2 (3),1,1,1,1
Potential therapeutics for SARS,Reactome,4,TLR9;IFNGR1;FXYD6;ATP1A2,80 (80),0.996,1,0,,1 (2),1,1,1,1
Hepatitis C - Homo sapiens (human),KEGG,11,BAK1;IKBKG;CLDN5;CLDN2;CLDN1;SCARB1;CLDN7;PPARA;NFKBIA;CLDN4;CHUK,157 (157),0.996,1,0,,1 (2),1,1,1,1
Internalization of ErbB1,PID,1,ARHGEF7,39 (39),0.996,1,0,,2 (2),1,1,1,1
DNA Repair Pathways Full Network,Wikipathways,3,XRCC5;MBD4;RAD50,119 (119),1,1,0,,0 (0),1,1,1,1
Mitotic G1 phase and G1/S transition,Reactome,6,CDKN2D;MCM3;MCM4;DHFR;ABL1;MCM10,104 (104),0.996,1,0,,4 (7),1,1,1,1
DNA Replication,Reactome,4,MCM3;MCM10;MCM4;ANAPC10,81 (81),0.997,1,0,,14 (17),1,1,1,1
FCGR3A-mediated phagocytosis,Reactome,9,ACTG1;VAV1;IGLC2;WASF2;ABL1;WASF3;FGR;ASB15;WAS,137 (137),0.997,1,0,,6 (10),1,1,1,1
Leishmania phagocytosis,Reactome,9,ACTG1;VAV1;IGLC2;WASF2;ABL1;WASF3;FGR;ASB15;WAS,137 (137),0.997,1,0,,6 (10),1,1,1,1
Parasite infection,Reactome,9,ACTG1;VAV1;IGLC2;WASF2;ABL1;WASF3;FGR;ASB15;WAS,137 (137),0.997,1,0,,6 (10),1,1,1,1
Autophagy - animal - Homo sapiens (human),KEGG,9,RRAGD;DDIT4;RAB7B;IGF1R;BCL2;BNIP3;PRKCQ;PRKAA2;DEPTOR,137 (137),0.997,1,0,,4 (6),1,1,1,1
Formation of TC-NER Pre-Incision Complex,Reactome,2,POLR2D;POLR2A,55 (55),0.997,1,0,,1 (2),1,1,1,1
Pathways of neurodegeneration - multiple diseases - Homo sapiens (human),KEGG,45,FZD4;TUBB1;PLCB4;FZD8;FZD9;CACNA1C;NEFH;CACNA1S;COX7A1;HIP1;OPTN;MAPK12;SLC25A4;TUBA1A;DNAH2;CSNK1E;CAMK2A;CACNA1D;WNT7B;SPTBN2;WNT11;COX6A2;WNT9B;GPX3;BAK1;PSMD1;NOX4;DLG4;CAT;BCL2;TUBB2B;DNAL1;UQCRC2;APP;MAPK11;IL1B;MAPK13;ATP2A1;ATP2A3;PTGS2;DNAH14;RYR1;CASP12;HSD17B10;ITPR3,475 (475),0.997,1,0,,20 (32),1,1,1,1
Signaling events mediated by HDAC Class I,PID,2,GATA2;NFKBIA,56 (56),0.997,1,0,,1 (1),1,1,1,1
Macroautophagy,Reactome,6,RRAGD;PRKAA2;PEX5;NBR1;PLIN2;PRKAG2,106 (106),0.997,1,0,,7 (12),1,1,1,1
Pre-NOTCH Transcription and Translation,Reactome,5,MAML1;RBPJ;RUNX1;MAMLD1;ELF3,95 (96),0.997,1,0,,3 (4),1,1,1,1
Classical antibody-mediated complement activation,Reactome,1,IGLC2,87 (87),1,1,0,,0 (1),1,1,1,1
Ubiquitin mediated proteolysis - Homo sapiens (human),KEGG,4,ANAPC10;WWP1;UBE2U;MAP3K1,140 (140),1,1,0,,0 (0),1,1,1,1
Transport of Mature Transcript to Cytoplasm,Reactome,4,NUP35;NDC1;POM121;MAGOHB,84 (84),0.998,1,0,,3 (5),1,1,1,1
Ciliopathies,Wikipathways,7,SCLT1;ATXN10;FAM161A;EVC2;GLIS2;DNAL1;TMEM231,183 (183),1,1,0,,0 (0),1,1,1,1
Endometrial cancer - Homo sapiens (human),KEGG,2,ERBB2;BAK1,58 (58),0.998,1,0,,1 (1),1,1,1,1
Non-small cell lung cancer,Wikipathways,3,PLCG2;ERBB2;BAK1,72 (72),0.998,1,0,,5 (7),1,1,1,1
Anchoring of the basal body to the plasma membrane,Reactome,5,SCLT1;CCP110;NINL;TUBA1A;CSNK1E,97 (97),0.998,1,0,,2 (3),1,1,1,1
Signaling by WNT,Reactome,23,CCDC88C;FZD4;SOX4;FZD8;RSPO3;SOX7;SFRP1;ARRB2;PRICKLE1;CSNK1E;CAMK2A;WNT7B;ROR2;GNB5;GNG2;WNT9B;CHD8;WNT11;CTBP2;WLS;GNG11;GNGT2;ITPR3,281 (282),0.998,1,0,,21 (26),1,1,1,1
E3 ubiquitin ligases ubiquitinate target proteins,Reactome,2,PEX13;PEX5,59 (59),0.998,1,0,,1 (1),1,1,1,1
Transcriptional regulation by small RNAs,Reactome,6,POLR2A;POLR2D;NUP35;NDC1;POM121;IPO8,110 (111),0.998,1,0,,1 (3),1,1,1,1
SARS-CoV Infections,Reactome,6,FXYD6;IFNGR1;ST6GALNAC4;ST3GAL2;TLR9;ATP1A2,111 (111),0.998,1,0,,13 (26),1,1,1,1
Alzheimer disease - Homo sapiens (human),KEGG,32,FZD4;TUBB1;FZD8;FZD9;CACNA1C;CACNA1D;CACNA1S;SLC25A4;TUBA1A;CSNK1E;WNT7B;WNT11;COX6A2;WNT9B;COX7A1;PSMD1;BACE1;NOX4;PLCB4;TUBB2B;MME;UQCRC2;APP;IL1B;ADAM10;ATP2A1;ATP2A3;PTGS2;CASP12;HSD17B10;CHUK;ITPR3,369 (369),0.998,1,0,,9 (16),1,1,1,1
RHO GTPases Activate Formins,Reactome,7,FMNL3;INCENP;CENPE;ACTG1;SKA2;SRF;FMNL1,123 (123),0.998,1,0,,7 (8),1,1,1,1
SUMO E3 ligases SUMOylate target proteins,Reactome,12,SATB1;IKBKG;NRIP1;HDAC7;HIC1;PPARA;NFKBIA;NUP35;NDC1;POM121;THRB;VDR,177 (177),0.998,1,0,,6 (8),1,1,1,1
Synthesis of DNA,Reactome,3,ANAPC10;MCM3;MCM4,76 (76),0.999,1,0,,13 (15),1,1,1,1
TLR JNK,INOH,2,PSMD1;TLR4,62 (62),0.999,1,0,,1 (1),1,1,1,1
Meiotic synapsis,Reactome,1,SYCP2,46 (47),0.999,1,0,,2 (3),1,1,1,1
Spliceosome - Homo sapiens (human),KEGG,4,HSPA1B;HSPA1L;MAGOHB;HSPA1A,151 (151),1,1,0,,0 (0),1,1,1,1
RNA polymerase II transcribes snRNA genes,Reactome,3,POLR2D;POU2F2;POLR2A,77 (77),0.999,1,0,,3 (4),1,1,1,1
mRNA surveillance pathway - Homo sapiens (human),KEGG,1,MAGOHB,98 (98),1,1,0,,0 (0),1,1,1,1
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,5,UCP3;UQCRC2;COX7A1;SLC25A4;COX6A2,103 (103),0.999,1,0,,10 (12),1,1,1,1
SUMOylation,Reactome,12,SATB1;IKBKG;NRIP1;HDAC7;HIC1;PPARA;NFKBIA;NUP35;NDC1;POM121;THRB;VDR,182 (182),0.999,1,0,,9 (11),1,1,1,1
Cytoprotection by HMOX1,Reactome,2,PPARA;ALB,65 (65),0.999,1,0,,23 (29),1,1,1,1
RHO GTPase Effectors,Reactome,25,FMNL3;FLNA;PAK1;LIMK1;SRF;ABL1;WAS;INCENP;IQGAP2;CENPE;KDM4C;ACTG1;ASB15;WASF2;WASF3;PPP1R14A;PAK3;KIF14;SKA2;DLG4;NCF2;SFN;MAPK11;FMNL1;IQGAP1,313 (314),0.999,1,0,,24 (29),1,1,1,1
Gap-filling DNA repair synthesis and ligation in TC-NER,Reactome,2,POLR2D;POLR2A,66 (66),0.999,1,0,,1 (3),1,1,1,1
Mitochondrial translation,Reactome,4,MRPS31;MTIF2;GFM2;MRPL16,94 (94),0.999,1,0,,5 (49),1,1,1,1
Estrogen-dependent gene expression,Reactome,8,POLR2D;GPAM;FOSB;BCL2;POLR2A;TFF1;TFF3;RUNX1,142 (143),0.999,1,0,,5 (7),1,1,1,1
G2/M Checkpoints,Reactome,6,MCM10;MCM3;MCM4;SFN;RMI2;RAD50,119 (120),0.999,1,0,,3 (5),1,1,1,1
Dual incision in TC-NER,Reactome,2,POLR2D;POLR2A,67 (67),0.999,1,0,,3 (4),1,1,1,1
HDR through Homologous Recombination (HRR),Reactome,2,RMI2;RAD50,68 (68),0.999,1,0,,5 (9),1,1,1,1
Nonhomologous End-Joining (NHEJ),Reactome,2,XRCC5;RAD50,69 (70),0.999,1,0,,4 (7),1,1,1,1
Transcriptional Regulation by TP53,Reactome,29,DDIT4;PLK2;TAF9B;TAF3;BTG2;RRAGD;NUAK1;NELFA;SGK1;POLR2A;RGCC;POLR2D;PRKAA2;RMI2;CTDP1;PERP;BRPF1;SESN3;SESN2;PIP4K2A;TNFRSF10B;PRKAG2;MAPK11;SESN1;E2F8;PMAIP1;SFN;PRDM1;RAD50,361 (361),1,1,0,,30 (39),1,1,1,1
Senescence-Associated Secretory Phenotype (SASP),Reactome,5,CDKN2D;ANAPC10;IGFBP7;RPS6KA2;MAPK7,112 (113),1,1,0,,4 (4),1,1,1,1
Formation of a pool of free 40S subunits,Reactome,1,RPL3L,113 (113),1,1,0,,0 (0),1,1,1,1
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,5,UCP3;UQCRC2;PM20D1;NUBPL;ETFDH,113 (113),1,1,0,,17 (25),1,1,1,1
Interferon alpha/beta signaling,Reactome,2,IRF8;EGR1,72 (72),1,1,0,,4 (4),1,1,1,1
Neddylation,Reactome,16,KCTD7;SOCS2;DCUN1D4;SPSB3;PSMD1;ANKRD9;ASB4;DCAF6;KLHL41;ASB5;SOCS5;DCAF11;OBSL1;ASB2;ASB15;WDTC1,236 (236),1,1,0,,4 (4),1,1,1,1
G2/M Transition,Reactome,7,AJUBA;NINL;TUBA1A;TUBGCP5;CCP110;CSNK1E;OPTN,138 (138),1,1,0,,8 (9),1,1,1,1
Adaptive Immune System,Reactome,68,BLK;KCTD7;PRKCQ;CD34;CD3D;ANAPC10;CD300LG;TRIM63;CD8A;WAS;IKBKG;LAT;FCGR2B;CD19;NFATC2;ASB2;ASB5;RAPGEF3;SEC24A;MRC2;HECW2;CD300A;INPP5D;RASGRP3;SH3RF1;CD300LB;NFKBIA;PVR;GRAP2;ENAH;RAPGEF4;CLEC4G;BLNK;C3;PAK1;RAP1GAP2;AP1M2;PAK3;AP1S2;CD79A;CD79B;NCF2;CARD11;IGLC2;KLHL41;CTLA4;PLCG2;WWP1;PJA1;LCK;ASB15;SIPA1;CD22;BTLA;ITGAL;LNX1;UBE2U;ITGB2;ASB4;CD300E;ITGB7;VASP;VAV1;SEC23A;CD200;CHUK;ITPR3;ICAM2,719 (719),1,1,0,,27 (51),1,1,1,1
Mitotic Anaphase,Reactome,12,LMNB1;TUBB1;CENPE;TUBA1A;SKA2;INCENP;TUBB2B;ANAPC10;NUP35;LBR;POM121;NDC1,195 (195),1,1,0,,11 (14),1,1,1,1
Interferon Signaling,Reactome,9,IRF8;TRIM8;CIITA;EGR1;FLNA;CAMK2A;IFNGR1;TRIM2;TRIM35,162 (162),1,1,0,,6 (12),1,1,1,1
Gene Silencing by RNA,Reactome,7,DROSHA;POLR2A;POLR2D;NUP35;NDC1;POM121;IPO8,139 (140),1,1,0,,5 (8),1,1,1,1
PKMTs methylate histone lysines,Reactome,2,PRDM16;ATF7IP,73 (73),1,1,0,,2 (2),1,1,1,1
Mitochondrial translation termination,Reactome,3,MRPS31;GFM2;MRPL16,88 (88),1,1,0,,3 (26),1,1,1,1
Mitochondrial translation initiation,Reactome,3,MRPS31;MTIF2;MRPL16,88 (88),1,1,0,,5 (9),1,1,1,1
UCH proteinases,Reactome,4,TGFBR2;KDM1B;PSMD1;FOXK1,102 (102),1,1,0,,1 (3),1,1,1,1
Mitotic Metaphase and Anaphase,Reactome,12,LMNB1;TUBB1;CENPE;TUBA1A;SKA2;INCENP;TUBB2B;ANAPC10;NUP35;LBR;POM121;NDC1,196 (196),1,1,0,,11 (14),1,1,1,1
Mitotic G2-G2/M phases,Reactome,7,AJUBA;NINL;TUBA1A;TUBGCP5;CCP110;CSNK1E;OPTN,140 (140),1,1,0,,8 (9),1,1,1,1
Respiratory electron transport,Reactome,3,NUBPL;UQCRC2;ETFDH,89 (89),1,1,0,,13 (17),1,1,1,1
Complex I biogenesis,Reactome,1,NUBPL,57 (57),1,1,0,,2 (3),1,1,1,1
mRNA 3_-end processing,Reactome,1,MAGOHB,58 (58),1,1,0,,1 (3),1,1,1,1
Reproduction,Reactome,4,HVCN1;CATSPER2;SYCP2;CATSPERD,105 (106),1,1,0,,9 (11),1,1,1,1
Role of phospholipids in phagocytosis,Reactome,4,PLCG2;PLPP5;IGLC2;ITPR3,105 (105),1,1,0,,11 (13),1,1,1,1
SRP-dependent cotranslational protein targeting to membrane,Reactome,1,RPL3L,123 (123),1,1,0,,0 (2),1,1,1,1
Oxidative phosphorylation - Homo sapiens (human),KEGG,6,COX7A1;LHPP;PPA1;UQCRC2;ATP6V0E2;COX6A2,133 (133),1,1,0,,14 (16),1,1,1,1
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Reactome,3,THBS1;PRKCQ;RUNX1,94 (95),1,1,0,,2 (2),1,1,1,1
Systemic lupus erythematosus - Homo sapiens (human),KEGG,6,C3;C6;C7;C8A;C8B;C9,134 (136),1,1,0,,2 (3),1,1,1,1
Oxidative phosphorylation,Wikipathways,1,GZMB,61 (61),1,1,0,,5 (5),1,1,1,1
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,2,POLR2D;POLR2A,79 (79),1,1,0,,5 (7),1,1,1,1
G2/M DNA damage checkpoint,Reactome,3,SFN;RMI2;RAD50,95 (96),1,1,0,,3 (4),1,1,1,1
Protein ubiquitination,Reactome,2,PEX13;PEX5,80 (80),1,1,0,,4 (4),1,1,1,1
RHO GTPases activate PKNs,Reactome,3,KDM4C;PPP1R14A;SFN,96 (97),1,1,0,,14 (15),1,1,1,1
rRNA processing,Reactome,1,MTERF4,63 (64),1,1,0,,3 (11),1,1,1,1
Cleavage of the damaged pyrimidine ,Reactome,1,MBD4,64 (65),1,1,0,,5 (11),1,1,1,1
Depyrimidination,Reactome,1,MBD4,64 (65),1,1,0,,5 (11),1,1,1,1
Proteasome Degradation,Wikipathways,1,PSMD1,64 (64),1,1,0,,1 (1),1,1,1,1
Cellular Senescence,Reactome,10,MAPK11;ETS2;CDKN2D;CBX6;IGFBP7;RPS6KA2;ANAPC10;RAD50;MAPK7;KDM6B,186 (187),1,1,0,,9 (13),1,1,1,1
RNA transport - Homo sapiens (human),KEGG,10,EEF1A2;MAGOHB;GEMIN2;GEMIN5;RPP40;NUP35;NDC1;POM121;XPOT;EIF4EBP3,186 (186),1,1,0,,2 (3),1,1,1,1
Amyotrophic lateral sclerosis - Homo sapiens (human),KEGG,27,TUBB1;NEFH;DNAH2;OPTN;NDC1;UBQLN1;MAPK12;POM121;NRG4;TUBA1A;COX6A2;GPX3;COX7A1;ACTG1;PSMD1;CAT;BCL2;TUBB2B;DNAL1;UQCRC2;MAPK11;MAPK13;SLC1A2;DNAH14;CASP12;NUP35;ITPR3,364 (364),1,1,0,,10 (14),1,1,1,1
Huntington disease - Homo sapiens (human),KEGG,21,DNAH2;SLC25A4;POLR2A;TUBA1A;SLC1A3;SLC1A2;PSMD1;COX7A1;DLG4;CREB3L3;DNAH14;TUBB1;HIP1;TUBB2B;KCNJ10;UQCRC2;DNAL1;PLCB4;COX6A2;POLR2D;GPX3,306 (306),1,1,0,,5 (6),1,1,1,1
mRNA Splicing - Major Pathway,Reactome,3,POLR2D;MAGOHB;POLR2A,177 (177),1,1,0,,0 (2),1,1,1,1
Ribosome - Homo sapiens (human),KEGG,2,RPL3L;MRPL16,158 (158),1,1,0,,0 (0),1,1,1,1
Base-Excision Repair_ AP Site Formation,Reactome,1,MBD4,66 (67),1,1,0,,9 (18),1,1,1,1
EML4 and NUDC in mitotic spindle formation,Reactome,3,SKA2;INCENP;CENPE,100 (100),1,1,0,,2 (3),1,1,1,1
RNA Polymerase II Transcription Termination,Reactome,1,MAGOHB,67 (67),1,1,0,,1 (6),1,1,1,1
Ub-specific processing proteases,Reactome,12,TAF9B;IKBKG;CCP110;PSMD1;USP13;NFKBIA;SMAD3;SMAD1;ARRB1;ARRB2;ADRB2;RNF128,214 (214),1,1,0,,1 (2),1,1,1,1
Initial triggering of complement,Reactome,3,IGLC2;MASP2;C3,102 (102),1,1,0,,4 (11),1,1,1,1
DNA methylation,Reactome,1,UHRF1,68 (69),1,1,0,,3 (5),1,1,1,1
Selenocysteine synthesis,Reactome,3,SEPHS2;RPL3L;SEPSECS,103 (103),1,1,0,,13 (20),1,1,1,1
Metabolism of proteins,Reactome,207,B4GALT2;GALNT15;THSD4;CCP110;NRIP1;ADAMTS5;HIC1;TSPAN15;ADRB2;GALNT3;B3GNT5;B3GNT3;NGLY1;SPP1;SPON1;ANKRD9;SEC24A;VNN3;SPTBN2;PENK;GAS6;VWA1;GATA6;CD55;BACE1;PEX13;PSMD1;BCHE;KLHL41;TUBB2B;USP13;IZUMO1R;ACE;GCNT4;ADAM10;F5;GALNT18;GALNT16;F8;F9;ITIH2;B4GALT6;PGM3;TUBB1;QSOX1;MFGE8;FBN1;PROZ;POM121;MIA2;GPC3;SATB1;MRPL16;HRC;TUBA1A;ADAMTS9;ASB5;BST1;VNN1;THSD7A;RAB30;PGAP1;NFKBIA;GFM2;FN1;CMA1;ADAMTS15;FGA;AHSG;PEX5;CHRDL1;DCUN1D4;C3;SPARCL1;RAB7B;MME;MMP2;CKAP4;CREB3L3;PLG;COG5;RNF128;GNG11;GNGT2;ADAMTSL4;ASB4;SDC2;SPSB3;FOXK1;RECK;KNG1;SEC23A;LTBP1;B3GNT7;VDR;ALB;PPA1;KCTD7;LMCD1;GPLD1;SEC16B;HSPG2;PIGL;MIA3;DCAF11;SOCS2;ADAMTSL1;KIFC3;FGG;ANK1;ANK2;ANPEP;GNE;ADAMTS2;ADAMTS1;APOA5;LONP2;TNC;MAN1C1;ADORA2B;FN3KRP;MXRA8;RCN1;OBSL1;APCS;MRPS31;LAMB1;LAMB2;LAMC1;CP;SEMA5A;GALNT12;CPB2;APOB;CPE;ADAMTS8;AMFR;PPARA;PRSS23;ASB15;APP;GNG2;ST8SIA3;RAB6B;AP3M1;HDAC7;ETFBKMT;TSPAN5;NARS2;LGALS1;ARSG;NUP35;TTLL7;EEF1A2;ADAMTS10;SLC17A5;TGFBR2;RAB36;THBS1;IARS2;ARRB1;ARRB2;NDC1;IGFALS;THRB;SEC22C;LMAN1;IKBKG;TAF9B;IGFBP6;IGFBP7;ART3;DCAF6;USO1;IGFBP1;RAB27B;MTIF2;FOLR2;THY1;VCAN;SOCS5;GNB5;FSTL1;PLET1;RAB15;PAPPA;SERPINC1;ST6GALNAC4;SERPINA10;KDM1B;GALNT6;CPA3;ASB2;SPTB;FUT8;MUC1;MDGA1;RPL3L;SERPIND1;RAB20;ST3GAL2;SMAD1;ADAMTSL2;SMAD3;ALG13;SORL1;WDTC1,1934 (1935),1,1,0,,131 (288),1,1,1,1
mRNA Splicing,Reactome,3,POLR2D;MAGOHB;POLR2A,185 (185),1,1,0,,0 (3),1,1,1,1
Mitochondrial translation elongation,Reactome,2,MRPS31;MRPL16,88 (88),1,1,0,,3 (28),1,1,1,1
S Phase,Reactome,3,ANAPC10;MCM3;MCM4,104 (104),1,1,0,,17 (21),1,1,1,1
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Reactome,1,KDM4C,70 (71),1,1,0,,10 (11),1,1,1,1
Role of LAT2/NTAL/LAB on calcium mobilization,Reactome,2,IGLC2;GAB2,92 (92),1,1,0,,3 (7),1,1,1,1
Resolution of Sister Chromatid Cohesion,Reactome,3,SKA2;INCENP;CENPE,109 (109),1,1,0,,6 (8),1,1,1,1
RMTs methylate histone arginines,Reactome,1,SMARCA2,74 (74),1,1,0,,4 (4),1,1,1,1
Oxidative Stress Induced Senescence,Reactome,4,MAPK11;CDKN2D;CBX6;KDM6B,124 (125),1,1,0,,7 (9),1,1,1,1
TCF dependent signaling in response to WNT,Reactome,9,CCDC88C;FZD4;SOX4;FZD8;RSPO3;SOX7;CSNK1E;CHD8;SFRP1,190 (191),1,1,0,,9 (11),1,1,1,1
Parkinson disease - Homo sapiens (human),KEGG,14,MAOB;COX7A1;TUBB1;TUBA1A;SLC25A4;SLC18A1;PSMD1;CAMK2A;GNAI1;DUSP1;TUBB2B;UQCRC2;COX6A2;ITPR3,249 (249),1,1,0,,19 (21),1,1,1,1
Creation of C4 and C2 activators,Reactome,2,IGLC2;MASP2,95 (95),1,1,0,,3 (10),1,1,1,1
PRC2 methylates histones and DNA,Reactome,1,MTF2,76 (77),1,1,0,,2 (3),1,1,1,1
Mitotic Prometaphase,Reactome,9,INCENP;NINL;CENPE;TUBGCP5;CCP110;SKA2;CSNK1E;TUBA1A;NCAPD2,192 (192),1,1,0,,6 (8),1,1,1,1
Class I MHC mediated antigen processing & presentation,Reactome,20,KCTD7;CHUK;TRIM63;IKBKG;ASB5;HECW2;SEC24A;MRC2;LNX1;NCF2;ASB4;WWP1;KLHL41;SEC23A;ANAPC10;PJA1;ASB2;ASB15;SH3RF1;UBE2U,316 (316),1,1,0,,14 (21),1,1,1,1
Infectious disease,Reactome,65,GNB5;IFNGR1;ADORA2B;PACS1;CORO1A;PLK2;ADCY4;TAF3;ADRB2;ABL1;NDC1;POM121;RAMP2;WAS;TAF9B;P2RX7;PRKAR2A;PTH1R;LCK;PRKAR1B;CXCR4;NELFA;HBEGF;DPEP1;WASF2;PYCARD;NMT2;POLR2A;SYT1;POLR2D;WASF3;GNG2;ANTXR1;ENTPD5;CTDP1;FXYD6;AP1M2;ACTG1;SCTR;AP1S2;SLC25A4;C3AR1;IGLC2;ST3GAL2;C3;ASB15;NUP35;PLCG2;TLR9;FGR;ATP1A2;XRCC5;IL1B;GNG11;GNGT2;PTGIR;ADCY2;CCR5;ST6GALNAC4;VAV1;ADCY9;GGT1;VPS37A;MVB12B;ITPR3,750 (750),1,1,0,,75 (127),1,1,1,1
Nucleotide Excision Repair,Reactome,2,POLR2D;POLR2A,97 (97),1,1,0,,7 (10),1,1,1,1
Processing of DNA double-strand break ends,Reactome,2,RMI2;RAD50,98 (99),1,1,0,,7 (10),1,1,1,1
Meiosis,Reactome,1,SYCP2,79 (80),1,1,0,,4 (6),1,1,1,1
Organelle biogenesis and maintenance,Reactome,12,SCLT1;MAPK11;NINL;TUBA1A;CCP110;CSNK1E;SIRT5;ALAS1;GLUD1;PRKAA2;MAPK12;PRKAG2,231 (231),1,1,0,,13 (16),1,1,1,1
Separation of Sister Chromatids,Reactome,4,ANAPC10;SKA2;INCENP;CENPE,130 (130),1,1,0,,2 (4),1,1,1,1
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Reactome,3,RPL3L;SMG9;MAGOHB,117 (117),1,1,0,,3 (5),1,1,1,1
Nonsense-Mediated Decay (NMD),Reactome,3,RPL3L;SMG9;MAGOHB,117 (117),1,1,0,,3 (5),1,1,1,1
Mitotic Prophase,Reactome,5,LMNB1;NDC1;USO1;POM121;NUP35,147 (148),1,1,0,,16 (19),1,1,1,1
Eukaryotic Translation Elongation,Reactome,2,RPL3L;EEF1A2,105 (105),1,1,0,,3 (26),1,1,1,1
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,14,KCTD7;TRIM63;UBE2U;ASB5;HECW2;ASB4;WWP1;KLHL41;LNX1;ANAPC10;PJA1;ASB2;ASB15;SH3RF1,265 (265),1,1,0,,4 (5),1,1,1,1
DNA Double-Strand Break Repair,Reactome,6,XRCC5;EYA4;ABL1;EYA2;RMI2;RAD50,168 (169),1,1,0,,12 (17),1,1,1,1
FCGR activation,Reactome,1,IGLC2,88 (88),1,1,0,,2 (3),1,1,1,1
Response of EIF2AK4 (GCN2) to amino acid deficiency,Reactome,2,RPL3L;ATF3,111 (111),1,1,0,,2 (4),1,1,1,1
Cellular response to starvation,Reactome,4,RRAGD;ATP6V0E2;RPL3L;ATF3,145 (145),1,1,0,,6 (8),1,1,1,1
Base Excision Repair,Reactome,1,MBD4,93 (94),1,1,0,,15 (26),1,1,1,1
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Reactome,3,ABL1;RMI2;RAD50,133 (134),1,1,0,,8 (13),1,1,1,1
Deubiquitination,Reactome,15,TAF9B;KDM1B;IKBKG;FOXK1;TGFBR2;CCP110;PSMD1;USP13;NFKBIA;SMAD3;SMAD1;ARRB1;ARRB2;ADRB2;RNF128,290 (290),1,1,0,,3 (10),1,1,1,1
Cellular responses to stress,Reactome,40,CDKN2D;ETS2;HSPA12A;ANAPC10;ATF5;NDC1;POM121;RRAGD;IGFBP7;CBX6;CAMK2A;SERPINH1;RPS6KA2;ATP6V0E2;TLR4;GPX3;CLEC1B;NOX4;CAT;NCF2;APOB;ATF3;ALB;PPARA;BAG4;MAPK7;KDM6B;MAPK11;AJUBA;HSPA12B;HSPA1A;HSPA1B;HSPA1L;RPL3L;HSPA9;HSPB1;PRDX6;CHAC1;NUP35;RAD50,553 (554),1,1,0,,55 (74),1,1,1,1
Cellular responses to external stimuli,Reactome,41,CDKN2D;ETS2;HSPA12A;ANAPC10;ATF5;NDC1;POM121;RRAGD;IGFBP7;CBX6;CAMK2A;SERPINH1;RPS6KA2;CSRP1;ATP6V0E2;TLR4;GPX3;CLEC1B;NOX4;CAT;NCF2;APOB;ATF3;ALB;PPARA;BAG4;MAPK7;KDM6B;MAPK11;AJUBA;HSPA12B;HSPA1A;HSPA1B;HSPA1L;RPL3L;HSPA9;HSPB1;PRDX6;CHAC1;NUP35;RAD50,568 (569),1,1,0,,57 (76),1,1,1,1
Peptide chain elongation,Reactome,1,RPL3L,100 (100),1,1,0,,3 (26),1,1,1,1
Homology Directed Repair,Reactome,3,ABL1;RMI2;RAD50,139 (140),1,1,0,,8 (13),1,1,1,1
Eukaryotic Translation Termination,Reactome,1,RPL3L,103 (103),1,1,0,,6 (11),1,1,1,1
HATs acetylate histones,Reactome,3,MBIP;BRPF1;KAT7,142 (142),1,1,0,,2 (2),1,1,1,1
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Reactome,1,RPL3L,105 (105),1,1,0,,1 (3),1,1,1,1
Cilium Assembly,Reactome,5,SCLT1;CCP110;CSNK1E;TUBA1A;NINL,178 (178),1,1,0,,6 (8),1,1,1,1
Cell Cycle Checkpoints,Reactome,10,INCENP;CENPE;RMI2;SKA2;MCM3;MCM4;ANAPC10;SFN;MCM10;RAD50,248 (249),1,1,0,,3 (5),1,1,1,1
Epigenetic regulation of gene expression,Reactome,2,UHRF1;MTF2,139 (140),1,1,0,,13 (22),1,1,1,1
L13a-mediated translational silencing of Ceruloplasmin expression,Reactome,1,RPL3L,123 (123),1,1,0,,3 (5),1,1,1,1
GTP hydrolysis and joining of the 60S ribosomal subunit,Reactome,1,RPL3L,124 (124),1,1,0,,3 (6),1,1,1,1
mRNA Processing,Wikipathways,1,POLR2A,127 (127),1,1,0,,2 (2),1,1,1,1
Cap-dependent Translation Initiation,Reactome,1,RPL3L,131 (131),1,1,0,,5 (8),1,1,1,1
Eukaryotic Translation Initiation,Reactome,1,RPL3L,131 (131),1,1,0,,5 (8),1,1,1,1
Generic Transcription Pathway,Reactome,93,ERBB2;PLK2;PPARA;ABL1;SPI1;ESRRB;GATA2;PERP;MAML1;ITGAL;TNFRSF10B;NR4A1;ITGA5;KLF4;PRKAA2;HNF4A;SESN1;MEF2C;PRDM1;BLK;ITGBL1;BTG2;RRAGD;NUAK1;NFATC2;BRPF1;PVALB;PIP4K2A;TRIM63;SESN2;PRKAG2;MMP13;TAL1;KIT;NR1I3;NR1H4;PMAIP1;NOTCH4;SFN;COL1A1;HSPD1;DDIT4;RARG;NELFA;SGK1;CAMK2A;WWP1;POLR2A;RGCC;POLR2D;RMI2;MAMLD1;SESN3;GPAM;CAT;WWTR1;CAV1;LBR;PPARD;RUNX1;RUNX3;HDAC7;ZFP37;E2F8;LGALS3;CITED4;RAD50;HIVEP3;RSPO3;LIFR;THBS1;TAF3;IGFBP1;TAF9B;ABCA6;THRB;CBX6;RBFOX1;RBPJ;CTDP1;PLXNA4;SMARCA2;CLDN5;PRKCQ;CTLA4;PAX5;MAPK11;VDR;PCK1;SMAD1;SMAD3;SMAD6;MAF,1177 (1178),1,1,0,,41 (55),1,1,1,1
M Phase,Reactome,19,LMNB1;TUBB1;NINL;TUBA1A;USO1;CENPE;CCP110;SKA2;CSNK1E;INCENP;KIF23;ANAPC10;TUBGCP5;NUP35;NDC1;POM121;LBR;NCAPD2;TUBB2B,382 (383),1,1,0,,22 (26),1,1,1,1
Cell Cycle_ Mitotic,Reactome,28,TUBB1;CDKN2D;CCP110;KIF23;ANAPC10;ABL1;NDC1;POM121;LMNB1;INCENP;TUBA1A;USO1;CSNK1E;DHFR;NCAPD2;NINL;SKA2;MCM3;MCM4;TUBB2B;LBR;MCM10;AJUBA;CENPE;TUBGCP5;CDC14A;NUP35;OPTN,523 (524),1,1,0,,34 (40),1,1,1,1
RNA Polymerase II Transcription,Reactome,96,ERBB2;PLK2;PPARA;ABL1;SPI1;ESRRB;GATA2;PERP;MAML1;ITGAL;TNFRSF10B;NR4A1;ITGA5;KLF4;PRKAA2;HNF4A;SESN1;MEF2C;PRDM1;BLK;ITGBL1;BTG2;RRAGD;NUAK1;NFATC2;BRPF1;PVALB;PIP4K2A;TRIM63;MLLT3;SESN2;PRKAG2;MMP13;TAL1;KIT;NR1I3;NR1H4;PMAIP1;NOTCH4;SFN;COL1A1;HSPD1;DDIT4;RARG;NELFA;SGK1;CAMK2A;WWP1;POLR2A;RGCC;POLR2D;RMI2;MAMLD1;MAGOHB;POU2F2;GPAM;CAT;WWTR1;CAV1;LBR;PPARD;RUNX1;RUNX3;HDAC7;ZFP37;E2F8;LGALS3;CITED4;RAD50;HIVEP3;RSPO3;LIFR;THBS1;TAF3;IGFBP1;TAF9B;ABCA6;SESN3;THRB;CBX6;RBFOX1;RBPJ;CTDP1;PLXNA4;SMARCA2;CLDN5;PRKCQ;CTLA4;PAX5;MAPK11;VDR;PCK1;SMAD1;SMAD3;SMAD6;MAF,1306 (1307),1,1,0,,44 (62),1,1,1,1
Translation,Reactome,9,MRPS31;MRPL16;RPL3L;IARS2;MTIF2;NARS2;GFM2;PPA1;EEF1A2,307 (307),1,1,0,,29 (80),1,1,1,1
Herpes simplex virus 1 infection - Homo sapiens (human),KEGG,14,IL1B;BAK1;IFNGR1;IKBKG;CARD9;CCL2;POU2F2;C3;ZFP37;BCL2;NFKBIA;TLR9;CHUK;ITGA5,498 (498),1,1,0,,1 (3),1,1,1,1
Processing of Capped Intron-Containing Pre-mRNA,Reactome,6,MAGOHB;POLR2A;POLR2D;NUP35;NDC1;POM121,241 (241),1,1,0,,3 (7),1,1,1,1
DNA Repair,Reactome,9,XRCC5;MBD4;POLR2A;EYA4;ABL1;POLR2D;EYA2;RMI2;RAD50,322 (323),1,1,0,,38 (54),1,1,1,1
Chromatin modifying enzymes,Reactome,10,SMARCA2;PRDM16;KAT7;PADI2;KDM4C;MBIP;ATF7IP;BRPF1;KDM1B;KDM6B,271 (271),1,1,0,,15 (17),1,1,1,1
Gene expression (Transcription),Reactome,104,ERBB2;PLK2;CAV1;ABL1;SPI1;ESRRB;GATA2;PERP;MAML1;TNFRSF10B;NR4A1;ITGA5;KLF4;ITGAL;HNF4A;SESN1;MEF2C;PRDM1;BLK;ITGBL1;BTG2;POM121;PRKAA2;RRAGD;NUAK1;NFATC2;BRPF1;PVALB;PIP4K2A;TRIM63;MLLT3;SESN2;NUP35;PRKAG2;MMP13;TAL1;KIT;NR1I3;NR1H4;PMAIP1;NOTCH4;SFN;COL1A1;HSPD1;CAVIN1;DDIT4;RARG;IPO8;MTF2;NELFA;SGK1;CAMK2A;WWP1;POLR2A;RGCC;POLR2D;RMI2;MAMLD1;SESN3;POU2F2;GPAM;CAT;WWTR1;PPARA;LBR;PPARD;RUNX1;RUNX3;HDAC7;ZFP37;E2F8;LGALS3;TAF3;RAD50;HIVEP3;RSPO3;LIFR;THBS1;CITED4;NDC1;THRB;TAF9B;ABCA6;MAGOHB;IGFBP1;CBX6;DROSHA;RBFOX1;RBPJ;CTDP1;PLXNA4;SMARCA2;UHRF1;CLDN5;PRKCQ;CTLA4;PAX5;MAPK11;VDR;PCK1;SMAD1;SMAD3;SMAD6;MAF,1438 (1439),1,1,0,,49 (74),1,1,1,1
Chromatin organization,Reactome,10,SMARCA2;PRDM16;KAT7;PADI2;KDM4C;MBIP;ATF7IP;BRPF1;KDM1B;KDM6B,271 (271),1,1,0,,15 (17),1,1,1,1
Cell Cycle,Reactome,32,TUBB1;CDKN2D;CCP110;SYCP2;KIF23;ANAPC10;ABL1;NDC1;POM121;LMNB1;INCENP;TUBA1A;USO1;CSNK1E;DHFR;OPTN;RMI2;NCAPD2;NINL;SKA2;MCM3;MCM4;TUBB2B;LBR;MCM10;AJUBA;CENPE;TUBGCP5;CDC14A;NUP35;SFN;RAD50,621 (622),1,1,0,,35 (44),1,1,1,1
Sensory Perception,Reactome,30,CACNA1D;EPS8;KCNMB1;RIPOR2;CLIC5;GPC3;RDH16;XIRP2;KCNQ4;NMT2;TPRN;AKR1B10;GNB5;HSPG2;KCNN2;SDC3;TWF2;APOA4;APOB;PRKCQ;GNAT1;EPB41L3;RETSAT;SDC1;SDC2;EPS8L2;EPB41L1;MSN;GSN;BCO1,585 (585),1,1,0,,49 (69),1,1,1,1
Olfactory transduction - Homo sapiens (human),KEGG,4,ARRB1;ARRB2;NCALD;CAMK2A,440 (443),1,1,0,,8 (8),1,1,1,1